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A Tribute to Walter Hines Page
Walter H. Page retired in November as chairman of the Board of Trustees,
concluding 25 years of active service to the Laboratory and a legacy of family
stewardship stretching unbroken for more than 60 years.
The Page family's commitment to science at Cold Spring Harbor began in 1924
when Walter's father, Arthur W. Page, became a founding director of the Long
Island Biological Association (LIBA). Including 13 years as president, Arthur Page
served continuously on the LIBA board until 1958, when Walter became president.
Jane Nichols Page (Walter's wife) was LIBA vice-president from 1952-1958. In
1962, Walter led negotiations that culminated in the merger of the Biological
Laboratory and the neighboring Carnegie Department of Genetics to form what
we now know as Cold Spring Harbor Laboratory. In 1972, he helped bring into
existence the Robertson Research Fund, the Laboratory's major endowment. He
was elected chairman of the Board of Trustees in 1980.
Born in nearby Huntington, Walter attended Milton Academy and graduated
from Harvard University in 1937. Choosing a career in banking, he served the
Morgan Bank and its successor, the Morgan Guaranty Trust Company, at home
and abroad until his retirement in 1979 as chairman of the board. He also served
as director of numerous companies, including United States Steel Corporation, the
Royal Group, Inc., and the Saudi International Bank.
Over the years, the Laboratory has benefited from the counsel of this truly wise
man and from his consummate business acumen. We look forward to his
continued advice as an honorary trustee and caring neighbor.

DIRECTOR'S
REPORT
Our genetic uniqueness, like that of all other forms of life, is determined by the
information present in DNA, the chromosomally located chemical substance out of
which our genes are made. Encoded within the sequences of the four nucleotide
bases (A, G, C, and T) that are used to construct all DNA molecules are the
instructions to make the very large numbers of specific proteins found in all cells.
These proteins, many of them enzymes, make possible the orderly growth and
multiplication of all cells as well as the developmental progression of fertilized eggs
into multicellular organisms.
That DNA plays such a central role in cellular existence only became unambig-
uously clear in 1953. Until then, most chemically oriented biologists still thought
that genetic specificity resided in the protein component of chromosomes. This
belief persisted despite the key 1944 announcement that bacteria could be
genetically transformed by the addition of pure DNA. At that time, however, the
relationship of bacteria to other forms of life was very unclear, leaving open the
question of whether DNA also carried the genetic instructions of higher cells.
Serious arguments about the chemical identity of genes ended when the double
helix was found to possess the essential attribute of a genetic molecule, a
structure that allows its accurate copying to yield progeny molecules identical in
structure to that of the parental DNA.
In the now over 30 years that have elapsed since the finding of the double
helix, all the general principles that underlie the functioning of DNA within cells
have been established. The genetic information within DNA is used not only to
make progeny DNA molecules, but also to make RNA, a second form of nucleic
acid that utilizes essentially the same four-letter alphabet used by DNA. RNA
molecules in turn serve as the source of information to order the 20 different
amino acids that are used to construct the polypeptide chains of proteins. Once
we learned how DNA works, the nature of genes, the genetic determinants first
found by Mendel, became clear at the molecular level. A gene is a linearly
contiguous group of nucleotide bases within a DNA molecule that specifies the
sequence of a specific polypeptide chain. The number of different genes located
along a DNA molecule varies greatly from only a few for the smaller viral DNA
molecules to many thousands along the much larger chromosomes of higher
organisms. As far as we know, only one DNA molecule is found within a given
chromosome. The DNA molecules isolated from very big chromosomes are thus
much larger than those of small chromosomes.
The simplest cells, those of bacteria, contain only one type of DNA molecule.
They each encode from 1 to some 5000 different genes. Many more genes are
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needed to code for the much larger number of proteins that underlie the existence
of the much more complex higher plants and animals. The genetic information of
each human being, for example, is carried by 46 DNA molecules, 23 from the
male parent and 23 from the female parent. Except for the X and Y sex
chromosomes, each chromosome contributed by the male parent is equivalent in
size and function to one contributed by the female parent (homologous
chromosomes). There thus exist 24 different types of human chromosomes, 22
autosomes (non-sex chromosomes), 1 X chromosome, and 1 Y chromosome.
The total number of human genes dispersed on the corresponding 24 different
human DNA molecules is far from known. Until now, only some 1000 different
proteins have been assigned to specific chromosomes. Arguing from the size of
known genes, however, we can predict that at least 50,000 different human genes
exist, and few human geneticists will be surprised if the total finally established
does not exceed 100,000 genes. Until the advent of recombinant DNA
procedures, and the powerful new procedures for sequencing DNA, the molecular
nature of these genes was not open to analysis. Now, however, given the
possession of a relatively small amount of the protein product, procedures exist for
the virtual routine cloning and subsequent sequencing of the corresponding gene.
Already more than a hundred different human genes have been cloned and over
a million base pairs of human DNA sequences are now known. Although this is a
large number, it still is only 1/3000 of the total human genome (3x109). Even with a
steady increase in the rate at which new genes are cloned, we would not expect
to see the whole human genome established in much less than 50 years from
now.
To achieve this goal much faster, say by the turn of this century, will require a
highly organized and focused effort of a magnitude that the world of molecular
biology has not yet experienced. Conceivably, a sum of several billion dollars and
some 30,000 scientist-years would be consumed by the project. So the human
genome project strikes many biologists as a form of big science that cannot be
organized with effective peer review. They worry that it might run badly out of
control, using up sums of money so large that it would necessarily have a
negative impact on the rate at which we go about solving fundamental biological
problems.
Human geneticists, however, have a very different perspective. To them, the
possession of the complete human DNA sequence would be a resource of
inestimable value. So they are much less concerned about altering the way their
science is done. To have it within our grasp and not go for it strikes them as an
act of gross irresponsibility to society. Given the human DNA sequence, the
finding and understanding of the many genes underlying currently intractable
diseases like the various cancers, schizophrenia, cystic fibrosis, and muscular
dystrophy would certainly be accelerated.
This extraordinary potential for understanding so many important diseases at
the genetic level has only come about over the past decade. Until very recently,
the inherently nonexperimental nature of human genetics has made it lag far
behind the genetics of the experimentally much more malleable organisms like E.
coli, the yeasts, Drosophila, and the mouse. It was not until 1968 that the first
human gene was mapped to an autosome. Human genetics only began to take
off with the development of somatic cell hybridization techniques, as well as the
working out of powerful cytogenetic techniques which revealed discrete banding
patterns that allowed the characterization of each human chromosome. Now the
pace at which new genetic diseases can be identified and then mapped goes
even faster because of the application of recombinant DNA procedures. As soon
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as a gene is cloned the resulting DNA probes can be used to assign a location
on a precise chromosome.
There furthermore exist many human "gene libraries': each made up of a very
large number of human DNA fragments (members) individually inserted into
autonomously replicating DNA molecules (vectors). The size of the library needed
to carry the human genome depends upon the length of the DNA inserted into
the DNA vector. Most existing gene libraries were made with approximately 5x104 -
base -pair segments inserted into the so-called cosmid vectors. To effectively
encompass the human genome of 3x109 base pairs, library sizes of greater than
105 members are needed to statistically ensure that virtually all the human
genome is on hand. Although the making of such a gene library is virtually
routine, the exact ordering of these library members is a manyfold more challeng-
ing task. Only over the past several years have techniques begun to be developed
to achieve this goal. Particularly crucial will be the new pulsed-field gel
electrophoretic procedures for separating megabase-size (106) DNA fragments as
well as the development of artificial yeast chromosome vectors into which these
megabase fragments can be stably cloned. Given the routine employment of such
megabase vector systems, the size of the human gene library can be reduced to
only several thousand members, thereby greatly reducing the task first of
assigning them to separate human chromosomes (regions) and then of determin-
ing their exact order along their respective chromosomes.
Equally important, recombinant DNA procedures can now generate a very
large number of new genetic markers to be used in family linkage studies. These
markers reflect the very large numbers of differences (polymorphisms) in
nucleotide sequence that characterize the genomes of all organisms. These
variations generate differences in the DNA-cutting patterns made by different
DNA-cutting (restriction) enzymes. Already, restriction fragment length polymor-
phisms (RFLPs, sometimes pronounced "riflips") have been used to allow the first
mapping of the mutant genes responsible for Huntington's disease and cystic
fibrosis.
The way has thus been opened up not only for prenatal diagnosis, but also for
the eventual isolation of the respective disease-causing genes and the working out
of their biochemical functioning. Because polymorphisms in DNA sequences are
so common, a large number of RFLP probes can be made for any desired
chromosomal segment. They now provide a way to map genetically the human
genome to a much higher resolution than can ever be provided by genetic
markers that reflect protein differences. Through the possession of only several
hundred RFLP markers randomly dispersed over the 24 human chromosomes, it
should be possible to find the appropriate location of almost any simple genetic
disease for which family linkage studies exist. And through the possession of
tenfold more RFLPs, these traits can be mapped to within the 1 megabase (107
bases) lengths that soon we will be able to clone using newly developed artificial
yeast chromosome vectors.
The time will thus soon be at hand when it will be possible to make an overlap-
ping set of cloned DNA fragments that collectively encompass each of the 24
human chromosomes. To do so will require an organized effort reaching over 3 to
6 years and costing some 25-50 million dollars. When this job is done, the
appropriate DNA will be available for analysis as soon as a given genetic disease
has been assigned a precise map location. This DNA can then be quickly
sequenced so as to spot the gene responsible for the respective disease.
Given the ordered set of human DNA clones, the question then will arise as to
whether we should sequence them immediately or wait and see if they are
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genetically interesting before so proceeding. In part, the way we shall respond will
be a function of the cost of DNA sequencing. At today's cost of sequencing of
from 1 to 2 dollars per base pair, at least 3 billion dollars would be required. There
is every reason to believe, however, that by the time an ordered set of DNA clones
exists, the cost of sequencing may be reduced to one-fifth to one-tenth of the
present cost, if not more. If so, the mapping and sequencing of the human
genome might cost as little as a half billion dollars.
This is still a sum of money far in excess of that spent on any previous tightly
focused biological effort. Special efforts will thus have to be made first to obtain
this money and then to organize the effort so that we shall do it well, reaching our
final goals with a minimum of false starts and with a final precision we have every
reason to trust. The many obvious short-term advantages of having the set of
overlapping human DNA clones provide strong reasons for accomplishing this
mapping job as soon as possible. It will most certainly help us get much faster to
the heart of complex genetic disorders like depression, schizophrenia, and
alcoholism. We should also waste no time in quickly devoting considerable funds
toward the development of the sequencing technologies that will not only greatly
lower the final cost, but also reduce the number of highly trained scientists
needed for the project. There already is a great shortage of individuals who
manipulate DNA well. Even if all the funds were now on hand, it is far from clear
that we could ever attract that many top-flight individuals to work on a sequencing
project whose nature is highly repetitive.
Setting a completion date of not more than 15 years from now, if not by the
year 2000, may well prove necessary if we are to do the job well. Unless the goal
can be reached by those who organize the effort, the job may not be well thought
out. In any case, the total cost per year of the program is unlikely initially to be
much greater than 25-50 million dollars rising toward the end to say 100 million
dollars per year. This sum is less than 2% of today's NIH budget and most likely
would be closer to 1% of the total NIH budget when the job is done.
The real problem that faces us is thus not the cost of the Human Genome
Program, but how to get it going, seeing both that the right people are in charge
and that they work under an administrative umbrella that will not tolerate uncritical
thinking and so will never promise more than the hard facts warrant. Only a
governmental body has reason to assume that it has the means to ensure ultimate
success, and within the United States only the NIH, the NSF, and the Department
of Energy (DOE) have missions that are commensurate with their taking on a
significant role.
Until now, only the DOE has seriously considered the matter and appointed a
senior committee to give it advice. Already it has proposed to Congress that it
have the mandate to oversee the project and has requested 10 million dollars over
the next fiscal year to commence the job. The reason they give for their managing
the effort-to be able to evaluate better the damage to our genomes by environ-
mental mutagens-is forced and in fact weakens their case by making them
appear at best disingenuous and at worst stupid. A much better reason for
thinking them suitable is their past track record of managing well the construction
of so many of the large-particle accelerators needed by the physics community.
There is also the presumption that additional monies given to them would not be
taken from the pockets of NIH research grants. Despite these advantages, DOE
sponsorship nonetheless brings chills to many senior members of the DNA world.
They worry that the DOE's track record in supporting high-quality extramural
research in biology has never matched that of either the NIH or the NSF and that
their way of giving out grants in the absence of true peer selection procedures will
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inevitably lead to support of too much of the second rate. Equally disquieting to
the DNA world is the fact that none of the national labs that the DOE manages is
a leader in recombinant DNA procedures. So the DOE cannot now draw on any
deep in-house expertise to help administrate even a modestly sized human
genome effort.
A quite different set of reasons seem to preclude the NSF from taking the lead.
Its budgets for biology have never been large, and so a major Human Genome
Program would consume a dangerously large fraction of its total effort in biology.
So the success of this program might only be accomplished by harming those
other biological disciplines, like evolutionary studies, for which the NSF is the main
research support. On the other hand, the NSF's increasing preoccupation in
promoting American technological vigor argues that it should take an active role in
supporting the technological advances that will reduce the cost of mapping and
sequencing and so ensure that the budget for the Human Genome Program
never gets out of control. Clearly, the NSF should at least maintain a vigorous
junior voice within the final consortium of agencies that handle this project.
The obvious lead agency thus remains the NIH. Not only does it routinely
handle very large sums of money, but the nature of the human genome will
increasingly be at the heart of the research that it supports over the next several
decades. The diseases that it wishes to banish, if not due to infectious agents, will
more and more be shown to have their origins in the imperfections of our
individual genetic instructions. Over the long term, fighting diseases without
thinking in terms of DNA will not be the perceived correct way to proceed. We
might have thus expected that the NIH would be campaigning hard to start up a
vigorous Human Genome Program. Until now, however, no strong voice within the
NIH has emerged to whom this project would naturally be entrusted. The reason
for this apparent lack of self-interest may be AIDS. Clearly, the NIH must lead the
national challenge to control this fearsome affliction, and in a real sense its future
creditability with the American people will depend upon its ability to mount an
outstanding AIDS program that will successfully bring together the very best of our
national medical research talents. It has to put AIDS at the top of its agenda and
ensure that the massive new monies for AIDS research are spent intelligently fast
as opposed to just fast. The NIH at this moment thus may feel itself unable to give
the Human Genome Project the deep attention that it soon will need. The
question of who will manage this nation's effort thus remains unresolved.
No matter where the funds come from, the question will remain as to where
they should be used. Clearly, much of the research needed to improve current
mapping and sequencing strategies will occur in academic surroundings.
Administering these efforts should involve no difficult decisions. On the other hand,
the final hard-core mapping and sequencing tasks will best be done in large,
especially designed "production centers: Conceivably, these production centers
should be located within one or more of our national labs like Brookhaven or
Livermore. Alternatively, they could be privately owned, operating under contracts
from the appropriate funding agency. The decision between these alternatives will
hopefully rest on the inherent motivations and past track records of the key individ-
uals prepared to manage production centers. At present, there are very few
individuals qualified to run them, and we may not be able to get rolling as fast as
we might wish. So an initial early emphasis of the Human Genome Program
should be the setting up of training programs centered on mapping and sequenc-
ing procedures.
To help in the initiation and then the monitoring of an effective national
program, an ad hoc organization, that could be called the Human Genome
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Organization (USA), should be set up. Its members should include the individuals
now serving on the several national genome committees functioning in behalf of
the National Academy of Sciences, the Department of Energy, and the Office of
Technology Assessment of the U.S. Congress. Initially, this organization could
sponsor a series of small, expert meetings whose reports might prove invaluable
to the several potential funding agencies as they decide how to set up their own
respective programs. Optionally, the Human Genome Organization might be
funded from a source independent of agencies like DOE, NSF, and NIH and so
be free to persue an independent intellectual course that lets its opinions fall
where they should.
Also to be solved is how the program within the United States will be
coordinated with efforts carried out in other countries. If they wished, either
Western Europe or Japan could by themselves take on this project and it must be
assumed that they will initiate their own efforts. So a new international body should
soon be formed to ensure that collaboration, not competition, marks the relation-
ship between these efforts in various parts of the world. In a real sense, the exact
sequence of the human genome will be a resource that should belong to all
mankind. So it is a perfect project for us to pool our talents, as opposed to
increasing still further the competitive tensions between the major nations of the
world.
It is thus clear that in saying now is the time to go for the total human genome
sequence, we are taking on an effort far different from those that previously
preoccupied us. Countless planning sessions and then years of hard repetitive
work lie before us. The final goal when reached should be more than worth the
effort. In seeing the exact order of the several billion base pairs that give to us the
ultimate basis for our uniqueness, we will have reached a major milestone in
human history. The task from then on will be to learn to read these messages. In
so doing, we shall remain very intellectually challenged for many centuries still to
come.
HIGHLIGHTS OF THE YEAR
Grace Auditorium Dedicated
The dedication of the Oliver and Lorraine Grace Auditorium on June 1 marked the
beginning of the second half-century of scientific meetings at Cold Spring Harbor.
Fittingly, the ceremony was held on Sunday during the 51st Symposium on
Quantitative Biology. A standing room only crowd jammed the 360-seat facility to
hear the keynote address, "Scientists and the Future," presented by Daniel E.
Koshland, Jr., professor of biochemistry at the University of California, Berkeley,
and editor of Science.
A plaque inside the front door emphasizes that construction of the facility "was
made possible through the generosity of over 400 members of the Long Island
Biological Association, including a special gift from Lorraine and Oliver Grace'
Designed by Centerbrook Architects of Essex, Connecticut, the auditorium at
once meshes with the historic architecture of the local environment and evokes its
cosmopolitan function as a gathering place for scientists from around the world.
During its first season of use, the facility won uniform praise from meeting
participants who appreciate that the discussion of high-level science is not
inhibited by comfortable surroundings.
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In addition to its conference function, the auditorium is also "home" to 20 staff
members. On the main level is the Public Affairs Office, and on the lower level are
the Meetings Office, Samuel Freeman Computer Center, and the Quest Protein Gel
Analysis Center.
51st Symposium Focuses on Human Genetics
The choice of the sweeping topic for the 51st Symposium, "The Molecular Biology
of Homo sapiens," signified a turning point in modern biology: a time when the
extraordinary techniques of DNA research are yielding up a wealth of detailed
knowledge about the human genetic material. Human genetics was the focus of
only one of the first 50 Symposia (in 1964), but it will be a topic that will be
returned to again and again during the next half-century.
An air of excitement was palpable throughout the meeting; there was a satisfy-
ing feeling that DNA science had at last come of age. Contrary to past Symposia,
when results were most often of no immediate concern to the "average person on
the street': research team after research team presented results with significant
implications for human health.
Significant Growth of the Summer Meetings Program
Attendance at Cold Spring Harbor and Banbury meetings rose from 2900 in 1985
to 3600 in 1986-a growth of 23%. Much of this expansion can be attributed to
the predictable, annual support now provided by industry. Since inception of the
Corporate Sponsor Program in 1984, overall meeting attendance has increased
42% and corporate attendance increased 48%. Moreover, the stable base of
support offered by Sponsors has allowed us to increase by one-third the number
of meetings offered each summer.
Plant Genetics Program Gathering Critical Mass
In 1986, we reached the turning point in our effort to rebuild a major plant
genetics program at Cold Spring Harbor. With the Uplands Farm Experiment
Walter H. Page at
Grace Auditorium
dedication
Plant Genetics Lab
J. Anderson and
J. Pflugrath
Station fully operational, in the spring we broke ground for the Arthur W. and
Walter H. Page Laboratory of Plant Genetics. When the 6500-square-foot Page
Laboratory is complete in summer 1987, we will have one of the nation's best
facilities for the study of plant genetics.
The arrival of Senior Staff investigators Venkatesan Sundaresan (in December)
and Stephen Briggs (in January) substantially increased our focus on maize
genetics. Dr. Briggs, who has a joint appointment with Pioneer Hi-Bred Interna-
tional, is working to isolate genes that confer resistance to the corn pathogens,
such as southern rust. Dr. Sundaresan, who joins us from the University of Califor-
nia, Berkeley, studies the role of transposable genetic elements in corn develop-
ment. Recently appointed to join us in the fall of 1987 is Tom Peterson who will
come to us after a three-year postdoctoral period working on maize in Canberra,
Australia in the Laboratory of Jim Peacock.
X-ray Crystallography Comes to CSH
The installation of specialized equipment for X-ray analysis will soon allow us to
work out the three-dimensional configuration of DNA and protein molecules.
Already arrived to head up the Laboratory's X-ray structure group are John
Anderson, from Harvard University, and Jim Pflugrath, from the Max-Planck
Institute in Munich, Germany.
For many years, X-ray crystallography studies on macromolecules were outside
the realm of possibility for any but the largest institutions. Construction and
maintenance of X-ray generators/detectors required a full-time physicist, and
computers with sufficient power to analyze diffraction patterns could fill a room.
Now, dependable generators and detectors can be purchased "off the shelf': and
super microcomputers the size of a travel trunk provide ample computing speed.
Our move into X-ray crystallography was made possible by grants totaling over
$1 million from the Lucille P Markey Charitable Trust, the Oliver S. and Jennie R.
Donaldson Trust, and Mr. and Mrs. Oliver R. Grace. A large portion of the Hershey
building has been renovated for the X-ray structure group and includes offices, a
seminar room, and a computer suite. A "wet" lab in Demerec Laboratory provides
all equipment for protein purification and crystal preparation, with the X-ray
generator and diffraction equipment occupying adjacent rooms.
Monoclonal Antibody Agreement with Amersham International
In October, the Laboratory signed an $800,000 joint research agreement with
Amersham International plc. The five-year program, which focuses on the
production of monoclonal antibodies for research purposes, follows other research
agreements with Monsanto Company (1984, $2.06 million) and Pioneer Hi-Bred
International, Inc. (1985, $2.5 million). Amersham will have first right to license and
distribute any antibodies arising from the 20-25 cell fusions to be carried out each
year at Cold Spring Harbor utilizing Amersham funding.
With operating headquarters in Buckinghamshire, England, Amersham Interna-
tional is a major producer of research reagents, including radioactively labeled
molecules. Amersham scientist Margaret Raybuck is now working with Senior Staff
Investigator Ed Harlow, who is in charge of the monoclonal antibody facility in
Sambrook Laboratory.
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Cairns Lab
Cairns Electron Microscopy Facility in Operation
The former "mouse house" underwent a spectacular metamorphosis to become an
up-to-date electron microscopy suite. The facility is named after John Cairns, who
did elegant research here on the nature of viral chromosomes while a visiting
fellow in Alfred Hershey's Lab, and who later returned here in 1963 to function as
the director as well as to continue research on the mechanism of DNA replication.
Upon leaving here in 1973, John became the Director of the Mill Hill Laboratory of
the Imperial Cancer Research Fund, moving later to the Harvard School of Public
Health as a Professor. Recently, John was honored with a prestigious MacArthur
Fellowship in recognition of his extraordinary intellect.
Grants totaling $385,000 from the National Institutes of Health, National Science
Foundation, and the Fannie E. Rippel Foundation have made possible the
purchase of a Hitachi H-7000 microscope, to be installed in the summer of 1987. A
great improvement over the Philips 201 microscope, which has been in use at the
Laboratory for over a decade, the Hitachi instrument can produce stereo effects in
a "scanning" mode or through backscatter electron imaging.
We have also purchased a computerized image-enhancement system (similar to
those used to assemble digital information relayed from space probes) that can
make three-dimensional reconstructions, add color, and make intracellular
measurements. In addition, the microscope has a "real-time" television monitor,
which allows observers to view along with the microscope operator.
The electron microscopy facility is run by Senior Staff Investigator David
Spector, who studies the three-dimensional organization of protein and nucleic
acid molecules in the cell nucleus. Of particular interest to David is a network of
small nuclear ribonucleoprotein particles (snRNPs or "snurps") that play a major
role in the RNA splicing events that precede protein synthesis.
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We Launch a New Journal
In 1986, a plan was set in motion to publish a new journal in cooperation with the
Genetical Society of Great Britain. The title, Genes & Development, emphasizes
the relationship between gene expression and the phenotype of living things. In
casting such a broad net, we wanted a journal sympathetic to the views of both
developmental biologists and molecular geneticists. Although the tragedy of Steve
Prentis' death just prior to the appearance of the first issue of the journal in March
1987 was a shobking loss, executive editor Grahame Bulfield, editorial board
member Mike Mathews, and editor Judy Cuddihy quickly pulled together to keep
the publication on schedule. The continuous flow of high-quality papers indicates
the scientific community's commitment to keeping Steve's dream alive.
Our Scientific Friends Consider Themselves Alumni
This past summer we wrote to meeting attendees, course instructors, and former
staff members asking them to consider how their own careers had benefited from
their Cold Spring Harbor experiences and to make a commitment to ensure that
the Laboratory's position as a crossroad in science would be maintained.
Our goal is to raise $100,000 for construction of "Alumni Cabin' -one of six
eight-bed structures that will replace dilapidated structures currently used to house
summer visitors. Response to the appeal was overwhelming; by year's end, nearly
200 scientists (one in four asked!) had contributed almost $34,000 to the Alumni
Cabin Campaign. We hope that other alumni will come forward to help us reach
our goal by the time construction is complete in 1988.
Creation of the Doubleday Professorship of Cancer Research
In the fall of 1984, upon the dissolution of the Russell and Janet Doubleday Fund,
the Laboratory was given a gift of 500 shares of Doubleday & Company. At that
time, the value of the shares of the tightly held company was known to be several
hundred thousand dollars, but we in no way expected that, upon the sale of the
company to the publishing giant Bertelsmann, Inc., we would receive slightly more
than 2 million dollars for ourselves. Before receipt of the shares, we indicated to
the Doubleday Trust that we would use their funds to support a Doubleday
Professorship of Cancer Research. So in February 1987, our Trustees voted to set
aside as endowment funds 1.5 million dollars from these proceeds for that
purpose. The remaining funds have been used to purchase property virtually
surrounded by our land and which contains a house that henceforth will be
known as Doubleday Cottage. Now expanded by a previous owner, the house was
built in the early 1930s by Hugo Fricke, a scientist then on our staff who
purchased the land from the Laboratory. Originally, the Laboratory had a buy-back
right, but this restriction was dropped when Dr. Fricke left our staff at the
beginning of World War II. Our ability to regain title to this key piece of property
and the delightful house located on it is an important event for the Laboratory,
and we remain most indebted to the efforts of Edward Pulling, whose intervention
with the Doubleday Trust led to our receiving the necessary funds.
Extending Our Role as a DNA Information Center
Cold Spring Harbor is a major international center for the exchange of information
on DNA science. In the past, this information-sharing role has been primarily
confined to high-level meetings and courses for advanced students and practicing
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scientists. However, over the past several years we have moved to extend our
educational role to include other audiences that need to be brought up-to-date on
advances in DNA science.
Our DNA Literacy Program now offers hands-on training workshops for high
school and college teachers across the country. Starting this coming fall, we
intend to develop a DNA Learning Center in Cold Spring Harbor Village that will
serve as a national center to focus on the problem of biotechnological illiteracy.
Our goal is to expose the American public to the potential benefits of molecular
biology and to provide an experimental basis for the rational evaluation of biotech-
nological progress.
Changes in Our Scientific Staff
Senior Staff Scientist Jim Hicks accepted a position to head up PPG Industries'
joint research program with the Scripps Clinic and Research Foundation in La
Jolla, California. Jim joined the Laboratory as a Staff Investigator in 1978 following
a postdoctoral period in Gerald Fink's group at Cornell. He, Jeff Strathern, and
Amar Klar helped to firmly establish yeast as a major system for studying develop-
ment when they showed at the molecular level that the mating-type switches in
Saccharomyces cerevisiae are achieved through the movement of genetic
cassettes.
Three Senior Staff Investigators accepted assistant professorships in academia:
Steve Dellaporta in the Department of Biology at Yale University, David Kurtz in
the Department of Pharmacology at the University of South Carolina Medical
School, and Clive Slaughter in the Department of Biochemistry at the University of
Texas Health Science Center.
Steve, who came here to clone maize genes using the Ac transposon
methodology, was instrumental in developing our current joint research program
with Pioneer Hi-Bred International. He came to Cold Spring Harbor as a postdoc-
toral fellow in Jim Hicks' lab in 1981 from Worcester Polytechnic Institute. David,
who studied hormonal control of gene expression, joined the Laboratory as Staff
Investigator in 1979 from the Biochemistry Department of the College of Physicians
& Surgeons of Columbia University. Clive came to the Laboratory in 1984 from the
University of Texas Health Science Center to reestablish a major focus in protein
chemistry in the then-new Demerec extension. In returning to the Health Science
Center, he also assumed responsibilities as an assistant investigator at the Howard
Hughes Medical Institute.
Staff Investigator Paul Thomas, who worked out efficient systems for in vitro
translation of proteins, came to the Laboratory as a postdoctoral fellow in 1978
after receiving his Ph.D. from the University of Cambridge. He returned to his
native England to assume family responsibilities. Also leaving his Staff Investigator
position was Tohru Kataoka, who came to the Laboratory as a visiting scientist in
1983 from Osaka University, and who now has moved to an assistant professor-
ship at Harvard Medical School. Working with Mike Wig ler, Tohru cloned genes for
key proteins in the ras/cAMP pathway in the yeast Saccharomyces cerevisiae.
Staff Investigators Steve Hinton, Pablo Scolnik, and Doug Youvan left at the
conclusion of our five-year research program on genetics with Exxon Research
and Engineering Company. Steve returned to the Exxon Facility in Annandale,
New Jersey; Doug went as an assistant professor to the Massachusetts Institute of
Technology; and Pablo went to the Experimental Station of du Pont Central
Research and Development where he will continue the work he initiated here on
plant molecular biology.
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New Staff Members
Joining the Laboratory were seven Senior Staff Investigators: John
Anderson, Jim
Pflugrath, David Frendewey, Michael Gilman, Nouria Hernandez, Dan Marshak,
and Venkatesan Sundaresan.
John Anderson and Jim Pflugrath form the nucleus of the new X-ray structure
group. John came to the Laboratory following graduate and postdoctoral work at
Harvard University where his research involved DNA-binding proteins that
selectively bind to specific regions of the DNA molecule. Jim came from the Max-
Planck Institute for Biochemistry in Munich, Germany, where he designed major
new software and computer graphics programs for obtaining and evaluating X-ray
diffraction information.
David Frendewey came from Walter Keller's lab at the German Cancer
Research Center in Heidelberg. He is characterizing the biochemical mechanism
of pre-mRNA splicing in the fission yeast Schizosaccharomyces pombe. Formerly
in Robert Weinberg's lab at the Whitehead Institute, Mike Gilman is interested in
how extracellular signals of growth factors are communicated to the cell nucleus to
ultimately induce transcription of the proto-oncogene c-fos.
Nouria Hernandez recently completed a postdoctoral fellowship in Alan Weiner's
lab at Yale University. She is studying the assembly of small RNA molecules in the
cell nucleus. A protein chemist, Dan Marshak arrived from Michael Brownstein's
group at the National Institute of Mental Health, where he had purified nerve
extension factor.
Venkatesan Sundaresan was associated with Michael Free ling at the Agricul-
tural Experiment Station of the University of California, Berkeley, before coming to
the Laboratory. Sundar studies the transposable element, Robertson's mutator, and
its role in generating diversity in maize.
Visiting scientists arriving in 1986 were Arie Admon, Andre-Patrick Arrigo, Loren
Field, and Margaret Raybuck. Arie Admon, who completed a postdoctoral
fellowship with G.G. Hammes at Cornell University, collaborates with Yakov
Gluzman. On sabbatical from the University of Geneva, where he is an assistant
professor in the Department of Molecular Biology, Andre-Patrick Arrigo is working
with Bill Welch. Now collaborating with Doug Hanahan, Loren Field was a
postdoctoral fellow with K.W. Gross at Roswell Memorial Park Institute in Buffalo.
Margaret Raybuck, a scientist with Amersham International of England, is working
with Ed Harlow.
Visiting scientists who completed their studies at Cold Spring Harbor during the
year and returned to their previous or new positions were Diane Esposito to
Memorial Sloan-Kettering Cancer Center; Mark Homonoff to Mt. Sinai Hospital;
Krystyna-Slaska Kiss to the Institute of Genetics in Szeged, Hungary; and
Massimo Romani to Cornell University. Marcel lo Siniscalco, who co-organized the
51st Symposium on "The Molecular Biology of Homo sapiens," returned to
Memorial Sloan-Kettering Cancer Center after sabbatical at Cold Spring Harbor.
Appointment of Douglas Hanahan as a Senior Scientist
In December, the Laboratory's Trustees approved the appointment of Doug
Hanahan to the position of Senior Scientist in recognition of his already well-
acclaimed studies using transgenic mice. Doug's association with Cold Spring
Harbor began in 1978, when he came as a Harvard graduate student to James
lab to do recombinant DNA experiments on the collagen gene. At that time,
Harvard lacked the so-called safe facilities then thought necessary for work with
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recombinant DNA. Later, when he became one of Harvard's prestigious Junior
Fellows, he spent even more time here, joining our staff in 1985 as a Staff Investi-
gator and being quickly promoted to Senior Staff Investigator.
Our Senior Scientist position is marked by a rolling five-year appointment,
which signifies that salary is now guaranteed by the Laboratory for a five-year
period that continuously moves forward with time. This guarantee, however, falls
short of the academic tenure offered by many universities. If we are to retain key
scientists like Doug for most of their research careers, we must increase greatly
our endowment funds specifically earmarked to fund truly tenured positions.
Staff Promotions
Senior Staff Scientists Richard Roberts and Terri Grodzicker accepted newly
created leadership positions. As Assistant Director for Research, Rich has primary
responsibility for staff recruitment. As Assistant Director for Academic Affairs, Terri
coordinates the Laboratory's professional education and meetings programs.
Rich received his Ph.D. in organic chemistry from the University of Sheffield.
He came to Cold Spring Harbor as a Staff Investigator in 1972, following a
postdoctoral period at Harvard University. Over the years, his research group has
isolated more than 25 now commercially available restriction enzymes. He was a
key member of the Cold Spring Harbor team that co-discovered the phenomenon
of RNA splicing.
Terri also came to Cold Spring Harbor in 1972 for a postdoctoral fellowship with
Joe Sambrook after receiving her Ph.D. from Columbia University. Terri was
among the first scientists to use restriction enzymes to map genes in tumor
viruses. She also demonstrated the feasibility of using virus vectors to correctly
express cloned genes in mammalian cells.
David Helfman, who studies the molecular and cellular biology of the cytoskele-
ton in normal and transformed cells, was promoted to Senior Staff Investigator. He
came to Cold Spring Harbor from the Department of Pharmacology of Emory
University in Atlanta in 1981 as a postdoctoral fellow in Jim Feramisco's lab and
became a Staff Investigator in 1985.
Four postdoctoral fellows trained in Mike Wigler's laboratory accepted positions
as Staff Investigators: Scott Powers, Carmen Birchmeier, Daniel Broek, and Takashi
Toda. Scott, who came to Cold Spring Harbor after receiving his Ph.D. from
Columbia University in 1983, has cloned several genes that affect the ras/adenyl-
ate cyclase pathway. Carmen received her Ph.D. with M.L. Birnsteil at the
University of Zurich and came to the Laboratory in 1984 from the Max-Planck
Institute in Tubingen, Germany. She has been exploring new assays for detection
of human oncogenes.
Now on a six-month sabbatical at the Medical Research Council in Cambridge,
England, Dan Broek studies the biochemical characterization of yeast and
mammalian ras proteins. He came to Mike Wigler's group in 1984, after receiving
his Ph.D. in biochemistry from Rutgers University. Also arriving in 1984, Takashi
Toda received his Ph.D. from Kyoto University; he studies the role of ras proteins
in growth control in yeast.
Others moving up from postdoctoral positions were Andrew Hiatt, Eileen White,
and Elizabeth Moran. Andy, who studies genes involved in secondary plant
metabolism, received his Ph.D. in biochemistry from Columbia University in 1983.
As a Damon Runyon Fellow, he worked with Jim Hicks. Also a Damon Runyon
Fellow, Eileen came in 1983 to work in Bruce Stillman's lab, after receiving her
Ph.D. from the State University of New York, Stony Brook. She examines the
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function of adenovirus E1B tumor antigens in transformation and lytic infections.
Elizabeth studies the role of adenovirus E1A protein in regulating transformation
and viral transcription. After receiving her Ph.D. in microbiology from New York
Medical College in 1983, she came to Cold Spring Harbor as a postdoctoral fellow
in Mike Mathew's lab.
Postdoctoral Fellows
Leaving after completion of their postdoctoral terms were William Addison to the
University of Alberta (Canada); Jychian Chen to Yale University to work with Steve
Dellaporta; Claude Dery to the University of Sherbrooke (Canada); Bob Gerard to
the University of Texas Health Science Center; Giovanni Guiliano to the University
of Pennsylvania; Janet Hearing to the State University of New York, Stony Brook;
Tohru Kamata to the Frederick Cancer Research Facility of the National Cancer
Institute; and Yuriko Kataoka to Harvard Medical School.
Also leaving were Antal Kiss to the Institute of Biochemistry of the Hungarian
Academy of Science; Richard Kostriken to the Department of Biochemistry at the
University of California, San Francisco; John Langstaff to the University of
Winnipeg (Canada); Nora Sarvetnick to Genentech Inc. in San Francisco; Marie
Wooten to the Hematology Division of the University of Alabama, Birmingham
School of Medicine; and Bradley Zerler to Molecular Therapeutics, Inc. in West
Haven, Connecticut.
Graduate student Sreenath Sharma received his Ph.D. from the State University
of New York, Stony Brook and began a postdoctoral fellowship in Mike Wigler's
lab.
Robertson Research Fund
Income from the Robertson Research Fund, the Laboratory's largest endowment
fund, continues to be an essential source of salary support for young scientists. In
addition, the high cost of living on Long Island makes it imperative that we
subsidize rent of many scientists living in the local community.
In 1986, full stipends were provided for visiting scientist Andre-Patrick Arrigo
and for postdoctoral fellows Jychian Chen and Guilio Draetta. Supplemental
salary/housing support was provided for an additional ten postdoctoral fellows and
six graduate students, while Cold Spring Harbor Fellow Adrian Krainer received
funding to start an independent research program on RNA splicing.
Two undergraduate researchers were supported for 10-week stays during the
summer. Honoraria and travel expenses were provided for speakers attending
several Cold Spring Harbor meetings. Robertson funds also allowed the extensive
renovations needed to transform the former "mouse house" into the Cairns Electron
Microscopy Laboratory, as well as helping with the construction of the new Arthur
and Walter Page Laboratory of Plant Genetics.
Undergraduate Research
Our Undergraduate Research Program, which began in 1959, is one of the oldest
in the nation. Four-year core support from the Alfred P Sloan Foundation, as well
as grants from the Burroughs Wellcome Fund, American Cyanamid Company, and
Pfizer Central Research allowed us to offer a summer of research to 14 excep-
tional students. The Olney Memorial Fund supported one additional fellow.
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Our Banbury Center Became an Even Greater Intellectual Asset
When Charles Robertson gave to us in 1977 his lovely house and beautiful land in
Lloyd Harbor, I told him we intended to establish there a site for intense small
meetings which today we call the Banbury Center. I imagined then that it would
complement well the increasingly large meetings held at the Laboratory itself. But
I never anticipated that it would work so well and bring each year such a
distinguished group of visitors. Originally, the main emphasis of these meetings
was risk-assessment studies that focused on cancer prevention. Since then,
through our Corporate Sponsor Program, we have added a series of six meetings
on biotechnology-related topics that include such subjects as microbial energy
transduction, recombination in yeast, and angiogenesis. Initially, we had to spend
much time seeking funds for our risk-assessment series at a time when grants for
research had the highest priority. Now through the support of the James D.
McDonnell Foundation of St. Louis, we have the freedom to plan for important
meetings that may not have obvious funding sources. Beginning in 1988, we shall
initiate a collaboration with the Preventive Medicine Institute (Strang Clinic) of New
York that will enable us to hold three additional meetings per year on the origins
and detection of human cancer. A grant from them will provide half the program
support needed over three years and funds to help cover the salary of a cancer-
oriented scientist to administer this program, which we hope will result in an
important set of timely books.
The tragic death of Steve Prentis this spring has created a gap that will be
difficult to fill. A search is now on for the new Banbury Director.
Lab Awarded Bristol-Myers Cancer Grant
At a ceremony held at the Waldorf-Astoria in April, the Laboratory received from
the Bristol-Myers Company one of its two annual cancer research grants, which
provides $500,000 in unrestricted support over the next five years. The Laboratory
became only the 18th institution to receive the prestigious award since 1977. The
Laboratory will also be a future site of a Bristol-Myers Symposium on Cancer
Research. A primary use of the funds will be the support of postdoctoral fellows
working to understand the functioning of oncogenes.
A Major Changeover in Our Board of Trustees
This year brought to conclusion an extraordinary era of leadership in which Walter
H. Page, Robert L. Cummings, and Edward Pulling working together presided
over the major period of physical and intellectual growth that has made this
Laboratory so important to the world of modern biology. An appreciation for
Edward Pulling's contributions appeared in last year's Annual Report, and at the
beginning of this year's report, we discuss more fully Walter Page's key contribu-
tions. I note here that the bylaws of our Board of Trustees limit our major officers
to six one-year terms, and thus both Walter Page and Robert Cummings
completed their formal service to the Laboratory in November of 1986.
Trustees of the Laboratory are limited to two consecutive three-year terms.
Leaving our Board at the conclusion of two such terms are Claudio Basilico,
representing the New York University School of Medicine; Mathew Scharff,
representing the Albert Einstein School of Medicine; and Robert Webster,
representing Duke University. The representative of Princeton University, Thomas
Shenk, was succeeded for the balance of his term by Thomas Silhavy. All of these
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Robert L. Cummings
Trustees played important roles in seeing that the Laboratory responded to
everchanging opportunities provided by the advances of today's molecular
biology.
It is with special appreciation that we note the retirement of Robert L.
Cummings of Glen Head, who joined the board in 1977 and served as treasurer
for the last seven years. During his tenure as treasurer, he tended well a total
budget that swelled from $10 million to $25 million. We look forward to his
continued close association as an honorary trustee.
Bayard D. Clarkson of Memorial Sloan-Kettering Cancer Center in New York
City was elected chairman of the board at the November annual meeting.
"Barney: who joined the board in 1968, holds the Enid Haupt Chair for Therapeu-
tic Research at Sloan-Kettering Institute for Cancer Research, where his research
involves cancers of blood cells. He is also chief of the Hematology/Lymphoma
Service at Memorial Hospital and professor of medicine at Cornell University
Medical College.
A partner in the law firm of Davis, Polk & Wardwell, Taggart Whipple was
elected to his first term as vice-chairman. David L. Luke, Ill, chairman of the board
and chief executive officer of Westvaco Corporation, was elected treasurer. Tag
joined the board in 1983, and Dave became a member last year.
Returning to the board after a two-year absence was Mary Lindsay. William
Everdell of the law firm Debevoise & Plimpton became a new individual trustee.
New institutional trustees are Thomas Maniatis, chairman of the Department of
Biochemistry and Molecular Biology, Harvard University; David D. Sabatini,
chairman of the Department of Cell Biology, New York University School of
Medicine; Thomas J. Silhavy, Warner-Lambert/Parke-Davis Professor of Molecular
Biology, Princeton University; and Jonathan R. Warner, chairman of the
Department of Cell Biology, Albert Einstein College of Medicine.
LIBA Continues to Provide the Strong Community Support
We So Depend Upon
Assuming the role of chairman of LIBA in January of 1986, George Cutting has
taken on a task performed so uniquely well by his predecessor, Edward Pulling.
Happily, I can report that under George's leadership, LIBA continues to function
most effectively both in informing our community about our activities and in
rallying its most valued financial support. This year, LIBA has played a key role in
helping initiate the planning for the centennial of the Laboratory and in setting up
the development efforts that will let us look upon our second hundred years with
true confidence. Equally important has been the creation of a new joint program of
LIBA and the Laboratory, the Cold Spring Harbor Laboratory Associates. Each
Associate will donate to the Laboratory an annual gift of at least $1000. Already in
this first year, 85 individuals have joined this most important new program.
Creation of the Centennial Fund
The need for new endowment funds to complement those of our Robertson
Research Fund has long been apparent. A very important step for ensuring our
future thus was initiated last fall through the creation of the Centennial Endowment
Fund, which will be one of the major objectives of the fund-raising efforts that will
take place in conjunction with the celebration of the Laboratory's 100th birthday in
1990. Initially, this fund will be established through gifts made by our Trustees,
past and present, and it is with great appreciation that I can already acknowledge
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the major gifts and further pledges made by Bayard Clarkson, Robert L.
Cummings, Wendy Hatch, Mary Lindsay, David Luke Ill, and Taggart Whipple.
Further Plans for the Upper Campus
Upon the site where the Page Motel and the cabins now sit, we have plans for a
new, much-improved, short-term housing complex for meetings participants. This
complex will consist of a new 30-room lodge and a set of six cabins to be located
just above the new parking facilities that we have created to the west (above) of
the Page Motel. Linking this parking area with our major parking area along route
25A is a new paved roadway, the Page Parkway, from which a wonderful view can
be had over the Grace Auditorium to St. John's Church. The hilltop is now also
graced by an octagon-shaped gazebo, whose copper roof originally adorned an
early 1920s pump house built on the Snake Hill Road estate of Mrs. Jeanette
Taylor. Plans are also being made to site a new research and teaching building to
the immediate north of the Lodge. We now envision approximately 24,000 square
feet. Besides a full basement, it will have two floors, the lower floor devoted to
neurobiology research and the upper floor to year-round expanded teaching
programs in neurobiology and structural studies. Optimally, a third accessory
building linked to both the Lodge and the new neurobiology-teaching building
would provide facilities for a neurobiology library.
Most of the funds needed to build the cabins are either in hand or have been
firmly pledged. So, construction of the cabins will begin early in 1988, hopefully in
time to allow their completion for use that summer. Funds for the much more
expensive lodge-neurobiology complex are now being sought, and already a
special gift obtained from the Samuel Freeman Trust will allow us to undertake
detailed plans sometime this fall.
Preparing Ourselves to Function as a Year-round University of DNA
With our centennial only three years distant, it is natural to ask what attributes we
shall need to play as important a role in biology worldwide in the 21st century as
we have in the 20th century. The answer to this should give us the focus to offer
convincing reasons to prospective donors as to why their gifts to our Second
Century Campaign will be so important. One attribute most certainly is our ability
to house and feed comfortably meetings and course attendees as they begin
increasingly to come to us throughout the year as opposed to only during the
warmer months. Second, we must have teaching laboratories that will allow our
courses to remain at the forefront of the technological development upon which
the future of so much of biology will depend. And finally, we must have the
endowment funds to guarantee the tenure of the scientists who will maintain the
intellectual integrity that major scientists like Barbara McClintock and Alfred
Hershey have given to the scientific life at Cold Spring Harbor.
I thus see that in the next few years, the major task for me and my fellow
trustees, working in conjunction with supporters in the community and with our by
now thousands of concerned alumni, will be to raise funds for the future
investments at Cold Spring Harbor that will enable us to match the achievements
of the past. We shall not have an easy few years ahead, for we shall have so
much to do. But the rewards of success will not let us falter.
June 22, 1987 James D. Watson
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Stephen James Prentis
1951-1987
The Laboratory staff gathered at a memorial service in Grace Auditorium on
March 6 to mourn the untimely death of Steve Prentis in a car accident on
February 28, 1987 During his brief time here, his blithe spirit and enthusiasm had
infected all with whom he came in contact.
Steve had shouldered dual responsibilities since his arrival in April 1986. As
Director of Banbury Center, he administered an extensive meeting program. As
Executive Director of Publications, he had labored to make real a long-standing
dream for a Cold Spring Harbor journal. Along with colleagues at the Genetical
Society of Great Britain, he persuaded prominent scientists in the United States
and Europe to join the editorial board and submit papers to the new publication,
Genes & Development.
Steve built his reputation as a brilliant scientific editor at Elsevier Publications in
Cambridge, England, where he was Managing Editor of three popular scientific
journals: Trends in Biochemical Sciences, Trends in Biotechnology, and Trends
in Genetics. He was the author of numerous scientific articles, and his widely
praised book Biotechnology: A New Industrial Revolution has been translated
into several languages.
Steve's death came only several days before copies of the first issue of Genes
& Development arrived, bearing a preface that, in part, read: "Taking a decision to
launch a scientific journal is never simple, not least because its real value can only
be properly measured after it comes into existence' Tragically, the real value of
Steve's contribution to science can now only be measured in his absence.
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ADMINISTRATION
Last year, there was serious concern that deep cuts in federal funding for research
would aggravate the deficit projected for the Laboratory's operating budget.
However, such cuts only partially materialized, and with strong support from
industry, foundations, and private individuals, we were able to approximately
balance revenues and expenditures after allowing for depreciation. The better-
than-expected financial results were also due to close attention to controlling
administrative costs.
In 1987, we will be faced with replacing the substantial revenues received in
recent years from the just-completed five-year research support agreement with
Exxon Corporation. At the same time, we will need to find start-up money for the
extraordinary group of young scientists recruited during the past year. Funding for
the plant research program must also be completed, particularly including
construction of the new Arthur and Walter Page Laboratory of Plant Genetics.
Finally, we will need money to build and operate the expensive new facilities that
are required for the Laboratory's dream of becoming a year-round teaching institu-
tion of DNA science and a center of neuroscience research. Nongovernment
funding sources will be essential to this effort. In this regard, we must keep in
mind the basic academic character of science at Cold Spring Harbor Laboratory
and the importance of freedom to do interesting research without regard for
commercial application.
Growth of the Laboratory will aggravate the already expensive and intrusive
problems of maintenance, security, sewage treatment, and waste disposal. These
problems must be resolved without altering the essential character of the
Laboratory and the "village of science" atmosphere that has made this place
unique. We must be especially sensitive to the feelings of our neighbors in the
villages of Laurel Hollow and Lloyd Harbor. Their feelings of pride in having a
world-class institution in their backyard must be coupled with confidence that the
Laboratory will not be a financial burden and that we share their concern for the
natural beauty of the area.
Crucial to achieving the Laboratory's future goals are the managers who head
our various nonscientific departments: commercial relations, publications, public
affairs, library, buildings and grounds, personnel, grants management, accounting,
and purchasing. Although the contributions of these exceptionally qualified and
motivated managers are great, too often they receive most notice when we lose
one of them. The tragic death of Steve Prentis in an automobile accident stunned
and saddened us all. Art Brings, Director of Safety, and Mike Balamuth, Director
of Data Processing, departed to establish their own consulting firms. Art has made
the Laboratory a pacesetter in the areas of biohazard and radiation safety. We are
delighted that he will be returning to the Laboratory after about a six-month
absence. Mike was invaluable in making all areas of the Laboratory computer-
literate and was the architect of our shortly to arrive state-of-the-art system of
networked PC-based microcomputers. His replacement, Fred Stellabotte, has had
extensive experience with such systems at TWA and Brookhaven National
Laboratory.
The fall of 1986 was marked by the retirement of Walter H. Page as Chairman of
the Board and Robert L. Cummings as Treasurer. Much is written elsewhere in this
report about their contributions to this institution. They are good friends to all of us
who have relied on their leadership and good sense.
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The charts preceding this report portray the upward path of operations. The
challenge will be to manage future growth in a way consistent with the excellence
that has been the hallmark of Cold Spring Harbor Laboratory.
G. Morgan Browne
BUILDINGS AND GROUNDS
As predicted in last year's Annual Report, 1986 brought with it much work for the
Buildings and Grounds Department. The Laboratory's agreement to conduct
research with Pioneer Hi-Bred International prompted a major renovation and
construction of several buildings at CSHL and its off-grounds properties. This year,
the Genetics Field Experimental Station at Uplands Farm was essentially
completed with the construction of a potting shed and a 2200-square-foot
greenhouse. The height of this greenhouse will accommodate a winter corn crop
so that researchers will be able to grow corn all year long. Pioneer funding also
made possible the addition to DelbrOck Laboratory. We completed a new
foundation for the Firehouse, which was relocated 90 feet north to make room for
the DelbrOck addition. As of this writing, the DelbrOck addition is up and the
roofing is being installed.
The existing structure of the Mouse House was completely rebuilt and two
rooms were added. Now named the John Cairns Laboratory, the building will
house an electron microscopy facility. In Hershey, we are converting the apartment
into offices and the repair shop area into a computer graphics analysis facility to
accommodate the newly arrived crystallographers. We also began work on their
laboratory as well as on Mike Wigler's laboratory at Demerec. The kitchen area
was reworked and a coldroom was installed.
Early in the year, we rebuilt Dave Helfman's laboratory in McClintock. The
laboratory had been destroyed by a serious fire caused by a short circuit in a gel
box. Although smoke leaking through the vents caused some damage to the
kitchen and hall, the rest of the building was spared because the laboratory door
had been closed.
Along with new construction and renovations, equally important is the upkeep of
all our other buildings. This year, the exterior of Olney and the trim on Demerec
Lab were painted, and over at Banbury, the trim on Robertson house was
repainted.
1986 saw the completion of many of our ongoing projects. The work on James
Lab was essentially finished with the completion of the lower floor. Furnishings for
the offices and computer rooms in Grace Auditorium were installed and personnel
were moved in before the summer meetings and courses began. The landscaping
around Grace, the building of the Gazebo, and the grading and surfacing of the
Motel parking lot were all completed. A copper roof for the gazebo was donated
to CSHL by the Taylor Estate in Lloyd Harbor. It was removed from the pump
house and stored behind Page Motel until our carpenters completed the structure
and foundation of the gazebo. After the landscaping of the hill behind Grace was
completed, the roof was hoisted into position and the structure was painted.
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In the spring, our Electrical Department began working on the site lighting and
the never-ending job of burying all electrical, TV, and telephone lines so that we
could remove all the utility poles along Bungtown Road. By November, half of the
poles were removed, and hopefully, the rest will be gone by late spring of 1987.
In looking back at our accomplishments for the year, I find that we completed
more work. Our own Buildings and Grounds building was reorganized to make
room for the Safety office, the B&G Purchasing Department, and Peter Stahl's
office. (Pete was promoted to Maintenance Manager from his position at Banbury.)
In our free time, we shoveled and plowed snow in the winter, planted bulbs and
flowers in the spring, cut grass in the summer, raked leaves in the fall, and so on.
All in all, we had a very productive year.
Jack Richards
PUBLIC AFFAIRS AND DEVELOPMENT
Public Affairs
It has been very satisfying over the past several years to see the maturation of the
Laboratory's public affairs function. Our organization has clearly reached a stage
in its evolution where it is large enough-and successful enough-to share its
unique expertise with the many nonscientific audiences with need for accurate,
up-to-the-minute information about DNA science. The hallmark of this transition
has been a heightened sense of social responsibility and an organizational
commitment to public education that extends from the Board of Trustees to the
scientific staff. Just as innovation has been crucial to our scientific progress, so,
too, have we been imaginative in our response to the problem of public
understanding of DNA science.
The DNA Literacy Program, explained in greater detail in the education section
of this report, has become the nation's most ambitious program to prepare individ-
uals to understand recombinant DNA and the social issues it generates. Last
summer, we introduced the Vector Mobile DNA Laboratory, which brought hands-
on training in DNA science to 210 high school and college instructors from 12
states and Great Britain.
The Genetic Knowledge of Man, a briefing workshop cosponsored with
Shearson Lehman Brothers Inc., brought together scientific and business leaders
to discuss the extraordinary applications of DNA research to health care in the
United States. Attending the October conference were scientists from leading
research institutions and corporate executives from health care and investment
companies: Tom Maniatis, Harvard; David Botstein, Massachusetts Institute of
Technology; Charles Cantor, Columbia; Harold Varmus, University of California,
San Francisco; Leroy Hood, California Institute of Technology; Michael Brown,
University of Texas; Thomas Caskey, Baylor College of Medicine; Allan Wilson,
University of California, Berkeley; Curt Engelhorn, Boehringer Mannheim; Henry
Wendt, SmithKline Beckman; Erik Danielsson, Pharmacia; Leo Jack Thomas,
Eastman Kodak; Abramo Virgilio, Bristol-Myers; Sigi Ziering, Diagnostic Products;
Richard Williams, Erbamont; John Wilkerson, The Wilkerson Group; Kenneth
Merrill, Tambrands; and Harvey Sadow, Boehringer-Ingelheim.
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The Laboratory entered the video era with the release in January of the
documentary The Biological Revolution: 100 Years of Science at Cold Spring
Harbor. This 30-minute video has done much to extend the reach of our public
affairs program; it is now possible (and cost-effective) to send the excitement and
beauty of the Laboratory to any part of the country. The documentary aired in the
spring on Cablevision systems throughout the Metropolitan New York area and
has sold briskly to high school science teachers across the nation. We were
especially pleased that the production was awarded the first prize for video
documentary in the 1986 competition of the Suffolk County Motion Picture and
Television Commission.
Development
In anticipation of the Laboratory's centennial, major steps were taken in formulating
an articulated development program to ensure a second century of scientific
excellence. A comprehensive plan, setting forth institutional goals and develop-
ment objectives, was approved by the Board of Trustees. John F Harper &
Company conducted a survey of the directors of both the Laboratory and the
Long Island Biological Association (LIBA) and provided many important insights
about how our organization is perceived and considered within the Long Island
community.
As our program unfolds, we will want to draw participation from an ever-
widening circle of friends and patrons. The key to success will be a number of
individuals who believe enough in our work to push the Laboratory to the very top
of their priority lists. There is so much to be done over the next three years.
Central to our overall development effort is an increased emphasis on annual
giving. We now have in place three programs aimed at building constituencies
that support the Laboratory with predictable, annual gifts (detailed in the grants
and contributions section).
Established in 1984, the Corporate Sponsor Program has encouraged the bio-
technology industry to support our summer meetings program. Proceeds from the
program have encouraged increased interaction between industry and academic
scientists and have allowed a 40% growth in our meetings program.
In 1986, the Alumni Cabin Campaign became our first attempt to reach meeting
attendees, course instructors, and departed staff members whose careers have
benefited from the Cold Spring Harbor experience. Response to an appeal to
support construction of "Alumni Cabin" (one of six four-bedroom cabins planned to
replace existing, dilapidated housing) exceeded all expectations. By the end of
1986, nearly 200 scientists (one in four asked) have contributed almost $34,000.
We hope that after reaching the goal of $100,000 by 1988, a good habit will have
been created, and we will continue to receive annual gifts from our alumni.
In cooperation with LIBA, we have instituted for calendar year 1987 a third
annual giving program that is aimed at our constituency of local friends. Cold
Spring Harbor Laboratory Associates, who contribute $1,000 or more annually,
receive a special education program designed to bring them face-to-face with the
world of biotechnology. In the first year, proceeds from the program will be used
to support four postdoctoral researchers to be called LIBA Fellows.
Staff Expansion
Joining the staff after serving extensive internship periods were Photographer/Artist
Susan Zehl and DNA Workshop Coordinator Christine Bartels. A recent graduate
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of The Cooper Union in Manhattan, Susan is in charge of nontechnical photogra-
phy for the Annual Report and does design and graphics for public affairs
publications. A native of West Germany, Christine administers the expanding
Vector DNA Workshop Program and other educational efforts. With graduate
degrees in both biochemistry and science journalism, she also assumes writing
chores. Jericho High School junior Jeff Mondschein performed admirably as
summer lab aide with the Vector program. Holding everything together is
Departmental Assistant Ellen Skaggs, who has special responsibility for liaison
with members of the Corporate Sponsor Program. Joan Pesek, whose husband
Dan Marshak is the Laboratory's protein chemist, joined the administrative staff in
Nichols as development liaison for LIBA.
David Micklos
LIBRARY SERVICES
Library Responds to Changing Needs of the
Laboratory's Science
In 1986, a variety of changes in our scientific direction challenged the library to
examine its collection and to provide new materials. The arrival of the crystal-
lographers required the purchase of three major serial titles and their backsets. We
also saw an increased interest in both plant and yeast molecular biology and
neurobiology as the laboratory prepared to expand its work in those disciplines.
Our protein chemistry section was also expanded.
On December 1, we began a three-month experiment, sending each day to our
senior scientists photocopies of the tables of contents of 44 journals selected by
them. Each scientist created his or her own profile using the ten most frequently
cited journals and five titles specific to the individual specialty. The project will be
evaluated in March 1987; its success to date indicates that it will most likely
continue.
Reference Services and Archives
Our reference department has expanded its online access to include databases
available from the National Library of Medicine. The following have been added:
Registry of Toxic Effects of Chemical Substances, and Cancer line, which provides
access to cancer research projects and clinical trials/protocols. The addition of
these databases and the increase in new area research resulted in a 37%
increase in online searches this year.
To accommodate this increased demand for services without increasing our
professional staff, we reorganized the reference complex on the second floor. The
terminal used for searching has been moved to the gallery at the top of the stairs,
which provides an atmosphere conducive to the reference interview required to
establish an accurate search.
During the summer, we received the remaining contents of the Jane Davenport
Harris DeTomasi estate. Jane Harris was the daughter of Charles B. Davenport, the
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Laboratory's Director from 1898 to 1934. She was also the wife of Reginald D.
Harris, the Laboratory Director responsible for establishing the
Cold Spring Harbor
Symposium on Quantitative Biology. An exciting collection, this
truckload of
material included Laboratory, Harris, and Davenport memorabilia
that will
eventually, when sorted and cataloged, greatly enrich our knowledge
of the history
of the Laboratory.
Annual Growth of Permanent Collection
In 1986, the book collection grew by a net total of 1403 bound volumes, bringing
the total number of volumes to 30,501. The serial collection numbers 503 unique
titles, of which 358 are periodicals and 145 are cataloged series. This year 15
titles were added and 6 were withdrawn.
This year, we have begun the tedious, yet important, process of weeding out our
scientific book collection. This involves determining where new editions must
replace old ones and buying new titles to enhance subject areas that are at the
cutting edge of scientific research.
Storage Facility Access Easier Than Expected
It has been more than a year since a library storage facility was established at the
East Side School in Cold Spring Harbor to house the older materials from our
overflowing journal collection. There was some concern that service to our
scientists for those volumes would be impeded; however, the retrieval system that
we have designed is working smoothly for both the library staff and the scientists.
In 1986, 287 volumes were retrieved and returned to storage. It is clear that the
items sent to storage in 1985 were chosen wisely, since the 287 volumes
represent only 3.7% of the collection housed at the school. Library staff members
stop at the school to and from work or following their lunch hour. Although our
published turnaround time is 24 hours, we will always retrieve a volume
immediately in an emergency.
A storage facility can only provide for little-used materials. The main library is at
capacity; realistically, more space is needed. Plans exist for renovation of the
second floor and the attic, which would ensure comfortable library service for 5
years. We hope to revitalize these plans late in 1987.
Susan Cooper
PUBLICATIONS
Several innovations and developments were introduced into our publications
program in 1986. These have been designed to extend the range of scientific
information we provide and to increase the efficiency with which this can be
achieved.
28
Integration of Banbury Publications into the Main
Publishing Program
From an organizational point of view, one of the most important developments has
been the incorporation of books emanating from the Banbury Center into CSHLs
main publications program. Although the editorial tasks related to the Current
Communications in Molecular Biology series (based on meetings held at the
Banbury Center) have always been handled by Nancy Ford and her staff at Urey
Cottage (on the grounds of CSHL), similar editorial and production tasks related to
books in the Banbury Report series had been undertaken by an independent
editor at Banbury Center. In an attempt to increase the speed and efficiency with
which the Banbury Reports are published, they will now be handled within the
framework of our main publications operation. There will still be a resident editor
at Banbury Center, but it is hoped that this organizational change will eliminate
some duplication of effort. In this context, it is noteworthy that, as mentioned in the
Banbury Director's report, a new series of books on the Origins and Detection of
Human Cancer will be launched as a result of the agreement reached last year
between the Banbury Center and the Preventive Medicine Institute/Strang Clinic.
New Technology Aids Production Efficiency
Nancy Ford and her colleagues have had yet another very active year, during
which we produced 13 titles, 10 reprints, abstracts for all of our meetings, plus, of
course, this Annual Report. As noted in previous reports, we have been "keyboard-
ing" manuscripts on site for some time now. This method of reducing typesetting
costs, while maintaining and even improving quality, has worked very successfully.
In 1986, virtually all publications were handled in this manner, enabling us to take
over some of the traditional tasks of the typesetter. A further advance has been
the installation of equipment that can read floppy disks provided by authors. This
is already reducing costs and, equally important, reducing errors and increasing
speed. We expect that the percentage of articles we receive on floppy disks will
increase rapidly in the next few years.
Three New Themes in Editorial Development:
A Journal, Videos, and a High School Manual
Three novel aspects of our publishing program have begun to emerge over the
past year: scientific journals, video tapes, and materials for high school students.
CSHLs first journal will be entitled Genes & Development, and we aim to
establish it as one of the first-rank journals for molecular biologists. It will contain
research articles that elucidate the manner in which genes control every stage of
development, from an egg to an adult organism. Genes & Development is being
published in association with the Genetical Society of Great Britain, and the
response from the scientific community in terms of papers submitted to the journal
has already been immensely favorable. The first issue will appear in March 1987.
After more than fifty years of successful book publishing, this venture into journal
publishing marks a significant step in our publication efforts. We are currently
examining a small number of other possible journal projects for the future.
The Laboratory's video The Biological Revolution: 100 Years of Science at
Cold Spring Harbor was prepared in 1985 in anticipation of the Centennial in
1990. It traces the major developments in biology by focusing on the many signifi-
cant events and achievements that took place at CSHL. Since this video tape
would clearly be of great interest to teachers and high school students, it was
decided to make it widely available to them, and it is now generating a great deal
of attention.
In 1986, we concluded an agreement with Carolina Biological Supply Co. to
produce and sell a high school/junior college laboratory manual entitled
Recombinant DNA for Beginners. This company is the major supplier of biologi-
cal materials and equipment to schools, and they will be assembling the
laboratory kit that will enable students to carry out the experiments described in
the manual.
It is quite clear that video tapes are becoming increasingly important in teaching
at all levels, from school students to advanced researchers. Our very successful
series of laboratory manuals, which was extended this year with the publication of
Manipulating the Mouse Embryo, might very usefully be augmented by instruc-
tional videos that would demonstrate some of the techniques involved. We are
currently investigating the possibility of producing one or more such video tapes.
Symposia and Other Well-established Book Series
The reception given throughout last year to Symposium 50 was even better than
we have come to expect for all the Symposium volumes. It is interesting to note
that its topic, Molecular Biology of Development, matches that of the new Genes
& Development journal rather closely. Volume 51 is based on the very timely 1986
Symposium concerning the Molecular Biology of Homo sapiens. This area of
research has seen countless fundamental advances in the past few years, and,
with the current discussions concerning the feasibility and desirability of sequenc-
ing the entire human genome, this volume is sure to be greatly valued for many
years. Other publications in our regular series included the fourth volume of
Cancer Cells: DNA Tumor Viruses; Vaccines 86; and five books in the Current
Communications in Molecular Biology series: Mechanisms in Yeast Recombina-
tion, Microbial Energy Transduction, Translational Control, DNA Probes, and
Computer Graphics and Molecular Modeling. This last title is particularly interest-
ing in view of the Laboratory's newly established research activities in this area.
Laboratory Manuals
As mentioned previously, our series of laboratory manuals for researchers has
been very successful. Manipulating the Mouse Embryo, added to the list in 1986,
presents a lucid and detailed description of studying mammalian development
and producing transgenic mice, a technique that is being used to great effect by
researchers at CSHL and is yielding very important information.
Several new manuals are currently being developed for publication, plus, of
course, the second edition of Molecular Cloning: A Laboratory Manual by Tom
Maniatis, Ed Fritsch, and Joe Sambrook. The first edition of this manual has now
sold over 50,000 copies.
Marketing Department Extends Its Services
Without an effective method of letting potential readers know about our publica-
tions, our editorial and production efforts would be largely in vain. 1986 brought
several innovations in the marketing department, headed by Susan Cooper, which
have built upon several developments in recent years.
CSHL Notebook, our thrice yearly newsletter, is distributed to 45,000 people. It
has proved to be very popular, allowing us to provide advance information on new
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publications, meetings, and courses. In addition, the Notebook has carried various
questionnaires that have helped us define the needs of scientists for publications
and other services.
In 1986, we also used, for the first time, a professionally designed booth on
which our publications can be displayed at scientific meetings. Six such meetings
were attended last year, and our publications were displayed at eight additional
meetings. We made our first appearance at the Frankfurt Book Fair, which
provided useful information on overseas distribution and the views of the many
booksellers who carry our titles. The marketing department has, of course, been
actively engaged in publicizing our new titles, especially Genes & Development,
and has now begun to become involved in selling advertising space to manufac-
turers who wish to advertise in the journal. All of these activities have been in
addition to the normal and vital tasks of publishing our catalogs, designing
advertisements, and maintaining one of the best and most-up-to-date mailing lists
available.
Order Fulfillment and the Warehouse
Complete Another Year of Smooth Operations
No news is usually good news when it comes to fulfilling orders for books and
dispatching them. The very low level of inquiries about missing orders or late
deliveries has reassured us that the Fulfillment and Warehouse Department, led by
Charlaine Apsel, continues to provide a very rapid turnaround of orders. The
advent of our new journal has required the implementation of new systems for
handling monthly subscriptions, in addition to our regular one of book sales.
Two Valued Employees Leave the Publications
Department in December
In December, Doug Owen left CSHL after seven years as an editor. His work
during this period brought him into contact with literally hundreds of scientists
from the Laboratory and elsewhere, all of whom appreciated his cheerful and
professional approach. All of his colleagues in the Publications Department wish
him well in his new career with Genetics Institute in Boston.
In the fall, Barbara Skelly left after working in our warehouse for three years.
She was present during a time of many changes in this essential part of our
operations, and her quiet efficiency was greatly appreciated.
Steve Prentis
Mere hours after completing the above report, Steve tragically lost his life in a car
accident. His zest for the new and innovative, so clearly reflected in the
enthusiasm with which he approached the expansion of the publications program
into new areas, is a legacy we will cherish and work to fulfill in his memory.
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TUMOR VIRUSES
The laboratories comprising this group employ the DNA tumor viruses, adenovirus
and SV40, to probe fundamental cellular mechanisms of gene regulation and
growth control at the molecular level. Drawn together by this research theme as
well as by common research facilities, the group also shares a joint source of
funding in the form of a large Program Project grant.
1986 was something of a vintage year for the Tumor Virus group. As recorded in
the pages that follow, it was a good year at the lab bench. Moreover, on the
strength of past achievements and of future promise, our application to the Na-
tional Cancer Institute for continued support was well received. With renewal for a
fourth 5-year term, this Program Project grant remains the longest-running as well
as the largest at the Laboratory. As recipients of this grant, we count ourselves
doubly fortunate: Under its aegis have flourished both individual research projects
and collaborative ventures among the constituent groups, and within the frame-
work of the grant, we have been able to bring in new blood and new technolo-
gies. This year, in April, we recruited Dan Marshak as head of the Protein Chemis-
try Laboratory, replacing Clive Slaughter who moved to Dallas at the end of 1985.
Dan's expertise in protein analysis and peptide synthesis has already played a part
in more than one project and will doubtless contribute to many others, while he
simultaneously develops his own interests in both tumor and neurobiology.
The complement of the Tumor Virus group now stands at eight laboratories,
divided equally between the James/Sambrook complex and the Demerec build-
ing. Reflecting the independent status of the four James/Sambrook research
groups, their reports appear separately for first time under the headings of
Adenovirus Genetics, Molecular Biology of SV40, Protein Immunochemistry, and
Transcription Control, instead of collectively as the Molecular Biology of Tumor
Viruses. These reports are accompanied by those of the Demerec laboratories:
DNA Synthesis, Nucleic Acid Chemistry, Protein Chemistry, and Protein Synthesis.
ADENOVIRUS GENETICS
T. Grodzicker R. Cone M.P. Quinlan M. Goodwin
X.-C. Fu D. Chao P Hinton
E. Lamas R. Chisum M. Jaramillo
Work in this section has concentrated on the prop-
erties of the adenovirus oncogene early region 1A
(E1A). This gene possesses diverse functions in
transcription and transformation, expressed
through a multiplicity of polypeptide products.
The complexity results from alternative splicing,
which yields different primary translation prod-
ucts, and from extensive posttranslational modifi-
cations. Our analysis involves studies using an array
of E1A gene mutants and expression vectors, with
the aim of understanding the functions of the sev-
eral gene products and of increasing the range of
primary cell types available for investigation.
Analysis of Epithelial Cell
Proliferation and Immortalization
by the E1A 12S Gene Product
M.P Quinlan, D. Chao, P Hinton, T. Grodzicker
We have been studying the ability of the 12S gene
product of the E1A region of adenovirus to immor-
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talize primary epithelial cells, using an adenovirus
5 (Ad5) 12S virus in which the E1A region is
replaced by the cDNA of the 12S mRNA. The 12S
protein induces quiescent primary baby rat kidney
(BRK) epithelial cells to synthesize cellular DNA
and to proliferate in the presence and absence of se-
rum, ultimately resulting in their immortalization,
but not transformation. Furthermore, cell lines es-
tablished from primary BRK cells infected with
Ad5 12S retain many of their original epithelial cell
characteristics, such as morphology, poor plating
efficiency, and the expression of cytokeratins.
Infection of primary BRK cells with the Ad5 12S
virus results in the production of a growth factor(s)
that can induce uninfected primary epithelial cells
to proliferate. 12S immortalized epithelial cells do
not constitutively produce detectable levels of
growth factor. However, superinfection of these
cells with the 12S virus results in the transient
production of growth factor(s). This growth factor
is associated with high-molecular-weight com-
plexes from which it can be released by high-salt
treatment. The growth factor(s) is stable for about
6 weeks at 4°C. Unlike EGF, TGF, or PDGF, it is
sensitive to acid and heat. In collaboration with D.
Marshak (Protein Chemistry Section), we have de-
termined that the growth factor binds to DEAE-
cellulose and that its activity is potentiated by hepa-
rin. Preliminary observations, in collaboration
with E. Lamas and R. Cone (this section), suggest
that the growth factor induced by 12S also affects
liver epithelial cells and hepatocytes.
A genetic analysis was undertaken to identify
regions of the 12S gene product that are necessary
for induction of cell proliferation and growth-
factor production. A series of deletion mutants that
produce amino-terminal nonsense fragments rang-
ing in size from 106 to 150 amino acids was pro-
duced by BAL-31 digestion (P. Whyte and E.
Harlow [Protein Immunochemistry Section] and
E. Ruley [MIT]). Thus, none of these mutants pro-
duce proteins containing amino acids encoded by
the carboxy-terminal exon of the 12S gene. Another
class of mutants consisted of amino-terminal frag-
ments that were in-frame upon ligation to the Xbal
site in the second exon, and thus encode the
carboxy-terminal 68 amino acids. These mutants
are internal deletion mutants. The mutant DNAs
were reconstructed into virus and used to infect
BRK cells.
Immunoprecipitates from infected BRK cells
demonstrate that polypeptides of the expected size
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are synthesized. None of the mutants exhibit the
trans-activation function of El A. Thus, they fail to
express the E2 72K protein and are host range with
respect to their ability to grow on HeLa and 293
cells. All of the mutants lacking the carboxy-
terminal amino acids were localized to both
cytoplasm and the nucleus, whereas wild-type 12S
and the mutants containing the carboxy-terminal
68 amino acids were localized to the nucleus. Mu-
tants producing a polypeptide encoded by at least
the first 402 nucleotides of the ElA region (134
amino acids) are able to initiate cellular DNA syn-
thesis and proliferation, but they are unable to
maintain the epithelial cells in a proliferative state
and thus are not immortalized. No growth factor
was detectable from cells infected with these mu-
tants. They are, however, able to cooperate with
Ha-ras in transformation (P. Whyte, Protein Im-
munochemistry Section). The presence of the
carboxy-terminal 68 amino acids from the second
exon confers upon the first exon of the 12S gene the
ability to maintain epithelial cell DNA synthesis
and proliferation, to produce the growth factor,
and to immortalize epithelial cells. We are presently
mapping and analyzing more precisely the carboxy-
terminal domain required for epithelial cell survival
and immortalization.
Construction of Retrovirus Vectors for
the Establishment of Primary Cells
R. Cone, T. Grodzicker, M. Jaramillo
Retroviruses are extremely useful tools for the effi-
cient introduction of genes into animals and pri-
mary cells in culture. Over the past year, we have
constructed or obtained from other laboratories
recombinant retroviruses expressing many of the
known nuclear oncogenes, including the adenovi-
rus E1A 12S and 13S proteins, SV40 T antigen,
polyoma middle T antigen, polyoma large T anti-
gen, murine c-myc, murine v-fos, and murine p53.
We are currently in the process of constructing
viruses that express adenovirus E1B proteins and
ElA plus E1B. Our interest in these viruses is two-
fold. First, we would like to develop methods for
the routine establishment of certain differentiated
cell types via infection of the primary cells with
recombinant oncogene-containing retroviruses. Sec-
ond, we would like to learn more about the mecha-
nism(s) by which these diverse gene products induce
cell proliferation in quiescent primary cells.
Our initial work has focused on viruses that we
constructed which express either the 12S or 13S
adenovirus E1A proteins. These two viruses express
equivalent levels of 12S and 13S E1A proteins in in-
fected NIH-3T3 cells, comparable to protein levels
seen in 293 cells. The 12S virus is capable of immor-
talizing primary cells from nearly every rat organ
tested, including kidney, heart, liver, pancreas, thy-
roid, and brain. Most of these cells have an
epithelioid morphology, and many are true epithe-
lial cells, as judged by positive staining with anti-
cytokeratin antibodies. Surprisingly, the 13S pro-
tein had much less immortalization potential than
the 12S, even though immunofluorescence studies
showed that the protein was stably expressed in the
nuclei of primary cells. This observation provides
support for the model of Spindler et al. (J. Virol.
53: 742 [1985]) that the 12S protein is required for
the full activation of the DNA replication ma-
chinery of quiescent epithelial cells.
We have also investigated the growth properties
of these 12S E1A immortalized cells. Epithelial cells
obtained from 12S retrovirus infection of heart and
liver were maintained in culture for 10 months with-
out any sign of crisis. At 3 months, these cells were
unable to grow in soft agar or cause tumors in syn-
geneic rats, although the addition of an activated
ras gene caused rapid focus formation and com-
plete transformation of the cells, as judged by their
ability to form tumors with a latency of 6-12 weeks.
To determine if E1A immortalized cells can re-
tain differentiated functions, we have turned to thy-
roid tissue as a model. Preliminary results (dis-
cussed in detail below) suggest that both rat and
human thyroid cells infected with the 12S retrovirus
remain highly differentiated, as assayed by their
ability to respond to thyroid-stimulating hormone,
and to express thyroglobulin. Because of the many
bioassays for thyroid function, thyroid cells should
provide an excellent system for determining the ef-
ficacy of different oncogenes for immortalization
with retention of the differentiated phenotype.
Characterization of Differentiated
Human Thyroid Cell Clones
R. Cone [in collaboration with T.F. Davies,
Mount Sinai Hospital]
The establishment of differentiated cell lines from
normal, primary cultures is a difficult procedure,
particularly with human tissues. For example, there
are very few human cell lines that retain endocrine
function. Although primary human thyroid cells
can be cultured for several weeks, no proliferation
of these cells can be obtained and no functional cell
lines have been isolated. For long-term studies of
human thyroid function, and for studies of thyroid
cells as immune targets in thyroid autoimmune dis-
ease, it is crucial to develop human thyroid cell
lines. We have attempted to do this using the 12S
E1A retrovirus vector described above, transferred
into the wAM cell line for production of virus capa-
ble of infecting human cells, as well as using an
adenovirus vector in which the El region was
replaced by SV40 T antigen (Van Doren and Gluz-
man, MoL Cell. Biol. 4: 1653 [1984]).
A histologically confirmed, 22-week-old, human
fetal thyroid was minced, digested with a dispase/
collagenase solution, and plated as a monolayer in
medium 199 with 10% FCS. After 2 days, the cells
were infected with the T-antigen adenovirus or the
12S E1A retrovirus. The T-antigen-adenovirus-
infected cells were split at low density, and rapidly
growing epithelial colonies were isolated and ex-
panded. The E1A-retrovirus-infected cells, which
initially grew slowly, were split at low density and
cloned on the basis of a G418 resistance marker en-
coded by the retrovirus. Mock-infected cells were
unable to proliferate under these conditions.
After 3 months of growth in culture, approxi-
mately 30 clones continued to proliferate. One T-
antigen clone (TAD2) and three E1A clones (12S2,
12S3, and 12S4) were selected for further analysis.
One sensitive assay of thyroid cell function is the
ability to respond to thyroid-stimulating hormone
(TSH). Thyroid cells respond to this pituitary hor-
mone with an activation of adenyl cyclase and an
increase in intracellular cAMP. This second mes-
senger greatly increases the metabolic activity of
these cells, inducing thyroglobulin expression and
enhancing thyroid hormone production. 12S2,
12S3, and 12S4 were sensitive to less than 10 µU /ml
of bovine TSH (bTSH), whereas TAD2 required
greater than 100 µU /ml bTSH when assayed for
cAMP accumulation. Maximal cAMP concentra-
tion attained was 1200-1400 and 500 fmoles per
105 cells for the E1A and T-antigen clones, respec-
tively, representing a four- to sevenfold increase in
intracellular cAMP concentration. Since the basal
TSH level in the blood is around 10 µU /ml, these
clones respond to TSH at biologically relevant lev-
els. Immediately following G418 selection, 12S E1A
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clones were found to be positive for thyroglobulin
expression by immunofluorescence using a mono-
clonal antibody, A3. We are currently quantitating
levels of thyroglobulin secretion in these clones by
radioimmunoassay.
Although it is too early to tell if our cell clones
will become permanent cell lines, these studies indi-
cate the potential of viral vectors for the establish-
ment of proliferating clones of differentiated hu-
man endocrine cells. Future studies will concentrate
on the response of these clones to known regulators
of thyroid function in vivo, notably TSH, thyroid
hormone, and iodide, with the eventual goal being
the study of the regulation of thyroid-specific gene
expression in a cell-culture system.
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DNA SYNTHESIS
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The DNA Synthesis laboratory continues to inves-
tigate two aspects of eukaryotic molecular biology,
namely, (1) the mechanism and control of DNA
replication in eukaryotic cells and (2) the functions
of the adenovirus early region 1B (E1B)-encoded
tumor antigens. A significant shift in focus on the
first subject has occurred over the past year by in-
creasing our effort on SV40 DNA replication,
which has already yielded valuable insight into cel-
lular replication proteins and their regulation. At
the same time, studies on adenovirus DNA replica-
tion, replication of cellular chromosomes in yeast,
and adenovirus E1B tumor antigens continue with
substantial progress.
Highlights of the past year include the purifica-
tion and characterization of a cellular protein that
is required for SV40 DNA replication. This replica-
tion protein is a cell-cycle-regulated protein called
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proliferating cell nuclear antigen (PCNA) or cyclin,
and we have demonstrated that it is a processivity
factor for a novel DNA polymerase called polymer-
ase 8. This finding suggests that multiple DNA
polymerases are involved in eukaryotic DNA repli-
cation; previously, it was thought that a single poly-
merase (a) was involved. Furthermore, since PCNA
is cell-cycle-regulated, it may play a regulatory role
in DNA replication.
Another interesting observation came from
genetic studies on the function of the adenovirus-
encoded E1B 19,000-molecular-weight (19K) tumor
antigen, which has been studied in this laboratory
for a number of years. We have clearly demon-
strated that the 19K tumor antigen acts as a nega-
tive regulator of adenovirus gene expression during
the productive infection of human cells. This
phenomenon has been observed in a number of hu-
man cell lines, but the magnitude of regulation
varies between different cells, suggesting the in-
volvement of cellular proteins in this process. The
negative regulation of gene expression by the E1B
19K protein is mediated by its effect on the adenovi-
rus E1A proteins, which normally function as posi-
tive regulators of early viral gene expression. Thus,
it appears that we have uncovered a complex regula-
tory pathway that controls adenovirus gene expres-
sion, although much effort is needed to completely
understand how this regulation works.
SV40 DNA Replication
M. Fairman, W. Heiger, G. Prelich, B. Faha, B. Stillman
The small DNA tumor virus, SV40, has long been
studied at Cold Spring Harbor Laboratory, provid-
ing a valuable tool for examining macromolecular
processes in the mammalian cell. We have con-
tinued this tradition and have used the SV40 ge-
nome as a model for studying mammalian DNA
replication. This work primarily involves studying
SV40 DNA replication in a cell-free system consist-
ing of an extract derived from human 293 cells that
is supplemented with purified SV40 T antigen, the
virus-encoded replication protein. The main goals
are to (1) identify the cellular proteins that are in-
volved in SV40 DNA replication, (2) study the
mechanism of DNA synthesis, and (3) study the
function of SV40 T antigen in this process. In last
year's Annual Report, we described the initial char-
acterization of this cell-free system, the DNA se-
quence requirements for SV40 origin function and
assembly of chromatin during DNA replication.
CELLULAR REPLICATION PROTEINS
To identify cellular proteins that are required for
DNA replication, a cell-free extract capable of sup-
porting replication from the SV40 origin region has
been fractionated into multiple components. Ini-
tially, three cellular protein fractions were derived,
each of which was required for complete replication
of the genome. These fractions, designated II, A,
and B, were the starting point for further purifica-
tion of individual replication proteins, and we have
concentrated on fraction B. Using conventional
column chromatography, we have purified a single
protein from fraction B that is required, in the pres-
ence of T antigen and fractions II and A, for corn-
plete DNA replication. This protein has a molecu-
lar weight of 36,000 (36K) and is required for the
complete elongation of DNA synthesis in vitro, but
not for the initiation of replication. Therefore, frac-
tions II and A, in the presence of SV40 T antigen,
are capable of forming the presynthesis complex at
the origin of replication (described in last year's
Annual Report), as well as a limited amount of
DNA synthesis.
During the purification of the 36K replication
protein, we noted that its physical properties were
similar to the properties displayed by a previously
identified cellular protein, alternatively called the
proliferating cell nuclear antigen (PCNA) or cyclin.
This protein was first detected by immunofluores-
cence in proliferating cells with sera from patients
with the autoimmune disease, systemic lupus ery-
thematosus (SLE), and was subsequently shown by
the Protein Synthesis group to be identical to a cell-
cycle-regulated protein called cyclin. Cyclin was
identified as a protein that is preferentially synthe-
sized in the S phase of the cell cycle and was sus-
pected to be involved in cellular growth control. We
therefore collaborated with M. Kostura and M.
Mathews (Protein Synthesis Section) and D. Mar-
shak (Protein Chemistry Section) to investigate the
relationship between PCNA and our replication
protein. It was shown that PCNA and the replica-
tion factor copurified over several chromato-
graphic columns, that they were both recognized by
the human autoantibodies, and that both have an
identical amino acid sequence at the amino termi-
nus of the protein. Furthermore, we demonstrated
that the purified replication protein was able to
block the nuclear immunofluorescence pattern
normally seen when cells are stained with sera from
SLE patients (see Fig. 1). This result demonstrated
that the variable, S-phase-specific nuclear immu-
nofluorescence pattern observed with the SLE
autoantibodies was due to PCNA. Since other in-
vestigators had noted that the PCNA immunoflu-
orescence pattern appeared to coincide with sites of
cellular DNA synthesis, we concluded that PCNA
is involved in cellular DNA replication as well as
SV40 DNA replication.
Shortly after the identification of the 36K repli-
cation protein as PCNA or cyclin, we noticed that
this protein had physical properties similar to those
of yet another cellular protein that was recently pu-
rified and shown to stimulate the activity of DNA
polymerase 8, a novel DNA polymerase found in
mammalian cells. In collaboration with K. Downey
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FIGURE -1 Immunofluorescent localization of PCNA, a protein required for SV40 DNA replication in
vitro, to the nuclei of human
He La cells using human autoantibodies. He La cells were fixed onto a glass coverslip and incubated with human autoantibody (ob-
tained from M. Mathews, Protein Synthesis Section). After eluting excess antibody, a second fluorescein-labeled goat anti-human
antibody was used as a reporter antibody. (A) Fluorescence micrograph; (B) phase-contrast micrograph. Note the variable staining
pattern in these asynchronously growing cells.
and A. So (University of Miami Medical School),
we demonstrated that the PCNA was identical to
the polymerase -6 auxiliary protein. Both proteins
stimulate the activity of the polymerase on primed,
single-stranded DNA by increasing the processivity
of the polymerization reaction. These results raise
the interesting possibility that DNA polymerase 8,
in addition to DNA polymerase a, is involved in
SV40 and cellular DNA replication. Previously, it
was thought that only DNA polymerase a was re-
quired for replicative DNA synthesis. We are cur-
rently seeking to identify directly the polymerases
involved, with the aid of monoclonal antibodies.
Similarly, studies are continuing to determine the
role of PCNA in replicative DNA synthesis, as well
as characterization of other cellular proteins. To
this end, a cellular protein derived from fraction A
that is required for formation of the presynthesis
complex at the replication origin has been partially
purified and its function in replication has been de-
termined.
SV40 T ANTIGEN
SV40 T antigen is a multifunctional protein that is
required for viral DNA replication and gene expres-
sion throughout the virus life cycle. It causes malig-
nant transformation of many cells. In collabora-
tion with Y. Gluzman's laboratory (Molecular
Biology of SV40 Section), we have previously stud-
ied the multiple activities of T antigen using puri-
fied proteins expressed from various mutants. Two
functions that reside within the T-antigen polypep-
tide, the site-specific origin DNA-binding activity
and an ATPase activity, are both required for DNA
replication in vitro. Recently, T antigen was shown
to contain a DNA helicase activity (Stahl et al.,
EMBO J. 5 1939 [1986]) that can unwind duplex
DNA, probably at the replication fork. The ATPase
activity of the protein is associated with this heli-
case activity. These multiple functions probably re-
flect the multiple roles that T antigen plays in vari-
ous stages of SV40 DNA replication; it facilitates
the formation of a multiprotein complex prior to
initiation of replication and most likely unwinds
the parental duplex DNA during the elongation
stage of replication.
In collaboration with I. Mohr and Y. Gluzman
(Molecular Biology of SV40 Section), a regulatory
role for T antigen in origin recognition has been
studied. It was demonstrated that dephosphoryla-
tion of SV40 T antigen with alkaline phosphatase,
which removed most, but not all, phosphate groups
from the molecule, stimulated the origin-binding
activity of T antigen, but not its ATPase activity.
Concomitant with the increased origin-binding
potential of the partially dephosphorylated protein
was an increased ability to support DNA replica-
tion in vitro. This suggests that phosphorylation of
SV40 T antigen during infection may contribute to
the temporal regulation of DNA replication. In the
future, it will be of value to examine the interaction
of phosphorylated and dephosphorylated forms of
SV40 T antigen with the cellular proteins that are
required for formation of the presynthesis complex
at the origin of replication.
DNA-Protein Interactions at
Viral and Cellular Origins
of DNA Replication
J. Diffley, S. Smith, B. Stillman
Replication origins from widely diverse organisms
commonly contain sites for high-affinity, sequence-
specific, DNA-binding proteins adjacent to highly
conserved, immutable A +T-rich domains. In SV40,
the virus-encoded large T antigen binds at sites ad-
jacent to a 17-bp A +T-rich domain. Deletion of
even 2 by from this domain, or deprivation of T an-
tigen from the system, inactivates the origin both in
vivo and in vitro. In most serotypes of adenovirus,
the cellular protein nuclear factor I (NFI) binds
with high affinity to a sequence abutting an A +T-
rich domain highly conserved among all serotypes
of adenovirus. NFI was first detected and purified
from HeLa cell nuclear extracts, using as an assay
the stimulation of in vitro adenovirus DNA replica-
tion in the presence of purified viral replication
proteins. Subsequently, we described a rapid and
sensitive assay for NFI, exploiting its high affinity
for DNA fragments containing the origin of
adenovirus replication. Using this assay to follow
NFI activity, we extensively purified NFI in the
presence of protease inhibitors, using a combina-
tion of conventional and affinity chromatography.
The final fraction of NFI was highly enriched for
a polypeptide of 160 kD. Since this report, we have
raised polyclonal antibodies against the 160-kD
polypeptide and have shown that this protein is
present in cell extracts from diverse cell/tissue
types, including chick embryo brain, mouse L cells,
and rat liver. Significantly, strongly antigenic poly-
peptides between 52 and 67 kD were detected in ex-
tracts from rat kidney and liver. Other groups have
purified forms of NFI with polypeptides in exactly
this range, and we are currently attempting to deter-
mine if they are derived from a 160-kD precursor
or if there are multiple proteins that can bind to a
similar site in the adenovirus origin. Furthermore,
we are continuing to study the role of the 160-kD
NFI in adenovirus replication.
Since the initiation of both adenovirus and SV40
replication requires virus-encoded proteins, in ad-
dition to cellular factors, it is difficult at present to
assess the degree to which understanding these
initiation systems will be helpful in understanding
the initiation of cellular DNA replication. To ad-
dress this problem directly, we have undertaken a
functional analysis of a potential cellular origin of
DNA replication from the yeast Saccharomyces
cerevisiae.
Using the filter-binding assay described for NFI,
we have identified and purified two very different
proteins that interact specifically with the yeast
chromosomal replicator ARS1. The first protein,
ARS-binding factor I (ABFI), was identified in
crude extracts and recently purified to near homo-
geneity. ABFI is a high-molecular-weight (300,000)
native protein consisting of polypeptides of ap-
proximately 140,000. This protein binds specifically
within a domain previously identified as being im-
portant for ARS function and which flanks the es-
sential A +T-rich ARS consensus sequence. In this
respect, ARS1 seems to be similar in overall anat-
omy to the origins of both SV40 and adenovirus
replication. Although ABFI does not bind to all
ARS elements, it does bind to an ARS within the
silent mating-type cassette, the HMR E region.
The second protein, ARS-binding factor II
(ABFII), was also identified in crude extracts and
purified to homogeneity as a 17-kD polypeptide.
Unlike ABFI, ABFII is not a sequence-specific
binding protein, exhibiting only a modest prefer-
ence for binding ARS1 sequences. Interestingly,
however, it was shown by retardation of DNA-pro-
tein complexes in polyacrylamide gels that ABFII
bends ARS1 DNA while not affecting control frag-
ments from pBR322. Furthermore, in the presence
of topoisomerase I, ABFII can introduce superheli-
cal turns in any relaxed, covalently closed, circular
plasmid DNA. In many respects, this protein
resembles the Escherichia coli HU protein, a small,
high-mobility-group-like protein that also exhibits
the supercoiling phenomenon. The HU protein is
required for E. coli oriC DNA replication in vitro
to help specify initiation of replication at the cor-
rect sequence. Since ABFII resembles the HU pro-
tein and exhibits ARS1-dependent DNA-bending
activity, it is possible that ABFII is involved in yeast
DNA replication. By combining these biochemical
studies with a genetic approach to understanding
the function of these two ARS-binding proteins, we
expect to gain further insight into the process of ini-
tiation of chromosomal DNA replication in yeast.
Functions of the Adenovirus
E1B Tumor Antigens
E. White, A. Denton, B. Stillman
Expression of adenovirus E1A and E1B gene prod-
ucts is required for the activation and regulation of
early gene expression and cellular transformation.
Several biological functions have been attributed to
the E1A gene products: (1) trans-activation of tran-
scription of adenovirus early genes and some cellu-
lar genes, (2) repression of enhancer-dependent
promoters, (3) stimulation of cellular DNA synthe-
sis and proliferation in quiescent cells, and (4) im-
mortalization of primary rodent cells in culture.
Considerably less is known about the function of
the major E1B gene products, the 19K and 55K tu-
mor antigens. Although the E1B 55K protein has
been assigned a role in the transport and stability
of mRNA and the shutoff of host-cell protein syn-
thesis, the E1B 19K protein function is less under-
stood.
Our research over the last few years has demon-
strated that the E1B 19K tumor antigen is required
to protect host-cell chromosomal DNA from degra-
dation during productive infection. It also appears
that the presence of the ElB 19K protein in the nu-
clear envelope is required to preserve the structural
integrity of cellular DNA. Furthermore, the host
range of adenovirus, as well as the morphology of
the infected cell, is grossly affected by the E1B 19K
gene product. Until recently, it has been difficult to
correlate the roles of the E1B 19K protein in DNA
protection, limiting host range, and modification
of cell morphology with any biochemical function.
Therefore, the function of this E1B-encoded poly-
peptide in either infection or transformation has re-
mained unclear.
To assess the role of the E1B 19K tumor antigen
during infection and transformation, we have relied
on the characterization of adenovirus mutants that
carry defined lesions in the E1B 19K gene. Experi-
ments carried out over the last year have elucidated
a number of important findings regarding E1B 19K
protein function. Foremost is the identification of
a functional interaction between the E1A and E1B
19K gene products. The ElA 13S and 12S gene
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products are responsible for inducing the degrada-
tion of host-cell chromosomal DNA in the absence
of the 19K protein, and, in turn, the E1B 19K pro-
tein functions in repressing E1A-dependent trans-
activation of adenovirus early gene transcription.
E1A GENE PRODUCTS INDUCE DNA DEGRADATION
We had determined previously that infection of hu-
man He La cells with adenovirus mutants that fail
to express the E1B 19K polypeptide results in the
degradation of host-cell chromosomal DNA (deg
phenotype) and enhanced cytopathic effect (cyt
phenotype). These phenotypes are the result of
early gene functions and occur prior to viral DNA
replication. We have sought to identify the early
gene product(s) that cause these phenotypes by
constructing double-mutant viruses. A series of
viruses were constructed that are unable to express
functional E1B 19K protein and, in addition, varied
in their ability to express each of the other early
gene products. Double-mutant viruses were then
assayed for the cyt and deg phenotypes, with the ex-
pectation that eliminating expression of both the
E1B 19K protein and the early gene product that
causes these phenotypes would result in reversion to
the wild-type phenotype (cyt+ and deg+). Analysis
of E1A-E1B double-mutant viruses yielded just
such a result.
Mutant viruses were constructed such that the in-
dividual 13S, 12S, or 9S E1A cDNA gene was ex-
pressed in place of the intact E1A gene, in conjunc-
tion with an E1B 19K gene mutation (Fig. 2). The
viruses were then assayed for cyt and deg in infected
He La cells. Expression of either 13S or 12S E1A
gene products was sufficient to induce DNA degra-
dation and enhanced cytopathic effect. Expression
of only the 9S E1A cDNA gene, however, resulted
in reversion to the wild-type cyt+ and deg+ pheno-
types, despite the absence of functional E1B 19K
protein. Therefore, expression of either the E1A 13S
or 12S gene products, which possess the trans-
activation and transforming activities of E1A, is ei-
ther directly or indirectly responsible for inducing
DNA degradation and enhanced cytopathic effect
during infection with E1B 19K gene mutant viruses.
Normally, during an infection with the wild-type
virus, the presence of functional E1B 19K protein
prevents this from occurring. Current efforts center
around mapping the functional domain within the
E1A proteins that causes the deg and cyt pheno-
types in the absence of the E1B 19K protein, with
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the ultimate intention of elucidating the biochemi-
cal relationship between E1A and E1B 19K gene
products.
E1B 19K TUMOR ANTIGEN REPRESSES E1A-DEPENDENT
TRANS-ACTIVATION
Another important finding that resulted from the
characterization of adenovirus E1B 19K gene mu-
tant viruses is that infection with these viruses
results in the overexpression of the E1A proteins.
The production of elevated levels of E1A proteins
leads to overstimulation of early gene transcription
and to an accelerated viral infection. These effects
of the E1B 19K gene product on E1A protein levels
and subsequent transcriptional trans-activation
were dependent on the expression of either the E1A
13S or 12S gene products. Eliminating expression
of E1A 13S and 12S genes by infection with an E1A
9S virus abolished any effect of the E1B 19K tumor
antigen on early gene expression.
We have concluded from these and other experi-
ments that the function of the E1B 19K tumor anti-
gen is to down-regulate the levels of E1A protein
during adenovirus infection. The absence of this
important regulatory phenomenon disturbs the
temporal sequence of transcription during produc-
tive infection and impairs the ability of adenovirus
to transform rodent cells.
The work on bacteriophage X set a precedent for
the importance of repressor mechanisms in the con-
trol of gene expression. Given the pivotal role of X,
repressor, similar mechanisms might be expected to
exist in eukaryotic systems. Further experiments
will determine whether adenovirus E1B 19K gene
mutant viruses represent an analogous system to
the repressor mutants of X. Nevertheless, defining
the precise mechanism by which the E1B 19K pro-
tein represses E1A-dependent trans-activation of
transcription should yield insight into the regula-
tory mechanisms of eukaryotic gene expression.
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MOLECULAR BIOLOGY OF SV40
Y. Gluzman A. Admon I. Mohr R. Frank
P. Argani W. Ryan M. Strauss
R. Gerard R. Chisum
D. McVey J. Cossetti
The SV40 T antigen is a large, multifunctional pro-
tein generated from the early region of the viral ge-
nome. It plays a role in the replication of the viral
DNA, in its transcription, and in SV40-mediated
cellular transformation. Our current studies focus
on the relationship between the structure of this
protein and its different functions. In particular, we
have been investigating the importance of post-
translational modifications, most notably phos-
phorylation, and defining the protein's origin-
binding domain. At the same time, we have con-
tinued our functional analysis of DNA sequences
in the origin itself.
Posttranslational Modifications of
SV40 T Antigen and Their Effect
on T-antigen Functions
Y. Gluzman, I. Mohr, A. Admon, W. Ryan
To examine the effect of phosphorylation on SV40
large T antigen, we purified 32P-labeled T antigen,
5171
w.t.
II
FIGURE 1 Three fragments of SV40 DNA containing the wild-type origin (w.t.), site
I (I), or site II (II) were cloned into the pAT153 plasmid. The wild-type plasmid (bp no.
5171-128) and site II (bp no. 5209-128) were cloned between HindlIl and Sphl sites
of the plasmid (Stillman et al., EMBO J. 4: 2933 [1985]); site I (bp no. 5171-5232) was
cloned between Hind111 and BamHl (no. 485) of pAT. For the assay, all of these plas-
mids were mixed in equimolar ratio and digested with Taql, which released four com-
mon plasmid fragments and three unique fragments: 295 by (w.t.), 257 by (II), and
233 by (I). The mixture of fragments was labeled by filling in the ends and used in
the assay.
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enzymatically dephosphorylated it with calf intesti-
nal alkaline phosphatase (CIAP), and assessed its
ability to act in several biochemical assays. The
phosphatase treatment successfully removed 80%
of the 32P label from large T antigen. Although
CIAP treatment did not affect the ability of the
protein to hydrolyze ATP, this partially dephos-
phorylated material displayed an increase in the
ability to direct SV40 origin-specific DNA synthe-
sis in vitro. Furthermore, this increase was most
profound at early time points in reactions pro-
grammed with suboptimal amounts of T antigen,
where a 20-fold activation was observed.
To check the interaction of normal and partially
dephosphorylated T antigens with the elements of
the SV40 origin of DNA replication, we used the T-
antigen-DNA complex immunoprecipitation tech-
nique (McKay, J. Mol. Biol. 145: 471 [1981]), in
which equimolar ratios of three SV40 fragments
were used. These fragments contain either a com-
plete wild-type origin (sites I and II), site I, or site
II element (see Fig. 1). The precipitation assay,
which was used in all of the experiments described
L-H
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below, reflects the stability of T-antigen-DNA
complexes and does not address the question of ini-
tial recognition of the DNA sites. The ability of the
partially dephosphorylated T antigen to bind spe-
cifically to DNA sequences contained within the
SV40 origin of replication was significantly altered,
when compared to that of untreated T antigen.
CIAP-treated material demonstrated at least a four-
fold increase in binding to site II, a core element
necessary for SV40 DNA replication, and a twofold
increase in binding to site I. The nature of these
quantitative changes is currently being investigated
in depth utilizing DNA footprinting techniques.
Preliminary data demonstrated a ninefold increase
in the ability of the T antigen to protect specifically
site II sequences following treatment with CIAP.
T antigen contains phosphorylated amino acids
that are localized at an amino-terminal cluster and
a carboxy-terminal cluster. Each region contains
several phosphoserine residues and a single phos-
phothreonine residue. Since treatment of purified T
antigen with CIAP only removes 8007o of the phos-
phate from the polypeptide, it is of interest to us to
determine those sites that are sensitive to enzymatic
dephosphorylation and to mediate the observed
changes in DNA replication/binding. To this end,
we developed a method for quantitative analysis of
the phosphoamino acids of the T antigen. This
method allows us to quantitate the amount of phos-
phoamino acid simultaneously with all other
amino acids. We have started peptide mapping of
the T-antigen protein by trypsin proteolysis and
reversed-phase chromatography. We are currently
in the process of identifying the modified peptides
as well as quantitating the phosphoamino acids on
each peptide.
Expression of SV40 T Antigen
in Escherichia coli
Y. Gluzman, R. Gerard, M. Strauss, I. Mohr
It is intriguing to envision that the numerous post-
translational modifications present on large T anti-
gen directly modulate the multiple activities of this
protein, influence its interaction with other cellular
components, or even target the protein to specific
intracellular locations. To produce T antigen lack-
ing all of the mammalian modifications, we have
made use of an Escherichia coli -based expression
system. The coding sequences for SV40 large T an-
tigen or truncated T antigens were cloned into an
expression plasmid between the phage T7 promoter
and transcriptional terminator. This plasmid was
used to transform bacteria that express T7 RNA
polymerase under the control of the lac UV5 pro-
moter. Addition of IPTG to the culture induces the
synthesis of T7 RNA polymerase, and this in turn
activates the transcription of the gene(s) cloned
downstream from the T7 promoter (Studier and
Moffatt, J. Mot Biol. 189: 133 [1986]). Full-length
T antigen (708 amino acids) produced in this man-
ner and purified by immunochemical techniques
possesses ATPase activity, and replicates SV40 ori-
gin containing DNA in vitro; however, this occurs
at substantially reduced levels when compared to T
antigen purified from a mammalian source. The
full-length protein produced in E. coli fails to bind
to a fragment containing only site II, a core element
of SV40 DNA replication, whereas its mammalian
counterpart binds to fragments containing either
site (see below). These data strongly implicate the
importance of posttranslational modifications of T
antigen on its biological activities.
Analysis of the Origin-binding
Domain of SV40 T Antigen
Y. Gluzman, M. Strauss, D. McVey, P Argani,
R. Frank
To determine the minimum protein domain that is
responsible for T-antigen binding to the origin of
SV40 DNA replication, we have isolated a series of
SV40 T-antigen mutants that code for amino-
terminal fragments of different lengths. Mutant
DNAs were used to produce truncated T-antigen
proteins in E. coli using the host vector system
described above. To screen the origin-binding prop-
erties of truncated T antigens in soluble E. coli
extracts, we used the T-antigen-DNA complex im-
munoprecipitation technique, as described above.
Full-length T antigen (708 amino acids), produced
in E. coli, precipitates separate fragments contain-
ing wild-type or site I, but not site II (see above).
Truncated T-antigen proteins that are 272 and 266
amino acids long precipitate only the wild-type
fragment at very low efficiency. However,
cated T antigen containing 259 amino acids regains
origin-binding activity to the wild-type fragment at
levels comparable to that of full-length T antigen;
binding to site I or site II is not detectable. Simul-
taneous analysis of the equivalent 259-amino-acid-
long T-antigen fragment produced in He La cells
demonstrated increased binding activity to the
wild-type origin; furthermore, binding to site II,
but not site I, was easily detected. These data fur-
ther support the importance of posttranslational
modifications in affecting the biological properties
of T antigen.
At present, we are analyzing a larger set of
amino-terminal T-antigen fragments produced in
E. coli. They form three classes with respect to their
origin-binding activities. One class behaves like
full-length T antigen. A second class binds to the
wild-type and site I fragments; in addition, it also
binds to site II, although at a reduced level. A
unique mutant binds to site-I-containing fragments
better than to wild-type or site II fragments. The
endpoints of these mutations are being determined
by sequence analysis.
Functional Analysis of the Role of
the A+T-rich Region and Upstream
Flanking Sequences in SV40
DNA Replication
Y. Gluzman, R. Gerard
The origin of SV40 DNA replication consists of
two major units: the core origin of DNA replica-
tion, which includes T-antigen-binding site II, and
the A +T-rich region adjacent to the core. The late
boundary of the minimal origin of replication of
SV40 DNA lies upstream of the A +T-rich region.
As we had previously reported, deletion of only a
few bases into the adenine-thymine (AT) stretch
results in a DNA template defective for replication
both in vivo and in vitro (Stillman et al., EMBO J.
4: 2933 [1985]). For a more detailed analysis of the
AT region and its role in origin function, such dele-
tion mutations have been reconstructed into an
SV40 genome containing an intact early promoter-
enhancer region. The resulting mutants synthesized
wild-type levels of T antigen but were defective for
replication and would not form plaques on CV-1
monkey cells.
Replication-competent phenotypic revertants were
selected after transfection of large quantities of the
replication-defective viral DNAs into CV-1 cells.
DNA sequence analysis showed that most of these
revertants contained insertions or point mutations
that partially regenerate the length of the AT
stretch. These genotypic alterations were shown to
be responsible for the revertant phenotype by repli-
cation analysis in vivo of subcloned revertant origin
fragments. In general, our results emphasize the
importance of the AT region to SV40 origin func-
tion. However, one revertant retained the altered
AT region but deleted six nucleotides upstream. Ex-
periments using this mutant indicate that the 21-bp
repeats identified as part of the early transcrip-
tional promoter may compensate for defects in
SV40 DNA replication in vivo caused by mutations
in the A +T-rich region when positioned at an ap-
propriate distance from the core origin.
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Repair of DNA Damage Caused by
5-Azacytidine in Escherichia coil
A.S. Bhagwat
5-Azacytidine (5-azaC), an analog of cytidine in
which the C -H group at position 5 is replaced by
a nitrogen, has a multitude of biological effects in
a wide variety of organisms. These effects range
from mutagenesis and inhibition of cell growth for
bacteria to an increase in sister chromatid exchange
in hamster cells, induction of differentiation in
mouse cells, and induction of synthesis of proteins,
such as hypoxanthine-guanine phosphoribosyl trans-
ferase and fetal globin, in human cells. At the bio-
chemical level, 5-azaC has been shown to cause
hypomethylation of DNA, to produce defective ri-
bosomal RNAs and tRNAs, and to inhibit protein
synthesis. The ability of 5-azaC to cause hypo-
methylation of DNA is believed to be the cause of
many of the phenotypic effects of the drug.
In vitro studies have shown that 5-azaC acts as
a mechanism-based inhibitor of cytosine methy-
lases. Most cytosine methylases link covalently to
position 6 of cytosine as a normal intermediate in
their action. Following the transfer of a methyl
group from S-adenosyl methionine to position 5 of
cytosine, the enzyme unlinks itself. 5-azaC, when
incorporated into DNA or RNA at the site of meth-
ylation, sabotages this reaction by making the
transfer of the methyl group to position 5 impossi-
ble. Hence, cytosine methylases form stable cova-
lent complexes with DNA (or RNA) containing
5-azaC.
The presence of such complexes in vivo has not
yet been demonstrated. If these complexes can exist
stably in vivo, they would be expected to interfere
with essential cellular functions such as DNA repli-
cation and hence cause cell death. A gene desig-
nated dcm codes for the only known DNA cytosine
methylase in the K-12 strain of Escherichia coli. But
contrary to expectation, wild-type E. coli is fairly
resistant to 5-azaC. We have taken this as evidence
for the existence of a repair pathway(s) for the
DNA damage caused by the drug and have inves-
tigated the genes involved in such repair.
Several interesting points have emerged from this
study. First, a recA-lexA-dependent pathway for the
repair of damage caused by 5-azaC exists. recA and
lexA control the inducible DNA repair ("SOS" re-
pair) in E. coli, and mutants that are defective in in-
ducible repair are very sensitive to the drug. The re-
quirement for the induction of SOS-repair genes
can be largely eliminated by overproducing the
RecA protein in the cell. Thus, RecA must play a di-
rect role in the repair. In contrast, uvr-dependent
excision repair does not appear to play a role in the
ability of cells to survive the damage. Together,
these data suggest that the repair of DNA damage
caused by 5-azaC in E. coli may be repaired by the
"postreplication repair" pathway, which uses the
ability of RecA to mediate homologous recombina-
tion.
Second, several lines of evidence suggest that
phosphorylation of 5-azaC and not of its decom-
position or degradation products, such as 5-aza-
uracil (5-azaU), is responsible for the lethal dam-
age. In contrast, we have found that the bacteri-
ostatic effects of 5-azaC are caused largely by the
conversion of the drug to 5-azaU and can be par-
tially overcome by the addition of an excess of nor-
mal uracil in the growth medium. Since the uracil
does not inhibit the conversion of 5-azaC to 5-aza-
dCTP, the potentially lethal effects arising from
DNA damage are unchanged. This is of great prac-
tical value since it permits the use of 5-azaC for the
selection of mutant methylases. Normally, selec-
tion is complicated by the bacteriostatic effects
caused by the drug that are unrelated to DNA
methylation. However, by including uracil in the
growth medium, the bacteriostatic effects of 5-
azaC are eliminated, and hence recA- cells carrying
a defective methylase gene are able to grow in the
presence of 5-azaC.
Finally, we have also found that dcm- recizi- and
Adcm recil- mutants of E. coli are significantly
more sensitive to 5-azaC than their recA+ parents.
This suggests either that E. coli carries an unknown
DNA cytosine methylase(s) or that 5-azaC causes
lethal damage in additional ways not presently un-
derstood.
Structure of EcoRII Endonuclease
and Methylase Genes and Their
Relationship to Other Restriction
Endonuclease and Methylase Genes
A.S. Bhagwat, F.B. Johnson, K. Weule [in collaboration
with S. Som and S. Friedman, SUNY-Health Science
Center, Brooklyn, New York]
The EcoRII restriction-modification (R-M) en-
zymes from E. coli are the prototype for one of the
largest set of isoschizomers, i.e., enzymes that
recognize the same DNA sequence. Over 40 restric-
tion endonucleases, including EcoRII, recognize
the sequence 5'-CC(A/T)GG-3'. Like EcoRII, each
of these enzymes is expected to be accompanied by
a modification methylase that recognizes the same
DNA sequence. Although all of these enzymes
recognize the same DNA sequence, they do so in
different ways. For example, if this sequence is not
methylated, EcoRII endonuclease cleaves the DNA
before the first cytosine. In contrast, BstNI en-
donuclease (from Bacillus stearothermophilus)
cleaves the sequence after the second cytosine,
regardless of whether either cytosine is methylated
at position 5. Several other interesting differences
between these isoschizomers are also known.
Hence, EcoRII and its isoschizomers present a fas-
cinating system for the study of sequence-specific
interactions between proteins and DNA.
We have cloned, mapped, and determined the
nucleotide sequences of the EcoRII genes. We have
also cloned a gene from the E. coli chromosome,
dcm, that codes for a methylase gene with specific-
ity identical to that of the EcoRII methylase. The
dcm gene has been mapped to a 1.5-kb fragment.
Parts of the EcoRII genes were cloned in M13
phage vectors, and the DNA sequence was deter-
mined by the dideoxy chain-termination method.
The genes are convergently transcribed, and the
corresponding termination codons are separated by
33 nucleotides. The direction of transcription of the
endonuclease gene determined from the nucleotide
sequence is consistent with the direction predicted
from the random protein fusions constructed be-
tween the endonuclease and the 3- galactosidase
gene. The predicted size of the methylase, 54,564
daltons, agrees well with the observed size of the
purified protein (55,000 daltons). At present, un-
certainty in the precise start of the endonuclease
gene prevents us from predicting the size of the en-
donuclease monomer.
We have used the nucleotide sequences of the
EcoRII genes and their predicted protein sequences
as starting points for a comprehensive search for se-
quence homologies among R-M systems. The data-
base includes sequences of 11 endonucleases and 17
methylases. This study has resulted in several in-
teresting observations: (1) All cytosine methylases
share several common protein domains. These con-
served domains are four to ten amino acids long
and are shared by methylases that recognize similar
DNA sequences, as well as by methylases that
recognize very different DNA sequences. Thus,
EcoRII, Mspl (from Moraxella species; recognition
sequence, CCGG), and Hhal (from Haemophilus
haemolyticus; recognition sequence, GCGC) share
at least six regions of protein sequence identity.
MspI and Hhal enzymes also share a great deal of
DNA sequence homology. (2) Adenine methylases
share little homology with the cytosine methylases
or with each other. The only adenine methylases to
share protein sequence homology are DpnII (from
Streptococcus pneumoniae) dam, and EcoRV; the
latter two are from E. coli. They recognize identical
or related sequences (GATC or GATATC). (3) None
of the endonuclease genes or proteins share signifi-
cant homology with any methylase or with each
other. Thus, even in the cases where the two methy-
lase proteins show significant homology with each
other, the corresponding endonucleases are non-
homologous. There is also significant rearrange-
ment around homologous methylase genes. The
EcoRII endonuclease and methylase genes are ad-
jacent to each other in a 5'->313'4--5' fashion,
whereas the MspI genes are arranged in a
3'.--515'3' fashion.
Overexpression of the MspI Methylase
B. Mollet
The MspI restriction-modification system, which
recognizes the DNA sequence 5'-CCGG-3', has
49
been previously isolated and sequenced (P.-M. Lin
and R.J. Roberts, unpubl.). A 3-kb-long DNA frag-
ment, containing the Mspl endonuclease and
methylase gene, has now been subcloned into a
pBR322 derivative plasmid. The endonuclease gene
has been deleted by further subcloning, and the
new clones have been tested for maintenance of
Mspl methylase activity. The inducible promoter
pTac has been introduced 85 by in front of the first
ATG start codon of the 418-amino-acid-long open
reading frame encoding the MspI methylase. When
E. coli cells carrying the overproducing plasmid are
induced with IPTG, a protein band of about 50 kD
appears on SDS protein gels of a crude extract. The
size of the protein is in good agreement with the cal-
culated molecular weight of 47,664 for the Mspl
methylase. After induction, this accounts for about
107o of the total cell mass of E. coll.
Cloning of the BspRI Restriction
Endonuclease Gene
A. Kiss
Analysis of the protein sequences deduced from the
DNA sequences of cloned modification methylases
has revealed structural similarities between several
enzymes that recognize identical or related DNA
sequences. This opens the way for a more detailed
analysis of the mechanism by which these enzymes
recognize their target sequence. Much less informa-
tion is available for restriction endonucleases,
mainly because few genes have been cloned and
even fewer genes have been sequenced. Further-
more, those endonucleases whose sequences have
been determined display different specificities. To
date, no isoschizomers have been compared at the
sequence level.
We previously cloned and sequenced the gene en-
coding the BsuRI endonuclease from Bacillus sub-
tilis (recognition sequence, GGCC). To find out
whether restriction enzymes with the same specific-
ity share sequence homology, we began cloning the
Bacillus sphaericus enzyme BspRI, which is an
isoschizomer of BsuRI. Initially, we tried to use hy-
bridization as a means of identifying suitable
clones. Hybridization at low stringency (56°C in
6 x SSC) allows the BspRI and BsuRI methylase
genes to hybridize. We tested whether this also
holds for the endonuclease genes. We have been un-
able to find, in Southern experiments, conditions
under which the BsuRI endonuclease gene would
specifically hybridize to B. sphaericus DNA. This
effectively prevented the use of this method as a se-
lection to clone the BspRI endonuclease gene.
As an alternative approach, we cloned several
large fragments of chromosomal DNA by selecting
for the methylase. If the endonuclease gene is lo-
cated close to the methylase gene, as has been found
in many systems, then this strategy would allow
both genes to be cloned. We obtained several clones
carrying the methylase gene on overlapping frag-
ments, but none of them showed BspRI en-
donuclease activity.
Another method to clone the BspRI en-
donuclease gene was tried. A host, already carrying
the methylase, was used, and selection for en-
donuclease function was carried out by infecting
the clones with nonmodified phage. This also
failed. These failures were not entirely surprising
because cloning of many restriction genes has not
been successful in other laboratories. This can basi-
cally happen for two reasons: Either the gene is not
expressed in the cloning host or it is deleterious to
the cell.
One way to circumvent this problem is to try to
clone the endonuclease gene, or part of it, by using
an oligonucleotide hybridization probe that was
synthesized on basis of the protein sequence. To
do this, we purified the BspRI endonuclease to
homogeneity, and a partial amino-terminal amino
acid sequence was determined in an automatic gas-
phase sequencer. The sequence was Ala Gln ? Lys
Tyr Gly Ala Leu Glu Gln Lys Val Ala Asn Ile Phe
Ile Asn. Using this information, we devised a mixed
probe of 17-mer oligonucleotides that correspond
to amino acid residues 10-14 and to the first two
nucleotides of the triplet coding for Ile-15. The
oligonucleotides were synthesized in two pools,
each containing 64 different sequences. These
oligonucleotide probes were used in Southern ex-
periments to hybridize to B. sphaericus chro-
mosomal DNA. In 6 x SSC at 37°C, both probes
hybridized to several fragments. No hybridization
was detected under more stringent conditions. We
also tested whether these probes hybridized to any
of those plasmids mentioned earlier, which in addi-
tion to the methylase gene carry large pieces of
B. sphaericus DNA. Pool I was found to hybridize
to one of these plasmids. This plasmid carried the
largest piece of B. sphaericus DNA downstream
from the methylase gene. The analysis of this plas-
mid is now in progress.
TABLE 1 Simple Hexanucleotide Palindromes
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Restriction Endonucleases
R.J. Roberts, K. Weule
The collection of restriction endonucleases con-
tinues to grow, and more than 750 such enzymes are
now known; 140 different specificities have been
characterized, including 123 type II enzymes. Dur-
ing the last year, 25 new enzymes have been isolated
and characterized as part of a collaborative pro-
gram with I. Schildkraut and D. Comb (New En-
gland BioLabs). Among these, only one, BspHI
(TCATGA), displays a new sequence specificity.
The remaining enzymes are isoschizomers of
known endonucleases. Several other enzymes, that
appear to display new sequence specificities are still
being examined. As shown in Table 1, 49 of the pos-
sible 64 enzymes that could recognize hexanucleo-
tide palindromes have now been discovered.
Sequence of the HpaII Methylase Gene
A. Kiss, J. Hasapes, K. Weule
Previously, we determined the complete sequence
of the genes of the Mspl restriction-modification
system. The Mspl endonuclease recognizes the se-
quence CCGG and cleaves between the two C
residues. The methylase recognizes the same se-
quence, and methylates the outer cytosine. Re-
cently, the HpaII methylase has been cloned by G.
Wilson at New England BioLabs. This methylase
also recognizes the sequence CCGG, but differs
from the Mspl methylase in that it methylates the
inner cytosine residue. To allow a comparison of
these two enzymes, we analyzed the sequence of the
HpaII methylase gene. The gene was obtained on a
2-kb insert in pBR322. The insert was transferred
to M13mp19 in both orientations and was used to
prepare a series of phased deletions suitable for se-
quence analysis. It should be noted that whereas
the original pBR322 plasmid carrying the gene was
completely resistant to HpaII digestion, both M13
clones showed only partial resistance when their Rf
DNA was isolated from JM107. Sequence analysis
of the gene is almost complete.
Purification of Factors Involved
in Nuclear Pre-mRNA Splicing
A.R. Krainer
My long term goal is to identify, purify, and charac-
terize factors necessary for nuclear pre-mRNA
splicing in mammalian cells. Previous work with
He La and Saccharomyces cerevisiae in vitro sys-
tems showed that pre-mRNA splicing occurs via a
two-step pathway, each step consisting of a cleavage
and a ligation reaction. At present, it appears that,
in addition to several unknown protein factors, the
small nuclear ribonucleoproteins (snRNPs) Ul,
U2, U4/U6, and U5 are involved in the first step of
the reaction. The Ul snRNP is involved in the selec-
tion of 5' splice sites by RNA-RNA base pairing. U2
and U5 appear to bind at the branch point and 3'
splice sites, respectively. However, the mechanism
of action of these snRNP particles is not known.
They may act in a stoichiometric manner to bind to
specific sites and fold the pre-mRNA into a confor-
mation that is optimal for the cleavage-ligation
reactions. Alternatively, the snRNAs may be ribo-
zymes, with intrinsic catalytic activities, or the
snRNP polypeptides may have enzymatic activities
that are brought to their sites of action by their as-
sociated snRNAs. Precedents for each of these
types of mechanisms are, for example, self-splicing
RNAs, RNase P, and ribosomes. Elucidation of the
detailed mechanisms of action of snRNPs and of
other splicing components will require their purifi-
cation in an active form.
To purify snRNPs that are active, at least with re-
spect to their involvement in the splicing reaction,
51
I have chosen to try an immunoaffinity scheme.
The basic methodology was developed by R. Luhr-
mann and co-workers, who showed that snRNPs
could be bound specifically via their snRNA moi-
eties by antibodies directed against modified nucle-
osides. Gentle elution from the antibody columns
could be accomplished by competition with the
relevant free nucleoside. My goal is to apply this
methodology to snRNPs present in splicing extracts
and to test the activity of the purified snRNPs by
biochemical complementation assays involving the
restoration of splicing activity to extracts depleted
of snRNPs.
With the help of C. Bautista and E. Harlow (Pro-
tein Immunochemistry Section), I have recently ob-
tained two mouse monoclonal antibodies specific
for 2,2,7-trimethylguanosine (m3G). This modified
nucleoside is present in the characteristic cap struc-
tures of all known snRNPs, except U6. These anti-
bodies can be used to immunoprecipitate specifi-
cally and efficiently the snRNPs Ul, U2, U4/U6,
and U5 from a crude splicing extract, with retention
of all of the previously characterized snRNP poly-
peptides. The snRNPs bound to a m3G monoclo-
nal antibody column can be eluted by competition
with free m3G at moderate ionic strength. I am pres-
ently scaling-up this purification step to obtain con-
centrated snRNPs that can be assayed for splicing
and splicing complex formation. I am also employ-
ing these antibodies to analyze the polypeptide com-
position of snRNPs under different conditions.
Ongoing myc-associated Projects
N. Sullivan [in collaboration with R.A. Watt,
Smith Kline and Beckman]
To approach the function of the human c-myc pro-
tein, the coding sequence has been cloned and in-
serted into bacteria, and the protein has been over-
expressed. The subsequently purified protein forms
a basis for the biochemical and structural studies
currently in progress.
Several monoclonal antibodies directed against
the bacterially produced human c-myc protein have
been isolated and mapped by immunoblotting
against truncated derivatives of the c-myc protein.
Two of these antibodies, B3 and Eio, which do not
compete in enzyme-linked immunosorbent assays,
map to the amino terminus of c-myc, whereas an-
other antibody, B7, recognizes an epitope in the
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carboxyl terminus of this protein. These antibodies
are being used in attempts to block the action of c-
myc in vivo by microinjection and to make affinity
columns for the isolation of myc-associated com-
plexes.
The c-myc protein is capable of binding to DNA,
although no specificity has yet been demonstrated.
Other experiments, namely, nuclease digestion of
fixed cells, indicate that the c-myc protein may in-
teract with nuclear RNA but not DNA. Thus,
nucleic-acid-binding experiments are now in pro-
gress (1) to determine the kinetics of the myc-RNA
association and (2) to identify cellular sequences
with which c-myc may interact.
In collaboration with J. Anderson (Demerec
Laboratory), we have initiated studies to crystallize
both the c-myc protein and two truncated deriva-
tives that correspond to the amino- and carboxy-
terminal proteins of the protein. These are currently
purified from broken E. coli lysates by detergent ex-
traction, followed by anion-exchange and gel-
filtration chromatography. This protein, which is
currently 9507o pure, is being purified further for the
purposes of crystallization. Together with a func-
tional domain analysis, we hope that the X-ray
crystal structure of the c-myc protein will lead us to
a better understanding of how this protein interacts
with nucleic acid.
That c-myc colocalizes with snRNPs leads us to
hypothesize a functional role for myc in RNA pro-
cessing. This is being investigated by examining the
formation of splicing complexes in nuclear extracts
prepared from a c-myc-expressing cell line. Does
the myc protein associate with larger complexes as
they form from smaller precursors and exogenous
RNA? In addition, immunoprecipitation experi-
ments are being performed in an attempt to identify
potential direct associations between c-myc and
proteins of the snRNP particles.
Adenovirus-2 Early Region 1A
Gene Products
B. Zerler, L. Schoenherr
In collaboration with E. Moran and M. Mathews
(Protein Synthesis Section), we are continuing to
study the relationship between the structure of the
adenovirus early region lA (E1A) gene and the bio-
logical roles of this gene in host-cell immortaliza-
tion and the regulation of gene expression. Com-
parison of the amino acid sequences of the E1A
regions of several adenovirus serotypes shows that
the E1A regions are highly conserved within three
distinct domains. Domains 1 and 2 are common to
both the 12S and 13S products and encompass
amino acids 22-45 and 120-139, respectively. The
third domain consists essentially of the 13S unique
region and encompasses amino acids 140-185. Ini-
tially, plasmids and viruses containing the separate
E1A 12S and 13S cDNA products were isolated.
These constructs identified domain 3 (the 13S
unique region) as being necessary for efficient acti-
vation of viral gene expression, but not for the in-
duction of host-cell immortalization. Subsequent
analysis by construction of in-frame and site-
specific point mutations (Moran et al., Mol. Cell.
Biol. 262: 3470 [1986]) identified domain 2 as an ac-
tive site for the stimulation of proliferation of pri-
mary baby rat kidney (BRK) cells and for the ability
to cooperate with the ras oncogene to transform
primary BRK cells fully; in addition, a noncon-
served region (amino acids 86-120) was identified
between domains 1 and 2 that is dispensable for the
functions associated with domains 2 and 3.
During this past year, we used these mutants to
analyze the changes in host-cell gene expression
that occur during the early stages of adenovirus-
induced proliferation of quiescent primary BRK
cells. We have identified different host-cell prod-
ucts, associated with DNA replication and trans-
formation, whose activation appears to be depen-
dent on different domains of the E1A products.
Nuclear runoff and cytoplasmic RNA dot blots
showed that expression of the DNA replicative en-
zyme, thymidylate synthase (TS), occurred 8 hours
after infection of quiescent primary BRK cells with
either wild-type or the E1A 13S cDNA virus. The
kinetics of expression of TS were essentially the
same as that of the adenovirus DNA-binding pro-
tein (DBP). Expression of TS and DBP was not de-
tected by 8 hours or even by 16 hours after infection
of BRK cells with the 12S cDNA virus or the E1A
host-range mutant virus hr3, which contains a sin-
gle amino acid change within domain 3. TS and
DBP expression eventually occurs during 12S viral
infection, but not until some time between 16 and
24 hours postinfection. Expression of TS and DBP
was not impaired during infection with the E1A
mutant transformation-defective virus E1A 928
that contains a single amino acid change within do-
main 2.
The expression of a different cellular product as-
sociated with DNA replication and transformation,
proliferating cell nuclear antigen (PCNA), appears
to be independent of the E1A activity required for
the efficient activation of DBP or TS. PCNA ex-
pression was detectable by immunoprecipitation by
8 hours postinfection of primary BRK cells with ei-
ther the 12S or 13S cDNA viruses. PCNA expres-
sion was not impaired in BRK cells infected with
the E1A 928 or E1A hr3 mutant viruses, and it was
not impaired in cells infected with viruses contain-
ing in-frame deletions of domain 2, domain 3, or
the nonconserved region between domains 1 and 2.
We also found that all the mutant viruses were able
to stimulate DNA synthesis, measured by [3H]thy-
midine incorporation into acid-precipitable mate-
rial, in quiescent primary BRK cells to levels at least
5007o of wild type.
These experiments identified two cellular prod-
ucts, TS and PCNA, that are activated during
adenovirus infection of primary BRK cells. Early
activation of TS correlates with the function of
E1A required for the efficient activation of early vi-
ral genes (domain 3) and may be associated with
usurpation of the host DNA replication machinery
for viral replication. Early activation of PCNA and
stimulation of DNA synthesis occurred in primary
BRK cells infected with mutant viruses that in com-
bination excluded all but the amino-terminal 85
amino acids of the E1A products. Activation of
PCNA and stimulation of DNA synthesis appear
to be independent of the early region gene-
activation functions associated with domain 3, as
well as the transformation-related functions as-
sociated with domain 2. These activities are also in-
dependent of the nonconserved amino acids be-
tween domains 1 and 2. On the basis of these
results, we felt that a function of conserved domain
1 (amino acids 22-45) involved the activation of
PCNA and the stimulation of DNA synthesis.
To test this idea more directly, we made a single
amino acid change (Leu- 49- Phe -49) in domain 1
and an in-frame deletion of amino acids 20-85 that
removed the entire domain. 12S cDNA viruses con-
taining the Leu-Phe mutation did not exhibit al-
tered growth characteristics compared with wild-
type virus during infection of He La cells, and the
mutant was able to stimulate DNA synthesis to
wild-type levels during infection of primary BRK
cells. However, the amino acid change resulted in a
2-3-kD decrease in apparent molecular mass of
both the 12S and 13S E1A proteins, whereas a
different Leu-Phe change at position 173 (the hr4
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mutation) did not result in any apparent change in
the mobility of the E1A proteins. Virus containing
the in-frame deletion that excludes domain 1 was
unable to activate PCNA, stimulate DNA synthe-
sis, or cooperate with the ras oncogene to transform
primary BRK cells fully. Plasmids containing this
deletion were still able to activate the adenovirus E3
promoter in a transient expression assay, indicating
that domain 1 is not involved in the trans-activation
of early region genes.
We also observed that the domain-1 deletion mu-
tant virus and viruses containing mutations in do-
main 2 were unable to stimulate proliferation of
primary BRK cells, as visualized by vital staining 6
days after infection. This result was not unexpected
for the domain-1 mutant, since it does not activate
PCNA or stimulate DNA synthesis. Domain-2 mu-
tants, however, do not affect the ability of the E1A
products to activate PCNA or stimulate DNA syn-
thesis in quiescent primary BRK cells. To examine
more closely the point in the cell cycle that domain-
2 mutants fail to pass, we determined the ability of
wild-type and mutant viruses to stimulate infected
BRK cells to enter mitosis. We used the drug
nocodazole to block cells in metaphase and found
that domain-2 mutants were extremely impaired in
their ability to induce mitosis. Therefore, it appears
that a function of domain 1 is to stimulate quies-
cent primary BRK cells to enter GI of the cell cy-
cle, whereas a function of domain 2 enables the
BRK cells to progress from GI to mitosis.
We have shown that conserved domain 3, unique
to the 13S gene product, is required for the acceler-
ated activation of adenovirus early region genes
and the cellular TS gene but is dispensable for pri-
mary BRK cell proliferation. Domain 2 is required
for the induction of mitosis and the stimulation of
proliferation of primary BRK cells but is dispens-
able for the stimulation of DNA synthesis and the
early activation of viral genes. Amino acids 20
through 85, which includes conserved domain 1,
appear to be sufficient for activation of PCNA and
the stimulation of DNA synthesis; however, these
activities of domain 1 are not sufficient to induce
cell proliferation.
We are extending our analysis of the functions of
domain 1 by making single-site alterations in this
region, and we are continuing to use the domain-1
and domain-2 mutants to explore the regulation of
host-cell proliferation. In addition, we are using TS
cDNA clones that contain mutations in the 5'
regulatory region to determine sequences respon-
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sive to the trans-activation functions of the E1A
products.
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PROTEIN CHEMISTRY
D.R. Marshak A. Admon D. Carroll
G. Binns N. Santoro
The Protein .Chemistry Section is involved in the
purification, structural analysis, and chemical syn-
thesis of proteins and peptides. In the laboratory,
we employ state-of-the-art instrumentation and
methodologies for protein chemistry. The chemical
analyses of proteins are essential to our group's ef-
forts to understand the basic mechanisms of cell
proliferation and cancer. Proteins are the molecular
phenotypes of genes, and the cellular responses to
changes in gene expression during oncogenesis are
due to the functions of the protein products of
those genes. Our investigations of protein structure
and function have shed light on the molecules that
transform normal cells into cancers.
We have focused our research in four major
projects: (1) analyses of posttranslational modifica-
tions on products of the oncogenes, adenovirus
early region 1A (E1A) and SV40 T antigen; (2)
purification and characterization of a new mito-
genic factor that is secreted by epithelial cells in-
fected by adenovirus; (3) structural analysis of the
proliferating cell nuclear antigen (PCNA) that has
been identified as a DNA replication factor; and (4)
development of new methods of protein sequence
analysis and peptide synthesis. We have completed
several structures using mass spectrometry, an
emerging technique in protein chemistry. Our im-
proved methods of peptide synthesis allow us to
build proteins of relatively large size (50-100 amino
acids). Thus, advanced technologies combined with
our multidisciplinary approach to important bio-
logical questions create an exciting atmosphere for
protein chemical analysis.
Modification of Oncogene Products
D. Carroll, A. Admon, N. Santoro, D. Marshak
[in collaboration with E. Harlow, C. Stephens,
and Y. Gluzman, Cold Spring Harbor Laboratory]
The protein products of the adenovirus ElA gene
and the SV40 T antigen gene are heterogeneous in
size and charge. Some of the heterogeneity can be
attributed to alternative splicing mechanisms that
give rise to different mRNAs; however, even the
products of specific mRNAs produce heteroge-
neous products. To uncover the basis of this hetero-
geneity, we have investigated the posttranslational
modification of the ElA proteins and T antigen.
The E1A proteins can be immunoprecipitated
from in vitro translation mixtures using antibodies
developed by E. Harlow (Protein Immunochemis-
try Section). Treatment of the E1A proteins with
phosphatases significantly decreases the heteroge-
neity of the E1A proteins on two-dimensional gel
electrophoresis, suggesting that many of the
modifications are phosphorylations. Two missense
mutants in E1A-containing point mutations at ser-
ine residues 132 and 219 were analyzed by im-
munoprecipitation and electrophoresis. The results
indicated that phosphorylation of these two serine
residues are the first two modification steps for
E1A. The mutant virus at Ser-132 has a reduced
ability to transform cells. Thus, the phosphoryla-
tion at this residue might be a crucial step in the ac-
tivation of E1A during transformation.
To pursue this phenomenon further, we are at-
tempting to identify and characterize the kinase
that is responsible for the phosphorylation of Ser-
132. We constructed a synthetic peptide consisting
of 14 residues surrounding the phosphorylation site
at residue 132. This peptide blocks the phosphory-
lation of E1A in vitro, and it appears that the pep-
tide itself is phosphorylated. We are currently using
this peptide as substrate to measure and purify the
E1A kinase. In addition, we have constructed a se-
ries of other peptides that are designed to be spe-
cific inhibitors of the enzyme.
Our studies on T-antigen phosphorylation take
advantage of the availability of large amounts of
the protein from overproduction systems in He La
cells or from Escherichia coll. We fragment the pro-
tein into pieces using enzymatic digestions and then
isolate the peptide fragments by high-performance
liquid chromatography (HPLC). A. Admon (this
section) has developed a new method for analysis
of the phosphorylated amino acids in the peptides:
The peptides are first subjected to complete en-
zymatic digestion using immobilized amino pepti-
dase and carboxyl peptidase. The resulting amino
acids are labeled with phenylisothiocyanate, and
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the derivatives are separated by HPLC. This separa-
tion permits the quantitation of all of the unmodi-
fied amino acids as well as the phosphorylated
amino acids. We anticipate that this new procedure
will allow us to identify rapidly the multiple phos-
phorylation sites on T antigen.
Further studies of the kinases that catalyze the
phosphorylation of T antigen are now in progress
using synthetic peptide substrates. Because T anti-
gen and E1A share regions of structural homology,
the research on T antigen and E1A phosphoryla-
tion are intertwined. We hope to identify enzymes
that are fundamental to the activation of nuclear
oncogenes and to cellular growth.
Mitogenic Factor Induced
by Adenovirus
D. Marshak, N. Santoro [in collaboration with M. Quinlan
and T. Grodzicker, Cold Spring Harbor Laboratory]
When adenovirus infects primary cultures of baby
rat kidney cells, the epithelial cells rapidly prolifer-
ate. Using serum-free defined media, we found that
the fibroblasts were overgrown by the immortalized
epithelial cells. The adenovirus responsible for the
establishment of these cells has had the E1A region
removed and replaced by a cDNA for the E1A 12S
gene product. This virus construction does not al-
low complete transformation or lytic growth of the
virus, but the virus does cause quiescent cells to
proliferate. The conditioned media harvested from
the infected epithelial cells cause other uninfected
cells to proliferate. The mitogenic factor in the me-
dia is heat-labile and sensitive to trypsin digestion,
indicating that the factor is likely to be a protein.
We have begun to characterize this mitogenic fac-
tor biochemically. From the media, the factor is re-
tained by ultrafiltration membranes with a 100,000 -
molecular- weight cutoff and is found in the pellet
upon centrifugation at 100,000g. After treatment
with 4 M sodium chloride, however, the mitogen
is freely soluble at neutral pH, and it does not sedi-
ment upon subsequent ultracentrifugation. Thus,
the protein appears to be associated with a high-
molecular-weight component, perhaps a cell matrix
protein such as fibronectin or laminin. Further evi-
dence that supports this hypothesis resides in the
fact that heparin potentiates the mitogenic activity,
and heparin is representative of glycosaminogly-
cans that naturally bind to the cell matrix and to a
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family of mitogenic proteins. Preliminary studies
indicate that the factor is acidic, with a molecular
weight of greater than 12,000.
Our future studies on this factor will focus on the
purification and complete structural analysis of the
protein. We will also initiate studies to identify a
receptor for the mitogenic factor. Eventually, we
hope to understand the mechanism of action of the
factor and the way in which the adenovirus 12S E1A
gene product stimulates its expression. Most of the
time, when wild-type adenovirus infects a tissue,
the virus finds adult, quiescent cells, not proliferat-
ing cells. As part of the earliest response after infec-
tion, it is advantageous for the virus to stimulate
the host cell to secrete mitogenic factor, so that the
surrounding cells proliferate. Such a paracrine re-
sponse would allow the progeny viruses to encoun-
ter a proliferating tissue, thus boosting the in-
fectivity of the viral particles and accelerating
oncogenesis. We believe that this mitogenic factor
may be an important part of the mechanism of viral
oncogenesis.
Proliferating Cell Nuclear Antigen
D. Marshak [in collaboration with G. Prelich,
M. Kostura, M. Mathews, and B. Stillman,
Cold Spring Harbor Laboratory]
PCNA is a protein that was initially identified by
an autoantiserum from patients with the autoim-
mune disease, systemic lupus erythematosus.
PCNA is localized to the nucleus of proliferating
normal cells and tumor cells, but it is not detected
in quiescent cells. The expression of PCNA is under
cell-cycle control such that it is preferentially syn-
thesized during the S phase. During the course of
their studies on PCNA, M. Kostura and M. Math-
ews (see Protein Synthesis Section) were able to pu-
rify the protein from human cells and rabbit tissues
by following immunoreactivity to the autoantise-
rum. We succeeded in identifying the first 26 amino
acid residues of the protein. G. Prelich and B.
Stillman (DNA Synthesis Section) had isolated a
protein that was active as a DNA replication factor,
and they noticed that its chemical and physical
properties were similar to those of PCNA. We
showed by sequence analysis of the DNA replica-
tion factor that the amino-terminal 26 residues were
identical to those of PCNA. Taken together with a
variety of biochemical, immunological, and tune-
tional data, our structural analyses have helped to
prove that PCNA is a DNA replication factor.
Structural Analysis of Peptides
D. Marshak, N. Santoro, G. Binns [in collaboration
with B. Fraser, Food and Drug Administration,
Bethesda, Maryland]
We have completed the structure of several novel
peptides using a multidisciplinary approach. Our
approach involves three stages: (1) purification, (2)
characterization, and (3) application. Purification
relies on an accurate biological or chemical assay to
measure the yield of active protein at each step.
Characterization should include several indepen-
dent and complementary methods of structural
analysis, e.g., amino acid analysis, chemical se-
quence analysis, and physical determination of
mass, usually by mass spectrometry. The applica-
tion of structural information is the most impor-
tant part of our strategy. Deciphering the complete
structure of the protein is not the end of our work;
rather, structural information permits us to study
the relationships between the detailed structure and
the function of the molecule. Often, these studies
of structure and function involve site-directed
mutagenesis, site-specific antibodies, and synthetic
peptide analogs of the protein.
The structures of several polypeptides have been
elucidated during the past year using our multidis-
ciplinary strategy. The structure of a new gonado-
tropin-releasing hormone (GnRH) was elucidated
by a combination of mass spectrometry and chemi-
cal analysis. Mass measurements by physical meth-
ods are quite accurate; in this case, the measured
mass of the GnRH molecule was 1226.54 and the
actual mass was 1226.59. Proof of the structure was
further demonstrated by synthesis of the molecule
by chemical methods and using the synthetic pep-
tide to stimulate ovulation in test animals.
The amino-terminal peptide structure of en-
dothelial cell growth factor 13 (ECGF-13) was deter-
mined by mass spectrometry. This molecule has an
acetylated alanyl residue at the amino terminus,
and subsequent proteolytic cleavages of the
blocked protein produces the daughter molecules,
ECGF-a, and acidic fibroblast growth factor. Our
studies have helped to demonstrate that the ECGF-
13 is a precursor for this family of mitogens.
We have improved our methods of solid-phase
peptide synthesis using an automated instrument,
the Applied Biosystems 430A. Peptides are pre-
pared by condensations of t-Boc amino acids as
symmetric anhydrides on solid-phase systems ac-
cording to the method of Merrifield. This proce-
dure is automated using the synthesizer, and we
sample the resin at each step for quantitative analy-
sis of the coupling efficiency. Recent procedures in-
clude double-coupling cycles, with capping of the
unprotected chains with acetic anhydride. This al-
lows the synthesis of longer (>40 residues) peptides
and simplifies the purification procedure. The
crude products of such syntheses generally contain
the major desired product and a series of smaller
termination fragments of the peptide, but very few
deletion products. This is an advantage because the
multiple deletion products are difficult to separate
from the desired product. The peptides are removed
from the resin by treatment with hydrogen fluoride
or trifluoromethane sulfonic acid, precipitated
twice with ether, and filtered on a gel permeation
column for desalting. The resulting crude peptide
products are further purified by preparative HPLC
on reversed-phase columns, 1-2 inches in diameter.
The products are routinely characterized by amino
acid analysis, sequence analysis, and analytical
rechromatography on HPLC.
During the past 3 years, we have been able to ana-
lyze synthetic peptide products by fast atom
bombardment mass spectrometry through a collab-
oration with B. A. Fraser (Food and Drug Adminis-
tration, Bethesda, Maryland). Our general proce-
dure is to analyze fraction samples from the HPLC
purification of the peptide. If the peptide mass is
within approximately 0.1 amu of the expected mass,
then we accept the material for use in biological ex-
periments. In addition, we have been able to iden-
tify several interesting by-products of the chemical
synthesis, such as dehydration, fluoridation, and
alkylation. Treatment of peptides with aspartyl-(0-
benzyl ester)-Gly sequences with strong acid under
dehydrating conditions (as in cleavage from the
resin) leads to cyclization of the side chain to yield
an aspartimide. The use of the O- cyclohexyl ester
of aspartic acid greatly reduces this cyclization. The
dehydrated products can be separated by isocratic
HPLC and display a nominal mass 18 amu lower
than the desired product. In another case, treat-
ment of a peptide with hydrogen fluoride resulted
in three products with additions of 19 amu. Prelim-
inary analysis of these products suggests that under
certain conditions, free radical of fluorine (F) can
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add to a stable free radical at a tertiary carbon atom
to form an alkyl fluoride derivative. This occurs on
residues of isoleucine and valine predominantly.
Finally, alkylation and oxidation of indole rings
in tryptophan residues have been routinely identi-
fied in peptide products. This most frequently oc-
curs during the cleavage procedures under strong
anhydrous acid, presumably by a free radical
mechanism.
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The Protein Immunochemistry Laboratory con-
sists of two units, one is a research group that is
studying the functions of nuclear oncoproteins and
the other serves as a central facility for the produc-
tion of monoclonal antibodies. The Monoclonal
Antibody Facility is run by Carmelita Bautista. In
collaboration with scientists at Cold Spring Harbor
Laboratory, the facility handles all stages of the
production of monoclonal antibodies. During the
last year, they have produced 12 different panels of
hybridomas secreting antibodies specific for a wide
range of antigens. Descriptions of many of these
projects can be found in the individual research
projects discussed in this Annual Report.
Research in the Protein Immunochemistry Labo-
ratory focuses on the function of nuclear on-
coproteins such as the adenovirus early region 1A
(E1A) and cellular p53 proteins. Much of our work
over the last year has concerned the analysis of the
ElA proteins. Several years ago, we prepared a
panel of monoclonal antibodies specific for the
E1A polypeptides, and these reagents have allowed
us to investigate a number of unusual properties of
these proteins. During the last year, we have corn-
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pleted a major segment of our studies on the physi-
cal characterization of the E1A proteins. These
studies have shown that the E1A region codes for
five mRNAs, that the primary translation products
of these five mRNAs are highly modified during
posttranslational processing, and that the ElA pro-
teins form a series of stable complexes with host-
cell polypeptides. Our goal now is to use this new
information to help understand the molecular basis
for the functions of the E1A proteins in both viral
growth and transformation.
Heterogeneity of the Adenovirus
Early Region 1A Proteins
C. Stephens, E. Harlow
When the adenovirus E1A proteins are separated by
two-dimensional, isoelectric-focusing polyacryl-
amide gel electrophoresis, the E1A-specific poly-
peptides can be resolved into approximately 80
different species. This polypeptide heterogeneity
arises from at least two sources: (1) The primary
transcript of the ElA region is differentially
processed to yield five mRNAs, and (2) these
mRNAs direct the synthesis of a polypeptide that
undergoes extensive posttranslational modifica-
tion. The combination of these two mechanisms
results in a large number of protein species arising
from a single genetic locus. We have begun to study
the role that these mechanisms play in contributing
to the different functions attributed to the E1A pro-
teins.
The two best-characterized ElA transcripts are
the 13S and 12S mRNAs. These two mRNAs can
be first detected shortly after infection, and they are
synthesized throughout the lytic cycle. During the
late phase of infection, three other mRNAs are pro-
duced from the E1A region. Until recently, only one
of these mRNAs had been identified and character-
ized. The previously characterized mRNA is known
as the 9S mRNA, and it has been cloned and ana-
lyzed in several laboratories. The structures of the
9S, 12S, and 13S mRNAs are shown in Figure 1. The
first evidence for other mRNAs came from the
analysis of E1A proteins immunoprecipitated with
monoclonal antibodies raised against a bacterially
produced ElA antigen. In addition to the 12S and
13S products, polypeptides with relative molecular
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weights of 30,000 and 35,000 could be detected dur-
ing the late phase of infection. Judging from the lo-
calization of the epitopes for the monoclonal anti-
bodies that specifically bound to these proteins, it
was determined that the previously described 13S,
12S, or 9S mRNAs could not encode E1A proteins
with the immunochemical properties of the 30K
and 35K polypeptides. Previously, three groups had
described a 30K E1A polypeptide that now appears
to be one of the species discussed here.
To characterize the origin of the 30K and 35K
polypeptides, poly(A)+ mRNA was prepared from
different stages of infection and used to program in
vitro translations. A 30K protein that was indistin-
guishable in size and in immunochemical proper-
ties from the in-vivo-synthesized protein was de-
tected in these translations. A cDNA library was
constructed from RNA prepared from cells at late
times after infection, and a clone was isolated that
coded for the 30K protein. In keeping with the
nomenclature for the E1A mRNAs, the 30K mRNA
is referred to as the 10S mRNA. The structure of
this RNA is shown in Figure 1. The 10S mRNA con-
tains a new splice between nucleotides 637 and 853
as well as the splice found in the 12S mRNA. In the
analysis of this clone, it was noticed that if the late
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Figure 1 Adenovirus type-5 E1A mRNAs. The five E1A mRNAs are
compared with the genomic E1A region. The
solid lines show the structures of the mRNAs, and the open
boxes represent the coding region for the E1A polypep-
tides.
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splicing event that is found in the 10S mRNA was
linked to the 13S splice, a protein with the proper-
ties of the 35K protein could be synthesized. A
cDNA construct was prepared by combining the
appropriate segments of the 10S and 13S cDNAs
and was designated the 11S cDNA. Both the 10S
and 11S cDNA clones directed the synthesis of pro-
teins that were identical to the 30K and 35K pro-
teins found during viral infections. The sequence of
these clones indicated that at late times in adenovi-
rus infection, a novel series of splice sites are used
to produce E1A-specific RNAs. These RNAs are re-
ferred to as the 10S and 11S mRNAs, and their
structures are shown in Figure 1. Both the 10S and
11S mRNAs encode proteins that lack 72 amino
acids in the amino-terminal region of the 12S and
13S E1A proteins. The amino acid sequence that is
removed during splicing of the 10S and 11S mRNAs
contains a region that is highly conserved between
adenovirus serotypes. Together, the appearance of
these mRNAs at late times in infection and the se-
quence conservation between divergent adenovirus
serotypes suggest that this region may be important
for an E1A function that is not required during the
late phase of infection. This suggestion is sup-
ported by data collected with adenovirus mutants
that carry a 10S or 11S cDNA in place of the wild-
type E1A sequences.
These viruses will not replicate on cells that read-
ily support the growth of wild-type viruses. We are
currently constructing mutant viruses that are un-
able to use the late splice donor and acceptor sites,
and these mutants should provide a system to
evaluate the role of these late proteins in the viral
lytic cycle. Interestingly, plasmids that direct the
synthesis of the 30K and 35K polypeptides fail to
cooperate with the human ras oncogene to yield
transformed foci when transfected into baby rat
kidney cells. These data suggest that the 72 amino
acids removed by this late splicing event may be im-
portant for one or more of the ElA functions essen-
tial for adenovirus transformation.
In addition to the different E1A mRNAs, the het-
erogeneity of the E1A proteins is also generated by
posttranslational modification. We are interested in
what role these modifications play in the functions
of the E1A proteins. Using pulse-chase experi-
ments, we have identified the primary translation
products of both the 12S and 13S mRNAs. These
experiments have also shown that the addition of
modifying groups moves the primary translation
products to more acidic isoelectric-focusing posi-
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tions and that some of the additions also decrease
the relative mobility of the proteins on polyacryl-
amide gels. Both of these changes are consistent
with the addition of acidic modifying groups such
as phosphate. Previous work has shown that the
E1A proteins are phosphorylated on serine resi-
dues. Treatment of the immunoprecipitated E1A
proteins with either bacterial alkaline phosphatase
or calf intestinal alkaline phosphatase simplifies
the patterns seen on two-dimensional gels, and
most of the E1A polypeptides then run at a position
identical to that of primary translation product.
This result suggests that phosphorylation accounts
for much, if not all, of the E1A protein modifica-
tion. By two-dimensional gel analysis of E1A mis-
sense mutants, we have identified residue Ser-132
(13S numbering) as a modified residue. Similar
analyses have been used to confirm the results of A.
Tsukomoto and A. Berk that the serine residue at
position 219 is also modified. The Ser-132 site is of
particular interest because mutants that change this
serine disrupt two biological activities associated
with E1A. The first is a decrease in the efficiency
with which ElA can transform baby rat kidney cells
in cooperation with an activated ras protein, and
the second is that the ability of E1A to repress the
transcription of genes found adjacent to some en-
hancers is lost. In collaboration with D. Carrol and
D. Marshak (see Protein Chemistry Section), we
have also shown that in rabbit reticulocyte lysates,
the modification of Ser-132 can be blocked by the
addition of a 15-amino-acid synthetic peptide with
the identical sequence to the region around Ser -132.
Pulse-chase experiments have shown that the serine
modifications at positions 132 and 219 are the first
modifications that are added to the E1A proteins.
We are presently trying to determine what other sites
on the E1A proteins are modified and whether these
modifications are necessary for ElA functions.
Mapping the Regions of the
Adenovirus E1A Proteins That
Are Needed for Transformation
P Whyte, E. Harlow [in collaboration with E Ruley,
Massachusetts Institute of Technology]
As with the transforming proteins of other DNA
tumor viruses, the adenovirus E1A proteins have
evolved to perform a number of different functions
during viral infection. To help determine which
regions of the E1A proteins are important in viral
transformation, a series of deletion mutants has
been constructed to locate the boundaries of
regions essential for these functions. Reports by
M.P. Quinlan, D. Chao, P. Hinton, and T. Grod-
zicker (Adenovirus Genetics Section), and this sec-
tion (P. Whyte, K. Buchkovich, A. Le le, C. Schley,
N. Williamson, and E. Harlow; see below) discuss
the use of these mutants in studies of viral replica-
tion and association with host-cell polypeptides,
respectively. This study presents the results of ex-
periments that help to localize the minimal region
of the E1A proteins necessary for transformation.
Two types of assays have been used. First, plasmids
that contain the mutant E1A-coding regions cloned
behind either the E1A promoter or mouse metal-
lothionein promoter are transfected into baby rat
kidney cells in conjunction with a plasmid that con-
tains an activated ras oncogene. In these cotransfec-
tion assays, transformed foci are scored approxi-
mately 3 weeks after the introduction of the E1A
mutant and ras plasmids into recipient cells. Sec-
ond, the same plasmids are transfected into baby
rat kidney cells alone, and mass cultures of trans-
fected cells are scored for their ability to continue
to divide under standard tissue-culture conditions.
Only the sequences common to the first exons of
the 12S and 13S mRNAs are necessary for coopera-
tion with the ras oncogene to yield transformed
foci. When mutant E1A proteins shorter than the
amino-terminal 139 amino acids are tested for
cooperation, a gradient of the number of trans-
formed foci is found. Although the 139-amino-acid
fragment will produce near wild-type levels of foci,
transfection of a plasmid that makes a 127-amino-
acid fragment fails to yield any transformed foci.
Between these two extremes, proteins that have in-
termediate lengths produce an intermediate num-
ber of foci per plate. Similarly, the amino acids
from 1 to 139 are sufficient to immortalize rat fi-
broblast cells in culture, and there appears to be a
similar decrease in the number of established cell
lines as the length of the protein is shortened.
Similar types of deletion mutants have been pre-
pared beginning at the amino terminus of the E1A
proteins. All mutants in this region that have been
tested are deficient in cotransfection assays. These
include a point mutation that changes the second
amino acid from an arginine to a glycine residue.
Previous work from other laboratories has shown
that mutants in the amino-terminal 14-amino-acid
residues are not necessary for transformation by vi-
ral infection. We are currently testing the ability of
the viruses carrying the amino-terminal mutations
to transform cells in an effort to resolve this appar-
ent discrepancy.
Association of the Adenovirus E1A
Proteins with Host Polypeptides
P. Whyte, K. Buchkovich, A. Le le, C. Schley,
N. Williamson, E. Harlow
In addition to the adenovirus E1A proteins, mono-
clonal antibodies specific for the ElA polypeptides
precipitate a series of proteins with relative molecu-
lar weights of approximately 28,000, 40,000,
50,000, 60,000, 80,000, 90,000, 105,000, 107,000,
130,000, and 300,000 from adenovirus-infected and
-transformed cells. The most prominent of these
are the 105K, 107K, and 300K polypeptides. Three
lines of evidence suggest that these proteins form
stable protein complexes with the E1A proteins: (1)
the 105K, 107K, and 300K proteins are not recog-
nized directly by the any of the anti -E1A monoclo-
nal antibodies, (2) these polypeptides copurify with
a subset of the E1A proteins, and (3) complexes of
these proteins and E1A proteins can be formed in
vitro. Because the in vitro association experiments
use labeled extracts from cells that do not contain
any adenovirus DNA, the complexed proteins must
be encoded by host DNA.
To identify the domains of the E1A proteins that
interact with the 105K, 107K, and 300K cellular
polypeptides, deletion mutants that remove regions
of the E1A-coding sequences have been con-
structed. Immunoprecipitations of the E1A-host
polypeptide complexes from cells infected with the
E1A deletion mutants have shown that the binding
sites for the 300K, 107K, and 105K polypeptides are
located in the portion of E1A encoded by the first
exon of the 12S and 13S mRNAs. All of our studies
to date suggest that the host-cell polypeptides other
than the 105K, 107K, or 300K proteins are not
bound directly to E1A and are apparently precipi-
tated because they are associated with one of these
three proteins. The binding site for the 300K protein
is found between amino acid 1 and 85 (13S number-
ing). The 105K and 107K proteins appear to have
identical or overlapping binding sites located be-
tween amino acids 121 and 139. Using monoclonal
antibodies raised against the 107K or 105K pro-
teins, we have shown that although the 105K and
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300K proteins can bind to the same E1A molecule,
the 105K protein is not found in the same E1A com-
plex as the 107K protein. In addition, gradient and
high-performance liquid chromatography (HPLC)
size fractionation, followed by immunoprecipita-
tion with anti -E1A antibodies, results in separate
peaks for the E1A-107K and the E1A-300K-105K
complexes. Together, our results have suggested
that there are at least four forms of E1A in infected
or transformed cells. These are (1) E1A associated
with 107K, (2) E1A associated with 300K, (3) E1A
associated with both 300K and 105K, and (4) free
E1A. This provides an attractive model to explain
the multifunctional capacity of the E1A proteins.
To help assign functions to the various E1A-host
protein complexes, we have begun to characterize
the biological activities of E1A mutants that have
lost the ability to bind to the cellular proteins. Per-
haps the most interesting observation in these
studies is the correlation between the localization
of the binding sites for the host proteins and the
regions of ElA that are necessary for transforma-
tion. All of the E1A mutants that have lost a bind-
ing site for one of the host proteins have also lost
the ability to cooperate with an activated ras on-
cogene in the transformation of primary rat cells.
However, the converse is not true. Several point mu-
tations in ElA (e.g., the 952 mutant of E. Moran
and M. Mathews, see Protein Synthesis Section)
that do not cooperate with an activated ras on-
cogene still bind with wild-type affinity to all of the
host proteins. Although further work will be neces-
sary to confirm these findings, they suggest that
binding to the host proteins may be necessary, but
not sufficient, for transformation. We are currently
preparing a large series of point mutations within
the binding regions for the cellular polypeptides to
help in these studies.
Using monoclonal antibodies raised against
immunoaffinity-purified E1A-host protein com-
plexes, we have begun analysis of the host proteins
in cells that have not been exposed to adenovirus
and in cells that have been infected with other
adenovirus serotypes. Both the 107K and 105K pro-
teins are normal constituents of many of the mam-
malian cells we have tested to date. In addition to
the 105K and 107K proteins, the antibodies raised
against these proteins precipitate novel polypep-
tides from uninfected cells. The anti-105K antibod-
ies also immunoprecipitate an 85K polypeptide,
whereas the anti-107K antibodies bring down 68K
and 65K proteins. We are currently investigating
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whether these proteins are recognized directly by
the monoclonal antibodies or whether they are
precipitated via a protein-protein complex with the
105K or 107K polypeptides. If the latter is true, it
is interesting to speculate that these proteins may be
cellular homologs for the adenovirus E1A proteins.
Expression of Adenovirus E1A
Proteins and Oncogenic ras
Proteins in the Rat Cell Line
REF52 Leads to Amplification
of the Endogenous p53 Oncogene
E. Harlow, R. Franza, C. Schley
The rat cell line REF52 was isolated from a primary
cell culture of rat embryonic fibroblasts as a rare
descendant that had overcome senescence and sur-
vived several cycles of passage under standard
mammalian tissue-culture conditions. This cell line
is resistant to transformation by an activated ras
oncogene but will produce fully transformed foci
when the activated ras gene is cotransfected with
the adenovirus E1A gene. During the analysis of
transformed cells prepared from cotransfection of
the E1A and ras genes, we noticed that the levels of
the cellular oncoprotein p53 were significantly
higher in these cells than in the parental REF52
cells. Comparsion of the levels of p53 proteins in
cells that contained either the E1A or ras gene alone
showed that the p53 levels were similar to those of
the parental line and well below the levels found in
cotransfected lines. Further study revealed that the
mRNA levels for p53 were correspondingly higher
in the E1A plus ras-transformed cells. Southern hy-
bridization showed that the endogenous p53 gene
was amplified at least 50-fold in these cells, com-
pared with that of parental, E1A-alone, or ras-alone
lines. Similar hybridization studies showed that
other rat endogenous genes were not amplified, nor
were the transfected E1A or ras genes. Together,
these data suggest that higher levels of p53 protein
may convey some selective advantage to cells in tis-
sue culture when both the E1A and ras proteins are
expressed. We are currently testing other cell lines
for similar amplifications. One interesting possibil-
ity is that the p53 protein serves as an intermediate
in the signaling pathways stimulated by the ras and
E1A polypeptides and that higher levels of p53 pro-
tein may allow or be necessary for rapid growth in
tissue culture.
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Work in the Protein Synthesis Section continues to
pursue the themes of transcriptional and transla-
tional control, with special emphasis on the
adenovirus early region 1 oncogenes and virus-
associated (VA) RNA products as probes of these
processes. Our interest in autoantibodies in human
immune disease has also borne fruit this year, with
the identification of an antibody-reactive epitope
and of the protein PCNA (proliferating cell nuclear
antigen) as a DNA replication factor. The latter
finding, made in conjunction with members of the
DNA Synthesis and Protein Chemistry Sections of
the Tumor Virus group, is particularly gratifying as
it forges a link between the themes of autoimmu-
nity, replication, and transformation. One project
that has now drawn to a close in this section
(though it continues at Cold Spring Harbor in Bill
Welch's laboratory) is our work on heat shock, a
topic that for some time had been indissolubly
linked to Paul Thomas, who returned to England
and will be sorely missed by many at the Lab.
VA RNA and Translational Control
A.P. Rice, M. Kostura, A. Maran, K. Mellits, R.P. O'Malley,
M.B. Mathews
Adenovirus encodes two small RNAs, the VA
RNAs, transcribed by RNA polymerase III. These
RNAs are approximately 160 nucleotides long and
accumulate to high concentrations in the cytoplasm
of adenovirus-infected cells. The role of the major
VA RNA species has been elucidated through study
of He La cells infected with a mutant, d1331, defi-
cient in the production of VA RNA'. As discussed
in last year's Annual Report, in d/331-infected
He La cells, protein synthesis fails during the late
phase of infection because of defective polypeptide
chain initiation. The defect results from phos-
phorylation of the eukaryotic initiation factor 2
(eIF-2) on its a-subunit and the consequent trap-
ping of a second initiation factor known as GEF
(guanine nucleoside exchange factor or eIF-2B).
The protein kinase responsible is DAI, the double-
stranded RNA-activated inhibitor of protein syn-
thesis. This enzyme, found in uninfected cells in an
inactive form, is activated during the late phase of
infection with d1331, a process antagonized by VA
RNA' during infection with wild-type virus.
Previous studies had suggested that the activator
present in d/331-infected cells is double-stranded
RNA (dsRNA): Deproteinized cytoplasmic extracts
of these cells were able to activate the quiescent
DAI enzyme from uninfected, interferon-treated
cells. (Interferon induces elevated synthesis of the
enzyme, but dsRNA is needed for activity.) Fur-
thermore, the activation exhibited the unusual bell-
shaped concentration curve that is characteristic of
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activation by dsRNA. We have now confirmed that
the component behaves like dsRNA in several addi-
tional ways. First, when fractionated on the basis of
secondary structure using column chromatography,
the activator was recovered in the fraction that con-
tains dsRNA. Second, the activator was found to be
sensitive to heating at 100°C, a treatment expected
to denature dsRNA, and to be restored by anneal-
ing under conditions allowing renaturation of the
duplex. Finally, the activity was destroyed by incu-
bation with RNase III, a dsRNA-specific enzyme.
From these experiments, we conclude that d1331-
infected cells contain dsRNA that is capable of ac-
counting for the observed DAI activity. As antici-
pated, when purified away from VA RNA, dsRNA
was also detected in extracts of wild-type adeno-
virus-infected cells. More surprisingly, however,
when the cytoplasmic RNA from uninfected cells
was similarly fractionated and tested, the dsRNA-
rich fractions also activated DAI in like fashion, de-
spite the fact that DAI activity is low or undetect-
able in uninfected cell extracts. This finding casts
some doubt on the notion that dsRNA is the DAI
activator in d1331-infected cells, although it is not
yet clear whether this dsRNA behaves like an acti-
vator of DAI in uninfected cells or whether there
exist cellular factors that, like VA RNA, analogs,
antagonize its action. Investigations along these
lines are currently under way.
DAI is induced by interferon treatment of animal
cells and is believed to participate in cellular
defenses that block viral replication. It is activated
in interferon-treated cells after infection with some
RNA viruses (reovirus, encephalomyocarditis vi-
rus) and correlates with inhibition of growth of
these viruses. In contrast, many of the more com-
plex DNA viruses appear to encode functions capa-
ble of blocking DAI action. Adenoviruses encode
VA RNA,; Epstein-Barr virus also encodes two
similar RNA polymerase III genes that are able, in
part, to substitute for VA RNA,-; and vaccinia vi-
rus also inhibits DAI activity, although the mecha-
nism is unknown. Its importance to the antivirus re-
sponse and the regulation of protein synthesis
notwithstanding, little is known about the mode of
action of DAI. What is known hints at rather subtle
and interesting regulatory mechanisms - inhibition
rather than activation by high concentrations of
dsRNA and by short or imperfect duplex RNA
molecules, and the association of autophosphory-
lation with the activation reaction are two such fea-
tures. To elucidate the interaction of DAI with its
activators and antagonists, we have purified the en-
zyme and prepared a number of defined RNA
ligands. The latter include a set of mutant VA
RNA, genes carrying linker-scanning or deletion
mutations in the 3' half of the RNA coding se-
quence, permitting study of the sequence and struc-
tural motifs relevant to its function. These mutants
have been tested for their ability to rescue transla-
tion in a transient expression assay. Plasmids con-
taining wild-type or mutant VA RNA genes are
transfected into human 293 cells, which are infected
with d1331 virus 24 hours later and labeled with
[35S]methionine at 48 hours. The results show that
the RNA is unexpectedly sensitive to structural
changes. The linker-scanning mutants and most of
the deletion mutants allow production of less than
1007o as much hexon (a viral late protein) as the
wild-type VA RNA' gene, although they make
comparable levels of steady-state RNA. Two dele-
tion mutants were, however, able to rescue late pro-
tein synthesis efficiently. We are now in the process
of analyzing the secondary structure of the mutant
RNAs to ascertain the role of duplex regions in VA
RNA function.
Viewed as a protein kinase, DAI phosphorylates
a highly restricted set of substrates. Only four such
substrates have been recognized to date: a 68-kD
polypeptide and the a-subunit of eIF-2, both in the
cytoplasm of many (if not all) mammalian cells;
histones, basic DNA-associated nuclear proteins;
and a 90-kD polypeptide that we have recently iden-
tified in reticulocyte lysates. The 68-kD polypeptide
substrate copurifies with DAI activity and, as men-
tioned above, is thought to be a kinase itself; its
autophosphorylation is believed to be an integral
aspect of the enzyme's activation. When activated,
DAI will phosphorylate eIF-2 on its a-subunit, and
it is this phosphorylation that impairs the ability of
eIF-2 to recycle, resulting in the inhibition of ini-
tiation of protein synthesis.
We first observed phosphorylation of the 90-kD
polypeptide while assaying kinase activity in crude
and partially purified DAI preparations from rab-
bit reticulocyte lysates. The reaction requires
dsRNA and follows the characteristic biphasic
dsRNA concentration curve, suggesting that the 90-
kD polypeptide is a substrate of DAI. To study the
90-kD polypeptide further, we purified the protein
to apparent homogeneity and found that it is
separable from DAI activity and has no detectable
intrinsic kinase activity, being phosphorylated only
in reactions where dsRNA and DAI activities are
included. These experiments demonstrate that the
90-kD polypeptide is indeed a newly identified sub-
strate of DAI.
Less expectedly, we found that the 90-kD poly-
peptide can be cross-linked to VA RNAI by irradi-
ation with UV light, indicating that the two moi-
eties bind each other tightly and suggesting that the
90-kD polypeptide may regulate DAI activity. To
look at this interaction more closely, we have used
a nitrocellulose-filter-binding assay with RNAs of
various kinds. The 90-kD polypeptide has a high
affinity for VA RNAI and 5S RNA, but not for
tRNA. We also generated a set of dsRNA molecules
of precisely known sizes by in vitro transcription of
a DNA fragment from bacteriophage X. The DNA
was introduced into a bacterial plasmid between
SP6 and T7 RNA polymerase promoters, and com-
plementary transcripts were made in separate reac-
tions. By exploiting appropriate restriction sites
within the X insert, a full-length (2.4 kb) transcript
was synthesized as well as complementary tran-
scripts of varying lengths. The transcripts were an-
nealed and then digested with RNase A to remove
single-stranded RNA (ssRNA) tails, creating
dsRNA structures of defined length. Using the
nitrocellulose-filter-binding assay, we found that
the 90-kD polypeptide has affinity for dsRNA
molecules, but not for ssRNA. It therefore seems
that the protein may be recognizing the duplex
regions in the VA and 5S RNAs, but not those in
tRNA, either because they are too short or because
they are buried by tertiary folding.
As a means to approach the function of the 90-
kD protein, we have raised a number of monoclo-
nal antibodies against it. In immunoprecipitation
reactions with these antibodies, we have been un-
able to detect the 90-kD polypeptide in He La or 293
cells, but it is not yet clear whether this reflects the
absence of a homologous protein in these cells or
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antigenic differences between the rabbit and hu-
man proteins. The antibodies are currently being
used to immunoprecipitate the 90-kD polypeptide
from reticulocyte lysates to see if there is any nu-
cleic acid bound to the polypeptide in vivo. We also
plan to use the antibodies to deplete the 90-kD
polypeptide from the reticulocyte lysate, to deter-
mine whether the ability of the lysate to synthesize
proteins is affected.
Functions of the Adenovirus E1A Gene
E. Moran, M.B. Mathews
The early region 1A (E1A) gene plays an important
role in adenovirus-mediated oncogenesis, and on
its own, it is able to immortalize primary rodent
cells. During the past year, we have continued our
analysis, in collaboration with B. Zerler and
R. Roberts (see Nucleic Acid Chemistry Section),
of the relationship between the structure of the
adenovirus 2 E1A gene and the biological effects in-
duced by E1A products. We have now constructed
and analyzed mutants covering almost the entire
E1A coding sequence, from amino acid 22 to the
carboxyl terminus at position 289, and have made
substantial progress in correlating various func-
tions of the E1A gene with specific regions of the
E1A proteins.
As illustrated in Figure 1, the ElA regions of
adenoviruses of different serotypes are composed
of alternating regions of high and low amino acid
sequence identity. There are three highly conserved
regions, two of which (domains 1 and 2) are com-
mon to the products of the 12S and 13S ElA
mRNAs and one of which (domain 3) consists es-
sentially of the 13S unique region. Our earlier
results, together with those from several indepen-
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FIGURE 1 Functional domains of E1A. The bar representing the
289-amino-acid-long product of
the E1A 13S mRNA is shaded to emphasize regions
that are highly conserved among the different
adenovirus serotypes. Beneath each conserved domain
is shown its function (in some cases still
only tentatively assigned).
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dent laboratories, showed that the 13S unique re-
gion plays an important role in facilitating trans-
activation of other adenovirus early genes but is
completely dispensable for the E1A-dependent in-
duction of proliferation of quiescent primary baby
rat kidney (BRK) cells. We then went on to study
the role of the 12S/13S common sequences in the
control of host-cell proliferation. Since it is likely
that viral oncogenes include counterparts of nor-
mal cell genes involved in regulating cell growth, the
study of E1A should offer insights into the nature
of cellular proliferation controls and their mecha-
nisms of action.
By last year, our analysis of the role of the
12S/13S common sequences had shown that the
nonconserved amino acid regions from position 86
to 120 and after position 140 were largely dispens-
able for the ElA activities involved in the induction
of primary cell proliferation. In addition, we had
shown that the second conserved domain, between
positions 120 and 139, plays an essential role in this
activity. Deletion of this region, or single missense
mutations at position 124, 130, 132, or 135, severely
impairs the ability of the 12S E1A product to in-
duce primary cell proliferation and to express other
transformation-related activities. None of the
domain-2 point mutations interferes with the viral
early gene trans-activation function, strongly sup-
porting the hypothesis that the induction of cell
proliferation and the trans-activation of viral early
genes are two independent functions. This does
not, however, exclude the possibility that gene
trans-activation is involved in immortalization:
Cellular genes activated during immortalization
may represent a different class of targets from the
viral early genes, and activation of this gene class
may require different ElA functions.
During the past year, we asked whether the
domain-2 activity required for the induction of cell
proliferation is involved in the activation of cell-
cycle-regulated host-cell products. Because unin-
fected primary BRK cells are quiescent with regard
to DNA synthesis and proliferation, we studied the
role of domain 2 in the activation of cellular prod-
ucts required for the onset of DNA synthesis in
quiescent cells. A rapid increase in the level of DNA
synthesis begins at 8-10 hours after infection with
a 13S or genomic E1A virus and at 12-16 hours af-
ter infection with a 12S E1A virus. Transcription of
the DNA synthesis enzyme, thymidylate synthase,
was accelerated by the presence of a functional 13S
product, in a manner similar to that of the viral
early genes. In contrast, the appearance of the
DNA replication factor PCNA (see below) was in-
duced coordinately with expression of either the
12S product or the 13S product, and thus appears
to be independent of the 13S unique region. PCNA
may be the first product known to be activated by
E1A in response to an activity other than that of
domain 3, although it remains to be shown that
PCNA is regulated at the RNA level.
Somewhat surprisingly, the induction of DNA
synthesis and the E1A-dependent activation of
thymidylate synthase and PCNA were unaffected
by the presence in the genomic E1A virus of the
domain-2 mutation at position 124, although this
mutation severely impairs the ability of the ElA
products to induce mitosis or proliferation of pri-
mary cells. The onset of DNA replication and the
activation of PCNA synthesis are about 8 hours
delayed during infection with viruses carrying
simultaneous mutations in both domains 2 and 3 of
the E1A region, but then come close to wild-type
levels. The pattern of DNA synthesis observed dur-
ing infection with these mutants is comparable to
that occurring during infection with viruses carry-
ing deletions of nonconserved E1A regions, which
remain competent for the induction of rapid cell
proliferation.
Each of a series of E1A region deletion mutants,
removing in combination all but the amino-
terminal 85 amino acids of the E1A region, remains
competent to induce DNA synthesis. This result im-
plies, at least indirectly, that more than a single E1A
activity is involved in the control of the host-cell cy-
cle and that these activities exert their effects at
different points in the cell cycle. There seems to be
an activity in the amino-terminal 85 amino acids
that is sufficient for the induction of DNA synthe-
sis in quiescent cells, as well as a second activity,
localized in domain 2, that is required for progres-
sion through mitosis. If any physical interaction be-
tween these domains is required for their function,
it appears to be independent of the spacing between
them, since deletion of 35 intervening amino acids
does not interfere with E1A- dependent induction of
rapid proliferation in BRK cells.
Separate points of cell-cycle control, operating at
the GI /S-phase and the G2/mitosis boundaries,
have been demonstrated in yeast, and the possibil-
ity that the mammalian cell cycle is controlled at
two separate points is suggested by the existence of
mutants that arrest in either GI or G2. The iden-
tification and study of mammalian cell-cycle-
control genes have been difficult, however, possibly
because mammalian genes in situ are under com-
plex regulation involving extracellular and cyto-
plasmic signals. Since the E1A gene seems to exert
its effects independently of these signals, it may be
an excellent tool for probing the biochemical mech-
anisms of cell-cycle control.
The amino-terminal 85 amino acids encode only
the first of the three conserved domains of the E1A
gene. To study the functions of this domain, we
have begun a mutational analysis of this region. A
deletion removing amino acids 22 to 107 abolishes
the ability of adenovirus to induce both cell
proliferation and DNA synthesis in infected quies-
cent primary BRK cells. The mutant retains some
ability to activate viral early genes in proliferating
cells, however: Using an E3-cat transient expression
assay in He La cells, the viral E3 promoter was acti-
vated equally well by a plasmid containing this dele-
tion and by a wild-type E1A plasmid. Nevertheless,
viral infection assays at low multiplicity of infec-
tion reveal a defect in the ability of this mutant to
support normal viral gene activation during
productive viral infection. The production of infec-
tious viral progeny or of late viral proteins is faster
during infection with the domain-1 deletion mutant
virus than during 12S cDNA viral infection, but
slower than during wild-type viral infection.
The domain-1 deletion mutant plasmid, like the
domain-2 deletion mutant plasmid described last
year, has no detectable ability to cooperate with the
ras oncogene in a cotransfection focus formation
assay in BRK cells. Interestingly, foci are formed
when both mutant plasmids are transfected simul-
taneously, together with the ras gene, suggesting
that the activities of conserved domains 1 and 2 are
independent enough to function even when present
on different polypeptides. To explore an alternative
explanation - that recombination between the two
deleted E1A plasmids might regenerate the wild-
type gene - single foci produced in the triple plas-
mid transfection experiment were grown out as
stable cell lines. Consistent with the idea of inde-
pendent domain function, immunoprecipitation re-
vealed the expected set of E1A proteins and no pro-
teins of wild-type appearance. Nevertheless, the
possibility remains that recombination takes place
at a level below the limit of sensitivity of this tech-
nique and that the establishment of the permanent
cell lines results from integration of a reconstituted
gene producing a single polypeptide containing
both domains. This issue will be addressed by fur-
ther experimental tests.
The independent nature of the conserved do-
mains is supported by their correlation with splic-
ing exons. Domain 3 consists essentially of the 13S
unique region, whereas domain 1 is contained
within the intron removed in forming two newly
identified (10S and 11S) E1A splice products that
accumulate late in infection (see Protein Immuno-
chemistry Section). These products resemble the
12S or 13S products except for the removal of se-
quences coding for amino acids 27-98. Thus, natu-
rally occurring E1A products are now known that
contain either all three conserved domains (13S),
domains 1 and 2 (12S), domains 2 and 3 (11S), or
domain 2 only (10S).
We are continuing to explore the function of do-
main 1 in more detail, by generating additional de-
letion and missense mutations in this region and by
probing the effects of this domain, alone and in
combination with domain 2, on the regulation of
the host-cell cycle. Since E1A can bring about both
activation and repression of target genes, as well as
the control of host-cell proliferation, it will be in-
teresting to see whether the functional domains of
ElA can serve as models in identifying active sites
in cellular regulatory proteins with homologous
functions.
Gene Activation by ElB
C. Herrmann, C. Dery, M.B. Mathews
The second gene required for full transformation of
primary cells by adenovirus is the E1B gene, which
lies adjacent to E1A at the left end of the viral ge-
nome. In last year's Annual Report, we discussed
the response of adenovirus promoters to products
of the E1A gene. Constructs in which each of the
nine adenovirus promoters was fused to the chlor-
amphenicol acetyltransferase (cat) gene were trans-
fected into HeLa cells, and the activity of each pro-
moter was assayed by measuring the level of cat
enzyme produced. We found that all of the early
promoters (E1A, E1B, E2e, E3, and E4) are active
in HeLa cells and, with the exception of the E1A
promoter itself, are stimulated by cotransfection
with the E1A gene. The major late promoter (MLP)
and other late promoters (IX, IVa2, and E2L) are
virtually inactive, irrespective of the presence of
E1A products. In 293 cells, human cells that con-
stitutively express both E1A and E1B, all of the
early promoters and the MLP are active, but the
other late promoters (IX, IVa2, and E2L) are not.
Continuing our study on the regulation of the
adenovirus gene expression in He La cells using the
promoter-cat constructs, we discovered that the
early promoters, but not the late promoters, are
also activated by a product of the other early region
1 gene, ElB. Consistent with a transcriptional ef-
fect, the stimulation of E1A-cat activity brought
about by the presence of the E1B gene correlates
with increased levels of cat mRNA in the cytoplasm
of transfected cells. In contrast to the effects of
E1A, however, the E1B gene products are capable
of activating expression from the E1A-cat con-
struct. Thus, the ElA region can be positively regu-
lated by E1B polypeptides, but not directly by its
own gene products.
To examine the mechanism of this effect, we
created a series of deletion mutations in the up-
stream transcriptional control region of the E1A
gene. Analysis of these mutants indicates that the
stimulation of E1A expression by E1B is sequence-
independent. For example, although the expression
of E1A-cat activity is reduced by deletion of the
E1A enhancer elements, the stimulation by E1B is
nevertheless retained. We are presently conducting
experiments to discover whether the increased
mRNA accumulation is due to a transcriptional
event (increased synthesis) or to a posttranscrip-
tional event, such as more efficient processing or
transport or increased stability.
The E1B region encodes two major proteins, with
apparent molecular weights of 19,000 (19K) and
55,000 (55K), as well as several minor proteins.
Since investigators in other laboratories have re-
cently shown that the 55K protein facilitates
mRNA transport from the nucleus to the cytoplasm
of adenovirus-infected cells, it was important to de-
termine which of the individual E1B polypeptides
is responsible for the stimulation of E1A expres-
sion. We have tested a number of plasmids contain-
ing deletions of the E1B region, with the following
result. Constructs synthesizing a normal 19K pro-
tein but a truncated 55K protein increase ElA ex-
pression to levels similar to those of wild-type E1B
products, whereas constructs synthesizing a mutant
19K protein are unable to stimulate E1A expression
above basal level. These data suggest that the
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elevated expression of E1A is due to an activity of
the E1B 19K protein. Rather different experiments
done by E. White (DNA Synthesis Section) suggest
that the E1B 19K protein can act as a negative regu-
lator of E1A activity. Work is in progress to resolve
the seeming contradiction between these two sets of
observations.
The Proliferating Cell Nuclear Antigen
M. Kostura, G.F. Morris, M.B. Mathews
The proliferating cell nuclear antigen, abbreviated
PCNA and also known as cyclin, initially attracted
our attention because it is recognized by antibodies
from the sera of a subset (about 3%) of patients
with the autoimmune disease, systemic lupus
erythematosus. Synthesis of the protein is regulated
during the cell cycle (hence the name cyclin) and is
greatly augmented in rapidly dividing and trans-
formed cells (hence PCNA). The protein is made
predominantly late in the G1 phase and early in
the S phase of the cell cycle, and, correspondingly,
it becomes detectable by immunofluorescence with
autoantibody in the cell nucleus during the S phase.
These observations suggested circumstantially that
PCNA might be involved in cellular DNA synthe-
sis. To explore its function, and explicitly to exam-
ine this possibility, we undertook the purification
of PCNA by conventional chromatographic meth-
ods. In the course of this work, it became increas-
ingly clear that the protein we were purifying on the
basis of its immunoreactivity and size (apparent
molecular weight of 36,000) resembled in its physi-
cal and chromatographic properties a DNA repli-
cation factor that was under investigation by
G. Prelich and B. Stillman in the DNA Synthesis
Laboratory. This factor is required for efficient
origin-dependent replication of SV40 DNA in
vitro, in a fractionated cell-free system derived
from human 293 cells.
Collaborative work subsequently showed that
PCNA and the replication factor are indeed one
and the same. First, the replication factor comi-
grates with PCNA (defined antigenically) through
several chromatographic steps and in a glycerol gra-
dient. Second, they share the same isoelectric point
and mobility in SDS-gel electrophoresis. Third, the
replication factor (defined biochemically) blocks
both nuclear immunofluorescence and immuno-
precipitation reactions with anti-PCNA autoanti-
body. Fourth, analyses conducted with D. Marshak
(Protein Chemistry Section) show that the two pro-
teins are identical in sequence for at least the first
26 amino acids from their amino termini. Finally,
adsorption by an anti-PCNA antibody column ef-
fectively removes PCNA and the replication factor
activity.
These data prove beyond all reasonable doubt
that PCNA is involved in SV40 DNA replication in
vitro. We presume that it plays a similar role in cel-
lular replication in vivo, although there is little di-
rect evidence to offer as yet. The temporal and
regulatory circumstances of its synthesis, and its
subcellular localization, are consistent with this
idea. In addition, the recent demonstration of its
identity with an accessory factor required for effi-
cient chain elongation by the cellular DNA poly-
merase 8 (detailed in the report of the DNA Synthe-
sis Section) lends further support.
Studies by M. Lambert (Two-dimensional Gel
Laboratory) suggest an involvement with DNA re-
pair mechanisms. Current efforts in our laboratory
are directed toward an understanding of the regula-
tion of PCNA synthesis and the cellular conse-
quences of its expression.
Ribonucleoprotein Particles
and Autoimmunity
C.C. Bunn, M.B. Mathews
Autoantibodies against cellular components such
as PCNA are made in a number of diseases. Last
year, we described a trio of autoantibody specifici-
ties characteristic of the muscle-wasting diseases
polymyositis and dermatomyositis, especially in
conjunction with severe pulmonary complications.
These antibodies differ from those common in con-
nective tissue diseases like systemic lupus erythe-
matosus in recognizing cytoplasmic constituents,
rather than nuclear constituents. All three specifici-
ties react with charging enzymes, aminoacyl-tRNA
synthetases, and one of them (known as PL-12) ad-
ditionally reacts with the corresponding tRNA.
It is widely believed that clues to the origin of the
autoimmune response and to the etiology of the
disease may arise from an understanding of the na-
ture of the antibodies and their reaction with anti-
gen. To this end, we have embarked on a detailed
analysis of the PL-12 specificity. Antibodies of this
class recognize both alanyl-tRNA synthetase and
tRNAA'a. So far, we have determined the complete
nucleotide sequence of two of the tRNAA'a species
immunoprecipitated by PL-12 antibody and the
partial sequence of a third species. All three tRNAs
contain the anticodon IGC embedded in a common
anticodon loop, but there are differences elsewhere
in the molecules, including the anticodon stem. Re-
cent data indicate that the antibody actually reacts
with the anticodon region. When the immune com-
plex, containing the antibody and tRNA, is ex-
posed to ribonucleases, the anticodon region is
found to be protected against digestion. Further-
more, submolecular tRNAA'a fragments containing
the anticodon loop retain the ability to interact with
antibody, whereas fragments containing other
regions of the molecule do not. Half-molecules cut
in the anticodon itself fail to bind, emphasizing the
importance of the anticodon for antibody recogni-
tion. Knowing this fact and that the PL-12 system
contains antibodies reactive with both members of
an RNA-enzyme complex, it seems possible that
the antibodies react with the RNA and enzyme at
the sites of their interaction with one another. We
are now beginning to address this question.
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TRANSCRIPTIONAL CONTROL
W. Herr R. Aurora
T. Baumruker
S. Burgess
J. Clarke A. Shepard
J. Harper R. Sturm
B. Ondek M. Tanaka
The focus of our research is regulation of transcrip-
tion and regulation of posttranscriptional mRNA
processing. We use SV40 to probe transcriptional
control in mammalian cells. Our strategy has been
to use viral genetics to identify and characterize
functional elements within the enhancer of the
SV40 early promoter. Enhancers are promoter ele-
ments that can activate transcription from a distant
position either upstream or downstream from the
transcriptional initiation site. Over the past few
years, we have described a series of SV40 enhancer
mutants in which three sets of closely spaced dou-
ble point mutations were engineered into three dis-
tinct regions of the SV40 enhancer. These muta-
tions impair both enhancer activity and SV40
growth and have allowed the isolation of numerous
viral revertants. These revertants carry characteris-
tic tandem duplications within the mutated en-
hancer region that are responsible for restored ac-
tivity. Comparison of the duplication patterns has
allowed identification of three separate SV40 en-
hancer elements called A, B, and C, each between
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15 and 22 by in length. We have now centered our
attention on the characterization of these three ele-
ments by assaying their intrinsic enhancer activi-
ties, the cell specificity of their function, and the
nature of the trans-acting factors that interact with
these elements.
Our results lead to a picture of the SV40 en-
hancer as a composite of individual enhancer ele-
ments, each responding differently to the cellular
environment.
To study regulation of posttranscriptional RNA
processing, we have focused on the regulation of al-
ternative splicing of the adenovirus early region 1A
(E1A) gene. Our main interest is to identify factors
that influence alternative splicing of mRNAs, and
to this end, we are making use of an in vitro system
to study splicing of E1A RNA precursors. Using
wild-type and mutant E1A precursors, we have been
able to establish a hierarchy of splice site selection
in vitro. We are now establishing how alterations in
the in vitro splicing reaction can alter the ratios of
splicing products.
IGTGGAATGI
Functional Elements within the
SV40 and Heterologous Enhancers
J. Clarke, M. Tanaka, R. Aurora, W. Herr
During the past year, we have continued our analy-
sis of SV40 revertants of the different SV40 double
point mutations (the dpm series). Figure 1 shows,
with respect to the SV40 early promoter, the loca-
tion of the A, B, and C SV40 enhancer elements
that we have identified by revertant analysis. Also
shown is the sequence of each element, along with
the base changes involved in each of the dpm muta-
tions. The mutations are called dpml, dpm2, and
dpm6 in A, B, and C elements, respectively, and
combinations of these mutations are called dpm12
for the A + B element mutant, etc. Analysis of
revertants of all the pairwise combinations of dpm
mutations has shown that, by duplication, each of
the A, B, and C elements can compensate for loss
of enhancer function in the remaining two ele-
ments.
During the course of these experiments, we also
found that the revertant duplications can arise by
illegitimate recombination between separate viral
genomes because a chimeric dpm2/dpm16 recom-
binant was obtained in a mixed infection with the
dpm2 and dpm16 viruses. To show conclusively that
it is duplication of the wild-type elements per se
that is responsible for restored enhancer activity of
the revertant viruses, we have taken a dpml2 rever-
tant, which contains mutated A and B elements and
a duplicated C element, and mutated each C ele-
ment separately. Whichever of the two C elements
is mutated, there is loss of virus viability, showing
clearly that both elements are important for re-
stored virus viability.
The experiments described above have led to the
identification of three separate SV40 enhancer ele-
ments. We are taking two related approaches to
analyze further elements within the SV40 and het-
erologous enhancers: The SV40 enhancer has been
cloned into polyomavirus, and heterologous viral
and cellular enhancers have been cloned into SV40.
To date, the analysis of SV40 revertants has been
carried out in the African green monkey kidney
(AGMK) cell line CV-1. Because of a block in DNA
replication, the host range of SV40 is largely re-
stricted to AGMK cell lines. The SV40 enhancer
may contain more than the three elements de-
scribed so far, but these putative additional ele-
ments may have gone undetected because they can-
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FIGURE 1 SV40 early promoter region showing the location
and sequence of the A, B, and C elements, the structure of the
synthetic oligonucleotides, and the pfle- expression plasmid.
(A) Diagram of the SV40 early promoter showing, from right to
left, the early transcriptional start sites, origin of replication, AT-
rich TATA-like element, one imperfect (dashed box) and two per-
fect 21-bp repeats complete with Sp1 binding sites (black
boxes), and a single copy of the 72-bp element. The A, B, and
C enhancer elements (stippled boxes) are shown below their
corresponding position within this region. (8) The complete
nucleotide sequence of each of the three elements A, B, and
C is shown in uppercase letters, with flanking sequences shown
as lowercase letters. The 8-bp consensus sequences, the SV40
core in A and C and the octamer in B, are boxed. The A, B, and
C enhancer-debilitating double point mutations, dpml, dpm2,
and dpm6, respectively, are shown above the wild-type se-
quences. The sequences included in the oligonucleotides used
to create synthetic enhancers are shown below the wild-type se-
quence by a black arrow; the name of each oligonucleotide is
shown to the left. The broken arrows with the Xs indicate the cor-
responding dpml, dpm2, or dpm6 mutant oligonucleotides. (C)
The experimental plasmid pi3e- is depicted with the pUC119 se-
quences as a solid line interrupted with open boxes represent-
ing the M13 replication origin, 13-lactamase gene, and plasmid
origin of replication. The polylinker (hatch marks) is split by in-
sertion of the human 13-globin gene sequences (stippled box).
The 13-globin start site is identified by a wavy arrow, with introns
shown as bent lines linked to exons shown as hatched (untrans-
lated) and solid (translated) boxes. The downstream enhancer
cloning site (Sphl) is labeled enhancer, and its distance from the
I3-globin start site is shown on the inner circle.
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not function effectively in CV-1 cells. To test this
possibility, we are using polyomavirus as a vector to
isolate SV40 enhancer rearrangements. As with
SV40, rearrangements such as duplications within
the polyomavirus enhancer can activate enhancer
function. Furthermore, growth of polyomavirus in
different cell lines is frequently limited by the activ-
ity of the enhancer region. Therefore, selection for
host-range mutants generally gives rise to new en-
hancers. These experiments necessitate the con-
struction of a viable polyomavirus-SV40 enhancer
recombinant in which the polyomavirus enhancer
sequences have been deleted. We have succeeded in
constructing such a chimeric virus that can grow in
the mouse embryo fibroblast cell line NIH-3T3. We
now plan to determine the effect of the dpm series
of mutations on growth of this chimeric virus and
to isolate revertant viruses in those cases where the
mutants do not grow.
To study heterologous viral and cellular en-
hancers, we have performed the complementary ex-
periment by replacing the SV40 enhancer with ei-
ther one or the other of two separate regions of the
polyomavirus enhancer, or with either the immuno-
globulin heavy-chain or insulin enhancers. The
polyomavirus enhancer region can be divided into
two separate restriction fragments, called A and B,
that can each act as an enhancer. To test the feasi-
bility of these SV40 enhancer replacement experi-
ments, we have chosen to use these two polyomavi-
rus enhancer fragments because Weber et al. (Cell
36: 983 [1984]) have shown that tandem copies of
the polyomavirus-"A" enhancer can functionally
replace the SV40 enhancer. The SV40 enhancer re-
gion was replaced by a single copy of the A or B en-
hancer, and chimeric viral DNA was transfected
into CV-1 cells to assay for virus growth.
We were unable to obtain plaques with either
construct, but revertants of the polyomavirus-A en-
hancer replacement did arise after passage of viral
lysates in CV-1 cells. These revertants contained
duplications that all spanned a single region 28 by
in length. This 28-bp polyomavirus-A enhancer ele-
ment contains a consensus sequence that is shared
with the adenovirus E1A enhancer and overlaps a
26-bp region that has been shown to confer en-
hancer activity when present in multiple tandem
copies (Veldman et al., Mol. Cell. Biol. 5: 649
[1985]). These results suggest that SV40 can be used
to identify elements within heterologous en-
hancers. To date, however, we have not obtained
revertants of the polyomavirus-B enhancer replace-
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ment, nor of chimeric SV40 carrying the immuno-
globulin heavy-chain or insulin gene enhancers.
SV40 A, B, and C Elements Represent
Autonomous Enhancer Elements
B. Ondek, W. Herr
SV40 revertant analyses identified the A, B, and C
enhancer elements but did not address whether
these elements themselves are sufficient for en-
hancer function. By using short, synthetic DNA
oligonucleotides, we have shown that each of these
elements can act autonomously as an enhancer
when present as multiple tandem copies. Figure 1B
shows the sequences of the 17-bp-long double-
stranded DNA fragments, called A17, B17, or C17,
that we synthesized to assay the activity of in-
dividual elements. The fragments were ligated as
multiple tandem copies into a plasmid vector con-
taining the human P-globin gene. This vector,
called p[3e- (see Fig. 1C), lacks SV40-derived se-
quences, and the synthetic enhancers are positioned
2.2 kb downstream or 3.3 kb upstream of the ini-
tiation site for 13-globin transcription. Assay of
these constructs, by transient expression in CV-1
cells, showed that the 17-bp fragments representing
the B and C elements could function as enhancers.
The A-element construction, however, was defec-
tive for enhancer function. This led us to test a
21-bp synthetic fragment containing the entire A-
element sequence (Fig. 1); multiple tandem copies
of this fragment effectively enhance transcription.
These results show that each of the three elements
that were identified by SV40 revertant analysis pos-
sesses intrinsic enhancer function.
To test the authenticity of the activities of these
synthetic enhancers, we constructed parallel oli-
gomerized elements containing the series of dpm
mutations that debilitate these elements within the
context of the SV40 enhancer. Each of these mu-
tant oligonucleotide constructs lacks any detect-
able enhancer activity. In contrast to this drastic in-
activity, the effect of the dpm mutations is variable
when in the context of the SV40 enhancer region.
In CV-1 cells, the dpm6 mutation in the C element
has the largest effect on enhancer function,
whereas the dpml mutation in the A element has
the least effect. Because we now know that the mu-
tations completely inactivate these elements, these
results suggest that the relative contribution of
these three elements to SV40 enhancer function in
CV-1 cells is A<B<C. We do not know, however,
whether these relative activities are due to the in-
trinsic strength of these elements, their neighboring
SV40 enhancer sequences, or their relative position
with respect to other promoter elements.
We have used the synthetic enhancers to study
the bidirectional activity and copy number require-
ment of individual enhancer elements. To study
directionality, B-element and C-element DNA frag-
ments containing six copies of either element were
cloned into pile- in both orientations and assayed
for activity. The results show that these individual
elements can each function in either orientation.
This suggests that the bidirectional activity of the
SV40 enhancer region results from the accumula-
tion of a number of individual bidirectional en-
hancer elements and is not due to the grouping of
a number of unidirectional elements in opposite
directions. Analysis of a progressive series of B-
element oligomers shows that a single copy of the
B element is ineffective in enhancing transcription;
with two or more elements, however, enhancer ac-
tivity increases linearly with each added (up to 14)
B-element oligomer.
SV40 Enhancer Elements Display
Different Cell-specific Enhancer
Activities
A. Shepard, B. Ondek, W. Herr
We have employed the synthetic enhancers de-
scribed above to study the relative activity of these
SV40 enhancer elements in different cell lines.
Using the B- and C-element constructs containing
six tandem copies of either element (6 x B17 and
6 x C17), we tested the relative levels of J3- globin ex-
pression in four different cell lines, in addition to
CV-1 cells: NIH-3T3, a mouse embryo fibroblast
cell line; NS-1, a nonsecreting mouse myeloma cell
line; MDCK, a canine kidney epithelium-like cell
line; and HeLa, a human epithelioid cervical carci-
noma cell line. Except for one case, these constructs
were active in all of these cell lines; the B-element
construct was not active in NIH-3T3 cells. Most
striking, however, was that the individual elements
displayed different activities relative to each other
in the various cell types. The 6 x B17 enhancer was
more active than 6 x C17 in CV-1 and MDCK cells,
whereas in NIH-3T3, NS-1, and HeLa cells, the
6 x C17 enhancer was more active. These results in-
dicate that the SV40 enhancer B and C elements
have different cell-specific enhancer activities. In
all cases, the closely spaced dpm mutations within
the B and C elements abolished enhancer function
in all cell lines tested. Taken together, the activity
of the wild-type oligomers and the inactivity of the
mutant oligomers indicate that the B and C ele-
ments represent single units of enhancer function.
The differential cell-specific activity of the B and
C elements and the ability of these elements to en-
hance transcription autonomously when dupli-
cated have led us to suggest that the duplication of
these elements by the wild-type SV40 72-bp repeat
serves to broaden the conditions under which the
SV40 enhancer can activate transcription. Figure 2
shows schematically how a duplicated enhancer
(2 x 72) may activate transcription under conditions
that the nonduplicated form (1 x 72) is inactive. At
the top of panels A and B is shown the 1 x 72 (A)
and 2 x 72 (B) enhancers interacting with putative
A-, B-, and C-element-specific trans-acting factors.
Under these conditions, in the presence of all three
factors, both enhancers should be active because
they are each capable of enhancing transcription.
In the presence of just a single B- or C-element-
specific factor, however, we predict that the 1 x 72
enhancer will be relatively inactive, whereas the
2 x 72 enhancer will still effectively enhance tran-
scription. This is because the activity of 1 x 72 in the
presence of just B- or C-element factors will be
similar to the weak activity of the dpm16 (A + C
mutated) and dpm12 (A + B mutated) enhancers,
whereas the 2 x 72 enhancer will activate transcrip-
tion effectively as do the dpml6 and dpm12 rever-
tants, which have a single wild-type element dupli-
cated.
These interpretations suggest that by carrying
single copies of two different elements that recog-
nize different trans-acting factors, the function of
an enhancer is restricted to the presence of both
trans-acting factors. By tandem duplication of
these same elements, however, expression is ex-
panded to the presence of either factor. Thus, ap-
propriate manipulation of enhancer elements can
either restrict or expand the conditions under
which a promoter can operate. Consistent with
these interpretations, we find that the activities of
the revertant enhancers, which contain duplica-
tions of a single functional element, show different
host-cell preferences.
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Late Transcription in Revertants
of SV40 Enhancer Mutants
S. Burgess, W. Herr
The late promoter of SV40 overlaps the early pro-
moter in the opposite orientation and is activated
by the early gene product large T antigen. Unlike
the early promoter, which contains a closely spaced
set of transcriptional start sites, the late transcripts
are initiated at a large number of sites spread over
the entire enhancer region. Although the majority
of late RNAs correspond to initiation at sites sur-
rounding nucleotide 325, nearly half of the late
RNAs are initiated elsewhere. It is not understood
how these initiation sites are selected or how their
levels are regulated. We have asked whether point
mutations that reduce enhancer function have an
effect on late transcriptional initiation site selec-
tion. To accomplish this, we isolated RNAs late af-
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FIGURE 2 Putative interactions and relative ac-
tivities of the 1x72 and 2x72 SV40 enhancers in
the presence of different sets of trans-acting fac-
tors. The position of the A, B, and C elements is
shown by the labeled rectangular boxes, and the
regions located within the 72-bp element are
shown by the black arrows. Putative element-
specific trans-acting factors are shown as circles,
with the bottom portion shaded differently to em-
phasize the postulated different DNA-binding
specificities of these factors. A shows the 1x72
enhancer and B the 2x72 enhancer in three
states: in the presence of all three A-, B-, and C-
element-specific factors (i), the C-element-specific
factor alone (ii), and the B-element-specific factor
alone (iii). The expected relative activities of each
enhancer in these three states are shown as very
high activity (heavy up-arrow), high activity (thin
up-arrow), and low activity (down arrow).
ter infection of CV-1 cells with the viral revertants
of the dpm mutants.
To measure the abundancies and structure of the
late transcripts, CV-1 cells were infected with SV40
and late RNAs were collected when present at maxi-
mal levels, as determined by Northern blot anal-
yses. The RNAs were hybridized to one of two
32P-labeled oligonucleotides downstream from the
transcriptional initiation sites, and a cDNA was
synthesized by reverse transcriptase in the 5' direc-
tion of the transcript. These cDNA fragments were
separated by electrophoresis through denaturing
polyacrylamide gels alongside sequencing reactions
primed with the same oligonucleotide. The relative
abundancies of the late transcriptional start sites
could thus be determined. The experiments indi-
cate that the dpml mutations that lie within a clus-
ter of late transcriptional start sites inhibit the use
of these initiation sites, but that the different rever-
tant duplications seem merely to duplicate the het-
erogeneous initiation sites. These results are consis-
tent with the hypothesis that late transcriptional
initiation sites are influenced by local nucleotide se-
quence but not "distant" elements such as a TATA
box.
Interaction between SV40 Enhancer
Elements and Nuclear Factors
Isolated from He La Cells
R. Sturm, T. Baumruker, W. Herr
To examine the nature of trans-acting factors that
may interact with the SV40 A, B, and C elements,
we have performed "gel retardation" assays using
nuclear extracts from He La cells. In the gel retarda-
tion assay, a radioactive DNA fragment is mixed
with a cellular extract, and, after an incubation
period to allow for complex formation, it is sub-
jected to electrophoresis through a polyacrylamide
gel. DNA fragments, which form complexes that
are stable during such an electrophoretic separa-
tion, are retarded in mobility with respect to the
free fragment. When an SV40 enhancer fragment
encompassing the A, B, and C elements (but not the
21-bp repeats) is mixed with a partially fractionated
He La cell nuclear extract, we observe two major
complexes. These complexes can be inhibited by
competition with restriction fragments containing
six copies of the B17 oligomer (refer to Fig. 1) but
not a 6 x C17 fragment. This result suggests that the
complexes are formed by interaction with the B
element.
The B17 oligomers, when placed in tandem,
recreate 18 by of wild-type SV40 sequence. This 18-
bp sequence contains two popular sequence motifs:
the octamer sequence ATGCAAAG and two near-
perfect 9-bp repeats, AAGT/cATGCA. The oc-
tamer sequence is shown boxed in Figure 1 and is
closely related (7/8 match) to a sequence found in
a number of promoters, including histone, snRNA,
and immunoglobulin gene promoters. The dpm2
mutations, which completely inactivate the B ele-
ment, lie outside of this octamer sequence. Com-
plex formation is inhibited not only by competition
with the wild-type 6 x B17 enhancer, but also by the
mutant dpm2 B17 construct 8 x MB17. This has led
us to analyze the significance of the octamer se-
quence.
We have created a further B-element double
point mutation called dpm7 that maps in the mid-
dle of the octamer domain (AT TTAAAG; the dpm7
mutations are italicized) and also maps in the up-
stream 9-bp repeat. The effect of the dpm7 mutant
on virus viability is significantly less than the effect
of the dpm2 mutations. Preliminary experiments
indicate that a synthetic enhancer composed of a
dpm7-containing 17-bp B oligomer can function to
enhance transcription of the human (3-globin gene
as well as the wild-type 17-bp oligomer. In gel
retardation experiments, the complexes formed
with the SV40 enhancer are only slightly affected
by either the dpm2 or dpm7 mutations alone but
are considerably reduced in quantity when the two
sets of point mutations are combined. These results
are consistent with interactions with the two 9-bp
repeats, rather than with the octamer sequence.
This B-domain DNA-protein interaction is being
further investigated using dimethylsulfate interfer-
ence studies and DNase I footprint analysis. We
plan to purify this activity further and to use in
vitro transcription assays to determine the role, if
any, that this DNA-protein interaction plays in
SV40 enhancer function.
To date, enhancer elements have not been shown
to activate transcription in vitro over large dis-
tances; therefore, step to establish-
ment of an in vitro transcription assay, we have
placed the synthetic oligomerized A, B, and C ele-
ments just upstream of the human P-globin pro-
moter. When assayed in vivo in either HeLa or CV-1
cells, these constructs effectively activate transcrip-
tion. We now plan to use these constructs to assay
the activity of the factor(s) that interacts with the
B element.
In Vitro Splicing of Adenovirus
E1A Pre-mRNA
J. Harper, W. Herr [in collaboration with R. Roberts,
Cold Spring Harbor Laboratory]
We are continuing our experiments on in vitro splic-
ing of adenovirus E1A pre-mRNA. Our primary in-
terest is to evaluate factors that may influence alter-
native splicing of mRNAs. In general, cellular
genes produce a single mRNA by utilization of a
single splicing pathway; however, a number of
genes produce multiple mRNAs by alternative
RNA splicing. In many instances, these mRNAs are
differentially expressed in a tissue-specific or tem-
porally regulated manner, suggesting that regula-
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tion of RNA splicing may play a role in regulating
gene expression during development. We have fo-
cused on the adenovirus E1A gene as a model sys-
tem because of its small size and relatively simple
alternative splicing pattern. ElA encodes multiple
mRNAs that differ only in the internal sequences
spliced out. Three of these, the 13S, 12S, and 9S
RNAs, are produced by splicing from different 5'
splice sites to a common 3' splice site. Expression of
these RNAs is differentially regulated during the
course of adenovirus infection: 13S and 12S RNAs
are expressed throughout the lytic cycle, whereas 9S
RNA does not accumulate until late times after in-
fection. Additional E1A mRNAs produced by
splicing from the 9S 5' splice site to an adjacent 3'
splice site also appear to be expressed specifically
at late times (see C. Stephens and E. Harlow, Pro-
tein Immunochemistry Section). This strengthens
the suggestion that the 9S 5' splice site is active spe-
cifically at late times.
Our first goal was to determine the relative
strengths of the 13S, 12S, and 9S 5' splice sites under
standard in vitro splicing conditions. Comparison
of the splicing products of wild-type and mutant
E1A pre-mRNAs in He La cell nuclear extracts indi-
cates that cis-competition between 5' splice sites de-
termines the ratio of RNAs produced. Splicing the
wild-type E1A substrate yields predominantly 13S
products. 9S splicing occurs at about 5070 of the
level of 13S splicing, and 12S splicing is less than
207o of 13S levels. Splicing a mutant substrate in
which the 13S 5' splice site is inactivated yields pre-
dominantly 12S splicing products and 9S splicing
products at somewhat higher levels than with the
wild-type substrate. Using a double-mutant sub-
strate in which both the 13S and 12S 5' splice sites
are inactivated yields predominantly 9S splicing
products. Other E1A splicing products produced at
low levels in these reactions have not yet been fully
characterized. These results indicate that the 13S 5'
splice site is extremely strong relative to the 12S and
9S 5' splice sites in these reactions and that competi-
tion by the 13S 5' splice site affects 12S splicing
more strongly than it does 9S splicing.
The goal of our subsequent experiments has been
to determine whether or not alterations of the splic-
ing extracts can alter the ratios of splicing products.
In particular, we have been interested in identifying
factors that might modulate the level of the late
specific 9S RNA relative to the early 13S and 12S
RNAs. We examined the effect of moderate heat
treatment of the extracts on their ability to carry
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out splicing of E1A pre-mRNA. We find that 9S
splicing activity in the extract is inhibited more se-
verely by the heat treatment than 12S or 13S splic-
ing activity. This may reflect different affinities of
the three 5' splice sites for a commom heat-sensitive
splicing factor or heat sensitivity of a specific factor
required for 9S splicing.
We have surveyed a series of different extracts
and crude fractions of extracts for activities that
might alter the ratio of 9S splicing relative to 12S
or 13S splicing during in vitro reactions. Because
some of the extracts and fractions assayed are not
capable of carrying out in vitro splicing reactions,
all activities were assayed in extract-mixing experi-
ments. In these experiments, the splicing reaction is
supported by a receptor extract and the extract or
fraction to be tested constitutes one sixth of the to-
tal extract volume. We have found two activities
that have opposite effects on the ratio of 9S to 12S
splicing. The first activity, present in nuclear ex-
tracts prepared from adenovirus-infected cells at
late times after infection, stimulates 9S splicing rel-
ative to either 12S or 13S splicing when assayed in
an uninfected He La cell receptor extract. Extracts
prepared from uninfected or early adenovirus-
infected cells lack this activity. We find, however,
that the particular uninfected cell extract used as a
receptor is critical for detection of this activity, and
we are currently characterizing this heterogeneity
among receptor extracts. The 9S stimulating activ-
ity fractionates with high-molecular-weight mate-
rial on a sizing column and precipitates at an am-
monium sulfate concentration between 4007o and
70°7o saturation. The second activity stimulates 12S
splicing and inhibits 9S splicing when assayed in a
partially heat-inactivated extract. It is found in the
fraction of a whole-cell extract that precipitates at
an ammonium sulfate concentration between 1007o
and 3007o saturation but is absent from either a mix-
ture of the 10-30% and a 30-60% fraction or a 10-
60% fraction, suggesting that some component of
the 30-60% fraction inhibits this activity. These ac-
tivities may represent trans-acting factors that regu-
late the splicing pattern of the E1A pre-mRNA. We
are working to purify the factors responsible for
these activities.
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MOLECULAR GENETICS OF EUKARYOTIC CELLS
This section includes three laboratories using molecular approaches to under-
standing aspects of the cellular and organismal biology of eukaryotes. The control
of the expression of the a2, globulins (see Hormonal and Developmental Control
of Gene Expression) is the focus of the laboratory of D. Kurtz. The a2, globulins
are products of a multigene family in rats; they are of unknown function. Their ex-
pression is under the control of multiple hormones that act at multiple levels as
well as under complex developmental control. The control of cell growth (see
Genetics of Cell Proliferation) is the focus of the laboratory of M. Wig ler. Cellular
oncogenes that can positively alter the proliferative capacity of cells are being
characterized. A human oncogene (mas) that encodes a product similar in struc-
ture to the visual rhodopsins has recently been discovered. The oncogene ros has
been shown to be expressed in glioblastomas and may be a marker for that neo-
plasia. Particular attention is given to the function of the ras oncogenes that are in-
volved in a wide variety of human neoplasia. The ras oncogenes have structural
and functional homologs in the yeast Saccharomyces cerevisiae, and the power-
ful genetics of yeast is being applied to understanding ras function. The laboratory
of D. Hanahan (Molecular Biology of Mouse Development) is using the extremely
powerful method of germ-line genetic manipulation to study several aspects of
gene expression and tumor formation in mice. Introduction into the germ line of
the SV40 T-antigen gene under the control of the insulin gene promoter/enhancer
leads to the heritable development of pancreatic n-cell tumors. Studies of such
mice have led to the discovery of a model for autoimmune diabetes. Other tissues
have been targeted for oncogenesis using tissue-specific promoters. Introduction
of a papilloma genome leads to the development of dermal fibrosarcomas. This
type of approach should lead to deep insights into the neoplastic process and the
development of animal models for human disease.
GENETICS OF CELL PROLIFERATION
M. Wig ler C. Birchmeier K. Ferguson S. Cameron
D. Broek J. Field K. O'Neil
T. Kataoka T. Michaeli M. Riggs
S. Powers J. Nikawa L. Rodgers
T. Toda P Sass G. Waitches
G. Bolger S. Sharma
J. Colicelli D. Young
Our laboratory has continued work on growth con-
trol in eukaryotes. Two experimental systems are
employed: the yeast Saccharomyces cerevisiae and
cultured mammalian cells.
The yeast studies have grown from a study of the
function of mammalian RAS oncogenes. Close
structural and functional homologs exist in yeast,
and they control adenylate cyclase. Two other
human oncogenes are under intensive scrutiny:
the ros gene, which appears to be expressed in
glioblastomas and encodes a transmembrane tyro-
sine kinase, and the mas gene, which encodes a
protein that resembles the visual rhodopsins in
structure.
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Growth Control in S. cerevisiae
M. Wig ler, T. Kataoka, S. Powers, T. Toda, D. Broek,
P. Sass, J. Nikawa, J. Field, K. Ferguson,
J. Colicelli, T. Michaeli, S. Cameron
The effort of this section is directed to define the
components of the RAS/CYR (adenylate cyclase)
pathway in yeast and to study their interactions.
Work from previous years (see last year's Annual
Report) resulted in cloning the two RAS genes
RAS1 and RAS2; SUPH, a gene required for matu-
ration of a factor and RAS proteins (Powers et al.,
Cell 47: 413 [1986]); CDC25, a gene required for
progression through GI (Broek et al., Cell [1987] in
press); CYR, which encodes adenylate cyclase;
TPKI, TPK2, and TPK3, which encode the cAMP-
dependent protein kinase catalytic subunits (T.
Toda et al., in prep.); BCY1, which encodes the
cAMP-dependent protein kinase regulatory subunit
(Toda et al., Mol. Cell. Biol. [1987a] in press);
PDE2, which encodes the high-affinity cAMP
phosphodiesterase (Sass et al., Proc. Natl. Acad.
Sci. 83: 9303 [1986]); and a variety of auxiliary
genes of unassigned function (JUN1, JUN2,
SUPC, SCHI, SCH2, and SCH9). There have been
several new developments in this area. CDC25 ap-
pears to control RAS function, and we have found
dominant lethal RAS mutations. Biochemical
studies now clearly indicate the complete GTP de-
pendence of RAS. Progress has been made in
purifying yeast adenylate cyclase. Study of the TPK
genes has led to a better understanding of their role
in regulating physiologic responses. We have cloned
and sequenced both yeast cAMP phosphodiester-
ase (PDE1 and PDE2) genes. Disruption of the
PDEs or mutations in the cAMP-dependent protein
kinases (TPK genes) have revealed an extraordinar-
ily powerful feedback mechanism for cAMP
homeostasis. Progress has been made in charac-
terizing additional genes related to the RAS/CYR
pathway (SCH1, SCH2, SCH9, JUN1, JUN2, and
SUPC). Our progress is described in greater detail
below.
SUPHwas originally isolated as an allele capable
of suppressing the phenotypic effects of the mutant
of RAS2va"9. The supH alleles were found to be a-
specific sterile. In collaboration with members of I.
Herskowitz's laboratory at the University of
California (San Francisco), we showed that supH
strains fail to secrete a-factor, fail to palmitylate
yeast RAS proteins, and fail to palmitylate many
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other yeast proteins that are normally palmitylated.
We derive two conclusions from these findings: (1)
The SUPH gene product is required for the normal
maturation of proteins containing the Cys-A-A-X
(where A is any aliphatic amino acid and X is the
terminal amino acid) consensus sequence for
palmitylation, and (2) this processing event is re-
quired for the maturation and/or secretion of a-
factor (Powers et al., Cell 47: 413 [1986]).
CDC25 was first described by Hartwell et al.
(Genetics 74: 267 [1973]) as the wild-type allele of
a temperature-sensitive mutation causing G1 ar-
rest. This gene was cloned, sequenced, and charac-
terized (Broek et al., Cell [1987] in press). It encodes
a 1589-amino-acid protein with no obvious struc-
tural similarities to known proteins. Disruption of
CDC25 causes a lethal phenotype that can be sup-
pressed by RAS2va119 but not by wild-type RAS2.
Most recent biochemical experiments indicate that
the adenylate cyclase of S. cerevisiae lacking
CDC25 has a very low level of activity in the ab-
sence of guanine nucleotides. From biochemical
and genetic data, we have concluded that the
CDC25 product controls RAS protein function
(Broek et al., Cell [1987] in press). Indeed, we have
identified a mutant RAS protein that behaves as
though it complexes irreversibly with CDC25 (see
below).
RASI and RAS2 genes have been previously
characterized (Kataoka et al., Cell 37: 437 [1984];
Cell 40: 19 [1985]; Powers et al., Cell 36: 607 [1984];
Toda et al., Cell 40: 27 [1985]). Recent biochemical
experiments with RAS proteins purified from Esch-
erichia coli expression systems indicate that they
fail to stimulate adenylate cyclase when bound to a
guanine dinucleotide (Field et al., Mol. Cell. Biol.
[1987] in press). These results strongly confirm the
model of RAS activation by point mutations that
destroy intrinsic GTPase activity. In addition, we
have determined that, in vitro, RAS bound to gua-
nine diphosphates does not compete with RAS
bound to guanine triphosphates for stimulation of
adenylate cyclase (Field et al., Mol. Cell. Biol.
[1987] in press).
In an unrelated series of experiments, a domi-
nant temperature-sensitive lethal RAS2 mutation
was found during a search for genes capable of sup-
pressing the phenotypic effects of RAS2va". This
temperature-sensitive defect cannot be suppressed
by high-copy RAS2 or by high-copy CDC25 alone,
but it can be suppressed by high-copy CDC25 when
at least one copy of wild-type RAS is present. These
experiments indicate the existence of a novel class
of RAS mutants capable of blocking the RAS path-
way in a dominant fashion. The simplest explana-
tion of the particular allele we have discovered is
that it encodes a protein that forms an ineffective
complex with CDC25. The existence of dominant
interfering mutations in regulatory components
has important implications for strategies to under-
stand RAS function as well as the functions of
other oncogenes.
We are still testing the hypothesis that RAS has
an alternate function in addition to stimulating ad-
enylate cyclase. This hypothesis appears to be
needed to explain two curious observations. First,
disruption of the CYRI gene is not always lethal,
whereas disruption of both RAS genes invariably is
(Toda et al., in Oncogenes and Cancer, Japan Sci-
entific Societies Press, Tokyo, Japan [1987b] in
press). Second, disruptions of CYR1 can be readily
suppressed by high-copy TPK genes, but disrup-
tions of RAS suppressed by these genes are
temperature-dependent. We are exploring the hy-
pothesis of alternate RAS function by both genetic
and biochemical analyses.
CYR1 encodes adenylate cyclase. Its sequence
and preliminary structural characterization were
previously published (Kataoka et al., Cell 43: 493
[1985]). Our current effort is directed at determin-
ing how the activity of adenylate cyclase is regu-
lated. As a first step, we have begun to purify this
enzyme from S. cerevisiae. For this purpose, we
have constructed a modified CYR1 gene encoding
a product with a novel amino-terminal domain.
This domain consists of a peptide derived from an
influenza virus protein, for which we have obtained
monoclonal antibodies from R. Lerner and I. Wil-
son at the Research, Institute of Scripps Clinic. A
single-step affinity purification with elution by
peptide has led to over 100-fold purification of
yeast adenylate cyclase activity. This purified activ-
ity is still RAS-responsive. These studies should re-
veal whether there are other proteins that purify as
part of the adenylate cyclase complex. Recent
studies of the phosphodiesterases and protein ki-
nases indicate that there is a negative feedback con-
trol of cAMP production (see below). We are test-
ing to determine if part of this feedback control
results in a physical modification of adenylate cy-
clase.
BCYI encodes the regulatory subunit of the
cAMP-dependent protein kinase (Toda et al., Mol.
Cell. Biol. [1987a] in press), and its properties were
reported in last year's Annual Report. Disruption
of BCY1, like the introduction of the RAS2va"9
gene, induces severe aberrations in G1 arrest, car-
bohydrate accumulation, carbon source utilization,
germination, sporulation, and heat-shock resis-
tance. Experiments described below indicate that
the phenotypes of disruptions of BCY1 appear to
be mediated through its associated kinases. We
have been unable to assign any role to BCY1 other
than its control of the TPK genes.
TPK1, TPK2, and TPK3 encode the cAMP-
dependent protein kinases (T. Toda et al., in prep.).
Their properties were partly described in last year's
report. More recently, we have obtained intragenic
mutations in each of the TPK genes that suppress
the heat-shock-sensitive phenotype of BCY1 dis-
ruptions. Cells containing these TPKw alleles and
bcyl therefore have a kinase activity that is not
responsive to fluctuations in cAMP. Yet such cells
can arrest in G1 upon starvation, can utilize non-
fermentable carbon sources, can sporulate and ger-
minate correctly, and can accumulate glycogen ap-
propriately (S. Cameron et al., in prep.). Thus, the
entire panoply of physiologic responses thought to
be at least partly controlled by the cAMP effector
system is performed normally despite the inability
to modulate this effector system. Therefore, these
processes must be under coordinate control, with
the cAMP kinase system a contributing (but not ex-
clusively determining) function. Most recently,
study of the TPKw genes has led to insights into
the feedback control of cAMP production (see be-
low).
PDE1 and PDE2, respectively, encode the low-
and high-affinity cAMP phosphodiesterases of S.
cerevisiae (Sass et al., Proc. Natl. Acad. Sci.
83: 9303 [1986]; J. Nikawa et al., in prep.). The
PDE2 gene was initially described last year. It has
weak homology with several vertebrate phos-
phodiesterases. PDE1, recently isolated as a high-
copy suppressor of RAS2va119, has weak homology
with phosphodiesterases of the slime mold, but no
homology with PDE2. Thus, there are at least two
distinct branches of phosphodiesterases in evolu-
tion.
Gene-disruption experiments with the phos-
phodiesterases have led to the surprising discovery
of a rigorous feedback control of cAMP produc-
tion. Strains lacking both PDE genes show only a
modest twofold elevation of cAMP levels. How-
ever, strains lacking the PDE genes but containing
the mutant RAS2val19 gene show a 1000-fold in-
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crease in cAMP. These results imply that there is a
strong feedback control of cAMP generation in S.
cerevisiae, which likely passes through the RAS
proteins. Further experiments with the TPK genes
indicate that feedback probably results from the ac-
tivity of the cAMP-dependent protein kinase. In
particular, activation of the kinase by disruption of
BCY1 depresses cAMP levels, whereas the presence
of the TPKW alleles, in the absence of wild-type
TPK genes, causes a great elevation of cAMP lev-
els. Work is in progress to characterize these inter-
actions at the biochemical level.
SCH9 and other genes (e.g., JUN1, SCH1, and
SCH2) that interact with the RAS/CYRI pathway
have been identified. We have not yet fully charac-
terized these genes at the nucleotide, genetic, or bio-
chemical level. SCH9 has the structure of a protein
kinase and can perform many functions of the
cAMP-dependent protein kinases.
Human Oncogenes
M. Wigler, C. Birchmeier, D. Young, G. Bolger,
S. Sharma, J. Colicelli, G. Waitches, L. Rodgers,
M. Riggs, K. O'Neil
We are studying two human oncogenes that we re-
cently isolated: the ros and mas genes. These genes
were isolated using a modification of the NIH-3T3
transfection assay, which identifies oncogenes by
their ability to induce tumorigenicity (Fasano et al.,
Mol. Cell. Biol. 4: 1695 [1984]). It is now clear that
this assay identifies normal human genes that have
the potential to act as oncogenes when amplified,
overexpressed, or rearranged as a secondary conse-
quence of DNA transfer (Birchmeier et al., Mol.
Cell. Biol. 6: 3109 [1986]; Young et al., Cell 45: 711
[1986]). These oncogenes map to the distal portion
of chromosome 6q (Rabin et al., Oncogene Res.
[1987] in press).
THE HUMAN ROS GENE
We previously described the isolation of two hu-
man oncogenes, called mcf2 and mcf3, using the
DNA cotransfer and tumorigenicity assay (Fasano
et al., Mol. Cell. Biol. 4: 1695 [1984]). Nucleotide
sequence analysis of mcf3 cDNA clones indicated
that the mcf3 gene arose by rearrangement of a hu-
man gene homologous to the v-ros gene. It is likely
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that this rearrangement occurred during or after
DNA transfer and was responsible for activating
the oncogenic potential of ros. This gene, like its v-
ros counterpart, contains a transmembrane domain
and a carboxy-terminal domain that is homologous
to the known tyrosine protein kinases. The rear-
rangement creating mcf3 resulted in the loss of a
putative extracellular domain. It is likely that the
normal ros gene, like the normal counterpart of the
v-erb and v-fms genes, is a growth factor or hor-
mone receptor. We are currently attempting to ob-
tain a full-length cDNA clone to help us identify
the extracellular domain and the physiologic ligand
of this receptor. Expression studies in progress
clearly indicate that the ros gene is expressed in a
very high proportion (80%) of human glioblasto-
ma cell lines and hence might be a useful tumor cell
marker for that cancer (Birchmeier et al., Cold
Spring Harbor Symp. Quant. Biol. 51: 993 [1986]).
We have recently identified a glioblastoma cell line
with a deletion of the ros sequences encoding ex-
tracellular sequences (C. Birchmeier et al., in prep.).
THE HUMAN MAS GENE
We have continued the characterization of another
human oncogene, which we call mas. This gene was
isolated using the same methodology used for
isolating the mcf3 gene described above (Young et
al., Cell 45: 711 [1986]). Comparison of the trans-
forming locus with the placental locus, cDNA clon-
ing and sequencing, and S1- nuclease -protection ex-
periments have led to the following conclusions.
Like mcf3, masl was activated in NIH-3T3 cells
during or after gene transfer by a DNA rearrange-
ment, and, like mcf3, there is no evidence that mas
was activated in the tumor cells from which it was
ultimately derived. Unlike mcf3, the transforming
mas gene is not rearranged within coding regions.
Rather, its ability to transform cells appears to be
entirely related to its high level of expression, a con-
sequence of a rearrangement involving DNA 5' to
coding sequences. The normal mas gene, cloned
from a human placental cosmid library, is only
weakly transforming.
Two aspects of the mas gene make it of consider-
able interest as an oncogene. First, NIH-3T3 cells
transformed with mas are highly tumorigenic and
grow to high saturation densities but are not radi-
cally morphologically altered compared with nor-
mal NIH-3T3 cells. Second, the protein encoded by
mas is very hydrophobic. Its hydropathy profile
closely resembles that of the visual rhodopsins, and
the mas product is predicted to have seven trans-
membrane domains. In this respect, it is novel
among cellular oncogenes. Our preferred hypothe-
sis is that the mas protein, like rhodopsin, is a
signal-transducing receptor that activates a GTP-
binding protein. An understanding of the mecha-
nism whereby mas transforms cells is likely to lead
to new insights into growth-control mechanisms.
We have been attempting to develop antibodies for
the protein and to test putative ligands.
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HORMONAL AND DEVELOPMENTAL CONTROL
OF GENE EXPRESSION
D.T. Kurtz W. Addison B. McDonald
D. Danna E. Louis
The rat an globulin gene family has proved to be
a valuable model system for the study of the hor-
monal, developmental, and tissue-specific control
of gene expression in higher eukaryotes. a2u was
first described as the major protein present in the
urine of male rats, but absent from the urine of fe-
male rats. Urinary an globulin is produced in the
liver, and the synthesis of hepatic a2u is under
complex hormonal control: Androgens, glucocorti-
coids, insulin, and growth hormone are all required
for a normal level of hepatic au globulin synthe-
sis, and estrogens strongly repress the synthesis of
this protein.
c(2u is produced in several other tissues in rats:
Preputial gland, mammary gland, submaxillary
gland, and lachrymal gland all produce au globu-
lin mRNA. a2u is encoded by a multigene family,
comprising 20-25 genes per haploid complement.
It appears that different gene sets are being tran-
scribed in the various tissues, and the hormonal
control of the expression of the a2u gene sets in
these various organs is distinct.
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INDUCTION OF a2u GLOBULIN BY GLUCOCORTICOIDS
The induction of a2u by glucocorticoid hormones
has been extensively studied at the molecular level.
In vivo, glucocorticoid induction occurs at the tran-
scriptional level and is a secondary response to the
hormone; i.e., protein synthesis is absolutely re-
quired for the induction of an globulin mRNA by
glucocorticoids. Virtually all of the studies in the
past several years on the molecular mechanism of
steroid hormone action have been on primary re-
sponse genes (mouse mammary tumor virus, lyso-
zyme, ovalbumin, etc.). Primary response is be-
lieved to involve the direct association of activated
steroid receptor with target sites near the induced
genes, resulting in increased transcription. Ongoing
protein synthesis is not required. Secondary re-
sponse almost certainly is the consequence of the
hormone inducing the transcription of the mRNA
for a regulatory protein(s). This mRNA must then
be translated, and the resultant protein is responsi-
ble for the induction of the secondary response
genes. The studies done on primary response genes
in several laboratories over the past few years have
resulted in a consensus as to the mode of action of
these hormones: (1) Activated receptor does indeed
bind to specific sequences near (or sometimes in)
the target genes. The binding sites tend to contain
the sequence -TGTTCT-. (2) Binding of activated
receptor is necessary, but not sufficient, to induce
transcription. The activated receptor must interact
with other nuclear proteins to be effective. (3) Mul-
tiple binding sites for activated receptor occur near
the target gene. Deletion or mutation of one of the
sites will reduce the level of induction, but not abol-
ish it. (4) These control regions tend to be enhancer-
like, in that they are relatively position- and
orientation-independent with respect to the pro-
moter, and can act on heterologous promoters.
The studies done in this laboratory over the past
few years on the an globulin gene system are (with
one exception discussed below) the only studies
done at a molecular level on a secondary response
gene. We have found some similarities, but some
major differences, between the mode of induction
of an and that of primary response genes. Exten-
sive linker-scanning mutagenesis of the 5'-flanking
region of a cloned a2u gene indicated that one pre-
cise region of DNA was absolutely required for glu-
cocorticoid induction of a2u mRNA in transfected
L cells. One linker-scanning mutation ( -137 to
-125 relative to the cap site) completely abolished
induction. Mutations adjacent to this sequence
greatly reduced induction, whereas mutants any-
where else in the 5'-flanking region had no negative
effect upon induction. It appears, at least for this
example of secondary induction, that the hormone
regulatory region is organized quite differently
from those found in primary response genes, which
are made of multiple copies of the regulatory se-
quence.
Curiously, a set of mutants farther upstream, be-
tween - 210 and -180, actually increased the level
of induction. We have termed this the "hyperindu-
cible" region.
Initially, these results showed that the hexanucle-
otide - GGAACA-, which was in the middle of the
sequence required for a2u globulin induction, was
in a similar position in the promoter of the rat al-
acid glycoprotein gene (al-AGP), another rat-liver
gene under secondary control by glucocorticoids. It
has subsequently been shown that induction of al-
AGP by glucocorticoids requires the sequence
- GGAACA- at -120 in the al-AGP promoter.
The sequence homology between the regulatory site
in the a2u promoter and the regulatory site in al-
AGP can be extended on either side of this hex-
anucleotide to encompass a 15-base sequence
- ANGGAACANTNNTTG Of course, two
genes are not sufficient to derive a consensus DNA
sequence for secondary glucocorticoid induction,
but the similarities between the two systems are
striking.
NUCLEAR FACTORS THAT BIND TO THE a2u GLOBULIN
CONTROL REGION
DNase I protection studies ("footprinting") have
demonstrated the presence of nuclear proteins from
male rat liver that bind to two specific regions of
the a2u globulin promoter. One factor was found
to bind to precisely the region that we had shown
to be required for glucocorticoid induction. Fur-
thermore, mutant genes that were poorly responsive
or nonresponsive to hormones showed no binding
to this factor. It was at first hoped that this protein
was the regulatory protein whose transcription was
being induced by the hormone; however, the level
of this protein was unchanged in hypophysec-
tomized rats with or without hormone treatment or
in L cells with or without dexamethasone. This
finding could be explained by several models. It is
possible that this putative regulatory protein must
be modified to an active form by glucocorticoids.
Alternatively, the protein may provide specificity to
the regulatory system while another protein, in-
duced by the hormone, activates transcription. The
protein that binds to the glucocorticoid regulatory
region has been found in virtually every tissue ex-
amined (male and female rat liver, rat kidney, and
L cells).
A second binding protein has been detected that
binds to sequences between - 210 and -185. This
partially overlaps with the "hyperinducible" region
mentioned above. This protein seems to be found
only in tissues that are competent to transcribe a2u
globulin: It is found in rat liver and in L cells, but
not in rat kidney. It is striking that both footprints
occur in regions of dyad symmetry; the upstream
footprint occurs over the sequence -ATAtgTTTt-
GCgAAAtgTAT- and the downstream footprint
precisely covers the units of symmetry contained
in the sequence -TGAcAtcGCCAAGTTNI7AAtc-
CTTGGCTTCA-. The presence of dyad symmetry
in regulatory regions is quite common in prokary-
otes and correlates with a dimeric structure of the
regulatory protein. Examples of eukaryotic regula-
tory proteins that bind to symmetric sequences are
the GAL4 protein of yeast and a protein that binds
to the chicken 13-globin promoter.
Experiments designed to purify the factors that
bind to the a2 globulin promoter, as well as the
cloning of their cDNAs, are currently under way.
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MOLECULAR BIOLOGY OF MOUSE DEVELOPMENT
D. Hanahan S. Alpert L. Field
V. Bautch S. Grant
S. Efrat J. Hager
M. Pizzolato
J. Skowronski
S. Toda
During the past several years, the effort in mouse
genetics at Cold Spring Harbor Laboratory has
shifted to focus on the use of transgenic mice to
study problems in control of gene expression and
consequences of oncogene expression. Particular
emphasis has been on using this approach to pro-
duce models of human diseases, notably certain
types of cancer. The essence of transgenic mice is
that they carry a specific new piece of DNA stably
integrated into one of their chromosomes, and this
new DNA is thus a heritable genetic element, which
is capable of endowing a reproducible phenotype
on the mice that inherit it. Transgenic mice are ini-
tially produced by microinjecting a solution of
DNA into one of the pronuclei of a fertilized mouse
egg, which is implanted into a foster mother and al-
lowed to develop. The original transgenic mice are
bred to found lineages, or families, of mice that
carry the "transgene" as part of their genome.
Transgenic mice are being used to study a number
of specific cancers, including those of the insulin-
producing pancreatic 13 cells, the heart atria, the
skin, and the vascular endothelium. Targeted on-
cogene expression is also being exploited in studies
of the immunological responses to transgene prod-
ucts and to cell lineage analyses. Other efforts are
seeking to explore the prospects for antisense RNA
inhibition of gene expression, and the conse-
quences of expressing different cellular oncogenes
in specific cell types, both individually and in
genetic complementation experiments produced by
mating different transgenic mice. The reports below
summarize some of the projects that have
progressed well during the past year and illustrate
the breadth of the current efforts in molecular
genetics studies using transgenic mice.
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Self- tolerance and Autoimmunity
in Wansgenic Mice
S. Alpert, J. Skowronski, D. Hanahan
[in collaboration with T. Adams, University
of Melbourne, Parkville, Australia]
The question of how organisms come to recognize
self-proteins as such, thereby becoming immuno-
logically nonresponsive, remains a central and enig-
matic problem in immunology. Similarly, the mech-
anisms by which nonresponsiveness to self-proteins
fail, resulting in autoimmune diseases, are also es-
sentially undefined, although they most probably
are closely related to the routes by which self-
tolerance is established in the first place. The in-
troduction of new genes into the mouse germ line
results in the stable establishment of the transgene
in a mouse chromosome, where it must now be con-
sidered self in a genetic sense. One would assume,
therefore, that its gene product would be a self-
antigen. We have investigated this question in the
RIP-Tag lineages of transgenic mice and find that
this is not always the case. The RIP-Tag transgene
is composed of the rat insulin II gene 5' regulatory
region aligned to transcribe the early region of
SV40. It is expressed exclusively in the pancreatic 13
cells of adult mice, which are the sole known source
of insulin synthesis. Thus, expression is targeted to
one specific cell type.
Four lineages have been examined for their im-
munological responses to the transgene product,
large T antigen: RIP1-Tag2, -Tag3, -Tag4, and RIR-
Tagl. Tolerance was addressed in two ways: (1) Se-
rum was tested for the presence of autoantibodies
to T antigen and (2) purified T antigen was injected
in an attempt to elicit an immune response to it.
Mice in the RIP-Tag3, -Tag4, and RIR-Tag lines
showed serum antibodies to large T antigen. The
frequency of autoantibodies was high, varying
from 25% to 60% of the mice tested in these three
lineages. In contrast, none of the RIP-Tag2 mice
tested showed appreciable levels of autoantibodies
to large T. The appearance of autoantibodies was
found to precede tumor formation, which suggests
that the immune response is not strictly a reaction
to the appearance of solid tumors. The distinction
between RIP-Tag2 and the other three lineages sug-
gested that they differed in their self-tolerance. To
address this directly, purified large T antigen was
presented to mice from each lineage, as well as nor-
mal (nontransgenic) mice, in a standard immuniza-
tion regimen of primary and secondary injections.
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Nontransgenic mice, and the mice from the RIP-
Tag3, -Tag4, and RIR-Tag lineages, mounted a
strong immune response to T antigen. In contrast,
mice in the RIP-Tag2 lineage did not.
The conclusion from these two types of analyses
is that mice in the RIP-Tag2 lineage are heritably
tolerant to the transgenic self-antigen large T,
whereas the other three lines are not. One conse-
quence of this nontolerance is the appearance of
autoantibodies, which is one characteristic of many
autoimmune diseases. To address the heritable es-
tablishment of tolerance or nontolerance in these
lines, we have examined the time course of the ap-
pearance of large T. In RIP-Tag2, large T appears on
day 12 of embryogenesis, concomitant with insulin,
and continues to be present in fl cells thereafter (see
following report). In contrast, no expression of T
antigen is detected in neonatal mice of the RIP-Tag3
and -Tag4 lineages. Instead, scattered 13 cells ex-
pressing T antigen begin to appear at 8-12 weeks of
age. This late onset of expression is provocative,
since the expression is cell-type-specific to the
cells but not correctly regulated in development. It
is possible that the random integration of the trans-
gene in the original injected embryos resulted in the
transgene being in chromosomal positions that re-
strict the accessibility of the gene during 13 cell de-
velopment. This "position" must be a frequent one,
given that the same effect appears in three indepen-
dent lineages.
Since the period of immunological self-learning
is thought to cover the last few days of embryogene-
sis in the mouse, as well as the first week or two af-
ter birth, one can propose that the RIP-Tag2 mice
are self-tolerant to T antigen as a result of expres-
sion during this period, whereas the late onset of
expression in the other lines occurs after the self-
learning period is over. The failure to establish self-
tolerance due to the late appearance of large T has
a significant consequence. Autoantibodies to large
T appear with high frequency, presumably as a re-
sult of the immune system viewing large T antigen
as a foreign antigen. Mice with autoantibodies to
large T also show lymphocyte infiltration of the is-
lets of Langerhans, indicating that the immune sys-
tem is seeking out the source of expression of this
"foreign" antigen, which is actually a self-antigen
that shows an aberrant pattern of expression. This
observation suggests a mechanism of autoimmune
disease: Delayed onset of expression of a protein
results in a failure to establish self-tolerance and a
consequent autoimmune response against it. We
will now address this question from several perspec-
tives, in order to define further the characteristics
of the tolerant state in the RIP-Tag2 lineage and the
development of the autoimmune response in the
nontolerant lines. One approach will be to present
purified T antigen to neonatal nontolerant mice, to
see whether antigen presentation during the "self-
learning" period is sufficient to render these indi-
viduals tolerant to the T antigen when it subse-
quently appears in the [3 cells, thus obviating the au-
toimmune response. Success with this approach
could be informative vis-a-vis the general concept
of preventing autoimmune disease by immunizing
with the autoantigen.
Cell Lineage Analyses of
Pancreatic Endocrine Cells
S. Alpert, D. Hanahan [in collaboration with G. Teitelman,
Cornell University Medical College]
The various cell types in the pancreas may originate
from different stem cells or from common precur-
sors. To examine this issue, we have sought to deter-
mine whether pancreatic cells can share common
antigens during development. The ontogeny of the
insulin-producing cells is being studied in develop-
ing transgenic mice by examining the appearance of
cells expressing insulin itself, as well as the other
pancreatic hormones, and tyrosine hydroxylase.
Tyrosine hydroxylase (TH), the first enzyme in
the catecholamine biosynthetic pathway, has been
used as a marker to study the development of the
islets of Langerhans. In the adult mouse, TH is ex-
pressed in a few of the insulin-producing 13 cells in
every islet. However, during development, TH is
present in both the glucagon- and the insulin-
containing cells (Teitelman et al., Peptides 2: 157
[1981]; Dev. Biol. [1987] in press). These findings
suggest that progenitor cells that contain enzymes
involved in catecholamine biosynthesis, and are
present in the developing pancreatic duct, give rise
to glucagon- and insulin-producing cells of adult is-
lets.
The developing mouse pancreas appears as a
diverticulum from the embryonic gut on day 10 of
gestation (e10). The first bundles of exocrine tissue
appear around this duct. Endocrine cells form
around the pancreatic duct and produce the islets
of Langerhans (Pictet and Rutter, Handb. Physiol.
7: 25 [1972]). In the mouse, cells with glucagon im-
munoreactivity have been noted on el 0, insulin as
early as el 2 (Teitelman et al., Dev. Biol. [1987] in
press), somatostatin on e17, and pancreatic poly-
peptide after birth (Teitelman et al., Proc. Natl.
Acad. Sci. 78: 5225 [1981]). The TH cells appear
alongside the duct and contain glucagon and/or in-
sulin. Postnatally, TH cells are not found along the
duct, but rather appear in a subset of the insulin-
producing cells in the islets.
We have conducted an immunohistochemical
analysis to clarify further the developmental lin-
eage of the cells in the islets of Langerhans in RIP1-
Tag2 mice. These mice harbor a hybrid gene con-
sisting of 695 by of the 5'-flanking region of the in-
sulin gene fused to the protein-coding region for the
SV40 large T antigen. Mice containing this gene ex-
press T antigen only in the f3 cells of the islets of
Langerhans (Hanahan, Nature 315: 115 [1985]). If
the transgene is regulated developmentally in the
same manner as the insulin gene, we can use T anti-
gen as a marker to investigate further the nature of
the R cells' progenitor. In addition, we can deter-
mine if the portion of the insulin gene contained in
our construct contains sufficient information for
proper developmental regulation.
Cells containing T antigen first appear in the
pancreas at el0 of development. Double-label ex-
periments have shown that these cells can contain
either glucagon or TH. (It is possible that some
cells contain both glucagon and TH as well as T an-
tigen, but the methods currently available cannot
detect a "triple-labeled" cell.) At e12, cells that con-
tain insulin and T antigen appear. Throughout de-
velopment, all cells that express insulin also contain
T antigen. However, the converse is not completely
correct; all cells that contain T antigen do not stain
for insulin. Instead, a few cells colabel for T antigen
and somatostatin, or for T antigen and pancreatic
polypeptide. These cells appear at ell and at postna-
tal day 1 (pl), respectively. This result is further sup-
ported by the finding that cells which contain both
glucagon and insulin appear at el 2. The fact that
T antigen coexpresses with markers for the other
three islet cell types during development supports
the possibility that a common precursor exists for
all of the cells in the islets of Langerhans.
Although T antigen can coexpress with each of
the islet cell types, it does not express in the acinar
cells of the exocrine pancreas. Double-label experi-
ments with T antigen and amylase have shown that
throughout development, T antigen and this exo-
crine cell marker are always in separate cells.
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At some point in postnatal development, T-
antigen expression becomes limited to the insulin-
producing cells. At pl, all of the insulin-producing
cells, several of the glucagon-producing cells, and
a few cells of the somatostatin and pancreatic poly-
peptides contain T antigen. The exact timing of
segregation has yet to be determined, but it must be
completed sometime between day 1 and day 14 of
postnatal life, since, by this time, T antigen coex-
presses only with insulin.
All of the studies described above were con-
ducted on sections of pancreas. When sections of
whole embryos were analyzed, T antigen was found
to be expressed in the ventral part of the neural tube
and in the neural crest. T-antigen expression in the
neural tube begins at e9 (the time of neural tube
formation) and has been followed through neural
crest formation and up until e16. No insulin could
be detected in these embryonic structures at any
time. The fact that T antigen is present in both the
non-0 cells of the pancreas and in the neural tube
and crest is somewhat puzzling. It is possible that
insulin is present in these cells, but at levels too low
to be detected by our methods. Radioimmunoas-
says will be conducted on the neural tissue of mouse
embryos to detect low levels of insulin production.
Alternatively, in these cell types, stable insulin tran-
scripts may be produced but are not translated.
RNA in situ experiments can determine the pres-
ence of insulin transcripts. It is also possible that
insulin transcripts are produced but are not stable
or that our hybrid construct has eliminated part of
the region required for proper developmental regu-
lation. We are currently trying to distinguish among
these possibilities.
There are several theories that can explain the ap-
pearance of T antigen in the neural tube. The first
is that neural and islet cells are phenotypically simi-
lar. Many neural markers are present in islet cells,
including TH, phenyl n-methyl transferase, dopa-
mine decarboxylase, y-aminobutyric acid, neuron-
specific enolase, 7B2, and PGP 9.5. It is possible
that some of the same trans-activating factors are
present in both neurons and islet cells. These fac-
tors may allow the neural proteins to be made in is-
let cells and islet cell markers to be expressed in
neurons (e.g., somatostatin is expressed in some
nerve cells). Alternatively, our construct could have
omitted a repressor-binding site that is normally
contained in the insulin 5'-flanking region. Nor-
mally, the repressor would prevent insulin expres-
sion in neural tissue.
88
Another hypothesis is that the islets of Langer-
hans are formed from the neural crest. Evidence
against this ontogeny comes from experiments in
which transplants of a quail neural crest into chick
embryos did not result in quail cells populating the
islets (Le Dourain, in Gut Hormones, Church-
Livingstone, Edinburgh [1978]). Additionally, in
vitro cultures of mouse embryos that have been en-
zymatically treated to remove the neural ectoderm
can develop a pancreas (Pictet et al., Science
191: 191 [1976]). As Pearse has proposed, the possi-
bility remains that an early migration of crest cells
could populate the islets (Pearse and Takor-Takor,
Fed. Proc. 38: 2288 [1979]). An additional analysis
will be conducted on a second line of mice, RIR-
Tag2, which also develops T-antigen-containing
insulin-producing tumors at a relatively young age,
to verify the cell lineage relationships. We will also
look for T-antigen expression before e10 to deter-
mine whether there is any early migration of T-
antigen-containing ectodermal cells.
13-cell Tumor Progression in
Transgenic Mice: Identification
of 13 Cells Containing
Embryonic Antigens
S. Alpert, D. Hanahan [in collaboration with G. Teitelman
and J. Lee, Cornell University Medical College]
The above report has raised the proposition that the
endocrine cells of the pancreas arise from a com-
mon progenitor cell, perhaps one that contains TH.
In addition to being expressed during development,
TH is expressed in a few of the r3 cells of the adult
mouse pancreas. Analyses of the neoplasia occur-
ring in adult RIP1-Tag2 may address the questions
of whether the hyperplasia of pancreatic islets is
produced by proliferation of precursor cells and
whether the few TH-containing cells could be this
precursor population.
At 13 weeks of age, most pancreatic islets of the
RIP1-Tag2 mice are hyperplastic and some have de-
veloped into solid insulinomas. When the animals
were perfused and the tissue was processed for im-
munohistochemical staining, we found that, in
most islets, all cells stained for insulin. The percent-
age of TH cells ranged from only a few percent to
100%, which is considerably greater than the nor-
mal 1% seen in a normal islet.
The presence of TH could be due to selective sur-
vival and proliferation of the few TH cells present
in the islets before neoplasia. An alternative hy-
pothesis is that all cells of the islet proliferate when
stimulated by the oncogene and that, at a certain
point, they regress to a more "immature" state and
reexpress TH.
Transgenic mice of various ages were injected
with [3H]thymidine, and, after 3 hours, the ani-
mals were sacrificed and the pancreases were pro-
cessed for immunohistochemistry and autoradiog-
raphy. At all stages in postnatal development, all
dividing cells contained insulin. Thus, it is unlikely
that growth is due to the proliferation of an un-
differentiated stem cell. Although the number of
both TH-containing cells and proliferating cells in-
creased throughout development, only rarely did a
dividing cell in the islets contain TH. Thus, it is un-
likely that TH marks an "embryonic" cell; rather,
it appears that during islet growth, TH expression
marks a postmitotic stage of adult 13 cells. Similar
results with TH have been obtained in two other
models of islet cell growth, the ob/ob mice and
pregnant mice (G. Teitelman et al., pers. comm.).
Only in embryos and in very advanced tumors can
the TH cells divide. The mechanisms responsible
for the sequence of phenotypic transformations of
13 cells during neoplasia and/or tumor formation
have yet to be determined.
Characteristics of 13-cell
Tumor Formation
S. Efrat, D. Hanahan
A common observation in the studies of targeted
oncogenesis in transgenic mice has been that only
a small number of the target cells expressing the on-
cogene develop into solid tumors. Tumor forma-
tion in the RIP-Tag mice follows the same pattern:
Of the several hundreds of islets in the pancreas, all
of which express a potent oncogene, the SV40 large
T antigen, only one to five develop into solid, vas-
cularized tumors. This implies that although the
oncogene product is necessary, it is not sufficient
for tumor formation. Secondary events, or tumor
progression factors, are likely to be involved in this
process. Since in our system we are analyzing the
consequences of oncogene activity in an entire ani-
mal, we have an opportunity of studying such
events.
One possibility for a secondary event is a muta-
tion that may cause activation of another oncogene
or growth factor in a small number of [3 cells. Previ-
ously, we were not able to detect any activated on-
cogenes in the tumor DNA by the 3T3-cell trans-
fection assay. Thus, our current approach is to
examine tumor RNA for expression of known on-
cogenes by RNA blot analysis. Normal (3 cells, as
well as 13 cells from transgenic mice in the pretumor
stage, can then be examined for expression of those
oncogenes that are expressed at high levels in the
tumors, to determine which of them has been newly
activated during tumor formation. To establish that
a given candidate is indeed a cause, rather than a
consequence, of tumor formation, we plan to use
genetic complementation. The gene for the putative
progression factor will be placed under the control
of the insulin promoter to generate transgenic mice
that express it in their 13 cells. These mice will be
crossed with the RIP-Tag mice, which will result in
mice expressing both T antigen and the putative
progression factor in all their islets. The prediction
is that in such mice, every islet will develop into a
tumor.
So far, we have identified three groups of on-
cogenes that are expressed at high levels in the
tumors: p53, members of the myc family, and an
endogenous retrovirus. p53 is an unstable cellular
protein that is present at very low levels in normal
cells, but it is stabilized in the presence of T antigen
and appears at high levels in cultured cells trans-
formed by SV40. Northern analysis shows ap-
preciable levels of p53 mRNA in the tumor cells.
Using monoclonal antibodies directed against the
large T and p53 proteins, we have performed im-
munohistological analysis on thin sections of pan-
creas of both fast and slow lineages (those that
develop tumors and die between 12 and 20 weeks
[fast] or 20 and 60 weeks [slow]). There is a com-
plete correlation between the presence of large T
and p53 in the 13 cells that are found in both islets
and tumors. In the fast lineages, p53 appears early,
concomitant with large T, whereas in the slow line-
ages, p53 is only detected relatively late, and not be-
fore T antigen is present. In all of the cases where
T antigen is present, p53 is detected as well. p53
cannot be detected in the 13 cells of normal mice. Al-
though this does not fit the simple criteria for a
progression factor (since p53 is detected both in is-
lets and in tumors), we nevertheless find it pertinent
to conduct p53/T antigen genetic complementa-
tion experiments. We have already generated sev-
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eral lineages of RIP-p53 mice, and these are cur-
rently being analyzed for expression.
Using probes for the human c-myc and N-myc
genes, we have detected high levels of transcripts to
each in the tumors. We do not yet have any infor-
mation on their expression in islets. Transgenic
mice harboring insulin-promoted mouse c-myc
genes have already been generated. We have also de-
tected transcripts in tumor RNA blots that hybrid-
ize to several retrovirus genomes, as well as to a
cloned long terminal repeat fragment, a regulatory
region shared by all retroviruses. This suggests that
an endogenous provirus is expressed in the tumor
cells and that it may have been activated in the pro-
cess of tumor formation.
Polyomavirus Gene Expression in
Transgenic Mice
V. Bautch, S. Toda, D. Hanahan [in collaboration with
J. Hassel, McGill University, Montreal]
We are analyzing the effects of the early region of
polyomavirus in transgenic mice. We plan to assess
the expression of the polyomavirus early region
promoter in the tissues of transgenic mice to deter-
mine the contribution of tissue-specific regulation
to the overall processes of infection and tumorigen-
esis in mice. If the polyomavirus promoter is ex-
pressed in murine cell types for which no cellular
promoter has been characterized, we may be able to
target oncogene expression to unique cell types. In
addition, we are also setting up a complementation
analysis of the polyomavirus T antigens in the natu-
ral host to help elucidate the cooperating roles of
these proteins in tumor formation. We are targeting
expression of the polyomavirus T antigens to the 13
cells of the pancreas using the rat insulin II pro-
moter to facilitate these complementation assays.
The permissive host for polyomavirus is the
mouse, and normal routes of transmission result in
a silent infection with no overt symptoms. How-
ever, newborn animals inoculated with high-titer
virus preparations can develop tumors in a variety
of tissues starting at 3 months of age. Polyomavirus
contains a region expressed early during a lytic in-
fection that is also required for transformation.
The broad tissue distribution of polyomavirus-
induced tumors suggests that many murine cell
types are permissive for early region transcription.
Polyomavirus encodes three early region pro-
teins, large T (100K), middle T (56K), and small T
(22K) antigens. Several lines of evidence suggest
that polyomavirus large T antigen (PyLT) contains
an establishment function that immortalizes pri-
mary cells in culture and that polyomavirus middle
T antigen (PyMT) contains an activity that mor-
phologically transforms established cells, but not
primary cells. These two proteins can cooperate
with each other and with other oncogenes to trans-
form primary cells. The function of polyomavirus
small T antigen (PyST) in in vitro transformation
is not well understood. The functions of the poly-
omavirus early proteins are less well defined in vivo,
although all three T antigens appear to be involved
in tumorigenesis in rats.
For these analyses, several genes have been in-
jected into the pronucleus of one-cell mouse em-
bryos. Table 1 summarizes the current progress in
the most complete analyses, and the results are dis-
cussed below.
In addition to the lines described in Table 1, we
have generated lines of mice carrying the insu-
lin-polyomavirus T antigen constructs. None of
these founder animals or their progeny have devel-
oped overt pathology at the age of 7.5 months. We
are currently analyzing selected lines for expression
of the polyomavirus T antigens by immunocyto-
chemistry and RNA analysis.
TABLE 1 Status of Polyomavirus Transgenic Lines
Copy Agea
Line Construct no. (months)
Py-1 Py/genomic 20-50 3.5
PyLT-1 PyLT(cDNA) 2-10 10.0
PyLT-2 PyLT(cDNA) 30-50 10.0
PyMT-1A PyMT(cDNA) 30-50 2.5
PyMT -1 B PyMT(cDNA) 2-10 7.5
PyMT-2 PyMT(cDNA) 5-15 6.5
Pathology
dead, bowel obstructionb
dead, lung/brain abnormalb
alive
dead, hemangiomas
dead, cause uncertainb
dead, hemangiomas
a Age of founder mouse at this writing or at death.
b Analysis is in progress to determine whether there is additional pathology.
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We have recently obtained founder mice carry-
ing polyomavirus-promoted SV40 T-antigen con-
structs. Because SV40 T antigen has led to pathol-
ogy in all tissues to which expression has been tar-
geted in transgenic mice, we hope that this gene will
serve as a phenotypic "reporter" gene and that all
tissues expressing the polyomavirus promoter will
be affected. We have also obtained mice carrying a
polyomavirus-promoted transformation-defective
SV40 T antigen; we hope that this construct repre-
sents a nonlethal reporter gene that can be assayed
in expressing tissues.
The PyLT and PyMT mice have been most exten-
sively analyzed. Although PyLT mice show no
pathology at this time (the recent death of one of
the founder mice cannot be linked to expression of
PyLT until tissue analysis is completed), the PyMT
mice have developed fatal hemangiomas. One lin-
eage has been analyzed in detail and will be de-
scribed. It should be noted, however, that a differ-
ent founder mouse also died with hemangiomas.
This fact indicates that the pathology is not due to
a position effect of integration but is most likely an
intrinsic property of polyomavirus-promoted MT
gene expression.
Hemangiomas are a proliferation of the en-
dothelial lining of the blood vessels. Of 50 positive
mice of the MT-1A lineage, 20 have died or have
been sacrificed, and all had hemangiomas with no
other overt pathology. No member of this lineage
has lived beyond 4 months of age. Hemangiomas
have been documented in most organs with a copi-
ous blood supply, including the liver, lung, and sub-
cutaneous tissue. To document expression of the
transgene, we performed a kinase assay on tissues.
This assay takes advantage of the fact that PyMT
complexes with cellular tyrosine kinases such as
c-src, and this complex has autophosphorylation
activity after immunoprecipitation. This assay
showed that MT was expressed and complexed in
tumor tissue and in several other organs (liver,
spleen, testes, and lung), whereas no MT kinase ac-
tivity was detected in kidney tissue from the same
animal. We have recently been successful in passag-
ing these tumors in vivo. This ability (1) indicates
that the tumors are neoplasias and not just hyper-
plasias and (2) provides a source of tumor material
for additional analysis.
These results pose several questions that we plan
to address. The first is, What is the contribution of
promoter specificity to the development of this very
specific phenotype? The two extreme hypotheses
are that the polyomavirus promoter may be ex-
pressed only in endothelial cells or that the pro-
moter may be expressed in several different cell
types, but only have some complementing activity
necessary for transformation in endothelial cells. A
direct test of promoter function using a high-
sensitivity RNA protection assay is in progress, and
preliminary results indicate that cell types other
than endothelial cells express stable PyMT RNA.
The second question, which is a corollary of the
first, is, Are there tissues containing PyMT that are
not neoplastic? The presence of such cell types
would indicate that some complementing activity
necessary for transformation is missing in these
cells. We are attempting in situ analysis using im-
munocytochemistry to determine if these cells exist.
The third question is, Does the coexpression of
PyLT alter in any way the dominant phenotype as-
sociated with PyMT expression in these mice? We
have started genetic complementation experiments
by mating mice carrying the PyLT gene with mice
carrying the PyMT gene. Several hybrid progeny
have recently been obtained, and these will be
monitored for alterations in phenotype. We are
concurrently using the techniques described above
to determine if the PyLT genes are being expressed.
Some possible results are that PyLT expression will
(1) suppress the development of hemangiomas due
to PyMT expression, since PyLT can repress tran-
scription from the polyomavirus promoter; (2)
redirect development of neoplasms to epithelial tis-
sues such as the parotid and mammary glands,
since infection with polyomavirus leads to this
pathology; and (3) have no effect on PyMT-induced
hemangiomas.
Alpha-1-Antitrypsin Deficiency
in Transgenic Mice
S. Grant, D. Hanahan [in collaboration with A. Pollard
and J. Sorge, Scripps Clinic]
Alpha-l-antitrypsin (A1AT), the principal serum
protease inhibitor, is a single polypeptide glycopro-
tein with a molecular weight of 52,000. It is synthe-
sized and secreted by the hepatocyte into the circu-
lation, whereby it readily diffuses through most
tissues. Its principal action is to inhibit neutrophil
elastase by forming a stable complex. In humans,
a deficiency in A1AT allows neutrophil elastase to
cleave elastin and other macromolecules compris-
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ing the connective tissue matrix. The associated
phenotype is primarily in the lung of adults as em-
physema and less frequently in the liver of infants
as cirrhosis.
A single autosomal allele is inherited from each
parent, and the phenotype is expressed in an au-
tosomal codominant pattern. The most common
form of A1AT is type M, and the best-studied vari-
ant is type Z. Homozygotes for the Z allele occur
once in 2000 people and have serum A1AT levels at
10-15% of the normal. The Z mutation arises from
a G-A transition that converts glutamic acid at resi-
due 52 to lysine. This mutation affects secretion of
the protein rather than its specific activity.
Our goal is to produce a model of A1AT defi-
ciency and study the expression of the human al-
leles in transgenic mice. The first step has been to
create transgenic mice with the human genomic
clones of the M and Z alleles. We have established
two lineages of the M allele, both of which express
the gene and secrete A1AT into serum. We have
three lineages that contain the Z allele, and no ab-
normal phenotype has so far been observed.
The next step is to try to inhibit the expression of
the mouse endogenous A1AT by expression of an
antisense RNA, which is complementary to the
mouse A1AT mRNA. A variety of experiments in
cultured cells have suggested that antisense RNA
can, under some circumstances, inhibit the expres-
sion of the mRNA to which it is complementary,
presumably through a mechanism that involves an-
nealing of the two RNAs. Two antisense constructs
will be used initially; the mouse cDNA will be
aligned in reverse (antisense) orientation in order to
be transcribed under the direction of either mouse
metallothionein or mouse albumin promoters,
both of which are normally expressed at high levels
in hepatocytes. The serum levels of A1AT will be as-
sayed and related to any phenotype, with particular
emphasis on lung and liver pathology. Mice with
low levels of serum A1AT will be crossed with those
mice carrying the human alleles to attempt to res-
cue the deficient phenotype.
The hepatic disease of Z-allele honiozygotes is
thought to be due to accumulation of A1AT in the
Golgi. We will attempt to recapitulate this liver dis-
ease in mice by overexpressing the human Z allele
with the mouse albumin promoter. Four lineages
have been established and will be analyzed for lev-
els of transgene expression, the intracellular local-
ization of the Z protein, and development of liver
pathology.
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GENETICS
For the past four decades, genetics has been used as an important tool of ex-
perimental biology at Cold Spring Harbor Laboratory. The combination of recom-
binant DNA technology and classical genetics gave rise to the field of molecular
genetics. An important element of these approaches is the ability to isolate genes
of interest, manipulate them in vitro, and return these constructs to the genome,
usually at their original location. Thus, with this so called "reverse genetics:' we can
make mutations at will and then test their effect on a particular cellular phenome-
non in vivo. In the past year, we have used these approaches on various systems
such as cell-type determination and cell-cycle controls of both Saccharomyces
cerevisiae and Schizosaccharomyces pombe and energy metabolism pathways
of Rhodobacter capsulata. In other areas, we have continued our molecular
studies of tobacco tissue culture and maize controlling elements.
During the past year, we witnessed a significant turnover of our colleagues in
this area. Jim Hicks moved to Scripps Institute, California, Steve Dellaporta took a
position at Yale University, Doug Youvan joined Massachusetts Institute of Technol-
ogy, Pablo Scolnik moved to Dupont Research Facility, Clive Slaughter joined
Howard Hughes Medical Institute at Dallas, and Steve Hinton moved to the Exxon
Research facility at Trenton. We will miss them, and we wish them continued suc-
cess and thank them for their contributions to Cold Spring Harbor Laboratory.
Continuing with the tradition of our laboratory of efficient use of space, the newly
vacated areas have already been assigned to new arrivals in the areas of molecu-
lar structure, yeast, and plant molecular biology.
YEAST GENETICS
A.J.S. Klar R. Cafferkey G.P. Livi
M. Kelly L. Miglio
C.I.P. Lin
Differentiated Parental DNA
Strands Confer Developmental
Asymmetry on Daughter Cells
in Fission Yeast
A.J.S. Klar, R. Cafferkey, M. Kelly, L. Miglio
As demonstrated in Figure 1, the alternate alleles of
the matl locus, called matl-P and matl-M, inter-
change (switch) by a transposition-substitution
event in which a replica of either the mat2-P or
mat3-M donor "cassette" is transmitted to the matl
locus via a gene-conversion process. This genotypic
change results in an interconversion between the P
and M cell types of Schizosaccharomyces pombe.
Miyata and Miyata (J. Gen. Appl. Microbiol.
27: 365 [1981]) (Fig. 2) observed that between two
sister cells, only one member (designated Ps or Ms
in Fig. 2) produces a single switched cell in the next
generation; i.e., only one grandchild is switched
among the four progeny produced by two cell divi-
sions of a single cell (the one-in-four rule). We want
to determine how sister cells acquire developmen-
tally different fates such that only one member of
a pair of sister cells produces a switched progeny.
At least two models come to mind. The first is that
the ability to switch is inherited through the chro-
mosome, and the second is that cytoplasmic (plus
nuclear) factor(s) asymmetrically transferred from
the mother cell influence switching in the next
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FIGURE 1 A portion of chromosome II showing the mating-type region. Smt indicates the site of the double-
strand DNA break found in vivo.
generation. Other genetic studies suggested that the
switching potential segregates in cis with the matl
locus. But why does only one among four descen-
dants of a given chromosome switch? We may
imagine a molecular model in which "Watson" and
"Crick" strands of DNA are viewed as nonequiva-
lent in their ability to acquire the developmental
potential for switching. We may imagine that some
sequence-specific DNA modification, such that
only one specific chain (e.g., the Watson strand) at
the mat/ locus is modified (Fig. 3, asterisk). We fur-
ther hypothesize that replication of the hemimodi-
fied chromosome generates sister chromatids, of
which one is cut (the one possessing the old Watson
chain, the left cell in Fig. 3) and the other is uncut.
We know that the recombination required for
switching is initiated by a double-strand break at
matl. On the basis of the model proposed here, the
cell inheriting the broken chromosome is hypothe-
sized to produce a single switched cell in the next
generation. Although the specific details of the
hypothesized "imprinting" event are not known,
the key idea - of the segregation of DNA strands
conferring developmental asymmetry to daughter
cells - can be tested.
A molecular test of the strand-segregation model
Pu
Ps Pu
Mu Ps Ps
Mu
N
Ps
Pu
Ps
N
Pu
FIGURE 2 The Miyata and Miyata pattern of matl switching
in a cell lineage showing the switching rule of one-in-four related
cells. The u designates cells that cannot produce a switched
progeny, and the s designates those that can.
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consists of determining the effect of cassette orien-
tation on the switching of tandem cassette duplica-
tions of mall. Both the strand-segregation model
and the cytoplasmic segregation model predict that
in the direct tandem duplication, a single cell could
acquire the competence to switch both cassettes in
the same cell cycle (Fig. 4A). In standard strains,
since nearly 20% of matl DNA is cut in vivo and
the break persists throughout the length of the cell
cycle, we can monitor at the molecular level the
competence of a given cassette to switch by directly
assaying for the presence of the double-strand
break at that cassette by Southern blot analysis.
More specifically, the chromosome of the cell
designated PsPs in Figure 4A should have a double-
strand cut at both cleavage sites to generate a 6.1-kb
fragment. The predicted fragment having homol-
ogy with the matl sequence was found when the un-
restricted DNA isolated from the strain with direct
duplication was subjected to Southern analysis
(Fig. 5b). This result does not distinguish between
the models under consideration, but it does show
that more than one cassette can become competent
to switch in a single cell and within a single cell-
division cycle.
A specific physical prediction that distinguishes
between these models is provided by the inverted
duplication. The analogous 7.2-kb fragment in the
inversely oriented duplication should be generated
according to the cytoplasmic segregation model
(the cut sites in this construction are 7.2 kb apart),
but it should not be generated according to the
strand-segregation model presented in Figure 3. As
predicted in Figure 4B by the strand-segregation
model, both strands of DNA should be modified
(see top of the figure), one strand on one cassette
and the other strand on the second cassette. Segre-
gation of these strands should generate two daugh-
ter cells, one having a break in one cassette and the
wC
w
C
wc
Mu
Pu
*Ag GRANDPARENT CELL
PARENTS
Pu
WC iv>-
Ps Pu
GRANDCHILDREN
FIGURE 3 Strand-segregation model. Arrows originating from the grandparent cell indicate
segregation of a particular DNA chain to the daughter cell. A gap in the continuity of the chromo-
some indicates the presence of a double-strand DNA break.
sister inheriting a break in the second cassette. In
other words, the strand-segregation model predicts
that a given cell should switch one or the other cas-
sette, but never both cassettes, in a single cycle. As
shown in Figure 5c, the 7.2-kb fragment is absent
in the DNA isolated from a strain with the inverted
duplication. More importantly, when the DNA was
digested at sites flanking the duplication and then
subjected to Southern analysis, we found that the
observed level of break at either cut site is similar
to that found in strains containing only one matl
cassette. Thus, in such a strain, two among four
A. DIRECT DUPLICATION
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cells must be switchable. Therefore, the additional
cell that acquires the capacity for switching must
not be lacking critical cytoplasmic components re-
quired for switching. In conclusion, these results
satisfy a key molecular prediction of the strand-
segregation model and rule out the cytoplasmic
segregation model. Thus, we conclude that the de-
velopmental asymmetry among sister cells of yeast
is a consequence of inheriting nonequivalent paren-
tal DNA chains. The double-helical nature of the
DNA molecule prompted the discoverers of that
structure to make a well-known understatement, "It
B. INVERTED DUPLICATION
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FIGURE 4 Predictions of the strand-segregation model with a direct (A) and an inverted (B) duplication of matl.
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FIGURE 5 Southern blot analysis of DNA isolated from a strain
with direct duplication (b) and inverted duplication (c). Un-
digested DNA was subjected to Southern blot analysis and was
probed with the matl sequence.
has not escaped our notice that the specific pairing
we have postulated immediately suggests a possible
copying mechanism for the genetic material." Our
studies with yeast suggest that such a pretty mole-
cule may also provide an inherent template for
asymmetry among daughter cells in any biological
system. For example, a modified strand or a preas-
sembled transcriptionally competent complex may
be delivered to only one daughter cell. Our future
studies are directed toward understanding the mo-
lecular basis of chromosomal imprinting. To that
end, trans- and cis-acting genetic elements that are
known to affect switching are under investigation.
In a related study, we have addressed another in-
teresting genetic property of this system. Egel (Cold
Spring Harbor Symp. Quant. Biol. 45: 1003 [1981])
showed that matl switching occurs only by obtain-
ing information from the donor loci present on the
same chromosome. Several other observations with
this system suggest that an unusual organization of
the mat region allows switching only in cis and also
totally inhibits recombination between mat2 and
mat3 genes, although these loci are located about
15 kb apart. When we meiotically crossed strains of
opposite mating type containing deletions of mat2
and mat3 (designated mat2,3A::LEU2), each mall
allele gene in about 10% of the tetrads converted to
the opposite allele. This was indicated by the gener-
ation of 3P:1M and 1P:3M tetrads. This mat] with
matl interaction occurs efficiently in meiosis when
both donor loci are absent. We determined whether
such an interaction would be blocked if the donor
loci were present in cis to the matl allele that is
competent to gene-convert during meiosis.
For this purpose, we crossed a strain of genotype
mall mat2-P mat3-m- (A strain) with one of geno-
type matl-M mat2,3A::LEU2 (B strain). The
meiotic products were subject to tetrad analysis.
The A strain has a mutation in the mat3 cassette
which, when transferred to matl, allows the cell to
mate as minus mating type; however, the zygotic
cells will not undergo sporulation because of the
mutation. A successful mating between these
strains can only occur among mall -P- containing
cells of strain A and cells of strain B. Such a zygote
will undergo sporulation. We found that in about
10% of the tetrads, the matl-P allele gene-
converted to the wild-type matl-M allele. That is ex-
actly the same frequency observed when mat2 and
mat3 are absent. Thus, in meiosis, the opportunity
for gene conversion by obtaining information from
the donor loci does not preclude matl interaction
between homologs. Why meiotic behavior should
be different from mitotic observations remains an
interesting question for future studies.
Isolation of Genes Required
for Mating-type Switching
in Fission Yeast
R. Cafferkey, A.J.S. Klar
The switching of mating type in fission yeast re-
quires the concerted action of at least ten SWI
(switching) genes. Mutations in these genes either
directly decrease the rate of mating-type switching
or cause a reduction due to rearrangements at the
mating-type expression locus (mail). At the colony
level, the phenotypes of swi mutations can be easily
monitored by iodine staining. In a wild-type strain,
cells of opposite mating type are generated at high
frequency, and consequently mating and sporula-
tion also occur at a high frequency. Since spore
walls can be stained with iodine, a wild-type colony
turns black on exposure to iodine vapors. By reduc-
ing the rate of mating-type switching, swi muta-
tions cause corresponding reductions in mating and
sporulation and therefore show reduced iodine
staining.
The mating-type-switching event is initiated by a
double-strand break at the matl locus. Three SWI
genes (swil+, swi3+, and swi7f) are required for the
generation of the break. Strains harboring these
mutations have (1) a reduced level of double-strand
breaks at matl, (2) a correspondingly reduced rate
of mating-type switching, and (3) a reduced rate of
meiotic gene conversion at matl in diploid cells.
Using iodine staining as a screen, we have isolated
the swi3+ gene. An S. pombe genomic DNA library
carried in the yeast/bacterial shuttle vector pDB248
was introduced into a strain of the genotype swi3-
leu1.32. Approximately 50,000 leu+ transformants
were selected and exposed to iodine vapors. One
iodine transformant was identified, and a plasmid
containing an 8.0-kb yeast DNA insert was recov-
ered from this strain. Southern blot analysis was
used to show that the yeast sequences in this plas-
mid were contiguous and present at a single copy
number in the S. pombe genome. Linearization at
a unique BglII site within the yeast sequences, fol-
lowed by transformation, was used to target in-
tegration at the homologous chromosomal site.
Genetic analysis demonstrated the absence of
recombination between the integrated plasmid se-
quences and the swi3 locus, thus establishing that
the cloned sequences do contain the swi3+ gene.
Recently, H. Schmitt (pers. comm.) used a similar
approach to clone the swirf gene. We have also
attempted the isolation of the swi7+ gene. How-
ever, although a large number of transformants
(>70,000) were examined, this attempt has thus far
been unsuccessful.
Future experiments will be directed toward
characterizing the structure and function of the
swir and swi3+ genes. Since all of the known swi]
and swi3 mutations are apparently leaky, gene-
disruption experiments will be undertaken to deter-
mine the phenotypes of null mutations. The possi-
bility that expression of these genes is cell-cycle-
dependent will also be examined. Temperature-
sensitive mutations of swi] and swi3 proteins will
be sought using in vitro mutagenesis of the cloned
genes. Such mutations will be useful in determining
the temporal order of protein action in the genera-
tion of the double-strand break at matl.
Mutational Analysis of matl
Open Reading Frames
M. Kelly, A.J.S. Klar [in collaboration with D. Beach,
Cold Spring Harbor Laboratory]
The matl gene functions are required for mating
and for meiosis and sporulation. An analysis of the
DNA sequence revealed the presence of two open
reading frames in each matl allele. We have charac-
terized transcripts covering the matl locus and have
found that each allele codes for two transcripts,
which encompass the open reading frames. These
transcripts are divergently transcribed from inside
the cassette to the outside. Biological functions of
these transcripts were defined by site-directed oligo-
nucleotide mutagenesis of each coding region. Pri-
marily nonsense opal mutations were generated.
Phenotypic analysis of the mutations showed that
two genes, one in each allele, are required for sporu-
lation, whereas the other transcript of each allele is
required for mating. Furthermore, it was found that
those functions required for mating are expressed
constitutively and those required for sporulation
are expressed only under conditions of nutritional
limitation.
Regulation of Silent Mating-type
Gene Expression in S. cerevisiae:
The Search for SUM1
G.P. Livi, A.J.S. Klar
Mating-type interconversion in the yeast S.
cerevisiae involves a genetic rearrangement in
which silent copies of a or a information, residing
at the HML and HMR loci, respectively, are trans-
posed to and expressed at MAT The expression of
HML and HMR is negatively regulated by the ac-
tion of four unlinked MAR (or SIR) loci. Repres-
sion of HM gene transcription has been ascribed to
the interaction of the MAR/SIR gene products,
with cis-acting control sites that flank each locus.
However, recent biochemical data suggest that the
MAR/SIR gene products may not directly interact
with these sites (Shore et al., EMBO J. 6: 461
[1987]).
To understand the molecular basis for this type
of control, we have been studying the effect of the
sum] -1 mutation on HM gene expression. sum] -1
acts as an extragenic suppressor of mutations in
SIR2, SIR3, and SIR4 and may therefore define a
gene more directly involved in regulating the ex-
pression of HML and HMR (Klar et al., Genetics
111: 745 [1985]). Northern blot analysis indicates
that this suppression occurs at the level of HM gene
transcription. The simplest genetic model to ac-
count for the involvement of the wild-type SUM]
locus is one in which the MAR/SIR gene products
negatively regulate SUM], whose gene product, in
turn, is required for HM gene expression. Consis-
tent with this model is the fact that the sum] -1 mu-
tation exhibits no effect on MAR/SIR gene tran-
scription.
Initial efforts to clone the SUMI gene have
resulted in the isolation of two unique DNA se-
quences that complement the sum] -1 mutation in
vivo when carried on a high-copy-number plasmid.
Each sequence codes for a single mRNA species.
Neither sequence, however, contains the wild-type
SUM] gene, as determined by selective integration
and genetic mapping relative to sum] -1. Work is in
progress to determine the effect of deleting each of
these genes and to distinguish the SUM] gene clone
from a new collection of complementing sequences
derived from a centromere-based plasmid library.
Molecular Genetics of the SUM
Genes of S. cerevisiae
C.I.P. Lin, G.P. Livi, A.J.S. Klar
The interconversion of budding-yeast mating type
also involves a gene transposition event in which
the silent information present at the HML and the
HMR loci is transferred to the expressed MAT lo-
cus. The silent mating-type cassettes at HM loci are
kept under negative transcriptional regulation by
the action of four trans-acting MAR/SIR genes.
We have previously identified an apparently posi-
tive regulatory gene, designated SUM1 (SUppressor
of Mar); mutation of this gene results in the sup-
pression of the marl-I mutant allele. The suml mu-
tation keeps the HM loci unexpressed even in the
marl background. Interestingly, this suppressor
also acted as the suppressor of a marl deletion and
a mar2 deletion. It also apparently suppressed the
sir4 ochre mutation, but very weakly. Our recent
results demonstrate that suml does not suppress the
sir4 deletion mutation, and thus we do not believe
that suml acts as a suppressor of sir4.
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To investigate possible interactions among the
MAR/SIR genes and to identify new genes involved
in regulating HML and IIMR expression, suppres_
sors of mar2-1 were isolated. The two mutations
thus identified have been designated sum2 -1 and
sum4-1. These suppressors also suppress a deletion
mutation of the mar2 locus but fail to suppress a
marl deletion and a sir4 deletion. Thus far in all of
the trans-acting regulators identified, both HML
and HMR are found to be coregulated regardless of
whether the a or the a information resides there.
The sum2 -1 and sum4 -1 mutations, however,
strongly repress the expression of the a information
at both HML and HMR loci but only weakly re-
press the expression of a cassettes at these same
loci. This genetic analysis suggests that the gene
products of sum2 and sum4 act downstream from
the MAR2 function but upstream of the MARI and
SIR4 functions. The SUM1 by this analysis can be
placed following MA R1 but before SIR4. The sim-
ple model that MAR/SIR and SUM genes tran-
scriptionally regulate each other in a cascade is not
supported, since the level of MAR2 and SIR4 is not
affected by the sum4 mutation. Further molecular
analysis of these genes is needed to understand
their role in silent cassette regulation.
The W and Z2 Sequence Difference
between HML and HMR
May Only Partially Regulate the
Donor-choice Mechanism
A.J.S. Klar, L.M. Mig lio
Our previous studies have shown that cells switch
in a nonrandom fashion and that the direction of
switching is dictated by the contents of the donor
HML and HMR loci. Specifically, we found that
MATa cells preferentially choose HMR as the do-
nor, whereas MATa cells preferentially choose
HML as the donor. There seems to be a competi-
tion between the donors, since when the preferred
donor is deleted, the remaining donor is used effi-
ciently (Klar et al., Cell 28: 551 [1982]). An obvious
feature that may affect the competition is the DNA
sequence difference between HML and HMR. A
700-bp sequence (designated W) and a 90-bp se-
quence (designated Z2) are present both at HML
and at MAT, but not at HMR. We have tested the
possibility that the presence of W anc: Z2 sequences
at HML, or their absence at HMR, plays a role in
the left-right donor-choice mechanism by replacing
HMR with HML. A 5.4-kb Xhol fragment contain-
ing HML was inserted into a deletion of HMR that
was constructed by combining the XhoI linker mu-
tations nos. 51 and 296 (Abraham et al., J. Mol.
Biol. 176: 307 [1984]). Such a strain with the cas-
sette arrangement HMLa-inc/HMLa-inc MATa/
MATa-inc hmr::HMLa /hmr::HMLa HO/HO was
constructed. The a spores obtained from this strain
were allowed to switch and mate with their a litter-
mates. The resulting diploids will be either MATa/
MATa or MATa/MATa-inc. In individual diploids,
the presence of a or a-inc at MAT was distin-
guished by digesting the DNA isolated from these
strains with Hhal endonuclease, which cuts a but
not the a-inc DNA at a sequence present at the Y/Z
junction.
With this procedure, we have found 65 cases
where the HML was used and 10 cases where the
hmr::HML donor was used. In our previous studies
(a similar experiment with a strain containing wild-
type HMRa), we found 47 cases where HML was
used and only 5 cases where HMR was used (Klar
et al., Cell 28: 551 [1982]). Thus, the W and Z2 se-
quence difference between HML and HMR only
partially regulates the donor-choice mechanism.
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MOLECULAR GENETICS OF CELL-CYCLE CONTROL
D. Beach M. McLeod L. Brizuela
J. Potashkin G. Draetta
R. Booher M. Stein
During the past year, our research has remained
concentrated in two main areas of interest: (1) the
molecular genetics of the cell-division cycle and (2)
the control of the transition from vegetative growth
to sexual differentiation. The fission yeast,
Schizosaccharomyces pombe, continues to be the
major organism of study, but we have recently used
a monoclonal antibody prepared against a yeast
cell-cycle-control protein to identify its homolog in
human cells. It is hoped that this finding will allow
us to become directly involved in studies on the con-
trol of the division cycle in mammalian cells.
Control of Meiosis
M. McLeod, M. Stein, D. Beach
Major components of the pathway that controls the
entry of yeast cells into meiosis and sporulation
have been previously worked out by ourselves and
investigators in other laboratories. The genes of the
mating-type locus encode four gene products
known as matPi, Pc, Mi, and Mc. All four genes ap-
pear to be required for meiotic initiation (M. Kelly,
Yeast Genetics Section), which occurs only in h + /h-
diploid cells. The mat genes act to control the tran-
scription of an unlinked gene, mei3 +, that is ex-
pressed only during meiosis. Expression of this
gene alone is sufficient to induce meiotic initiation.
We believe that the product of the mei3+ gene, a
protein of 21 kD, acts to inhibit the product of the
rani+ gene. The sequence of rani+ suggests that it
encodes a protein kinase.
With the assistance of E. Harlow's laboratory
(Protein Immunochemistry Section), monoclonal
antibodies have been raised against the 21-kD mei3+
gene product and the 52-kD rani+ gene product.
The 21-kD protein was found only in meiotic cells,
whereas the 52-kD rani+ gene product is present in
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both vegetatively growing cells and meiotic cells.
We are presently using the monoclonal antibodies
to investigate the protein kinase activity of rani+
and to understand how it is controlled by mei3+.
Two new mutants, cgsl and cgs2, that play a role
in meiotic initiation have been isolated. The cgs
mutants suppress the ability of the temperature-
sensitive ran2 mutants to undergo meiosis and
sporulation; they are thus extragenic suppressors of
rani mutants. We have found that the cgsl mutant,
which itself is meiotically defective, can be rescued
by introduction of the gene of Saccharomyces
cerevisiae encoding the regulatory subunit of
cAMP-dependent protein kinase (BCY1 gene,
provided by M. Wigler's laboratory). This suggests
that the cgsl gene may encode the fission yeast
regulatory subunit. The nucleotide sequences of
both the cgsl and cgs2 genes are currently being de-
termined.
Cell Cycle of Fission Yeast
G. Draetta, R. Booher, L. Brizuela, J. Potashkin,
D. Beach
The product of the cdc2+ gene is unique in being re-
quired during both the GI and the G2 phases of
the cell cycle and is still the major focus of our re-
search. A series of 40 monoclonal antibodies
against the 34-kD cdc2+ gene product was prepared
with the assistance of C. Bautista and E. Harlow
(Protein Immunochemistry Section). These anti-
bodies recognize the cdc2 protein in a Western blot,
and several were also effective in immunoprecipita-
tion. We have been able to establish that the cdc2
protein exists in at least six forms in yeast. Some of
these forms represent different states of protein
phosphorylation. We are presently attempting to
identify the sites of phosphorylation.
Since the cdc2 product is a protein kinase, we are
interested in identifying its natural substrates. One
possible candidate, the product of the SUCP gene,
has been tested. This gene was isolated 5 years ago
by virtue of the ability of the plasmid-borne gene
to rescue some, but not all, temperature-sensitive
cdc2 mutants. The gene was sequenced, mapped by
S1 nuclease, and found to encode a product of 13
kD. The coding region of the gene was interrupted
by two introns. The 13-kD product of the Suc14-
gene was expressed at high levels in Escherichia coli
and purified. We have not been able to find evi-
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dence that the Suer protein is a substrate of the
cdc2+ protein kinase in vitro.
Further genetic
screens for potential substrates of the cdc2 protein
kinase have been devised and have resulted in the
isolation of many new mutants that are presently
being characterized.
A new approach toward identification of pro-
teins that associate with cdc2 has recently been
developed. We constructed an allele of cdc2
(cdc2Arg33) that is mutated at the anticipated ATP-
binding site. This "null allele" had an unexpected
property. Overexpression of cdc2Arg33 in a wild-
type (cdc2+) cell provoked a cdc- phenotype,
whereas overexpression of the wild-type cdc2f gene
caused no overt phenotype. We suspect that the
product of cdc2Arg33, a protein that lacks kinase
activity, competes with the wild-type gene product
for a scarce activator of cdc2. The mutant allele
might bind the activator, and in excess titrate out
the activator, but of course not carry out its role in
the cell cycle due to the A rg33 mutation. We are
currently attempting to identify sequences that, at
high copy number, will rescue yeast strains express-
ing cdc2Arg33.
Identification of 34-kD Homolog of
cdc2+ Product in Human Cells
G. Draetta, J. Potashkin, D. Beach
The cdc2+ gene of S. pombe is homologous to the
CDC28 cell-cycle "start" gene of S. cerevisiae. The
gene products are protein kinases that have 62%
overall amino acid sequence homology. Each gene
is biologically active after introduction into the
other yeast. Budding yeast and fission yeast are
evolutionarily very distant, and since the cdc2 and
CDC28 gene products are so similar, it seems likely
that the cells of higher eukaryotes might contain an
equivalent protein.
We have sought a human homolog of the 34-kD
cdc2+ gene product using monoclonal antibodies
prepared against cdc2+. First, each of 40 antibodies
was tested for its capacity to recognize the CDC28
gene product. Only two, J4 and JP4, cross-reacted
with both the cdc2 and CDC28 proteins. We felt
that these would be suitable antibodies with which
to search for homologs in the cells of higher organ-
isms. To our surprise, both the J4 and JP4 antibod-
ies recognized a 34 -kD protein in extracts of HeLa
cells. The human 34-kD protein was identified both
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6 7 from HeLa cells is a homolog of the cdc2 and
CDC28 gene products of S. pombe and S. cere-
visiae. We are presently testing whether the 34-kD
protein has protein kinase activity and are inves-
tigating its properties in different growth states and
at different stages of the cell cycle.
FIGURE 1 Proteolytic cleavage pattern of p34cdc2 p36cDc28
and human p34. (1) Standard markers with molecular weights
indicated in kilodaltons. (2-7) N-chlorosuccinimide/urea cleaved
proteins; (2) Coomassie-stained p34cdc2; (3) 355-labeled
p34cdc2; (4) Coomassie-stained p34cdc2; (5) 355-labeled
p36cpc28; (6) Coomassie-stained p34cdc2; (7) 355-labeled hu-
man p34. Lanes 2 and 3, 4 and 5, and 6 and 7 are different
visualizations (Coomassie blue or autoradiography) of single gel
lanes. In each lane the uppermost band represents un-
degraded protein, and the smallest major band (20 kD) carries
the entire amino-terminal two thirds of the polypeptide. The inter-
vening three bands are, in each case, partial cleavage products.
in Western blots and by immunoprecipitation.
Mapping of the tryptophan residues in the human
protein by means of N-chlorosuccinimide/urea
cleavage revealed complete conservation in the
number and distribution of tryptophans between
human p34, the CDC28, and the cdc2+ gene prod-
ucts (Fig. 1).
It seems highly probable that the 34-kD protein
SITE-SPECIFIC MUTAGENESIS
M. Zoller K. Johnson
L. Levin
J. Kuret
We are studying protein-protein interactions of
yeast cAMP-dependent protein kinase. The ex-
perimental system of yeast is perfectly suited to the
study of protein structure and function, since mu-
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tated proteins can be examined in the absence of the
wild-type protein, and nonfunctional proteins can
be analyzed using the power of yeast genetics. Dur-
ing the past year, we have been examining a number
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of Escherichia coli expression systems in order to
produce large amounts of protein for subsequent
structural studies.
Structure-Function of Yeast
cAMP-dependent Protein Kinase
M. Zoller, K. Johnson, L. Levin, J. Kuret
Our studies are aimed at an understanding of
protein-protein interactions at the molecular level.
cAMP-dependent protein kinase provides a system
through which a number of questions can be ad-
dressed: (1) How does an enzyme, in this case a pro-
tein kinase, recognize its substrate? (2) What
regions of the regulatory and catalytic subunits are
important for association into the holoenzyme and
how does cAMP disrupt this association? (3) How
does phosphorylation change the structure and
function of a protein? (4) What are the substrates
in yeast?
A second area of research interest concerns the
"new science" of protein engineering. Can existing
proteins be modified to conduct new reactions, to
eliminate undesirable reactions, or to operate under
normally suboptimal conditions? The current ap-
proach has been largely through directed substitu-
tions of amino acids at regions of the protein
thought to be important. For example, protein en-
gineering has successfully increased protein stabil-
ity by introduction of disulfide bonds, has re-
stricted substrate specificity in a protease, and has
meticulously determined the importance of certain
residues in binding. In the field of protein kinases,
we are interested in understanding the specificity of
the cAMP-dependent protein kinase for its sub-
strates, in contrast to the tyrosine protein kinases of
receptors and viral oncogene kinases. By using a
genetic approach, we are trying to screen for a pro-
tein kinase with a new or restricted substrate speci-
ficity.
Catalytic Subunit (TPK1, TPK2, TPK3)
M. Zoller, K. Johnson, L. Levin, J. Kuret
We previously expressed TPKI in E. coli using the
T7 phage promoter system. The protein was highly
expressed, although we found that only about 10%
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of the total TPK protein was soluble. This, however,
proved to be sufficient for use in phosphorylation
studies, and thus we will soon begin purification.
Upon the completion of sequencing of the other
two related catalytic subunit genes, TPK2 and
TPK3, by T. Toda in M. Wigler's group (Genetics
of Cell Proliferation Section), we began to express
these genes as well. Genetic studies by S. Cameron
and T. Toda demonstrated that any one of the three
TPK genes was sufficient to maintain cell growth.
Comparison of the putative protein sequences re-
vealed that the major differences were in the amino-
terminal regions. To compare the functions of the
three kinases, we expressed TPK2 and TPK3, as
well as TPKI, in E. coli. It is possible that TPK2 or
TPK3 expressed in E. coli will be more soluble than
TPKI expressed in E. coli.
RESULTS
Monoclonal Antibodies to TPK1. TPKI was ex-
pressed in E. coli, and the protein was isolated
in pure form by electroelution from an SDS-
polyacrylamide gel. In collaboration with E.
Harlow, with the help of C. Bautista (Protein Im-
munochemistry Section), the protein was used as
antigen to develop monoclonal antibodies against
TPKI. We obtained 17 monoclonal antibodies that
recognized TPKI bound to nitrocellulose paper.
Yeast cell extracts from strains containing just one
of the three TPK genes were electrophoresed on an
SDS-polyacrylamide gel and transferred elec-
trophoretically to nitrocellulose. Western blot anal-
ysis revealed that the monoclonal antibodies raised
against TPKI only recognized a protein in the
TPKI strains. Preliminary evidence suggests that
we could not detect TPK2 or TPK3 because the lev-
els of these proteins are low compared with that of
TPKI; activity studies in yeast by S. Cameron sup-
port this. With large quantities of TPK2 and TPK3
proteins expressed in E. coli, we will have TPK2 and
TPK3 protein available for specific monoclonal an-
tibody production.
Studies on the ATP-binding Site of TPK1. We pre-
viously constructed a mutant TPKI in which Lys-
116 was changed to Arg-116. This resulted in the loss
of catalytic activity, suggesting that charge alone
was not sufficient for catalytic activity. A subse-
quent study demonstrated that the new Arg-116
protein could still bind to the regulatory subunit
(BCY 1) and was dissociated by the addition of
cAMP to the solution. This experiment was carried
out by first binding BCY I to an anti-BCY/ mono-
clonal antibody column and then passing "S-
labeled TPKI through the column to form the
holoenzyme on the column. Both the wild-type and
Arg-116 TPKI proteins bound to the column, and
upon addition of cAMP, the "S-labeled proteins
were released.
Production of TPK2 and TPK3 in E. coli. The
coding sequences of these genes were engineered
into our T7 expression vector. These vectors have
been modified from our earlier version by the addi-
tion of the F1 origin sequences that turn these vec-
tors into "phagemids" from which single-stranded
DNA can be isolated for sequencing or oligonucle-
otide-directed mutagenesis. Our results indicate
that the level of expression of TPK2 and TPK3 is
approximately the same as that of TPKI. Similarly,
the majority of the protein was insoluble. Activity
analysis is now in progress.
FUTURE EXPERIMENTS
Purification of TPK1, TPK2, and TPK3. Re-
cently, Jeff Kuret joined our laboratory as a post-
doc; he had previously worked at the laboratory of
P. Cohen, who is known for work on protein phos-
phorylation. Jeff and Lonny Levin will be responsi-
ble for developing a purification procedure for
TPK. Pure catalytic subunit has never been puri-
fied from yeast, probably because the levels were
low and there is a problem with proteolysis. Prior
to the cloning of the TPK genes, the existence of
three catalytic subunits was unknown. By using the
E. coli strains, we can produce sufficient amounts
of protein to characterize the three proteins fully.
The availability of yeast strains that express and
overproduce only one of the three TPKs (developed
by M. Wigler's group) makes it possible to isolate
the individual proteins from yeast. Expression of
individual TPK genes using the ADH promoter
should improve our yield of protein. The natural
amino-terminal sequences of the three proteins are
not yet known. Amino-terminal modification is
also a question that remains to be answered.
Probing Protein-Protein Interactions between the
Catalytic and Regulatory Subunits. We are in-
terested in identifying regions within TPK and
BCY1 that are involved in the specific interaction
between the two proteins. The approach for study-
ing the catalytic subunit will be to use a genetic
screen (developed in M. Wigler's laboratory) to
identify suppressors of CYR" and RAS" pheno-
types. These strains are characterized by a defect in
the production of cAMP at 37°C. Among the pos-
sible suppressors will be activated catalytic sub-
units. Of these, some will be activated because
of a defect in the association with regulatory
subunit. They will be identified, sequenced, and
biochemically analyzed for the ability to complex
with BCY1. This analysis should yield a map of
sites within the catalytic subunit that are involved
in complex formation. Recently, we sequenced one
of these suppressors and found that the defect is a
single amino acid change of Thr-241 to Ala-241 in
TPK1. This site is conserved in all cAMP-dependent
protein kinases and was found to be phos-
phorylated in the bovine catalytic subunit. The re-
gion in which Thr-241 lies is thought to play a role
in substrate interaction, and preliminary evidence
indicates that this mutation does not affect cata-
lytic activity. Current studies are in progress to test
whether this mutant complexes with BCY I.
Phosphorylation of Specific Substrates of the Yeast
Catalytic Subunit. To study the manner in which
protein kinases recognize their substrates, it is im-
portant to identify natural substrates for TPK. The
enzymes trehalase and fructose -1,6- bisphosphatase
have been tentatively identified to be regulated by
cAMP-dependent phosphorylation. Recently, R.
Fletterick and co-workers (University of Califor-
nia, San Francisco) suggested that yeast glycogen
phosphorylase was a substrate by inspection of its
phosphorylation site (ArgArgLeuThr). We plan to
obtain purified samples of these proteins to use as
substrates for each TPK. In addition, these proteins
may be used as reagents to probe enzyme-substrate
interactions.
Cloning Kinase Substrates from Expression
Libraries. The biological recognition sequence
for cAMP-dependent phosphorylation has been
characterized by both natural and synthetic sub-
strates as ArgArgXaaSer(or Thr) or LysArgXaa-
XaaSer(or Thr). Generally, it is believed that this
sequence is found in an exposed region of the na-
tural substrate. We are interested in identifying
other substrates and have developed a scheme to
clone genes for other substrates from a yeast ex-
pression library. An expression library is plated out
and prepared as for antibody screening. The filters
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are incubated in buffer and [32P]ATP, and an ali-
quot of TPKI is purified from E. coli. Clones ex-
pressing proteins with the proper recognition se-
quence will become phosphorylated and will be
identified by autoradiography. This method pro-
vides direct access to the gene. Preliminary tests
using known substrates and nonsubstrates have
been encouraging. It is still not clear how fre-
quently the kinase will phosphorylate a protein in
vitro that is not a natural in vivo substrate. We hope
that this will become a general method for identify-
ing potential kinase substrates.
BCYI, the Regulatory Subunit of
cAMP-dependent Protein Kinase
M. Zoller, K. Johnson, L. Levin, J. Kuret
BCYI encodes the gene for the regulatory subunit
of cAMP-dependent protein kinase. The protein se-
quence of the isolated regulatory subunit matched
the coding sequence of the BCYI gene (T. Toda and
co-workers). We were interested in structure-
function relationships of this protein. The protein
consists of three major domains: (1) an amino-
terminal region, which maintains a dimer structure;
(2) a hinge region, which is a major site for
regulatory-catalytic (R-C) subunit interaction and
contains a phosphorylatable substrate consensus
sequence, ArgArgThrSerVal; and (3) a carboxy-
terminal region, which consists of two tandemly
repeated cAMP-binding domains. Previously, we
overexpressed the BCYI protein in E. coli, purified
the protein to homogeneity, and characterized the
purified protein (K. Johnson and co-workers). The
functional characteristics of the protein were indis-
tinguishable from those of the natural yeast pro-
tein. In the absence of cAMP, the protein inhibited
yeast TPKI, one of the three catalytic subunits
from yeast. In addition, BCYI was phosphorylated
by TPKI.
RESULTS
Monoclonal Antibodies to BCY1. The purified
protein was used as antigen to produce monoclonal
antibodies. From our initial fusion, only three posi-
tive clones were isolated, and all three clones
reacted against BCYI produced in E. coll. A West-
ern blot procedure was used to detect BCYI in yeast
strains. A strain containing a multicopy plasmid
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with the BCYI gene showed an increased level of
regulatory subunit, compared with a strain contain-
ing a single copy of BCYI. This analysis revealed
that the protein in yeast migrated as a doublet on
an SDS-polyacrylamide gel. The lower band mi-
grated in coincidence with BCYI (E. coli- produced)
and the upper band migrated 2000 daltons slower.
This suggests that the protein in yeast undergoes
posttranslational modifications. We previously
demonstrated that phosphorylation of BCYI by
TPKI in vitro did not change the mobility of the E.
coli- produced protein. Efforts are under way to
identify the nature and location of these modifica-
tions.
Mutations in the Hinge Region That Alter R-C In-
teraction and Phosphorylation of the Regulatory
Subunit. The "hinge" region of the regulatory
subunit is characterized by a substrate consensus
sequence, ArgArgThrSerValSer, and is thought to
be a major site for interaction between the regula-
tory and catalytic subunits. The role of phosphory-
lation in vivo is still unclear. To probe the impor-
tance of the hinge region in subunit-subunit
interaction and the role of phosphorylation in the
function of cAMP-dependent protein kinase, we
systematically introduced amino acid substitutions
into the BCYI protein. Our first mutations were
aimed at Ser-145, the site of phosphorylation by
catalytic subunit (ArgArgThrSerValSer). Using oli-
gonucleotide-directed mutagenesis, we changed
Ser-145 to Ala, Asp, Glu, Gly, Lys, Pro, and Thr.
Each variant was expressed in E. coli, purified using
a cAMP-agarose affinity column, and assayed for
the ability to inhibit the yeast catalytic subunit
(TPKI) in the absence of cAMP. Of these, the Ala,
Gly, Glu, and Lys derivatives inhibited catalytic ac-
tivity and presumably formed a complex with the
catalytic subunit. Careful inspection of the data in-
dicated that the Ala-145 and Gly-145 derivatives
bound tighter to TPKI than to wild-type BCY1 and
that Glu-145 and Lys-145 derivatives bound less
well to TPKI than to wild type. These results sug-
gest that this region is a major site of R-C interac-
tion, since single-amino-acid alteration can perturb
stable complex formation.
We next assayed for the ability of each protein
variant to be phosphorylated by TPKI in vitro. Of
these, the Thr-145 derivative was phosphorylated to
the same level as wild-type BCYI, and at approxi-
mately the same rate. The Lys-145 derivative was
phosphorylated poorly. These results indicate that
the site of phosphorylation of the wild-type protein
is Ser-145. The identification of the phosphorylated
amino acid in the Lys-145 and Thr-145 derivatives
is currently being determined in collaboration with
D. Marshak (Protein Chemistry Section). It is
known that the catalytic subunit can phosphorylate
the sequence ArgArgXaaThr, and thus we predict
that Thr-145 is phosphorylated in that derivative.
The phosphorylated amino acid in the Lys-145
derivative could be either Thr-144 (ArgArgThrLys)
or, possibly, Ser-147 (ArgArgThrLysValSer).
FUTURE EXPERIMENTS
In Vivo Role of Phosphorylation of BCY1. Hav-
ing characterized seven different modifications at
the phosphorylated serine, we will next probe the
role of phosphorylation in the cell. This is an ex-
periment that cannot be conducted in higher eu-
karyotic cells.
Identification of Amino Acids Involved in cAMP
Binding. A comparison of the primary sequences
of mammalian regulatory subunits, E. coli cap, and
the yeast regulatory subunit revealed a number of
conserved amino acids within the cAMP domains.
Some of these residues have been shown to be in-
volved in cAMP binding in cap by crystallographic
analysis. We are interested in exploring the specific
role of these conserved amino acids, as well as other
regions that may be important and that cannot be
identified by homology. The conserved amino acids
can be systematically mutated and the properties of
the resultant protein can then be studied. To iden-
tify the nonconserved regions that play a role in
cAMP binding, we are using a random mutagenesis
approach followed by a biochemical screen. Ini-
tially, we will pass the BCYI expression vector
through a mutD strain that is deficient in replica-
tion error repair. The mutagenized plasmid will
then be placed into the E. coli expression strain,
and the colonies will be plated onto nitrocellulose.
The filters will be prepared as for antibody screen-
ing, and 32P-labeled cAMP will be added to the
filters. The filters will then be washed and autoradi-
ographed. Clones that can still bind cAMP will be
detected on the autoradiogram. Mutants will then
be isolated and subsequently screened for expres-
sion of BCYI and cAMP binding. Some of the mu-
tants will be simply truncated proteins or unstable
protein. We will conduct biochemical experiments
to distinguish between the various mutants. Out of
this analysis, we hope to obtain a map of positions
that are important for cAMP binding. These data
will complement crystallographic data obtained by
J. Pflugrath and co-workers.
Localization of BCY1 Protein in Yeast. Monoclo-
nal antibodies that recognize BCYI will be used to
localize the protein in vivo. This will be accom-
plished by indirect immunofluorescence. A report
on the mammalian cAMP-binding subunit local-
ized the protein in the Golgi. Upon stimulation of
adenyl cyclase, the localization of the regulatory
subunit did not change; the catalytic subunit moved
into the nucleus. It will be of interest to conduct this
experiment in yeast to identify localization signals
and to understand differences between the three
TPK proteins.
Three-dimensional Structure of BCY1. We will
be collaborating with J. Pflugrath and co-workers
on determination of the three-dimensional struc-
ture of BCYI. The levels of protein produced by the
E. coli expression system are now in the range
needed to begin these studies. We will help with the
expression and purification of the wild-type pro-
tein, as well as provide mutant proteins.
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Ac Activity and DNA Modification
S.L. Dellaporta, M. Alfenito, J. Chen, P.S. Chomet,
B.A. Lowe, C. Mitchell, J. Wood
During 1986, our research efforts continued to be
focused on the biology and utility of the maize
transposable element Activator (Ac). Ac has the
ability to cycle from an active phase to an inactive
phase. As reported last year, we have found a corre-
lation between Ac activity and Ac DNA modifica-
tion. We have extended these studies to show that
this modification appears specific for Ac
since flanking DNA sequences are not affected.
This observation has allowed us to distinguish the
active Ac element from several homologous cryptic
Ac-like sequences found in the maize genome.
Moreover, when genomic DNA is digested with
methylation-sensitive restriction enzymes that do
not cut within Ac, most, if not all, cryptic se-
quences remain in the high-molecular-weight frac-
tion of DNA, whereas the active Ac element re-
mains in the lower-molecular-weight fraction of
DNA. Using this approach, we have cloned the P
locus of maize by locating a genomic fragment in
the hypomethylated DNA fraction containing Ac
inserted into P.
MECHANISM OF AC TRANSPOSITION
We have analyzed the donor and target sites of Ac
transposition from the P locus. Previous genetic
analysis has indicated that the two mitotic daughter
lineages that result from Ac transposition from P
differ in their Ac constitution at the P locus. Both
lineages, however, usually contain transposed Ac
elements that map to the same genetic position.
Using methylation-sensitive restriction enzymes
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and genomic blot analysis, we identified Ac ele-
ments at both the donor P locus and Ac target sites.
Daughter lineages were shown to be mitotic descen-
dants from a single transposition event. When both
lineages contained Ac genetic activity, they both
contained a transposed Ac element on identical
genomic fragments independent of the genetic po-
sition of the target site. This indicates that in a
majority of cases, Ac transposition takes place af-
ter replication of the donor locus but before com-
pletion of replication at the target site.
Other examples of somatic transposition of Ac
from the P locus were analyzed where Ac activity
was detected in only one of the two daughter lin-
eages. In these cases, we did not detect the presence
of the Ac element in the daughter lineage that lacks
Ac activity. We are addressing the possibility that
this lineage contains an inactive form of Ac. How-
ever, it appears that Ac has the ability to excise from
P after replication and integrate into replicated tar-
get sites.
GENE-TAGGING EXPERIMENTS
We have performed several experiments to tag gene
loci using maize transposable elements. As re-
ported last year, we were able to clone the R locus
of maize by transposon tagging with Ac. This past
year, we attempted to mobilize Ac and Mu], an-
other maize transposable element system, into
genes involved in insect resistance (bx), gravitro-
pism (la), and starch biosynthesis (su). Several mu-
tations of la and su have been recovered, and we are
presently confirming their inheritance by genetic
analysis as well as their molecular nature by geno-
mic blot analysis. We will begin molecular cloning
experiments if these mutations are confirmed by
these experiments. Another phase of this work has
been random insertional mutagenesis experiments.
We have selected several hundred independent trans-
positions of Ac from gene loci on chromosome 1 (P
locus), chromosome 9 (Bz and Wx loci), and chro-
mosome 10 (R locus). This material, heterozygous
for the newly transposed Ac element, was self-
pollinated to obtain homozygous insertions. We are
presently screening several thousand progeny for
mutations segregating in this F2 population. Any
mutations of interest will be cloned using Ac as a
molecular probe.
Regulation of Polyamine Metabolism
in Plant Cell Cultures
A.C. Hiatt, J. Mclndoo, B.A. Lowe
Work on the regulation of polyamine metabolism
in plants during the last year has focused on the in-
volvement of polyamines in plant stress responses,
regeneration of plants from cultured cells, gene
regulation controlled by the rate of polyamine
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production, and purification of the enzymes
responsible for polyamine synthesis.
POLYAMINES AND PLANT STRESS
The induction of polyamine production in plants
exposed to many stress conditions is a well-
characterized phenomenon that has been observed
for more than 30 years. The use of plant cell cul-
tures and mutants has enabled us to study the sig-
nificance of this response to determine whether the
increased synthesis of polyamines is a metabolic
dead end or a response that enables the cell to with-
stand a particular adverse environmental condi-
tion. We have concentrated on low-pH stress, al-
though many other stress conditions have the same
effects (e.g., low potassium, high NaC1, high os-
moticum, and desiccation). These studies were per-
formed with tobacco cells in suspension culture
growing in defined medium. We discovered that
low-pH stress specifically induces the synthesis of
only the first polyamine, putrescine (Fig. 1), and
that this is specifically a decarboxylation of argi-
nine. Increased synthesis of putrescine from or-
Putrescine
Sam DC M6B6
,1/2=0-7
SpSyn DCHA
Spermidine
Spermine
Mgr 3 ? ED
FIGURE 1 Polyamine pathway in tobacco. (OrnDC) Ornithine decarboxylase; (ArgDC) arginine
decarboxylase; (SamDC) S-adenosylmethionine decarboxylase; (SpSyn) spermidine or spermine
synthase; (DFMO) difluoromethylornithine; (DFMA) difluoromethylarginine; (MGBG) methylglyoxal-
bis(guanylhydrazone); (DCHA) dicyclohexylammonium sulfate.
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nithine was not observed. We also found that the
increased conversion of arginine is an essential
stress response, since addition of difluoromethylar-
ginine (DFMA) during the response is lethal,
whereas at neutral pH, DFMA has no effect on cell
growth (Fig. 2). Finally, we also observed that the
increased titer of putrescine during stress does not
lead to increases in the other polyamines (spermi-
dine or spermine), nor does it lead to increased con-
jugation of putrescine as an amide.
The polyamine conjugates are an interesting class
of compounds because in the whole plant, they are
only synthesized in abundance in the reproductive
organs, especially the postfertilization ovary.
Tobacco cell cultures also contain a substantial
amount of polyamine conjugates (amides). During
the past year, we have characterized the conjuga-
tion of polyamines in cell cultures of true poly-
amine mutants and have found that resistance to le-
thal inhibitors of free polyamine synthesis also
results in abnormal polyamine conjugation, which,
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in turn, affects other metabolic pathways. In partic-
ular, the phenylpropanoid pathway in these mu-
tants may be induced to produce large amounts of
anthocyanin. This effect is due to abundant conju-
gation of polyamines to hydroxycinnamic acids,
which are precursors to the anthocyanins, flavo-
noids, and lignin.
These observations prompted us to undertake a
more direct approach toward understanding the
metabolic function of the conjugates by measuring
the involvement of conjugation in certain disease
responses. In collaboration with the cell-culture
group at Pioneer-Hi-Bred International, we have
begun to study the biochemistry of certain disease
responses in corn. In corn, infection by the fungus
Helminthosporium carbonum results in a dramatic
increase in synthesis of the phenylpropanoids from
phenylalanine. This is true in both resistant and
susceptible varieties of corn. The resistance re-
sponse is characterized by rapid conversion of
phenylpropanoids into antifungal phytoalexins. In
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FIGURE 2 Effect of difluoromethylarginine and low pH on cell growth. Stationary-phase cultures were diluted fourfold
into medium containing citrateTris (pH 3.5) of varying ionic strengths. An aliquot from each culture was taken to determinethe initial dry weight. To half of the paired cultures was added 10 mm difluoromethylarginine. After 24 hr, an aliquot fromeach culture containing no difluoromethylarginine was taken to determine the intracellular free putrescine levels. The
cultures were further allowed to grow for 7 days and were harvested to determine the increase in dry weight.
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the susceptible response, however, these com-
pounds are not synthesized and do not appear
around the infection site; the fungus is then able to
spread through the whole plant. Our efforts in the
last few months have been directed toward trying to
account for the induced phenylpropanoids and to
determine if conjugation to polyamines subverts
phytoalexin synthesis in susceptible varieties. Pre-
liminary studies using purified fungal toxin and a
resistant corn cell line have shown that the toxin
alone specifically inhibits the flux of polyamines
conjugated to the cell wall. These studies are cur-
rently being extended to include infection with
whole fungus (both toxin-producing and non-
producing) of susceptible and resistant varieties of
corn in culture.
POLYAMINES AND DEVELOPMENT
The primary characteristic of tobacco cell lines that
are resistant to inhibitors of polyamine synthesis is
a failure to regenerate from culture into whole
plants. In addition, plants that do regenerate and
are developmentally abnormal are invariably slow
to initiate the process of regeneration. However,
this offers a way of isolating revertant cell lines by
virtue of an enhanced rate of regeneration from a
large population of cultured cells. Our results in the
last year have shown that all revertants isolated by
virtue of a restored ability to regenerate also have
a restored ability to maintain the correct titer of free
polyamines. One example is a difluoromethylor-
nithine (DFMO)- resistant regeneration-deficient
cell line that has a very low level of ornithine decar-
boxylase (OrnDC). The six revertants of this cell
line isolated by virtue of restored initiation of
regeneration also have restored levels of OrnDC
and the wild-type levels of polyamines. Our results
have suggested that there are a number of enzymes,
in addition to the ones directly involved in biosyn-
thesis, that control the polyamine titer. We have re-
cently begun to try to isolate some of these genes
by transforming regeneration-deficient polyamine
mutants and selecting for restored regenerates. The
transformation system we are using involves the use
of Agrobacterium tumefaciens. An Arabidopsis
genomic library in a bacterial plasmid was con-
structed in a disarmed Agrobacterium (Fig. 3); the
resulting Agrobacterium recombinants are now be-
ing used to transform either leaf disks or pro-
toplasts to select for kanamycin-resistant transfor-
mants with restored regeneration. Arabidopsis was
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FIGURE 3 Agrobacterium-derived vector containing a plant
promoter (P) and a dominant selectable marker (KnR).
used as the source of DNA because of the relatively
small size of its genome, compared to that of
tobacco.
Another approach to understand how produc-
tion of polyamines may be involved in floral devel-
opment involves the use of thin cell layer explants
(TCL). In this system, floral stem sections at anthe-
sis are induced to form either vegetative shoots,
roots, or flower buds. It is not understood what de-
termines the choice of developmental pathway in
the cells of a TCL; however, any single TCL usually
gives rise to only one type of structure. We have
found that the production of polyamines, particu-
larly from ornithine, is critical in giving rise to flo-
ral buds, whereas enhanced conversion of arginine
to polyamines favors production of vegetative
shoots. We are currently transferring the flowering
polyamine mutants into TCL to see if a particular
developmental abnormality of the parent plant (Ta-
ble 1) is transferred in culture.
MOLECULAR GENETICS OF POLYAMINE REGULATION
Little is known about how polyamines control gene
expression. To date, polyamine-regulated genes
have not been well characterized from either
animals or plants, with the exception of the murine
OrnDC gene. In plants, it is known that many stress
responses induce large increases in the titer of free
polyamines. Thus, it is possible to isolate, by
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TABLE 1 Whole Plant Phenotypes of Polyamine Synthesis Variants
Coral
Strain like
Very Petal
dwarf sepal
Extra
petal
Class I
Mgr5-R0a X
Mgr6 -RO X
Mgr23 -RO X
Class II
Dfr1-R0
ts4 -RO
Class III
Mgr15-R0
Mgr21-R0
Class IV
Mgr25 -RO
Rt1-R0
Mgr3 -RO
Mgr3-Flb
Mgr31-R0
Mgr9 -RO
Mgr12-R0
Mgr12-Fl
Mgr1-R0
Mgr27 -RO
Petal Stigma
anther anther
X
Stamen Puzzle
ovule box
a RO, plants regenerated from culture.
b El, progeny from a cross of an RO plant to wild type.
differential hybridization, cDNAs that are highly
regulated by the polyamine titer, since a high per-
centage of mRNAs that are stress-induced are also
very sensitive to the titer and ratio of intracellular
polyamines. We have been interested in isolating
these cDNAs to characterize the mechanism by
which polyamines influence gene expression. Two
dozen cDNAs were isolated that had greatly in-
creased hybridization to mRNAs from stressed
tobacco plants (both low pH and low potassium
stress). One of these cDNAs has been shown by
hybrid-selected translation and immunoprecipita-
tion to be arginine decarboxylase (ArgDC). The
abundance of ArgDC mRNA was greatly dimin-
ished when production of any polyamine was re-
duced in culture through feedback regulation by the
addition of exogenous polyamines to the medium;
ArgDC mRNA was also developmentally regu-
lated, being found predominantly in leaves and
much less in floral parts. Other cDNA probes have
revealed developmentally regulated mRNAs or
stress-regulated mRNAs, but not both. In general,
the probes hybridized to near-single-copy genomic
sequences. In contrast, ArgDC mRNA is com-
plementary to approximately 50-100 genomic se-
quences that have extensive restriction polymor-
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phisms. Of 24 stress-regulated cDNA probes used
in Southern blots, only the ArgDC probe hybrid-
ized to numerous genomic copies; 18 of these se-
quences have thus far been cloned and partially
mapped. Restriction polymorphisms suggest that
they fall into four or five groups. One such genomic
clone has been characterized in detail, and the pro-
moter region and 5'-coding region have been iso-
lated. The sequence immediately 5' to the transcrip-
tional start site is unremarkable; however, extensive
sequencing of the entire 5'-untranslated region has
not yet been completed. This promoter region has
been reintroduced into a tobacco plant such that it
produces a truncated ArgDC transcript and a 3' oc-
topine synthase polyadenylation signal and can
thus be distinguished from the endogenous ArgDC
mRNA. We are in the process of studying the ef-
fects of various stresses on transcription of the rein-
troduced sequence. Ultimately, we would like to de-
termine which regulatory sequences are responsible
for the transcriptional response to different types
of stress. We also hope to understand why there are
abundant, polymorphic ArgDC sequences in the
tobacco genome and if this genetic organization is
responsible for sensitivity of ArgDC to different
environmental conditions.
Chloroplast Differentiation, Nuclear
Gene Expression, and Transcription
of Nuclear Genes in Tomato Plants
G. Giuliano, D. Pollock, P. Hinton, M. Delannoy,
P Scolnik [in collaboration with D. Spector,
Cold Spring Harbor Laboratory]
Although the role of some environmental factors,
such as light, in the regulation of plant gene expres-
sion has been extensively studied, little information
exists on the action of other factors. That light is
not the only factor controlling nuclear gene expres-
sion in plants is obvious from the fact that tissues
such as roots, flowers, and fruits express certain nu-
clear genes at very low levels. In plant leaves, two
typical examples of highly regulated genes are those
coding for the small subunit (ssu) of ribulose-1,5-
bisphosphate carboxylase/oxygenase (RuBPCase)
and the chlorophyll-a/b-binding protein (cab).
Both proteins are coded by small nuclear gene fami-
lies, and the protein precursors are synthesized in
the cytoplasm and then imported posttranslation-
ally into the chloroplasts. A genetic approach to the
study of the role of chloroplast differentiation in
the regulation of nuclear gene expression is to uti-
lize plants in which the development of these or-
ganelles is blocked by mutation.
Carotenoids are chloroplast membrane pigments
whose basic function is to protect the photosyn-
thetic membranes against the potentially harmful
combination of light and oxygen. A mutant plant
affected in carotenoid biosynthesis can suffer ex-
tensive photooxidative damage to its chloroplast
membranes, but other cellular compartments seem
to be relatively unaffected. Thus, plant carotenoid
mutants constitute an attractive system for the
study of nuclear-cytoplasmic interactions in plants.
However, the problem with this approach is that
this type of mutation is generally lethal due to the
lack of photosynthesis. Seedlings develop using
storage material, but after this supply is exhausted,
plants die. Therefore, most studies with plant carot-
enoid mutants have been conducted on 1-3-week-
old seedlings.
Our aim was to develop a system that would al-
low the study of gene expression in leaves of plants
in which chloroplast differentiation is genetically
blocked. We chose the tomato ghost mutant be-
cause previous reports indicated that this mutant is
somatically unstable. Furthermore, among the
dicots, tomato is one of the most attractive systems
because of its well-developed genetics and the fact
that it is transformable.
We germinated ghost seeds and observed that,
consistent with the early observations of C. Rick,
green sectors form in the ghost white leaves. Char-
acterization of pigments in both types of tissues in-
dicated that no colored carotenoids or chlorophyll
accumulates in white sectors, whereas wild-type
concentrations of both types of pigments are pres-
ent in the white sectors. Electron microscopy was
used to characterize the plastids in white and green
leaves. Undifferentiated plastids, with little mem-
brane structure, form in white leaves, but fully
differentiated chloroplasts are observed in green
tissue (Fig. 4). Thus, the somatic instability of the
ghost mutation results in the restoration of carot-
enoid biosynthesis in the green sectors. The main
function of carotenoids is to protect chlorophyll
FIGURE 4 Plastids from leaves of tomato ghost plants grown in a growth chamber. (A) White sectors; (8) green sectors. (GI) Globuli;
(Th) thylakoids; (V) vacuole; (PE) plastid envelope; (M) mitochondrion; (G) grana; (S) starch; (N) nucleus. Bar, 0.5 µm. Magnifications:
(A) 18,900x; (B) 11,900x.
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FIGURE 5 Northern blot analysis. Probes: (A) Small subunit
of carboxylase; (8) chlorophyll-a/b-binding protein; (C) actin
gene. (WT) Wild-type; (GL) green leaves of ghost plants grown
in the light; (WL) white leaves of ghost plants grown in the light;
(GD and WD) green and white leaves of ghost plants, respec-
tively, grown in the light and placed in the dark for 2 days.
against photooxidation, and thus chlorophyll ac-
cumulation in the green sectors is probably a sec-
ondary event due to the restoration of carotenoid
biosynthesis. Green sectors are photosynthetic and
can support the growth of a variegated ghost plant.
Micropropagation through tissue culture was used
to generate variegated ghost plants containing
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FIGURE 6 In vitro transcription experiment. Ethidium-
bromide-stained gel containing plasmid DNA from ssu (lane 1),
cab (lane 2), and actin (lane 3) were blotted onto nitrocellulose
and hybridized to RNA extracted from different tissues. See Fig.
5 for abbreviations.
enough green leaves to support growth to maturity.
Thus, we have the first plant system in which
the effects of a mutation in the carotenoid pathway
can be monitored throughout development.
For our first study of gene expression in ghost,
we obtained probes for two families of nuclear
genes (ssu and cab) that code, respectively, for the
chloroplast RuBPCase and chlorophyll-a/b-bind-
ing proteins. Northern probing of extracts from
white and green ghost tissue from plants grown in
the light shows that the mRNA levels for ssu and
cab are similar to wild-type levels in ghost green tis-
sue but are sharply reduced in ghost white tissue
(Fig. 5). The influence of light on the expression of
these two families can be studied by transferring the
plants to the dark for 48 hours. A reduction in the
mRNA levels of the two gene families can be ob-
served in both white and green tissue (Fig. 5). Thus,
even in the absence of colored carotenoids, light
regulates the expression of these genes in mature
ghost plants.
The decrease in mRNA levels observed in ghost
white tissue could be due to transcriptional or post-
transcriptional events. To differentiate between
these two possibilities, we pulse-labeled mRNA in
nuclei isolated from white and green tissue. The
mRNAs were then extracted and hybridized to the
corresponding DNA probes immobilized on nitro-
cellulose filters. The results indicate (Fig. 6) that the
primary effect of both light and colored carot-
enoids takes place at the transcriptional level.
We have demonstrated that maximum transcrip-
tion of the two gene families studied requires both
light and colored carotenoids. The mechanism of
the carotenoid effect remains unknown. However,
evidence gathered from different systems suggests
that fully differentiated chloroplasts are required
for the expression of some nuclear genes in plant
leaves. A signal, of hitherto unknown nature,
would be generated by the chloroplast and would
act as a positive activator of nuclear gene expres-
sion. In vitro reconstitution systems currently un-
der way should help characterize the effect of chlo-
roplast components on transcription in isolated
nuclei.
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redox-driven proton pumps, cytochrome oxidase,
and ATP synthetase, all involved in microbial
energy transduction. These organisms have versa-
tile growth modes (Fig. 1) that enable the selection
of mutants defective in only some of these com-
plexes, which are viable through other pathways.
Often, bacterial complexes are structurally simpler,
but functionally, they are very similar to higher or-
ganisms. Some of these organisms, upon disrup-
tion, yield sealed membrane vesicles (chromato-
phores) containing all of the components of
energy-transducing chains. Thus, in vitro studies of
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FIGURE 1 Various growth modes of R. capsulatus. (Ps) Pho-
tosynthesis in the absence of oxygen but in the presence of
light; (Res) respiration; (DMSO) anaerobic growth in the pres-
ence of dimethylsulfoxide; (NADH and SDH) respiratory
dehydrogenases; (0/0H2) quinone/quinol pool; (R.C) photo-
synthetic reaction center; (bc1) ubiquinol:cytochrome c2 oxido-
reductase; (c2) cytochrome c2; (C ox410 and C ox260) respira-
tory terminal oxidases. Dashed lines indicate newly discovered
electron pathways.
the electron-transfer pathways using flash-activable
"single-electron-turnover" techniques are possible.
Furthermore, the electrochromic red shift of the ca-
rotenoid absorption spectrum (carotenoid band-
shift) of photosynthetic bacteria is an invaluable
tool for determining the transmembrane potential
and for identifying electrogenic steps in electron
flow through these complexes. Perhaps most im-
portantly, some of these species are amenable to
genetic analysis,
capsulatus (formerly called Rhodopseudomonas
capsulata) genetics is well developed.
Role of Cytochrome c2 in
Photosynthesis and Respiration
F. Daldal, E. Davidson, S. Rook
Cytochrome c2 is an electron carrier common to
photosynthetic and respiratory apparatuses of R.
capsulatus. It takes electrons from the ubi-
quinol:cytochrome c oxidoreductase and donates
them to the reaction center (in photosynthesis) or
to the cytochrome oxidase (in respiration) (Fig. 1).
To understand how this cytochrome interacts with
various membrane complexes while carrying elec-
trons, a multidisciplinary approach that we ini-
tiated 2 years ago was continued this year.
CYTOCHROME C2 IN PHOTOSYNTHESIS
In the past, cytochrome c2 was considered to be es-
sential for photosynthesis and for the cytochrome
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c,-dependent branch of respiration on
the basis of
the nonphotosynthetic
phenotype of a mutant,
MT113, which lacks c2. However, our recent
studies have shown that MT113 is not only defective
in c2, but also lacks all known c-type cytochromes,
even though it can synthesize b-type cytochromes
(E. Davidson et al., Biophys. Biochem. Acta [1987]
in press). Therefore, to define the role of c2 in vivo,
we sought mutants missing only this protein. To
isolate a c2- mutant, we first cloned the structural
gene for c2 (cycA) and determined its nucleotide
sequence. Then, using the cloned gene, we con-
structed mutant alleles in vitro and introduced
them into the chromosome of an otherwise wild-
type strain. The mutants obtained were devoid of
c2 but, interestingly, they were proficient in pho-
tosynthesis and in respiration. Therefore, an alter-
native way(s), independent of c2 and capable of
reducing the oxidized R. capsulatus photosynthetic
reaction center, must exist. This led us to the dis-
covery of a c2-independent photosynthetic electron
pathway between the reaction center and the bc,
complex (Fig. 1) (Daldal et al., Proc. Natl. Acad.
Sci. 83: 2012 [1986]).
CHARACTERIZATION THE PHOTOSYNTHETIC
ELECTRON PATHWAYS IN THE ABSENCE OF C2
Study of a c2- mutant by flash spectroscopy, in
collaboration with R. Prince (Exxon Corporation),
established that in this new pathway, the electron
donor to the reaction center is a membrane-bound
c-type cytochrome, most likely cytochrome CI of
the ubiquinol:cytochrome c oxidoreductase. This
electron donation is very rapid (<100 tisec) but is
only equal to approximately one fifth of that ob-
served in the wild-type. Although this direct elec-
tron transfer from the bc, complex to the reaction
center is low, it appears to be sufficient to support
growth fully when high light intensity is available.
CHARACTERIZATION OF THE PHOTOSYNTHETIC
ELECTRON PATHWAYS IN THE ABSENCE OF
BOTH CYTOCHROMES C2 AND C1
To further previous studies, mutants missing only
cytochrome cl, as well as double mutants defective
in both cytochromes cl and c2, have been obtained.
In contrast to c2- mutants, the or c, -,c,- double
mutants are deficient in photosynthesis, indicating
the essential role of cytochrome cl during this pro-
cess. Although other c-type cytochromes are detect-
able in chromatophores derived from the double
c,-,c2- mutant, they are not photooxidizable in
vitro, suggesting that c-type cytochromes other
than ci and c2 are not involved in photosynthesis.
This finding rules out the presence of other c-type
cytochromes as an intermediate between the c1 of
the bc, complex and the reaction center. The elec-
tron donation from ci to the reaction center must
therefore be direct. This is the first example of a di-
rect electron transfer between two membrane com-
plexes and thus we will continue its study in the
future.
CYTOCHROME C2 IN RESPIRATION
Analysis of the role of cytochrome c2 in respira-
tion is more complex because R. capsulatus has a
branched respiratory pathway. One branch contains
cytochrome c2 and a cytochrome c2-dependent
cytochrome oxidase, and the alternate branch con-
tains a cytochrome c2-independent quinol oxidase
(Fig. 1). Fortunately, mutants blocking either of
these terminal oxidases exist, and thus a double
mutant lacking cytochrome c2 and also defective in
quinol oxidase was constructed. This mutant can
still grow by respiration and is sensitive to myx-
othiazol, a specific inhibitor of the bc, complex.
Therefore, electron transfer from the bc, complex
to cytochrome oxidase can also take place indepen-
dently of c2. Determination of the nature and the
characteristics of the electron donor in this case is
under way.
IN VITRO SITE-DIRECTED MUTAGENESIS OF
CYTOCHROME C2
Encouraged by the recent resolution of the three-
dimensional structure of R. capsulatus c2 by H.
Holden and I. Rayment at the University of Ari-
zona, we have initiated in vitro site-directed muta-
genesis of this protein for relevant amino acid
residues that are known to be involved in electron
transfer. Our first attempt, in collaboration with
Dr. Cusanovich at the University of Arizona, is
directed at replacing the Lys-12 with an aspartic
acid residue. This amino acid residue, situated near
the water-exposed edge of the heme group, is
thought to play an important role during electron
transfer. A change from a basic residue to an acidic
residue may drastically perturb electron donation
rates and, hopefully, begin to reveal the underlying
molecular rules of this process.
Genetic Analysis of the Structure and
Function of the Ubiquinol:Cytochrome c2
Oxidoreductase
E. Davidson, S. Rook, B. Naiman, F. Daldal
Ubiquinol:cytochrome c oxidoreductases (or bc,
complexes) are membrane-bound, redox-driven
proton pumps found in photosynthetic bacteria,
plant chloroplasts, eukaryotic mitochondria, and
many nonphotosynthetic bacteria. In R. capsula-
tus, this complex is common to photosynthetic and
respiratory electron-transfer chains and consists of
three subunits carrying prosthetic groups: Rieske
Fe-S protein, cytochrome b, and cytochrome ci. It
oxidizes quinols generated by the photosynthetic
reaction center or by respiratory dehydrogenases,
and subsequently rereduces quinones. As a net re-
sult of these oxidation and reduction reactions,
protons are translocated from the cytoplasmic side
of the membrane to the periplasmic side, and the
accompanying electrons are conveyed either back to
the reaction center (in photosynthesis) or to
cytochrome oxidase (in respiration) (Fig. 1).
ISOLATION OF THE STRUCTURAL GENES OF
THE BC1 COMPLEX COMPONENTS
This year, we have continued studies initiated last
year on the electron pathways in and around the
bc, complex. Earlier, using a nonphotosynthetic
mutant with a lesion related to the bc, complex,
we isolated by complementation the structural
genes for the Rieske Fe-S protein (petA),
cytochrome b (petB), and cytochrome ci (petC).
On the plasmid obtained, these three genes were
found located adjacent to each other, constituting
an operon (pet). To determine the role of the bc,
complex, mutations localized in each of these genes
were obtained using the available clones. These
bc,- mutants are nonphotosynthetic, indicating
that a functional bc, complex is absolutely essen-
tial for this growth mode. However, as expected,
they are able to grow by respiration via the alternate
pathway. These results indicate that the branch
point of the respiratory pathways must be before
the bc, complex, most likely at the quinone pool
(Fig. 1).
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GENETIC STRUCTURE OF PET OPERON
The approximately 4000-bp-long nucleotide se-
quence of the pet operon, consisting of the struc-
tural genes for Rieske Fe-S protein (petA),
cytochrome b (petB), and cytochrome c1 (petC),
has been completed and is shown in Figure 2. The
amino acid sequence deduced from it indicates that
the Rieske Fe-S protein, cytochrome b, and
cytochrome c,, respectively, are 191, 437, and 279
amino acid residues long. They all present several
regions of strong homology with the same proteins
from various organisms. Furthermore, compari-
sons based on their hydropathy plots indicate an
overall similarity in their spatial folding. The
nucleotide sequence establishing the entire primary
structure of the bc, complex now provides impor-
tant basic knowledge for future studies on the
structure-function relationship of the bc, complex,
a redox-driven proton pump.
During these studies, we realized that an extraor-
dinarily high homology at the nucleotide level ex-
isted between the bc, sequences derived from two
distinct Rhodospirillaceae species, namely, the
above-mentioned pet operon of R. capsulatus and
the corresponding fbc operon of Rhodopseudo-
monas sphaeroides recently reported by N. Gabel-
lini and W. Sebald. However, a detailed examina-
tion of the R. sphaeroides isolate used in earlier
studies indicated that it is not a genuine R.
sphaeroides strain, but rather a species closely
related to R. capsulatus. Consequently, the pet op-
eron of a bona fide R. sphaeroides strain has also
been isolated and partially sequenced. This com-
parison established that R. capsulatus is currently
the only organism from which the entire primary
structure of the bc, complex is known.
SUBUNIT COMPOSITION OF R. CAPSULATUS
BC1 COMPLEX
The minimum number of the subunits required for
a functional bc, complex is an important issue. To
attack systematically this and other structural and
functional questions related to the bc, complex,
we have initiated the generation of specific mono-
clonal antibodies using the purified R. capsulatus
complex provided by L. Dutton from the University
of Pennsylvania. Using native complex, we have
obtained a number of monoclonal antibodies
recognizing specifically each one of the Rieske Fe-S
protein, cytochrome b, and cytochrome cl sub-
units. Interestingly, although some of these anti-
bodies interact only with denatured subunits,
others appear to inhibit the function of the bc,
complex, as tested by a cytochrome c2-dependent
quinol oxidase assay done in collaboration with L.
Dutton's group. Using these antibodies, we have
proved that the bc, complex of R. capsulatus con-
tains only three subunits. The 10-kD subunit, ear-
lier observed in purified complexes, does not seem
to be necessary for the quinol oxidation reaction in
vitro. Therefore, this complex appears to bind and
process quinones and quinols without the need of
a quinone-binding protein postulated to be present
in some other organisms. Undoubtedly, these
monoclonal antibodies will provide excellent tools
for various future structural and functional studies.
STRUCTURALLY INTACT, BUT FUNCTIONALLY
PERTURBED, BC1 COMPLEX MUTANTS
Although our ongoing studies using null mutants
have already begun to define the electron pathways
in and around the bc, complex, we have realized
that deeper insights into the structure-function
relationship of the bc, complex could perhaps be
obtained if mutants perturbed functionally, but as-
sembling the complex properly, were available. One
such mutant, R126, defective in only one of the two
functional sites of the bc, complex, already exists
and has been used to isolate the structural genes. To
obtain other mutants of this type, we have begun to
screen the effect of various bc, inhibitors, such as
myxothiazol, stigmatellin, antimycin, UHDBT, and
UHNQ, on the photosynthetic growth of R. cap-
sulatus. These inhibitors have previously been stud-
ied only in vitro using chromatophores. We have
found that myxothiazol and stigmatellin, specific
for the quinol oxidation site, are potent inhibitors
of photosynthetic growth in this species. For un-
known reasons, antimycin and funiculosin, which
affect the quinone reduction site, appear for the
moment to be ineffective in vivo. Spontaneous mu-
tants resistant to myxothiazol and stigmatellin have
FIGURE 2 Nucleotide and deduced amino acid sequence of the pet operon of R. capsulatus encoding the structural genes for
the Rieske Fe-S protein (petA), cytochrome b (petB), and cytochrome c1 (petC) subunits of the bc1 complex. Boxed areas indicate
the putative ribosome binding sites, and highlighted areas indicate the differences between the pet and fbc operons (see the text).
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been obtained, and several were shown to map in
the bc, gene cluster by a novel genetic tool, called
"interposon tagging," that we have recently de-
veloped.
INTERPOSON TAGGING, A NEW TOOL FOR
R. CAPSULATUS GENETICS
This tool is a natural extension of the "interposon
mutagenesis" technique, developed by P. Scolnik,
that we have been using to generate null mutants.
In contrast to the mutagenesis technique, the tag-
ging scheme takes advantage of a silent insertion,
introduced in vitro in close proximity to the gene to
be studied. It provides a selectable genetic marker
for mapping using genetic crosses, and at the same
time it tags the corresponding restriction fragments
with a selectable marker for easy cloning of the
studied mutations. With this technique, we have
proved that the aer126 mutation of R126 is located
in the cytochrome b gene and have also shown that
all of the mutations conferring myxothiazol resis-
tance and most of the mutations conferring stig-
matellin resistance are located in the pet operon.
Several of these mutations have now been cloned,
and determination of the corresponding nucleotide
changes is now in progress.
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CELL BIOLOGY
The cell biology and biochemistry of mammalian growth control continue to be the
major focus of the Cell Biology group. Over the past several years, we have
evolved to five major sections encompassing oncogenes and growth factors,
cytoskeletal structures, and stress proteins. As each group advances in its particu-
lar field, we find more and more overlapping principles that have increased the in-
teractions within the group. This has allowed for synergistic collaborative efforts
and speedy progress to be made. An account of some of the work carried out
over the past year by the five subgroups is given below.
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Role of the ras Protein in
Membrane Signal Transduction
D. Bar-Sagi, J.R. Feramisco
Essential to the understanding of the mechanism
whereby ras proteins exert their effects on cell
proliferation is the identification of molecular
events that are directly modulated by these pro-
teins. The mammalian ras family consists of three
proto-oncogenes, Ha-ras, Ki-ras, and N-ras, each
of which can acquire oncogenic properties by single
missense mutations usually at either codon 12 or
codon 61. The mutated forms of the ras genes are
prevalent in human and rodent tumor cells and
have been implicated in transformation in vitro and
tumorigenesis in vivo.
Mammalian ras genes encode homologous 21-kD
proteins that are membrane-associated guanosine
triphosphate (GTP)-binding proteins. The proteins
have an intrinsic low guanosine triphosphatase
(GTPase) activity that, in certain cases, is impaired
in the mutated oncogenic protein. The GTP hydro-
lytic activity is a common property of all known
guanine-nucleotide-binding (G) proteins. Members
of the G-protein family regulate the activities of
their cellular target by a cycle of GTP binding and
GTP hydrolysis. On the basis of an analogy be-
tween ras proteins and G proteins, it has been pro-
posed that the reduction in GTPase activity that ac-
companies mutational activation of ras genes
impairs the regulatory function of ras proteins,
thereby leading to the derangement of cellular sig-
nals that control cell proliferation. Although the
specific biochemical function of ras proteins has
not as yet been identified, several studies have indi-
cated that ras proteins may participate in the molec-
ular events initiated by growth factors. Elucidation
of the role of ras proteins in the acquisition of the
transformed phenotype has been hampered by the
pleiotropic nature of the transformation process.
As has been shown previously, microinjection of
the ras oncogene protein into quiescent cells results
in the transient stimulation of proliferation. There-
fore, the transforming properties of ras proteins are
faithfully expressed in this assay. Furthermore, the
microinjection approach offers the means by which
oncogenic ras protein can be introduced abruptly
into normal cells and therefore can allow identifica-
tion of the immediate effects of ras proteins.
ROLE OF THE RAS PROTEINS IN CELL-SURFACE
ACTIVITIES AND PHOSPHOLIPID TURNOVER
Confluent rat embryo fibroblasts (REF52) have a
flattened polygonal shape. The cell-surface struc-
ture, as revealed by scanning electron microscopy,
consists predominantly of short, slender extensions
and small folds (Fig. 1). As early as 30 minutes after
microinjection of the human Ha-ras oncogene pro-
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FIGURE 1 Scanning electron micrographs of REF52 cells injected with the ras oncogene protein. Cells were injected with either
buffer alone (a) or with the ras oncogene protein (b-d). The time after injection was 30 min (b), 2 hr (c), and 10 hr (a,d).
tein, pronounced ruffling activity begins, as is indi-
cated by the large lamellipodia that rise up along
the periphery of the injected cells. Two hours after
the cells are injected, large ruffles that form
elaborate branching patterns are prominent on the
dorsal surface. Ten hours after injection, the cells
assume a partially rounded shape, and large regions
of the membrane are now occupied by the surface
ruffles. These sequential changes in surface mor-
phology were reproducible both between different
experiments and between the population of the in-
jected cells in a given experiment. Microinjection of
buffer alone or similar amounts of control protein
(mouse immunoglobulin G, IgG) has no apparent
effect on cell-surface morphology.
The occurrence of membrane ruffling is closely
associated with pinocytotic activity. To test the ef-
fect of microinjection of the Ha-ras protein on
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fluid-phase pinocytosis, we monitored the uptake
of fluorescein-conjugated dextran (FITC-dextran)
by the injected cells. This substance meets the ma-
jor criteria required for a marker of fluid-phase
pinocytosis; it is readily soluble in aqueous medi-
um, membrane-impermeable, stable within the in-
tracellular milieu, and does not bind to the plasma
membrane. Cells microinjected with the Ha-ras on-
cogene protein display a large number of intracel-
lular vesicles containing the fluorescent marker, in-
dicating a high rate of ongoing pinocytosis. The
pinocytotic vesicles are mostly formed in small
groups and are found predominantly along the in-
ner margin of well-developed ruffled membranes
(visible as a dark rim with many folds). In contrast,
the level of pinocytotic uptake of FITC-dextran in
cells that were microinjected with the control pro-
tein is very low and is comparable to that observed
in buffer-injected cells or uninjected cells. The
stimulatory effect of ras oncogene protein on mem-
brane ruffling and pinocytosis was not restricted to
the particular cell type used because we found that
microinjection of the protein into normal rat kid-
ney cells similarly results in the enhancement of
ruffling and pinocytosis. Comparison between the
rates of uptake of FITC-dextran in ras-injected cells
and in buffer-injected cells, as determined by the
rate of formation of pinocytotic vesicles, has been
done. The number of vesicles containing FITC-dex-
tran increases linearly with time of exposure of cells
to the fluorescent marker. These are the kinetics
predicted for FITC-dextran uptake by fluid-phase
pinocytosis. Furthermore, the rate of pinocytotic
activity is ten times higher in cells that were injected
with ras oncogene protein than in cells that were in-
jected with buffer.
A common characteristic of cell-surface stimuli
that trigger membrane-related events is their ability
to alter phospholipid metabolism. We therefore
decided to test whether the effects of ras proteins
on membrane ruffling and pinocytosis are accom-
panied by changes in phospholipid metabolism.
The phospholipid composition of the ras-injected
cells was analyzed. The cells injected with buffer
alone showed the same phospholipid composition
as mock-injected cells. Injection of the ras on-
cogene protein had no apparent effect on the levels
of "P-labeled phosphatidylcholine, phosphatidyl-
ethanolamine, phosphatidylinositol, and phospha-
tidic acid at this level of resolution. Our attempts
to quantify the levels of 32P incorporated into the
polyphosphoinositides PIP and PIP2 were ham-
pered by the very low net phosphorylation signal
caused by the rapid turnover of the phosphates in
these phospholipid species. Using an acidic TLC
solvent system to analyze the lipid extracts, we have
observed that the levels of lysophosphatidylcholine
and lysophosphatidylethanolamine in ras-injected
cells are reproducibly 1-1.5 times higher than in
buffer-injected cells. This increase is detectable as
early as 30 minutes after injection and becomes
more apparent by 1 hour after injection. Lysophos-
pholipids are the products of phospholipase A2 ac-
tivity. This enzyme catalyzes the hydrolysis of fatty
acid ester bonds at the 2-position of 1,2-diacyl-sn-
phosphoglyceride, thereby producing two products:
free arachidonic acid and lysophospholipids.
Therefore, the increase in lysophosphatidylcholine
and lysophosphatidylethanolamine detected in
cells injected with the ras oncogene protein is an in-
dication that the activity of phospholipase A2 was
stimulated in these cells.
Activation of phospholipase A2 accompanies
several distinct types of responses triggered by
ligands. The magnitude of the effect produced by
microinjection of ras oncogene protein is similar to
that observed upon ligand-induced activation of
phospholipase A2. The activity of the enzyme is
calcium-dependent and leads to the release of ara-
chidonic acid, which provides the precursor for the
formation of prostaglandins and other metabolites.
Free arachidonic acid, moreover, may partition into
membranes and alter their structural properties by
virtue of its effect on bilayer fluidity. Likewise,
lysophospholipids, formed as a consequence of
phospholipase A2 activation, can exert profound
effects on cell-surface organization by virtue of
their detergent-like properties. Since membrane
ruffling and pinocytosis are inevitably associated
with dynamic changes in cell-surface properties,
the activation of phospholipase A2 by microinjec-
tion of the ras oncogene protein may be directly in-
volved in the ras-induced stimulation of these cell-
surface activities.
MICROINJECTION OF ANTIBODIES TO THE RAS
ONCOGENE PROTEIN INHIBITS RUFFLING AND
PINOCYTOSIS IN RAS-TRANSFORMED CELLS
F. McCormick of the Cetus Corporation, Califor-
nia, collaborated with us on this research. Normal
rat kidney cells transformed by the v-Ki-ras on-
cogene (KNRK) (ATCC 1569) grow in culture as
rounded cells that display numerous cell-surface
ruffles, whereas normal rat kidney cells (NRK)
grow as flat cells with fewer surface ruffles. Previ-
ous studies in our laboratories have shown that
microinjection of neutralizing antibodies against
the ras oncogene protein into KNRK cells induced
the morphological reversion of these cells (Fig. 2).
In a time-dependent manner, the injected anti-ras
antibodies cause the KNRK cells to flatten, lose
many of the cell-surface ruffles, and slow their
growth. Injection of control Ig Gs had no effect on
the morphology of these cells, and dilution of the
immune IgG, so that less than 5 x 104 molecules of
IgG were injected per cell, led to a loss of the mor-
phological reversion as well.
Conversely, we have previously shown that
microinjection of the human Ha-ras (T24) on-
cogene protein into normal rat cells causes the rapid
appearance of cell-surface ruffles. Thus, it seems
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FIGURE 2 Morphological changes in KNRK cells following
microinjection of anti-ras antibodies. KNRK cells growing in the
presence of 10% calf serum were microinjected either with
5x105 molecules/cell of nonimmune IgG (a) or with 5x105 mol-
ecules/cell of mouse monoclonal anti-ras IgG (b). The mouse
monoclonal anti-ras binds to both the proto-oncogenic and on-
cogenic forms of the ras protein. Cells were identified through
the use of ink circles drawn on the bottom of the culture dish.
The antibodies were dissolved in 5 mm sodium phosphate (pH
7.2) containing 70 mm sodium chloride. Ten hours postinjection,
the cells were fixed and examined by scanning electron micros-
copy. Note the lack of surface ruffles in the cells injected with
the anti-ras antibodies, whereas cells injected with control IgG
retain the surface ruffles.
highly probable from these two sets of studies that
the expression of the ras oncogene protein is some-
how directly responsible for the enhanced cell-
surface ruffling associated with the transformed
cells.
One of the biological phenomena intimately as-
sociated with cell-surface ruffling is fluid-phase
pinocytosis. KNRK cells, which display many sur-
face ruffles, show a high level of uptake of horse-
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radish peroxidase (HRP; used as a cytochemical
marker of this activity by addition to the growth
medium) into intracellular vesicles. The character-
istics of this uptake of the HRP by the cells are
similar to those that define fluid-phase uptake (i.e.,
the uptake is linear with time of incubation,
proportional to the amount of HRP added to the
medium, and not saturable with respect to the
amount of HRP added to the medium). In a series
of experiments in which we microinjected anti-ras
antibodies into these cells prior to the measurement
of fluid-phase pinocytosis, it was found that injec-
tion of the anti-ras IgG led to a decrease in the
pinocytotic activity in the KNRK cells, which cor-
related with the cell-flattening response and the loss
of cell-surface ruffles (Fig. 3). Again, the diminu-
tion of pinocytotic activity was dependent on the
amount of immune IgG injected and was not seen
with comparable amounts of injected nonimmune
IgG.
Work from our laboratories and from others has
shown that the ras oncogene protein obviates both
the need for growth factors in the stimulation of
proliferation in fibroblasts and the need for nerve
growth factor in differentiation of PC-12 cells.
Moreover, blockage of the function of the ras
proto-oncogene protein in fibroblasts or PC-12
cells prevents the mitogenic or neurogenic effects of
growth factors or nerve growth factor, respectively.
Examination of the cell surface shows that en-
hanced membrane ruffling is an early change ob-
served on fibroblasts in the mitogenic response to
growth factors and on PC-12 cells in the neurogenic
response to nerve growth factor. Together, these
data support the idea that the ras proteins play a
role in the signal transduction process of these dis-
tinct biological systems, and it is likely that mem-
brane ruffling is an essential feature of the common
biochemical reactions that are regulated by the ras
proteins in these systems.
Influence of ras Protein Expression
on Fluid-phase Endocytosis in Yeast
A. Fernandez-Solt, D. Bar-Sagi, J.R. Feramisco
[in collaboration with S. Powers, T. Toda, and
M. Wigler, Cold Spring Harbor Laboratory]
As M. Wigler's laboratory has uncovered the regu-
lation of cAMP metabolism in yeast by the ras pro-
teins, they have generated many defined strains of
yeast that have altered expression of the ras genes.
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FIGURE 3 Inhibition of fluid-phase pinocytosis in KNRK cells
by microinjection of anti-ras antibodies. KNRK cells were
microinjected either with 5x105 molecules/cell of nonimmune
IgG (a) or with a similar amount of anti-ras IgG (b). Ten hours
postinjection, HRP was added to the medium (1 mg/ml). After
a 30-min incubation period, the cells were washed, fixed, and
processed to localize cell-bound enzyme with the diaminoben-
zidine hydrogen peroxide substrate mixture (dark, electron
dense areas). Note the diminution of the uptake of HRP from the
medium in the cell injected with the anti-ras antibodies, whereas
cells injected with control IgG retain the high level of uptake of
HRP
We have undertaken a study of these strains to de-
termine whether, in yeast, the ras proteins affect
fluid-phase endocytosis as the proteins do in mam-
malian cells.
Fluid-phase endocytosis was measured in various
yeast RAS1/RAS2 strains by means of the uptake
of a fluorescent dye, Lucifer yellow carbohydrazine
(LYch). These measurements reveal a positive rela-
tionship between ras gene expression and the level
of endocytosis in the yeast cells. Although
rasl-/ras2- strains exhibited a very low level of en-
docytosis, strains expressing high levels of RAS1 or
RAS2 showed high levels of endocytosis (Fig. 4).
FIGURE 4 Endocytosis in the galactose-inducible RAS2val19
yeast strain. Yeast strain JR-281D-2-3 was grown overnight at
30°C in glucose medium (a), acetate medium (b), and acetate
+ galactose medium (c,d). Cells were then harvested and fur-
ther incubated for 2 hr at 37°C with 6 mg/ml Lucifer yellow (in
d, glucose was added). Cells were washed, mounted, and pho-
tographed using phase or fluorescence optics. Fluorescence
pictures were shot with a constant exposure time of 40 sec.
Growth of this strain in glucose alone represses the expression
of RAS2va119 by 90 %; growth in galactose induces RAS2val19
expression up to 500-1000 copies/cell.
We also found a strong effect of glucose on endocy-
tosis in strains expressing mutated RAS, where the
sugar stimulated endocytosis by 10-50-fold com-
pared with its effect on wild-type strains. The
glucose-induced enhancement of endocytosis ap-
peared to be the result of a synergistic effect of ras
and glucose on this biological activity. The effect of
ras on endocytosis probably is not mediated
through its previously demonstrated effect on ade-
nylate cyclase, since strains lacking adenylate cy-
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clase still showed normal levels of endocytosis. Fur-
ther work is being carried out in order to determine
more clearly the connection between the ras pro-
teins and endocytosis in yeast.
Reduced Protein-kinase-C Activity in a
ras-resistant Cell Line Derived
from Ki-MSV-transformed Cells
T. Kamata, N.F. Sullivan, M.W. Wooten
We have examined phosphatidylinositol turnover
and C-kinase distribution in a flat, cellular ras-
resistant cell line (CII) derived from Kirsten murine
sarcoma virus (Ki-MSV)-transformed NIH-313
cells (DT). This cell type has been shown to express
high levels of the p21 Ki-ras gene product, yet it is
resistant to the transforming effects of this protein.
Our data indicate that CII cells have reduced levels
of total C-kinase activity when compared with that
of NIH-3T3 cells and do not retain the ability to
phosphorylate the growth-associated 80-kD C-
kinase substrate either in vivo or in vitro. Further-
more, the steady-state levels of diacylglycerol and
the sum of inositol phosphates are elevated in DT
cells, whereas in CII cells, these levels are reduced
to an amount equivalent to that seen in NIH-3T3
cells. These data indicate a correlation between a
protein-kinase-C-dependent pathway and resis-
tance to transformation by ras.
FIGURE 5 Immunofluorescence analysis of fos expression in stimulated and unstimulated fibroblast
cells. Cells grown to near confluence on glass coverslips in DMEM and 10% serum were treated with
medium containing 1% serum for 24 hr, followed by DM EM in the absence of serum for an additional 24
hr. Cells in panels A (parental), C, and E (v-fos sense transfectants) were then fixed in 3.7% formaldehyde.
Parental 208F fibroblasts refed with DMEM and 10% serum (panel B) and cell lines containing v-fos sense
constructs refed with DMEM containing 10-6 M dexamethasone (panels D and F) were incubated 60
min and fixed in formaldehyde. Coverslips were processed for immunofluorescence using affinity-purified
anti-fos antibody. All fields were photographed using identical exposure times.
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Cell Lines Inducible for the
Production of fos Sense and
Antisense RNA
K.T. Riabowol, J.R. Feramisco
Transcriptional induction of the c-fos proto-
oncogene occurs within 5 minutes of mitogen stim-
ulation in fibroblast cells and is the earliest known
effect of growth factors on gene expression. Once
transcribed, a wide variety of posttranslationally
modified forms of fos proteins bind DNA with
differing avidity. Cotransfection of v-fos constructs
with several test promoters suggests that the v-fos
gene either encodes or induces an activator of tran-
scription. Although the function of fos is at present
unknown, the low levels observed in quiescent cells,
high transient amounts seen upon mitogen stimula-
tion, and intermediate levels seen in cycling cells
suggest a role in cell proliferation.
To test this idea, we have made steroid-inducible
constructs containing the sense or antisense orien-
tations of v-fos downstream from the mouse mam-
mary tumor virus long terminal repeat. Transfec-
tion of rat 208F fibroblast cells has yielded several
cell lines that show induction of fos sense or an-
tisense RNA by Northern analysis. In addition, in-
creased fos-specific nuclear fluorescence is seen in
lines containing v-fos sense constructs upon addi-
tion of dexamethasone as shown in Figure 5, indi-
cating production of v-fos p55. Staining of cells
with affinity-purified fos antibody directed against
a portion of the fos protein common to the viral
and cellular forms demonstrates an increase of c-
fos in serum-stimulated (panel B) versus quiescent
(panel A) 208F cells. The remaining panels show
similarly stained quiescent cell lines containing v-
fos sense constructs in the absence (C and E) and
presence (D and F) of 10-6 M dexamethasone.
The results of recent experiments in which 3T3 fi-
broblasts were transfected with steroid-inducible c-
fos antisense constructs make the role of fos during
the cell cycle unclear. Although one study reported
that fos antisense RNA expression markedly re-
duced growth rate in unsynchronized cells, a subse-
quent report indicated that expression of fos an-
tisense RNA resulted in a decreased ability of cells
to reenter the cell cycle from a quiescent state but
had no effect on rate of growth during the logarith-
mic phase of cell growth. We have not been able to
demonstrate an effect of fos antisense RNA expres-
sion upon cell lines during logarithmic growth;
however, its expression does inhibit [3H]thymidine
incorporation in quiescent cells stimulated with se-
rum (Fig. 6A-D). Conversely, higher levels of
[31-I]thymidine incorporation are seen in cell lines
containing sense orientations of v-fos when quies-
cent cells are stimulated with low levels of serum
(Fig. 6E-H). We are now in the process of determin-
ing the effect of different levels of v-fos p55 and fos
antisense RNA on cell growth in several cell lines
under a variety of growth conditions.
Cell Biology of cAMP-dependent
Protein Kinase
J.C. Lamb, W.J. Welch, J.R. Feramisco [in collaboration
with D. Glass, Emory University, and R. Adelstein
and M. Conti, National Institutes of Health]
We have been interested in investigating the role of
cAMP-dependent protein kinase (A-kinase) as a
mediator of a number of cellular processes. In-
cluded among these are (1) the regulation of cell
proliferation, (2) the control of cell shape, and (3)
the modulation of cytoskeletal dynamics. We have
approached this through a combination of bio-
chemical, immunological, and pharmacological
techniques, including microinjection of the puri-
fied kinase, antibodies to specific proteins, drugs,
and hormones. Our previous studies have shown
that elevating intracellular A-kinase activity
through either the injection of the catalytic subunit
or treatment of cells with defined drugs or hor-
mones that raise intracellular cAMP results in dra-
matic changes in cell shape and the cytoskeleton. A
closer analysis reveals that elevating A-kinase in-
duces major rearrangements in the actin cytoskele-
ton and in the vimentin-containing intermediate
filaments but does not apparently significantly re-
order the third major cytoskeletal network, the
microtubules. In our investigations, we have also
identified a number of changes in the levels of pro-
tein phosphorylation that accompany these altera-
tions in cell shape and the cytoskeleton. The most
prominent changes are associated with the inter-
mediate filament protein, vimentin, which shows
an increase of five- to eightfold with respect to
background levels of phosphorylation, and the nu-
clear lamins, a group of proteins that appear to be
closely associated with the intermediate filaments.
It therefore appears that the major rearrangement
of the intermediate filament is associated with
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FIGURE 6 DNA synthesis in the fos cell lines in response to serum. Cells grown and serum-starved as outlined in Fig. 5 were
refed with DMEM containing 1 4Ci/m1 [3H]thymidine, 10-6 M dexamethasone, and 0% serum (A,E,I), 0.1% serum (B,F,J), 0.25%
serum (C,G,K), or 2.5% serum (D,H,L) and grown for 24 hr. Cells were then fixed and processed for emulsion autoradiography,
changes in the phosphorylation of the intermediate
filament protein subunits.
Our work this year has concentrated on a num-
ber of other changes in protein phosphorylation
caused by the elevation of A-kinase activity, nota-
bly, those associated with the reorganization of the
microfilaments. In this case, we have identified sig-
nificant changes in the phosphorylation levels of
two microfilament-associated proteins, myosin
light chain and myosin light-chain kinase. Previ-
ously, a number of authors have suggested that ac-
tin microfilament assembly in cells may be regu-
lated through the differential phosphorylation of
these two proteins, which would, in turn, modulate
the avidity of actin and myosin (two integral pro-
teins in microfilaments). Indeed, in smooth-muscle
cells, there appears to be a good correlation be-
tween the levels of light-chain phosphorylation,
myosin light-chain kinase activity, and muscle
tension. It has been proposed that this system is
regulated through the action of A-kinase, which in-
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activates myosin light-chain kinase through phos-
phorylation. In our present studies, we have shown,
through the microinjection of A-kinase, that phos-
phorylation of myosin light-chain kinase and the
accompanying reduction in myosin light-chain
phosphorylation correlate with the depolymeriza-
tion of the microfilaments. These data support the
idea that such a mechanism exists for the regulation
of microfilament assembly in living cells.
As an alternative approach, we have directly in-
activated myosin light-chain kinase in living cells by
injecting an affinity-purified antibody directed
against myosin light-chain kinase. In these experi-
ments (Fig. 7), we have shown that the injected
antibodies cause the disassembly of the actin
microfilaments. This effect is specific since control
antibodies do not show the same effect. These
results support the potential mechanism in which
cells regulate microfilament assembly by modulat-
ing the activity of myosin light-chain kinase. At
present, we are investigating the role of this mecha-
FIGURE 7 Effect of microinjecting affinity-purified anti-myosin light-chain kinase on the
distribution of the microfilaments. Rat embryo fibroblasts grown on coverslips were
microinjected with 0.1 mg/ml of affinity-purified rabbit polyclonal antibody directed
against myosin light-chain kinase. Sixty minutes after microinjection, the cells were fixed
and stained for the distribution of the injected antibody with FITC-conjugated goat anti-
rabbit antibody or rhodamine phalloidin, a cyclopeptide specific for F actin. (A) Distribu-
tion of injected antibody; (8) distribution of the microfilaments.
nism in actin microfilament assembly in cells dur-
ing the normal rearrangements seen in the microfil-
ament networks during such events as cell division.
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MAMMALIAN STRESS RESPONSE: A CELLULAR
DEFENSE MECHANISM
W.J. Welch P Arrigo M. Mulcahy
L. Mizzen G. Blose
J.P. Suhan N. Kronenberg
In the last year, considerable progress has been
made in defining the biological changes that occur
in cells experiencing physiological stress. Work
from our own laboratory, as well as from other
laboratories, has demonstrated that the stress pro-
teins fall into two major families, the so-called
glucose-regulated proteins and the heat-shock pro-
teins, and that both families exhibit considerable
interrelated properties. For example, members of
both families appear to be immunologically
related, in addition to sharing certain biochemical
properties, including the binding of ATP. Hence,
what we learn regarding one member of the stress
protein family will likely prove useful in our under-
standing of the properties of the other members of
the stress protein family.
Most of our efforts continue to focus on the biol-
ogy and biochemistry of the individual stress pro-
teins. We have now succeeded in purifying six of the
seven major stress proteins and have prepared ei-
ther monoclonal or polyclonal antibodies against
each. Using these reagents, we have succeeded in
characterizing some of the properties of the in-
dividual stress proteins and have determined their
intracellular locations, both in the normal cell and
in cells experiencing physiological stress (for a sum-
mary of these data, see Table 1). Thus, the major
task remaining is to determine the biochemical
functions of the individual stress proteins and their
putative roles in cellular protection. As discussed
below, we have begun to realize some success in this
difficult endeavor.
This year, I am pleased to welcome two new
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scientists. Patrick Arrigo arrived from the Univer-
sity of Geneva in early spring as a visiting scientist
and has already succeeded in purifying and par-
tially characterizing the small 28,000-dalton mam-
malian stress protein. While in Geneva, Patrick
participated in many of the first biochemical ex-
periments examining the small heat-shock proteins
of Drosophila melanogaster and therefore brings
with him considerable experience in analyzing the
small mammalian stress protein. Lee Mizzen, a
postdoctoral fellow, arrived from the University of
Western Ontario and has already made consider-
able progress in dissecting some of the biological
and biochemical parameters involved in the mecha-
nism by which cells protect themselves during ex-
posure to physiological stress. A third addition to
our staff was Mary Mulcahy. A recent graduate of
the State University of New York at Binghamton,
she arrived during the winter and has proved in-
valuable in helping with our biochemical studies.
Purification and Characterization
of the Small 28,000-dalton
Mammalian Stress Protein
P Arrigo, J.P Suhan, W.J. Welch
We have begun to pay considerable attention to the
properties and structure of the small 28-kD mam-
malian stress protein. This protein has often been
overlooked, since it contains very few methionine
residues and therefore requires metabolic labeling
with [3H]amino acid mixtures for easy visualiza-
tion. Previous work from our laboratory had
shown that the 28-kD protein is heavily phos-
phorylated, with such phosphorylation increasing
in quiescent cells following exposure to various
growth factors, tumor promoters, or agents (e.g.,
ionophores) that interfere with calcium homeosta-
sis (Welch, J. Biol. Chem. 260: 3058 [1985]). This
result, along with previous observations implicat-
ing a role for the small heat-shock proteins in nor-
mal developmental and differentiation processes in
Drosophila and yeast, indicates that the 28-kD pro-
tein may serve an essential role in normal cellular
growth processes and that phosphorylation may
serve in regulating its function.
During the past year, we have carried out a num-
ber of biochemical fractionation studies aimed at
determining the intracellular locale of the 28-kD
protein in cells before, during, and after recovery
from physiological stress. Early after its synthesis,
we find that the majority of the 28-kD protein is
present within the nuclear fraction of the heat-
treated cells. Because the intermediate-filament
cytoskeletal network collapses around the nucleus,
we are not yet certain whether the 28-kD protein is
actually present within the nucleus or whether it
copurifies with nuclei owing to an "entrapment"
within the collapsed filaments. Once we have ob-
tained antibodies specific for the 28-kD protein, we
should be able to pinpoint its precise location in the
cells through indirect immunofluorescence analy-
sis. During recovery from heat-shock treatment, we
find that most of the 28-kD protein relocates within
the soluble cytoplasmic fraction. Accompanying its
redistribution into the soluble portion of the cells
is a corresponding decrease in its phosphorylation.
Hence, we are investigating whether phosphoryla-
tion of the 28-kD protein might be involved in
regulating its intracellular locale.
Despite an increased synthesis after heat shock,
the absolute amount of the 28-kD protein that ac-
cumulates in the cell is not as great as that observed
for most of the other stress proteins. Consequently,
purification of the protein has been difficult, and
only recently have we succeeded in purifying the
protein to apparent homogeneity. A key step in the
purification involves gel filtration, since the protein
appears to have an unusually large native molecular
mass of approximately 500,000 daltons or greater.
Hence, we have developed a rapid three-step purifi-
cation of the protein and can purify approximately
1 mg of the protein from 8-10 liters of suspension
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FIGURE 1 Steps in the purification of the small 28,000-dalton
mammalian heat-shock protein. HeLa cells, growing in suspen-
sion, were heat-shock-treated at 43°C for 90 min and then al-
lowed to recover at 37°C for 8 hr. The cells were collected,
washed, and lysed by dounce homogenization in hypotonic
buffer. The cell lysate was centrifuged at 15,000g, the superna-
tant was applied to a hydroxyapatite column, and the column
was washed with a buffer containing 30 mm K2HPO4. The ma-
terial eluting off the column and containing the majority of 28-kD
protein was concentrated and directly applied to a gel-filtration
column. The peak fractions of the 28-kD protein eluting from the
column were pooled and directly applied to a DEAF- cellulose
ion-exchange column, and the 28-kD protein was eluted using
a linear gradient of NaCI. Shown in the figure are the protein pro-
files of each step of the purification as analyzed by SDS-PAGE.
(a) Heat-shocked cell lysate; (b) 15,000g pellet; (c) 15,000g su-
pernatant; (d) material eluting off the hydroxyapatite column; (e)
peak fraction of the 28-kD protein eluting off the gel filtration
column; (f) purified 28-kD protein eluting off the DEAE-cellulose
column.
HeLa cells in a matter of a few days (see Fig. 1). Pre-
liminary data utilizing a variety of biophysical tech-
niques indicate that the 28-kD protein exists as a
well-defined particle easily visible in the electron
microscope. Efforts to characterize further the
properties and possible function of this very in-
teresting stress protein are currently under way.
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Purification and Characterization
of the Glucose-regulated
Stress Proteins
W.J. Welch
The synthesis of three of the mammalian stress pro-
teins is markedly affected by changes in extracellu-
lar levels of glucose or calcium. For example, when
incubated in culture medium containing little or no
glucose or calcium, cells respond by increasing the
synthesis of proteins (Mr = 80,000 and 100,000)
and correspondingly decreasing the production of
the 90-kD heat-shock protein. Upon refeeding with
glucose or calcium, the cells now respond in the op-
posite manner, decreasing the production of the 80-
kD and 100-kD proteins and increasing the synthe-
sis of the 90-kD protein. Interestingly, this inverse
regulatory relationship also occurs in cells follow-
ing anoxia (oxygen starvation): increased 80-kD
and 100-kD protein synthesis and a corresponding
decreased 90-kD protein synthesis. Following reox-
ygenation of the cells, there is a decreased produc-
tion of the 80-kD and 100-kD proteins and an in-
crease in the 90-kD protein, as well as an increase
in production of some of the other stress proteins.
In addition to their reciprocal regulation in the
cell, in the last year, we and other investigators have
learned that the glucose-regulated proteins (GRPs)
appear to be similar to the heat-shock proteins
(HSPs). Specifically, DNA sequence information,
along with biochemical and immunological studies,
has demonstrated that the 80-kD GRP is highly
related to the 70-kD HSP family and that the 100-
kD GRP is homologous to the 90-kD HSP. All of
the proteins, however, appear to be located at
different sites within the cell. Hence, it is likely that
all of the stress proteins, be they GRPs or HSPs, are
performing similar functions within the cell, albeit
in different intracellular compartments.
This year, we succeeded in purifying to homo-
geneity the two major (80-kD and 100-kD) GRPs.
Purification of the 90-kD HSP was accomplished
a few years earlier (Welch and Feramisco, J. Biol.
Chem. 257: 14949 [1982]). The 80-kD and 100-kD
proteins, located in the endoplasmic reticulum and
Golgi, respectively, are extracted from the particu-
late fraction with nonionic detergents and can be
partially purified by ion-exchange chromatogra-
phy. As a final purification step, we have taken ad-
vantage of two pertinent biochemical properties
that we have determined for the proteins. First, we
130
have shown that the 80-kD protein, like the 70-kl)
HSPs, binds ATP, and we have utilized affinity
chromatography on agarose columns containing
covalently linked ATP as a final purification step
for the protein (Welch and Feramisco, Mol. Celt
Biol. 5: 1229 [1985]; W. Welch, in prep.). In the case
of the 100-kD protein, we have shown it to be a
glycoprotein and have purified the protein to
homogeneity via columns containing a covalently
linked lectin, concanavalin A (Welch et al., J. Biol.
Chem. 258: 7102 [1983]; W. Welch, in prep.). Using
the purified proteins, we plan to compare further
the structural and biochemical properties of the 80-
kD and 100-kD GRPs and determine which do-
mains are homologous to the corresponding 70-kD
and 90-kD HSPs, respectively. In addition, we are
examining how the two GRPs are situated (e.g.,
topography) within the endoplasmic reticulum and
Golgi apparatus.
A Function for the Major Stress
Protein in Stabilizing
Macromolecular Complexes?
L. Mizzen, W.J. Welch
Much of our work has and will continue to focus
on the biology of the 72-k D mammalian stress pro-
tein. This follows from the facts that the 72-kD pro-
tein (1) represents the most highly induced protein
in cells experiencing physiological stress, (2) ap-
pears to be highly conserved among different
organisms, and (3) appears to be integral to the pro-
tection of the cell and the acquisition of thermo-
tolerance (discussed below). Consequently, we be-
lieve that the key to understanding how cells defend
against physiological stress will ultimately lie in our
dissecting the function of the 72-kD protein.
Our previous studies have resulted in the purifi-
cation, characterization, and determination of the
intracellular locale of the 72-kD protein before,
during, and after recovery from physiological
stress. We have found that the 72-k D protein ex-
hibits an avid affinity for ATP and have exploited
this property to develop a rapid two-step purifica-
tion of the protein using affinity chromatography
on agarose columns containing covalently linked
ATP (Welch and Feramisco, Mol. Cell. Biol. 5: 1229
[1985]). Using biochemical fractionation and im-
munological procedures, we have shown that
shortly after induction of the stress response, the
majority of the 72-kD protein accumulates within
the nucleus, most notably within the nucleolus
(Welch and Feramisco, J. Biol. Chem. 259: 4501
[1984]). Using high-resolution immunoelectron mi-
croscopy, we find most of the protein present within
that region of the nucleolus involved in the assem-
bly of ribosomes and other small ribonucleopro-
teins (Welch and Suhan, J. Cell Biol. 103: 2035
[1986]). This locale of the 72-kD protein is quite in-
teresting considering that nucleolar function is im-
paired (i.e., production of rRNA and assembly of
new ribosomes) and that the organization of the
nucleolus is severely perturbed after heat-shock
treatment. We and others have therefore suggested
that the 72-kD protein plays a role in the repair of
such nucleolar abnormalities and thereby facilitates
the recovery of normal nucleolar function during
recovery from heat-shock treatment.
During the later periods of recovery from stress,
most of the 72-kD protein begins to accumulate
within the cytoplasm, with a portion of the protein
associating with unusually phase-dense structures
that appear to consist of large aggregates of dena-
tured protein (Welch and Suhan, J. Cell Biol.
103: 2035 [1986]). In addition, we find some of the
72-kD protein colocalized with ribosomes, reminis-
cent of its codistribution within that region of the
nucleolus involved in ribosomal assembly. As dis-
cussed below, we believe that this association with
the ribosomes is integral to the proper functioning
of the translational machinery in the stressed cell.
Two previous observations have suggested an ap-
proach to examine the function of the 72-kD pro-
tein. First, it has been shown that cells can acquire
resistance to severe heat-shock treatment simply by
prior exposure of the cells to a mild sublethal heat-
shock challenge. This phenomenon, referred to as
acquired thermotolerance, appears to be dependent
on the production of the heat-shock proteins dur-
ing the initial heat exposure. Along with this acqui-
sition of resistance, it has been shown that the cells
can also acquire a resistance to translational inhibi-
tion. Specifically, if mammalian cells are brought
to a rather high temperature (e.g., 45°C for 30 min),
overall translation is severely inhibited and does not
return until the cells have recovered at 37°C for a
number of hours. If, however, the cells are
presented with a mild heat shock (e.g., 43°C for 1
hr), allowed to recover and synthesize the stress pro-
teins, and then presented with the more severe
(45°C for 30 min) heat-shock treatment, transla-
tion patterns are not nearly so inhibited (see Fig. 2).
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FIGURE 2 Protection of translation in the thermotolerant cell.
(Panel A) Rat embryo fibroblasts, growing on 35-mm dishes,
were heat-shock-treated at 45°C for 30 min, returned to 37°C,
and pulse-labeled with [35S]methionine for 1 hr at various times
after heat shock. After labeling, the cells were harvested, and
the labeled proteins were analyzed by SDS-PAGE. Shown is a
fluorogram of the gel. Labeling times after heat shock: (A) 0-1;
(B) 2-3; (C) 4-5; (D) 6-7; (E) 8-9; (F) 12-13; (G) 14-15 hr. (Panel
B) Rat embryo fibroblasts, growing on 35-mm dishes, were heat-
shock-treated to 37°C. Follow-
ing their recovery at 37°C for 12 hr, the cells were again heat-
shock-treated at 45°C for 30 min, returned to 37°C, and pulse-
labeled with [35S]methionine, and the labeled proteins were
analyzed as described above. Labeling times after heat shock:
(A) 0-1; (8) 2-3; (C) 4-5; (D) 6-7; (E) 8-9 hr. Note the increased
translational capacity of the cells made "thermotolerant" by the
prior heat-shock treatment.
Hence, since we have demonstrated a colocalization
of the 72-kD protein with the translational ma-
chinery, we are pursuing the possibility that such an
association may be responsible for the development
of translational thermotolerance.
We think that the 72-kD protein probably has a
similar role in the stabilization of other macro-
molecular complexes in the cell; i.e., similar to its
role in protecting the translational machinery, the
72-kD protein may serve a rather promiscuous role
in protecting other protein containing complexes,
such as those involved in transcription and/or
heterogeneous nuclear RNA (hnRNA) processing.
This is suggested since most of the agents that in-
duce the stress response are potent protein denatur-
ants that probably perturb protein function. Com-
plexes that contain multiple protein components
would therefore be large targets for such protein
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denaturants, and hence there might occur an inhibi-
tion of many cellular activities. Consistent with this
idea are the results of Yost and Lindquist (Cell
45: 185 [1986]), who have shown that rather severe
heat-shock treatment of Drosophila cells results in
diminished hnRNA processing. However, if the
cells are first made thermotolerant, the inhibition
of hnRNA processing is less pronounced. Thus,
like its possible role in protecting the translational
machinery, the 72-kD protein may also allow the
thermotolerant cell to process new mRNA tran-
scription correctly. This proposed general protec-
tive role of the 72-kD protein seems plausible, since
(1) such high levels of the protein are produced after
stress, (2) the protein is observed to distribute
throughout much of the cytoplasm and nucleus,
and (3) many cellular activities can be protected
simply by inducing the synthesis of the 72-kD pro-
tein (as well as that of the other stress proteins)
prior to a severe heat-shock treatment, which, by it-
self, usually results in a diminishment of these
different cellular activities. Hence, using a combi-
nation of in vitro and in vivo techniques, we are
designing experiments aimed at addressing this
possible function of the 72-kD protein in protecting
different cellular machineries after heat-shock
treatment.
A Family of ATP-binding Stress
Proteins
W.J. Welch
A key to understanding their possible function was
the observation that a number of mammalian stress
TABLE 1 Characterization and Localization of the Stress Proteins
Stress
protein
( x10 -3) Modification
Location
37 42
Major
28 phosphorylation n.d. n.d.
72 methylation cytoplasmic nuclear
nucleolar
73 methylation
90 phosphorylation
methylation
cytoplasmic cytoplasmic nuclear
(nucleolar?)
cytoplasmic cytoplasmic
(nuclear?)
110 nucleolar
Minor
80 phosphorylation endoplasmic
ADP-ribosylation reticulum
100 phosphorylation
glycosylation
Golgi
plasma
membrane
nucleolar
cytoplasmic
endoplasmic
reticulum
Golgi
plasma membrane
nuclear
n.d. indicates not determined.
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Remarks
increased phosphorylation to growth factors, tumor
promoters, or calcium perturbations; partial homol-
ogy with lens a crystalline; native molecular mass,
400,000 daltons
most highly induced stress protein; binds nucleotides
(ATP) and perhaps RNA; portion colocalizes with
ribosomes; expression in primates at 37°C and cell-
cycle-regulated; elevated expression in human cells
after transformation
homology with 72 kD; portion present with cycled
microtubules/intermediate filaments; homology with
clathrin-coated vesicle uncoating ATPase
abundant cellular phosphoprotein with multiple isoe-
lectric forms; increased phosphorylation in response
to dsDNA: transient association with tyrosine
kinases; present in steroid hormone receptor com-
plex; synthesis repressed following glucose/calci-
um deprivation
present in nucleolar fibrillar regions; sites of pol Ill tran-
scription
increased synthesis following glucose/calcium depri-
vation; homology with immunoglobulin heavy-chain
binding protein; binds ATP and immunologically
related to 72-kD/73-kD stress proteins
increased synthesis during glucose/calcium depriva-
tion; portion associated with 90-kD stress protein;
shows homology with hsp 90
proteins exhibit avid binding of ATP in vitro
(Welch and Feramisco, MoL Cell. Biol. 5: 1229
[1985]). Specifically, the 72-kD and 73-kD heat-
shock proteins and the 75-kD and 80-kD glucose-
regulated proteins have all been shown to bind ATP,
but they appear to function within different intra-
cellular compartments: The 72-kD and 73-kD pro-
teins are present within the cytoplasm, nucleus, and
nucleolus; the 80-kD protein is present within the
endoplasmic reticulum; and the 75-kD protein is lo-
cated within the mitochondria. Moreover, cDNA
sequence analysis, as well as immunological data,
has now demonstrated that ATP-binding proteins in
this family are structurally related, perhaps via a
conserved domain involved in their ability to bind
nucleotides. Domains in the proteins that are
unique probably account for the different intracel-
lular compartmentalization of the individual pro-
teins.
Many workers in the field are leaning toward the
idea that this family of related stress proteins serve
similar functions within their different locales.
Moreover, this general function appears to involve
an association with other macromolecules, with a
subsequent hydrolysis of ATP. In the case of the
constitutive and abundant 73-kD protein, evidence
has implicated it serving a role in the ATP-de-
pendent dissociation of clathrin coats, which enve-
lope lipid vesicles involved in endo- and exocytosis.
As discussed above, we think that the highly stress-
induced 72-kD protein may serve some ATP-depen-
dent protective and/or reparative role involved in
stabilizing and/or restoring macromolecular com-
plex activity. Finally, H. Pelham's laboratory
(MRC) has provided evidence that the 80-kD
glucose-regulated stress protein is identical to a pre-
viously described protein involved in the ATP-
dependent solubilization of denatured and/or ag-
gregated IgG heavy-chain molecules within the en-
doplasmic reticulum. We are pursuing the possibil-
ity that the related, 75-kD glucose-regulated
protein may serve a role similar to that of the 80-kD
protein, but within its intracellular compartment,
the mitochondrion.
We will continue to examine and compare the
physical and biological properties of this family of
ATP-binding stress proteins. Specifically, with re-
spect to their physical properties, we plan to map
the domains within the proteins involved in ATP
binding and/or determine those domains common
to the proteins that underlie their immunological
relatedness. In addition, using the purified proteins
and their corresponding antibodies, we are examin-
ing possible substrates and associated proteins in-
volved in stress-protein-dependent ATP hydrolysis.
We are confident that what we learn regarding one
member of the family will prove useful in dissecting
the functions of the other members.
Antibody Production
W.J. Welch, L. Mizzen, P Arrigo, N. Kronenberg
As we purify more stress proteins and determine
which molecules they interact with in the cell, we
also continue to produce both polyclonal and
monoclonal antibodies to these various proteins.
Special emphasis this year has been placed on ob-
taining antibodies to the small 28-kD stress protein.
In addition, we have immunized mice with a num-
ber of the other purified stress proteins and hope
to isolate specific hybridomas to each over the next
few years. Finally, in the last year, we completed our
characterization of a number of monoclonal anti-
bodies to the 72-kD and 73-kD stress proteins. We
have used them extensively and have provided them
to over 50 different investigators throughout the
world.
The Stress Response in the
Transformed Cell
L. Mizzen, J. Lamb, J.R. Feramisco, W.J. Welch
In collaboration with J. Mendecki at the Montefi-
ore Hospital in the Bronx, we have begun to exam-
ine the effects of hyperthermic treatment of tumors
within mice. Using a laser to direct microwaves to
the tissue, we have succeeded in raising the tempera-
ture of the tumor to greater than 42°C. Using two-
dimensional gel electrophoresis and immunological
assays, we have demonstrated that such treatment
results in a vigorous production of the stress pro-
teins. More importantly, in our preliminary studies,
we have achieved considerable regression of the tu-
mor, in some cases after only a single 1-hour hyper-
thermic treatment. Obviously, we are continuing
these efforts; we are examining which tumors may
respond better and are looking for agents that,
when coupled with the hyperthermic treatment, re-
sult in a synergistic killing effect. Indeed, we have
now found a class of agents that appear to increase
the killing effects of heat dramatically. Current ef-
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forts are under way to determine the underlying
mechanism that allows for such a synergistic killing
effect.
Coupled with these studies is our intent to step
up studies designed to address why transformed
cells grown in vitro appear to be highly sensitive to
heat-shock treatment as compared with their nor-
mal cell counterparts. Using a variety of normal
and transformed cells, we want to determine
whether there is a difference in either the amount,
locale, modification, and/or regulation of the stress
proteins between the two different cell types. Al-
though little was accomplished in this endeavor
during the past year, we hope to bring on additional
help in the upcoming year to examine more closely
this differential sensitivity of transformed cells to
heat-shock treatment and to exploit this observa-
tion in the in vivo hyperthermic treatment of
tumors in animals.
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MOLECULAR BIOLOGY OF THE CYTOSKELETON
D.M. Helfman S. Cheley E. Kuismanen
S. Erster L.A. Finn
J.C. Lamb
Role of Tropomyosin in Cytoskeleton
Organization and Cell Shape
S. Cheley, J.C. Lamb, J.R. Feramisco, D.M. Helfman
Transformation of cells in tissue culture results in
a variety of cellular changes, including alterations
in cell growth, adhesiveness, motility, morphology,
and organization of the cytoskeleton. Morphologi-
cal changes are perhaps the most readily apparent
feature of transformed cells. These changes are
clearly associated with the cytoskeleton. Recent
studies using comparative two-dimensional protein
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gel analysis of normal and transformed cells have
revealed that of the numerous cytoskeletal proteins,
tropomyosin expression is selectively altered in
transformed cells. These alterations in tropomyosin
expression appear to correlate well with the rear-
rangement of microfilament bundles and the mor-
phological alterations observed in transformed
cells.
We have used an established rat embryonic fibro-
blast cell line (REF52 cells) and its adenovirus-
transformed counterpart (Ad5D.4A) to examine
the role of a major tropomyosin isoform in
cytoskeleton organization and cell shape. Of the
five tropomyosin (TM) isoforms present in cultures
of normal rat fibroblasts (e.g., REF52 cells), only
TM-1 is absent in the adenovirus-transformed
Ad5D.4A cells. These cells are characterized by a
somewhat rounded morphology and by the absence
of microfilament bundles (stress fibers). The ab-
sence of TM-1 protein in the Ad5D.4A cell line has
been suggested to be responsible for the absence of
microfilament bundles and the accompanying
changes in cell morphology. To address this ques-
tion directly, we examined the effects of "forced"
expression of the TM-1 isoform on cell shape and
the cytoskeleton in transformed Ad5D.4A cells. To
introduce TM-1 into living fibroblasts, we microin-
jected in-vitro-synthesized mRNA encoding TM-1.
A full-length cDNA encoding TM-1 was subcloned
into Sp6 plasmids for the generation of TM-1
mRNA. Microinjection of TM-1 mRNA into
Ad5D.4A cells led to cell spreading and concomi-
tant restoration of actin microfilament bundles.
These results were blocked by pretreatment of the
cells with cycloheximide. Cell spreading and forma-
tion of the microfilament bundles were not seen af-
ter microinjection with truncated forms of TM-1
mRNA, nor after microinjection of mRNA encod-
ing two other fibroblast tropomyosin isoforms nor-
mally expressed in transformed cells. Our results
support the hypothesis that selective loss of a major
tropomyosin isoform may be responsible for the
changes in cell shape and microfilament organiza-
tion that accompany transformation.
Analysis of Sequences Involved
in Internal Splice-site
Selection of the TM-1 Gene
D.M. Helfman, L.A. Finn
Recently, we reported that rat fibroblast TM-1 and
skeletal-muscle (3 TM are expressed from a single
gene by alternative RNA splicing and polyadenyl-
ation (Helfman et al., Mol. Cell. Biol. 6: 3582
[1986]). The tropomyosin gene has 11 exons and
spans approximately 10 kb (Fig. 1). Sequences com-
mon to all mRNAs expressed from this gene were
found in exons 1 through 5 (amino acids 1-188) and
exons 8 and 9 (amino acids 214-257). Exons 6 and
11 are specific for fibroblast mRNA (amino acids
189-213 and 258-284, respectively), whereas exons
7 and 10 are specific for skeletal-muscle mRNA
(amino acids 189-213 and 258-284, respectively). In
addition, exons 10 and 11 contain the entire 3'-
untranslated sequence including the polyadenyl-
ation site. Although the gene is also expressed in
smooth muscle (stomach, uterus, and vas deferens),
only the fibroblast-type mRNA can be detected in
these tissues. Furthermore, S1- nuclease and primer-
extension analyses indicated that all mRNAs ex-
pressed from this gene are transcribed from a single
promoter. The molecular basis for the tissue-
specific expression is currently unknown.
To study which sequences 5' and 3' of the tissue-
specific exons contain the necessary information
for alternative RNA splicing, a series of DNA con-
structions (minigenes) was constructed and trans-
fected into cultured cells. The RNA products were
then characterized by S1- nuclease -protection analy-
sis. One simple construct we have used contains se-
quences from exon 5 through exon 9. To express the
cloned regions of the tropomyosin gene, these se-
quences were ligated to a plasmid containing the
SV40 early promoter and poly(A) site. Expression
of this minigene in rat fibroblasts and L6 myoblasts
resulted in an RNA product containing the fibro-
blast-specific exon. Thus, the product contains
exons 5, 6, 8, and 9 (see Fig. 1). We are currently
trying to express this minigene in appropriate cell
types (e.g., fused myoblasts) that represent skeletal
muscle to determine if the skeletal-muscle-specific
sequences (exon 7) will be utilized. In the future, we
hope to develop in vitro systems to study the fac-
tor(s) responsible for tissue-specific splicing.
1-38 39 - 80 81 - 125 126 - 164 165 - 188
- UNTRANSLATED
REGION
189 - 213 214 - 234 235 - 257 258 284 258 284AATAAA AATAAA
FIGURE 1 Schematic diagram of the tropomyosin gene and model
for the generation of rat embryonic fibroblast TM-1 and skeletal-
muscle D-tropomyosin mRNAs by alternative RNA processing.
Open boxes represent common exons, hatched boxes represent fibro-
blast or smooth-muscle exons, closed boxes represent
skeletal-muscle exons, and horizontal lines represent introns; they are not
drawn to scale. The amino acids encoded by each exon are
indicated. The cap site and polyadenylation signal AATAAA are also
indicated.
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In Vivo Analysis of 3'-proximal
Sequences Involved in Splicing
and Polyadenylation
S. Erster, L.A. Finn, D.M. Helfman
We have begun to study the 3'-end processing events
of the TM-1 gene, which require both alternative
exon selection and utilization of the appropriate
poly(A) site (Fig. 1). To localize the cis-acting se-
quence elements required for these processes, a
number of tropomyosin DNA minigene construc-
tions were generated. These minigenes are initially
being transfected into COS cells, and the products
analyzed by S1-nuclease-protection experiments.
We eventually plan to express the minigenes in ap-
propriate cell types (fibroblasts and myotubes) to
determine if the RNAs expressed from these con-
structions are processed in a tissue-specific manner
that reproduces the in vivo events. Deletion analysis
indicates that more than 100 by 3' of the fibroblast
poly(A) site are required for cleavage and polyade-
nylation. Tropomyosin minigene constructions
have also been prepared to localize sequences 5' of
the alternatively spliced exons that are involved in
tissue-specific expression of these exons. A series of
BAL-31 deletions have been constructed in the large
intron (r\-,2.8 kb) separating exon 9 (common exon)
and exon 10 (skeletal-muscle-specific exon). Pre-
liminary results indicate that removal of most of
the internal sequences (2.2 kb) from this large in-
tron does not affect the processing products ob-
served in vivo by transient expression. We hope that
these experiments will determine the minimal in-
tron sequences required for tissue-specific RNA
processing. Ideally, we will be able to study the
sequence requirements for processing in vivo and
reproduce the effects in vitro in order to identify
possible trans-acting factors responsible for the tis-
sue-specific RNA processing.
Identification of Promoter
Sequences of the TM-1 Gene
E. Kuismanen, D.M. Helfman
We have begun to define those sequences within the
5'-flanking regions of the TM-1 gene that are re-
quired for transcription. DNA sequence analysis
revealed that the promoter region is G-C-rich, with
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very few AT sequences. A sequence resembling a
TATA box, TTTTA, is located 19 by upstream of
the cap site. In contrast to most of the characterized
eukaryotic genes, no sequence resembling a
CCAAT box is found upstream of the putative
TATA-like sequence. Further analysis revealed the
occurrence of two putative Spl-binding sites
(CCGCCC or GGGCGG). These sequence motifs
are contained in many other cellular and viral
promoters and are thought to function by interact-
ing with the positively acting transcription factor
Spl. The first occurrence of an Spl-binding site is
38 nucleotides upstream of the cap site, and the sec-
ond sequence is located 148 nucleotides upstream
of the cap site. In addition, this second putative
Spl-binding site is flanked on each side by an 8-bp
direct repeat, CCGAGGGG. The functional sig-
nificance, if any, of this repeat remains to be estab-
lished. In addition, using gel mobility shift and
footprint analyses, we have identified a number of
regions in the promoter that appear to interact with
DNA-binding proteins.
To define functionally the sequences in the pro-
moter needed for transcription, a number of con-
structions have been prepared using the promoter
region of the tropomyosin gene ligated to the chlor-
amphenicol acetyltransferase gene (cat). Prelimi-
nary experiments indicate that expression of cat re-
quires less than 600 by upstream of the site of
transcription initiation. In addition, expression
from the tropomyosin promoter was found to be
rather weak, but it could be increased significantly
(>tenfold) when the SV40 enhancer element was
ligated to the plasmid. These results suggested that
the tropomyosin gene may require an enhancer ele-
ment for expression. In preliminary experiments
using an enhancer-trap construct containing the
tropomyosin promoter and cat gene, we identified
a putative enhancer element in the structural part
of the tropomyosin gene. Work is currently under
way to define precisely which sequences in the
tropomyosin gene apparently behave like an en-
hancer element.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector M.R. Delannoy
The overall aims of our laboratory are (1) to iden-
tify specific nuclear regions with specific functions
and to understand how these functional domains
are organized and how they interact with each other
during the cell cycle, and (2) to elucidate the sub-
nuclear distribution of the myc oncogene protein as
a basis for subsequent biochemical analyses aimed
at determining the functional associations of this
nuclear protein.
Identification of a Nucleoplasmic
Reticulum: The Putative Heterogeneous
Nuclear RNA Processing Machinery
D.L. Spector
In previous studies (Spector et al., Biol. Cell 49: 1
[1983]; Spector, Biol. Cell 51: 109 [1984]; Smith et al.,
Cell Biol. 101: 560 [1985]), we have examined the
organization of the nucleoplasm using monoclonal
and polyclonal antibodies that recognize seven dis-
tinct nuclear proteins. Of particular interest was the
colocalization of (1) a monoclonal anti-Sm anti-
body that recognizes a 28-kD protein associated
with Ul, U2, U4/U6, and U5 small nuclear ribonu-
cleoprotein particles (snRNPs); (2) autoantibodies
against Ul or U2 snRNPs; and (3) CRLM, a poly-
clonal antibody raised against a rat liver nuclear
matrix preparation that recognizes two major
EDTA- and RNase-sensitive nuclear-matrix-asso-
ciated proteins of 107 kD and 103 kD, respectively.
All of the proteins recognized by these antibodies
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colocalized within a discrete nuclear domain that
we have named the nucleoplasmic reticulum on the
basis of its network-like organization and location
within the cell nucleus (Figs. la and 2). The
nucleoplasmic reticulum contains at least two mac-
rocomponents, nuclear protein clusters (NPCs) and
linkers, which are the connections between the
NPCs (Fig. la). We have observed such a network
to be a common component of all eukaryotic cell
and tissue types thus far examined. This snRNP-
enriched nuclear region does not colocalize with
the bulk of nuclear DNA (Fig. 3) or RNA polymer-
ase II and is resistant to DNase and high-salt (2 M
NaC1) extraction. These data suggest that the
nucleoplasmic reticulum may not be directly as-
sociated with the transcriptional regions of the
nucleoplasm. Alternatively, the concentration of
snRNPs within the nucleoplasmic reticulum raises
the possibility that this nuclear region is involved in
heterogeneous nuclear RNA (hnRNA) processing.
Along this line, we have shown that the inhibition
of hnRNA synthesis by the drug 5,6-dichloro-1-13-
D-ribofuranosylbenzimidazole (DRB) causes a
marked alteration in the organization of the
nucleoplasmic reticulum. After drug treatment, the
NPCs appear more rounded and uniform in shape
(compare a and b in Fig. 1) and their fluorescence
intensity is increased, whereas the linkers are less
evident (Fig. lb). Therefore, the linkers may repre-
sent elements being transported from NPC to NPC
or from NPC to the nuclear envelope, where they
may be extruded into the cytoplasm as mature
mRNP particles. These data raise the possibility
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FIGURE 1 (a) Immunofluorescence of the nucleoplasmic reticulum in a PtK2 cell nucleus immunostained with the anti-Sm antibody.
The heterogeneously shaped NPCs (arrows) are connected via linkers (arrowheads) to form a reticulum. Numerous NCPs and linkers
may be observed depending on the plane of focus. (b) When hnRNA synthesis was inhibited by the drug DRB (25 jig/ml, 1 hr),
the NCPs assumed a more uniform, rounded shape (arrows) and increased in fluorescence intensity, whereas the linkers were less
evident. Magnification, 2820 x .
that the nucleoplasmic reticulum is a dynamic
structure involved directly in hnRNA processing
and/or in the transport of processing intermediates
and spliced messages within the nucleoplasm.
Our current studies are intended to characterize
this nuclear region biochemically and ultrastruc-
turally. We are specifically interested in isolating
the nucleoplasmic reticulum and in determining its
protein and nucleic acid constituents. Using nucleic
acid probes, we will evaluate the in situ spatial orga-
FIGURE 2 Immunoelectron microscopic localization of the nucleoplasmic reticulum
stained with the anti-Sm antibody and peroxidase-conjugated second antibody. Both
NPCs (arrows) and linkers (arrowheads) may be observed in this thin section (100 nm).
The cytoplasm (C) and nucleolus (No) did not exhibit immunoreactivity (no poststaining).
Magnification, 4047x.
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AFIGURE 3 Double-label immunofluorescent images with the anti-Sm (8) and anti-DNA (C) antibodies showing that the
regions of the nucleoplasm that contain the nucleoplasmic reticulum are exclusive of the nuclear regions that contain the
bulk of DNA. Compare arrowheads in B and C. Magnification, 1000x.
nization of specific genes and determine whether
the pre-mRNAs for certain genes or gene families
are processed in specific macromolecular com-
plexes (NPCs).
Co localization of the myc Oncogene
Protein and snRNP Particles
D.L. Spector, M.R. Delannoy, N.F. Sullivan [in collaboration
with R.A. Watt, Molecular Oncology Group, Smith,
Kline and French Laboratories]
In an attempt to examine the nuclear associations
of the myc oncogene protein, we examined its sub-
nuclear distribution in situ by immunofluorescence
microscopy in quail cells (Q8) nonproductively
transformed with the avian myelocytomatosis virus
MC29. The MC29 virus encodes an 875-amino-
acid c-myc-related protein of approximately 110 kD
(P110gag-myc or v-myc). The amino-terminal portion
of the protein (454 amino acids) is derived from the
retroviral gag gene, whereas the carboxy-terminal
portion of the protein is not of retroviral origin and
specifies 5 amino acids from the 5'-untranslated re-
gion and 416 amino acids from the coding sequence
of the avian c-myc gene (Reddy et al., Proc. Natl.
Acad. Sci. 80: 2500 [1984]). Antibodies used in this
study have been raised against the recombinant c-
myc protein synthesized in and purified from Esch-
erichia coli (Watt et al., Mol. Cell. Biol. 5: 448
[1985]).
The nuclear distribution of v-myc appeared as a
speckled pattern that occupied a portion of the
nucleoplasm (Fig. 4c). This protein-distribution
pattern was identical regardless of the fixative used
(methanol, acetone, glutaraldehyde, or parafor-
maldehyde). Since the distribution of v-myc resem-
bled that which has been reported for snRNPs
(Spector et al., Biol. Cell 49: 1 [1983]), Q8 cells were
further examined by triple-label fluorescence using
(1) a monoclonal anti-Sm antibody that recognizes
the 28-kD protein associated with Ul, U2, U4/U6,
and U5 snRNPs (Lerner et al., Proc. Natl. Acad.
Sci. 78: 2737 [1981]), (2) a polyclonal antibody that
recognizes the v-myc protein (p110) in quail cells
(Watt et al., Mol. Cell. Biol. 5: 448 [1985]), and (3)
Hoechst stain, a fluorochrome that binds noninter-
calatively to double-stranded DNA. Both antigens
(Sm and v-myc) colocalized within the nucleus in ir-
regularly shaped clusters (Fig. 4c-d), which formed
a network, as determined by serial sections,
throughout the nucleoplasm (Fig. 5c-g). The
nucleoli and cytoplasm were devoid of im-
munoreactivity (Fig. 4c-d). The nuclear regions im-
munostained by both of these antibodies were ex-
clusive of those regions that exhibited reactivity
with Hoechst stain (Fig. 4b). Hoechst staining
localized concentrations of DNA in the perinucleo-
lar region as well as in several patches throughout
the nucleoplasm (Fig. 4b). To determine if the
colocalization of the v-myc protein and snRNPs
was due to interactions between the gag or myc por-
tions of v-myc, immunofluorescence was per-
formed on neuroendocrine cells of a human colon
adenocarcinoma (COLO 320). In COLO 320 cells,
the c-myc gene is amplified and expressed at
elevated levels, and the c-myc protein produced is
not associated with a retroviral gag protein (Alitalo
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FIGURE 4 (See facing page for legend.)
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FIGURE 5 (a) Immunoelectron microscopic sublocalization of v-myc in quail (Q8) cells. The immunostained regions
(arrowheads) identified a branched network traversing the nucleoplasm. The network appeared to come into contact
with the nucleolar surface (arrow) but was rarely observed to contact the nuclear lamina and/or envelope. Neither the
nucleoli (No) nor cytoplasm (C) was immunostained (no poststaining). (b) Cells immunolabeled with rabbit preimmune
sera in place of the primary anti-c-myc antibody did not exhibit immunostaining (no poststaining). (c-g) Adjacent serial
sections (200 nm) showing continuity of the nuclear regions immunostained with the anti-c-myc antibody by light micros-
copy (follow arrowheads through series of pictures). Magnifications: (a) 13,800x; (b) 10,000x; (c-g) 1500x.
FIGURE 4 Phase-contrast (a) and triple-label fluorescence (b-d) of quail (08) cells immunolabeled with anti-Sm (d), anti-c-myc
(c) antibodies, and Hoechst stain for DNA (b). Both snRNPs and v-myc colocalized in a speckled staining pattern within the
nucleoplasm (arrowheads in c,d). The bulk of nuclear DNA as visualized by Hoechst stain (b) was exclusive of the Sm and v-myc
immunostained regions (compare arrowheads in b, c, and d). The nucleoli (No) and cytoplasm (C) did not stain with the anti-Sm
and anti-c-myc antibodies (c,d). Magnification, 1520x.
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FIGURE 6 Phase-contrast (a) and double-label immunofluorescence (b,c) of COLO 320 cells immunolabeled with anti-Sm
(b) and anti-c-myc (c) antibodies showing the colocalization of c-myc and snRNPs (compare arrowheads in b and c). Magnifica-
tion, 1500x.
et al., Proc. Natl. Acad. Sci. 80: 1707 [1983]). Simi-
lar to the results obtained for v-myc, a colocaliza-
tion of c-myc and snRNPs was observed in COLO
320 cells (Fig. 6), strongly suggesting that the
colocalization of myc and snRNPs is not mediated
by the retroviral gag protein.
Data from several laboratories over the last few
years has contributed to the elucidation and mor-
phological characterization of a nuclear region
with concentrations of snRNP particles as well as
several other nonhistone nuclear proteins (Sharp et
al., Am. J. Med. 52: 148 [1972]; Deng et al., J. Cell
Biol. 91: 654 [1981]; Spector et al., Biol. Cell 49: 1
[1983]; Smith et al., J. Cell Biol. 101: 560 [1985]; Ny-
man et al., J. Cell Biol. 102: 137 [1986]). The fact
that these proteins preferentially associate with spe-
cific nuclear regions rather than being diffusely dis-
tributed suggests that a particular function or set
of functions of which these proteins are a part, may
be localized to this region of the nucleoplasm. On
the basis of previous studies showing (1) a concen-
tration of snRNPs to be present within this region
(Spector et al., Biol. Cell 49: 1 [1983]), (2) the bulk
of nuclear DNA to be absent from this region
(Smith et al., J. Cell Biol. 101: 560 [1985]), (3) the
inability of DNase I and high-salt extraction (2 M
NaC1) to alter the protein distribution patterns
(Spector et al., Biol. Cell 49: 1 [1983]), and (4) the
sensitivity of the distribution pattern of proteins in
this region to drugs that inhibit hnRNA synthesis,
it is most likely that the functions associated with
this nuclear region include one or more aspects of
hnRNA processing such as splicing and/or polyad-
enylation, of which both have been shown to re-
quire snRNPs. The colocalization between the myc
protein and snRNPs raises the possibility that the
myc protein may have a direct or indirect involve-
ment in hnRNA processing. Alternatively, both the
myc protein and the hnRNA-processing machinery
may be anchored to a common nuclear region and
serve different functions. For example, the myc pro-
tein has been shown to bind DNA in a nonspecific
manner (Donner et al., Nature 296: 262 [1982]),
and recently, it has been implicated in the elonga-
tion of nascent chains during DNA replication
(Studzinski et al., Science 234: 467 [1986]). Thus,
several intriguing possibilities currently exist for the
functional role of the myc protein. Experiments are
in progress to distinguish between these possibili-
ties.
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QUEST LABORATORY/TWO-DIMENSIONAL GEL
BIOTECHNOLOGY RESOURCE
J.I. Garrels C. Chang M. Hannaford S. Scheib
B.R. Franza H. Sacco P Myers G. Mak
M.E. Lambert J. Kos G. Blose R. Cardinale
J. Ross
The building of databases derived from analysis of
two-dimensional gels is an ongoing activity in our
laboratory. This activity has now progressed from
a prototype effort, coupled with intensive software
development, to a routine operation based on a ma-
ture software system. Our facility now supports the
development of several databases and allows other
investigators at Cold Spring Harbor Laboratory
and from other institutions to interact easily with
them. We maintain an annotated spot map for each
of our databases, and we support efforts to identify
more of the protein spots for each of our databases.
Most importantly, the databases are proving useful
in research.
As our databases have developed, our ways of
thinking about them have developed as well. They
obviously contain much information about the
regulation of protein synthesis, turnover, and
modification in defined experimental systems that
is not otherwise accessible, but the information
cannot all be digested at once. Much will not be
relevant until more proteins are identified and until
more critical experiments are done. Conventional
two-dimensional gel analysis, without a database,
gives a broad but uninterpretable view of the cell.
A database has both breadth (many spots) and
depth (many experiments). It is the depth features
that make the database useful. In any particular
study, an investigator may decide there is no need
to report or discuss the many changes seen on two-
dimensional gels; this information is stored away
safely in the computer for future use. The database
will later be used (1) to find out what is already
known about particular proteins of interest, (2) to
judge whether the known proteins are among the
most significant changes in the investigator's sys-
tem, and (3) to select a manageable number of un-
known proteins for future study. Once proteins for
study have been selected, the database may guide
the investigators in efforts to purify the protein, to
obtain antibodies, or to obtain the gene.
In this report, we describe the databases that are
being built and how they have been used. We focus
on a few of the known proteins, including prolifer-
ating cell nuclear antigen (PCNA) and a coregu-
lated protein of 85 kD, which are objects of study
in each mammalian database. These and other
markers, such as the heat-shock proteins and the
major cytoskeletal proteins, are readily identified in
all mammalian species and serve to unify our un-
derstanding. In fact, the proteins that are shared by
many cell types and that have highly characteristic
modes of regulation may be among the most im-
portant to understand, because these can most
readily indicate altered physiological states. As
we complete the studies of virally transformed
cells, and begin detailed analysis of oncogene-
transformed cells, we expect to understand more
clearly some of the altered states and to focus on
the pathways that are targets of the transforming
genes.
Core Databases
J.I. Garrels, B.R. Franza
THE RAT DATABASE
The database for REF52 cells and related rat cell
lines is being developed as a tool to detect and un-
derstand cellular changes of protein synthesis,
degradation, and modification associated with
transformation, and the regulation of prolifera-
tion. This database now contains data for 155
samples, most of which contain more than 2000
quantitated and accurately matched proteins. Ap-
proximately 80 of the proteins now have names that
are referenced in the published literature, and sev-
eral hundred more have been identified as nuclear,
cytoskeletal, or mitochondrial.
Our current studies are focusing on a set of
transformation-induced proteins, including PCNA,
a PCNA-related satellite spot, and a coregulated
protein of 85 kD ("85K"), and a set of growth-
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sensitive proteins, including the tropomyosin iso-
forms, vimentin, vinculin, and caldesmon. Figure 1
reveals what the present database has to say about
these proteins. It contains data from experiments to
compare normal REF52 cells with a variety of
virally transformed derivatives, experiments to
study the effects of growth to saturating density in
each line, and experiments to study the response of
several lines to serum stimulation of quiescent cells.
The graphs show that PCNA and "85K" are in-
duced by the same transformed lines, that both are
proliferation- and serum-sensitive in normal REF52
cells, and that both are largely unregulated in trans-
formed cells. Since PCNA is known to be an acces-
sory protein for DNA replication (see DNA Synthe-
sis Section), we now plan to study the 85-k D
protein, in collaboration with B. Stillman, to deter-
mine whether it too has a role in DNA replication.
Conversely, the tropomyosin forms 1 and 2 are
elevated in confluent cells but are repressed by
transformation or serum stimulation (in normal
cells). Another cytoskeletal protein, caldesmon, has
been identified on our gels using antibodies ob-
tained from Fumio and Shigeko Matsumura. Cal-
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FIGURE 1 Database analysis of selected
known proteins. Each graph shows the quan-
titative analysis of one protein in one experi-
ment. Each row of graphs presents data for
one protein as named at the left; each column
presents data for a different experiment as de-
scribed below. A vertical bar is plotted for
each sample analyzed by a two-dimensional
gel; the height of the bar shows the amount of
radioactive methionine incorporated into the
protein during the labeling interval, relative to
the incorporation into all proteins. The full-
scale height (indicated at the left as parts per
million) is the same for all graphs in a row. The
experiment in column 1 is a comparison of
normal REF52 cells (first bar in each graph) to
nine transformed derivatives. Bars 2-7 are
SV40-transformants (WT2, AG2, NU2, WT6,
AG6, and NU6), bar 8 is a Ki-MSV transfor-
mant, and bars 9 and 10 are adenovirus trans-
formants (A5D and A5W). WT2 and WT6 are
minimal SV40 transformants, AG2 and AG6
are anchorage-independent lines, and NU2
and NU6 are fully tumorigenic lines. The ex-
periments in columns 2-7 show the rates of
protein synthesis during growth to confluence
followed by refeeding in REF52 cells (2), WT2
cells (3), AG2 cells (4), NU2 cells (5), A5D cells
(6), and A5W cells (7). Bars 1, 2, and 3, in each
graph show cells at days 2, 3, and 4 during
proliferative growth, bar 4 shows cells at con-
fluence on day 6, and bar 5 shows day 6 cells,
15 hours after being refed with fresh medium
and serum. Column 8 shows the specific ef-
fect of fresh serum on serum-deprived cells.
The first 3 bars are normal REF52 cells la-
beled (1) without refeed, (2) 1-4 hr after stimu-
lation, and (3) 21-24 hr after stimulation. The
second 3 bars show the same treatment for
WT6 cells, and the last 3 bars show the same
treatment for A5D cells.
desmon has a pattern of regulation very much like
that of tropomyosin 1, except that it is not com-
pletely repressed in adenovirus-transformed cells.
One method to determine the significance of
these changes relative to all changes occurring in
the cell is to use a correlation plot (Fig. 2). All pro-
teins are plotted as points on a logarithmic scale.
On the x-axis, one pair of samples (normal vs.
SV40-transformed cells) are compared, and on the
y-axis, another pair of samples (normal vs. adeno-
virus-transformed cells) are compared. A correla-
tion between the responses to SV40 and adenovirus
is apparent, and the positions of the spots of in-
terest (marked by special symbols) within the distri-
bution of all changes can be readily noted. PCNA
and "85K" are among the most significantly in-
duced proteins, and the tropomyosin isoforms rep-
resent some of the largest decreases of protein syn-
thesis due to transformation.
Other proteins induced by both viruses might be
of great interest; in particular, there may be pro-
teins that share overall patterns of regulation with
PCNA and "85K." To learn more about these other
induced proteins, we ask the computer to show us
all the proteins within a box we have drawn on the
screen (box in upper right of Fig. 2). The computer
then shows us where each of these proteins is on the
two-dimensional gel image and allows us to display
their database graphs (Fig. 3). We see that there is
at least one other protein that is regulated in the
same manner as PCNA and "85K." Of course, the
correlation plots are useful for analyzing many
other combinations of samples and for selecting
proteins with other regulatory patterns. With these
software tools, interesting proteins from any group
of gels can be selected, and quantitative informa-
tion from the database can be displayed within a
few minutes.
FIGURE 2 Correlation analysis of the effects of SV40 and adenovirus-induced transformation. Each protein detected
in REF52,
WT6, and A5D was plotted as a point showing its relative rate of synthesis in WT6 (x-axis) and A5D (y-axis) relative to REF52. Each
axis is a logarithmic scale divided by factors of 2. The correlation of the proteins
increased and decreased by each type of transforma-
tion is clear. Points marked by special symbols are PCNA (+), 85K (x), tropomyosin 1 (*), and tropomyosin 2 (0).
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FIGURE 3 Proteins of interest selected from correlation analysis. Proteins that increase in
both SV40-transformed cells and adenovirus-transformed cells were selected using the box
shown in Fig. 2. The proteins from this box are highlighted on the two-dimensional gel image,
and database graphs for experiments 1, 2, and 8 are displayed for some of these. Note that
several have overall patterns of regulation similar to those of PCNA and 85K.
Many other comparisons have been made using
the current database, including comparisons of (1)
reproducibility of transformation by SV40 in sev-
eral different cell line isolates, (2) cell lines indepen-
dently selected for anchorage-independence or
tumorigenicity, (3) cells transformed by DNA tu-
mor viruses and an RNA tumor virus, and (4) den-
sity and serum-stimulation responses of normal
versus transformed cells. Other controls (not shown
here) include reproducibility of a given sample ana-
lyzed on multiple gels and the reproducibility of
labeling in clones of REF52 cells. This work (J.I.
Garrels and B.R. Franza, submitted) shows the exis-
tence of a rigorous and self-consistent database
containing more than 200,000 separate spot quanti-
tations; it shows new data of interest for proteins
that have already been identified and has also iden-
tified some new proteins of interest for each type of
comparison. Future additions to the REF52 data-
base will focus on cells transformed by oncogenes.
THE HUMAN LYMPHOBLAST DATABASE
We have not directly pursued the assembly of a
database for any human cell type. However, as a
consequence of some specific experiments on hu-
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man B and T lymphoblasts that utilized two-
dimensional gel analysis, we have derived some in-
triguing results, and we see as a logical outcome of
these studies the initiation of the development of a
human lymphoblast database.
The analysis of cell lines established in tissue cul-
ture by B. Clarkson and co-workers at the Memor-
ial Sloan-Kettering Cancer Center represents a
study of B lymphoblasts derived from patients di-
agnosed as having chronic myelogenous leukemia
(CML). These lymphoblasts are unique in that they
represent either normal diploid cells or cells carry-
ing the 9;22 translocation marker of CML isolated
from the same individual at different stages of the
disease process. Such "matched pairs" are being uti-
lized in an attempt to define a set of cellular pro-
teins that are uniquely altered in the cells bearing
the chromosomal rearrangement. In addition to
comparisons made between cells grown under nor-
mal tissue-culture conditions, the matched pairs are
being subjected to the stress of elevated tempera-
ture to determine if inducible responses in the nor-
mal cells are altered in the translocation-positive
cells. At this time, it appears that a small number
of cellular proteins are reproducibly altered in the
translocation-positive cells, and indeed the re-
sponse to stress highlights these differences. Fur-
ther sets of matched pairs are being analyzed to
confirm these initial observations.
An integral part of the development of a human
lymphoblast database would be the identification
of the products of the histocompatibility genes. As
a result of a collaboration with R. De Mars (Univer-
sity of Wisconsin-Madison Medical School), we
have been able to identify products of the HLA
class I and class II genes. The project was initiated
to study the ability of the two-dimensional gel sys-
tem to detect quantitative alterations in proteins en-
coded by the HLA genes in cell lines previously
documented to have mutations in such genes.
De Mars has developed a unique family of B-
lymphoblast cell lines, all derived from one paren-
tal diploid lymphoblast line. These cells have dele-
tions in the region of chromosome 6 that encodes
HLA class I and class II proteins. A combination
of two-dimensional gel analysis of whole-cell ly-
sates and immunoprecipitations utilizing antibod-
ies that recognize the class I and class II gene prod-
ucts has been utilized, resulting in the identification
of such proteins and their entry into the database
for further analysis. An interesting future aspect of
this study involves the ability of the database al-
gorithms to detect proteins, other than the class I
and class II gene products, that have been altered
as a result of the chemically induced mutagenesis
of their respective genes. Such analysis may point
out proteins that always change whenever a class I
or class II gene product is altered and therefore may
suggest some linkage with the HLA loci.
In collaboration with S. Josephs, F. Wong-Staal,
M. Popovic, and R.C. Gallo (NIH/NCI Laboratory
of Tumor Cell Biology) and D. Zagury and col-
leagues (Pierre-Marie Curie University, Paris), we
have begun the analysis of the effects of the expres-
sion of a strain of human T-lymphotropic virus
type III (HTLV-III) on normal human T lympho-
blasts and on the human T-lymphoblast cell line
H9. Initial results of these studies demonstrate that
the synthesis of one of the viral protein products,
referred to as p24, is altered, depending on the
proliferation status of the cell. Normal, freshly iso-
lated T lymphoblasts show minimum production
of p24 when infected by virus, during a time course
when the same cells infected by HTLV-III and
simultaneously stimulated by the lectin, phyto-
hemagglutinin (PHA), show substantial produc-
tion of this viral protein. Interestingly, in the same
experiment, exposure of the same cells to the mito-
gen interleukin-2 (IL-2), concomitant with infec-
tion with the virus, did not result in detectable p24
production. When the immortalized cell line H9 is
infected with the same virus, production of p24 oc-
curs readily within the first 24 hours, suggesting
that cellular processes mediated by exposure of
normal T lymphoblasts to PHA are constitutive in
H9 cells. By using the database system to follow the
response of these different cell types to the condi-
tions mentioned above, we have also been able to
extract information on the behavior of the cellular
proteins PCNA and "85K" mentioned earlier in the
rat database studies. We have found that normal
human T lymphoblasts stimulated with either PHA
or IL-2 show a coordinate induction in the synthe-
sis of PCNA and "85K." In addition, the infection
of such cells with HTLV-III results in induction of
synthesis of these two proteins. Extensive time-
course and cell-cycle studies on whole populations
of T lymphoblasts, as well as on subpopulations of
T lymphoblasts, after exposure to lectins, mito-
gens, and/or virus are planned to elucidate the na-
ture of such responses.
Other studies on the response of cells to HTLV-
III have suggested to us that certain extracellular
stimuli and intracellular events (e.g., as mediated by
the expression of a gene, such as the adenovirus
type-5 early region lA gene) would modulate the
expression of genes controlled through the viral
long terminal repeat (LTR) sequences in an appar-
ently positive or negative manner, depending on the
specific experimental conditions. Given our interest
in actually determining the proteins involved in
such regulatory processes, we are developing an as-
say system to detect cellular and/or viral gene prod-
ucts that interact either directly with putative
regulatory nucleic acid sequences or indirectly with
proteins already associated with such sequences.
This assay system is designed to utilize the two-
dimensional gel separation of proteins, and its use
is meant to add to the depth of the database. In ad-
dition, it will provide a sensitive, quantitative
means of monitoring such complex interactions
both in whole-cell systems and in subcellular frac-
tions shown to maintain the ability to mimic whole-
cell activities such as transcription.
We are now beginning to compare these various
experiments within the database structure and look
forward to the ability, for example, to point to the
quantitative alteration in a class I gene product in
a normal T lymphoblast stimulated by PHA and
simultaneously infected with HTLV-III. Such intra-
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database investigations point to the real future of
cellular protein analysis utilizing the database sys-
tem described herein.
THE MOUSE DATABASE
We are constructing a mouse embryo database by
analyzing carefully staged early embryos provided
by D. Solter's laboratory (Wistar Institute). Condi-
tions for labeling of early embryos have been estab-
lished and several series of gels have been run. Dr.
Solter and colleagues will perform a full analysis
and interpretation of the data during visits to our
laboratory in 1987. These early stages of develop-
ment will complement our earlier studies with L.
Silver and M. Krangel on postimplantation stages
of development.
We have collaborated with D. Hanahan (see Mo-
lecular Biology of Mouse Development) to build a
database for his studies of transgenic mice. In the
samples of pancreatic islet cells expressing the SV40
T antigen, we have identified the proliferation-
sensitive markers PCNA and "85K." These and
other proteins mark the progression of preneoplas-
tic cells to a fully neoplastic phenotype, indicating
that the mouse system will have parallels with the
other transformation system under study.
THE YEAST DATABASE
The yeast database has been initiated with J.
Warner (Albert Einstein College of Medicine) as
project coordinator and with major input from
the laboratories of C. McLaughlin (University of
California, Irvine) and M. Wig ler (Cold Spring
Harbor Laboratory). McLaughlin has carried out
an analysis of strain diversity, finding that common
laboratory strains are easily compared, although
some more distant strains are highly divergent. He
has also placed on our maps the names of 20 en-
zymes, based on earlier work from his laboratory
and that of H. Boucherie (University of Bordeaux).
The plan for the yeast database is to add more
physiological experiments and to identify many
more proteins. Future experiments will include the
dependency of the pattern on carbon source; the
rates of labeling and turnover; comparison of a, a,
and diploid strains; and analysis of the tempera-
ture-sensitive RNA splicing mutants, RNA2. More
proteins will be identified by soliciting antibodies
from the yeast community and, if possible, by plas-
mid overexpression.
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A Protein Database for the Study of
Inducible Responses to DNA Damage
M.E. Lambert, J.I. Garrels
The REF52 database now also contains experi-
ments designed to study cellular responses elicited
in cells after exposure to different classes of DNA-
damaging agents, including chemical carcinogens
and irradiation. The objective of these studies is to
identify specific markers for inducible responses to
different classes of DNA damage and to study the
involvement of these proteins in DNA repair
processes, regulation of growth arrest, and cellular
transformation. These studies have now revealed
that PCNA is a DNA-damage-inducible protein
and is expressed at an elevated level after exposure
of the DNA to a variety of different agents, includ-
ing the metabolically activated form of benzo[a]py-
rene, BPDE, and the alkylating agent MNNG. This
induction can be elicited rapidly after exposure of
either exponential or quiescent confluent cultures
of REF52 and is correlated with long patch DNA-
repair synthesis. Studies with biochemical inhibi-
tors of DNA replication and repair further suggest
that the triggering of this induction is itself par-
tially dependent on hydroxyurea- and aphidicolin-
sensitive metabolic pathways. Experiments are in
progress (in collaboration with M. Mathews and B.
Stillman), using permeabilized cell systems and
subcellular DNA-repair assays, to characterize the
potential involvement of PCNA in unscheduled
DNA synthesis and to investigate the regulation
of this induction at both the transcriptional and
translational levels. In addition to PCNA, we have
also identified a unique family of DNA-damage-
inducible proteins that are rapidly induced by either
the protein synthesis inhibitor cycloheximide or by
the DNA polymerase inhibitor aphidicolin. Prelim-
inary studies indicate that a related family of pro-
teins is also induced in human fibroblasts by similar
agents and that these proteins are related to major
histocompatibility class I genes.
Changes in Gene Expression during
Proliferation and Immortalization
of Nonestablished Rat Kidney
Epithelial Cells
M.E. Lambert, J.I. Garrels [in collaboration with N. Sullivan,
M. Quinlan, and T. Grodzicker, Cold Spring Harbor
Laboratory]
We have used the QUEST (quantitative electropho-
resis technologies) system to study changes in gene
expression during proliferation and immortaliza-
tion of nonestablished rat kidney epithelial (RKE)
cells, derived from the same inbred strain of rat
(F344) as is REF52. Addition of conditioned media
from cultures of RKE cells infected with adeno-
virus-5 12S to fresh cultures of noninfected RKE
cells has previously been shown to result in continu-
ous cellular DNA synthesis and proliferation (see
Adenovirus Genetics Section). In metabolic label-
ing studies of proteins synthesized after addition of
this factor, we have now observed pleiotropic ef-
fects on cellular gene expression starting within
the first 24 hours. These include an increase in the
expression of PCNA (cyclin), as well as a coregu-
lated 85K protein, and a decrease in expression of
tropomyosin I and II. In addition, further specific
polypeptide subsets have been identified that are
either specifically increased or decreased in their
level of expression. We have also studied changes in
cellular protein expression associated with the im-
mortalization of RKE cells. Fresh cultures of RKE
cells were treated with single low doses of the chem-
ical carcinogen MNNG (0.1 pg/ml) and then
selected in the presence of the proliferation factor
for periods of up to 2 weeks. Further selection, for
preneoplastic enhanced growth variants (EGVs),
was imposed by growth in 5% serum for an addi-
tional 2 weeks. Both spontaneous and MNNG-
induced EGVs have been analyzed, and all were
found to have decreased expression of several ma-
jor cytokeratin epitopes as well as decreased expres-
sion of tropomyosin I and II. Using the QUEST
system, we have distinguished between changes in
gene expression that are associated, in this system,
with either induced proliferation per se or commit-
ment to continuous proliferation (cellular immor-
talization).
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NEUROSCIENCE
The Neuroscience Program at Cold Spring Harbor Laboratory focuses on the
functional development of neurons. We are particularly interested in understanding
the differentiation of neurons in the brain, including the seat of higher cognitive
functions, the cerebral cortex. We face many mysteries in studying neuronal devel-
opment: What causes neurons to stop cell division after migrating to specific loca-
tions in the brain? What stimulates neurons to grow the long axonal and dendritic
fibers that connect nerve cells together? What induces electrical excitability and
neurotransmitter production in neurons? These are a few of the broad questions
we address in our research. To answer such questions, we employ a multidisciplin-
ary approach using modern methods of cell biology, molecular genetics, biochem-
istry, and physiology. The environment at Cold Spring Harbor Laboratory provides
a unique setting for such research as we draw on all the scientific resources to
support our efforts.
NEURONAL GROWTH AND DIFFERENTIATION
D.R. Marshak J.C. Figueiredo
L.O. Goodwin
R. Tonner
Last year, we described the purification and charac-
terization of a new neuronal growth factor, neurite
extension factor (NEF) (Kligman and Marshak,
Proc. Natl. Acad. Sci. 82: 7136 [1985]). This factor
is a protein that causes embryonic neurons from
chick cerebral cortex to elaborate processes in
serum-free, defined media. NEF appears to have
some specificity for the central nervous system over
the peripheral nervous system. If we can uncover
the mechanism of action of neuronal growth and
differentiation factors such as NEF, we might dis-
cover new ways to approach degenerative neurolog-
ical diseases, such as Alzheimer's disease. Our ulti-
mate goal is to use neuronal growth factors or their
genes for therapeutic intervention in such degenera-
tive diseases.
In Press, Submitted, and In Preparation
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51st COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
Molecular Biology of Homo sapiens
May 28 - June 4
314 participants
Thirteen years marked the time between the discovery of the double helix in
1953 and the elucidation of the genetic code in 1966. A similar interval has now
passed since the development by Cohen and Boyer of a simple procedure for
the cloning of selective DNA fragments. The scientific advances made possible
by the subsequent modification and elaboration of these original cloning proce-
dures now amaze, stimulate, and increasingly often overwhelm us. Facts that un-
til recently were virtually unobtainable now flow forth almost effortlessly. Most ex-
citingly, the frenetic pace of these new discoveries, instead of marking the
impending end of a glorious moment of learning, gives every indication of open-
ing up scientific frontiers that will take hundreds if not thousands of years to ex-
plore thoroughly.
This new era of enlightenment is nowhere more apparent than in our new-
found ability to study ourselves at the molecular level. So it was very easy to
chose the title for this, our 51st Symposium. By focusing on "The Molecular Biol-
ogy of Homo sapiens," we would be chosing a topic that most certainly will be
returned to over and over during the second 50 Symposium years. In contrast,
only once in our first 50 Symposium years did our discussions focus exclusively
on ourselves (Human Genetics in 1964).
Happily, this year's Symposium marked the first year of use of our new facility
built expressly for the holding of meetings, the very wonderful Oliver and Lor-
raine Grace Auditorium. The formal dedication ceremonies occurred on June
1st, during the Symposium, with the main dedicatory speech delivered by Daniel
Koshland, editor of Science magazine and Professor of Biochemistry at the Uni-
versity of California, Berkeley.
In organizing the program for this Symposium, with Marcel lo Siniscalco, we
have benefited from the thoughtful advice of many colleagues, in particular Paul
Berg, Sir Walter Bodmer, David Botstein, Michael Brown, Charles Cantor,
Thomas Caskey, Joseph Goldstein, Lee Hood, Tom Maniatis, Joseph Sambrook,
and Allan Wilson. Many more potential speakers were suggested than could be
included in this our most intense Symposium yet attempted. The final program
comprised 123 speakers, with most of the audience of 314 staying virtually to the
end. Sir Walter Bodmer, a participant of our 1964 Symposium, gave an incisive
introductory talk, and Tom Caskey, a participant of our 1966 Genetic Code Sym-
posium, gave the very able summarizing remarks. Near the conclusion, at a spe-
cial session presided over by Walter Gilbert and Paul Berg, the feasibility of be-
ginning soon a total sequencing of the human genome was discussed. This is a
topic that generates diverse reactions, many of which were clearly expressed
during the discussion.
This meeting was supported in part by the Banbury Fund; the Department of
Energy; Lucille P Markey Foundation; National Cancer Institute/National Insti-
tutes of Health; The National Science Foundation; and the Rita Allen Foundation.
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Welcoming Remarks: J.D. Watson
Introduction: W.F. Bodmer, Imperial Cancer Research Fund: Human genetics-The molecular challenge.
SESSION 1 HUMAN GENE MAP (1)
Chairman: V. McKusick, Johns Hopkins Hospital
McKusick, V.A., Johns Hopkins University, Baltimore, Mary-
land: The gene map of Homo sapiens-Status and pro-
spectus.
Gray, J.W., van den Engh, G., Trask, B., Lucas, J., Pinkel,
D., Van Dilla, M., Fuscoe, J., Yu, L., Lawrence Livermore
National Laboratory, Livermore, California: Chromosome
classification and purification using flow cytometry and
sorting.
Pinkel, D.,' Gray, J.W.,1 Trask, B.,1 van den Engh, G.,'
Fuscoe, J.,1 van Dekken, 'Lawrence Livermore
SESSION 2 HUMAN GENE MAP (2)
Chairman: D. Botstein, Massachusetts Institute of Technology
White, R., Julier, C., Leppert, M., Nakamura, Y., O'Connell,
R, Woodward, S., Lathrop, G.M., Lalouel, J.-M., Howard
Hughes Medical Institute, Salt Lake City, Utah: Construc-
tion of human genetic linkage maps. I. Progress and per-
spectives.
Lalouel, J.-M., Lathrop, G.M., White, R., Howard Hughes
Medical Institute, University of Utah Medical Center, Salt
Lake City: Construction of human genetic maps. II. Meth-
odological issues.
Lander, E.,1,2,3 Botstein, D.,2 'Whitehead Institute for Bio-
medical Research, 2Dept. of Biology, Massachusetts In-
stitute of Technology, 3Harvard University, Cambridge,
Massachusetts: Mapping complex genetic traits in hu-
mans-New methods using a linkage map of RFLPs.
Cantor, C.R., Smith, C.L., Dept. of Genetics and Develop-
ment, Columbia University, College of Physicians & Sur-
geons, New York, New York: Approaches to physical
mapping of the human genome.
Weissman, S.M.,' Lawrance, S.K.,' Srivastava, R.,' Chro-
ney, M.J.,' Rigas, B.,' Vasavada, H.,' Gillespie, G.A.,'
National Laboratory, Livermore, California;
2Radiobiological Institute, TNO, The Netherlands: Cyto-
genetic analysis by in situ hybridization with fluorescently
labeled nucleic acid probes.
Deaven, L.,1 Van Dilla, M.,2 'Los Alamos National Labora-
tory, New Mexico; 2Lawrence Livermore National Labo-
ratory, Livermore, California: Construction of human
chromosome-specific DNA libraries from flow-sorted
chromosomes.
Smith, C.,2 Cantor, C.,2 Collins, F.S.,3 'Dept. of Human
Genetics, Yale University School of Medicine, New Ha-
ven, Connecticut; 2Dept. of Human Genetics, Columbia
University, New York, New York; 3Dept. of Internal Medi-
cine, University of Michigan Medical School, Ann Arbor:
The human MHC-Approaches to characterization of
large regions of DNA.
Lehrach, H., Poustka, A., Pohl, T., Barlow, D., Craig, A.,
Zehetner, G., Frischauf, A.-M., EMBL, Heiledberg, Fed-
eral Republic of Germany: Molecular approaches to
mammalian genetics.
Antonarakis, S.E.,1 Warren, A.C.,1 Wong, C.,1 Metaxotou,
C.,2 Chakravarti, A.,3 'Dept. of Pediatrics, Johns Hop-
kins University School of Medicine, Baltimore, Maryland;
2Dept. of Pediatrics, Athens University School of Medi-
cine, Greece; 3Dept. of Biostatistics, University of Pitts-
burgh, Pennsylvania: Reduced recombination rate in
chromosomes 21 which undergo nondisjunction in tri-
somy 21.
V. McKusick, F Rudd le
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G. Attardi, M. Siniscalco, A. Wilson
M. Witunsky, G. M. Browne R. Myers, T. Maniatis
SESSION 3 HUMAN CANCER GENES (1)
Chairman: G.F. Vande Woude, NCI-Frederick Cancer Research Facility
Park, M., Dean, M., Kaul, K., Gonzatti-Haces, M., lyer, A.,
Robins, T, Blair, D., Vande Woude, G.F., NCI-Frederick
Cancer Research Facility, Frederick, Maryland: The hu-
man met oncogene is a member of the tyrosine kinase
family.
Toyoshima, K.,' Semba, K.,1 Akiyama, T.,2 Ikawa, S.,1 Ya-
mamoto, T,"Institute of Medical Science, University of
Tokyo, 2Meiji College of PharMacy, Japan: c-erbB-2
gene encodes a receptor-like protein with tyrosine kinase
activity.
Barbacid, M., Sukumar, S., Martin-Zanca, D., Katzav, S.,
Mitra, G., NCI-Frederick Cancer Research Facility, Fred-
erick, Maryland: ras and trk - Two transforming genes of
human tumors.
SESSION 4 HUMAN GENE MAP (3)
Chairman: L. Hood, California Institute of Technology
Hood, L.,' Concannon, P.,' Klein, M.,3 Lai, E.,' Siu, G.,'
Strauss, E.,1 Pickering, L.,2 'California Institute of Tech-
nology, Pasadena; 2T-Cell Sciences, Inc., Cambridge,
Massachusetts; 3Toronto Cancer Institute, Canada: T-cell
receptor genes-Organization, diversification, and rear-
rangements.
Mak, T.W., Yoshikai, Y, Iwamoto, I., Minden, M., Ohasi, P.,
Caccia, N., Toyonaga, B., Ontario Cancer Institute and
Dept. of Medical Biophysics, University of Toronto, Can-
ada: Genes of the T-cell antigen receptors in normal and
malignant T cells.
Strominger, J.L., Dept. of Biochemistry and Molecular Biol-
ogy, Harvard University, Cambridge, Massachusetts: Hu-
man histocompatibility antigens-Structure, genetics,
and regulation of expression.
Mach, B., Rollini, P., Berdoz, J., Berte, C., Reith, W., Gorski,
J., Dept. of Microbiology, University of Geneva Medical
Wig ler, M., Fasano., 0., Birnbaum, D., Birchmeier, C.,
Young, D., Cold Spring Harbor Laboratory, New York: Tu-
morigenicity assays for human protooncogenes.
Shimizu, K.,' Nakatsu, Y.,' Oh-uchida, M.,1 Nomoto, S.,1
Sekiguchi, M.,2 'Dept. of Biology, of Science,
2Dept. of Biochemistry, Faculty of Medicine, Kyushu Uni-
versity, Fukuoka, Japan: Structure of the activated c-raf-1
gene from human stomach cancer.
Gonzalez, FJ., Jaiswal, A.K., Nebert, D.W., NCI, National
Institutes of Health, Bethesda, Maryland: P450 genes-
Structure, evolution, regulation, and relationship in can-
cer.
School, Switzerland: Human la antigens-Complexity,
polymorphism, and regulation.
McDevitt, H.O., Bell, J.I., Depts. of Medicine and Medical
Microbiology, Stanford University, California: Polymor-
phism in the class II region of the human major histocom-
patibility complex.
Kohonen-Corish, M.R.J., Dunckley, H., Reid, M.A., Ser-
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Blaese, R.M.,' Kohn, D.,' Gilboa, E.,2 Armentano, D.,2
Gillio, A.,3 Bordignon, C.,3 O'Reilly, R.,3 'National Insti-
tutes of Health, Bethesda, Maryland; 2Princeton Univer-
sity, New Jersey; 3Memorial Sloan-Kettering Cancer Cen-
ter, New York, New York: Gene transfer and expression in
nonhuman primates using retroviral vectors.
Beaudet, A.L.,1.2 Jackson, M.J.,' Wood, P.A.,' O'Brien,
\ALE., 1 ,2
'Dept. of Pediatrics, Baylor College of Medicine,
2Howard Hughes Medical Institute, Houston, Texas: The
human argininosuccinate synthetase locus-Gene regu-
lation and potential for gene therapy.
Mulligan, R.C., Whitehead Institute for Biomedical Re-
search and Dept. of Biology, Massachusetts Institute of
Technology, Cambridge: Gene transfer-A potential new
therapy for the treatment of genetic disease.
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196 participants
The 1986 meeting on G-Proteins and Signal Transduction was the first of its kind
at Cold Spring Harbor Laboratory. Its focus was on those processes of signal
transduction (hormonal and sensory) that are mediated by guanine-nucleotide-
binding proteins. Scientific presentations included analysis of the receptor mole-
cules, such as the visual rhodopsins and the [3-adrenergic receptor, the G-pro-
teins themselves, and G-protein-like molecules of the ras family, and the effector
systems, such as adenylate cyclase and phospholipases. The major themes of
the meeting were the overall similarity of very diverse signaling systems; the mo-
lecular structure of receptors and G-proteins; the diversity of G-proteins; the role
of GTP in regulating phospholipases; and the structure and function of the ras
proteins and their similarity to G-proteins. The highlights of the meeting included
reports of the primary structure of various G-proteins; the primary structure of the
f3-adrenergic receptor and its similarity to rhodopsin and to a newly discovered
oncogene; and evidence that phosphatidyl inositol is regulated by GTP binding
proteins.
This meeting was supported in part by the National Science Foundation; Na-
tional Institute of General Medical Sciences and Child Health and Human Devel-
opment/National Institutes of Health.
SESSION 1 THE PRIMARY STRUCTURE OF G PROTEINS
Chairmen: M. Simon, California Institute of Technology
A. Gilman, University of Texas Health Science Center
Robishaw, J.D.. Graziano, M.P.. Smigel, M.D.. Gilman,
A.G.. Dept. of Pharmacology, University of Texas Health
Science Center, Dallas: Analysis of cDNAs for G and
G3.
Itoh, H.,'.2 Kozasa, T.,' Nakafuku. M.,' Fukui, Y.,' Yama-
moto, M.,' Nagata, S.,' Nakamura. S.,' Katada. T..2 Ui.
M.,2 Kaziro, Y.," Institute of Medical Science, University
of Tokyo; 2Faculty of Pharmaceutical Sciences, Hokkaido
University, Sapporo, Japan: Cloning of cDNAs coding for
G proteins from rat brain and function of the ras gene in
Schizosaccharomyces pombe.
Fong, H.K.W.,' Hurley, J.B.,2 Doolittle, R.F.,3 Simon, M.I.,'
'Biology Division, California Institute of Technology, Pasa-
dena; 2Howard Hughes Medical Institute, Seattle, Wash-
ington, 'Dept. of Chemistry, University of California, San
Diego, La Jolla: Repetitive segmental structure of the
transducin /3-subunit and homology with the yeast CDC4
gene.
Bourne, H.R., Sullivan, K., Masters, S.B., Dept. of Pharma-
cology. University of California, San Francisco: G protein
a-chains-Structure versus function.
Nukada, T., Tanabe, T., Sugimoto, K., Takahashi, H., Noda,
M., Numa, S., Depts. of Medical Chemistry and Molecu-
lar Genetics, Kyoto University Faculty of Medicine, Ja-
pan: Primary structures of the a- and 0-subunits of G pro-
teins deduced from the cDNA sequences.
Michel, T..1.4 Winslow, J.W.,1.4 Smith, J.A.,2.5 Seidman,
J.G.,3 Neer, E.J.,'.4 Depts. of 'Medicine, 2Pathology,
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3Genetics, Harvard Medical School, Boston;
'Cardiovascular Division, Brigham and Women's Hospi-
tal; 5Dept. of Molecular Biology and Pathology, Massa-
chusetts General Hospital: cDNA cloning of the GTP-
binding protein, a, and of a novel G protein, ah.
Bray, P.,1 Carter, A.,2 Kamholz, J.,3 Puckett, C.,3 Spiegel,
A.,2 Nirenberg, M.,1 1NHLBI, 2NIADDK, 3NINCDS, Na-
tional Institutes of Health, Bethesda, Maryland: Human
cDNA clones for a-subunits of Gs and an unidentified G
protein.
SESSION 2 THE REGULATION AND STRUCTURE OF ADENYLATE CYCLASE
Chairmen D. Storm, University of Washington
R. Lefkowitz, Duke University Medical Center
Ross, E.M., Brandt, D.R., May, D.C., Dept. of Pharmacol-
ogy, University of Texas Health Science Center, Dallas:
Regulation of Gs function by (3- adrenergic receptors in re-
constituted phospholipid vesicles.
Lefkowitz, R.J., Benovic, J.L., Strasser, R.H., Caron, M.G.,
Duke University Medical Center, Durham, North Carolina:
Molecular and regulatory properties of adenylate cy-
clase-coupled adrenergic receptors.
Birnbaumer, L., Codina, J., Mattera, R., Sunyer, T., Toro,
M.J., Baylor College of Medicine, Houston, Texas: Func-
tional and structural properties of N, and other N pro-
teins.
Smigel, M., Dept. of Pharmacology, University of Texas
Health Science Center, Dallas: Purification and properties
of bovine brain adenylate cyclase.
Minocherhomjee, A., Rosenberg, G., Shattuck, R., Storm,
D.R., Dept. of Pharmacology, University of Washington,
Seattle: Comparison between calmodulin-sensitive aden-
ylate cyclases purified from bovine brain and Bordetella
pertussis.
SESSION 3 POSTER SESSION
Allen, T.J.A., Baker, P.K., Dept. of Physiology, King's Col-
lege, London, England: Serotin-sensitive cyclic nucleo-
tide levels in the perfused axon.
Amons, R., Jansen, G.M.C., Maessen, G.D.F., Maassen,
J.A., Moller, D.W., Dept. of Biochemistry, University of
Leiden, The Netherlands: Structure and properties of Ar-
temia and human EF-1.
Anand-Srivastava, M.B., Srivastava, A.K., Clinical Research
Institute of Montreal, Canada: Protein kinase C modu-
lates adenylate cyclase activity in rat brain striatum. Pos-
sible involvement of G,-guanine nucleotide regulatory
protein.
Anderson, G.R., Farkas, B.K., Dept. of Cell and Molecular
Biology, Roswell Park Memorial Institute, Buffalo, New
York: Guanine nucleotide regulation of a transformation-
associated lactate dehydrogenase.
Aub, D.L., Frey, E.A., Sekura, R.D., Cote, T.E., Dept. of
Pharmacology, USUHS, Bethesda, Maryland: Coupling
of the TRH receptor to phospholipase C by a GTP-bind-
ing protein distinct from Ns or N,.
Berta, P,1 Le Peuch, C.J.,' Cavadore, J.C.,1 Alouf, J.E.,2
Haiech, J.,"Centre de Recherches de Biochimie Ma-
cromoleculaire, CNRS, INSERM, Montpellier; 2Unite des
Antigenes bacteriens, CNRS, Institute Pasteur, Paris,
France: Involvement of GTP in the regulation of cultured
vascular smooth muscle cell response to 5-hydroxytrypt-
amine.
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Peterkofsky, A.,1 Gazdar, C.,1 Liberman, E.,1 Miller, D.,2
Reddy, P.,1 'National Institutes of Health, Bethesda,
Maryland; 2New York State Institute of Basic Research in
Developmental Disability, Staten Island: Regulation of E.
coli adenylate cyclase (AC) activity by factors with shared
functions.
Klein, P., Theibert, A., Vaughan, R., Devreotes, P., Dept. of
Biological Chemistry, Johns Hopkins University School of
Medicine, Baltimore, Maryland: Receptor G-protein inter-
actions and Dictyostelium development.
Kataoka, Broek, D.,1 Field, J.,1 Wig ler, M.,1 'Cold
Spring Harbor Laboratory, New York; 2Dept. of Physiol-
ogy and Biophysics, Harvard Medical School, Boston,
Massachusetts: Interaction of RAS proteins with yeast
adenylate cyclase.
Smith, R.F., Choi, K.-W., Tully, T., Quinn, W.G., Dept. of Biol-
ogy, Massachusetts Institute of Technology, Cambridge:
Deficient protein kinase C activity in turnip, a Drosophila
learning mutant.
Bigay, J., Deterre, P., Pfister, C., Chabre, M., Laboratory
Biophysique Moleculaire et Cellulaire, Grenoble, France:
Activation of transducin by fluoride and aluminum: AlF4
mimicks the y-phosphate of GTP in the binding site of
TaGDP.
Bojanic, D., Fain, J.N., Dept. of Biochemistry, University of
Tennessee, Memphis: Regulation of [3H]vasopressin
binding to liver membranes and detergent extracts by a
guanine nucleotide.
Bokoch, G.M.,1 Sklar, L.A.,' Button, D.,' Smolen, J.E.,2
'Scripps Clinic and Research Foundation, La Jolla, Cali-
fornia; 2Mott Hospital, University of Michigan, Ann Arbor:
Regulation of ligand- receptor dynamics by guanine nu-
cleotides-Rapidly interconverting states for the neutro-
phil formyl peptide receptor.
Braun, A.R, Sulakhe, P.V., University of Saskatchewan Col-
lege of Medicine, Saskatoon, Canada: Distribution and
characteristics of guanine nucleotide binding proteins in
bovine heart.
Correze, C.,' d'Alayer, J.,' Coussen, F.,1 Berthillier, G.,'
Deterre, P,2 Monneron, A.," Dept. de Biologie Molecu-
laire, Institute Pasteur, Paris; 2Laboratoire de Biophy-
sique Moleculaire, Grenoble, France: Interference of anti-
/3 antibodies with adenylate cyclase activity in brain mem-
branes.
Dixon, R.A.F.,' Kobilka, B.K.,4 Strader, D.J.,3 Benovic,
J.L.,4 Dohlman, H.G.,4 Friel le, T.,4 Bolanowski, M.A.,'
Bennett, C.D.,2 Mumford, R.A.,3 Slater, E.E.,3 Sigel,
I.S.,' Caron, M.G.,4 Lefkowitz, R.J.,4 Strader, C.D.,3
Depts. of 'Virus and Cell Biology Research, 2Medicinal
Chemistry, Merck Sharp and Dohme Research Laborato-
ries, West Point, Pennsylvania; 3Dept. of Biochemistry,
Merck Sharp and Dohme Research Laboratories, Rah-
way, New Jersey; 4Howard Hughes Medical Institute,
Depts. of Medicine, Biochemistry, and Physiology, Duke
University Medical Center, Durham, North Carolina: Pep-
tide mapping and production of antibodies to the mam-
malian f32-adrenergic receptor.
Dudycz, L.W., Kelleher, D.J., Johnson, G.L., Wright, G.E.,
University of Massachusetts Medical Center, Worcester:
Ability of N2-(p-n-butylphenyl) derivatives of guanine nu-
cleotides to bind and activate bovine transducin.
Fain, J.N.,1 Litosch, Dept. of Biochemistry, University
of Tennessee, Memphis; 2Dept. of Pharmacology, Uni-
versity of Miami School of Medicine, Florida: Hormonal
activation of phosphoinositide breakdown in the pres-
ence of guanine nucleotides using cell-free systems from
blowfly salivary glands.
Fitzgerald, T.J., Uhing, R.J., Exton, J.H., Howard Hughes
Medical Institute and Dept. of Molecular Physiology and
Biophysics, Vanderbilt University School of Medicine,
Nashville, Tennessee: Evidence for a vasopressin recep-
tor-GTP binding protein complex.
Guerrero, I.,' Pellicer, A.,1 Green, S.,2 Green, L.A.,2 Bur-
stein, D.,"Dept. of Pathology, 'Dept. of Pharmacology,
New York University Medical Center, New York: Activated
and highly expressed normal N-ras gene induces neu-
ronal differentiation in PC12 rat pheochromocytoma cells
and in sublines nonresponsive to nerve growth factor.
Guillon, G.,' Kirk, C.J.,2 'CNRS, INSERM, Montpellier,
France; 2Dept. of Biochemistry, Birmingham, England:
GTP-dependent activation of PIP2 phosphodiesterase by
vasopressin in WRK1 cells-Studies with intact cells and
partially purified membranes.
Hamm, H.E.,1 Deretic, D.,1 Hatta, 5.,1 Bennett, N.,2
'Dept. of Physiology and Biophysiology, University of Illi-
nois College of Medicine; 2Laboratory of Biophysiology,
CNRG, Grenoble, France: Monoclonal antibodies to the
photoreceptor G protein which block its light activation-
Antigenic sites and mechanism of action.
Hingorani, V., Ho, Y.-K., Dept. of Biological Chemistry, Uni-
versity of Illinois Health Sciences Center, Chicago: Chem-
ical modification of bovine transducin by fluorescein-5'-is-
othiocyanate.
Homburger, V., Audigier, Y., Brabet, P., Bockaert, J., Rouot,
B., CNRS, INSERM, Montpellier, France: Immunolike
reactivity against the GTP-binding protein subunit a-0 in
neuronal and nonneuronal tissues from different species.
Jacquemin, C.,' Thibout, H.,' Lambert, B.,2 Correze, C.,'
'INSERM, Unite de Recherche sur la Glande Thyroide et
la Regulation Hormonale, Bicetre; 2Dept. of Biochemis-
try, Faculte des Science, Reims, France: Autonomous
regulation of adenylate cyclase in rat adipocytes-Endo-
geneous ADP-ribosylation of Gs under the influence of
adenosine.
Lad, R.,1 Gerfen, C.,2 Milligan, G.,3 Gierschik, p,4 Spie-
gel, A.,"NIADDK, 2NIMH, National Institutes of Health,
Bethesda, Maryland; 3Dept. of Biochemistry, University
of Glasgow, Scotland; 4Dept. of Pharmacology, Univer-
sity of Heidelberg, Federal Republic of Germany: Immu-
nohistochemical localization of guanine nucleotide bind-
ing proteins in rat retina.
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SESSION 4 SIGNAL TRANSDUCTION. I. HORMONE ACTION
Chairmen: P. Sternweis, University of Texas Health Science Center
J. Northup, University of Calgary
Perkins, J.P., Dept. of Pharmacology, Yale University School
of Medicine, New Haven, Connecticut: Ligand-induced
uncoupling of the functional interaction of (3- adrenerigic
receptors and Gs.
Orellana, S.T., Brown, J.H., University of California, San
Diego, La Jolla: Phorbol ester inhibits guanine nucleo-
tide-regulated inositol phosphate formation in membrane
and permeabilized preparations of 1321N1 astrocytoma
cells.
Bauer, S., Gierschik, P., Grandt, R., Jakobs, K.H., Pharmak-
ologisches Institute der Universitat Heidelberg, Federal
Republic of Germany: Phosphorylation of G proteins by
intracellular signal-controlled protein kinases.
Valentine-Braun, K., Fraser, E.D., Hollenberg, M.D., Nor-
thup, J.K., Dept. of Pharmacology, The University of Cal-
gary, Canada: Purification and properties of the major
EGF-kinase substrate of human placental membranes.
Tota, M.R., Rosenbaum, L.C., Peterson, G.L., Schimerlik,
M., Dept. of Biochemistry and Biophysics, Oregon State
SESSION 5 SIGNAL TRANSDUCTION. II. Sensory Systems
Chairman: H. Bourne, University of California Medical Center,
Jones, D., Barbosa, E., Reed, R., Dept. of Molecular Biol-
ogy and Genetics, Johns Hopkins School of Medicine,
Baltimore, Maryland: G proteins of the olfactory system.
Corson, D.W.,1,2 Fein, A.,1,2 Payne, R.,"Marine Biological
Laboratory, Woods Hole; 2Dept. of Physiology, Boston
University School of Medicine, Massachusetts: Chemical
excitation of quantal events in Limulus photoreceptors.
Se linger, Z.,1 Devary, O.,' Blumenfeld, A.,1 Heichal, 0.,1
Minke, B.,2 Depts. of 'Biological Chemistry,
2Physiology, The Hebrew University of Jerusalem, Israel:
Light-activated GTP hydrolysis and breakdown of phos-
phoinositides in musca eye membranes.
Lerea, C.L.,1 Somers, D.E.,1Klock, I.B.,2 Bunt-Milam,
A.H.,2 Hurley, J.B.,' Howard Hughes Medical Institute,
2Dept. of Opthalmology, University of Washington, Seat-
tle: Identification of a transducin (Tc) specifically ex-
pressed in bovine cone outer segments.
Kuhn, H., Wehner, M., Institute fur Neurobiologie, Julich,
Federal Republic of Germany: Interaction between pho-
toactivated rhodopsin and transducin.
Gillespie, P.G., Charbonneau, H., Zelus, B., Beavo, J.A.,
Dept. of Pharmacology, University of Washington, Seat-
tle: Subunit structure and functions of photoreceptor
cyclic GMP phosphodiesterase(s).
Deterre, R,1 Bigay, J.,' Robert, M.,' Pfister, C.,' Kuhn,
H.,2 Chabre, M.,"Dept. of Molecular and Cellular Biol-
ogy, CNRS, Grenoble; 2lnstitute fOr Neurobiologie der
Julich, Federal Republic of Germany: Activation mecha-
nism of cGMP phosphodiesterase by transducin-Char-
acterization of the complex formed by phosphodiester-
ase inhibitor and transducin a-subunit.
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University, Corvallis; Atrial muscarinic receptor-Charac-
terization and interaction with guanine nucleotide binding
proteins.
Sternweis, P.C., Florio, V.A., Dept. of Pharmacology, Univer-
sity of Texas Health Science Center, Dallas: GTP-depen-
dent regulatory proteins and their interaction with mus-
carinic-cholinergic receptors.
Breitwieser, G.E., Lapointe, J.Y., Szabo, G., Dept. of Physi-
ology and Biophysics, University of Texas Medical
Branch, Galveston: Muscarinic activation of K+ conduct-
ance is mediated by a guanine nucleotide binding pro-
tein in the heart.
Fischer, J.B., Schonbrunn, A., Laboratory of Toxicology,
Harvard School of Public Health, Boston, Massachusetts:
Bombesin receptors are coupled to a G protein not sensi-
tive to cholera or pertussis toxin.
Gomperts, B.D., University College London, England: NP
and NE -Two sites of GTP control in stimulus-secretion
coupling.
San Francisco
H. R. Bourne
SESSION 6 G PROTEINS AND PHOSPHOLIPID METABOLISM
Chairmen: M. Gershengorn, Cornell University School of Medicine
J. Putney, Medical College of Virginia
Ui, M.. Okajima, F., Katada, T., Murayama, T., Kurose, H.,
Dept. of Physiological Chemistry, Hokkaido University,
Sapporo, Japan: G proteins serving as the substrate of
pertussis toxin-catalyzed ADP-ribosylation mediate re-
ceptor-linked adenylate cyclase inhibition and inositol
phospholipid breakdown.
Putney, J.W., Jr., Taylor, C.W., Merritt, J.E., Rubin, R.P., Divi-
sion of Cellular Pharmacology, Medical College of Vir-
ginia, Richmond: Receptor regulation of inositol trisphos-
phate production in exocrine glands.
Harden, T.K., Hepler, J.R., Dept. of Pharmacology, Univer-
sity of North Carolina School of Medicine, Chapel Hill:
Evidence for the involvement of a guanine nucleotide
regulatory protein that is not G, in muscarinic receptor-
stimulated phosphoinositide hydrolysis in 1321N1 human
astrocytoma cells.
Williamson, J.R., Coll, K.E., Mah, S., Hansen, C., Dept. of
Biochemistry and Biophysics, University of Pennsylvania,
Philadelphia: Hormone-receptor coupling to phospholi-
pase C and production of inositol phosphates in rat liver.
Gershengorn, M.C., Dept. of Medicine, Cornell University
Medical College and New York Hospital, New York, New
SESSION 7 RAS/G-LIKE PROTEINS
Chairmen: D. Gallwitz, University of Marburg
M. Wig ler, Cold Spring Harbor Laboratory
Jurnak, F.,1 Xuong, N.,2 Hamlin, R.,2 'Dept. of Biochemis-
try, University of California, Riverside; 2Dept. of Physics,
University of California, San Diego: The GOP site in E.
coil elongation factor Tu at 2.7 A resolution.
Kjeldgaard, M., Nyborg, J., la Cour, T., Clark, B.F.C., Dept.
of Chemistry, Arhus University, Denmark: A model for the
three-dimensional structure of the G binding site in GDP/
GTP-binding proteins.
Gallwitz, D., Brdkel, R., Molenaar, C.M.T., Rauh, A., Wag-
ner, P, Schmitt, H.D., Institut fOr Physiologische Chemie
I, Universitat Marburg, Lahnberge, Federal Republic of
Germany: The ras-related YPT gene product in yeast-A
GTP-binding protein involved in cytoskeletal function.
Madaule, P.,1 Myers, A.,2 Axel, R.,1.3 'Howard Hughes
Medical Institute, 2Dept. of Biological Sciences, 3Dept.
of Biochemistry, Columbia University, New York, New
SESSION 8 POSTER SESSION
Levine, M.A.,' Ahn, T.G..1 Van Dop, C.,' Kaufman, K.,'
Smallwood, P.,' Bourne, H.R..2 Sullivan, K..2 'Johns
Hopkins University, Baltimore, Maryland; 2University of
California, San Francisco: Molecular basis for genetic de-
ficiency of aGs in pseudohypoparathryoidism la.
Liao, Y.C., Chen, E., Levinson, A.D., Dept. of Molecular Bi-
ology, Genentech Inc., South San Francisco, California:
Primary structure of a-subunit of human G protein that
stimulates adenylate cyclase- Homology with transdu-
cin, ras, and elongation factors.
York: Calcium, inositol trisphosphate, and lipids in signal
transduction by thyrotropin-releasing hormone in pituitary
GH cells-Evidence for involvement of a novel G protein.
Wojcikiewicz, R.J.H., Kent, P.A., Fain, J.N., Dept. of Bio-
chemistry, University of Tennessee, Memphis: Evidence
that receptors which activate phospholipase-C interact
with a G protein that is not G, or G.
Blackmore, P.F., Bocckino, S.B., Exton, J.H., Howard
Hughes Medical Institute and Dept. of Molecular Physiol-
ogy and Biophysics, Vanderbilt University School of Med-
icine, Nashville, Tennessee: Role of a guanine nucleotide
binding protein in the hormone-induced hydrolysis of he-
patic phosphotidylinositol 4,5-P2 -Formation of myo-in-
ositol 1,3,4,5-P4.
Has lam, R.J., Hrbolich, J.K., Dept. of Pathology, McMaster
University, Hamilton, Ontario, Canada: Activation of
phospholipase C in washed platelet membranes by
GTPyS and by agonists added with GTP.
Paris, S., Pouyssegur, J., Centre de Biochimie, CNRS,
Nice, France: Evidence of a role for a GTP-binding pro-
tein in thrombin-induced activation of phosphoinositide
hydrolysis and Na+/H+ exchange in hamster fibroblasts.
York: The p21 rho of Saccharomyces cerevisiae.
Evans, T., Fraser, E.D., Brown, M.L., Northup, J.K., Dept. of
Pharmacology, University of Calgary, Canada: The purifi-
cation and properties of GTP-binding proteins from hu-
man placental membranes.
Chardin, P., Tavitian, A., INSERM, Faculte de Medecine,
Paris, France: ral: A new ras-related gene.
Lowe, D., Delwart, E., Capon, D., Goeddel, D., Dept. of
Molecular Biology, Genentech Inc., South San Francisco,
California: R-ras, a new member of the ras proto-onc
gene family with intrinsic GTPase activity.
Young, D., Waitches, G., Birchmeier, C., Fasano, 0., Wig ler,
M., Cold Spring Harbor Laboratory, New York: A human
oncogene encoding a protein with a structure similar to
rhodopsin.
Litosch, I.. Dept. of Pharmacology, University of Miami
School of Medicine, Florida: Guanosine 5'-(3-0-
thio)trisphosphate activates phospholipase C-mediated
breakdown of exogenous phosphatidylinositol-4,5-bis-
phosphate substrate in rat cerebral cortical membranes.
Lombardo, B., Anglade, G., Monneron, A., Dept. de Biolo-
gie Moleculaire, Institut Pasteur, Paris, France: Immunolo-
calization of /3-subunits in brain sections.
Longabaugh, J.P.,1 Vatner, D.E.,2 Vatner, S.F.,2 Homcy,
C.J.,"Cellular and Molecular Research Laboratory,
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Massachusetts General Hospital, Boston; 'New England
Regional Primate Research Center, Southborough: Chol-
era toxin promoter ADP ribosylation in dogs with conges-
tive heart failure.
McMahon, K.K., Dept. of Pharmacology, University of
South Carolina School of Medicine, Columbia: Functional
characteristics and pertussis toxin ADP-ribosylation pat-
terns of a 39K G protein in fetal, neonatal, and adult rat
heart.
Melchiore, S., Mitchell, C., Vary, J., Ho., Y.-K., Dept. of Bio-
logical Chemistry, University of Illinois Health Sciences
Center, Chicago: Bacillus megaterium spore proteins that
cross-react with transducin (3- subunit antibodies.
Mochly-Rosen, D., Koshland, D.E., Jr., Dept. of Biochemis-
try, University of California, Berkeley: Enzymatic proper-
ties of protein kinase C.
Nambi, P, Whitman, M., Aiyar, N., Crooke, S.T., Dept. of
Molecular Pharmacology, Smith Kline and French Labo-
ratories, Philadelphia, Pennsylvania: Induction of func-
tional inhibitory guanine nucleotide regulatory protein (G,)
in canine kidney cell line by sodium butyrate.
Parmeggiani, A., Anborgh, PA., Canceill, D., Crechet, J.B.,
Jacquet, E., Jensen, M., Merola, M., Mortensen, K.K.,
Swart, G.W.M., Laboratoire de Biochimie, Ecole Polytech-
nique, Palaiseau, France: Properties of the guanine nu-
cleotide binding of EF-Tu.
Polonis, V.R.,1 Anderson, G.R.,2 Doyle, D.J.,"State Uni-
versity of New York, 'Roswell Park Memorial Institute,
Buffalo, New York: Pl,P4-DI(guanosine-5')tetraphosphate
(Gp4G) is a competitive inhibitor of v-ras-Ha p21 auto-
phosphorylation.
Pribilla, I. Free University of Berlin, Institute of Biochemistry,
Federal Republic of Germany: Inhibition of dopaminergic
agonist binding to striatal D2-receptors by the action of
protein kinase C.
Ranu, R.S., Dept. of Microbiology, Colorado State Univer-
sity, Fort Collins: Eukaryotic initiation factor elF-2 as a G
protein.
Rasenick, M.M., Hatta, S., Marcus, M.M., Dept. of Physiol-
ogy and Biophysics, University of Illinois College of Medi-
cine, Chicago: Guanine nucleotide exchange among
GTP-binding proteins which regulate neuronal adenylate
cyclase.
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Rosenthal, W., Sezer, 0., Rudolph, U., Koesling, D., Cetin,
E., Yajima, M., Schultz, G., Pharmakolog, Institut der
Freien Universitat, Berlin, Federal Republic of Germany:
Involvement of guanine nucleotide binding proteins (N
proteins) in the regulation of intracellular calcium in hu-
man neutrophil leukocytes (PMNs).
Simon, M., Oosawa, K., Mutoh, N., Kaplan, N., Biology Di-
vision, California Institute of Technology, Pasadena: Ge-
netic and biochemical analysis of signalling by bacterial
chemoreceptors.
Stadel, J.M., Poksay, K.S., Nakada, M.T., Crooke, S.T.,
Smith Kline & French Laboratories, Philadelphia, Penn-
sylvania: Sodium butyrate modulates the p-adrenergic re-
ceptor-adenylate cyclase complex of 313-L1 fibroblasts.
Tripp, MI.,' Bouchard, R.A.,' Pinon, R.,1 Meisenhelder,
J.,' Hunter, T.,2 'Dept. of Biology, University of Califor-
nia, La Jolla; 'Molecular Biology and Virology Labora-
tory, Salk Institute, San Diego: Developmentally regulated
phosphoproteins in Saccharomyces cerevisiae- Positive
and negative regulation by environmental signals.
Taylor, C.W., Merritt, J.E., Rubin, R.P., Putney, J.W., Jr.,
Dept. of Pharmacology, Medical College of Virginia, Rich-
mond: Receptor coupling to phospholipase C in exocrine
pancreas and parotid gland.
Vatner, D.E.,' Vatner, S.F.,2.3 Fujii, A.M.," Homcy, C.J.,1
Harvard Medical School, 'Massachusetts General Hos-
pital, 'Brigham and Women's Hospital, Boston; 3New
England Regional Primate Research Center, Southbor-
ough, Massachusetts: Decreased muscarinic receptors
and inhibition of adenylate cyclase in dogs with heart fail-
ure.
Wehrmann, M.,1 Ehbrecht, H.-J.,' Wittinghofer, F.,' Pin-
goud, A.,1 'Zentrum Biochemie, Medizinische Hochs-
chule Hannover; 'Max-Planck-Institute fOr Medizinische
Forschung, Heidelberg, Federal Republic of Germany:
The v-Ha-ras oncogene product p21 cross-reacts immu-
nologically with the E. coli EF-Tu.
Weiss, E.R., Johnson, G.L., Dept. of Biochemistry, Univer-
sity of Massachusetts Medical Center, Worcester: Char-
acterization of antibodies raised against synthetic pep-
tides corresponding to cytoplasmic domains of
rhodopsin.
SESSION 9 RAS PROTEINS
Chairmen: R. Firtel, University of California, San Diego
J. Feramisco, Cold Spring Harbor Laboratory
Birchmeier, C.. Wig ler, M., Cold Spring Harbor Laboratory,
New York: Maturation of amphibian oocytes is induced
by microinjected ras protein.
Bar-Sagi, D., Feramisco, J.R., Cold Spring Harbor Labora-
tory, New York: Rapid induction of cell-surface activities
in quiescent fibroblasts following microinjection of H-ras
proteins.
Stacy, D.W., Smith, M.R., Roche Institute of Molecular Biol-
ogy, Nutley, New Jersey: C ras activity and transforma-
tion by separate viral oncogenes.
Furth, M.E.,' Swanson, M.E.,2 Aldrich, T.A.,1 Elste, A.M.,'
Greenberg, S.M.,' Schwartz, J.H.,' 'Memorial Sloan-
Kettering Cancer Center, New York, New York; 'Howard
Hughes Medical Institute, Columbia University, New York,
New York: Abundant expression of a ras protein in Aply-
sia neurons.
Firtel, R.A.,' Reymond, C.D.,' Gomer, R.H.,1 Thiebert,
A.,2 Devreotes, P,2 Nellen, W.,"Dept. of Biology, Uni-
versity of California Chemistry; 'Johns Hopkins Medical
School, Baltimore, Maryland: ras gene regulation and
function in Dictyostelium.
Sigal, I.S.,' Gibbs, J.B.,1 Smith, G.M.,' D'Alonzo, J.S.,'
Eukaryotic Transposable Elements
Schultz, L.D.,' Socher, S.H.,' Wolanski, B.,' Jurnak, F.,2
Scholnick, E.M.,"Merck Sharp & Dohme Research Lab-
oratories, West Point, Pennsylvania; 'University of Cali-
fornia, Riverside: Structure-function of Ha-ras.
Hall, A.,' Marshall, C.J.,' McCormick, F.,2 McKay, I.,' Mil-
ley, R.,2 Paterson, H.,' Trahy, M.,2 'Institute of Cancer
Research, Chester Beatty Laboratories, London, Eng-
land; 'Cetus Corp., Emeryville, California: Biochemical
consequences of N-ras activation.
Fasano, 0., De Vendittis, E., Zahn, R., Vitelli, A., European
Molecular Biology Laboratory, Heidelberg, Federal Re-
public of Germany: Role of nucleotides and Mg ions in
the regulation of the function of yeast and human ras pro-
teins.
Toda, T., Powers, S., Kataoka, T., Wigler, M., Cold Spring
Harbor Laboratory, New York: Alternate RAS pathway in
yeast-Activation of adenylate cyclase is not only func-
tion of yeast RAS.
Powers, S.,' Broek, D.,' Field, J.,' Wigler, M.,' Michaelis,
S.,2 Santa Anna, S.,2 Herskowitz, 1.,2 'Cold Spring Har-
bor Laboratory, New York; 'University of California, San
Francisco: Effect of fatty acid acylation on RAS function.
May 7-May 11
ARRANGED BY
Gerald R. Fink, Whitehead Institute for Biomedical Research
Gerald M. Rubin, University of California. Berkeley
Stephen L. Dellaporta, Cold Spring Harbor Laboratory
James Hicks, Cold Spring Harbor Laboratory
124 participants
This meeting brought together workers on yeast, C. elegans, Drosophila, plants
and vertebrates. The unifying theme was the molecular biology of transposable
elements in each of these systems. Over 85 abstracts were presented on ele-
ments ranging from the Ty of yeast, the ICI of C. elegans, the P and copia of
Drosophila, the Spm and Ac of maize, and retroviruses of vertebrates. Much of
the discussion focused on the regulation of expression of transposable elements.
The expression of these elements appears to be under the control of genes both
within the elements and elsewhere in the genome. The expression of the genes
within the transposable elements has profound effects upon the genes into which
the elements have inserted as well as the ability of the element to transpose. Sev-
eral reports suggested that DNA modification was related to the stability of a
transposable element.
This meeting was supported in part by the National Institute of General Medi-
cal Sciences/National Institutes of Health, the National Science Foundation, and
the United States Department of Agriculture.
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SESSION 1 GENE REGULATION BY TRANSPOSABLE ELEMENTS. I.
Chairman: G.S. Roeder, Yale University
Coney, L.R., Roeder, G.S., Dept. of Biology, Yale University,
New Haven, Connecticut: Control of HIS4 expression by
Ty elements.
Kapakos, J., Farabaugh, R, Dept. of Microbiology, Univer-
sity of Connecticut Health Center, Farmington: Interac-
tions between the Ty91 7 enhancer and silencer sites and
the upstream promoter element in regulating adjacent
gene expression.
Clare, J., Kapakos, J., Farabaugh, P., Dept. of Microbiol-
ogy, University of Connecticut Health Center, Farmington:
Transcription by yeast transposable elements and that of
adjacent genes is controlled by both enhancer and si-
lencer sites.
Errede, B.,1,2 Company, M.,1 Hutchison, C.A. 111,23 Tea-
gue, M.A.,' Connell, L.B.,2 'Dept. of Chemistry,
2Curriculum of Genetics, 3Dept. of Microbiology and Im-
munology, University of North Carolina, Chapel Hill: Yeast
cell type regulation of Ty1 enhancer function.
Kingsman, S.M., Mellor, J., Fulton, A., Rathjen, R, Wilson,
W., Kingsman, A.J., Dept. of Biochemistry, University of
SESSION 2 FAMILIES OF TRANSPOSABLE ELEMENTS
Oxford, England: Multicomponent expression signals in
the yeast transposon Ty.
Van Arsdell, S., Thorner, J., Dept. of Biochemistry, Univer-
sity of California, Berkeley: Yeast transposable element
sigma functions as a hormone-inducible promoter.
Fedoroff, N.V., Kingsbury, J.A., Dept. of Embryology, Car-
negie Institution of Washington, Baltimore, Maryland: Iso-
lation of the maize Spm element and characterization of
the a-m2 alleles.
Schwarz-Sommer, Z., Tacke, E., Saedler, H., Max-Plank-In-
stitut filir ZOchtungsforschung, KOIn, Federal Republic of
Germany: Sequence comparison of states of al-m/ sug-
gests a model of Spm (En) action.
Kim, H.Y., Raboy, V., Schiefelbein, J., Furtek, D., Nelson,
0., Dept. of Genetics, University of Wisconsin, Madison:
Transcription of defective Spms in bz-m13 and change of
state derivatives in maize.
Gierl, A., Pereira, A., Cuypers, H., Schwarz-Sommer, Z.,
Saedler, H., Max-Planck-Institut fOr nchtungsforschung,
'<bin, Federal Republic of Germany: Molecular analysis
of En/Spm transposable element system of Zea mays.
Chairman: G. Fink, Whitehead Institute for Biomedical Research
Kermicle, J., Alleman, M., Laboratory of Genetics, Univer-
sity of Wisconsin, Madison: Analysis of tissue-specific dif-
ferences among maize R alleles by transposable element
mutagenesis and recombination.
Hoffman-Liebermann, B.,1 Liebermann, D.,' Cohen, J.B.,2
Kedes, L.K.,2 Cohen, S.N., 1 'Dept. of Genetics, 2The
MEDIGAN Project, Dept. of Medicine, Stanford University
School of Medicine, California: TU elements-A hetero-
geneous family of modularly structured eukaryotic trans-
posons.
Fawcett, D.H., Lister, C.K., Kellett, E., Finnegan, D.J., Dept.
of Molecular Biology, University of Edinburgh, Scotland:
Structure of the I factor controlling I-R hybrid dysgenesis
in Drosophila melanogaster.
Spence, S., Gilbert, D., Jenkins, N., Copeland, N., NCI-
Frederick Cancer Research Facility, Frederick, Maryland:
Acquisition, structure, and expression of newly acquired
ecotropic proviruses in SWR/J-RF/J hybrid mice.
Gerats, A.G.M., Dept. of Genetics, Free University, Amster-
dam, The Netherlands: Transposable elements in Petunia
hybrida.
Rhodes, PR., Vodkin, L.O., Plant Molecular Genetics Labo-
ratory, USDA, Beltsville, Maryland:
ders characterize the Tgm1 element of soybean.
Cornu, A., Farcy, E., INRA, Dijon, France: Genetics of trans-
position at anthocyanin loci in petunia.
Yang, W.K.,1 Ou, C.Y.,' Chang, L.Y.,2 Myer, F.E.,1 Yang,
D.M.,1 Roberson, L.E.,1 'Biology Division, Oak Ridge
National Laboratory; 2Dept. of Microbiology, University
of Tennessee, Knoxville: Expression of three distinct fami-
lies of related endogenous retroviral gene elements in
normal mouse tissues.
Salamini, F.,1 DiFonzo, N.,2 Marotta, R.,2 Motto, M.,2
'Max-Plank-Institut fur ZOchtungsforschung, Köln, Fed-
eral Republic of Germany; 2lstituto Sperimentale per la
Cerealicoltura Via Stezzano, Bergamo, Italy: Stability of
components of the o2-m(r)-Bg system of maize control-
ling elements.
SESSION 3 GENE REGULATION BY TRANSPOSABLE ELEMENTS. II.
Chairman: P. Schedl, Princeton University
Tsubota, S., Schedl, P., Dept. of Biology, Princeton Univer-
sity, New Jersey: Characterization of control mutations
generated by the mobilization of P elements.
Voelker, R.A., Sterling, J., National Institute of Environmen-
tal Health Sciences, Research Triangle Park, North Caro-
lina: Genetic and molecular characterization of suppres-
sor of sable in Drosophila melanogaster.
Parkhurst, S., Corces, V., Dept. of Biology, Johns Hopkins
University, Baltimore, Maryland: Retroviral elements and
transcriptional suppression in Drosophila.
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Zachar, Z., Chou, T.-R., Bingham, P.M., Dept. of Biochemis-
try, State University of New York, Stony Brook: Molecular
analysis of an allele-specific suppressor locus in Dro-
sophila.
Strand, D.,1 Lambert, M.,2 Franza, B.R.,2 McDonald, J.,1
'Dept. of Genetics, University of Georgia, Athens; 2Cold
Spring Harbor Laboratory, New York: Molecular analysis
of the transcriptional effects of insertion of a copia ele-
ment into the Adh locus of Drosophila melanogaster.
O'Hare, K.,1 Roiha, H.,2 Rubin, G.M.,2 'Dept. of Biochem-
istry, Imperial College of Science and Technology, Lon-
don, England; 2Dept. of Biochemistry, University of Cali-
fornia, Berkeley: P transposable element insertions at the
singed and white loci of Drosophila melanogaster.
Mount, S.M., Rubin, G.M., Dept. of Biochemistry, University
of California, Berkeley: Reversion and suppression of the
copia insertion mutation white-apricot in the fruit fly Dro-
sophila melanogaster.
Horak, I., Baumruker, T., Wirth, T., Gehe, C., Institut ftlir Vi-
rologie and Immunobiologie der Universitat WOrzburg,
Federal Republic of Germany: Tissue-specific expression
of mouse retrotransposons LTR-IS/MuRRS.
Goodenow, M., Hayward, W.S., Memorial Sloan-Kettering
Cancer Center, New York, New York: Insertional activa-
tion of the c-myc gene by avian leukosis virus- Integra-
tion and deletion of the provirus.
SESSION 4 CONTROL OF TRANSPOSITION AND EXCISION. I. MAINLY DROSOPHILA
Chairman: G.M. Rubin, University of California, Berkeley
Rubin, G.M., Laski, FA., Rio, D.C., Dept. of Biochemistry,
University of California, Berkeley: P-element transposition
in Drosophila.
Mullins, M.C., Rio, D.C., Rubin, G.M., Dept. of Biochemis-
try, University of California, Berkeley: Definition of the cis
sequences necessary for P-element transposition.
Simmons, M., Raymond, J., Boedigheimer, M., Dept. of Ge-
netics and Cell Biology, University of Minnesota, St. Paul:
The influence of nonautonomous P elements on manifes-
tations of hybrid dysgenesis in Drosophila melanogaster.
Robertson, H.M., Engels, W.R., Laboratory of Genetics,
University of Wisconsin, Madison: P-element regulation in
Drosophila melanogaster-A sensitive assay of the re-
pressor.
Engels, W., Robertson, H., Dept. of Genetics, University of
Wisconsin, Madison: Cytotype regulation of P elements in
the Drosophila germ line.
SESSION 5 POSTER SESSION
Sol, K., Lapoine, M., MacLeod, M., Nadeau, C., Du Bow,
M.S., Dept. of Microbiology and Immunology, McGill Uni-
versity, Montreal, Canada: A cloned fragment of He La
DNA containing consensus sequences of satellite II and
III DNA hybridizes with Drosophila P element and with
the 1.8-kb family of human Kpnl fragments.
Deka, N., Paulson, K.E., Willard, C., Schmid, C.W., Dept. of
Chemistry, University of California, Davis: A transposon-
like element in human DNA.
Furano, A.V., Robb, FT., Robb, S.M., D'Ambrosio, E., Na-
tional Institutes of Health, Bethesda, Maryland: Members
of the rat long interspersed repeated DNA family (LINE or
L1 family) are mobile DNA elements.
Potter, S.S.,' Bourekas, E.,' Lamb, A.,2 Lloyd, J.,2 Mc-
Neish, J.,' Pine, D.,1 Smyth-Templeton, N.,1 'Children's
Hospital Research Foundation, Division of Basic Science
Research, Cincinnati, Ohio; 2Wesleyan University, Mid-
dletown, Connecticut: Phylogenetic screening for trans-
posable elements, insertion of Drosophila transposable
elements into transgenic mice, and the nucleotide se-
quence of the loop of a complete foldback element.
Carlson, J.E., Kemble, R.J., Dept. of Plant Biology, Allelix,
Inc., Mississauga, Ontario, Canada: The corn elements
Ac (nuclear) and S2 (mitochondrial) share peptide se-
quence homology with viral reverse transcriptases.
Heidler, S.A., Liebman, S.W., Dept. of Biological Sciences,
University of Illinois, Chicago: Transposition of the yeast
Ty element into all regions of a gene.
Lim, K.J.,' Judd, B.H.2 'Dept. of Biology, University of
Wisconsin, Eau Claire; 2National Institute of Environmen-
tal Health Sciences, Research Triangle Park, North Caro-
lina: Mobility of a retrovirus-like transposable element
gypsy in two laboratory strains of Drosophila melanogas-
ter.
Walbot, V., McLaughlin, M., Warren, C., Dept. of Biological
Sciences, Stanford, University, California: Inactivation
and reactivation of the mutator transposable element sys-
tem in maize assayed by somatic instability of bronze2-
Mul .
Baker, B.J.,1 Fedoroff, N.,2 Schell, 1,"Max-Planck-Insti-
tut fOr Zuchtungsforschung, KOIn, Federal Republic of
Germany; 2Dept. of Embryology, Carnegie Institution of
Washington, Baltimore, Maryland: Transposition of maize
controlling element Ac in tobacco.
Ruan, K., Emmons, S., Dept. of Molecular Biology, Albert
Einstein College of Medicine, Bronx, New York: Excision
of the Caenorhabditis elegans transposable element Tc1
can be precise or imprecise.
Garon, C.F., Jansen, L.L., Rocky Mountain Laboratories,
NIAID, Hamilton, Montana: Molecular cloning and char-
acterization of inverted repeat sequences in human pla-
cental DNA.
Shell, B., Szurek, P., Dunnick, W., Dept. of Microbiology
and Immunology, University of Michigan Medical School,
Ann Arbor: Interruption of immunoglobulin heavy-chain
switch regions by insertion of transposon-like element
MS3 in murine plasmacytoma P3.
Kim, B.D., Dept. of Plant Sciences, University of Rhode Is-
land, Kingston: Four-stranded DNA-An intermediate of
site-specific recombination.
Dreyfus, D.H., Emmons, S.W., Dept. of Molecular Biology,
Albert Einstein College of Medicine, Bronx, New York:
Properties of a polymorphic foldback family in Caenor-
habditis elegans.
Coup land, G.,1 Baker, B.,2 Fedoroff, N.,3 Schell, J.,2 Star-
linger, P.,"Institut fur Genetik, University of Cologne;
2Max-Planck-Institut fOr ZOchtungsforschung, }<bin, Fed-
eral Republic of Germany; 3Carnegie Institution of Wash-
ington, Baltimore, Maryland: An assay for Ac excision in
tobacco.
Kunze, R., Star linger, P., Institut fOr Genetik, University of
Cologne, Federal Republic of Germany: Studies on the
expression of transposable element Ac.
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Lechelt, C.,' Laird, A.,2 Star linger, P.,"Institut fur Genetik,
University of Cologne, Federal Republic of Germany;
2State Dept. of Science, Canberra, Australia: The P locus
of Zea mays.
Merckelbach, A., Star linger, P., Institut fOr Genetik, Univer-
sity of Cologne, Federal Republic of Germany: The aber-
rant Ds element in the Adh 1 -2F 11 allele.
Wier-Neumann, M., Fusswinkel, H , Star linger, P, Institut
fOr Genetik, University of Cologne, Federal Republic of
Germany: Studies on the expression of the Zea mays
controlling element activator at the protein level.
SESSION 6 CONTROL OF TRANSPOSITION AND EXCISION. II
Chairman: P. Anderson, University of Wisconsin
Anderson, R, Collins, J., Eide, D., Saari, B., Dept. of Ge-
netics, University of Wisconsin, Madison: Insertion and
excision of the nematode transposable element Tcl.
Levitt, A., Ruan, K., Nelson, K., Emmons, S., Dept. of Mo-
lecular Biology, Albert Einstein College of Medicine,
Bronx, New York: Regulation of transposable elements in
Caenorhabditis elegans.
Moerman, D.G., Mori, I., Benian, G.M., Waterston, R.H.,
Dept. of Genetics, Washington University, St. Louis, Mis-
souri: Genetic and molecular studies of the transposable
element Tcl in Caenorhabditis elegans.
Rose, A.M., Harris, L.J., Rattray, B., Babity, J.M., Dept. of
Medical Genetics, University of British Columbia, Van-
couver, Canada: Tcl transposition in Bristol strains of
Caenorhabditis elegans.
WORMS AND YEAST
Garfinkel, D.J., NCI-Frederick Cancer Research Facility,
Frederick, Maryland: The transpositional competence of
Ty elements in yeast.
Clare, J., Farabaugh, P., Dept. of Microbiology, University
of Connecticut Health Center, Farmington: The gene en-
coding the reverse transcriptase of Ty elements is ex-
pressed by translational frameshifting.
Rothstein, R., Chrebet, G., Beniaminowitz, A., Wallis, J.W.,
Dept. of Genetics and Development, Columbia University
College of Physicians & Surgeons. New York, New York:
Genetic control of delta recombination.
Kingsman. A.J., Adams, S., Mellor, J.. Malim, M., Kings-
man, S.M., Dept. of Biochemistry, University of Oxford,
England: Proteins and particles of yeast transposon Ty.
SESSION 7 MUTATIONS CAUSED BY TRANSPOSABLE ELEMENTS IN PLANTS
Chairman: D.S. Robertson, Iowa State University
Robertson, D.S., Dept. of Genetics, Iowa State University,
Ames: Genetic analysis of putative deletions induced by
the Mu system of maize.
Free ling, M., Sundaresan, V., Chen, C.-H., Oishi, K., Vayda.
M., Lillis, M., Dept. of Genetics, University of California,
Berkeley: The Mu transposons of maize.
Bennetzen, J.L., Dept. of Biological Sciences, Purdue Uni-
versity, West Lafayette, Indiana: Genetic and molecular
properties of the Mu transposable element system of
maize.
Chandler, V.,' Rivin, C.,2 'Institute of Molecular Biology.
University of Oregon, Eugene; 2Dept. of Botany and
Plant Pathology, Oregon State University, Corvallis: Mo-
lecular properties of endogenous Mu elements in maize.
Chourey, RS.,12 Still, RE.,2 DeRobertis, G.A.,2 'USDA-
ARS, 2University of Florida, Gainesville: Altered temporal
and/or spatial expression of sucrose synthetase genes in
McClintock's sm-m6258 and Ac-induced revertant alleles
in maize.
SESSION 8a USES OF TRANSPOSONS
Chairman: P.A. Peterson, Iowa State University
Peterson, P.A.,' Wienand, U.,2 Paz-Ares, J.,2 Weydemann,
U.,2 Niesbach-KlOsgen, U.,2 Martin, W.,2 Saedler, H.,2
'Dept. of Agronomy, Iowa State University, Ames; 2Max-
Plank-Institut, KOln, Federal Republic of Germany: Four
decades of studies with the 9.4-kb enhancer transposa-
ble element lead to the cloning of four genes in Zea
mays.
Shepherd, N.S., ' Schwarz-Sommer, Z.,2 Sorrentino, J.,'
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Dennis. E.S.,' Taylor. B.H..' Peterson, T.A.,' Howard,
E.A.,' Walker, J.A.,' Gerlach, W.L.,' Sachs, M.M.,1 Pea-
cock, W.J.,' Schwartz. D.,3 Beach, L.,"CSIRO Division
of Plant Industry, Canberra, Australia; 2University of Indi-
ana, Bloomington: 3Washington University, St. Louis,
Missouri; 'Pioneer Hi-Bred Seeds, Johnston, Iowa: The
Ac/Ds controlling element system of maize.
Dbring. H.-P., Nelsen. B., Tillmann, E., Institut fOr Genetik.
University of Cologne, Federal Republic of Germany: Ds-
mediated rearrangements at the sh locus of maize.
Coen, E., Martin, C.. Robbins, T., Mackay. S.. Hudson, A..
Almeida, J.. Carpenter, R., John Innes Institute, Norwich,
England: Novel patterns of plant gene expression arise
by transposable element excision and rearrangement.
Sommer. H.. Bonas, U., Hehl, R.. Krebbers. E., Piotrowiak,
R., Saedler, H., Max-Plank-Institut fOr Zuchtungsfor-
schung. KO ln, Federal Republic of Germany: Transposa-
ble elements at the nivea locus of Antirrhinum majus.
Mattes, M..' 'E.I. du Pont de Nemours & Co., Wilming-
ton, Delaware: 2Max-Planck Institut fOr ZOchtungsfor-
schung, KOln, Federal Republic of Germany: Unstable al-
leles of the Al gene of Zea mays.
Williamson, V.M., Paquin. C.E.. Walton, J.. ARCO Plant Cell
Research Institution, Dublin, California: Cloning of the
Adh4 gene of yeast by Ty tagging.
SESSION 8b EVOLUTION AND DISTRIBUTION OF P ELEMENTS
Chairman: P.A. Peterson, Iowa State University
Petes, T.D.,' Goebl, M.,2 Vincent, A.,' Stamenkovich, D.,1
'Dept. of Molecular Genetics and Cell Biology, University
of Chicago, Illinois; 2Dept. of Genetics, University of
Washington, Seattle: Genetic factors influencing the
spread of transposable elements in the yeast genome.
Langley, C.H., National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina: Popu-
lation genetics of copia-like elements.
Saedler, H., Schwarz-Sommer, Z., Max-Plank-Institut kir
ZUchtungsforschung, KOln, Federal Republic of Ger-
many: Plant transposable elements and their role in evo-
lution.
SESSION 9 INTERMEDIATES AND ENZYMES
Bucheton, A., Simone lig, M., Crozatier, M., Vaury, C., Pe lis-
son, A., Laboratoire de Genetique, Universite de Cler-
mont-Ferrand, Aubiere, France: Intraspecific and inter-
specific distribution of sequences homologous to the I
factor involved in IR hybrid dysgenesis in Drosophila me-
lanogaster.
Georgiev, G.P., Gerasimova, Mizrokhi, L.J., Ilyin, Y.V.,
Institute of Molecular Biology, USSR Academy of Sci-
ences, Moscow: Transposition explosions and transposi-
tion memory in Drosophila melanogaster.
Chairman: J. Strathern, NCI-Frederick Cancer Research Facility
Varmus, H.E.,1.2 Mossie, K.G.,' Hagino-Yamagishi, K.,2
Donehower, L.,2 Basu, S.,2 Depts. of 'Biochemistry and
Biophysics, 2Microbiology, University of California, San
Francisco: Characterization of Mo-MLV integration and
putative retrotransposon intermediates in Drosophila and
yeast.
Strathern, J.N., Raveh, D., NCI-Frederick Cancer Research
Facility, Frederick, Maryland: Physical intermediates gen-
erated during the mating-type switch in Saccharomyces
cerevisiae.
Skalka, A.M.,' Duyk, G.,2 Alexander, F.," Cobrinik, D.,2
Soltis, D.,' Leis, J.,2 Dept. of Molecular Oncology,
Roche Institute of Molecular Biology, Nutley, New Jersey;
2Dept. of Biochemistry, Case Western Reserve University,
Cleveland, Ohio: Integration of avian retroviral DNA-
Biochemical studies.
Klar, A.J.S., Cold Spring Harbor Laboratory, New York: De-
velopmental asymmetry among daughter cells is a con-
sequence of inheriting nonequivalent parental DNA
chains in fission yeast.
Grandgenett, D., Institute for Molecular Virology, St. Louis
University, Missouri: Nuclease mechanism of the avian
retrovirus pp32 integrase.
Goff, S.R, Roth, M.J., Tanese, N., Colicelli, J., Dept. of Bio-
chemistry and Molecular Biophysics, Columbia Univer-
sity College of Physicians & Surgeons, New York, New
York: Analysis of the integration site and integrase func-
tion of the Moloney murine leukemia virus.
Flavell, A., Brier ley, C., Dept. of Biochemistry, University of
Dundee, Scotland: Structure and origin of extrachromo-
somal copia elements.
Veluthambi, K., Jayaswal, R.K., Hallberg, C., Gelvin, S.B.,
Dept. of Biological Sciences, Purdue University, West La-
fayette, Indiana: Molecular genetics of Agrobacterium tu-
mefaciens- Plant interactions.
Greenblatt, I.M., Depts. of Molecular and Cell Biology, Uni-
versity of Connecticut, Storrs: Ac transposition from P in
maize.
Chen, J., Greenblatt, I., Dellaporta, S.L., Cold Spring Har-
bor Laboratory, New York: Molecular analysis of Ac trans-
position from P locus in maize.
Ilyin, Y.V., Arkhipova, I.R., Mazo, S., Institute of Molecular
Biology, USSR Academy of Sciences, Moscow: Reverse
transcriptase intermediates in transposition of mdg ele-
ments in Drosophila melanogaster.
I. Mori, K. Nelson
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RNA Processing
May 14-May 18
ARRANGED BY
Robert P. Perry, Institute for Cancer Research, Philadelphia
Hugh D. Robertson, Rockefeller University
Susan M. Berget, Baylor College of Medicine
322 participants
The RNA Processing spring meeting brought together researchers
interested in
all aspects of the maturation of primary transcripts into mature
functional RNA
molecules, as well as the processing reactions involved in forming transfer,
mes-
senger, and ribosomal RNAs in bacteria, yeast, and higher cells.
The five-day program included two full poster sessions and eight sessions on
RNA catalyzed reactions, structure and mechanisms, tRNA processing, rRNA
processing, mRNA splicing, mRNA processing, and metabolism, small RNAs
and RNPs, and Poly(A) and 3' ends.
This meeting was supported in part by the National Institute of General Medi-
cal Sciences/National Institutes of Health and the National Science Foundation.
SESSION 1 RECOGNITION SIGNALS FOR mRNA SPLICING
Chairman: C. Weissmann, University of Zurich
Aebi, M., Hornig, H., Weissmann, C., Institut fOr Molekular-
biologie I, Universitat Zurich, Switzerland: Sequence re-
quirements for splicing of pre-mRNA of higher eukary-
otes.
Ohshima, Y., Tatei, K., Kitayama, H., Takemura, K., May-
eda, A., Institute of Biological Sciences, University of Tsu-
kuba, Japan: Sequence-specific binding to 5' and 3'
splice sites by an snRNP fraction.
H. Robertson, R. Cole, W. Filipowicz
176
Reed, R., Maniatis, T., Dept. of Biochemistry and Molecular
Biology, Harvard University, Cambridge, Massachusetts:
A role for exon sequences and splice site proximity in
splice site selection.
Zhuang, Y., Chabot, B., Weiner, A.M., Dept. of Molecular
Biophysics and Biochemistry, Yale University, New Ha-
ven, Connecticut: Design and construction of a suppres-
sor U1 snRNA.
Zillman, M., Robberson, B., Berget, S.M., Dept. of Bio-
chemistry, Baylor College of Medicine, Houston, Texas:
Ul, U2, and U4/6 snRNPs are required for ordered as-
sembly of the active spliceosome.
Black, D.L., Steitz, J.A., Dept. of Molecular Biophysics and
Biochemistry, Yale University, New Haven, Connecticut:
Evidence for the involvement of the snRNP containing
the U4 and U6 RNAs in premessenger splicing.
Noble, J., Chaudhuri, M., Prives, C., Manley, J.L., Dept. of
Biological Sciences, Columbia University, New York, New
York: Alternative splicing path-ways of SV40 early pre-
mRNA in vitro.
Cellini, A., Rossi, J., Dept. of Molecular Genetics, Beckman
Research Institute of the City of Hope, Duarte, California:
Intron-encoded features governing the choice of branch
site during pre-mRNA splicing in yeast.
Pikielny, C.,' Rosbash, M.,2 Depts. of 'Biochemistry,
2Biology, Brandeis University, Waltham, Massachusetts:
A high-resolution assay of spliceosome assembly and
identification of three snRNAs associated with the yeast
spliceosome.
Freistadt, M.S.,' Cross, G.A.M.,' Branch, A.D.,2 Robert-
son, H.D.,2 Laboratory of 'Molecular Parasitology,
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chusetts: Selective degradation of mRNAs mediated by a
sequence in the 3' noncoding region.
Svensson, C., Akusjarvi, G., Dept. of Medical Genetics.
Uppsala University, Biomedical Center, Sweden: Defec-
tive RNA splicing in the absence of adenovirus VA RNA,.
Caffarelli, E., Gehring, C., Fragapane, P., Cutruzzola, F..
Bozzoni, I., Centro Acidi Nucleici, CNR, Roma, Italy:
SESSION 6 CATALYTIC RNA
Chairman: P. Sharp, Massachusetts Institute of Technology
Zaug, A.J., Cech, T.R., Dept. of Chemistry and Biochemis-
try, University of Colorado, Boulder: Discovery of a new
RNA enzyme.
Burke, J.,' Kerker, B.,' Tierney, W.,' Williamson, C.,'
Zaug, A.,2 Cech, T.,2 'Dept. of Chemistry, Williams Col-
lege, Williamstown, Massachusetts; 2Dept. of Chemistry
and Biochemistry, University of Colorado, Boulder: Func-
tions of highly conserved pairing and nonpairing se-
quences in self-splicing of the Tetrahymena rRNA inter-
vening sequence.
Hall, D.,' Povinelli, C.,' Ehrenman, K.," Pedersen-Lane.
J.,2 Belfort, M.,2 'School of Applied Biology, Georgia
Tech, Atlanta; 2Wadsworth Laboratories, New York State
Dept. of Health, 3Dept. of Microbiology and Immunology.
Albany Medical College: Nondirected splicing-defective
mutations in the intron of the phage T4 td gene.
Peebles, C.L.,' Romiti, S.L.,' Perlman, P.S.,2 Jarrell, K.A.,2
'Dept. of Biological Sciences, University of Pittsburgh,
Pennsylvania; 2Dept. of Genetics, Ohio State University,
Columbus: Alternative reactions of a type II self-splicing
intron.
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Splicing of ribosomal protein transcripts in Xenopus lae-
vis
Dabeva, M.A., Warner. J.R., Dept. of Cell Biology, Albert
Einstein College of Medicine. Bronx, New York: A yeast
ribosomal protein regulates the splicing of the transcript
of its own gene.
Ross, J., Kobs, G., Peitz, S.W.. Brewer, G., McArdle Labo-
ratory for Cancer Research and Dept. of Pathology, Uni-
versity of Wisconsin, Madison: Turnover of mRNA in cell-
free extracts.
Yost, H.J., Lindquist. S.L., Dept. of Molecular Genetics and
Cell Biology. University of Chicago, Illinois: RNA splicing
is interrupted by heat shock and rescued by heat-shock
protein synthesis.
Tabak. H.F., ' Van der Horst, G.,' Kamps, L.,' Arnberg,
A.C.,2 Van der Veen, R.,' Grivell. L.A.,' Laboratory of
Biochemistry, University of Amsterdam: 2Laboratory of
Biochemistry, State University of Groningen, The Nether-
lands: Intron- catalyzed formation of interlocked RNA cir-
cles.
Altman, S., Baer. M., Gold, H., Guerrier- Takada, C., Law-
rence. N., Vioque, A., Dept. of Biology, Yale University,
New Haven, Connecticut: Enzymatic cleavage of RNA by
RNA.
Pace, N.R., Reich, C.. Olsen. G.J., Waugh. D.S., James.
B.D., Liu, J., Pace, B.. Gardiner, K.J., Marsh, T.L., Dept.
of Biology, Indiana University, Bloomington: The Bacillus
subtilis RNase P.
Chang, D.D.. Clayton, D.A.. Dept. of Pathology. Stanford
University School of Medicine, California: A site-specific
endoribonuclease involved in the priming of mitochon-
dria) DNA synthesis at the heavy-strand origin-The en-
zymatic activity requires a novel
- 130-nucleotide RNA
species.
SESSION 7 RIBOSOMAL RNA PROCESSING
Chairman: A. Lambowitz, St. Louis University School of Medicine
Garriga, G., Lambowitz, A., Dept. of Biochemistry, St. Louis
University School of Medicine, Missouri: Protein-depen-
dent splicing of a group I intron in RNP preparations and
by soluble fractions.
Tanner, N.K., Cech, T.R., Dept. of Chemistry and Biochem-
istry, University of Colorado, Boulder: A guanosine bind-
ing site required for cyclization of the self-splicing IVS
RNA from Tetrahymena thermophila.
Uhlenbeck, 0.C., Wu, H., Milligan, J., Sampson, J., Dept.
of Chemistry and Biochemistry, University of Colorado,
Boulder: Structure:Function relations in RNA.
Robertson, H.D., Benenfeld, B.J., Niebling, K., Branch,
A.D., Rockefeller University, New York, New York: Local
tertiary structure at an RNase III cleavage site as defined
by ultraviolet light-induced cross-linking.
Wollenzien, PL., Dept. of Biochemistry, St. Louis University
School of Medicine, Missouri: Structure of E. coil 16S
Posters:
Plunkett, G., III, Echols, H., Dept. of Molecular Biology, Uni-
versity of California, Berkeley: The role of RNA process-
ing and degradation in retroregulation of bacteriophage
lambda int gene expression.
Porter, T.N., Berget, S.M., Wilson, J.H., Dept. of Biochemis-
try, Baylor College of Medicine, Houston, Texas: In direct
competition, splicing predominates over polyadenylation.
Raziuddin, Braaten, D.C., Schlessinger, D., Dept. of Micro-
biology and Immunology, Washington University School
of Medicine, St. Louis, Missouri: Transfected mouse
rDNA is expressed from a new upstream start site.
Reddy, R., Henning, D., Das, G., Dept. of Pharmacology,
Baylor College of Medicine, Houston, Texas: U6 RNA, a
capped snRNA, is transcribed by RNA polymerase III.
Reyes, V.M., Strobel, M., Abelson, J., Division of Biology,
California Institute of Technology, Pasadena: tRNA splic-
ing in Saccharomyces cerevisiae.
Riva, S.,' Morandi, C.,' Tsoulfsas, P.,' Biamonti, G.,'
Werr, H.,2 Henrich, B.,2 Melchers, K.,2 Schafer, K.R,2
'CNR/Instituto di Benetica Biochimica Pavia, Italy; 2Ruhr-
Universitat Bochum, Federal Republic of Germany:
hnRNA core protein Al is a precursor of ssDNA binding
protein UP I -cDNA cloning reveals a complex family of
sequences.
Rymond, B., Rosbash, M., Dept. of Biology, Brandeis Uni-
versity, Waltham, Massachusetts: In vitro nuclease map-
ping of yeast RP51A pre-mRNA during splicing.
Sachs, A.B.,' Bond, M.W.,2 Kornberg, R.D.,' 'Dept. of
Cell Biology, Stanford University; 2DNAX Research Insti-
tute of Molecular and Cellular Biology, Palo Alto, Califor-
nia: A single gene for both nuclear and cytoplasmic poly-
adenylate-binding proteins- Isolation, sequence, and
expression.
Sakamoto, H., Ohno, M., Shimura, Y., Dept. of Biophysics,
Faculty of Science, Kyoto University, Japan: Preferential
excision of a 5'-proximal intron in the in vitro splicing re-
action of chicken d-crystallin pre-mRNA.
Sarkar, N., Karnik, P., Taljanidisz, J., Sasvari-Szekely, M.,
Boston Biomedical Research Institute and Dept. of Bio-
rRNA-RNA sites in contact with the 3' terminal region
identified by psoralen cross-linking and reverse transcrip-
tion.
Rairkar, A., Rubino, H., Lockard, R.E., Dept. of Biochemis-
try, Cornell University Medical College, New York, New
York: The secondary structure of rabbit 18S ribosomal
RNA determined from biochemical and phylogenetic
data.
Kass, S.,' Craig, N.,2 Sollner-Webb, B.,1 'Johns Hopkins
University School of Medicine, Baltimore; 2University of
Maryland Baltimore County, Catonsville: The primary pro-
cessing events of mouse and human rRNA are analo-
gous and directed by conserved sequences.
Mishima, Y., Katayama, M., Mitsuma, T., Ogata, K., Dept. of
Biochemistry, Niigata University School of Medicine, Ja-
pan: Processing of mouse rRNA in a cell-free system.
logical Chemistry, Harvard Medical School, Massachu-
setts: Poly(A) mRNA in prokaryotes.
Sato, K., Ito, R., Baek, K.-H., Agarwal, K., Dept. of Bio-
chemistry and Molecular Biology, University of Chicago,
Illinois: RNA polymerase II transcription termination is
regulated by a specific DNA sequence.
Scherrer, K.,' Grossi de Sa. F.,' de Sa, C.,' Akhayat, O.,'
Ouvion, F.,1 Pal, WK.,' Buri, J.,' Schmid, P.,2 'Institut
Jacques Monod, Paris, France; 2University of Stuttgart,
Federal Republic of Germany: Presenting the prosome-
An ubiquitous morphologically defined RNP particle re-
lated to heat-shock and autoimmune antigens possibly
involved in posttranscriptional controls.
Shapiro, R., Herrick, D., Steel, L., Blinder, D., Manrow, R.,
Jacobson, A., Dept. of Molecular Genetics and Microbi-
ology, University of Massachusetts Medical School,
Worcester: Determinants of mRNA stability in Dictyo-
stelium.
Shiraishi, H., Sakamoto, H., Shimura, Y., Dept. of Biophys-
ics, Faculty of Science, Kyoto University, Japan: Func-
tional regions fo the RNA subunit of RNase P.
Sierakowska, H.,' Furdon, R,2 Szer, W.,' Kole, R.,2 'Dept.
of Biochemistry, New York University School of Medicine,
New York, New York; 2Dept. of Pharmacology and Line-
berger Cancer Research Center, University of North Car-
olina, Chapel Hill: Inhibition of splicing and cleavage at
the 5' splice site by anti-hnRNP and anti-Ul-RNP anti-
bodies.
Siliciano, P., Patterson, B., Riedel, N., Guthrie, C., Dept. of
Biochemistry and Biophysics, University of California,
San Francisco: Two yeast snRNAs thought to be involved
in splicing are essential for growth.
Spector, D.L.,' Smith, H.C.,2 Ochs, R.L.,2 Bennett, C.F.,2
Yeoman, L.C.,2 'Cold Spring Harbor Laboratory, Cold
Spring Harbor, New York; 2Dept. of Pharmacology, Bay-
lor College of Medicine, Houston, Texas: Antibody
probes to U snRNPs and other nuclear antigens define a
subnuclear domain-The nucleoplasmic reticulum.
Sperry, A.O., Berget, S.M., Dept. of Biochemistry, Baylor
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cleavage of the SV40 early poly(A) site within the down-
stream "TG box."
Stanford, D.R., Roh leder, A., Neiswanger, K., Wieben, E.,
Dept. of Biochemistry and Molecular Biology, Mayo
Foundation, Rochester, Minnesota: Characterization and
sequence analysis of a cDNA and genomic clones for an
Sm antigen.
Steger, G.,' BrOggemann, W.,' Rosenbaum, V.,' Klotz,
G.,2 Tab ler, M.,3 Sanger, H.L.,3 Riesner, D.,"Institut fur
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2Abteilung fur Mikrobiologie, Universitat Ulm, 3Max-
Planck Institut kir Biochemie, Martinsried, Federal Re-
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Strittmatter, G., Koessel, H., Institut fuer Biologie III, Univer-
sitaet Freiburg, Federal Republic of Germany: Splicing
activity for tRNA processing in extracts from maize chlo-
roplasts.
Sullivan, FX., Latham, J.A., Jr., Cech, T.R., Dept. of Chem-
istry and Biochemistry, University of Colorado, Boulder:
Tertiary structure probes of a catalytic RNA's active site.
Tamm, J., Couto, J., Parker, R., Guthrie, C., Dept. of Bio-
chemistry and Biophysics, University of California, San
Francisco: Suppressors that restore RNA splicing in
yeast.
Tazi, J., Alibert, C., Temsamani, J., Reveillaud, I., Cathala.
G., Brunel, C., Jeanteur, P., CNRS, Laboratoires de
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Thomas, C.L., Winslow, G., Muto, A.. Gregory, Zim-
mermann, R.A., Dept. of Biochemistry, University of Mas-
sachusetts, Amherst: Analysis of site-specific mutations
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Thomas, J.R., Little, R., Braaten, D.C., Powers, J., Schles-
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Pasteur, Paris, France: Fungal snRNAs.
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SESSION 8 TRANSFER RNA PROCESSING
Chairman: W. Filipowicz, Friedrich Miescher Institute
Clark, M.W., Abelson, J., Division of Biology, California Insti-
tute of Technology, Pasadena: The cellular location of
tRNA ligase in Saccharomyces cerevisiae.
Willis, I.,' SOII, D.,' Greer, C.L.,2 'Dept. of Molecular Bio-
physics and Biochemistry, Yale University, New Haven.
Connecticut; 2Dept. of Biological Chemistry, College of
Medicine, University of California, Irvine: Inefficient, im-
precise, and independent splice-site cleavage of mutant
tRNA precursors by the Saccharomyces cerevisiae splic-
ing endonuclease.
Belford, H.G., Greer, C.L., Dept. of Biological Chemistry,
College of Medicine, University of California, Irvine: Sta-
ble complex formation in tRNA splicing in vitro.
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dle tuber viroid RNAs in vitro.
Tschudi, C., Ullu, E., Crothers, D.M., Richards, F.F., Yale
McArthur Center, New Haven, Connecticut: In vivo
expression of the calmodulin locus in Trypanosoma bap
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Umesono, K.,' Kohchi, T.,' Fukuzawa, Ohyama,
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of Science, 'Research Center for Cell and Tissue Cul-
ture, Faculty of Agriculture, Kyoto University, Japan: A
possible role of in vivo trans-splicing- Organization of a
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Walstrum, S.A., Uhlenbeck, 0.C., Dept. of Chemistry and
Biochemistry, University of Colorado, Boulder: Determin-
ing the substrate specificity of a self-splicing RNA using
modified oligoribonucleotides.
West, D., Belfort, M., Maley, G., Maley, F., New York State
Dept. of Health, Albany, New York: In vivo and in vitro
expression of an intron-deleted phage T4 td gene.
Westaway, S., Phizicky, E., Abelson, J., Division of Biology,
California Institute of Technology, Pasadena: Saccharo-
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Whitelaw, E., Proudfoot, N.J., Sir William Dunn School of
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Word, C.W., Chen, Y.-W., Vitetta, E.S., Tucker, P.W., Dept. of
Microbiology, University of Texas Health Science Center,
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Yancey, S.D., Arraiano, C.M., Kushner, S.R., Dept. of Ge-
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thesda, Maryland: Purification and characterization of a
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cursor processing of a rat tRNAGI, gene.
Hai, T.-Y, Reilly, R.M., RajBhandary, U.L., Dept. of Biology,
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Massachusetts Institute of Technology, Cambridge: The
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Analyses of mutants in the Ti C loop of the Escherichia
coli Su III tRNATYr.
Roe, B.A., Wilson, R.K., Dept. of Chemistry, University of
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Escherichia coli tRNAPhe-Aminoacylation kinetics and
codon-reading properties.
Buzayan, J.M., Hampel, A., Gerlach, W.L., Bruening, G.,
Dept. of Plant Pathology, College of Agriculture and Envi-
RNA Tumor Viruses
ronmental Sciences, University of California, Davis: Auto-
lytic processing and subsequent spontaneous ligation of
RNAs that are complementary to a plant virus satellite
RNA.
Tab ler, M., Tsagris, M., Gunther, I., Sanger, H.L., Max-
Planck Institut fOr Biochemie, Martinsried, Federal Re-
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Robert Eisenman, Fred Hutchinson Cancer Research Center
Anna M. Skalka, Roche Institute of Molecular Biology
353 participants
The 1986 RNA Tumor Virus meeting brought together over 400 researchers with
interests ranging from clinical medicine to molecular genetics. The meeting re-
flected three major currents in the RNA tumor virus field: retroviral structure and
replication, the biology of human retroviruses, and the structure and function of
retroviral and cellular oncogenes. Each of these areas tended to draw upon one
another. Studies on retroviral replication focused on the structure and mecha-
nism of action of the viral endonuclease in mediating integration of viral DNA and
on the interaction of retroviral structural proteins with nucleic acids. An important
concept concerned the prevalence of ribosomal frameshifting in generating and
regulating the quantities of viral gene products. Progress was reported in identi-
fying a viral RNA structural motif that may promote frameshifting.
Considerable attention was devoted to the mechanisms regulating retroviral
gene expression both by cell-type-specific factors and by factors encoded within
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the viral genome. The theme of trans-activation
was particularly apparent in stud
ies of the human retroviruses. Of potential importance
was the finding of an RNA
from a new open reading frame within the HIV
(AIDS retrovirus) trans-activator
region, whose product may play a role in relieving repression
of HIV structural
gene expression. Virus-encoded trans-activating
factors appear likely to not only
affect viral genes, but probably modulate expression
of cellular genes as well,
and thus their action may have important consequences
for the host cell. Studies
on HIV showed that this virus infects B cells as
well as T cells and neuronal cells.
Nearly half of the presentations at the meeting
concerned viral and cellular
oncogenes. Sessions dealt with oncogene proteins
related to growth factors and
their receptors and oncogenes whose products
function in the nucleus and cyto-
plasm. Highlights included the findings that inhibition of phosphorylation
at the
carboxy terminus of the c-src activates its kinase activity, a transformation
pheno-
type induced by v-src is related to splicing of a cryptic
intron, the protein en-
coded by myc can be found in association with snRNPs,
and the function of the
v-fms/CSF-1 receptor product may involve activation of
phospholipase C.
This meeting was supported in part by the Cold Spring Harbor Laboratory
Cancer Center Grant from the National Cancer Institute, National
Institutes of
Health.
SESSION 1 MOLECULAR BIOLOGY OF REPLICATION AND PROVIRAL INTEGRATION
Chairmen: J. Coffin, Tufts University School of Medicine
H. Robinson, Worcester Foundation
Vijaya, S.. Steffen. D.L.. Robinson. H.L., Worcester Founda-
tion for Experimental Biology, Shrewsbury. Massachu-
setts: Retroviral integrations map near regions of open
chromatin structure.
Shih. C.-C., Coffin, J.M., Tufts University School of Medi-
cine. Boston, Massachusetts: Analysis of avian retrovirus
integration sites.
Soltis, D.,1 Cobrinik, D.,2 Terry. R.,' Leis. J..2 Skalka,
A.M.,"Dept. of Molecular Oncology, Roche Institute of
Molecular Biology, Nutley, New Jersey: 'Dept. of Bio-
chemistry. Case Western Reserve University, Cleveland.
Ohio: Active avian retroviral pol gene proteins expressed
in E. co /i.
Roth, M.J., Tanese, N., Okada, A., Goff. S.P., Dept. of Bio-
chemistry and Molecular Biophysics. Columbia Univer-
sity College of Physicians & Surgeons. New York. New
York: Expression of the 3' terminal region of the pol gene
of Mo-MLV in bacteria and animal cells.
Levin, J.G..' Hu, S.C..' Court. D..' Zweig. M..3 Rein. A
'NICHD, 'NCI, National Institutes of Health. Bethesda.
Maryland: 3PRI, 4NCI-Litton Frederick Cancer Research
Facility. Frederick. Maryland: A disulfide-linked reverse
transcriptase-endonuclease complex in MLV particles.
Ramsey. C.A.. Luk. K.-C.. Panganiban, A.T., McArdle Labo-
ratory for Cancer Research, University of Wisconsin,
Madison: DNA-DNA interaction is required for SNV DNA
integration; the integrase can mediate insertion of nonre-
troviral DNA in trans: integrase produced in E. coli has
DNA binding activity.
Katz, R.A., Skalka, A.M., Roche Institute of Molecular Biol-
ogy, Roche Research Center, Nutley. New Jersey: Ge-
netic and biochemical analysis of mutations in the ASLV
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po/ and pol-env overlap regions- Implications of pol pro-
teolytic processing and env splicing.
Cobrinik, D.,1 Katz, R.,2 Terry, R.,2 Skalka, A.M.,2 Leis,
JO 'Case Western Reserve University, Cleveland, Ohio;
2Roche Institute of Molecular Biology, Nutley, New Jer-
sey: LTR junction sequences required for in vitro ASLV
po/-endo cleavage and virus production.
Miller, C.K., Temin, H.M., McArdle Laboratory for Cancer
Research, University of Wisconsin, Madison: Analysis of
spontaneously arising revertants of nontransforming rel-
containing viruses.
Jacks, T.,1 Majors, J.,2 Luciw, P.,3 Varmus, H.E.,"Depts.
of Biochemistry and Microbiology, University of Califor-
nia, San Francisco; 2Dept. of Biological Chemistry, Uni-
versity of Washington School of Medicine, St. Louis, Mis-
souri; 3Chiron Research Laboratories, Chiron Corp.,
Emeryville, California: Analysis of ribosomal frameshifting
in retroviral gene expression.
Gloger, I., Panet, A., Hebrew University-Hadassah Medical
School, Jerusalem, Israel: Regulation of the readthrough
of the gag-pol genes in Mo-MLV-infected cells by gluta-
mine starvation.
SESSION 2 MOLECULAR BIOLOGY OF REPLICATION/RETROVIRAL VECTORS
Chairmen: V. Vogt, Cornell University
S. Hughes, NCI-Frederick Cancer Research Facility
Miernicki-Steeg, C., Southard, L., Vogt, V.M., Section of Bio-
chemistry, Molecular and Cellular Biology, Cornell Univer-
sity, Ithaca, New York: Binding of avian sarcoma and leu-
kosis virus p19gag to nucleic acids and membranes.
Leis, J.,1 Phillips, N.,1 Fu, X.,1 Tuazon, P.,' Traugh, J.,2
'Case Western Reserve University School of Medicine,
Cleveland, Ohio; 2University of California, Riverside:
RNA binding properties of the minor nucleocapsid pro-
tein pp19 of AMV- Possible regulation by phosphoryla-
tion.
Fu, X.,' Katz, R.,2 Skalka, A.,2 Leis, J.,' 'Case Western
Reserve University School of Medicine, Cleveland, Ohio;
2Roche Institute of Molecular Biology, Nutley, New Jer-
sey: Site-specific mutations of the major nucleocapsid
protein pp12 of RSV (Pr-C).
Gorelick, R.J.,1 Karpel, R.K.,2 Henderson, L.E.,' Orosz-
lan, S.,1 'NCI-Frederick Cancer Research Facility, Fred-
erick, Maryland; 2Dept. of Chemistry, University of Mary-
land, Catonsville: Interaction of murine viral proteins with
single-stranded polynucleotides.
Cunningham, J., Tseng, L., Scadden, D., Howard Hughes
Medical Institute and Dept. of Medicine, Brigham and
Women's Hospital, Boston, Massachusetts: Transfer of
the gene encoding the murine ecotropic virus receptor
into nonpermissive cells.
Booth, S.C., To, R.Y.-L., Neiman, P.E., Fred Hutchinson
Cancer Research Center, Seattle, Washington: Inhibition
of retroviral replication by anti-sense RNA.
Emerman, M., Temin, H.M., McArdle Laboratory for Cancer
Research, University of Wisconsin, Madison: Biochemical
analysis of gene suppression in retrovirus vectors.
Petropoulos, C.J.,' Ordahl, C.R,2 Hughes, S.H.,"NCI-
Frederick Cancer Research Facility, Frederick, Maryland;
2Dept. of Anatomy, University of California, San Fran-
cisco: Tissue-specific expression of chicken actin pro-
moters in retroviral vectors.
S. Hughes
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Stuhlmann, H., Jaenisch, R., Mulligan, R.C., Whitehead In-
stitute for Biomedical Research, Cambridge, Massachu-
setts: Insertion of a mutant DHFR cDNA into postimplan-
tation mouse embryos by a replication-competent murine
retrovirus.
Yu, S.F.,' Kantoff, P.W.,2 Giglio, A.,3 Eglitis, M.A.,2 Armen-
tano, D.,' McLachlin, J.R.,2 O'Reilly, R.,3 Karlsson, S.,2
Nienheuis, A.,2 Gilboa, E.,' Anderson, F.W.,2 'Dept. of
Molecular Biology, Princeton University, New Jersey;
2NCI, National Institutes of Health, Bethesda, Maryland;
3Sloan-Kettering Institute, New York, New York: Transfer
and expression of genes in primates using retroviral-me-
diated gene transfer.
SESSION 3 POSTER SESSION
Bache ler, L., Fels Research Institute, Temple University
School of Medicine, Philadelphia, Pennsylvania: Tran-
scriptional activity of integration sites for Mo-MLV.
Schulz, A.,' Hess, N.,2 Friedrich, R.,"University of Frei-
burg, 2Heinrich Pette Institute, University of Hamburg,
Federal Republic of Germany: Construction of an infec-
tious Fr-MLV containing a selectable marker.
Furkes, R.,' Evans, R.R.,2 Levin, J.G.,3 Yang, W.K.,2
'University of Tennessee, Oak Ridge Graduate School of
Biomedical Science, 2Biology Division, Oak Ridge Na-
tional Laboratory, 3NICHD, National Institutes of Health,
Tennessee: Identification of endonucleases in Gross pas-
sage A strain MLV.
Quinn, T., Mumm, S., Grandgenett, D., St. Louis University,
Institute for Molecular Virology, Missouri: Avian retrovirus
pp32 protein-In vitro, in situ, and in vivo analysis.
Sharmeen, L., Cywinski, A., Taylor, J., Fox Chase Cancer
Center, Philadelphia, Pennsylvania: The priming of retro-
virus plus-strand DNA synthesis.
Tanese, N., Roth, M.J., Goff, S.P., Dept. of Biochemistry
and Molecular Biophysics, Columbia University College
of Physicians & Surgeons, New York, New York: Analysis
of retroviral poi gene products by expression of fusion
proteins in E. coli.
Panet, A.,1.2 Baltimore, D.,"Whitehead Institute for Bio-
medical Research and Massachusetts Institute of Tech-
nology, Cambridge; 2Hebrew University-Hadassah Medi-
cal School, Jerusalem, Israel: Characterization of DNA
binding proteins and endonuclease activities in Mo-MLV.
Krump-Konvalinkova, V.,' Armentano, D.,' Hwang, L.,2
Gilboa, E.,"Dept. of Molecular Biology, Princeton Uni-
versity, New Jersey; 2Wistar Institute of Anatomy and
Physiology, Philadelphia, Pennsylvania: Alternative splic-
ing within the retroviral intron -A model for regulation of
RNA processing.
Stoltzfus, C.M., Berberich, S.L., Dept. of Microbiology, Uni-
versity of Iowa, Iowa City: Sequences between the env
and src genes influence splicing efficiency of RSV RNA.
Wills, J.W.,1 Weldon, R.A.,' Hunter, E.,2 'Dept. of Microbi-
ology, Oklahoma State University, Stillwater; 2Dept. of Mi-
crobiology, University of Alabama, Birmingham: Expres-
sion of the RSV gag gene in mammalian cells with an
SV40 vector.
Hecht, S.J., Coffin, J.M., Tufts University School of Medi-
cine, Boston, Massachusetts: Expression and processing
of the retroviral gag protein in E. coli.
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von Ruden, T,' Kantoff. PA Kohn, D A Armentano
D.,' Blaese, R M Gilboa, E.,' Anderson, F W 'Dept
of Molecular Biology, Princeton University, New Jersey;
:NCI, National Institutes of Health, Bethesda, Maryland
Correction of adenosine deaminase deficiency in human
T and B cells using retrovirus-mediated gene transfer.
Hizi, A.,' Henderson, L.E.,' Copeland, T.D.,' Majors, J. 2
Oroszlan, S.,"NCI-Frederick Cancer Research Facility'
Frederick, Maryland: ?Dept. of Biological Chemistry,
Washington University School of Medicine, St. Louis, Mis-
souri: Isolation and characterization of p30 -A putative
translational frameshift protein of MMTV.
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structural alterations.
Cooper, J.A., Fred Hutchinson Cancer Research Center,
Seattle, Washington: The carboxyterminus of p60°-src reg-
ulates its kinase activity.
Kmiecik, T.E., Shalloway, D., Dept. of Molecular and Cell Bi-
ology, Pennsylvania State University, University Park: Ac-
tivation of pp60c-sr, transforming activity by an amino
acid substitution at its major site of in vivo tyrosine phos-
phorylation.
Filson, A.,' Yonemoto, W.,' Lustig, A.,' Wang, J.,2
Brugge, J.,"Dept. of Microbiology, State University of
New York, Stony Brook; 2Dept. of Biology, University of
SESSION 13 ONCOGENES. IV. sislerbA-B/fms
Chairmen: C. Sherr, St. Jude Children's Research Hospital
S. Martin, University of California, Berkeley
Hannink, M., Donoghue, D.J., Dept. of Chemistry, Univer-
sity of California, San Diego, La Jolla: Mutants of the v-sis
gene encoding membrane-anchored and biologically ac-
tive gene products.
Escobedo, J.A.,1 Yarden, Y.,2 Daniel, T.O.,1 Fried, V.A.,3
Ullrich, A.,2 Williams, L.T.,"Howard Hughes Medical In-
stitute, University of California, San Francisco;
2Genentech, Inc., San Bruno, California; 3Dept. of Bio-
chemistry, St. Jude Children's Hospital, Memphis, Ten-
nessee: Structure of the PDGF receptor.
Ellis, L.,1 Morgan, D.O.,2 Clauser, E.,1 Edery, M.,1 Roth,
R.A.,2 Rutter, W.J.,"Hormone Research Institute, Uni-
versity of California, San Francisco; 2Dept. of Pharmacol-
ogy, Stanford University, California: Functional analysis of
genetically engineered insulin receptor mutants.
Rettenmier, C.W., Jackowski, S., Rock, C.O., Sherr, C.J.,
Depts. of Tumor Cell Biology and Biochemistry, St. Jude
Children's Research Hospital, Memphis, Tennessee:
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Woude, G.F., NCI-Frederick Cancer Research Facility,
Frederick, Maryland: The met oncogene in MNNG-HOS
cells is a rearranged gene with homology to tyrosine kin-
ases.
Sadowski, I.,' Stone, J.C.,2 Pawson, T.,"Mount Sinai
Hospital Research Institute, Toronto, Canada; 2Jackson
Laboratory, Bar Harbor, Maine: Contiguous catalytic and
extracatalytic domains required for transformation by
FSV p130gag-IPs.
California, San Diego, La Jolla: Detection of phosphoty-
rosine-containing proteins in polyoma-transformed cells.
Ballmer-Hofer, K., Burger, M.M., Biocenter of the University,
Basel, Switzerland: Complex formation between pp6Osrc
and vinculin in the plasma membrane of RSV-trans-
formed cells.
Simon, M.,1 Arrigo, A.-P.,2 Spahr, P.-F.,"Dept. of Molecu-
lar Biology, University of Geneva, Switzerland; 2Cold
Spring Harbor Laboratory, Cold Spring Harbor, New
York: Purification of a particle containing p34, the major
target of the tyrosine kinase activity of pp6Osrc.
Carter, C.,1 Howlett, A.R.,2 Bissell, M.J.,2 Martin G.S.,1
'Dept of Zoology, 2Lawrence Berkeley Laboratory, Uni-
versity of California, Berkeley: The tyrosine phosphoryla-
tion substrate p36- Developmental regulation in avian
limb, induction in cell culture, associa-
tion.
Sukegawa, J., Semba, K., Yamamoto, T., Toyoshima, K., In-
stitute of Medical Science, University of Tokyo, Japan:
Nucleotide sequences of cellular homologs of the yes on-
cogene of Y73 sarcoma virus.
Transformation by the v-fms oncogene product/ CSF-1
receptor.
Wheeler, E.F., Roussel, M.F., Rettenmier, C.W., Sherr, C.J.,
Dept. of Tumor Cell Biology, St. Jude Children's Research
Hospital, Memphis, Tennessee: The v-fms gene product
contains a functional leader peptide enabling transforma-
tion in the absence of FeLV gag sequences.
Van Beveren, C.,1 Coussens, L.,2 Wamsley, P.,' Dull, T.,2
Ullrich, A.,2 Verma, I.M.,1 'Molecular Biology and Virol-
ogy Laboratory, Salk Institute, San Diego; 2Genentech,
Inc., South San Francisco, California: The human c-fms
gene-Structure and transforming potential.
Gamett, D.C.,' Tracy, S.E.,2 Robinson, H.L.,1 1Worcestor
Foundation for Experimental Biology, Shrewsbury;
2Dept. of Molecular Genetics and Microbiology, Univer-
sity of Massachusetts, Worcester: Sequences encoding
the C-terminal domain of the EGF receptor determine the
disease specificity of v-erb B genes.
Damm, K., Beug, H., Graf, T., VennstrOm, B., European Mo-
lecular Biology Laboratory, Differentiation Programme,
Heidelberg, Federal Republic of Germany: The coopera-
tive active of v-erbA with a defection v-erbB can trans-
form a cell type not transformed by either oncogene
alone.
Gandrillon, 0., Jurdic, P., Xiao, J.-H., Samarut, J., CNRS,
Biologie generale et appliquee, Universite C. Bernard,
France: Analysis of some functions of v-erbA oncogene.
Johnson, A.C.,1 Ishii, S.,' Brady, J.,' Kadonaga, J.,2
Tjian, R.,2 Merlino, G.T.,1 Pastan, I.,"NCI, National In-
stitutes of Health, Bethesda, Maryland; 'Dept. of Bio-
chemistry, University of California, Berkeley: Analysis of
the promoter region of the human EGF receptor proto-
oncogene- Detection of binding factors.
SV40, Polyoma, and Adenoviruses
August 13-August 17
ARRANGED BY
Terri Grodzicker, Cold Spring Harbor Laboratory
Michael Botchan, University of California, Berkeley
390 participants
The Tumor Virus meeting on SV40, polyoma, and adenoviruses continues to be
the major forum for bringing together a group of over 400 scientists, who pre-
sented their latest findings in a variety of areas. The small DNA tumor viruses
continue to serve as model systems for dissecting the mechanisms of eukaryotic
transcription, RNA processing, replication, and transformation.
There was a great deal of emphasis on the use of biochemical approaches
and in vitro systems to analyze important control pathways. Many papers were
presented in extremely active areas of research such as SV40, polyomavirus,
and adenovirus in vitro DNA replication; the purification of transcription factors
and enhancer-binding proteins and their interaction with target DNA sequences;
regulation of promoters and enhancers by adenovirus E1A proteins and SV40 T
antigen; the role of different domains and protein modifications on the function of
E1A and SV40 T antigen proteins; the splicing, termination, and polyadenylation
of viral mRNAs; control of translation by VA RNA; the role of different domains of
virus-transforming proteins on immortalization and transformation; and interac-
tion of transforming proteins with cellular proteins such as p53 and tyrosine kin-
ases.
The many talks that were presented, as well as well-attended poster sessions
and hours of informal discussion, attest to the continuing productivity of tumor
virus research and the new findings that continue to arise in the field.
This meeting was supported in part by the Cancer Center Grant to Cold
Spring Harbor Laboratory from the National Cancer Institute, National Institutes
of Health.
SESSION 1 REPLICATION
Chairman: Bruce Stillman, Cold Spring Harbor Laboratory
Wobbe, R., Weissbach, L., Dean, F., Murakami, Y., Hurwitz,
J., Graduate Program in Molecular Biology and Virology,
Sloan-Kettering Institute for Cancer Research, New York,
New York: In vitro replication of SV40 DNA.
Prelich, G., Fairman, M., Stillman, B., Cold Spring Harbor
Laboratory, New York: Cell-free replicaton of SV40 DNA.
Mohr, I., Gerard, R., Strauss, M., Argani, P., Gluzman, Y.,
Cold Spring Harbor Laboratory, New York: Properties of
SV40 T antigen produced in HeLa cells or in E. coli.
Bradley, M.K.,' Weiner, B.,2 Possenti, R.,2 Decker, S.,'
DePamphilis, MI.,' 'Dept. of Pathology, Harvard Medi-
cal School and Dana-Farber Cancer Institute, 'Dept. of
Biological Chemistry, Harvard Medical School, Boston,
Massachusetts: SV40 large T antigen and replication of
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SV40 DNA in vitro.
Kenny, M.K., Balogh, L.A., Shneidman, P.S., Lindenbaum,
J., Hurwitz, J., Graduate Program in Molecular Biology,
Memorial Sloan-Kettering Cancer Research Center, New
York, New York: Studies on the mechanism of initiation of
adenovirus DNA replication.
Bennett, E.R., Naujokas, M., Collins, C., Hassell, J.A., Dept.
of Microbiology and Immunology, McGill University, Mon-
treal, Canada: The host range for replication of SV40-po-
lyomavirus hybrid origins for DNA replication.
Campbell, B.A., Villarreal, L.P., Dept. of Molecular Biology
and Biochemistry, University of California, Irvine: The po-
lyomavirus B enhancer can activate or repress DNA rep-
lication in mouse lymphoid cell lines.
Bradley, M.K., Webster, T., Smith, T., Livingston, D.M.,
SESSION 2 TRANSCRIPTION. 1. ADENOVIRUSES
Chairman: A. Berk, University of California, Los Angeles
Postel, E.H., Marton, M., Flint, S.J., Dept. of Molecular Biol-
ogy, Princeton University, New Jersey: A HeLa cell factor
required for in vitro transcription of the Ad2 IVa2 gene.
Buckbinder, L., Flores, 0., Reinberg, D., Dept. of Biochem-
istry, State University of New York, Stony Brook: Recon-
stitution of transcription at the adenovirus major late pro-
moter.
Goding, C., Temperley, S., Fisher, F., Marie Curie Memorial
Foundation, Research Institute, Surrey, England: Interac-
tions between HeLa cell factors and the Ad2 E2-late pro-
moter.
Garcia, J., Teitel, M., Wu, F., Gaynor, R., Dept. of Medicine,
University of California School of Medicine, Los Angeles:
Identification of regulatory sequences and cellular factors
involved in adenovirus early region 3 transcription regu-
lation.
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Dana-Farber Cancer Institute, Harvard Medical School
and School of Public Health, Boston, Massachusetts: Fur-
ther analyses of the SV40 large T antigen nucleotide-
binding site and adenylation reaction.
Deb, S., DeLucia, A., Koff, A., Tsui, S., Tegtmeyer, P., Dept.
of Microbiology, State University New York, Stony
Brook: The AT domain of the SV40 core origin regulates
DNA replication and DNA bending.
Fanning, E., Vogt, B., Arthur, A., Vakalopoulou, E., Institute
for Biochemistry, Munich, Federal Republic of Germany:
Allosteric control of SV40 T antigen binding to viral origin
DNA.
Roberts, J., Weintraub, H., Dept. of Genetics, Fred Hutchin-
son Cancer Center, Seattle, Washington: Negative control
of DNA replication in SV40-BPV composite plasmids.
Wu, L., Schmidt, M., Berk, A., Molecular Biology Institute,
University of California, Los Angeles: Regulation of hu-
man Ad2 El B transcription.
Parks, C.L., Spector, D.J., Dept. of Microbiology, Pennsyl-
vania State University College of Medicine, Hershey: Ge-
netic analysis of the El B promoter of Ad5.
White, E., Denton, A., Stillman, B., Cold Spring Harbor Lab-
oratory, New York: Role of the adenovirus El B 19K tumor
antigen in negatively regulating El A-dependent early
gene expression.
Senear, A.W.,' Anderson, C.W.,2 Lewis, J.B.,"Fred
Hutchinson Cancer Research Center, Seattle, Washing-
ton; 'Brookhaven National Laboratories, New York: Ad2
region El B- New proteins and effects on expression of
El A.
Donath, C., Gander, R I
. , Mack, A., Marschall, A., Meister-
ernst, M., Muller, U., Thalmeier, K., Winnacker, E.L., Insti-
tut fur Biochemie, Universitat MOnchen, Federal Republic
of Germany: Purification and properties of nuclear factor
SESSION 3 POSTER SESSION
Albin, R.L., Flint, S.J., Dept. of Molecular Biology, Princeton
University, New Jersey: Stimulation of promoter ele-
ment-protein interactions in adenovirus-infected He La
cell extracts.
Cousin, C., Leite, J.P.G., D'Halluin, J.C., Laboratoire de Vi-
rologie Moleculaire, INSERM, Life, France: Autoregula-
tion of adenovirus DNA-binding protein preferentially oc-
curred at the E2A early promoter level.
Brunet, L.J.,' Babiss, L.E.,3 Mills, D.R.,' Young, C.S.H.,2
Depts. of 'Human Genetics and Development,
2Microbiology, Columbia University, New York;
3Rockefeller University, New York, New York: Role during
infection of sequences flanking the TATA box of the Ad5
major late promoter.
Leza, A., Hearing, P., Dept. of Microbiology, State Univer-
sity of New York, Stony Brook: Genetic analysis of the
Ad5 E4 transcriptional control region.
Hough, R,' Mastrangelo, I.,' Sawadogo, M.,2 Roeder, R.,2
'Dept. of Biology, Brookhaven National Laboratory, Up-
ton, 2Rockefeller University, New York, New York: The
Ad2 gene-specific transcription factor, USF- Mass and
15-A structure by STEM.
SivaRaman, L., Bhat, G., Murthy, S., Dourer, P., Thimmap-
paya, B., Dept. of Micro-Immunology, Northwestern Uni-
versity Medical School, Chicago, Illinois: Adenovirus
E2A-late promoter-Transcriptional control regions and
effect of the two El A gene products on its expression.
Clark, L., Barrett, P., Hay, R.T., Dept. of Biochemistry and
Microbiology, University of St. Andrews, Scotland: Inter-
actions of cellular proteins with DNA sequences at the
left terminus of Ad2.
Vasudevachari, M.B., Natarajan, V., Salzman, N.R, NIAID,
National Institutes of Health, Bethesda, Maryland: Co-
transfection with adenovirus DNA enhances transcription
from linear plasmids containing eukaryotic promoters.
Takemori, N., Kumai, H., Ishi, M., Hashimoto, S., Division of
Molecular Biology, Meiji Institute of Health Science, Oda-
wara, Japan: Expression of El B gene functions of hu-
man adenoviruses in gpt+ KB cell lines.
Barker, D.D., Berk, A., Molecular Biology Institute, Univer-
sity of California, Los Angeles: The role of the Ad2 early
region 1B gene products during infection and transfor-
mation.
Schaller, M.D., Caussy, D., Mak, S., Dept. of Biology, Mc-
Master University, Hamilton, Canada: Regulation of gene
expression by cytocidal mutants of Ad12.
McGlade, C.J., Tremblay, M.L., Branton, RE., Dept. of Pa-
thology, McMaster University, Ontario, Canada: Posttrans-
lational modifications of the Ad5-176R El B protein.
Chroboczek, Viard, D'Halluin, J.-C.,2 'European
Molecular Biology Laboratory, Grenoble, 2Laboratoire de
Virologie Moleculaire, Lille, France: Human Ad2 is mu-
tant 112 contains two mutations in the protein Illa gene.
Lavery, D.,1 Fu, S.M.,2 Chen-Kiang, S.,1 lImmunobiology
Weyer, U., Langner, K.-D., Klimkait, T., Knebel, D., Doerfler,
W., Institute of Genetics, University of Cologne, Federal
Republic of Germany: Complex controls in the activity of
viral promoters.
Center, Mount Sinai Medical School, New York, New
York; 2Oklahoma Medical Research Foundation and
Dept. of Medicine, University of Oklahoma, Oklahoma
City: Molecular interaction of adenovirus with human lym-
phocytes.
Hong, J.S., Shu, L., Wei, Y.-F., Engler, J.A., Dept. of Bio-
chemistry, University of Alabama, Birmingham: The nu-
cleotide sequence of early region 2B of Ad12.
Wu, G.-J., Dept. of Microbiology and Immunology, Emory
University School of Medicine, Atlanta, Georgia: Tran-
scription of the canine Ad2-specific VA RNA gene.
Abmayr, S.M., Roeder, R.G., Rockefeller University, New
York, New York: Further studies on the effect of the PRV
IE protein on in vitro transcription.
Van Dyke, M., Roeder, R.G., Rockefeller University, New
York, New York: Proteins that interact with the VA RNA
genes of adenovirus.
Yoshinaga, S.K., Dean, N., Boulanger, P., Berk, A., Molecu-
lar Biology Institute, University of California, Los Angeles:
Adenovirus E1A functions stimulate transcription of class
III genes by increasing the amount of active transcription
factor TFIIIC.
Mirza, A., Institut kir Molekularbiologie, Essen, Federal Re-
public of Germany: Cellular proteins mediated binding of
Ad12 E1A- encoded tumor antigens to viral transcrip-
tional complexes.
Reichel, R., Kovesdi, I., Nevins, J., Rockefeller University,
New York, New York: A developmentally regulated tran-
scription factor is also regulated by the El A gene prod-
uct.
Nishigaki, T., Hanaka, S., Maeyanagi, H., Watanabe, H.,
Handa, H., Institute of Medical Science, University of To-
kyo, Japan: Transactivation of transcription of adenovirus
early region 4 by E1A gene products.
Webster, L.C., Friedman, D.J., Glenn, G.M., Ricciardi, R.R,
Wistar Institute of Anatomy and Biology, Philadelphia,
Pennsylvania: Conserved cysteines in the 289R E1A pro-
tein are essential for E1A- induced transcription.
Stein, R.,1 Ziff, E.,2 'Dept. of Molecular Physiology and
Biophysics, Vanderbilt University, Nashville, Tennessee;
2Dept. of Biochemistry, New York University Medical Cen-
ter, New York, New York: Repression of insulin gene
expression by Ad5 E1A proteins.
Zerler, B., Roberts, R.J., Mathews, M.B., Moran, E., Cold
Spring Harbor Laboratory, New York: Different domains
of the adenovirus E1A gene are involved in the regulation
of host-cell-cycle-dependent genes.
Zullo, J., Stiles, C.D., Garcea, R.L., Dana-Farber Cancer In-
stitute, Boston, Massachusetts: Induction of c-myc and c-
fos by polyomavirus.
Lipp, M., Kausel, G., Institut fur Biochemie der Universitat,
MOnchen, Federal Republic of Germany: Trans-activation
of the human c-myc promoter by E1A of adenoviruses.
Pannuti, A., La Mantia, G., Pascucci, A., Lania, L., Dept. of
203
Genetics, University of Naples, Italy: Regulation of mouse
H-2 class-I gene expression by DNA tumor viruses.
Morimoto, R.I., Milarski-Brown, K., Williams, G., Wu, B.J.,
Dept. of Biochemistry, Molecular and Cellular Biology,
Northwestern University, Evanston, Illinois: Trancription of
a growth-regulated and adenovirus-inducible human
heat-shock gene.
Solomon, W.,1,2 Gwinn, K.,1,2 Cowie, A.,3 Kingston, R.,1.2
'Dept. of Molecular Biology, Massachusetts General Hos-
pital, Boston, Massachusetts; 2Dept. of Genetics, Har-
vard Medical School, Cambridge, 3Genetics Institute,
Cambridge, Massachusetts: Regulation of the human
hsp70 promoter by papovavirus T antigens.
Tsuzuki, H., Dept. of Microbiology, Immunology and Parasi-
tology, Louisiana State University Medical Center, New
Orleans: Effect of adenovirus El A on protein synthesis in
normal human cells.
Opalka, B., Roy, A., Reith, M., Koppe, J., Schulte-Holthau-
sen, H., Institut fOr Molekularbiologie, Universitatskli-
nikum Essen, Federal Republic of Germany: Regulation
of cellular genes by El A deletion mutants of Adl 2.
Picardi, J., Alwine, J.C., Dept. of Microbiology, University of
Pennsylvania, Philadelphia: Evidence for repression of
the SV40 late promoter during the early phase of infec-
tion.
Thompson, M.A., Brady, J., NCI, National Institutes of
Health, Bethesda, Maryland: Trans-acting functions in
SV40 late gene expresson.
Ghosh, P.K., Garcia-Blanco, M.A., Ivory, S., Payne, M., Le-
bowitz, P., Depts. of Internal Medicine and Molecular Bio-
physics and Biochemistry, Yale University School of Med-
icine, New Haven, Connecticut: Viral late transcription
and upstream shift of viral early start sites in the absence
of DNA replication in He La cells transfected with SV40
DNA.
Ghosh, P.K., Garcia-Blanco, M.A., Rao, V.N., Payne, M.,
Bloodgood, R., Weissman, S.M., Lebowitz, R, Depts. of
Internal Medicine, Human Genetics and Molecular Bio-
physics and Biochemistry, Yale University School of Med-
icine, New Haven, Connecticut: SV40 late transcription in
cycloheximide and cytosine arabinoside-treated cells-
Two classes of late transcription initiation sites and nega-
tive regulation.
Kupelian, A., Acheson, N.H., Dept. of Microbiology and Im-
munology, McGill University, Montreal, Canada: Ribonu-
cleoside triphosphate-dependent pausing of RNA poly-
merase II in vitro nearby the SV40 late promoter.
Das, G.C., Saikh, K.U., School of Basic Life Sciences, Uni-
versity of Missouri, Kansas: Organization and regulation
of overlapping early and late promoters of SV40.
Chalifour, L.E.,' Wirak, D.O.,3 Hansen, U.,2 Wassarman,
P.M.,4 DePamphilis, M.L.,3 'National Research Council
on Biotechnology, Montreal, Canada; 2Dana-Farber Can-
cer Institute 3Harvard Medical School, Boston, Massa-
chusetts; 4Roche Institute, Nutley, New Jersey: SV40 pro-
moter analysis in microinjected mouse oocytes.
Ondek, B., Sturm, R., Herr, W., Cold Spring Harbor Labora-
tory, New York: Multiple copies of separate SV40 enhan-
cer "modules" confer transcriptional activation.
Green, J.C., Khoury, G., NCI, National Institutes of Health,
Bethesda, Maryland: The 72-bp element contains a criti-
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cal control region for SV40 late expression in X. laews oo-
cytes.
Firak, T.A., Chandrasekharappa, S.C., Gong, S.-S., Subra-
manian, K.N., Dept. of Microbiology and Immunology,
University of Illinois College of Medicine, Chicago: Multi-
ple functions of the SV40 72-bp repeat enhancer.
Gong, S.-S., Chandrasekharappa, S.C., Hartzell, S.W., Sub-
ramanian, K.N., Dept. of Microbiology and Immunology,
University of Illinois College of Medicine, Chicago: The
72-bp repeat enhancer, large T antigen, and Spl-binding
sites and activation of the SV40 late promoter.
Lutter, L.C., Petryniak, B., Had lock, K.G., Quasney, M.W.,
Dept. of Biological Chemistry, University of Michigan,
Ann Arbor: T-antigen content and topological character-
ization of SV40 transcription complexes.
Brown, M., Livingston, D., Hansen, U., Roberts, T., Dana-
Farber Cancer Institute and Harvard Medical School,
Boston, Massachusetts: The E. coli lactose operon re-
pressor and operator can function to regulate the activity
of the SV40 early promoter in animal cells.
Pater, A., Pater, M., Faculty of Medicine, Memorial Univer-
sity of Newfoundland, St. John's, Canada: Differential
expression of BK virus and SV40 early promoter se-
quences in nontransformed and transformed human em-
bryonic kidney cells.
Min, N.Y., Auborn, K., Manley, J., Prives, C., Dept. of Bio-
logical Sciences, Columbia University, New York, New
York: SV40 large T antigen binds specifically to human
U-1 and U-2 genes.
Carey, M., Karambir, S., Cozzarelli, N.R., Botchan, M.,
Dept. of Molecular Biology, University of California,
Berkeley: Induction of specific transcription by RNA poly-
merase III in SV40-transformed cells-An in vitro analysis.
Piette, J., Kryszke, M.-H., Yaniv, M., Institut Pasteur, Paris,
France: Specific interaction of mouse cellular factors with
the functional domains of the polyomavirus enhancer.
Perona, R.,' Wirak, D.,' Chalifour, L.,2 Cupo, D.,' Hassell,
J.,3 Wassarman, P,4 DePamphilis, D.,' 'Dept. of Biolog-
ical Chemistry, Harvard Medical School, Boston, Massa-
chusetts; 2NRC Biotechnology Research Institute, 3Dept.
of Microbiology and Immunology, McGill University, Mon-
treal, Canada; 4Roche Institute of Molecular Biology, Nu-
tley, New Jersey: Positive and negative regulation of tran-
scriptional elements during mouse development and
their role in DNA replication.
Bonnell, K., Carmichael, G., Dept. of Microbiology, Univer-
sity of Connecticut Health Center, Farmington: Se-
quences required for the function of the polyoma virus
late promoter.
Grinnell, B., Berg, D., Walls, J., Dept. of Molecular Biology,
Lilly Research Laboratories, Lilly Corporate Center, Indi-
anapolis, Indiana: The BK virus enhancer potentiates the
adenovirus type-2 late promoter in the presence of trans-
acting viral proteins.
Loeber, G., DOrries, K., Institut fOr Virologie, Universitat
WOrzburg, Federal Republic of Germany: Structural rear-
rangements in the control region of the human polyoma-
virus JC, strain GS.
Abraham, G., Manor, H., Dept. of Biology, Technion-Israel-
Institute of Technology, Haifa, Israel: Transcription map of
the African green monkey lymphotropic papovavirus.
SESSION 4 TRANSCRIPTION. 2. TRANSACTIVATION
Chairman: J. Alwine, University of Pennsylvania, Philadelphia
Kovesdi, I., Reichel, R., Nevins, J., Rockefeller University,
New York, New York: Role of the transcription factor E2F
in E1A-mediated coordinate gene control.
Loeken, M.R., Duvall, J., Brady, J., NCI, National Institutes
of Health, Bethesda, Maryland: Trans-activation of the
adenovirus E2 early promoter by SV40 T antigen and ad-
enovirus E1A may involve interaction between transcrip-
tion factors bound to inducible promoter elements.
Subramanian, S., Siva Raman, L., Thimmappaya, B., Dept.
of Microbiology and Immunology, Northwestern Univer-
sity Medical School, Chicago, Illinois: Identification of a
factor in He La cells specific for an upstream transcrip-
tional control sequence of an E1A- inducible adenovirus
promoter and its relative abundance in infected and unin-
fected cells.
Leong, K., Brunet, L., Berk, A.J., Molecular Biology Insti-
tute and Dept. of Microbiology, University of California,
Los Angeles: Adenovirus E1A protein increases the num-
ber of template molecules transcribed in cell-free ex-
tracts.
Glenn, G.M., Ricciardi, R.R, Wistar Institute of Anatomy and
Biology, Philadelphia, Pennsylvania: The protein product
of an E1A missense mutant gene of adenovirus blocks
wild-type E1A trans-activation by sequestering a positive
transcription factor.
Velcich, A., Kern, F., Kegler, D., Basilico, C., Ziff, E., Depts.
of Biochemistry and Pathology and Kaplan Cancer Cen-
ter, New York University Medical Center, New York: Ade-
novirus proteins repress expression the polyoma-
virus early and late promoters.
Sassone-Corsi, P., Fromental, C., Chambon, P., CNRS, IN-
SERM, University of Strasbourg, France: A trans-acting
repressor is responsible for the nonfunction of the poly-
omavirus enhancer in undifferentiated embryonal carci-
noma cells.
La Thangue, N.B., Rigby, P.W.J., Laboratory of Eukaryotic
Molecular Genetics, National Institute for Medical Re-
SESSION 5 TRANSCRIPTION 3: SV40, POLYOMA
Chairman: R. Tjian, University of California, Berkeley
Tjian, R., Briggs, M., Mitchell, P., Lee, W., Kadonaga, J.,
Jones, K., Dept. of Biochemistry, University of California,
Berkeley: Interplay of multiple sequence-specific tran-
scription factors within the SV40 promoter and enhancer
elements.
Gallo, G.J., Picardi, J., Alwine, J.C., Dept. of Microbiology,
University of Pennsylvania School of Medicine, Philadel-
phia: Activation of the SV40 late promoter- Evidence that
T antigen affects a cellular trans-acting factor.
Beard, P., Bruggmann, H., Swiss Institute for Experimental
Cancer Research, Epalinges, Switzerland: A transcription
factor activating the SV40 late promoter.
Kim, C.H., Heath, C., Bertuch, A., Hansen, U., Dana-Farber
Cancer Institute, and Dept. of Pathology, Harvard Medi-
cal School, Boston, Massachusetts: Stimulation of the
M. Horwitz, D. Lane
search, London, England: Regulated expression of SV40
and adenovirus promoters in murine embryonal carci-
noma stem cell extracts.
Lee, K.A.W., Lin, Y.S., Green, M.R., Dept. of Biochemistry
and Molecular Biology, Harvard University, Cambridge,
Massachusetts: In vivo and in vitro analysis of an adeno-
virus E1A-dependent transcriptional enhancer.
Natarajan, V., Salzman, N.P., NIAID, National Institutes of
Health, Bethesda, Maryland: Ad2 E1A and E1B gene
products regulate enhancer-mediated transcription.
Bruder, J., Hearing, P., Dept. of Microbiology, State Univer-
sity of New York, Stony Brook: Genetic and biochemical
analyses of the Ad5 E1A enhancer region.
postreplicative (late) mode of SV40 transcription by a cel-
lular factor that specifically binds the SV40 21-bp re-
peats.
Kern, F.G.,1 Pellegrini, S.,' Cowie, A.,2 Basilico, C.,1
'Dept. of Pathology, New York University School of Medi-
cine, New York; 2Genetics Institute, Cambridge, Massa-
chusetts: Effect of the polyomavirus early proteins on late
promoter function.
Shepard, A., Clarke, J., Ondek, B., Herr, W., Cold Spring
Harbor Laboratory, New York: Revertants of SV40 enhan-
cer mutants-Structure and cell preference.
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Laboratory, Utrecht, The Netherlands: Altered expression
of cellular genes in adenovirus-transformed cells.
Jelsma, A.N., Evelegh, C.M., Denman, J.E., Bayley, S.T.,
Dept. of Biology, McMaster University, Ontario, Canada:
Site-specific mutations in the coding sequences of the
E1A region of human Ad5.
Montano, X., Lane, D., Dept. of Biochemistry, Imperial Col-
lege of Science and Technology, London, England: The
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hart, W., Salk Institute, San Diego, California: Altered ty-
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Implications for cell transformation.
Kornbluth, S., Sudol, M., Hanafusa, H., Rockefeller Univer-
sity, New York, New York: Association of the polyomavi-
rus middle T antigen with c-yes protein in middle-T-anti-
gen-transformed chicken embryo fibroblasts.
Piwnica-Worms, H.,' Cheng, S.H.,2 Saunders, K.B.,1
Smith, A.E.,2 Roberts, TM.,' Dana-Farber Cancer Insti-
tute, Boston, 'Integrated Genetics, Framingham, Massa-
chusetts: Interactions between polyomavirus middle T
antigen and avian pp60c-src.
Walter, G.,' Carbone, A.,' Welch, W.J.,2 'Dept. of Pathol-
ogy, University of California, San Diego, La Jolla: 2Cold
Spring Harbor Laboratory, New York: Medium T antigen
Dabrowski, C., Alwine, J.C., Dept. of Microbiology, Univer-
sity of Pennsylvania School of Medicine, Philadelphia:
Analysis of SV40 late gene expression-Effects of intra-
genic sequences on transcription and translation.
Soloway, P., Shenk, T., Dept. of Molecular Biology, Prince-
ton University, New Jersey: An Ad5 mutant that fails to
synthesize the i leader protein.
adenovirus E1A gene induces differentiation of F9 terato-
carcinoma cells.
Egan, C.,1 Yee, 5.-P.,2 Ferguson, B.,3 Bayley, S.T.,1 Bran-
ton, P.E., 1,2 Depts. of 'Biology, 2Pathology, McMaster
University, Hamilton, Canada; 3Experimental Station, E.I.
DuPont de Nemours, Wilmington, Delaware: Analysis of
cellular proteins associated with Ad5 E1A products.
Whyte, P., Harlow, E., Cold Spring Harbor Laboratory, New
York: Association of adenovirus E1A proteins with cellular
polypeptides.
Akagi, K., Murai, K., Haddada, H., Levine, A.S., Patch,
C.T., NICHD, National Institutes of Health, Bethesda,
Maryland: Mitogenic and antimitogenic transforming
growth factors secreted by Ad2- and SV40-transformed
hamster embryo cells-Possible role in promoting tumori-
genesis.
Kenyon, D.J., Raska, K., Jr., Dept. of Pathology, UMDNJ-
Rutgers Medical School, Piscataway, New Jersey: Re-
gion E1A of highly oncogenic Ad12 in transformed cells
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2Dept. of Biology, Johns Hopkins University, Depts. of
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oma middle T gene stably integrated into the genome of
rat cell lines.
Ozer, H.L.,1 Caton, Y.,1 Neufeld, D.,' Radna, R.,' Res-
nick, L., ' Ripley, 5.,1 Small, M.S.,2 Zainul, B.,1 'Dept. of
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ical School, Hanover, New Hampshire; 2Dept. of Microbi-
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The 1986 meeting on bacteria and phages demonstrated again that work on
phage and bacterial systems is making fundamental contributions to our under-
standing of basic molecular biology. This year's meeting was divided into ten ses-
sions of oral presentations and two poster sessions, reflecting active areas of
prokaryotic molecular biological research, including DNA replication, recombina-
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tion and transposition, and regulation of gene expression. As a result of the ex-
pansion of the meetings a year ago to include bacterial molecular biology, sev-
eral areas of interest were represented to a much greater extent than was true in
the past. These included bacterial development (sporulation), physiological regu-
lation (nitrogen metabolism and response to heat shock), and the synthesis of
membrane proteins. There were 40-50 talks on detailed investigations of DNA-
protein interactions and transcriptional regulation and exciting evidence was pre-
sented for the existence of enhancer-like elements essential for regulation of pro-
karyotic transcription.
SESSION 1 DNA REPLICATION
Novick, R.P., Gruss, A., Ross, H.F., Dept. of Plasmid Biol-
ogy, Public Health Research Institute of the City of New
York, Inc., New York: A palindromic sequence involved in
the initiation of plasmid lagging-strand synthesis.
Gennaro, M.L., Novick, R.P., Dept. of Plasmid Biology, Pub-
lic Health Research Institute, New York, New York: A cis-
acting plasmid locus alters DNA supercoiling and the in-
teraction between replication origin and initiator protein.
Gilchrist, C.A., Denhardt, D.T., Dept. of Biochemistry, Uni-
versity of Western Ontario, Canada: E. coil rep gene-Se-
quence of the gene, the encoded helicase, and its ho-
mology with uvrD.
Keller, J.A., Simon, L.D., Waksman Institute of Microbiol-
ogy, Rutgers University, Piscataway, New Jersey: Pheno-
typic suppression of a bacteriophage A Ots allele by E.
coil mutants.
Greenstein, D., Fulford, W., Horiuchi, K., Rockefeller Uni-
versity, New York, New York: Multistep binding of the initi-
ator protein to the replication region of bacteriophage f1.
Flensburg, J., Klevolin, M., Calendar, R., Christian, R.,
Dept. of Molecular Biology, University of California,
Berkeley: P4 phage DNA replication.
Wickner, S., Chattoraj, D., NCI, National Institutes of Health,
Bethesda, Maryland: In vitro replication of a bacterio-
phage P1 miniplasmid.
Chattoraj, D.K., NCI, National Institutes of Health, Be-
thesda, Maryland: An autoregulation protein can be
made rate-limiting by sequestration.
Powell, D.,1 Franklin, J.,1 Arisaka, F.,2 Mosig, G.,1
'Vanderbilt University, Nashville, Tennessee; 2Hokkaido
University, Sapporo, Japan: DNA sequence and tran-
scription of the phage T4 DNA packaging genes 16 and
17-Partial homology with the replication/recombination
gene 32.
Hill, T., Kuempel, R, Dept. of Molecular, Cellular, and Devel-
opmental Biology, University of Colorado, Boulder: The
terminus region of the chromosome of E. coli contains
two separate sites that exhibit polar inhibition of DNA rep-
lication.
Monod, M., Projan, S.J., Dubnau, D., Depts. of Microbiol-
ogy and Plasmid Biology, Public Health Research Insti-
tute of the City of New York, Inc., New York: Interspecific
plasmid mobility-pIM13, a naturally occurring B. subtilis
plasmid, probably arose from pE5, a plasmid native to S.
aureus.
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SESSION 2 RECOMBINATION AND REPAIR
Thaler, D.S.,' Sampson, E.,' Rosenberg, S.M.,' Stahl,
F.W.,' Stahl, M.M.,' Higgens, N.P.,2 'Institute of Molecu-
lar Biology, University of Oregon, Eugene: Dept. of Bio-
chemistry, University of Alabama, Birmingham: Roles of
double-chain ends in recombination of bacteriophage A.
Rosenberg, S.M., Stahl, M.M., Stahl, F.W., Institute of Mo-
lecular Biology, University of Orgeon, Eugene: Asymme-
try of Chi-stimulated patch recombinants.
Basu, S.K., Margolin, P, Dept. of Biology, City College of
New York, New York: Transduction-mediated recombina-
tion between segments of a transducing DNA fragment.
Poteete, A.R., Fenton, A.C., Murphy, K., Dept. of Molecular
Genetics and Microbiology, University of Massachusetts
Medical School, Worcester: Activities of the E. coil, P22,
and A homologous recombination systems in a direct
physical assay.
Sassanfar, M., Roberts, J., Section of Biochemistry, Molecu-
lar and Cell Biology, Cornell University, Ithaca, New York:
DNA replication is required for UV induction of the SOS
SESSION 3 POSTER SESSION
Ang, D., Johnson, C., Chandresekhar, G.N., Zylicz, M..
Georgopoulos, C.. Dept. of Cellular, Viral, and Molecular
Biology, University of Utah, Salt Lake City: The E. coh
grpE gene product is required for A replication.
Ball, T., Saurugger, P., Benedik, M., Dept. of Biology. Texas
A&M University, College Station: Extracellular secretion
of Serratia marcescens nuclease in E. cob.
Barth, K., Mosig, G., Trupin, M., Powell, D.. Dept. of Molec-
ular Biology, Vanderbilt University, Nashville, Tennessee
Phage T4 gene 49 (endonuclease VII) is transcribed early
and late.
Bear, S.E.,' Clemens. J.B..' Court. D.L..2 'E.!. du Pont de
Nemours and Company, Wilmington. Delaware: 'NCI-
Frederick Cancer Research Facility, Frederick. Maryland
Mutational analysis of the A int gene.
Bej, A., Jacob, R., Merrell, E., Perlin, M., University of
Louisville and University of Kentucky Medical Center,
Lexington: Restriction enzyme analysis and electron mi-
croscopic study of plasmid bacterial origin after reisola-
tion from transformed fungal species.
Benson, K.H., Kreuzer, K.N., Dept. of Microbiology and Im-
munology, Duke University Medical Center, Durham,
North Carolina: Selection of T4 mutants deficient in ter-
tiary replication initiation.
Boyd. D., Manoil, C., Beckwith, J.. Dept. of Microbiology
and Molecular Genetics, Harvard Medical School. Bos-
ton, Massachusetts: Topology of an inner membrane pro-
tein of E. coli.
Calendar, R.,' Grossman. A..2 Yhou, Y. -N.,2 Erickson,
J.W.,2 Gross, C.,2 'Dept. of Molecular Biology. Univer-
sity of California, Berkeley; 2Dept. of Bacteriology. Uni-
versity of Wisconsin. Madison: Mutations of the htpR
(rpoH) gene that suppress the temperature sensitivity of
rpoD285(800) and are incompatible with rhoD
Castano, I..1 Bastarrachea, F.,2 Covarrubias, A.A.,'
'Centro de InvestigaciOn sobre Fijacion de NitrOgeno.
UNAM: 2lnstituto de Fisiologia Celular. UNAM, Mexico:
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Ennis, D.G , Ossanna, N , Mount, D W, Dept of Molecular
and Cellular Biology. University of Arizona. Tucson. Ge-
netic analysis of the recA mutagenesis function.
Tessman, E.S., Tessman, I , Peterson, PK , Forestal, J D.,
Dept. of Biological Sciences, Purdue University, West La-
fayette, Indiana. Second role of the RecA protein in muta.
genesis and repair.
Wang. W.-B., Tessman, E.S., Dept. of Biological Sciences,
Purdue University, West Lafayette, Indiana. Functional
re-gions of the RecA protein of E. coh.
Heitman, J Model, P, Rockefeller University, New York,
New York. A new locus in E. coh, mar, mediates SOS in-
duction in response to site-specific adenine methylation
Bhagwat, A.S., Roberts, R J , Cold Spring Harbor Labora-
tory, New York. Possible repair of DNA-protein covalent
complexes in E. coh - 5-azaC sensitivity of DNA repair
mutants
Control of the glutamate synthase synthesis of E. coh K-
12.
Catron, K.M., Schnaitman, C.A., Dept. of Microbiology. Uni-
versity of Virginia. Charlottesville: Analysis of an ompC
mutant that affects protein transport in E. coh K-12
Chang. B..' Wanner, B L , "Purdue University, West La-
fayette. Indiana; Emory University, Atlanta. Georgia:
Control of bacterial alkaline phosphatase synthesis in E.
°Chcunlig. Y-B Hinkle. D.C.. Dept. of Biology, University of
Rochester. New York Recombinant plasmids containing
the concatemer junction of bactenophage T7 are pack-
aged into transducing particles during phage infection.
Clyman. J Cunningham. R P. Dept of Biological Science.
State University of New York. Albany. Characterization
and cloning of the rdgB gene of E. coh.
Cowan. J.. Drivdahl. R.. D'Acci, K , Lindsay, P. Williams. S..
Loring. G McKinney, J Erickson. D., Kutter, E., Ever-
green State College, Olympia, Washington Detailed two-
dimensional analysis of T4 proteins.
Daniels. D L Blattner, F R.. Laboratory of Genetics, Univer-
sity of Wisconsin. Madison Dissection of the E. coh ge-
nome into bactenophage A clones and construction of
detailed restriction maps
Daub. E , Walsh, C Botstein, D Depts. of Chemistry and
Biology. Massachusetts Institute of Technology. Cam-
bridge Isolation and characterization of cell-wall biosyn-
thesis genes in S typhimurium.
de Boer, PA J Rothfield, L I.. Dept of Microbiology, Uni-
versity of Connecticut Health Center, Farmington: Isola-
tion and properties of the E. coh rninB locus.
Donovan, W P., Zheng. L
. Sandman, K., Losick, R.. Dept.
of Cellular and Developmental Biology, Harvard Univer-
sity. Cambridge. Massachusetts Genes for spore coat
proteins from B subtihs
French, S Miller, 0.L., Jr . Dept. of Biology, University of
Virginia, Charlottesville Electron microscopic visualiza-
tion of chromosome replication in E. coh -A comparison
of gene activity on sister strands.
Gloor, G., Chaconas, G., Dept. of Biochemistry, University
of Western Ontario, Canada: Cloning and identification of
the gene coding for the 64-kD Mu virion protein, which is
injected and circularizes infecting Mu DNA.
Guijarro, J.A., Dept. of Cellular and Developmental Biology,
Harvard University, Cambridge, Massachusetts: Molecu-
lar cloning of S. coelicolor spore-associated proteins.
Gussin, G.N., Matz, K., Brown, S., Dept. of Biology, Univer-
sity of Iowa, Iowa City: New mutations causing defects in
repressor synthesis directed by the PRM promoter.
Hausmann, R., LOtzelschwab, M., Messerschmid, M., Insti-
tut fOr Biologie, Universitat Freiburg, Federal Republic of
Germany: Genetic comparison of phages following the
T7-specific strategy of infection.
Hayes, S., Hayes, C., Dept. of Microbiology, University of
Saskatchewan, Saskatoon, Canada: Exclusion pheno-
type of selected replicative-killing-defective A lysogens.
Heck, D., Hatfield, G.W., Dept. of Microbiology and Molec-
ular Genetics, University of California College of Medi-
cine, Irvine: In vivo and in vitro transcriptional analysis
and complete nucleotide sequence of the va/S gene of E.
coli K-12.
Hsu, T., Wei, R., Dawson, M., Karam, J., Dept. of Biochem-
istry, Medical University of South Carolina, Charleston:
Expression of an operon for T4-induced RNA polymer-
ase-binding proteins.
Huff, A.C., Leatherwood, J.K., Kreuzer, K.N., Dept. of Mi-
crobiology and Immunology, Duke University Medical
Center, Durham, North Carolina: Characterization of
phage T4 DNA topoisomerase from mAMSA-resistant
phage mutants.
Hwang, J.-J., Gussin, G.N., Dept. of Biology, University of
Iowa, Iowa City: Kinetic analysis of transcription initiation
at the PRM promoter- Independent effects of prmE37
and prmup-1 on promoter function.
lordanescu, S., Dept. of Plasmid Biology, Public Health Re-
search Institute, New York, New York: Change in the
specificity of the interactions between the Rep proteins
and replication origins of three staphylococcal plasmids
in a host mutant.
Keeler, C.L., Jr., University of Maryland, Baltimore County,
Catonsville: Overproducing the terminase proteins of A.
Kiino, D.R., Dept. of Molecular Genetics and Cell Biology,
University of Chicago, Illinois: PrIfF1, a mutation that re-
lieves the lethality associated with export of f3- galactosi-
dase hybrid proteins in E. coli-Cloning and sequencing
of the gene.
Kirby, T.W., Hindenach, B.R., Greene, R.C., Basic Science
Laboratory, U.S. Veterans Administration Medical Center
and Dept. of Biochemistry, Duke University Medical Cen-
ter, Durham, North Carolina: Studies on the binding of
the E. coli metJ regulatory protein to a DNA region be-
tween the metJ and metB genes.
Kleina, L.G.,' Masson, J.-M.,' Miller, J.H.,1 Norman ly, J.,2
Abelson, J.N.,2 'University of California, Los Angeles;
2California Institute of Technology, Pasadena: Construc-
tion and use of an E, coli amber suppressor tRNA bank.
Kokjohn, T.A., Miller, R.V., Loyola University of Chicago,
Maywood, Illinois: Control of expression of the recA gene
of P. aeruginosa PAO.
Kwoh, T.J.,1 Kwoh, D.Y.,2 McCue, A.,2 Davis, B.,2 Patrick,
D.,2 Gingeras, T.R.,2 'La Jolla Biological Laboratories,
W. Szybalski
San Diego; 2Salk Institute Biotechnology/Industrial Asso-
ciates, Inc., San Diego, California: Expression of a bacte-
rial DNA methylase gene in mammalian cells.
Lazinski, D., Das, A., Program in Molecular Biology and
Biochemistry, University of Connecticut Health Center,
Farmington: Construction of hybrid proteins to determine
the domain of N responsible for nut-site recognition.
Lin, E., Wilson, D.B., Section of Biochemistry, Molecular
and Cell Biology, Cornell University, Ithaca, New York:
Regulation of cellulase genes in Thermomonospora
fusca.
Lin-Chao, S., Bremer, H., Dept. of Biology, University of
Texas, Dallas: Physiological control of replication of plas-
mid pBR322.
Macaluso, A.,' Best, E.,2 Bender, R.A.,' Depts. of
'Biology, 2Microbiology, and Immunology, University of
Michigan, Ann Arbor: The nitrogen assimilation control
(nac) gene is an essential element of the Ntr system of K.
aerogenes.
Mandecki, W., Corporate Molecular Biology, Abbott Labo-
ratories, Abbott Park, Illinois: Mutagenesis by oligonu-
cleotide-directed repair of a double-strand break in plas-
mids of E. coli.
Marinus, M.G., Carraway, M., Wu, T., Dept. of Pharmacol-
ogy, University of Massachusetts Medical School,
Worcester: Mutation spectrum in a dam mutant of E. coli
K-12.
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SESSION 4 TRANSPOSITION AND SITE-SPECIFIC RECOMBINATION
Ahmed, A., Dept. of Genetics, University of Alberta, Can-
ada: Evidence for replicative transposition of Tn5 and
Tn9.
Lichens, A., Syvanen, M., Dept. of Microbiology and Mo-
lecular Genetics, Harvard Medical School, Boston, Mas-
sachusetts: Integration of bacteriophage A by IS5OR as a
model system for studying IS50-mediated cointegration.
Rak, B., Brombacher, F, Eibel, H., Fuchs, K., von Reutern,
M., Schnetz, K., Institut fur Biologie, Universitat Freiburg,
Federal Republic of Germany: Studies on DNA insertion
element IS5.
Waddell, C., Arciszewska, L., Kubo, K., Or le, K., Craig, N.,
Dept. of Microbiology and Immunology and Hooper Re-
search Foundation, University of California, San Fran-
cisco: Tn7 transposition-DNA sites and proteins.
Nakayama, C.,' Tep low, D.B.,2 Harshey, R.M.,2 'Dept. of
Molecular Biology, Research Institute of Scripps Clinic,
La Jolla, 2Division of Biology, California Institute of Tech-
nology, Pasadena: Structural domains in the phage Mu
transposase- Identification of the site-specific DNA-bind-
ing domain.
Surette, M., Buch, S., Chaconas, G., Dept. of Biochemistry,
University of Western Ontario, Canada: Transposo-
somes-Stable protein-DNA complexes involved in the
transposition of phage Mu DNA.
Stirling, C.J., Stewart, G., Sherratt, D.J., Institute of Ge-
netics, University of Glasgow, Scotland: Site-specific re-
SESSION 5 DNA-PROTEIN INTERACTIONS
Bushman, ED., Wharton, R.P., Ptashne, M., Harvard Uni-
versity, Cambridge, Massachusetts: The repressor of
bacteriophage 434 activates transcription by two sepa-
rate mechanisms.
Sarai, A., Jernigan, R.L., Takeda, Y., NCI, National Institutes
of Health, Bethesda, and NCI-Frederick Cancer Re-
search Facility, Frederick, Maryland: Quantitative analysis
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combination at the ColE1 cer locus is blocked by muta-
tions in two different genes on the E. coli K-12
chromosome.
Miller, H.I., Kuang, W.J., Chen, E., Depts. of Cell Genetics
and Molecular Biology, Genentech, Inc., South San Fran-
cisco, California: The E. coli himA gene is cotranscribed
with the genes for phenylalanyl tRNA synthetase.
Granston, A.E., McGrath, D.M., Friedman, D.I., Dept. of Mi-
crobiology and Immunology, University of Michigan Med-
ical School, Ann Arbor: cos cleavage-Studies of host
factors.
Ou, J.T., Baron, L.S., Rubin, FA., Kopecko, D.J., Dept. of
Bacteriology and Immunology, Walter Reed Army Insti-
tute of Research, Washington, D.C.: Reversible expres-
sion in E. coli of Citrobacter freundii Vi capsular antigen
genes is controlled by the insertion and deletion of an
IS1-like DNA element.
Hill, C.W., Pencek, M.S., Davidson, A.E., Kirschman, J.A.,
Vlazny, D.A., Gray, J.A., Dept. of Biological Chemistry,
Hershey Medical Center, Pennsylvania State University,
Hershey: A novel family of large repeated genetic ele-
ments of E. coll.
Youderian, R, Brewer, K.L., Sugiono, P., Dept. of Biological
Sciences, University of Southern California, Los Angeles:
Tn10 transposition events in Salmonella that generate
locked-in P22 prophages.
of Cro repressor-operator interaction.
Eliason, J.L., Sternberg, N.L., Central Research and Devel-
opment Dept., E.I. du Pont de Nemours and Co., Wil-
mington, Delaware: The C1 repressor of phage P1 rec-
ognizes an asymmetric operator.
Benson, N., Sugiono, P., Youderian, R, Dept. of Biological
Sciences, University of Southern California, Los Angeles:
DNA determinants of A repressor binding.
Bass, S., Youderian, P., Dept. of Biological Sciences, Uni-
versity of Southern California, Los Angeles: Genetic anal-
ysis of E. coli tryptophan repressor binding.
Gardella, T., Susskind, M.M., Dept. of Biological Sciences,
University of Southern California, Los Angeles: Mutations
of the a7° subunit of E. coli that suppress mutations of the
P22 ant promoter.
Garges, S., Kim, J., Adhya, S., NCI, National Institutes of
Health, Bethesda, Maryland: Sites of allosteric shift within
the structure of the cAMP receptor protein of E. coll.
Ebright, R.,1,2 Kolb, A.,2 Buc, H.,2 Cossart, P.,2 Gicquel-
Sanzey, B.,2 Kunkel, T.,3 Krakow, J.,4 Beckwith, J.,'
'Harvard Medical School, Boston, Massachusetts;
SESSION 6 TRANSCRIPTION INITIATION AND REGULATION
Hammer, K., Dandanell, G., Institute of Biological Chemis-
try, University of Copenhagen, Denmark: DeoR repres-
sion in E. coli can be caused by a site located down-
stream from the regulated genes.
Miller, R.V., Kokjohn, T.A., Loyola University of Chicago,
Maywood, Illinois: Role of the bacteriophage D3 repres-
sor in lysogeny establishment in Rec+ and Rec- P. aeru-
ginosa.
Gourse, R.L., Dept. of Genetics, University of Georgia, Ath-
ens: Upstream activation of rRNA synthesis in E. coli.
Lampe, M., Binnie, C., Paoletti, R., Dept. of Cellular and
Developmental Biology, Harvard University, Cambridge,
Massachusetts: Cloned genes encoding the B. subtilis
a37 and d RNA polymerase transcription factors.
Igo, M., Schafer, R., Dept. of Cellular and Developmental
Biology, Harvard University, Cambridge, Massachusetts:
Genetic studies on the regulation of a promoter that is uti-
lized by minor forms of RNA polymerase in B. subtilis.
SESSION 7 DEVELOPMENTAL REGULATION
Grossman, A., Losick, R., Dept. of Cellular and Develop-
mental Biology, Harvard University, Cambridge, Massa-
chusetts: Extracellular control of sporulation in B. subtilis.
Zuber, R, Dept. of Cellular and Developmental Biology,
Harvard University, Cambridge, Massachusetts: Tran-
scription of a developmentally regulated gene of B. sub-
tilis is under positive and negative control.
Carter, H.L. III, Moran C.R, Jr., Dept. of Microbiology and
Immunology, Emory University School of Medicine, At-
lanta, Georgia: New RNA polymerase a factor under
spo0 control in B. subtilis.
Schauer, A., Losick, R., Dept. of Cellular and Develop-
mental Biology, Harvard University, Cambridge, Massa-
chusetts: Measuring Streptomyces gene expression with
light.
Adams, T., Chelm, B., DOE-Plant Research Laboratory and
Dept. of Microbiology, Michigan State University, East
Lansing: A gene in Bradyrhizobium japonicum that is
necessary for anaerobic gene expression and soybean
symbiotic differentiation.
Mullin, D.A., Munnich, S.A., Newton, A., Dept. of Molecular
Biology, Princeton University, New Jersey: Nucleotide
consensus sequences in developmentally regulated fla-
gellar promoters in C. crescentus.
2lnstitut Pasteur, Paris, France; 3NIEHS, Research Trian-
gle Park, North Carolina; 4Hunter College, New York,
New York: Role of Glu-181 and Lys-188 in DNA-se-
quence recognition by the catabolite gene activator pro-
tein (CAP).
Harman, J.G., Mc Kenney, K., Peterkofsky, A., National In-
stitutes of Health, Bethesda, Maryland: Structure-function
analysis of three cAMP-independent forms of the cAMP
receptor protein.
Kim, J.G.,1 Takeda, Y.,2 1 NCI, National Institutes of
Health, Bethesda, Maryland; 2NCI-Frederick Cancer Re-
search Facility, Frederick, Maryland: Kinetic studies of
Cro repressor-operator DNA interaction.
Lin, L.-L., Little, J.W., Dept. of Biochemistry, University of
Arizona, Tucson: Isolation and characterization of non-
cleavable (Ind-) mutants of LexA repressor.
Smith, C.M.,1 Orrego, C.,2 Eisenstadt, E.,1,2 'Laboratory
of Toxicology, 2Dept. of Cancer Biology, Harvard School
of Public Health, Boston, Massachusetts: TopA and the
SOS response in S. typhimurium LT2.
Sal les, B., Weinstock, G.W., Dept. of Biochemistry and Mo-
lecular Biology, University of Texas Medical School,
Houston: Regulation of cea gene - .expression.
Lamont, I.L., Egan, J.B., Dept. of Biochemistry, University
of Adelaide, Australia: UV induction of coliphage 186-A
novel control circuit involving LexA.
Schwartz, I., Wertheimer, S., Klotsky, R.A., Dept. of Bio-
chemistry, New York Medical College, Valhalla: Transcrip-
tional events in the thrS -infC -rp/T region of the E. coli ge-
nome.
F. Stahl
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Minnich, S.A., Mullin, D.A., Chen, L.-S., Newton, A., Dept.
of Molecular Biology, Princeton University, New Jersey:
Evidence for a regulatory cascade in the temporal
expression of fla genes in C. crescentus.
Pato, M., Toussaint, A., National Jewish Center, Denver,
Colorado, and Universite Libre de Bruxelles, Belgium:
Host functions required for late transcription of phage
Mu.
Birkeland, N.K.,12 Christie, G.E.," Lindqvist, B.H.,2 'Dept.
of Microbiology and Immunology, Virginia Common-
wealth Univeristy, Richmond; 2lnstitute of Medical Biol-
ogy, University of Tromsp, Norway: Analysis of P2 ogr
gene expression.
DehO, G., Zangrossi, S., Ghisotti, D., Sironi, G., Diparti-
SESSION 8 POSTER SESSION
Makris, J.C., Reznikoff, W.S., Biochemistry Dept., University
of Wisconsin, Madison: Effects of single base changes of
the outer-ends of IS50 on Tn5 transposition.
Moline, K.W., Barbieri, S., Musso, R.E., Dept. of Biology,
University of South Carolina, Columbia: Genetic determi-
nation of transposition factors encoded by the DNA
transposable element IS2.
Murphy, K.C., Fenton, A.C., Poteete, A.R., Dept. of Molecu-
lar Genetics and Microbiology, University of Massachu-
setts Medical Center, Worcester: Recombination system
of bacteriophage P22.
Musso, R.E., Black, T., Dept. of Biology, University of South
Carolina, Columbia: Transcription of the insertion se-
quence IS2 is regulated by an IS2-encoded protein.
Nicosia, A., Rappuoli, R., Sclavo Research Center, Siena,
Italy: Structure and expression of the operon coding for
pertussis toxin.
Ossanna, N., Mount, D., Dept. of Molecular and Cellular Bi-
ology, University of Arizona, Tucson: Isolation and char-
acterization of SOS constitutive mutants in E. coli.
Palchaudhuri, S.,' Patel, V.,' McFall, E.,2 'Dept. of Micro-
biology, Wayne State University School of Medicine, De-
troit, Michigan; 2Dept. of Microbiology, New York Univer-
sity School of Medicine, New York: Sequence of the D-
serine deaminase activator gene dsdC.
Plumbridge, J.A., SO II, D., Dept. of Molecular Biophysics
and Biochemistry, Yale University, New Haven, Connecti-
cut: Mutations affecting glutamine-tRNA synthetase
expression.
Popham, D.L., Wong, P.-K., Keener, J.X., Kustu, S.G., Dept.
of Bacteriology, University of California, Davis: DNA se-
quence of the S. typhimurium ntrA gene.
Raleigh, E.A., Trimarchi, R., Latimer, E., New England Biol-
abs, Beverly, Massachusetts: Genetic mapping and mo-
lecular cloning of the E. coli mcrA and mcrB loci.
Ranes, M., Schauer, A., Dept. of Cellular and Develop-
mental Biology, Harvard University, Cambridge, Massa-
chusetts: In vivo and in vitro studies of the utilization of a
promoter from Streptomyces plicatus.
Ray, J., Hess, J., Hong, S.-C., Bauer le, R., Dept. of Biology,
University of Virginia, Charlottesville: Domain mapping of
two tryptophan-regulated enzymes of aromatic biosyn-
thesis.
Reitzer, L.J., Ninfa, A.J., Magasanik, B., Massachusetts In-
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mento di Genetica e di Biologia dei Microrganismi, Univ-
ersita di Milano, Italy: Alternative promoters for the devel-
opment of the genetic element P4.
Dale, E.C.,' Hailing, C.,' Calendar, R.,' Morrison, T.,1
Christie, G.E.,' Zylbert, B.,1 Keener, J.,2 Kustu,
Lane, K.,3 Sunshine, G.,3 Six, E.W.,3 'Dept. of Molecu-
lar Biology, University of California, Berkeley; 2Dept. of
Bacteriology, University of California, Davis; 3Dept. of Mi-
crobiology, University of Iowa, Iowa City: Expression of
the P4 phage late promoter.
Downs, D., Roth, J., Dept. of Biology, University of Utah,
Salt Lake City: S. typhimurium contains an archived P22-
like prophage.
stitute of Technology, Cambridge: Effects of relocation
and deletion of activator NR, binding sites on transcrip-
tion from glnAp2 in vitro and in vivo.
Rennell, D., Knight, J., Poteete, A.R., Dept. of Molecular
Genetics and Microbiology, University of Massachusetts
Medical School, Worcester: Genetic analysis of phage ly-
sozyme structure.
Rockenbach, Lutkenhaus, J.,' 'Dept. of Microbiol-
ogy, University of Kansas Medical Center, Kansas City;
2Upjohn Company, Kalamazoo, Michigan: Construction
of a single copy, promoter assay vector that can be used
in parallel with the pK0 series of promoter detection vec-
tors.
Rojiani, M., Goldman, E., Dept. of Microbiology, New Jer-
sey Medical School, Newark: Dependence of MS2
T4 phage growth on host amino acid biosynthesis during
infections of E. coli.
Schlagman, S.L., Hattman, S., Dept. of Biology, University
of Rochester, New York: Analysis of the translation initia-
tion site of the T4 Dam DNA methyltransferase protein.
Schmellik-Sandage, C., Wanner, B., Purdue University,
West Lafayette, Indiana: Control of bacterial alkaline
phosphatase (BAP) clonal variation in a E. coli K-12
"phase mutant."
Semerjian, A.V., Poteete, A.R., Dept. of Molecular Genetics
and Microbiology, University of Massachusetts Medical
School, Worcester: Phage P22 genes between erf and
immC.
Sengupta, D., Basu, S., Maitra, U., Division of Biology, Al-
bert Einstein College of Medicine, Bronx, New York: Spe-
cific binding of bacteriophage T3 RNA polymerase to its
cognate promoter requires the initiating nucleoside tri-
phosphate (GTP).
Shapiro, J.A., Dept. of Biochemistry and Molecular Biology,
University of Chicago, Illinois: Embryology of E. coli colo-
nies viewed by SEM.
Snyder, L., Jorissen, L., Dept. of Microbiology, Michigan
State University, East Lansing: E. coli mutations that de-
lay the bacteriophage-T4-induced unfolding of the nu-
cleoid.
Sparkowski, J., Das, A., Program in Molecular Biology and
Biochemistry, University of Connecticut Health Center,
Farmington: Temperature-sensitive alleles of RNA poly-
merase [3-subunit that compensate for the antitermination
defect of altered NusA protein.
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Thomas, M.S., Nomura, M., Dept. of Biological Chemistry,
University of California, Irvine: A novel form of transla-
tional coupling in E. coli.
Traxler, B., Mink ley, E., Jr., Dept. of Biological Sciences and
Mellon Institute, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Study of the tral gene of the F sex factor.
Verkamp, E., Chelm, B., DOE-Plant Research Laboratory
and Dept. of Microbiology, Michigan State University,
East Lansing: Genetic analysis of heme biosynthesis in E.
coli.
Vogel, J.L.,' Hawkins, M.D.,' Howe, M.M.,2 Higgins,
N. Dept. of Biochemistry, University of Alabama, Bir-
mingham; 2Dept. of Bacteriology, University of Wiscon-
sin, Madison: Characterization of mutations in bacterio-
phage Mu that cause thermoinducible prophage
activation through different pathways.
Wang, P.-Z., Novick, R.P., Dept. of Plasmid Biology, Public
Health Research Institute of the City of New York, New
York: Construction of a series of gene fusion S. auerus-B.
subtilis-E. coli shuttle vectors using the staphylococcal /3-
lactamase as an index enzyme.
Wek, R.C., Hatfield, G.W., Dept. of Microbiology and Molec-
ular Genetics, California College of Medicine, University
of California, Irvine: Nucleotide sequence and in vivo
SESSION 9 PHYSIOLOGICAL AND METABOLIC CONTROL
Straus, D., Cowing, D., Erickson, J., Zhou, Y.-N., Gross, C.,
Dept. of Bacteriology, University of Wisconsin, Madison:
Negative regulation of the E. coli heat-shock response.
Johnson, C., Chandrasekhar, G.N., Ang, D., Zylicz, M.,
Georgopoulos, C., CVM Biology, University of Utah, Salt
Lake City: E. coli heat-shock proteins dnaK and grpE-
Isolation of dnaK suppressors for grpE 280.
Bahl, H.,' Straus, D.,2 Crowl, R.,3 Echols, H.,"Dept. of
Molecular Biology, University of California; 2Dept. of Bac-
teriology, University of Wisconsin, Madison; 3Dept. of Mo-
lecular Genetics, Hoffmann-La Roche, Inc., Nutley, New
Jersey: Induction of the heat-shock response through
stabilization of o32 of E. coli by the bacteriophage A clll
expression of the ilvY and i/vC genes in E. coli K -12-
Transcription from divergent overlapping promoters.
Wierzbicki, A., Abremski, K., Hoess, R., Central Research
and Developmental Dept., E.I. Du Pont de Nemours and
Co., Wilmington, Delaware: A mutational and biochemi-
cal analysis of the bacteriophage P1 recombinase, Cre.
Wu, J.H., Ippen-lhler, K., Dept. of Medical Microbiology
and Immunology, Texas A&M University, College Station:
Identification of traQ and other new genes in the transfer
operon of the E. coil K-12 F factor.
Yap, W.Y., Kreuzer, K.N., Dept. of Microbiology and Immu-
nology, Duke University Medical Center, Durham, North
Carolina: Tertiary replication initiation of phage T4 DNA.
Zagotta, M.T., Wilson, D.B., Section of Biochemistry, Molec-
ular and Cell Biology, Cornell University, Ithaca, New
York: Time of appearance and localization of the A S pro-
tein.
Zhu, L., Cudny, H., Deutscher, M.P., Dept. of Biochemistry,
University of Connecticut Health Center, Farmington: A
mutation of the cca gene that affects AMP incorporation
by E. coli tRNA nucleotidyltransferase.
Kearney, C., Molineux, I.J., Dept. of Microbiology, Univer-
sity of Texas, Austin: "Incompatability" between gene
products of phage T7 and the F plasmid.
protein.
Bardwell, J.C.A., Craig, E.A., Dept. of Physiological Chem-
istry, University of Wisconsin, Madison: The E. coli heat-
inducible gene homologous to the Drosophila 83,000-Mr
heat-shock protein gene is dispensable.
Ninfa, A.J., Reitzer, L.J., Hunt, T.P., Magasanik, B., Dept. of
Biology, Massachusetts Institute of Technology, Cam-
bridge: Activation of transcription initiation from the nitro-
gen-regulated promoter glnAp2 of E. coli.
Keener, J., Wong, P.-K., Wallis, J., Popham, D., Kustu, S.,
Dept. of Bacteriology, University of California, Davis: Met-
abolic regulation of glnA transcription.
Ludwig, R.A., Donald, R.G.K., Loroch, A.I., Nees, D.W.,
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Dept. of Biology, Thimann Laboratories, University of Cal-
ifornia, Santa Cruz: Regulation of Rhizobium sp. ORS571
N2 fixation genes.
Wanner, B.L., Purdue University, West Lafayette, Indiana:
Bacterial alkaline phosphatase (BAP) clonal variation in
phase and state mutants.
Storz, G., Christman, M.F., Jacobson, ES., Ames, B.N.,
Dept. of Biochemistry, University of California, Berkeley:
Characterization of the bacterial response to oxidative
stress.
Jones, H.M., Kalman, L.V., Gunsalus, R.P., Dept. of Micro-
biology and Molecular Biology Institute, University of Cal-
ifornia, Los Angeles: Regulation of fumarate reductase
gene expression (frdABCD) in E. coli by oxygen, nitrate,
and fumarate.
Connell, N., Kolter, R., Dept. of Microbiology and Molecular
Genetics, Harvard Medical School, Boston, Massachu-
setts: Genetic studies of a stationary-phase-induced pro-
moter.
SESSION 10 TRANSCRIPTION TERMINATION AND ANTITERMINATION
Granston, A.E., Carver, D.L., Eades, L.J., Craven, M.G.,
Friedman, D.I., Dept. of Microbiology and Immunology,
University of Michigan Medical School, Ann Arbor: Stud-
ies on nusA and second-site supressors of nus mutations.
Ghosh, B., Zhu, L., DeVitto, J., Barik, S., Das, A., Program
in Molecular Biology and Biochemistry, University of Con-
necticut Health Center, Farmington: Cellular components
that participate in transcription antitermination.
Barik, S., Ghosh, B., Whalen, W., Lazinski, D., Das, A., Pro-
gram in Molecular Biology and Biochemistry, University
of Connecticut Health Center, Farmington: Site-specific
entry and assembly of a regulatory component into the
elongating transcription apparatus detected by its immu-
noprint.
Oberto, J.,' Sloan, S.,' Harbrecht, D.,2 Gottesman, M.E.,3
Weisberg, R.A.,"NICHD, National Institutes of Health,
Bethesda, Maryland; 2Molecular Genetics, Inc., Minne-
tonka, Minnesota; 3lnstitute of Cancer Research, Colum-
bia University, New York, New York: Further studies on
nun, a phage-encoded transcription termination factor.
Almond, N.M., Lupski, J.R., Godson, G.N., Dept. of Bio-
chemistry, New York University Medical Center, New
York: Regulation of transcription termination in the rpsU-
dnaG-rpoD macromolecular synthesis operon.
Morgan, E., Chang, T., Sigmund, C., Ettayebi, M., Roswell
Park Memorial Institute, Buffalo, New York: Effect of BoxA
mutations on ribosomal RNA transcription in vivo.
Whalen, W., Ghosh, B., Das, A., Program in Molecular Biol-
ogy and Chemistry, University of Connecticut Health
Center, Farmington: The nutL region of bacteriophage A
required for transcription antitermination encodes a sig-
nal for NusA-dependent termination.
Hasan, N., Szybalski, W., McArdle Laboratory for Cancer
Research, University of Wisconsin, Madison: Transcrip-
tional activity of the promoter-less N+ fragment of bacte-
riophage A and its enhancement by the nutL module.
Somasekhar, G., Szybalski, W., McArdle Laboratory for
Cancer Research, University of Wisconsin, Madison: Q-
utilization (qut) site required for antitermination of late
transcription in bacteriophage A-The functional bounda-
ries.
Ferstandig Arnold, F., Fassler, J.S., Tessman, I., Dept. of Bi-
ological Sciences, Purdue University, West Lafayette, In-
diana: Involvement of the rho protein of E. coil in the reg-
ulation of DNA supercoiling.
Drivdahl, R.H., Kutter, E., Evergreen State College, Olym-
pia, Washington: Inhibition of transcription of dC-DNA by
the alc gene product of phage T4.
R. Ebright, B. Magazanik
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SESSION 11 RNA PROCESSING AND TRANSLATIONAL CONTROL
Shub, D.A.,' Gott, J.M.,1 Xu, M.-Q.,1 Belfort, M.,2 'Dept.
of Biology, State University of New York, Albany;
2Wadsworth Center for Laboratories and Research, New
York State Department of Health, Albany: Multiple self-
spliced introns in bacteriophage T4.
Chu, F.K., Maley, F., Maley, G.F., Wadsworth Center for Lab-
oratories and Research, New York State Dept. of Health,
Albany: Genomic localization of the nrdA gene encoding
T4 phage ribonucleotide reductase A subunit and evi-
dence for multiple introns in the T-even phages.
Hall, D.H.,1 Povinelli, C.M.,1 Ehrenman, K.,2,3 Pedersen-
Lane, J.,2 Belfort, M.,2 'School of Applied Biology, Geor-
gia Tech, Atlanta; 2Wadsworth Laboratories, N.Y. State
Dept. of Health; 3Dept. of Microbiology and Immunology,
Albany Medical College, New York: Two splicing domains
in the intron of the phage T4 td gene established by non-
directed mutagenesis.
Takiff, H., Patterson, T., Court, D., NCI-Frederick Cancer
Research Facility, Frederick, Maryland: Cloning, genetic
mapping, overexpression, and essential nature of the
RNase III and era genes in E. coli.
Cole, J.R., Yamagishi, M., Nomura, M., Dept. of Biological
Chemistry, University of California, Irvine: Overproduc-
tion of rRNA enhances the half-lives of specific mRNAs in
E. coll.
SESSION 12 MEMBRANE PROTEINS/DNA MANIPULATIONS
Manoil, C., Beckwith, J., Harvard Medical School, Boston,
Massachusetts: Use of TnphoA in determining the struc-
ture of integral membrane proteins.
Ito, K., Akiyama, Y., Shiba, K., Institute for Virus Research,
Kyoto University, Japan: Characterization of the secY
(pr/A) gene-encoded membrane protein involved in pro-
tein export in E. coli.
Overdier, D.G., Druger-Liotta, J., Dunlap, V.J., Csonka,
L.N., Dept. of Biological Sciences, Purdue University,
West Lafayette, Indiana: Selection of osmoregulatory mu-
tants of S. typhimurium.
Kadner, R.J., Friedrich, M.J., Weston, L.A., Dept. of Micro-
biology, University of Virginia, Charlottesville: Identifica-
tion of the uhp polypeptides and their role in exogenous
induction of the sugar phosphate transport system.
Friedman, S., Austin, S., NCI-Frederick Cancer Research
Facility, Frederick, Maryland: Regulation of P1 partition
operon.
Taylor, R.,1 Miller, V.,2 Mekalanos, J.,2 'University of Ten-
nessee Center for the Health Sciences, Memphis;
2Harvard Medical School, Boston, Massachusetts: Coor-
dinate activation of genes encoding virulence determi-
nants of V. cholerae by a transmembrane protein.
Smith, C.L., Dept. of Genetics and Development, Columbia
University College of Physicians & Surgeons, New York,
New York: Structure and dynamics of entire bacterial ge-
nomes.
Trun, N.J., Silhavy, T.J., Dept. of Molecular Biology, Prince-
ton University, New Jersey: A general method for in vivo
cloning in E. coli.
Ludwig, R.A., Dept. of Biology, Thimann Laboratories, Uni-
versity of California, Santa Cruz: Infection of diverse bac-
Krinke, L., Cascio, M., Mahoney, M.E., Wulff, D.L., Dept. of
Biological Sciences, State University of New York, Al-
bany: Control of cll gene expression in bacteriophage A.
Matthews, L.C., Nomura, M., Dept. of Biological Chemistry,
University of California, Irvine: Protein S8 regulates L13
and L24 in the spc operon of E. coli.
Ivey, M.R., Steege, D.A., Dept. of Biochemistry, Duke Uni-
versity Medical Center, Durham, North Carolina: Transla-
tional regulation of bacteriophage f1 gene expression.
Ewen, M.E., Revel, H.R., Dept. of Molecular Genetics and
Cell Biology, University of Chicago, Illinois: Organization
and expression of bacteriophage ¢6 L-segment genes.
Engelberg-Kulka, H., Kopelowitz, J., Dept. of Molecular Bi-
ology, Hebrew University-Hadassah Medical School, Je-
rusalem, Israel: Influence of codon context on UGA read-
through.
Whoriskey, S.K., Nghiem, V.-H., Leong, P.M., Masson, J.-
M., Miller, J.H., Molecular Biology Institute, University of
California, Los Angeles: Genetic rearrangements and
gene amplification in E. coli.
Bergs land, K., Kao, C., Snyder, L., Dept. of Microbiology,
Michigan State University, East Lansing: Interaction be-
tween the bacteriophage T4 gol site and the lit gene
product of E. coli.
teria with E. coli bacteriophage A.
Howard, K.A., Card, C., Benner, J.S., Callahan, H.L.,
Maunus, R., Silber, K., Wilson, G., Brooks, J.E., New
England Biolabs, Beverly, Massachusetts: Cloning the
Ddel restriction-modification system using a two-step
method.
Moyle, H., Youderian, P., Dept. of Biological Sciences, Uni-
versity of Southern California, Los Angeles: Cloning vec-
tors derived from phage P22.
Finkel, S., Hal ling, C., Calendar, R., Dept. of Molecular Biol-
ogy, University of California, Berkeley: Selection of A
transducing phages using the P2 old gene cloned onto a
plasmid.
G. Mosig
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Molecular Biology of Hepatitis B Viruses
August 28-August 31
ARRANGED BY
Jesse Summers, Institute for Cancer Research, Philadelphia
Pierre Toillais, Institut Pasteur, Paris
198 participants
The second meeting on the Molecular Biology of Hepatitis B Viruses was at-
tended by 212 registered participants. Although last year's meeting served to
define the basic replication pathway, viral RNA transcripts, and viral gene prod-
ucts, more emphasis was apparent this year on factors that control gene expres-
sion and the function of viral gene products. Viral regulatory elements appear to
be utilized with enhanced efficiencies after transfection into cells that already
contain integrated viral DNA, suggesting a virus-encoded trans-acting control
mechanism. Regions of the viral genome responsible for cis-acting transcrip-
tional activation were identified, and evidence that these regions are acted on by
tissue-specific factors was presented. Considerable evidence that virus-encoded
proteins regulate intracellular and extracellular movement of viral gene products
was also presented, and these minor proteins may have crucial regulatory roles
in viral morphogenesis.
Hepatocellular carcinomas associated with hepadnaviral infections commonly
contain integrated viral DNA. The general structures of these integrated DNAs
now suggest that the replicative form of viral DNA is the precursor to the inte-
grated form. A number of genetic changes in virus-induced hepatocellular carci-
nomas were described, some of which are associated with viral DNA integration.
The role of these genetic changes in the etiology of hepatocellular carcinoma
continues to be investigated.
Finally, the molecular biology of hepatitis B viruses will become more accessi-
ble to a genetic approach due to the availability of tissue-culture systems for
HBV production from transfected cloned viral DNA. This long sought-after devel-
opment was reported by a number of laboratories at this year's meeting and
should add new and definitive data to next year's hepatitis B meeting, to be held
at the end of September.
This meeting was supported in part by the following divisions of the National
Institutes of Health: National Institute of Allergy and Infectious Diseases, National
Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases; and National
Science Foundation.
SESSION 1 REPLICATION AND THE CONTROL OF VIRAL GENE EXPRESSION
Chairman: J. Summers, Institute for Cancer Research, Philadelphia
Lien, J.-M., Petcu, D.J., Aldrich, C.E., Goldberg, J., Taylor,
J.M., Mason, W.S., Institute for Cancer Research, Phila-
delphia, Pennsylvania: Initiation and termination of DHBV
DNA synthesis.
Enders, G.,1 Ganem, D.,2.3 Varmus, H.,1.2 Depts. of
'Biochemistry and Biophysics, 2Microbiology and Immu-
nology, 3Medicine, University of California, San Fran-
cisco: As few as 21 additional 5'-terminal nucleotides dis-
tinguish unpackaged from packaged GSHV RNAs.
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Laub, O.,' Faktor, 0.,2 Shaul, Y.,2 Depts. of 'Genetics,
2Virology, Weizmann Institute of Science, Rehovot, Israel:
Efficient expression of the HBV enhancer element in hep-
atoma cell lines associated with HBV- Possible involve-
ment of virus-coded transacting factor(s).
Spandau, D.F., Lee, C.H., Dept. of Pathology, Indiana Uni-
versity School of Medicine, Indianapolis: Evidence for a
negative regulator that suppresses HBV enhancer activ-
ity.
Zahm, R, Hoschneider, P.H., Institute of Biochemistry, Mar-
tinsried, Federal Republic of Germany: Trans-activation
by DNA sequences of HBV.
Farza, H.,1 Hadchouel, M.,1 Salmon, A.M.,2 Babinet, C.,2
Tiollais, P,' Pourcel, C.,"Unite de Recombinaison et
Expression Genetique des Mammiferes, Institut Pasteur,
Paris, France: Developmental and hormonal regulation of
HBsAg gene expression in transgenic mice.
Tur-Kaspa, R., Moore, D., Burk, R.D., Shafritz, D.A., Albert
Einstein College of Medicine, Bronx, New York, and Mas-
sachusetts General Hospital, Boston: HBV DNA contains
a binding site for the glucocorticoid receptor.
Bulla, G.A., Siddiqui, A., Dept. of Microbiology and Immu-
nology, University of Colorado School of Medicine, Den-
ver: Role of the HBV enhancer on HBsAg gene expres-
sion.
Burk, R.D.,' DeLoia, J.,2 El Awady, M.K.,1 Gearhart, J.,2
'Albert Einstein College of Medicine, Bronx, New York;
'Johns Hopkins University School of Medicine, Balti-
more, Maryland: Putative HBsAg promoters not required
for preferential liver gene expression of HBV DNA in
transgenic mice.
Lever, A.M.L.,1 Saito, 1.,2 Stark, G.,2 Thomas, H.C.,'
'Royal Free Hospital, 2lmperial Cancer Research Fund,
London, England: Interferon sensitivity in the HBV vivo
and in vitro studies.
SESSION 2 BEHAVIOR AND FUNCTION OF VIRAL GENE PRODUCTS
Chairman: D. Ganem, University of California, San Francisco
Mack, D., Sninsky, J.J., Dept. of Diagnostics, Cetus Corpo-
ration, Emeryville, California: Two-dimensional protein
analysis of hepadnaviral particles using antisera gener-
ated to ORFs expressed in E. coli.
McLachlan, A., Milich, D.R., Raney, A.K., Riggs, M.G.,
Hughes, J.L., Sorge, J., Chisari, F.V., Dept. of Basic and
Clinical Research, Scripps Clinic and Research Founda-
tion, La Jolla, California: A hepatitis-B amphotropic retro-
viral expression system.
Kay, A.,' d'Auriol, L.,' Mandart, E.,1 Bouchier, C.,' Sha-
moon, B.,1 Galibert, F,' TrOpo, C.,2 'Laboratoire d'He-
matologie Expermentale, Centre Hayme, HOpital St.
Louis, Paris, 2INSERM, Lyon, France: Site-directed muta-
genesis of the pre-C region of WHV.
Brub, V., Gerlich, W.H., Dept. of Medical Microbiology, GOt-
tingen, Federal Republic of Germany: The pre-core se-
quence of HBV functions as signal for translocation to the
ER membrane.
Ou, J.,1,2 Garcia, P.,' Walter, P.,' Standring, D.,1,2 Rutter,
W.J.,1,2 'Depts. of Biochemistry and Biophysics,
2Hormone Research Institute, University of California,
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R.,' Van Davelaar, M.J.,"Dept. of Medicine, Stanford
University, California; 2Dept. of Microbiology, Pathology,
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Medical School, Boston, Massachusetts: HBV inhibition
of bone-marrow stem cells.
and Dept. of Medicine, Harvard Medical School, Boston;
2Liver Unit, Dept. of Medicine, Hadassah University Hos-
pital, Jersalem, Israel: Isolation and partial characteriza-
tion of a human hepatoma-associated cell-surface anti-
gen.
Kuroki, K.,' Kaneko, K.,2 Kodama, K.,' Kobayashi, K.,2
Hattori, N.,2 Murakami, S.,' 'Biophysics Division, Can-
cer Research Institute, 2lnternal Medicine, Kanazawa
University Medical School, Japan: Transcriptional activa-
tion of a chromosome region where the enhancer of
WHV DNA harbors in a cell line of woodchuck hepatoma.
Dejean, A.,' Bougueleret, L.,2 Tiollais, P.,"INSERM,
CNRS, 2lnstitut Pasteur, Paris, France: HBV DNA integra-
tion in a sequence homologous to v-erb-A and steroid re-
ceptor genes in a hepatocellular carcinoma.
Ochiya, T., Fujiyama, A., Fukushige, S., Hatada, I., Matsu-
bara, K., Institute for Molecular and Cellular Biology,
Osaka University, Japan: Molecular cloning of a novel
oncogene from an HBV-related human hepatocellular
carcinoma.
Zhou, Y.-Z., Butel, J.S., Dept. of Virology and Epidemiology,
Baylor College of Medicine, Houston, Texas: Integrated
state of subgenomic fragments of HBV DNA in hepato-
cellular carcinoma from mainland China.
and Parasitology, North Carolina State University School
of Veterinary Medicine, Raleigh: Experimental transmis-
sion of DHBV to domestic geese.
Tsurimoto, T., Matsubara, K., Institute for Molecular and
Cellular Biology, Osaka University, Japan: Stable expres-
sion and replication of the HBV genome in an integrated
state in a human hepatoma cell line transfected with the
cloned viral DNA.
Yaginuma, K., Shirakata, Y., Kobayashi, M., Koike, K., Dept.
of Gene Research, Cancer Institute, Tokyo, Japan: For-
mation of HBV-like particles in cell culture with a transient
expression system.
Sureau, C., Romet-Lemonne, J.-L., Essex, M., Dept. of
Cancer Biology, Harvard University School of Public
Health, Boston, Massachusetts: Production of HBV-like
particles in Hep G2 after transfection with cloned, circu-
lar HBV DNA.
Sureau, C., Romet-Lemonne, J.-L., Essex, M., Dept. of
Cancer Biology, Harvard University School of Public
Health, Boston, Massachusetts: Replication of HBV DNA
in human lymphoblastoid cells after transfection with
cloned, circular HBV DNA.
Sells, M.A., Acs, G., Dept. of Biochemistry, Mount Sinai
School of Medicine, New York, New York: In vitro HBV
DNA expression in transfected human liver cells.
Sells, M.A., Zelent, A., Shvartsman, M., Price, P.M., Acs, G.,
Dept. of Biochemistry, Mount Sinai School of Medicine,
New York, New York: Expression of HBV core protein,
pregenomic RNA, and episomal DNA by transfected mu-
rine cells.
Colucci, G.,' Lyons, P.,' Waksal, S.D.,' 'Dept. of Medi-
cine, Cornell University Medical College, 'Institute for
Cellular and Molecular Oncology, New York, New York:
Transcription and translation of the HBV genome in a hu-
man-human hybridoma.
International Workshop on Papillomaviruses
September 3-September 7
ARRANGED BY
Bettie M. Steinberg, Long Island Jewish Medical Center
Janet L. Brandsma, Long Island Jewish Medical Center
Lorne B. Taichman, State University of New York, Stony Brook
286 participants
This year, the International Workshop on Papillomaviruses attracted the largest
group ever, comprising more than 200 conferees from around the globe. An
enormous interest currently centers on papillomavirus research because it repre-
sents an area of direct clinical and epidemiologic relevance, as well as an area
where many basic molecular findings are now coming into focus. Because of the
unique blend of basic scientists and clinicians who join together in efforts to un-
derstand this group of viruses, two short workshops were offered: Molecular Biol-
ogy for the Clinician and Pathology for the Molecular Biologist.
The meeting was dedicated to Richard Shope and Yokei Ito for their pioneer-
ing work in this field using animal models. Interestingly, some of the more signifi-
cant developments this year related again to animal models, including a method
to grow human tissue explants infected with HPV in vitro in the nude mouse and
the development of transgenic mice carrying the complete BPV genome.
Abstracts on the involvement of HPVs in human disease accounted for well
over one third of the presentations and revealed the complexity of the associa-
tion of various types of HPV with both benign and malignant disease. Prevalence
rates of subclinical infection were also reported in many cases to be unexpect-
edly high.
The meeting also gave considerable attention to the molecular biology of pap-
illomaviruses. BPV was shown to express an E2 gene product that trans-acti-
vates two transcriptional enhancer regions of BPV. In addition, evidence for a
negative transcriptional regulatory factor was presented. Some studies ad-
dressed the mapping of particular viral transcripts in vivo, whereas other studies
looked at the replication and transformation of papillomaviruses in vivo and in
vitro. A number of groups presented the generation of papilloma-specific pro-
teins and analysis of their distribution in various cells and tissues.
This meeting was supported in part by the following divisions of the National
Institutes of Health: the National Cancer Institute and the National Institute of Al-
lergy and Infectious Diseases; the National Science Foundation; the Burroughs
Wellcome Company; the Council for Tobacco Research-USA, Inc.; the Otolaryn-
gology Foundation, Inc.; and the Sanford C. Bernstein & Company Foundation,
Inc.
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SESSION 1 ANIMAL PAPILLOMAVIRUSES
Chairperson: M.S. Campo, The Beatson Institute for Cancer Research
Dedicatory Address: C. Olson, Dept. of Veterinary Sci-
ence, University of Wisconsin, Madison: Richard Shope
and Yokei Ito and the Origins of Papillomavirus Research.
Seto, A.,' Miyoshi, 1.,2 Ito, y 1 Dept. of Microbiology,
Kyoto University, 2Dept. of Medicine, Kochi Medical
School, Japan: Introduction of inbred rabbits into tumor
virus research.
Amtmann, E.,1 Wayss, K.,2 Institute for 'Virus Research,
2Pathology, German Cancer Research Center, Heidel-
berg, Federal Republic of Germany: Interaction of MnPV
and carcinogenic agents.epSundberg, J.P.,1 O'Banion,
M.K.,2 Reichmann, M.E.,2 'Dept. of Pathobiology, Col-
lege of Veterinary Medicine, 2Dept. of Microbiology,
School of Life Sciences, University of Illinois, Urbana:
Mouse papillomavirus-Pathology and viral characteriza-
tion.
Schneider-Maunaury, S., Georges, E., Orth, G., Institut Pas-
teur, Paris, France: Structure and expression of CRPV ge-
nome and of the myc and Ha-ras genes during progres-
sion of domestic rabbit skin tumors.
SESSION 2 HUMAN DISEASES
Chairperson: C. Crum, Columbia University
Gissmann, L., German Cancer Research Center, Heidel-
berg: Association of papillomaviruses with human malig-
nancies.
Syrjanen, K.,' Mantyjarvi, R.,2 Vayrynen, M.,3 Syrjanen,
S.,4 Parkkinen, S.,2 Yliskoski, M.,3 Saarikoski, S.,3 Sark-
kinen, H.,2 Nurmi, T.,2 Castren, O.,3 1Laboraroty of Pa-
thology and Cancer Research, Finnish Cancer Society,
Depts. of 2Clinical Microbiology, 3Gynecology and Ob-
stetrics, 40ral Pathology, University of Kuopio, Finland:
Assessing the biological potential of HPV infection in
cervical carcinogenesis.
Shimoda, K., Lancaster, W.D., Dept. of Obstetrics and
Gynecology, Georgetown University, Washington, D.C.:
Integration of HPV-16-related sequences in mild cervi-
cal dysplasia.
Ostrow, R.,1 Manias, D.,1 Clark, B.,2 Okagaki,
Twiggs, L.,2 Faras, A.,1 'Dept. of Microbiology and Insti-
tute of Human Genetics, 2Dept. of Obstetrics and Gyne-
cology, 3Laboratory Medicine and Pathology, University
of Minnesota, Minneapolis: The analysis of malignant tu-
mors of the vulva, vagina, and cervix for HPV DNA.
Bistoletti, P.,1 Zellbi, A.,1 Hjerpe, A.,2 "Dept. of Obstetrics
SESSION 3 WORKSHOPS
Lowy, R., National Cancer Institue, NIH, Bethesda, Mary-
land: Workshop on Molecular Biology for the Clinician.
Kurman, R., Dept. of Pathology, Georgetown University,
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M.S. Campo
and Gynecology, 2Dept. of Pathology, Huddinge Hospi-
tal, Karolinska lnstitutet, Stockholm, Sweden: Genital
papillomavirus infection in women with adenomatous en-
dometrial hyperplasia.
Jablonska, S., Dept. of Dermatology, Warsaw School of
Medicine, Poland: Natural killer cell activity in patients
with skin lesions induced by HPV.
Fey, S.J., Institute for Medical Microbiology and Institute for
Human Genetics, Arhus University,' Denmark: New tech-
nique for viral diagnosis.
Syrjanen, S.,1 Partanen, P,2 Syrjanen, K.,3 "Dept. of Oral
Pathology, University of Kuopio, 2Labsystems Oy, Hel-
sinki, 3Finnish Cancer Society, Kuopio, Finland: Compari-
son of the in situ DNA hybridization protocols using 355 -
labeled probes and biotin-labeled probes in detection of
HPV DNA sequences.
Fuchs, P.G.,1 Girardi, F.,2 Engelhardt, A.,' Pfister, H.,1
'Institut fOr Klinische Virologie der Universitat Erlangen -
NUrnberg, Federal Republic of Germany;
2Geburtschilflich-Gyna-kologische Universitatsklinik,
Graz, Austria: Papillomaviruses in genital tumors of Aus-
trian patients.
Washington, D.C.: Workshop on Pathology for the Molec-
ular Biologist.
SESSION 4 THERAPIES
Chairperson: A.L. Abramson, Long Island Jewish Medical Center
Weck, P.K., Whisnant, J.K., Dept. of Immunology and On-
cology, Burroughs Wellcome Co., Research Triangle
Park, North Carolina: Therapeutic approaches to the
treatment of human papillomavirus diseases.
Steinberg, B.,1 Gallagher, T.,1 Trobridge, L.,2 Healy, G.,2
Abramson, A.,"Dept. of Otolarynogology, Long Island
Jewish Medical Center, New Hyde Park, New York;
2Dept. of Otolarynogology, Childrens Hospital Medical
Center, Boston, Massachusetts: Interferon and laryngeal
papillomatosis, effect of HPV type, and possible IFN
mechanism.
Shikowitz, M.,1 Steinberg, B.,1 Galli, R.L.,1 Wettstein,
F.O.,2 'Dept. of Otolaryngology, Long Island Jewish
Medical Center, New Hyde Park, New York; 2Dept. of Mi-
crobiology and Immunology, University of California, Los
Angeles: Molecular analysis of CRPV-induced papillomas
treated with hematoporphyrin photodynamic therapy.
SESSION 5 POSTER SESSION: ANIMAL PAPILLOMAVIRUS; HUMAN DISEASES. I.
O'Banion, M.K.,1 Reichmann, M.E.,1 Sundberg, J.P.,2
'Dept. of Microbiology, School of Life Sciences, 2Dept. of
Pathobiology, College of Veterinary Medicine, University
of Illinois, Urbana: Homologous DNA and protein se-
quences of the rabbit oral papillomavirus with CRPV,
HPV-1, and HPV-16.
Trenfield, K.,1 Spradbrow, P.B.,2 Vanselow, B.A.,3 'Dept.
of Medicine, Princess Alexandra Hospital, 2Dept. of Vet-
erinary Pathology and Public Health, University of
Queensland, Brisbane; 3Braund Street, Armidale, New
South Wales, Australia: Papillomavirus DNA resembling
BPV-2 DNA detected in an ovine cutaneous horn of the
ear.
Bunney;, M.H., Dept. of Dermatology, Royal Infirmary, Edin-
burgh, Scotland: Experience of five allograft patients with
extensive HPV infections treated with human lymphoblas-
toid interferon a.
Friedman-Kien, A.E.,1 Eron, L.,2 Conant, M.,2 Badiak, H.,2
Bradstreet, R,2 Geffen, J.," Fedorczyk, D.,2 Trout, J.R.,2
Plasse., T.,2 'New York University Medical Center, New
York; 2lnterferon Sciences, Inc., New Brunswick, New
Jersey: Intralesional a-interferon treatment of condylom-
ata acuminata-A multicenter trial.
Gross, G.,' Roussaki, A.,1 Drees, N.,3 Ikenberg, H.,2
Dept. of 'Dermatology, 2Gynecology and Obstetrics, Uni-
versity of Freiberg, Federal Republic of Germany;
3Hoffmann-La Roche Inc., Grenzach-Wyhlen: Systemic
treatment of genital warts with recombinant interferon-
2A- HPV DNA persistence in epithelia after regression of
the lesions?
Bernstein, A.,1 Lanier, J.' Buddin, D.A., 2 Weck, P.K.,2
'Georgia Baptist Hospital, Atlanta; 2Burroughs Wellcome
Co., Research Triangle Park, North Carolina: Interferon
alfa-n1 as adjuvant to laser therapy for severe or recur-
rent condyloma acuminata.
Mills, J.,1 Gottleib, A.,' Britt, RH.,2 Weck, P.K.,2
'University of California, San Francisco; 2Burroughs Well-
come Co., Research Triangle Park, North Carolina: Inter-
feron alfa-n1 for the treatment of refractory perianal and
rectal condylomata acuminata.
Smotkin, D.,1 Fu, Y.S.,2 Wettstein, F.O.,3 'Division of Gyne-
cologic Oncology, Depts. of 2Pathology, 3Microbiology
and Immunology, University of California School of Medi-
cine, Los Angeles: Distribution of HPV-16 and HPV-18 in
lesions of the female lower genital tract.
Villa, L.L.,1 Tamashiro, M.S.,2 Pereyra, E.,2 'Ludwig Insti-
tute for Cancer Research, 2Dept. of Gynecology, Univer-
sidade de Sdo Paulo, Brasil: HPV DNA in cervical and
urethral swabs from Sao Paulo.
von Krogh, G.,1 Syrjanen, S.M.,2 Syrjanen, K.J.,3 'Dept.
of Dermatology, Karolinska Institutet, Stockholm, Swe-
den; 2Dept. of Oral Pathology and Radiology, University
of Kuopio, 3Laboratory of Pathology and Cancer Re-
search, Finland Cancer Society, Kuopio: Detection of
HPV DNA in genitoanal warts of the male using in situ
DNA hybridization applied on paraffin sections.
Malcolm, A.D.B.,1 Wickenden, C.,' Coleman, D.V.,2
"Dept. of Biochemistry, Charing Cross and Westminster
Medical School, 2Dept. of Pathology, St. Mary's Hospital
Medical School, London, England: Papillomaviruses in
cervical epithelial scrapes.
Webb, D.H., Rogers, R., Fife, K., Indiana University Medical
School, Indianapolis: Detection of HPV genomes in cervi-
cal scrapes using reverse-blot DNA hybridization.
Stoler, M.,1 Wolinsky, S.,2 Chow, L.,3 Broker, T.,3 Depts. of
'Pathology, 2Medicine, 3Biochemistry, University of Roch-
ester Medical Center, New York: In situ hybridization us-
ing HPV type-specific subgenomic RNA probes.
Wilczynski, S.,' Bergen, S.,2 Sheets, E.,2 Depts. of
'Pathology, 2Obstetrics and Gynecology, University of
California, Irvine: Analysis of HPV DNA in cervical carci-
nomas.
Giorgi, C.,' Leopardi, 0.,2 Goisis, F.,' Bolis, P.F.,3 de Vir-
giliis, G.,4 Broich, G.,5 Divisions of 'Obstetrics and
Gynecology, 2Pathology, Ospedale di Lodi; 3Dept. of Ob-
stetrics and Gynecology, University of Pavia; 4Section of
Obstetrical and Gynecological Pathology, University of
Milan, Italy; 5Dept. of Oral Biology and Pathology, State
University of New York, Stony Brook: Immunohistochemi-
cal demonstration of HPV and carcino-embryogenic anti-
gens in the lower female genitary tract.Franceschi, S.,'
Zaninetti, P.,2 Baccolo, M.,2 Bonazzi, B.,2 Gottardi, G.,
Serraino, D.,' 'Centro di Riferimento Oncologico, Avi-
ano, 2lstitute of Obstetrical and Gynecological Pathology,
University of Milan, Italy: Papillomavirus infection and
cervical intraepithelial neoplasia in 2,040 women under
20.
de Villiers, E.-M.,' Wagner, D.,2 Schneider, A.,3 Miklaw,
H.,4 Grussendorf-Conen, W.,5 zur Hausen, H.,1
'Referenzzuntrum fur humanpathogene Papillomviren,
Deutsches Krebsforschungszentru Heidelberg;
2University of Freiburg; 3Universitat Frauenklinik, Ulm;
4Salem-Krankenhaus, Heidelberg, Federal Republic of
Germany: A survey of the infection rate in a normal popu-
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lation with genital papillomaviruses.
Pater, M.M., Dunne, J., Hogan, G., Ghatage, P., Pater, A.,
Dept. of Obstetrics and Gynecology, Memorial University
of Newfoundland, St. John's, Canada: Association of
HPVs with precancerous and cancerous lesions of the
cervix.
Reeves, W.C.,1 Caussy, H.,3 Cuevas, M.,' Arosemena, J.,'
Torrazza, 1.,2 Rawls, W.E.,3 'Gorgas Memorial Labora-
tory, 20ncology Institute, Panama, Republic of Panama;
3Mc Master University, Hamilton, Canada: HPV infection
in Panamanian prostitutes.
Reeves, W.,' Caussy, H.,3 Brinton, L.,4 Gomez, B.,'
Brenes, M.M.,' Torrazza, 1.,2 Rawls, W.E.,3 'Gorgas
Memorial Laboratory, 20ncology Institute, Panama, Re-
public of Panama: 3McMaster University, Hamilton, Can-
ada; 4NCI, National Institutes of Health, Bethesda, Mary-
land: Case-control study of HPV and cervical cancer in
Latin America.
Barraso, 0., Debrux, J., Croissant, 0., Orth, G., Unite des
Papillomavirus, Institut Pasteur, Paris, France: HPV-asso-
ciated lesions of male genitalia.
Reid, R.,' Greenberg, M.,' Jenson, A.B.,2 Husain, M.,1
Willett, J.,2 Daoud, Y," Temple, G.,3 Stanhope, C.R.,4
Sherman, A.,1 Phibbs, G.,5 Lorincz, A.,3 'Sinai Hospital,
Detroit, Michigan; 2Georgetown University School of
Medicine, Washington, D.C.; 3Bethesda Research Labo-
ratories, Gaithersburg, Maryland; 4Mayo Clinic, Roches-
ter, Minnesota; 5Medical College of Ohio, Toledo: Sex-
ually transmitted papillomaviral infections. I. The
anatomic distribution and pathologic grade of neoplastic
lesions associated with different viral types.
Boden, E.,' Evander, M.,2 Rylander, E.,' Wadell, G.,2
Depts. of 'Obstetrics and Gynecology, 2Virology, Umea,
Sweden: HPV present in benign cervical epithelium sev-
eral years after surgical removal of precancerous lesions.
ter Schegget, J.,' Walboomers, J.M.M.,2 Fokke, H.E.,'
Briet, M.A.,3 Struyk, A.P.H.B.,3 Wouters, E.,' Lammes,
F.B.,3 van der Noordaa, J.,' Depts. of 'Virology,
2Pathology, 30bstetrics and Gynecology, Academic Medi-
cal Centre, University of Amsterdam, The Netherlands:
Detection of HPV DNA in cervical neoplasias.
A. Faras, J. McDougall
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Schneider, A.,' Hotz, M.,2 Gissmann, L.,2 'Dept. of Ob-
stetrics and Gynecology, Univeristy of Ulm, 2German
Cancer Research Center, Heidelberg, Federal Republic
of Germany: Prevalence of genital HPV infections in
pregnant women.
Toon, P.G.,1,2 Wilson, L.P.,' Sharp, D.S.,2 Arrand,
'Paterson Laboratories, 2North Manchester General Hos-
pital, Manchester, England: HPV infection of the uterine
cervix of women without any cytological signs of neopla-
sia.
Bergeron, C.,1 Naghashfar, Z.,2 Shah, K.,2 Fu, Y,3 Feren-
czy, A.,' "Dept. of Pathology, Sir Mortimer- B. Davis Jew-
ish General Hospital, Montreal, Canada; 2Dept. of Immu-
nology and Infectious Diseases, Johns Hopkins
University School of Hygiene and Public Health, Balti-
more, Maryland; 3Dept. of Pathology, University of Cali-
fornia, Los Angeles: HPV-16 in intraepithelial neoplasia
(Bowenoid papulosis) and coexistent invasive carcinoma
of the vulva.
Bistoletti, P.," Zellbi, A.,1 Hjerpe, A.,2 Depts. of 'Obstetrics
and Gynecology, 2Pathology, Huddinge Hospital, Karolin-
ska Institutet, Stockholm, Sweden: Genital papillomavirus
infection after conization for cervical intraepithelial neo-
plasia.
Carson, L.F., Twiggs, L.B., Okagaki, T., Manias, D., Clark,
B., Faras, A.J., Depts. of Obstetrics and Gynecology, Pa-
thology and Microbiology, University of Minnesota, Min-
neapolis: Incidence of HPV DNA in specific histologic
types of invasive vulvar carcinoma.
Chen, R.-H.,1 Lee, S.-C.,2 Hsieh, C.-Y.,3 Huang, S.-C.,3
'Dept. of Clinical Research, National Taiwan University
Hospital, 2Graduate Institute of Clinical Medicine, School
of Medicine, National Taiwan University, and Institute of
Biological Chemistry, Academia Sinica, Tapei, Taiwan,
3Dept. of Obstetrics and Gynecology, School of Medi-
cine, National Taiwan University, People's Republic of
China: Presence and expression of HPV-16 and HPV-18
DNA in cervical carcinomas.
Del Mistro, A., Vallejos, H.,1 Kleinhaus, S.,2 Braunstein,
J.D.,1 Halwer, M.,1 Koss, LG.,' Depts. of 'Pathology,
2Surgery, Montefiore Medical Center, Albert Einstein Col-
lege of Medicine, Bronx, New York: HPV types in condy-
loma acuminata in prepubertal children.
Fife, K.H., Boggs, D., Zwickl, B., Rogers, R., Indiana Uni-
versity School of Medicine, Indianapolis: Asymptomatic
cervical infection with HPV during pregnancy.
Fu, Y.S.,1 Huang, Beaudenon, S.,2 lonesco, M.,3 Bar-
rasso, R.,3 de Brux, J.,3 'Dept. of Pathology, University
of California School of Medicine, Los Angeles; 2lnstitut
Pasteur, 3IPECA, Paris, France: Correlative study of HPV
DNA, histopathology, and morphometry in cervical con-
dyloma and intraepithelial neoplasia.
Ikenberg, H., Kleine, W., Pfleiderer, A., Dept. of Gynecol-
ogy and Obstetrics, University of Freiburg, Federal Re-
public of Germany: HPV DNA in primary tumors and
lymph node metastases of genital carcinomas-Correla-
tion of HPV prevalence with clinical stage and histology.
Murdoch, J.B., Cassidy, L., Cordiner, J.W., Macnab,
J.C.M., MRC Institute of Virology, University of Glasgow.
Scotland: The HPV genome and its association with col-
poscopically normal and colposcopically abnormal tissue
of the uterine cervix.
Caussy, D.,' Roth, P.,1 Reeves, W.,2 Rawls, W.,1
'McMaster University, Hamilton, Canada; 2Gorgas Mem-
orial Institute, Panama, Republic of Panama: Evaluation
of methods for detecting HPV DNA in clinical specimens.
Parkkinen, S.,1 Mantyjarvi, R.,1 Syrjanen, K.,2 Ranki, M.,3
'Dept. of Clinical Microbiology, University of Kuopio,
2Laboratory of Pathology, Finnish Cancer Society Ku-
opio, 30rion Genetic Engineering Laboratory Helsinki,
Finland: Sandwich hybridization for detecting papilloma-
virus DNA in cervical scrapings.
Malcolm, A.D.B.,' Nicholls, P.J.,' Wickenden, C.,' Cole-
man, D.V.,2 'Dept. of Biochemistry, Charing Cross and
Westminster Medical School, 2Dept. of Pathology, St.
Mary's Hospital Medical School, London, England: Sand-
wich hybridizations in the detection of HPV strains.
Syrjanen, S.,1 Happonen, R.-P.,2 Virolainen, E.,3 Siivonen,
L.,3 Syrjanen, K.,4 'Dept. of Oral Pathology and Radiol-
ogy, University of Kuopio, Depts. of 20ral Pathology,
30torhinolaryngology, University of Turku, 4Finnish Can-
cer Society, Kuopio, Finland: Demonstrations of HPV-11
and HPV-16 DNA in nasal inverted papillomas and squa-
mous cell carcinomas by in situ hybridization.
Fey, S.J., Mose Larsen, P., Institute for Medical Microbiol-
ogy and Institute for Human Genetics, Arhus University,
Denmark: Identification of putative HPV coat proteins
(L1) in cervical biopsies by 2D gel electrophoresis.
Mose Larsen, P.,1 Hansen, K.,2 Frandsen, K.,2 Vetner, M.,3
Gissmann, L.,4 'Institute for Medical Microbiology and
Institute for Human Genetics, Arhus University, 2Herning
Central Hospital, 3Holstebro Central Hospital, Denmark;
4German Cancer Research Center, Heidelberg, Federal
Republic of Germany: A clinical study of cervical HPV in-
fections using the putative coat proteins to determine the
type of HPV present.
Ritter, D.B., Kadish, A.S., Vermund, S.H., Romney, S.L.,
Saed, S.O., Burk, R.D., Albert Einstein College of Medi-
cine, Bronx, New York: Detection of HPV infection of the
cervix by cervicovaginal lavage and molecular hybridiza-
tion.
Goldsborough, M.D., DiSilvestre, D.A., Temple, G.F., LOr-
incz, A.T., Bethesda Research Laboratories, Life Technol-
ogies, Inc., Gaithersburg, Maryland: Nucleotide se-
quence analysis of HPV-31.
Lorincz, A.T., Quinn, A.R, Temple, G.F., Bethesda Research
Laboratories, Life Technologies, Inc., Gaithersburg,
J. Brandsma, L. Taichman, B. Steinberg
Maryland: Cloning and characterization of three new
HPV predominantly associated with mild cervical lesions.
Naghashfar, Z.,1 Rosenshein, N.,' Lorincz, A.,2 Shah,
K.V.,1 'Johns Hopkins Medical Institutions, Baltimore,
2Bethesda Research Laboratory, Maryland: A new HPV-
18-related genital tract papillomavirus from a patient with
mild cervical pathology.
Beaudenon, S., Kremodor, D., Croissant, 0., Orth, G., Unite
des Papillomaviruses, Institut Pasteur, Paris, France: Two
novel types of genital human papillomaviruses.
Lazo, P.A., Institute for Cancer Research, Fox Chase Can-
cer Center, Philadelphia, Pennsylvania: Structure of papil-
lomavirus (HPV-18) integrated in the genome of HeLa
cells.
El Awady, M.K.,1 Kaplan, J.,1 O'Brien, S.,2 Burk, R.D.,1
'Albert Einstein College of Medicine, Bronx, New York;
2NCI-Frederick Cancer Research Facility, Frederick,
Maryland: Molecular analysis of integrated HPV-16 in
cervical cancer.
Campion, M.J.,1 McCance, D.J.,2 Cuzick, J.,3 Singer, A.,'
'Dept. of Gynecology, Whittington Hospital, 2Dept. of Mi-
crobiology, Guy's Medical School, 3lmperial Cancer Re-
search Fund, London, England: The progressive poten-
tial of mild cervical atypia-A prospective cytological,
colposcopic, and virological study.
SESSION 6 TRANSCRIPTION
Chairperson: J. Brandsma, Long Island Jewish Medical Center
Spalholz, B.A., Lambert, P.F., Howley, P.M., NCI, National
Institutes of Health, Bethesda, Maryland: Mapping of the
BPV-1 LCR enhancer and promoters responsive to E2
transcriptional trans-activation.
Lambert, RE, Spalholz, B.A., Howley, P.M., NCI, National
Institutes of Health, Bethesda, Maryland: Evidence that
papillomaviruses may encode a transcriptional repressor.
Thierry, F, Carranca, A.G., Heard, J.-M., Cereghini, S.,
Yaniv, M., Institut Pasteur, Paris, France: Characterization
of transcription control elements in the noncoding region
of HPV-18.
Seeberger, R.,1 Haugen, T.,2 Turek, L.,2 Pfister, H.,1
'Institut fOr Klinische Virologie, Erlangen, Federal Repub-
lic of Germany; 2Dept. of Pathology, Veternas Administra-
tion Medical Center, Iowa City, Iowa: An enhancer of
HPV-8 is trans-activated by the BPV-1 E2 function.
Schwarz, E., Boukamp, P., Fusenig, N.E., zur Hausen, H.,
Deutsches Krebsforschungszentrum, Heidelberg, Fed-
eral Republic of Germany: HPV-18 transcription in He-
La1/4normal cell hybrids.
Chow, LT.,' Nasseri, M.,1 Wolinsky, S.M.,2 Broker, T.R.,"
Depts. of 'Biochemistry, 2Medicine, University of Roches-
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ter School of Medicine, New York: Electron microscopic
analysis of R-loops of HPV-6 and HPV-11 mRNAs from
condyloma acumina.
Ward, P., Mounts, P., Dept. of Immunology and Infectious
Diseases, Johns Hopkins University, Baltimore, Mary-
land: Transcriptional activity of HPV-6 subtypes in squa-
SESSION 7 WORKSHOP
T. Broker, Dept. of Biochemistry, University of Rochester,
New York: Workshop on Computer-associated Bibliog-
raphy and Word Processing for Papillomavirus Research.
SESSION 8 REPLICATION
Chairperson: K. Shah, Johns Hopkins University
Prives, C., Dept. of Biological Sciences, Columbia Univer-
sity, New York, New York: The replication of SV40 and po-
lyomaviruses.
Botchan, M., Molecular Biology and Virus Laboratory, Uni-
versity of California, Berkeley: Papillomavirus replication.
Reilly, S. S., Taichman, L., Dept. of Oral Biology and Pathol-
ogy, School of Dental Medicine, State University of New
York, Stony Brook: Underreplication of HPV-1 DNA in cul-
tured epidermal keratinocytes.
Christian, C.B.,' Reddel, R.R.,2 Shah, K.V.,' "Dept. of Im-
munology and Infectious Diseases, Johns Hopkins Uni-
versity School of Hygiene and Public Health, Baltimore,
2NCI, National Institutes of Health, Bethesda, Maryland:
Papillomavirus DNA replication in cultured cells of respi-
ratory tract origin.
mous papilloma of the respiratory tract.
Crum, C.,1.3 Nuovo, G.,1 Friedman, D.,1 Silverstein, S.,2.3
Depts. of 'Pathology, 2 Microbiology, 3Cancer Research
Center, Columbia University, New York, New York: In situ
hybridization analysis of HPV-16 RNA in genital precan-
cers.
B. Steinberg, E.-M. de Villiers
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Beiss, B.," Sundberg, J.,4 Douglas, J.,5 Burk, R.,2 Ritter,
D.,3 Kadish, A.,1 Depts. of Pathology, 2Pediatrics,
30bstetrics and Gynecology, Albert Einstein College of
Medicine, Bronx, New York; 4Dept. of Veterinary Patho-
biology, College of Veterinary Medicine, University of Illi-
nois, Urbana; 5Dept. of Health and Hospitals, Disease
Control Service, Denver, Colorado: Host immune re-
sponses to genital or laryngeal HPV infections.
ROdlinger, R.,1 Bunney, M.H.,2 Smith, I.W.,3 Hunter,
J.A.A.,2 1Dermatologische Klinik, Universitatsspital Zu-
rich, Switzerland; Depts. of 2Dermatology, 3Virology, Uni-
versity of Edinburgh, Scotland: Detection of HPV-5 DNA
in a renal allograft patient from Scotland.
Zachow, K., Ostrow, R., Faras, A., Dept. of Microbiology
and Institute of Human Genetics, University of Minne-
sota, Minneapolis: Nucleotide sequence of HPV-5.
Tanigaki, T.,1 Kanda, R.,1 Yoshikawa, K.,1 Kitano, Y.,' Yut-
sudo, M.,2 Hakura, A.,2 'Dept. of Dermatology, Osaka
University Medical School, 2Research Institute for Micro-
bial Diseases, Osaka University, Japan: Epidemiologic
aspects of epidermodysplasia verruciformis (L-L 1922) in
Japan-Clinical observations and virological studies in
11 patients with epidermodysplasia verruciformis.
Tanigaki, T.,' Kanda, R.,1 Yoshikawa, K.,1 Kitano, Y.,1 Yut-
sudo, M.,2 Hakura, A.,2 "Dept. of Dermatology, Osaka
University Medical School, 2Research Institute for Micro-
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bial Diseases, Osaka University, Japan: Epidermodyspla-
sia verruciformis in Japan-Characteristics of the lesions
and risk of widespread conversion in relation to the types
of HPV involved.
Brandsma, J.,' Barrezueta, N.,1 Galli, R.,1 Shah, K.,2
'Long Island Jewish Medical Center, New Hyde Park,
New York; 2Johns Hopkins University, Baltimore, Mary-
land: HPV-11 in some cases of nasal inverted papilloma.
de Villiers, E.-M.,1 Le, J.-Y.,1 Weidauer, H.,2 Greenspan,
D.,3 zur Hausen, H.,' 1Referenzzentrum fOr humanpath-
ogene Papillomviren, Deutsches Krebsforschungszen-
trum, Heidelberg, 2University of Heidelberg, Federal Re-
public of Germany; 3University of California, San
Francisco: DNA related to HPV-32 in a fibrolipoma of the
human parotid and HPV-7 DNA in some oral papillomas.
Takagi, M.,1 Yamada, T.,1 Yamamoto, H.,1 Terada, M.,2
'Dept. of Oral Pathology, Tokyo Medical and Dental Uni-
versity, 2National Cancer Center Research Institute, To-
kyo, Japan: HPV in oral lesions.
Adler-Storthz, K.,1 Newland, J.R.,2 Tessin, B.A.,' Yeudall,
W.A.,3 Shillitoe, E.J.,' Depts. of 'Microbiology,
2Pathology and Radiology, University of Texas Dental
Branch, Houston; 3Dept. of Oral Medicine and Pathology,
Glasgow Dental Hospital, Scotland: HPV-2 DNA in oral
verrucous carcinoma.
Hernandez-Jauregui, P.,1 Perez, R.T.,1 Ericsson, A.,2 Pet-
F. Cuzin
tersson, U.,3 Moreno-L., J.,2 'Unidad de Investigacion
Medica Institute Mexicano del Seguro Social, Mexico;
2Dept. of Veterinary Microbiology, Virology Biomedical
Center, 3Dept. of Medical Genetics and Microbiology,
Biomedical Center, Uppsala, Sweden: HPV-13 DNA in fo-
cal epithelial hyperplasia among Mexicans.
Kashima, H.,1 Mounts, P.,3 Kuhajda, F.,2 Loury M.,1
Depts. of 'Otolaryngology-Head and Neck Surgery,
2Pathology, Johns Hopkins Hospital, 3Dept. of Immunol-
ogy and Infectious Diseases, Johns Hopkins University,
Baltimore, Maryland: Demonstration of HPV capsid anti-
gen in carcinoma-in-situ of the larynx.
Zaslav, A.,1,2,3 Steinberg, B.,2 Stamberg, J.,1 Lin, Y.,3
'Schneider Children's Hospital, 2Dept. of Otolaryngology,
Long Island Jewish Medical Center, New Hyde Park; 3St.
John's University, Jamaica, New York: Cytogenetic evalu-
ation of laryngeal papillomas.
McDonnell, P.J., McDonnell, J.M., Kessis, T., Green, W.R.,
Shah, K.V., Johns Hopkins Medical Institutions, Balti-
more, Maryland: Detection of HPV-6 DNA in conjunctival
neoplasia by in situ hybridization with radioactive probes.
Nasseri, M., Hirochika, R., Broker, T.R., Chow, L.T., Dept. of
Biochemistry, University of Rochester School of Medi-
cine, New York: An HPV-11 transcript encoding an El-E4
fusion protein.
Wolinsky, S.M.,' Stoler, M.H.,2 Broker, T.R.,3 Chow, L.T.,3
Depts. of 'Medicine, 2Pathology, 3Biochemistry, Univer-
sity of Rochester School of Medicine, New York: Messen-
ger RNA exon-specific probes for HPV transcriptional
analysis.
Mitrani-Rosenbaum, S., Kitron, N., Dept. of Virology, He-
brew University-Hadassah Medical School, Jerusalem,
Israel: Expression of integrated HPV-6 recombinant DNA
in mouse cells.
Baker, C.,' Phelps, W.,1 Lingren, V.,' Braun, M.,2 Gonda,
M.,2 Howley, P.,1 "NCI, National Institutes of Health, Be-
thesda, 2NCI-Frederick Cancer Research Facility, Freder-
ick, Maryland: A structural and transcriptional analysis of
integrated HPV-16 DNA in human cervical carcinoma cell
lines.
Scott, C.L., Temple, G.F., LOrincz, A.T., Bethesda Research
Laboratories, Life Technologies, Inc., Gaithersburg,
Maryland: Construction and characterization of a partial
cDNA library from a cervical intraepithelial neoplasia.
Hirochika, H., Chow, L.T., Broker, T.R., Dept. of Biochemis-
try, University of Rochester School of Medicine and Den-
tistry, New York: Enhancer structure and trans-acting E2
transcriptional factors of HPVs.
Hurley-Guis, D.,' Laimins, L., 'Committee on Virology,
2Howard Hughes Medical Institute, University of Chi-
cago, Illinois: Characterization of an HPV-18 enhancer
element.
Phelps, W.C., Howley, P.M., NCI, National Institutes of
Health, Bethesda, Maryland: Transcriptional trans-activa-
tion of a conditional enhancer in HPV-16.
Marshall, T., Pater, A., Pater, M.M., Memorial University of
Newfoundland, St. John's, Canada: Identification of regu-
latory elements in the genomes of oncogenic human
papillomaviruses.
Haugen, T.H.,1 Cripe, T.R,1,2 Karin, M.,3 Turek, L.R,1
'Dept. of Pathology, 2Dept. of Genetics, VAMC and Uni-
versity of Iowa, Iowa City; 3Dept. of Medicine, University
of California, San Diego: BPV E2 function trans-activates
the major early viral promoter.
Cripe, Haugen, T.H.,1 Karin, M.,3 Turek, L.R,1
'Dept. of Pathology, 2Dept. of Genetics, VAMC and Uni-
versity of Iowa, Iowa City; 3Dept. of Medicine, University
of California, San Diego: An HPV-16 E2 function trans-ac-
tivates a cryptic cis enhancer upstream of the early viral
genes.
Harrison, S.M., Midgley, C.A., Kim, S., King, L.A., Kings-
man, A.J., Kingsman, S.M., Dept. of Biochemistry, Uni-
versity of Oxford, England: Analysis of the cis- and trans-
acting factors involved in the regulation of transcription in
BPV-1.
Baker, C.C., Howley, P.M., NCI, National Institutes of
Health, Bethesda, Maryland: Control of late transcription
in BPV.
Stamps, A., Campo, M.S., Beatson Institute for Cancer Re-
search, Glasgow, Scotland: Analysis of the mRNA tran-
scripts of BPV-4.
Lusky, M., Berg, L., Stenlund, A., Botchan, M., Dept. of Mo-
lecular Biology, University of California, Berkeley: A mod-
ulator function for BPV replication is required for the sta-
ble maintenance of the viral plasmid state.
Holmstedt, E., Nilsson, S., Pharmacia Biotechnology, Upps-
ala, Sweden: The El ORF is not sufficient to maintain
pBPV as a stably replicating episome in transfected cells.
King, L.A., Harrison, S.M., Wilson, L.E., Kingsman, A.J.,
Kingsman, S.M., Dept. of Biochemistry, University of Ox-
ford, England: Analysis of the cis- and trans-acting se-
quences involved in the replication of BPV.
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L. Taichman, L. Chow
Dietrich, W., Pfister, H., Institut fur klinische Virologie der
Universitat Erlangen-NOrnberg, Federal Republic of Ger-
many: Mutation in BPV-1 ORF E4 affects persistence of
viral DNA.
Romanczuk, H., Wormington, M., Brandeis University, Ro-
senstiel Center, Waltham, Massachusetts: Replication
and persistence of BPV in Xenopus embryos.
Ahola, H.,1 Str Orn, A.-C.,2 Bergman, P.,2 Eriksson, A.,'
Moreno-Lopez, G.,1 Pettersson, U.,2 Depts. of
'Veterinary Microbiology (Virology), 2Medical Genetics,
Uppsala University, Biomedial Center, Sweden: Structure
and expression of the transforming region from the Euro-
pean elk papillomavirus.
Sarver, N., Link, J., Nathan, M., Meloy Laboratories, Molec-
ular Biology Division, Springfield, Virginia: Modulation of
cDNA expression in mammalian cells by 3' flanking se-
quences.
Law, M.-F.,1 Baker, C.,2 Gardner, S.M.,' Register, R.B.,1
'Salk Institute Biotechnology/Industrial Associates Inc.,
La Jolla, California; 2NCI, National Institutes of Health,
Bethesda, Maryland: A combination cDNA cloning and
expression vector derived from BPV DNA.
Jensen, N.A., Pedersen, FS., Dept. of Molecular Biology,
SESSION 10 TRANSFORMATION
University of Aarhus, Denmark: Expression of BPV-1 late
genes in a retroviral expression and expression-transmis-
sion vector system.
Giordano, T.J., McAllister, W.T., Dept. of Microbiology and
Immunology, State University of New York Science Cen-
ter, Brooklyn: BPV-derived shuttle vectors containing the
hygromycin B resistance gene.
Jablonska, 5.,1 Kawashima, M.,2 Obalek, 5.,1 Orth, G.,2
'Dept. of Dermatology, Warsaw School of Medicine, Po-
land; 2lnstitut Pasteur, Paris, France: Human cutaneous
papillomas.
Malejczyk, J.,1 Majewski, 5.,2 Jablonska, S.,2 Orth, G.,3
'Dept. of Histology and Embryology, 2Dept. of Dermatol-
ogy, Warsaw Medical School, Poland; 3lnstitut Pasteur,
Paris, France: Natural cell-mediated cytotoxicity (NCMC)
in patients with an 0-genital lesions induced by poten-
tially oncogenic HPVs.
Majewski, 5.,1 Malejczyk, J.,2 Jablonska, S.,' Orth, G.,3
'Dept. of Dermatology, 2Dept. of Histology and Embryol-
ogy, Warsaw Medical School, Poland; 3lnstitut Pasteur,
Paris, France: In vitro effects of interferons a and y on
SKV cells.
Chairperson: J.K. McDougall, Fred Hutchinson Cancer Research Center
Lowy, D.R., Androphy, E.J., Vousden, K.H., Schiller, J.T.,
NCI, National Institutes of Health, Bethesda, Maryland:
Cellular transformation by BPV.
Di Maio, D.,1 Neary, K.,1 Kaczmarek, L.,2 Andrews, E.,'
Horwitz, B.,1 Guralski, D.,' 'Dept. of Human Genetics,
Yale University School of Medicine, New Haven, Con-
necticut; 2Dept. of Pathology, Temple Medical School,
Philadelphia, Pennsylvania: Mutational analysis of BPV
transformation functions.
Di Paolo, J.A., Doniger, J., Popescu, N., Yasumoto, S., Lab-
oratory of Biology, NCI, Bethesda, Maryland: Transforma-
tion and extended life span of human fibroblasts and epi-
thelial cells.
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Brandt, C.R., McDougall, J.K., Galloway, D.A., Fred Hutch-
inson Cancer Research Center, Seattle, Washington: Am-
plification of HPV DNA in cervical carcinoma cell lines oc-
curs following HSV-2 infection or treatment with a
chemical carcinogen.
Jones, K., Long, J., Laimins, L., Howard Hughes Medical
Institute, University of Chicago, Illinois: Transformation of
primary cells with HPV-16 and HPV-18 sequences.
Burnett, S., Pettersson, U., Dept. of Medical Genetics, Bio-
medical Center, Uppsala, Sweden: Transformation of
C127 cells by BPV-1 with its noncoding region replaced
by that of HPV-1.
Levenson, R.M., Brinckmann, U.G., Androphy, E. Schiller,
J., Broker, T.R., Chow, L.T., Young, D.A., Depts. of Medi-
cine, Biochemistry, and Biophysics, University of Roches-
ter, New York: Papillomavirus-specific inductions of cellu-
lar proteins in murine C127 cells-Role of the E5 and E6
transforming regions.
Nasseri, M., Wettstein, F.O., Dept. of Microbiology and Im-
SESSION 11 TISSUE-SPECIFIC EXPRESSION
Chairperson: F. Cuzin, Universite de Nice
Kreider, J.W.,1,2 Howett, M.K.,2 Lill, N.L.,2 Leure-Dupree,
A.E.,3 Zaino, R.J.,1 Depts. of 'Pathology, 2Microbiology,
3Anatomy, Hershey Medical Center, Pennsylvania: Tis-
sue-specific expression of HPV-11.
Sippola-Thiele, M.,1 Hanahan, D.,2 Lindgren, V.,1 Howley,
P.M.,' 'Laboratory of Tumor Virus, NCI, Bethesda, Mary-
land; 2Cold Spring Harbor Laboratory, New York: Analy-
sis of BPV-1 expression in transgenic mice.
munology, School of Medicine and Molecular Biology In-
stitute, University of California, Los Angeles: Character-
ization of CRPV deletion maintained as a plasmid in both
rabbit tissue and NIH-3T3 cells and its transforming activ-
ity.
Campione-Piccardo, J., Fanok, A., Garvie, P., Mandy, F.,
Health and Welfare Canada, LCDC, Ottawa: Cell differen-
tiation independent expression of late HPV-la genes in
human and monkey cell lines.
Watts, S.L., Brewer, E.E., Walton, L.A., University of North
Carolina, Chapel Hill: Culture of dysplastic uterine exo-
cervical cells and analysis of HPV DNA and mRNA in
cervical lesions.
SESSION 12 POSTER SESSION: TISSUE-SPECIFIC EXPRESSION, TRANSFORMATION,
AND PAPILLOMAVIRUS-SPECIFIC PROTEINS
DOrst, M.,1 Boukamp, P,2 Gissmann, L.,1 Institut fOr
'Virusforschung, 2Biochemie, Duetsches Krebsfor-
schungszentrum, Heidelberg, Federal Republic of Ger-
many: Transfection of primary human keratinocytes using
the complete HPV-16 genome-Analysis of a stable cell
clone.
Watts, S.L., Brewer, E.E., University of North Carolina,
Chapel Hill: Transformation of mouse C127 cells by HPVs
associated with genital neoplasia.
Kaur, P., McDougall, J.K., Fred Hutchinson Cancer Re-
search Center, Seattle, Washington: Transformation of
cells with cloned HPV-6b and HPV-18 DNAs.
Matlashewski, G., Banks, L., Spence, P., Murray, A., Craw-
ford, L., Imperial Cancer Research Fund, London, Eng-
land: Transformation by HPV-16 and production of tu-
mors in nude mice.
Sarkkinen, H.,1 Syrjanen, S.,2 Mantyjarvi, R.,1 Depts. of
'Clinical Microbiology, 20ral Pathology and Radiology,
University of Kuopia, Finland: Transformation of C127
cells by HPV-16 and HPV-31.
Yasumoto, S., Doniger, J., Di Paolo, J.A., NCI, National Insti-
tutes of Health, Bethesda, Maryland: Analysis of two
stage-transformation of HPV-16-transfected NIH-3T3
cells.
Chesters, P.M., McCance, D.J., Dept. of Microbiology,
Guy's Medical School, London, England: Transformation
of NIH-3T3 cells with pSVNE02 cloned HPV-6 and -16.
Green, M., Brackmann, K.H., Loewenstein, P.M., Institute
for Molecular Virology, St. Louis University Medical Cen-
ter, Missouri: Rat embryo fibroblast cells expressing HPV-
la genes exhibit altered growth properties and tumori-
genicity.
Modjtahedi, N., Feunteun, J., Brison, 0., Institut Gustave
Roussy, Villejuif, France: Cis-activation of the myc gene in
a BPV-1/human c-myc hybrid plasmid.
Groff, D.E., Dept. of Obstetrics and Gynecology, George-
town University Medical Center, Washington, D.C.: HPV-
16 DNA enhances stable biochemical transformation of
mouse cells.
Binetruy, B.,1 Meneguzzi, G.,' Cerni, C.,2 Cuzin, F.,1
1INSERM, Universite de Nice, France; 2lnstitut fur Tumor-
biologie der Universitat, Vienna, Austria: Tumoral pro-
gression induced by BPV-1 oncogenes in rodent fibro-
blasts.
Levenson, R.M., Brinckmann, U.G., Broker, T.R., Chow,
L.T., Young, D.A., Depts. of Medicine, Biochemistry, and
Biophysics, University of Rochester, New York: Specific
protein phosphorylations in murine C127 cells-Effects of
transformation by BPV-1 and v-Ha-ras and treatment with
the phorbol tumor promoter, TPA.
Brinckmann, U.G., Levenson, R.M., Broker, T.R., Chow,
L.T., Young, D.A., Depts. of Medicine and Biochemistry,
and Biophysics, University of Rochester, New York: Spe-
cific proteins secreted by murine C127 cells transformed
by HPV, BPV, and CRPV, v-fes, v-mos and v-Ha-ras.
Bergman, P.,' Ustav, M.,2 VennstrOm, B.,3 Pettersson, U.,1
'Dept. of Medical Genetics, Uppsala University, Sweden;
2Dept. of Molecular Biology, University of Tartu, Estonia,
USSR; 3EMBL, Heidelberg, Federal Republic of Ger-
many: Analysis of BPV-1 transforming function by the use
of a retrovirus vector.
Viac, J., Bouvard, V., Chardonnet, Y., Thivolet, J., INSERM,
CNRS, Hopital E. Herriot, Lyon, France: Incidence of
HPV infection on epithelial antigen expression in papillo-
mas.
Metcalfe, L., Mounts, P., Dept. of Immunology and Infec-
tious Diseases, Johns Hopkins University, Baltimore,
Maryland: Sequence homology among HPV-6 isolates
from condyloma acuminata and juvenile-onset and adult-
onset respiratory papillomata.
Farr, A., Roman, A., Dept. of Microbiology and Immunol-
ogy, Indiana University School of Medicine, Indianapolis:
Transfection of human keratinocytes with pRSVcat and
HPV-6 DNA.
Morgan, D.M., Pecoraro, G., Le, J., Defendi, V., Dept. of
Pathology, New York University Medical Center, New
York: Persistence, physical state, and transforming ability
of papillomavirus DNA in fibroblast/epithelial cells.
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Di Lorenzo, T., Risdon, G., Pumo, D.E., Hofstra University,
Hempstead, New York: Defined culture conditions for
C127 and BPV-infected ID13 cells.
Thompson, C., Rose, B., Parker, B., Morris, B., Cossart, Y.,
Depts. of Infectious Diseases and Physiology, University
of Sydney, Australia: Persistence of papillomavirus DNA
in keratinocytes cultured from anogenital warts.
Wilbanks, G.,1 Hawkins, J.,1 Turyk, M.,' Golub, T.,1 Mer-
cer, L.,2 McCance, D.,3 'Dept. of Obstetrics and Gyne-
cology, Rush University, 2Dept. of Obstetrics and Gyne-
cology, University of Chicago, Illinois; 3Dept. of
Microbiology, Guy's Hospital Medical School, London,
England: Tissue culture of human cervical intraepithelial
neoplasias.
Villari, D.,1 Kress, Y.,1 Burk, R.,2 Kadish, A.,1 Depts. of
'Pathology, 2Pediatrics, Albert Einstein College of Medi-
cine, Bronx, New York: Ultrastructural identification of
viral particles and filamentous forms in dysplastic cervical
lesions associated with different HPV types.
Gallagher, T.,1,2 Chardonnet, Y.,1 Viac, J.,1 Steinberg, B.,2
1CNRS, Lyons, France; 2Long Island Jewish Medical
Center, New Hyde Park, New York: Comparative investi-
gation of somatic hybrids, human carcinoma He La cells
(containing HPV-18 DNA)x mouse fibroblasts 3T3.4E,
prepared with PEG and electrofusion.
Schiller, J.T., Androphy, E.J., Lowy, D.R., NCI, National In-
stitutes of Health, Bethesda, Maryland: Genetic and bio-
chemical analysis of the BPV El ORF and its encoded
polypeptide.
Seedorf, K., Bernard, H.U., Roewekamp, W., Institute of
Cell and Tumor Biology, German Cancer Research Cen-
ter, Heidelberg, Federal Republic of Germany: Expres-
sion of HPV ORFs in E. coli and transfected mammalian
cells.
Giri, I.,' Danos, O.," Yaniv, M.,1 Drigeon, G.,2 Haenni,
A.L.,2 'Institut Pasteur, 2Universite Paris, France: Charac-
C. Olson, D. Owen
terization and properties of polypeptides encoded by the
CRPV early region.
Thompson, G.H., Roman, A., Dept. of Microbiology and Im-
munology, Indiana University School of Medicine, Indian-
apolis: Expression of HPV-6b ORFs in E. coli.
Li, C.-C.H.,1,2 Shah, K.,1 Seth, A.,3 Gilden, 'Johns
Hopkins University, Baltimore, 2PRI, NCI-Frederick Can-
cer Research Facility, 3Litton Bionetics, Inc., NCI-Freder-
ick Cancer Research Facility, Frederick, Maryland:
Expression of Ll ORF of HPV-6b-Potential of expressed
protein in serological surveys.
Browne, H.M., Minson, A.C., Smith, G.L., Stanley, M.A.,
Dept. of Pathology, University of Cambridge, England:
Production of vaccinia virus recombinants containing
ORFs of HPV-16.
Cowsert, L.M.,1 Jenson, B.,2 Depts. of 'Microbiology,
2Pathology, Georgetown University, Washington, D.C.,
Monoclonal antibodies define conformational and non-
conformational epitopes on BPV-1.
Doorbar, J., Gallimore, P.H., Dept. of Cancer Studies, Uni-
versity of Birmingham, England: Analysis of proteins en-
coded by HPV-1 and HPV-2.
Schneider-Gadicke, A.,' Schwarz, E.,1 Kaul, S.,2 Ganse-
pohl, H.,3 Frank, R.,3 ROwekamp, W.,1 Bastert, G.,4
1Deutsches Krebsforschungszentrum, Heidelberg,
2lnstitut fur Biologische Chemie, Frankfurt, 3EMBL, Hei-
delberg, 4Universitats-Frauenklinik, Homburg, Federal
Republic of Germany: Expression of HPV-18 in human
cervical carcinoma cell lines and production of monoclo-
nal antibodies against the HPV-18 E6 polypeptide.
Danos, 0.,1.2 Yaniv, M., 'Dept. de Biologie Moleculaire, In-
stitut Pasteur, Paris, France; 2Whitehead Institute for Bio-
medical Research, Cambridge, Massachusetts: Evolution
of the E6 and E7 gene products of papillomavirus from a
33 amino acid peptide with a potential nucleic
acid-binding structure.
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Patel, D., Chesters, P.M., McCance, D.J., Dept. of Microbi-
ology, Guy's Medical School, London, England: Expres-
sion of HPV-16 ORFs E6, L1, and E4 and a spliced frag-
ment of HPV-6 in bacteria and immunochemical analysis
of the proteins.
Barbosa, M.S., Wettstein, FO., Dept. of Microbiology and
Immunology, University of California School of Medicine,
Los Angeles: Identification of the protein encoded by the
E6 ORF of the CRPV.
Nakai, Y., Lancaster, W.D., Jenson, A.B., Dept. of Pathol-
SESSION 13 PAPILLOMA-SPECIFIC PROTEINS
Chairperson: F. Breitburd, Institut Pasteur
Smotkin, D.,1 Wettstein, F.O.,2 'Division of Gynecologic
Oncology, 2Dept. of Microbiology and Immunology, Uni-
versity of California School of Medicine, Los Angeles: E7,
the product of the major HPV-16 transcript in cervical
cancer, is a partially aggregated cytoplasmic phospho-
protein.
Firzlaff, J.M., Hsia, C.N., Halbert, C., Galloway, D.A., Fred
Hutchinson Cancer Research Center, Seattle, Washing-
ton: Generation and use of HPV-6B and HPV-16 antigens
and antibodies to detect viral gene expression and im-
mune response.
Palefsky, J.,1 Winkler, B.,2 Nizet, V.,1 Kidd, J.L.,1 School-
nik, G.K.,1 'Stanford Medical School, Stanford,
2University of California, San Franscisco Medical School:
HPV-16 DNA-positive cervical intraepithelial neoplasia
and cervical carcinoma demonstrate expression of an E6
ORF protein in the more differentiated cell layers.
Mallon, R., Wojciechowicz, D., Defendi, V., Dept. of Pathol-
ogy, New York University Medical Center, New York:
Expression and characterization of viral proteins from
BPV-1, HPV-6b, and HPV-16.
Androphy, E.J., Schiller, J.T., Lowy, D.R., NCI, National In-
stitutes of Health, Bethesda, Maryland: A peptide en-
coded by the BPV-1 E2 ORF specifically binds to the up-
stream regulatory regions of the BPV-1 and HPV-16
genomes.
Schlegel, R., Wade-Glass, M., Rabson, M., Yang, Y.-C.,
NCI, National Institutes of Health, Bethesda, Maryland:
The E5 transforming gene of BPV directs synthesis of a
small hydrophobic polypeptide.
Summary: PM. Howley, National Cancer Institute
ogy, Georgetown University, Washington, D.C.: Isolation
of papillomavirus structural polypeptides by immunoaffin-
ity columns using monoclonal antibodies.
Breitburd, F, Croissant, 0., Orth, G., Unite des Papillomavi-
rus, Institut Pasteur, Paris, France: Expression of E4 gene
products in the HPV-1-induced warts.
Smith, K.T., Campo, M.S., Beatson Institute for Cancer Re-
search, Glasgow, Scotland: BPV -4 -In vitro cell transfor-
mation and viral specific transcription.
P. Howley
Modern Approaches to New Vaccines Including
Prevention of AIDS
September 9-September 14
ARRANGED BY
Robert Chanock, NIAID National Institutes of Health
Harold Ginsberg, Columbia University
Richard Lerner, Research Institute of Scripps Clinic
Fred Brown, Wellcome Biotechnology Ltd.
253 participants
The series of annual meetings on Modern Approaches to Vaccines, held at the
Cold Spring Harbor Laboratory since 1983, has proved to be of considerable
popular interest. Although the general pattern of the program in 1986 was similar
to that of previous years, it was decided that the meeting should be extended by
one day so that a full discussion of all aspects of AIDS could be included. The
shadow of AIDS continues to spread over many parts of the world and its pre-
vention presents a challenge not only to governments and their agencies, but
also to those of us who believe that modern approaches to vaccination can offer
some answers.
The program also included sessions on immunology; recombinant vectors;
pathogenic bacteria and viral glycoproteins; and pathogenesis and attenuation;
as well as a poster session.
This meeting was funded in part by The Rockefeller Foundation, the National
Institute of Allergy and Infectious Diseases Intramural Research Program, and
the Johnson & Johnson Biotechnology Center, Inc.
A. Neurath, F. Brown
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van Mansfeld, A.D.M., van Teeffelen, H.A.A.M., Baas, P.D.,
Jansz, H.S., Institute of Molecular Biology and Medical
Biotechnology, University of Utrecht, The Netherlands:
Two neighboring tyrosyl residues are involved in cleav-
age and ligation of DNA by +X174 gene A protein.
Ghelardini, P.,1 Liebart, J.C.,2 Paolozzi, L.,1 Pedrini,
A.M.,3 "Centro Acidi Nucleici del CNR, Rome, Italy;
2lnstitut de Microbiologie, Faculty des Sciences d'Orsay,
France; 3lstituto di Genetica Biochimica ed Evoluzionis-
tica del CNR, Pavia, Italy: The lig product of phage Mu
affects the superhelicity of intracellular DNA.
Gennaro, M.L., Novick, R.P., Dept. of Plasmid Biology, Pub-
lic Health Research Institute, New York, New York: A cis-
acting plasmid locus alters DNA supercoiling and the in-
teraction between replication origin and initiator protein.
Umek, R.M., Kowalski, D., Dept. of Molecular and Cellular
Biology, Roswell Park Memorial Institute, Buffalo, New
York: Torsional stress induces an altered DNA conforma-
tion in a yeast ARS and gene terminator region.
Lockshon, D., Galloway, D.A., Fred Hutchinson Cancer Re-
search Center, Seattle, Washington: Palindromic replica-
tion origins of HSV.
Sumners, D.W.,1 Cozzarelli, N.R.,2 Spengler, S.J.,3 'Dept.
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of Mathematics, Florida State University, Tallahassee;
2Dept. of Molecular Biology, University of California,
Berkeley; 3Biomed Division, Lawrence Berkeley Labora-
tory, California: A topological model for site-specific re-
combination.
Kim, B.D., Dept. of Plant Sciences, University of Rhode Is-
land, Kingston: Four-stranded DNA and intercoiled
DNA- Intermediates of recombination.
Weber, P.C., Dinh, Y.-C.T., Abremski, K., Beran, R.K., Bren-
ner, S.L., Cox, M.J., Salemme, FR., Zlotnick, A., Oh len-
dorf, D.H., E.I. du Pont de Nemours and Company, Dept.
of Central Research and Development, Wilmington, Dela-
ware: Structural studies of proteins involved in DNA re-
combination and strand topology.
Hoess, R., Abremski, K., Wierzbicki, A., E.I. du Pont de
Nemours and Company, Dept. of Central Research and
Development, Wilmington, Delaware: A mutational and
biochemical analysis of the site-specific topoisomerase
Cre.
Kanaar, R.,' van de Putte, P.,' Cozzarelli, N.R.,2 'Dept. of
Biochemistry, State University of Leiden, The Nether-
lands; 2Dept. of Molecular Biology, University of Califor-
nia, Berkeley: Gin-mediated DNA inversion-Product
structure and strand exchange.
Stasiak, A., Willer, B., Koller, T., Institute for Cell Biology,
ETH-HOnggerberg, Zurich, Switzerland: DNA structure in
recombination intermediates.
Blaho, WA., Wells, R.D., Dept. of Biochemistry, Schools of
Medicine and Dentistry, University of Alabama, Birming-
ham: Left-handed Z-DNA binding by the RecA protein of
E. coll.
Leis, J.,' Cobrinik, D.,' Katz, R.A.,2 Soltis, D.,2 Terry, R.,2
Skalka, A.M.,2 'Dept. of Biochemistry, Case Western Re-
serve University, Cleveland, Ohio; 2Dept. of Molecular
Oncology, Roche Institute of Molecular Biology, Nutley,
New Jersey: Biochemical studies of retroviral DNA inte-
gration.
SESSION 5 INHIBITORS AND CELLULAR LOCALIZATION OF TOPOISOMERASES
Chairman: L. Liu, Johns Hopkins University
Earnshaw, W.C., Heck, M.M.S., Dept. of Cell Biology and
Anatomy, Johns Hopkins School of Medicine, Baltimore,
Maryland: Topoisomerase II- A specific marker for cell
proliferation.
Cockerill, P.N., Blasquez, V.C., Huang, S.-Y., Yuen, M.-H.,
Garrard, W.T., Dept. of Biochemistry, University of Texas
Health Science Center, Dallas: Immunoglobulin gene
chromosomal loops are anchored adjacent to enhancers
by (A + T)-rich DNA elements containing topoisomerase II
sites.
Laemmli, U.K., Gasser, S.M., Mirkovitch, J., Dept. of Molec-
ular Biology, University of Geneva, Switzerland: Cohabi-
tation of scaffold binding regions with upstream/enhan-
cer elements of three developmentally regulated genes of
SESSION 6 POSTERS
Scholten, P.M., Runkel, L., Herrera, R.E., Nordheim, A.,
Zentrum fur Molekulare Biologie, Heidelberg, Federal Re-
public of Germany: In vitro DNA supercoiling stabilizes
conformations that exhibit increased chemical reactivities
with diethylpyrocarbonate.
Walba, D.M.,' Armstrong, J.D. 111,1 Simon, J.K.,2 'Dept. of
Chemistry and Biochemistry, University of Colorado,
Boulder; 2Dept. of Mathematics, University of Iowa, Iowa
City: Topological stereochemistry from an organic chem-
ist's perspective.
Beran, R.K., Dinh, Y-C.T., E.I. du Pont de Nemours and
Company, Dept. of Central Research and Development,
Wilmington, Delaware: Simplified procedure for the purifi-
cation of E. coli DNA topoisomerase I from an overprod-
ucing strain.
Domanico, PL., Beran, R.K., Doran, E., Dinh, Y-C.T., E.I.
du Pont de Nemours and Company, Dept. of Central Re-
search and Development, Wilmington, Delaware: Physi-
cal and kinetic studies on the interaction between E. coli
topoisomerase I and oligonucleotides.
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D. melanogaster.
Darby, M.K.,1 Herrera, R.E.,2 Vosberg, H.-P.,' Nordheim,
A.,2 'Abteilung Molekulare Biologie, Max-Planck-Institut
fur medizinische Forschung, 2Zentrum fOr Molekulare
Biologie, Heidelberg, Federal Republic of Germany: DNA
topoisomerase II cleaves at specific sites in the 5'-flank-
ing region of c-fos proto-oncogenes in vitro.
Pommier, Y., Markovits, J., Kerrigan, D., Kohn, K.W., NCI,
National Institutes of Health, Bethesda, Maryland: Altera-
tions in topoisomerase activities associated with cell pro-
liferation and drug resistance.
Shen, L.L., Abbott Laboratories, Abbott Park, Illinois: Quin-
olone antibacterials-Structure, activity, and mechanism
of inhibition of DNA gyrase.
Barot, H.A., Fisher, L.M., Dept. of Biochemistry, St.
George's Hospital Medical School, University of London,
England: Site-specific DNA breakage by E. coli DNA gy-
rase.
Hooper, D., Wolfson, J., Souza, K., Ng, E., McHugh, G.,
Swartz, M., Infectious Disease Unit, Massachusetts Gen-
eral Hospital, Boston: Quinolone antimicrobial agents-
Inhibition of DNA gyrase and mechanisms of resistance
in E. coli.
Tornaletti, S., Pedrini, A.M., Istituto di Genetica Biochimica
ed Evoluzionistica del CNR, Pavia, Italy: Effect of nalidixic
acid on DNA conformation.
Lin, G., Mosig, G., Dept. of Molecular Biology, Vanderbilt
University, Nashville, Tennessee: Inactivation of both
phage T4 DNA topoisomerase and E. coil DNA gyrase
differentially affects T4 late transcripts.
Balke, V.L., Gralla, J.D., Molecular Biology Institute and
Dept. of Chemistry and Biochemistry, University of Cali-
fornia, Los Angeles: Changes in E. coil plasmid super-
coiling in response to growth transitions.
Yamamoto, N.,' Yoshizawa, Y.,' Thomulka, K.W.,2 Hoober,
J.K.,3 'Dept. of Microbiology and Immunology, Hahne-
mann University School of Medicine, 2Dept. of Biological
Sciences, Philadelphia College of Pharmacy and Sci-
ences, 3Dept. of Biochemistry, Temple University School
of Medicine, Philadelphia, Pennsylvania: Relation be-
tween strict aerobic mutants of facultative anaerobes (E.
coli and S. typhimurium) and the action of DNA gyrase
inhibitors.
Jovanovich, S.B.,' Martinell, M.,' Lebowitz, J.,2 Burgess,
R.R.,"McArdle Laboratory for Cancer Research, Uni-
versity of Wisconsin, Madison; 2Dept. of Microbiology,
University of Alabama, Birmingham: Use of operon fu-
SESSION 7 DNA REPLICATION TOPOLOGY
sions to examine the in vivo effects of supercoiling.
Yamamoto, N.,' Thomulka, K.W.,2 Yoshizawa, Y.,' Hoober,
J.K.,3 'Dept. of Microbiology and Immunology, Hahne-
mann University School of Medicine, 2Dept. of Biological
Sciences, Philadelphia College of Pharmacy and Sci-
ence, 3Dept. of Biochemistry, Temple University School
of Medicine, Philadelphia, Pennsylvania: Control of gene
expression by aerobic or anaerobic conditions.
Hsieh, W.-T., Wells, R.D., Dept. of Biochemistry, University
of Alabama, Birmingham: Influence of left-handed Z-DNA
and supercoiling on the binding of the lactose repressor
to its operator.
Chairman: J. Hurwitz, Memorial Sloan-Kettering Cancer Center
Baker, T.A., Funnell, B.E., Sekimizu, K., Bramhill, D., Korn-
berg, A., Dept. of Biochemistry, Stanford University
School of Medicine, California: Enzymatic studies on rep-
lication of oriC plasmids.
McMacken, R., Wold, M., Mensa-Wilmot, K., Seaby, R.,
Dept. of Biochemistry, Johns Hopkins University, Balti-
more, Maryland: Roles of DNA gyrase in the replication
of bacteriophage A DNA.
Marians, K., Minden, J., Graduate Program in Molecular Bi-
ology, Memorial Sloan-Kettering Cancer Center, New
York, New York: Segregation of replicating pBR322 DNA
daughter molecules in vitro.
Dean, F, Bullock, P., Murakami, Y., Weissbach, L., Wobbe,
R., Borowiec, J., Hurwitz, J., Graduate Program in Mo-
K. Mizuuchi
lecular Biology and Virology, Sloan-Kettering Institute for
Cancer Research, New York, New York: SV40 T antigen
is required for unwinding template plasmid DNA contain-
ing the SV40 origin of replication.
Yang, L.,' Wold, M.S.,2 Li, J.J.,2 Kelly, T.J.,2 Liu, L.F.,1
Depts. of 'Biological Chemistry, 2Molecular Biology and
Genetics, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Multiple roles of DNA topoisomer-
ases in SV40 DNA replication in vitro.
Fields-Berry, S., DePamphilis, M.L., Dept. of Biological
Chemistry, Harvard Medical School, Boston, Massachu-
setts: Effect of yeast centromeric sequences on formation
of catenated dimers during plasmid DNA replication in
mammalian cells.
A. Klug N. Cozarelli
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SESSION 8 TOPOLOGICAL APPROACHES TO SITE-SPECIFIC RECOMBINATION
Chairman: H. Nash, National Institutes of Health
Nash, H., Abcarian, P., Kitts, P., Richet, E., Laboratory of
Molecular Biology, National Institute of Mental Health, Be-
thesda, Maryland: Mechanism of A integrative recombi-
nation-Topological studies and beyond.
Nunes-DOby, S., Pargellis, C., Moitoso de Vargas, L., Egner,
C., Franz, B., Landy, A., Division of Biology and Medi-
cine, Brown University, Providence, Rhode Island: De-
sign and use of suicide substrates to study topoisomer-
ase and recombination intermediates in the Int-
dependent pathway.
Hatfull, G.E, Salvo, J.J., Grindley, N.D.F., Dept. of Molecu-
lar Biophysics and Biochemistry, Yale University, New Ha-
ven, Connecticut: Site-specific recombination by the yd
resolvase-Formation of a kink at the crossover site?
Benjamin, H., Dungan, J., Haskins, B., Kanaar, R., Richard-
son, M., Wasserman, S., Weinberg, R., Cozzarelli, N.,
Dept. of Molecular Biology, University of California,
Berkeley: Specificity in synapsis and exchange in site-
specific recombination.
Boocock, M.R., Brown, J.L., Sherratt, D.J., Institute of Ge-
netics, University of Glasgow, Scotland: Topological
specificity of Tn3 resolvase.
Abremski, K., Hoess, R.H., Frommer, B., Wierzbicki, A., E.I.
Du Pont de Nemours and Co., Dept. of Central Research
and Development, Wilmington, Delaware: Mechanisms of
synapsis and strand exchange during Cre-/oxP site-spe-
cific recombination.
SESSION 9 DNA TOPOLOGY AND GENERAL RECOMBINATION
Chairman: K. Mizuuchi, National Institutes of Health
Kahmann, R., Brauer, B., Max-Planck-Institut fOr Molekulare
Genetik, Berlin, Federal Republic of Germany: DNA to-
pology changes associated with G inversion.
Craigie, R., Mizuuchi, K., NIADDKD, National Institutes of
Health, Bethesda, Maryland: Role of DNA topology in Mu
transposition-Mechanism of sensing the relative orienta-
tion of two DNA segments.
Morisato, D., Kleckner, N., Dept. of Biochemistry and Mo-
lecular Biology, Harvard University, Cambridge, Massa-
chusetts: Tn10 and IS10 transposition in vitro.
Radding, C.M., Bainton, R.J., Chow, S.A., Flory, J., Gonda,
D.K., Honigberg, S.M., Leahy, M., Muniyappa, K., Tsang,
S.S., Depts. of Human Genetics and Molecular Biophys-
ics and Biochemistry, Yale University School of Medicine,
New Haven, Connecticut: Topology and topography of
homologous pairing and strand exchange.
Griffith, J.D.,1 Christiansen, G.C.,2 Register, J.,' Harris,
L.D.,' 'Lineberger Cancer Center, University of North
Carolina, Chapel Hill; 2Dept. of Medical Microbiology,
University of Aarhus, Denmark: Electron microscopic vi-
sualization of the intermediates in strand exchange reac-
tions.
Champoux, J., Bullock, R, McCoubrey, W., Dept. of Micro-
biology and Immunology, University of Washington, Seat-
tle: Evidence consistent with a role for the eukaryotic
type I topoisomerase in nonhomologous recombination.
SESSION 10 EFFECTS OF DNA SUPERCOILONG AND BENDING ON TRANSCRIPTION
Chairman: H. Weintraub, Fred Hutchinson Cancer Research Center
Worcel, A.,1 Kmiec, E.,' Ruberti, 1.,2 'Dept. of Biology,
University of Rochester, New York; 2lstituto di Fisiologia
Generale, Universita degli Studi di Roma, Italy: Chroma-
tin assembly and gene expression in vitro.
Hochschild, A.,1 Griffith, J.,2 Ptashne, NA.,1 Dept. of Bio-
chemistry and Molecular Biology, Harvard University,
Cambridge, Massachusetts; 2Lineberger Cancer Re-
search Center, University of North Carolina Medical
School, Chapel Hill: Cooperative binding of A repressors
to separated operator sites.
Summary: M. Gellert, National Institutes of Health
Gralla, J., Borowiec, J., Dept. of Chemistry and Biochemis-
try, University of California, Los Angeles: DNA supercoil-
ing induces bent DNA during recognition of the /ac oper-
ator and promoter.
Dinh, Y.-C.T., E.I. du Pont de Nemours and Company, Dept.
of Central Research and Development, Wilmington, Dela-
ware: Transcription of E. coli DNA topoisomerase I gene
from multiple promoters and its regulation by DNA super-
coiling.
Poxvirushlridovirus
September 24-September 26
ARRANGED BY
Richard Condit, State University of New York, Stony Brook
Dennis Hruby, Oregon State University
132 participants
The 1986 Poxvirus/Iridovirus Workshop was the sixth in a series that began in
1977. The purpose of the meetings is to discuss all aspects of the biology of
DNA-containing viruses that undergo a significant portion of their replication
cycle in the cytoplasm of infected cells. The viruses considered include a large
variety of poxviruses and iridoviruses, with the current emphasis focusing on
vaccinia virus, Shope fibroma virus, African swine fever virus, and frog virus 3.
Sessions in this year's meeting covered virus structure, virus-cell interactions, ge-
nome structure and organization, transcription, DNA metabolism and recombina-
tion, virus-host interactions, including studies on the interferon-induced antivirus
state, persistent infections, and transformation, and finally the use of vaccinia vi-
rus as an expression vector and as a live recombinant vaccine.
The meeting was the largest yet, with worldwide participation by over 100 in-
vestigators, over 90 oral presentations, and a poster session. As in the past, the
group continues to draw strength from the diversity of virus systems represented,
and from an extraordinary degree of cooperation and interaction among the par-
ticipants.
This meeting was supported in part by the Bethesda Research Laboratories
and Life Technologies, Inc.
A. Ball, R. Condit
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SESSION 1 VIRION STRUCTURE AND VIRUS-CELL INTERACTIONS
Chairman: S. Dales, University of Western Ontario
Berthiaume, L.,1 Alain, R.,' Robin, J.,2 'Institut Armand-
Frappier, 2Dept. of Biology, University of Sherbrooke,
Quebec, Canada: Electron microscopic study of lympho-
cystis disease virus (LDV) grown in cell cultures- Ultra-
structure and morphogenesis.epDales, S., Dept. of Mi-
crobiology and Immunology, University of Western
Ontario, London, Canada: Concerning definitions of
"membrane" and "envelope" in the biology of poxviruses.
Schloer, G.M., Geering, G., Plum Island Animal Disease
Center, Greenport, New York: Isolation of African swine
fever virus polypeptides.
Carrascosa, A.L., Santaren, J.F, Vinuela, E., Centro de
Biologia Molecular (CSIC-UAM), Universidad AutOnoma,
Madrid, Spain: External proteins of African swine fever vi-
rus (ASFV) particles.
LOpez-Otin, C., Rey, J., Simon, C., Mendez, E., Carrascosa,
A.L., Vinuela, E., Centro de Biologia Molecular, Universi-
dad AutOnoma (CSIC-UAM), Madrid, Spain: African
swine fever virus (ASFV) late proteins.
SESSION 2 GENOME STRUCTURE
Chairman: L. Archard, Westminster Medical School
Robinson, A.J., Barnes, G., Carpenter, E., Mercer, A.A.,
MRC Virus Research Unit, Dunedin, New Zealand: Con-
servation and variation in parapoxvirus genomes.
Binns, M.M., Tom ley, FM., Boursnell, M.E.G., Mockett,
A.P.A., Houghton Poultry Research Station, Huntingdon,
England: Cloning and restriction mapping studies on
fowlpox virus.
Gershon, P.D., Black, D.N., Animal Virus Research Institute,
Pirbright, England: Location of genomic differences be-
tween capripoxvirus isolates.
Blasco, R., Almendral, J.M., AgUero, M., Almazan, F., Vin-
uela, E., Centro de Biologia Molecular (CSIC-UAM), Univ-
ersidad Aut6noma, Madrid, Spain: Multigene families
and genetic variation of African swine fever virus (ASFV).
Dixon, L.K., Wilkinson, P.J., Hutchings, G., Animal Virus Re-
search Institute, Pirbright, England: Molecular analysis of
African swine fever virus isolates from tick populations in
Zambia and Malawi.
Porter, C.D., Archard, L.C., Dept. of Biochemistry, Charing
Cross and Westminster Medical School, London, Eng-
land: Structure of molluscum contagiosum virus DNA and
SESSION 3 GENOME ORGANIZATION
Chairman: R. Wittek, Institut de Biologie Anima le, Lausanne
Tom ley, FM., Binns, M.M., Boursnell, M.E.G., Mockett,
A.P.A., Houghton Poultry Research Station, Cambridge,
England: Molecular structure and organization of an
11.3-kb fragment of fowlpox virus.
Tham, T.N., Mesnard, J.M., Tondre, L., Aubertin, A.M.,
Groupe de Recherches INSERM, Laboratoire de Virolo-
gie, Strasbourg, France: RNA transcript organization
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del Val, M., Vinuela, E., Centro de Biologia Molecular
(CSIC-UAM), Universidad AutOnoma, Madrid, Spain: Gly-
cosylated components of African swine fever virus
(ASFV) in virus particles and virus-infected cells.
Cabirac, G.F., Strayer, D.S., Leibowitz, J.L., University of
Texas Health Science Center, Houston: The surface poly-
peptides of three leporipoxviruses.
Rodriguez, J.F., Paez, E., Esteban, M., Depts. of Biochem-
istry, Microbiology and Immunology, Health Science Cen-
ter, Brooklyn, New York: A 14K envelope protein of vacci-
nia virus is involved in virus-induced cell fusion.
Gordon, J., Dales, S., Dept. of Microbiology and Immunol-
ogy, University of Western Ontario, London, Canada:
Physical mapping of the gene encoding a prominent vac-
cinia virus antigen.
Alvarez, R.M., Schlemm, D.J., Keller, S.J., Dept. of Biologi-
cal Sciences, University of Cincinnati, Ohio: Association
of host cytoskeletal proteins with vaccinia virus.
mapping of a novel EGF-like gene.
Reisner, H., Scholz, J., Darai, G., Institut of Medical Virol-
ogy of the University, Heidelberg, Federal Republic of
Germany: Characterization of the genome of molluscum
contagiosum virus type 2.
ROsen, A.,' Pilaski, J.,2 Darai, G.,"Institute of Medical Vi-
rology of the University, Heidelberg, 2Medizinisches In-
stitut fOr Umwelthygiene, DOsseldorf, Federal Republic of
Germany: Genomic characterization of a poxvirus iso-
lated from a child.
Soltau, J., Schnitz ler, P., Reisner, H., Scholz, J., Darai, G.,
Institute of Medical Virology of the University, Heidelberg,
Federal Republic of Germany: Analysis of the genome of
insect iridescent virus type 6 by molecular cloning and
physical mapping.
Schnitz ler, P.,1 Delius, H.,2 Darai, G.," Institute of Medical
Virology of the University, 2European Molecular Biology
Laboratory, Heidelberg, Federal Republic of Germany:
Analysis of the repetitive DNA sequences in the genome
of fish lymphocystis disease virus.
within the Sall F fragment of frog virus 3-Nucleotide se-
quences of two genes.
Beckman, W., Willis, D.B., Dept. of Virology and Molecular
Biology, St. Jude Children's Research Hospital, Memphis,
Tennessee: Cloning and sequencing of the immediate-
early frog virus 3 gene that encodes ICR489.
Macaulay, C., Upton, C., Macen, J., McFadden, G., Dept.
of Biochemistry, University of Alberta, Canada: Charac-
terization of the genes within the terminal inverted repeat
of Shope fibroma virus.
Patel, D., Pickup, D.J., Dept. of Microbiology and Immunol-
ogy, Duke University Medical Center, Durham, North Car-
olina: Identification and characterization of the gene en-
coding the major component of the A-type inclusions
formed by cowpox virus.
Niles, E., Condit, R., Seto, J., Dept. of Biochemistry, State
University of New York, Buffalo: Gene organization in the
vaccinia virus HindlIl D fragment.
SESSION 4 TRANSCRIPTION
Chairman: B. Moss, National Institutes of Health
Bertholet, C., Van Meir, E., Wittek, R., Institut de Biologie
animale, Batiment de Biologie, Lausanne, Switzerland:
Evidence for processing at the 5' end of vaccinia virus
late mRNAs.
Thompson, J.P., Willis, D.B., Granoff, A., Dept. of Virology
and Molecular Biology, St. Jude Children's Research
Hospital, Memphis, Tennessee: Transcription of methyl-
ated DNA in frog virus 3-infected cells.
Willis, D.B., Dept. of Virology and Molecular Biology, St.
Jude Children's Research Hospital, Memphis, Tennessee:
DNA sequences required for virus-induced activation of
an immediate-early frog virus 3 promoter.
Ryan, T.W., Ball, L.A., Biophysics Laboratory and Dept. of
Biochemistry, University of Wisconsin, Madison: Pro-
moter activity for E. coli RNA polymerase associated with
Lee-Chen, J., Davidson, K., Bourgeois, N., Condit, R.,
Niles, E., Dept. of Biochemistry, State University of New
York, Buffalo: Transcript mapping of the genes in the
HindIll D fragment.
Weinrich, S.L., Hruby, D.E., Dept. of Microbiology, Oregon
State University, Corvallis: Expression of a tandemly ori-
ented late gene cluster of vaccinia virus.
Ryan, T.E., Ball, L.A., Biophysics Laboratory and Dept. of
Biochemistry, University of Wisconsin, Madison: Deletion
of the thymidine kinase gene of vaccinia virus and its
reinsertion at a new locus in the viral genome.
the vaccinia virus thymidine kinase gene-Analysis of se-
quence requirements.
Vassef, A., Institut Jacques Monod, Paris, France: Tran-
scriptional characterization of vaccinia virus genomic
fragments possessing the early promoter activity.
Davison, A.J., Weir, J.P., Rosel, J.L., Moss, B., NIAID, Na-
tional Institutes of Health, Bethesda, Maryland: Structural
and functional analysis of vaccinia virus late promoters.
Talavera, A.,' Beloso, A.,' Granoff, E.,2 Willis, D.,2 Moss,
B.,3 Vinuela, E.,' 'Centro de Biologia Molecular (CSIC-
UAM), Universidad Autonoma, Madrid, Spain; 2Division
of Virology and Molecular Biology, St. Jude Children's
Research Hospital, Memphis, Tennessee; 3NIAID, Na-
tional Institutes of Health, Bethesda, Maryland: RNA
polymerase-promoter recognition in African swine fever
virus (ASFV). vaccinia virus (VV), and frog virus 3 (FV3).
D. Hruby, M. Ferguson, D. Brown, R. Pacha
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Yuen, L., Moss, B., NIAID, National Institutes of Health, Be-
thesda, Maryland: Identification of vaccinia virus regula-
tory sequences responsible for termination of early tran-
scription.
Broyles, S., Moss, B., NIAID, National Institutes of Health,
Bethesda, Maryland: Sedimentation of an RNA polymer-
SESSION 5 DNA METABOLISM
Chairman: M. Slabaugh, Oregon State University
Esteves, A., Costa, J.V., Gulbenkian Institute of Science,
Oeiras, Portugal: DNA-binding proteins of African swine
fever virus.
Barros, M.F., Cunha, C.V., Costa, J.V., Gulbenkian Institute
of Science, Oeiras, Portugal: Single-stranded DNase of
African swine fever virus.
Essani, K., Goorha, R., Granoff, A., Dept. of Virology and
Molecular Biology, St. Jude Children's Research Hospital,
Memphis, Tennessee: Mutation in a DNA-binding protein
reveals an association between DNA methyltransferase
activity and a 26,000-dalton polypeptide in frog virus 3-
infected cells.
Upton, C., McFadden, G., Dept. of Biochemistry, University
of Alberta, Canada: Identification and nucleotide se-
quence of the thymidine kinase gene of Shope fibroma
virus.
Slabaugh, M., Davis, R., Mathews, C.K., Dept. of Biochem-
istry and Biophysics, Oregon State University, Corvallis:
The ribonucleotide reductase genes of vaccinia virus-
Isolation and analysis of HUR variants.
Shaffer, R., Kunzi, M., Traktman, P., Depts. of Microbiology
SESSION 6 POSTERS
Lichtenstein, D.,' Wertz, G.,2 Ball, A.,' 'Biophysics Labo-
ratory and Dept. of Biochemistry, University of Wisconsin,
Madison; 2Dept. of Microbiology and Immunology, Uni-
versity of North Carolina, Chapel Hill: Site-specific muta-
genesis of the putative membrane anchor region of an
unusual viral envelope glycoprotein.
Orange, N.,' Cerutti, M.,' DeVauchelle, G.,2 'Laboratoire
de microbiologie de la faculte des sciences de Rouen,
Mont Saint Aignan, 2Laboratoire de pathologie compa-
ree INRA CNRS, Saint Christol les Ales, France: Charac-
ase complex from vaccinia virus that specifically initiates
and terminates transcription.
Thompson, C., Condit, R., Dept. of Biochemistry, State Uni-
versity of New York, Buffalo: Characterization of two is
mutants affecting a 22-kD subunit of the vaccinia virus-
encoded RNA polymerase.
and Cell Biology and Anatomy, Cornell University Medi-
cal College, New York, New York: Isolation and charac-
terization of enzymes associated with DNA replication
from vaccinia virions.
Kahn, J.S., Rodriguez, J., Esteban, M., Depts. of Biochem-
istry, Microbiology and Immunology, Health Science Cen-
ter, Brooklyn, New York: Molecular cloning, encoding se-
quence, and expression of vaccinia virus nucleic acid-
dependent nucleoside triphosphatase gene.
Traktman, P., Crozel, V., Pacheco, S., Dept. of Cell Biology
and Anatomy, Cornell University Medical College, New
York, New York: Molecular genetic analysis of the vacci-
nia virus DNA polymerase.
Evans, E., Traktman, R, Dept. of Cell Biology and Anatomy,
Cornell University Medical College, New York, New York:
Molecular genetic analysis of vaccinia virus mutants defi-
cient in DNA replication.
Roseman, N.A., Hruby, D.E., Dept. of Microbiology, Oregon
State University, Corvallis: Analysis of a vaccinia virus
gene required for DNA replication.
terization and localization of Chilo iridescent virus (CIV)
polypeptides.
Nii, S., Uno, F, Tsutsui, K., Yoshida, M., Dept. of Virology,
Okayama University Medical School, Japan: The interac-
tion between virions of poxviruses and the surface mem-
brane of infected cells.
Tajbakhsh, S.,1,2 Lee, P.E.,2 Seligy, V.L.,1,2 'Division of Bi-
ological Sciences, National Research Council, 2Dept. of
Biology, Carleton University, Ontario, Canada: Molecular
studies on Tipula iridescent virus (TIV).
SESSION 7 DNA REPLICATION, RECOMBINATION, TRANSFORMATION
Chairman: G. McFadden, University of Alberta
Gonzalez, A., Calvo, V., Vinuela, E., Centro de Biologic, Mo-
lecular (CSIC-UAM), Universidad AutOnoma, Madrid,
Spain: Structural features at the ends of the African swine
fever virus (ASFV) genome.
Parsons, B.L., Pickup, D.J., Dept. of Microbiology and Im-
munology, Duke University Medical Center, Durham,
North Carolina: Tandemly repeated sequences are pres-
ent at the ends of the DNA of racoonpox virus.
Merchlinsky, M., Moss, B., NIAID, National Institutes of
Health, Bethesda, Maryland: Resolution of recombinant
plasmids containing the terminal sequences of vaccinia
virus into replicating linear minichromosomes.
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McFadden, G.,' Delange, A.M.,2 Upton, C.,' Reddy, M.,3
'Dept. of Biochemistry, University of Alberta, 2Dept. of
Human Genetics, University of Manitoba, Canada;
3Dept. of Microbiology, State University of New York,
Stony Brook: Mutational analysis of cloned poxvirus te-
lomeres reveals conserved core sequences required for
the replication and resolution of linear viral minichromo-
somes.
Reddy, M.,' McFadden, G.,2 Bauer, W.,"Dept. of Micro-
biology, State University of New York, Stony Brook;
2Dept. of Biochemistry, University of Alberta, Canada: In
vitro resolution of poxvirus telomeres.
G. McFadden, E. Paoletti, R. Moyer
Fathi, Z., Sridhar, P., Pacha, R., Condit, R., Dept. of Bio-
chemistry, State University of New York, Buffalo: Efficient
targeted insertion of an unselected marker into the vacci-
nia virus genome.
Spyropoulos, D.,' Panicali, D.,2 Cohen, L.K.,1,2 Roberts,
B.E.,"Dept. of Biological Chemistry, Harvard Medical
School, Boston, 2Applied bioTechnology, Inc., Cam-
bridge, Massachusetts: In vivo recombination in vaccinia
virus.
Archard, L.C.,' Kinchington, D.,2 Rice, A.P.,2 'Dept. of
Biochemistry, Charing Cross and Westminster Medical
SESSION 8 VIRUS HOST INTERACTIONS. I.
Chairman: D. Hruby, Oregon State University
Wilton, S., Dales, S., Dept. of Microbiology and Immunol-
ogy, University of Western Ontario, London, Canada:
RNA polymerase II (Pol II) in vaccinia virus (VV) transcrip-
tion and translation.
Hruby, D.E., Villarreal, E.C., Dept. of Microbiology, Oregon
State University, Corvallis: Host cell nuclear involvement
in vaccinia virus replication.
Chinchar, V.G.,1 Caughman, G.B.,2 'Dept. of Microbiol-
ogy, University of Mississippi Medical Center, Jackson;
2Dept. of Oral Biology and Microbiology, Medical College
of Georgia, Augusta: Selective shutoff of equine herpes-
virus type 1 protein synthesis by heat-inactivated frog vi-
rus 3.
Beaud, G.,1 Person-Fernandez, A.,1 Buendia, B.,2 Madjar,
J.J.,2 'Institut J. Monod, Paris, 2UFR de Medicine A.
Carrel, Lyon, France: Shutoff of host protein synthesis
and ribosomal protein phosphorylation by vaccinia virus.
Moussatche, N., Lobo, D.S., Damaso, C.R.A., Rebel lo,
M.A., Institute de Bio fisica Carlos Chagas Filho, Rio de
Janeiro, Brazil: In vitro inhibition of protein synthesis in-
duced by vaccinia virus is restored by ribonucleoside tri-
phosphates.
Bablanian, R.,1 Goswami, S.K.,1 Esteban, M.,1 Banerjee,
A.K.,2 'State University of New York Health Science Cen-
School, 2lmperial Cancer Research Fund Laboratories,
London, England: Duplication of an orthopox virus gene
by genomic rearrangement.
Ball, A., Biophysics Laboratory and Dept. of Biochemistry,
University of Wisconsin, Madison: An approach_to the
isolation of recombination-deficient mutants of vaccinia
virus.
Obom, K.M., Pogo, B.G.T., Center for Experimental Cell Bi-
ology and Dept. of Microbiology, Mount Sinai School of
Medicine, New York, New York: Characterization of the
transformation properties of Shope fibroma virus.
ter, Brooklyn; 2Roche Institute, Nutley, New Jersey:
Mechanism of selective inhibition of protein synthesis by
vaccinia virus-Role of poly A.
Paez, E., Esteban, M., Depts. of Biochemistry, Microbiology
and Immunology, Health Science Center, Brooklyn, New
York: Genetic and biological properties of spontaneous
deletion mutants of vaccinia virus.
Paez, E., Esteban, M., Depts. of Biochemistry, Microbiology
and Immunology, Health Science Center, Brookiyn, New
York: Isolation and characterization of spontaneous mu-
tants of vaccinia virus sensitive to inhibition by interferon.
Pacha, R., Condit, R., Dept. of Biochemistry, State Univer-
sity of New York, Buffalo: Precise genetic characteriza-
tion of a vaccinia virus mutant (ts22) with an abortive late
phenotype, and investigation of the relationship between
ts22 and the effects of isatin-f3-thiosemicarbazone (IBT).
Cohrs, R.J.,' Goswami, B.B.,' Condit, R.C.,2 Pacha, R.F.,2
Sharma, 0.K.,"Dept. of Molecular Biology, AMC Can-
cer Research Center, Denver, Colorado; 2Dept. of Bio-
chemistry, State University of New York, Buffalo: Synthe-
sis of 2-5A during infection with a temperature-sensitive
mutant of vaccinia virus (ts22) at nonpermissive tempera-
ture.
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SESSION 9 VIRUS HOST INTERACTIONS. II.
Chairman: D. Moyer, Vanderbilt University
Novembre, F., Natuk, R., Holowczak, J.A., Dept. of Molecu-
lar Genetics and Microbiology, UMDNJ, Piscataway, New
Jersey: The immune response to infection with vaccinia
virus in mice.
Novembre, F., Holowczak, J.A., Dept. of Molecular Ge-
netics and Microbiology, UMDNJ, Piscataway, New Jer-
sey: The humoral response to infection with vaccinia vi-
rus in mice.
Alcami, A., Carrascoca, A.L., Vinuela, E., Centro de Biolo-
gia, Molecular (CSIC-UAM), Universidad Autbnoma,
Madrid, Spain: Role of receptor-mediated interaction in
African swine fever virus (ASFV) infection of sensitive and
resistant cells.
Spehner, D., Drillien, R., Transgene, Laboratoire de Virol-
ogy, Strasbourg, France: Characterization of a cowpox
gene required for multiplication in Chinese hamster ovary
cells.
Chang, W.,' Upton, C.,3 Hu, S.-L.,2 Purchio, A.,2 Mc-
Fadden, G.,3 'Dept. of Microbiology and Immunology,
University of Washington, 2Oncogen, Seattle, Washing-
ton; 3Dept. of Biochemistry, University of Alberta, Can-
ada: Cloning of an EGF-related growth factor from Shope
fibroma virus.
Strayer, D.S., Leibowitz, J.L., University of Texas Health
Science Center, Houston: Shope fibroma virus and malig-
nant rabbit virus code for factors that inhibit epidermal
growth factor-induced cellular proliferation.
Buller, R.M., Fredrickson, T.N., Chakrabarti, S., Moss, B.,
NIAID, National Institutes of Health, Bethesda, Maryland:
Vaccinia virus growth factor is important for virus viru-
lence.
Pogo, B.G.-T., Lai, A.C.-K., Holland, J.G., Friend, C., Center
for Experimental Cell Biology and Dept. of Microbiology,
Mount Sinai School of Medicine, New York, New York:
Differences in the susceptibility of hematopoietic human
cell lines to vaccinia virus.
Lai, A.C.-K., Obom, K.M., Holland, J.G., Pogo, B.G.-T.,
Friend, C., Center for Experimental Cell Biology and
Dept. of Microbiology, Mount Sinai School of Medicine,
New York, New York: Isolation and characterization of
vaccinia virus mutants from persistently infected Friend
erythroleukemia cells.
Da llo, S., Maa, J.-S., Esteban, M., Depts. of Biochemistry,
Microbiology, and Immunology, Health Science Center,
Brooklyn, New York: Isolation and characterization of at-
tenuated mutants of vaccinia virus.
S. Dales, J. Holowczak, A. Granoff
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SESSION 10 VECTOROLOGY
Chairman: E. Pao letti, New York State Dept. of Health
Hruby, D.E., Wilson, E.M., Hodges, W.M., Franke, C.A.,
Dept. of Microbiology, Oregon State University, Corvallis:
Development of alternative vaccinia virus expression vec-
tor systems.
Fuerst, T.R.,1 Niles, E.G.,2 Studier, F.W.,3 Moss, B.,1
1NIAID, National Institutes of Health, Bethesda, Mary-
land; 2Dept. of Biochemistry, State University of New
York, Buffalo; 3Dept. of Biology, Brookhaven National
Laboratory, Upton, New York: Eukaryotic transient
expression system based on recombinant vaccinia virus
that synthesizes bacteriophage T7 RNA polymerase.
Shida, H.,1 Hinuma, Y.I.,1 Hatanaka, S.,1 Ito, Y.,1 Hayami,
M.,2 Sugimoto, M.,3 Morita, M.,4 'Institute for Virus Re-
search, Kyoto University, 2lnstitute of Medical Science,
University of Tokyo, 3Tao Nenryo Kogyo, K.K., 4Chiba
Serum Institute, Japan: Expression of the HTLV-1 enve-
lope gene inserted in the hemagglutinin gene of vaccinia
virus.
Ball, A.,1.2 Ryan, T.,' King, A.,3 Stott, J.,3 Wertz, G.,3
'Biophysics Laboratory, 2Dept. of Biochemistry, Univer-
sity of Wisconsin, Madison; 3Dept. of Microbiology and
Immunology, University of North Carolina, Chapel Hill:
Construction and analysis of a double vector-A recom-
binant vaccinia virus that expresses both the N and G
genes of human respiratory syncytial virus.
Hruby, D.E.,' Thomas, G.,2 Hodges, W.M.,1 Herbert, E.,2
'Dept. of Microbiology, Oregon State University, Corval-
lis; 2Oregon Health Sciences Center, Portland: Use of
vaccinia virus as a neuropeptide expression vector.
Edwards, S.J.,1 Corcoran, L.M.,2 Langford, C.J.,2
'Commonwealth Serum Laboratories, 2Walter and Eliza
Hall Institute of Medical Research, Victoria, Australia:
Expression of malaria antigens in recombinant vaccinia
virus.
Belanger, L., Cormier, N., Destree, A., Dunn, J., Gritz, L.,
Hudson, G., Jensen, E., Katz, S., Mazzara, G., McKenzie,
S., Panicali, D., Applied bioTechnology, Inc., Cambridge,
Massachusetts: Expression of multiple pseudorabies gly-
coproteins in recombinant vaccinia virus.
Kost, T.A.,1 Jones, E.V.,2 Miller, T.J.,1 Smith, K.M.,1
Brown, A.L.,1 'Norden Laboratories, Lincoln, Nebraska;
2Smith Kline and French Molecular Genetics, Swede land,
Pennsylvania: Expression of pseudorabies gp50 from a
recombinant vaccinia virus.
Esposito, J.,' Brechling, K.,2 Baer, G.,' Auperin, D.,'
McCormick, J.,1 Kinney, R.,1 Trent, D.,1 Moss, B.,2
'Centers for Disease Control, Atlanta, Georgia; 2NIAID,
National Institutes of Health, Bethesda, Maryland: Prog-
ress on vaccinia recombinant vaccines for rabies, Lassa
fever, and Venezualan equine encephalitis.
Franke, C.A., Hruby, D.E., Dept. of Microbiology, Oregon
State University, Corvallis: Vaccinia virus-The hitchhiker
syndrome.
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Molecular Neurobiology of Drosophila
October 6-October 9
ARRANGED BY
Corey Goodman, Stanford University
Gerald Rubin, University of California, Berkeley
134 participants
The neurobiology of Drosophila, initiated nearly two decades ago by Seymour
Benzer (to whom our meeting was dedicated), has finally come of age. Kindled
by the application of genetic approaches to neurobiology, and fueled by the infu-
sion of modern recombinant DNA and moloclonal antibody approaches, the last
few years have witnessed an enormous explosion of interest in the neurobiology
of Drosophila. In this first meeting on the topic, the sessions were devoted to
studies on neuronal development (neurogenesis, axon guidance, and synapto-
genesis), to the visual system as a model system, to studies on receptors, chan-
nels, excitability, and synaptic transmission, and to studies on behavior, biologi-
cal rhythms, and learning. The quality of the science presented was excellent,
and the overall feeling of those that attended was that this is a very exciting field
that is bursting with interesting mutations, genes, and molecules.
G. Rubin, C. Goodman, W. Quinn
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SESSION 1 NEUROGENESIS
Chairman: S. Artavanis-Tsakonas, Yale University
Artavanis-Tsakonas, S., Grimwade, B., Hartley, D., Johan-
sen, K.M., Preiss, A., Ramos, R., Wharton, K., Xu, T.,
Dept. of Biology, Yale University, New Haven, Connecti-
cut: Molecular biology of neurogenesis.
Brand, M., Bremer, K., de la Concha, A., Dietrich, U., Jime-
nez, F, Knust, E., Technau, G.M., Tepass, U., Vassin, H.,
Weigel, D., Campos-Ortega, J.A., Institut fur Entwicklung-
sphysiologie, [(bin, Federal Republic of Germany: Ge-
netics of early neurogenesis in Drosophila.
Muskavitch, M.A.T.,1,2 Alton, A.K.,12 Fechtel, K.,2 Kop-
czynski, C.C.,1.2 Shepard, S.B.,2 Terry, A.L.,2 Meikle,
S.B.,2 'Institute for Molecular and Cellular Biology,
2Dept. of Biology, Indiana University, Bloomington: Mo-
lecular genetics of neurogenesis in Drosophila.
Mahowald, A., Furst, A., Perkins, L., Neumann, E., Huff, R.,
SESSION 2 AXON GUIDANCE AND SYNAPTOGENESIS
Chairman: C.S. Goodman, Stanford University
Patel, N.H., Snow, P.M., Goodman, C.S., Dept. of Biological
Sciences, Stanford University, California: Cellular and
molecular characterization of a cellsurface glycoprotein
expressed on a subset of axons in the Drosophila em-
bryo.
Schubiger, M., Blair, S.S., Palka, J., Dept. of Zoology, Uni-
versity of Washington, Seattle: Changing spatial patterns
of DNA replication in developing wings-Are they related
to axon guidance?
Murphey, R.K., Neurobiology Research Center, State Uni-
versity of New York, Albany: Mechanisms for the forma-
tion of selective synaptic connections in crickets and
flies.
SESSION 3 VISUAL SYSTEM
Chairman: S. Benzer, California Institute of Technology
Benzer, S., California Institute of Technology, Pasadena:
Molecular genetics of visual system development.
Tomlinson, A., Ready, D.F., Dept. of Biology, Princeton Uni-
versity, New Jersey: Drosophila photoreceptors express
neural antigens in a precise sequence.
Heisenberg, M., Wolf, R., Institut fur Genetik and Mikrobiol-
ogie, WOrzburg, Federal Republic of Germany: Synergis-
tic effects of two mutant genes reducing cell number in
the optic lobes.
Matsumoto, H., Ozaki, K., Isono, K., Randall, L., Floreani,
M., Larrivee, D., Pye, Q., Pak, W.L., Dept. of Biological
Sciences, Purdue University, West Lafayette, Indiana:
SESSION 4 RECEPTORS, CHANNELS, EXCITABILITY. I.
Chairman: 0. Siddiqi, Tata Institute
Siddiqi, 0., Rodrigues, V., Ayyub, C., Molecular Biology
Unit, Tata Institute of Fundamental Research, Bombay, In-
dia: Odor perception in Drosophila-A neurogenetic ap-
proach.
Perrimon, N., Dept. of Developmental Genetics and Anat-
omy, Case Western Reserve University, Cleveland, Ohio:
Cellular, genetic, and molecular analyses of embryonic
neurogenesis.
Thomas, J.B., Crews, S.T, Goodman, C.S., Dept. of Biolog-
ical Sciences, Stanford University, California: Molecular
genetics of the S8 locus-A gene involved in the early
events of neurogenesis in the Drosophila embryo.
Jan, Y.N.,1 Bodmer, R.,' Jan, L.Y.,1 Grell, E.,' Ghysen,
A.,2 Dambly-Chaudiere, C.,2 'Howard Hughes Medical
Institute and Dept. of Physiology, University of California,
San Francisco; 2Universite Libre de Bruxulles, Faculte
des Sciences-Genetique, Belgium: Mutations affecting
neurogenesis, neuronal identity, and path finding in D.
melanogaster.
Meinertzhagen, LA.,' Kral, K,,2 'Dept. of Psychology, Dal-
housie University, Halifax, Canada; 2lnstitut fOr Zoologie,
Universitat Graz, Austria: Functional plasticity of the feed-
back synapses in the lamina ganglionaris of the fly, M.
domestica.
Ghysen, A., Laboratory of Genetics, University Libre de
Bruxelles, Belgium: Origin of peripheral nerves in Dro-
sophila.
Steller, H., Rubin, G.M., Dept. of Biochemistry, University of
California, Berkeley: disconnected-A locus required for
neuronal pathway formation in the visual system of Dro-
sophila.
nina-Class of mutations affecting photoreceptor-specific
gene functions.
Montell, C., Zuker, C., Rubin, G., Dept. of Biochemistry,
University of California, Berkeley: Molecular analysis of
phototransduction- Identification and characterization of
the genes encoding trp, ninaC, and two R7-specific op-
sins.
Hotta, Y.,' Yoshioka, T.,2 Inoue, H.,2 'Dept. of Physics,
Faculty of Science, University of Tokyo, 2Dept. of Physi-
ology, School of Medicine, Yokohama City University, Ja-
pan: Molecular and biochemical analyses of Drosophila
visual behavior mutants.
Wu, C.-F., Haug land, F., Sun, Y.-A., Komatsu, A., Dept. of
Biology, University of Iowa, Iowa City: K± channels in
Drosophila
So lc, C., O'Dowd, D., Zagotta, W., Germeraad, S., Aldrich,
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R., Dept. of Neurobiology, Stanford University, California:
Gating of A-type K+ channels and Na+ channels in wild-
type and mutant Drosophila neurons and muscle cells.
Bowers, C., Branton, D., Lee, P., Phillips, H., Jan, Y.N., Jan,
L.Y., Howard Hughes Medical Institute and Dept. of
Physiology, University of California, San Francisco: Stud-
ies of neuronal excitability and ion channels in Drosoph-
ila.
SESSION 5 RECEPTORS, CHANNELS, EXCITABILITY. II.
Chairman: B. Ganetzky, University of Wisconsin
Ganetzky, B., Loughney, K., Kreber, R., Laboratory of Ge-
netics, University of Wisconsin, Madison: Genetic and
molecular analysis of the para locus.
Salkoff, L.,' Butler, A.,' Hiken, M.,' Wei, A.,' Giffen, K.,'
Ifune, C.,' Goodman, R.,2 Mandel, G.,2 'Dept. of Anat-
omy and Neurobiology, Washington School of Medicine,
St. Louis, Missouri; 2Dept. of Medicine, Tufts New Eng-
land Medical Center, Boston, Massachusetts: A Drosoph-
ila gene with homology to the vertebrate Na+ channel.
Hall, L.M.,' Kasbekar, D.P.,' Gil, D.W.,1 Keen, J.K.,' Ur-
quhart, D.,' Nelson, J.C.,2 Jackson, FR.,3 'Dept. of Ge-
netics, Albert Einstein College of Medicine, Bronx, New
York; 2Dept. of Biology, Yale University, New Haven,
Connecticut; 3Worcester Foundation for Experimental Bi-
ology, Shrewsbury, Massachusetts: Molecular and ge-
netic analysis of voltage-sensitive Na channels from D.
melanogaster.
Nelson, J.C., Wyman, R.J., Dept. of Biology, Yale Univer-
sity, New Haven, Connecticut: Drosophila neurological
Tanouye, M.A., Division of Biology, California Institute of
Technology, Pasadena: The Shaker locus.
Ferrbs, A., Llamazares, S., Canal, I., de la Pompa, J.L.,
Yuste, R., Centro de Biologia Molecular, Universidad Au-
tbnoma de Madrid, Spain: Biological functions of the
Shaker complex.
mutations do not block the giant fiber pathway.
Hermans-Borgmeyer, I., Sawruk, E., Zopf, D., Gundelfinger,
E., Betz, H., Zentrum fOr Molekulare Biologie, Heidel-
berg, Federal Republic of Germany: Characterization of
the mRNA and the gene of a putative neuronal nicotinic
acetylcholine receptor protein from D. melanogaster.
Bossy, B.,' Hall, L.M.C.,1 Ballivet, M.,2 Spierer, P,' Depts.
of 'Molecular Biology, 2Biochemistry, University of Ge-
neva, Switzerland: Molecular genetics of the cholinergic
synapse of Drosophila.
Salvaterra, RM.,' Itoh, N.,' Maines, V.,' Slemmon, R.,1
Mori, N.,2 'Division of Neurosciences, 2Dept. of Biology,
Beckman Research Institute of the City of Hope, Duarte,
California: Drosophila choline acetyltransferase-Molecu-
lar biology and evolution.
Gnagey, A.L., Forte, M., Rosenberry, T.L., Dept. of Pharma-
cology, Case Western Reserve University, Cleveland,
Ohio: Isolation and characterization of acetylcholinester-
ase from Drosophila.
H. Stellar, S. Benzer
264
SESSION 6 BEHAVIOR, RHYTHMS, LEARNING
Chairman: J. Hall, Brandeis University
Yu, Q., Abovich, N., Citri, Y., Co lot, H., Ewer, J., Hamblen,
M., Lorenz, L., Petersen, G., Siwicki, K., Wheeler, D.,
Hall, J., Rosbash, M., Dept. of Biology, Brandeis Univer-
sity, Waltham, Massachusetts: Molecular studies on bio-
logical rhythms in D. melanogaster.
Young, M.W.,1 Bargiello, T,' Jackson, F.R.,2 'Rockefeller
University, New York, New York; 2Worcester Foundation
for Experimental Biology, Shrewsbury, Massachusetts:
Abundance of per locus product sets the pace of the
Drosophila clock.
Smith, R.F., Choi, K.-W., Mardon, G., Tully, T., Quinn, W.G.,
Dept. of Brain and Cognitive Science and Biology, Mas-
sachusetts Institute of Technology, Cambridge: Deficient
protein-kinase-C activity in turnip, a Drosophila learning
mutant.
Dudai, Y., Buxbaum, J., Corfas, G., Orgad, S., Segal, D.,
Sher, B., Shilo, B., Yovell, Y., Weizmann Institute of Sci-
ence, Rehovot, Israel: Role of the rut gene in neuronal
and behavioral plasticity.
POSTERS
Yedvobnick, B., Smoller, D., Dept. of Biology, Emory Uni-
versity, Atlanta, Georgia: Transposon tagging of the neu-
rogenic locus mastermind.
Knust, E., Dietrich, U., Weigel, D., Tepass, U., Vassin, H.,
Bremer, K., Campos-Ortega, J.A., Entwicklungsphysiolo-
gie, KOln, Federal Republic of Germany: Molecular ge-
netics of neurogenic genes in Drosophila.
Technau, G.M., Campos-Ortega, J.A., Institut fOr Entwick-
lungsphysiologie der Universitat, KOln, Federal Republic
of Germany: Lineage studies of singly transplanted ecto-
dermal cells of the Drosophila embryo.
Johansen, K.M.,1 Slaughter, C.,2 Artavanis-Tsakonas, S.,'
'Dept. of Biology, Yale University, New Haven, Connecti-
cut; 2Dept. of Biochemistry, University of Texas, Dallas:
Characterization and localization of the embryonic Notch
product in D. melanogaster using antibodies.
Hartley, D., Dept. of Biology, Yale University, New Haven,
Connecticut: Spatial pattern of Notch gene expression
during D. melanogaster embryogenesis.
Hoppe, RE., Greenspan, R.J., Dept. of Biology, Princeton
University, New Jersey: Localized requirement for Notch
gene product in embryonic neural-epidermal determina-
tion.
Alton, A.K.,1 Terry, A.L.,2 Meikle, S.B.,2 Muskavitch,
M.A.T.,1,2 'Institute of Molecular and Cellular Biology,
2Dept. of Biology, Indiana University, Bloomington: Ge-
netic analysis of a chromosomal interval including Delta,
a neurogenic gene in D. melanogaster.
Smouse, D.,1 Perrimon, N.,2 Mahowald, A.,2 Goodman,
C.,1 'Dept. of Biological Sciences, Stanford University,
California; 2Dept. of Developmental Genetics and Anat-
omy, Case Western Reserve University, Cleveland, Ohio:
topless-A new class of zygotic mutations that causes
hypertrophy of the nervous system in the Drosophila em-
bryo.
Chen, C.-N., Takayasu, H., Davis, R.L., Dept. of Biochemis-
try, Michigan State University, East Lansing: Molecular
characterization of the dunce locus.
Gabor Miklos, G.L.,1 Kelly, L.,2 Coombe, P.,1 Davies, J.,1
De Couet, G.,1 Pirrotta, V.,3 Yamamoto, M.,1 Schalet,
A.,4 Lefevre, G.,5 'Research School of Biological Sci-
ences, Australian National University, Canberra; 2Dept.
of Genetics, University of Melbourne, Australia; 3Baylor
College of Medicine, Houston, Texas; 4Dept. of Radiation
Genetics, State University of Leiden, The Netherlands;
5California State University, Northridge: Mapping, char-
acterizing, and cloning behavioral genes in a small re-
gion at the base of the X chromosome.
Tompkins, L., Dept. of Biology, Temple University, Philadel-
phia, Pennsylvania: Regulation of female- and male-spe-
cific sexual behaviors by the sex-lethal gene.
Hayashi, I., Division of Cytogenetics, City of Hope National
Medical Center, Duarte, California: Function of nerve
growth factor in early nervous system development.
Beachy, P.A., Dept. of Embryology, Carnegie Institution of
Washington, Baltimore, Maryland: Regulatory targets of a
protein encoded by the homeotic locus Ultrabithorax.
Helfand, S.L.,' Lipshitz, H.D.,2 Hogness, D.S.,2 'Dept. of
Biology, Yale University, New Haven, Connecticut; 2Dept.
of Biochemistry, Stanford University, California: Regula-
tion of Ubx expression in the CNS.
Schneiderman, A.M., Tao, M.L., Wyman, R.J., Dept. of Biol-
ogy, Yale University, New Haven, Connecticut: Transfor-
mation of identified muscle and its motorneuron in bi-
thorax Drosophila.
Schneuwly, S.,' Gehring, W.J., 2 'Dept. of Biological Sci-
ences, Purdue University, West Lafayette, Indiana;
2Dept. of Cell Biology, Biozentrum der Universitaet Basel,
Switzerland: Molecular and functional analysis of the
homeotic gene Antennapedia in D. melanogaster.
Y., 2 Gehring, W.,2 Goodman, C.S.,1Doe, C.O.,' Hiromi,
'Dept. of Biological Sciences, Stanford University, Califor-
nia; 2Biozentrum, University of Basel, Switzerland:
Expression and function of fushi tarazu during neuroge-
nesis.
Hiromi, Y., Gehring, W.J., Biocenter, University of Basel,
Switzerland: Regulation of fushi tarazu gene expression
during Drosophila embryogenesis.
Dambly-Chaudiare, C.,' Ghysen, A.,' Jan, Y.N.,2 Jan,
L.Y.,2 'Laboratory of Genetics, Libre de Bruxelles, Bel-
gium; 2Howard Hughes Medical Institute, University of
California, San Francisco: Genetics of the determination
of larval sense organs.
Campos, A.R., Fleming, R.J., Robinow, S., Rosen, D.,
White, K., Brandeis University, Waltham, Massachusetts:
Molecular analysis of ewg and elav loci.
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0. Siddiqi, E. Macagno
Taylor, B.J., Dept. of Biology, University of California, San
Diego, La Jolla: Sexually dimorphic neurons in the geni-
tal disk of D. melanogaster.
Stocker, R.F., Gendre, N., Institute of Zoology, University of
Fribourg, Switzerland: lozenge-A mutant in Drosophila
devoid of basiconic antennal sensilla.
Katz, F.,' Moats, W.,' Jan, Y.N.,2 Howard Hughes Medical
Institute, 'University of Texas Health Science Center, Dal-
las; 2University of California, San Francisco: Mutations in
the development of the imaginal nervous system of D.
melanogaster.
Zinn, K., McAllister, L., Snow, P., Harrelson, A., Bastiani, M.,
Goodman, C., Dept. of Biological Sciences, Stanford Uni-
versity, California: Molecular characterization of fasciclin
I, a cell-surface glycoprotein expressed on a subset of
axon pathways in the insect embryo.
Baird, D.,' Aceves, E.,' Wyman, R.,' Davies, J.,2 Miklos,
G.,2 Dept. of Biology, Yale University, New Haven, Con-
necticut; 2Pop. Biology, Australian National University,
Canberra: Genetics and cloning of Passover, a mutant
with altered neural connectivity.
Caudy, M., Jan, Y.N., Jan, L.Y., Howard Hughes Medical In-
stitute, University of California, San Francisco: Pioneer
growth cone guidance by segment boundary epithelium
in Drosophila embryos.
Ready, D.F., Dept. of Biology, Princeton University, New
Jersey: Segmental nerves, a connection between seg-
ments and parasegments?
Burg, M.G., Wu, C.-F, Dept. of Biology, University of Iowa,
Iowa City: Effects of excitability on the development, pro-
jection, and arborization of mechanosensory cells in Dro-
sophila mosaics.
Costello, W.J., Hummon, M.R., Dept. of Zoology and Bio-
medical Science/COM, Ohio University, Athens: Coated
vesicles and formation of adult motor systems in Dro-
sophila.
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Anderson, H., Dept. of Zoology, University of California,
Davis: Pioneer neurons use basal lamina as a substrate
for axon outgrowth.
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BANBURY CENTER
DIRECTOR'S REPORT
The ninth year of the Banbury Center's operation saw the continuation of the
Center's well-established programs, along with indications of novel directions for
our meetings and publications in the next few years. Fourteen meetings were held
and, as in previous years, the Center was the location for four advanced lecture
courses.
A New Program on the Origins and Detection of Human Cancer
Among the newer aspects of the Center's activities is one that promises to be
particularly important for the future-a collaboration with the Preventive Medicine
Institute/Strang Clinic of New York City. PMI/Strang has agreed to fund a series of
three meetings a year on the Origins and Detection of Human Cancer. These
meetings will build on the Center's well-established reputation as a leading location
for cancer-related meetings and as a prime source of publications on such topics.
In addition, we hope to bring information from certain Banbury meetings to a
larger audience. Our established range of books (discussed below) has an
excellent reputation for reporting the data and views of the small groups of about
35 leading scientists who attend each meeting. Such books will continue to play a
vital role in disseminating research results to specialists who were not at the
meeting. However, it is clear that much of the information discussed at our
Banbury Meeting House
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meetings would be very useful and interesting to less-specialized readers, if it were
presented in an appropriate form. Therefore, it has been decided that the
Center will begin to publish booklets written for nonspecialist scientists and
clinicians. Such booklets will be written in-house and will be based on those
Banbury meetings that have especially broad implications.
This new source of funding from PMI/Strang Clinic came only a year after the
$300,000 grant over three years from the James S. McDonnell Foundation. As
expected, this grant has greatly facilitated the Center's ability to organize first-rate
meetings at a time when grants from federal agencies have become both scarcer
and smaller.
Risk Assessment Program
In 1986, four meetings were held within the Risk Assessment Program. This
program forms the original core of the Center's activities and has lost none of its
importance since the addition of various other programs.
The first meeting in the program concerned Antibiotic Resistance Genes, a
topic of great concern, given the ever-increasing use of antibiotics in medicine and
animal farming, which has already led to a worrying spread of antibiotic-resistant
microbes. The next meeting, on Nongenotoxic Mechanisms in Carcinogenesis,
examined the multitude of ways in which known carcinogens interact with cells,
apart from their effects on DNA. The most complex problem is to distinguish
between the primary and secondary effects of carcinogens. Clearly, this aspect of
research will continue to require further intensive study before definitive answers
can be obtained.
The first fall meeting was entitled Mechanistic Approaches to Developmental
Toxicology. The molecular mechanisms by which certain chemicals interfere with
normal development in mammals are now becoming understood in much greater
detail. The experts at this meeting reviewed recent results and addressed the
vitally important possibility of predicting deleterious effects of new chemicals in
medicines or in the environment. The final meeting of the year, the Neurochemistry
of Aging, was particularly felicitously timed. Here, several groups reported major
advances in our knowledge of the genes and proteins implicated in Alzheimer's
disease.
Finally, a workshop closely related to our Risk Assessment program, but
organized independently by the National Institute of Environmental Health
Sciences, was held in October on DNA Adducts.
Corporate Sponsor Program Continues Its Emphasis on the
Applications of Science
The Corporate Sponsor program had another active year. These meetings, which
address issues of particular interest to molecular biologists and biotechnologists,
have proved to be increasingly popular. Like all other Banbury meetings,
invitations to attend are almost invariably accepted-a fact that is very gratifying
when one bears in mind that leaders in science receive a steady stream of
invitations to meetings that take them away from their laboratories.
The three spring meetings in the Corporate Sponsor series focused on
Microbial Energy Transduction, Mechanisms of Yeast Recombination, and DNA
Probes. The first addressed fundamental questions about the methods that
microorganisms use to convert the energy they receive from nutrients (and, in
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some cases, from light) into forms that can be used to maintain their metabolism.
The second meeting reviewed the latest knowledge about the molecular
mechanisms by which genetic information is recombined and modified in yeasts.
Meetings in the Corporate Sponsor series are intended to have a particularly
strong emphasis on the application of molecular biology to human health. This
aim was very well exemplified by the DNA Probes meeting, at which there were
many reports on the ways that diseases can be diagnosed and better understood
by examining certain parts of an individual's genetic constitution. Particular interest
was also generated by reports on "genetic fingerprinting': as method of examining
DNA that can precisely distinguish one individual from any other.
Both of the fall meetings also had very clear applied aspects. Participants at
the Tumor Angiogenesis meeting examined newly discovered clues about the
manner in which blood is supplied to cancers. Obviously, the hope is that some
way will be found to starve tumors of the blood they need to survive. The meeting
on Gene Transfer Vectors brought a valuable interchange of knowledge concern-
ing new methods of introducing DNA into cells, one of the crucial steps in all
forms of genetic engineering.
The third main facet of the Center's activities consists of the meetings funded
by the Alfred P Sloan Foundation grant, first received in 1980. The 1986 Workshop
for Congressional Aides examined the problems caused by radon in homes.
Exposure to radon gas, which collects in some homes as it seeps out of the
ground, is now thought to be a very significant health hazard, perhaps responsible
for as many as 10,000 cases of lung cancer a year in the United States. The
experts at this meeting discussed the geographical distribution of radon-rich
materials in the ground, the methods by which it can accumulate in houses, the
biological effects of high concentrations of radon, and methods for making houses
safer. An unusual combination of approaches, ranging from radiation biology
through epidemiology to civil engineering, made for an especially stimulating and
useful workshop. The aides, many of whom work for members of Congress who
represent areas with a major radon problem, received a day and a half of "expert
testimony" in an informal setting. Equally importantly, they were able to provide
information on the political and economic aspects of the issue.
In keeping with Banbury's purpose of promoting the application of knowledge,
chief executive officers of major corporations spent a weekend in October meeting
eight of the country's leading scientists. During this meeting, which was organized
in collaboration with Shearson Lehman Brothers Inc., the company representatives
were able to learn more about the future impact of biological research on their
businesses.
Finally, the staff of the Banbury Center was particularly pleased to welcome an
assembly of people connected with the Esther A. and Joseph Klingenstein Fund,
Inc. The Fund has provided generous support to many younger neuroscientists;
this meeting brought them together with the trustees and scientific advisors of the
Fund to exchange information on their research. The Banbury Center of Cold
Spring Harbor Laboratory was an especially appropriate site for such a
gathering,
since the Klingenstein Fund has been very generous in its support for the Center
and the Laboratory over many years.
Banbury Publications
As noted elsewhere in this Annual Report (see Publications, under Departmental
Reports), the organization of Banbury's publications program has been
modified.
To ensure that the books and other types of publications arising
from future
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Banbury meetings are published as efficiently and rapidly as possible, the
Banbury editorial activities are being more closely integrated into the larger
publications department at Cold Spring Harbor Laboratory. This will eliminate
some duplication of effort while retaining a full-time editor at the Center.
Departure of Michael Shodell
In March 1986, Michael Shodell left the Center after four years as its Director.
Mike's enthusiasm and knowledge had been instrumental in expanding Banbury's
activities and consolidating the Center's international reputation. Furthermore, his
efforts in raising support have been very important in putting the Center's finances
on a sound foundation. We wish him well in his return to a career of teaching at
C.W. Post College of Long Island University and scientific writing.
Steve Prentis
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MEETINGS
Microbial Energy Transduction: Genetics, Structure and Function
February 23-February 26
ARRANGED BY
D. C. Youvan, Cold Spring Harbor Laboratory, New York
SESSION 1 REACTION CENTER
Chairperson: S. G. Boxer, Stanford University, California
H. Michel, Max-Planck Institut fOr Biochemie, Munich,
Federal Republic of Germany: Structure of the photosyn-
thetic reaction center from Rhodopseudomonas viridis.
W. Parson, University of Washington, Seattle: Fast electron
transfer steps in photosynthetic reaction centers.
W. Lubitz, Freie Universitat Berlin, Federal Republic of
Germany: Structural aspects of primary reactants in
bacterial reaction centers studied by ENDOR
spectroscopy.
SESSION 2 LIGHT HARVESTING ANTENNAE
Chairperson: S. Kaplan, University of Illinois, Urbana
A. N. Glazer, University of California, Berkeley:
Phycobilisomes-Relationship of structure to energy flow
dynamics.
R. Huber, Max-Planck Institut fOr Biochemie, Munich, Federal
Republic of Germany: Crystal structural studies of
cyanobacterial C-phycocyanins and functional aspects.
D. A. Bryant, Pennsylvania State University, University Park:
B. Marrs, E. I. du Pont de Nemours & Company, Wilmington,
Delaware: Molecular genetics in Rhodopseudomonas
capsulata.
J. T. Beatty, University of British Columbia, Vancouver,
Canada: Regulation of expression of the rxcA operon of
Rhodopseudomonas capsulata.
C. Arntzen, E. I. du Pont de Nemours & Company, Wilming-
ton, Delaware: Genetic analysis of PSII polypeptides.
Genetic analysis of the cyanobacterial phycobilisome.
R. J. Cogdell, University of Glasgow, Scotland: The structure
and function of purple bacteria antenna complexes.
H. Zuber, Institut fOr Molekularbiologie and Biophysik, ETH,
Zurich, Switzerland: Structural principles and variability of
light-harvesting antennae.
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SESSION 3 OXIDOREDUCTASE AND TERMINAL OXIDASE
Chairperson: P. L. Dutton, University of Pennsylvania Medical School, Philadelphia
G. von Jagow, University of Munich, Federal Republic of
Germany: Structural and functional diversity of microbial
and mitochondrial ubiquinol-Cytochrome c reductase.
B. L. Trumpower, Whitehead Institute for Biomedical
Research, Cambridge, Massachusetts: Purification and
properties of a three subunit cytochrome bc1 complex
from Paracoccus denitrificans grown under aerobic and
denitrifying conditions.
D. Robertson, University of Pennsylvania Medical School,
Philadelphia: Quinones and electrogenic reactions of the
SESSION 4 ATP AND LIGHT DRIVEN PROTON PUMPS
Chairperson: R. M. Pearistein, Indiana-Purdue University,
P Pedersen, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Structure of F1 ATPase-metal
binding.
H. S. Penefsky, Public Health Research Institute, New York,
New York: Mechanism of action of mitochondrial ATPase.
J. E. Walker MRC Laboratory of Molecular Biology,
Cambridge, England: Genes for ATP synthases from
SESSION 5 TRANSPORT AND CHEMOTAXIS
bci complex.
R. Prince, Exxon Research and Engineering Company,
Annandale, New Jersey: Genetic and biophysical
approaches to elucidating the mechanism of the
cytochrome bc1 complex.
R. B. Gennis, University of Illinois, Urbana: Structure and
function of the E. coli cytochrome d terminal oxidase.
T G. Frey, University of Pennsylvania School of Medicine,
Philadelphia: Cytochrome c oxidase-Structure and
function.
Indianapolis
photosynthetic bacteria, chloroplasts, and mitochondria.
R. H. Fillingame, University of Wisconsin, Madison: Mutants
and function of E. coli H+-ATP synthase.
C. W. Slayman, Yale University Medical School, New Haven,
Connecticut: H+-ATPase of the Neurospora plasma
membrane.
Chairperson: M. D. Kamen, University of California, San Diego, La Jolla
M. Saier, University of California, San Diego, La Jolla: The
bacterial phosphotransferase system-Structure,
evolution, and mechanisms of action.
H. R. Kaback, Roche Institute of Molecular Biology, Nutley,
New Jersey: Passage to permease.
R. M. Macnab, Yale University, New Haven, Connecticut:
Bacterial flagellar motor.
G. R. Moe, University of California, Berkeley: Transmem-
brane signaling through the aspartate receptor.
M. I. Simon, California Institute of Technology, Pasadena:
The role of the receptor in signal transduction.
Mechanisms of Yeast Recombination
March 9-March 12
ARRANGED BY
A. Klar, Cold Spring Harbor Laboratory, New York
SESSION 1 RECOMBINATION HOT SPOT I
Chairperson: J. R. Broach, Princeton University, New Jersey
M. M. Cox, University of Wisconsin, Madison: The FLP
protein of the yeast 2-micron plasmid.
P D. Sadowski, University of Toronto Faculty of Medicine,
Ontario, Canada: The FLP sife-specific recombinase of
the 2-micron circle of yeast.
J. R. Broach, Princeton University, New Jersey: Function
and mechanism of site-specific recombination in yeast
plasmids.
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M. Jayaram, Research Institute of Scripps Clinic, La Jolla,
California: Cuts, gaps, and recombination.
R A. Butow, University of Texas Health Science Center,
Dallas: Mitochondrial DNA recombination.
S. Roeder, Yale University, New Haven, Connecticut: A
recombination-stimulating sequence in the yeast
ribosomal RNA gene cluster.
SESSION 2 RECOMBINATION HOT SPOT II
Chairperson: A. Klar, Cold Spring Harbor Laboratory, New York
H. Gutz, Technische Universitat, Braunschweig, Federal
Republic of Germany: (a) Switching genes in Schizosac-
charomyces pombe; (b) DNA rearrangements in the
mating-type region of Schizosaccharomyces pombe.
R. Egel, University of Copenhagen, Denmark: Asymmetries
in mating-type switching in Schizosaccharomyces
pombe.
A. Klar, Cold Spring Harbor Laboratory, New York: Develop-
mental switches of the fission yeast mating-type locus.
J. N. Strathern, Frederick Cancer Research Facility, National
Cancer Institute, Maryland: Mating-type switching in
Saccharomyces cerevisiae.
F Heffron, Research Institute of Scripps Clinic, La Jolla,
California: Recombination in yeast is increased near a
synthetic HO recognition sequence.
F W. Stahl, Massachusetts Institute of Technology,
Cambridge: Double-strand breaks-Thinking about them
in phage and fungi.
SESSION 3 REC GENES AND THEIR PRODUCTS
Chairperson: M. Esposito, University of California, Berkeley
R. E. Esposito, University of Chicago, Illinois: Genes control-
ling meiotic recombination.
P J. Hastings, University of Alberta, Edmonton, Canada:
Screening for recombination-defective mutants with a
positive selection system for plasmid excision.
M. A. Resnick, National Institute of Environmental Health
J. Strathern
Sciences, Research Triangle Park, North Carolina: Sister
chromatid and meiotic recombination.
R. Malone, University of Iowa, Iowa City: Initiation of meiotic
gene conversion in yeast.
M. Esposito, University of California, Berkeley: Rec mutants
and their DNA-binding proteins.
SESSION 4 GENETIC CONSEQUENCES OF RECOMBINATION
Chairperson: F. W. Stahl, Massachusetts Institute of Technology, Cambridge
H. Klein, New York University Medical Center, New York:
Recombination between repeated genes.
T D. Petes, University of Chicago, Illinois: Generation of
translocations by meiotic recombination.
J. Haber, Brandeis University, Waltham, Massachusetts:
Physical monitoring of recombination events in mitosis
and meiosis.
J. Wallace, Columbia University College of Physicians &
S.
L.
Surgeons, New York, New York: Genetic control of repeat
sequence recombination.
Fogel, University of California, Berkeley: Recent
molecular-genetic studies on meiotic recombination.
Roman, University of Washington, Seattle: Gene
conversion and associated recombination in heterozy-
gous vs. heteroallelic diploid cells.
SESSION 5 PHYSICAL CONSEQUENCES OF RECOMBINATION
Chairperson: J. N. Strathern, Frederick Cancer Research Facility, NCI,
Frederick, Maryland
S. Kunes, Massachusetts Institute of Technology, Cambridge:
Synapsis-dependent mechanism of illegitimate
recombination.
D. Kaback, UMDNJ-New Jersey Medical School, Newark: Is
there distributive pairing in yeast?
R. Kolodner, Dana Farber Cancer Institute, Boston,
Massachusetts: Genetic recombination and mismatch
correction catalyzed by cell-free extracts of yeast.
D. J. Garfinkel, Frederick Cancer Research Facility, NCI,
Frederick, Maryland: Retrotransposition of Ty elements.
A. Nicolas, Massachusetts General Hospital, Boston:
Comparison of yeast and Ascobolus recombination.
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Evolution and Environmental Spread of
Antibiotic Resistance Genes
March 31-April 3
ARRANGED BY
S. B. Levy, Tufts University School of Medicine, Boston, Massachusetts
R. P. Novick, The Public Health Research Institute of the City of New York, New York
SESSION 1A BREADTH OF ENVIRONMENTAL INTERSPECIES GENE EXCHANGE IN THE NATURAL ENVIRONMENT
Chairperson: R Voytek, U.S. Environmental Protection Agency, Washington, D.C.
T. O'Brien, Brigham and Women's Hospital, Boston,
Massachusetts: Global surveillance of the deployment of
antibiotic resistance genes and plasmids.
S. B. Levy, Tufts University School of Medicine, Boston,
Massachusetts: Ecology of antibiotic resistance
determinants.
B. E. Murray, University of Texas Medical School, Houston:
Plasmid-mediated penicillinase in enterococci.
F. White, Kansas State University, Manhattan: The exchange
of genetic material between higher plants and
Agrobacterium.
B. R. Levin, University of Massachusetts, Amherst:
Population biology of plasmids and transposons-Gene
exchange in natural environments.
L. Chao, Northwestern University, Evanston, Illinois: Correla-
tions between antibiotic resistances.
SESSION 1B MICROBIAL ECOLOGY AND GENE EXCHANGE
Chairperson: B. Wiedemann, University of Bonn, Federal Republic of Germany
R. G. Freter, University of Michigan, Ann Arbor: Parameters
that are important in the colonization of natural habitats
by bacteria, using the large intestine as an example, and
the relation between colonization and plasmid transfer.
W. Witte, Institut fOr Experimentelle Epidemiologie, Werniger-
ode, German Democratic Republic: Occurrence, develop-
ment, and spread of antibiotic resistance in Staphylococ-
cus aureus, studied in man and in animal husbandry.
P Smith, University of Galway, Ireland: Uptake of antibiotic
resistance plasmid during antibiotic therapy in a salmon
hatchery.
SESSION 2 MOLECULAR MECHANISMS OF GENE TRANSFER
Chairperson: J. R. Scott, Emory University School of Medicine, Atlanta, Georgia
W. Paranchych, University of Alberta, Edmonton, Canada:
Comparison of the transfer genes of F-like conjugative
plasmids.
D. B. Clewell, University of Michigan, Ann Arbor: Conjuga-
tion in streptococci.
H. 0. Smith, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Genetic transformation in
H. influenzae.
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SESSION 3 FACTORS AFFECTING THE FATE OF TRANSFERRED GENES
Plasmid Replication
Chairperson: D. Sherratt, University of Glasgow, Scotland
J. R. Scott, Emory University School of Medicine, Atlanta,
Georgia: Replication regulation in the plasmid prophage
P1.
K. Nordstrom, University of Uppsala, Sweden: Molecular
aspects on control of replication of plasmid Rl.
D. R. Helinski, University of California, San Diego, La Jolla:
Regulation of replication of the narrow-host-range plasmid
R6K and the broad-host-range plasmid RK2.
M. Bagdasarian, Umea University, Sweden: Proteins
required for the broad-host-range mode of replication by
the plasmid RSF 1010.
R. H. Rownd, Northwestern University, Chicago, Illinois:
IncF11 plasmid replication control and stable inheritance.
R. P Novick, The Public Health Research Institute of the City
of New York, New York: Host-specific factors affecting
plasmid maintenance.
Plasmid Stability and Partitioning
Chairperson: R. P. Novick, The Public Health Research Institute of the City of New York, New York
S. N. Cohen, Stanford University School of Medicine, Califor-
nia: Chromosomal and extrachromosomal functions that
affect plasmid stability in E. coli.
D. Sherratt, University of Glasgow, Scotland: Novel recombi-
nation mechanisms in the maintenance and propagation
of plasmid genes.
S. Molin, The Polytechnical University, Copenhagen,
Denmark: Plasmid stabilization in populations of cells.
S. Austin, Frederick Cancer Research Facility, NCI,
Frederick, Maryland: The cis-acting site responsible for
the partition of P1 miniplasmids.
Plasmid and Gene Expression
Chairperson: D. Dubnau, The Public Health Research Institute of the City of New York, New York
J. C. Rabinowitz, University of California, Berkeley:
Determinants of transcription and translation in gram-
positive microorganisms.
G. C. Walker, Massachusetts Institute of Technology,
Cambridge: Plasmid biology of pkM101-The role of the
mucAB genes.
M. Bibb, John Innes Institute, Norwich, England: Gene
expression in the streptomyces.
SESSION 4 ORIGIN AND EVOLUTION OF GENES AND GENE TRANSFER SYSTEMS
Chairperson: S. B. Levy, Tufts University School of Medicine, Boston, Massachusetts
B. Wiedemann, University of Bonn, Federal Republic of
Germany: Gene alterations leading to resistance to 13-
lactam antibiotics.
P. M. Bennett, University of Bristol, England: Transposition
and plasmid evolution-Variations on a theme.
D. Dubnau, The Public Health Research Institute of the City
of New York, New York: Regulation and evolution of MLS
resistance.
S. Harayama, University of Geneva, Switzerland:
Mechanisms of and constraints to laboratory evolution of
plasmid-specified metabolic pathways.
Nongenotoxic Mechanisms in Carcinogenesis
April 13-April 16
ARRANGED BY
B. E. Butterworth, Chemical Industry Institute of Toxicology, Research Triangle Park, North
Carolina
T. J. Siege, University of Texas System Cancer Center, Smithville
SESSION 1 PROMOTION
Chairperson: A. Sivak, Arthur D. Little, Inc., Cambridge, Massachusetts
anthrone derivatives.
H. C. Pitot, University of Wisconsin Medical School,
Madison: Liver tumor promotion.
S. M. Cohen, University of Nebraska Medical Center,
T. J. Slaga, University of Texas System Cancer Center,
Smithville: Skin tumor promotion.
J. Di Giovanni, University of Texas System Cancer Center,
Smithville: Studies on the skin-tumor-Promoting action(s)
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Omaha: Bladder tumor promotion.
B. F. Trump, University of Maryland School of Medicine,
Baltimore: Calcium cell injury and tumor promotion.
SESSION 2 FORCED CELL PROLIFERATION
Chairperson: D. S. R. Sarma, University of Toronto, Ontario, Canada
W. Parzefall, University of Vienna, Austria: Measurement and
role of stimulation of liver growth in hepatocarcinogenesis.
R. H. Reitz, Dow Chemical Company, Midland, Michigan:
Regenerative growth of liver following toxic injury and its
role in hepatocarcinogenesis.
D. J. Loury, Chemical Industry Institute of Toxicology,
Research Triangle Park, North Carolina: The value of
measuring cell replication as a predictive index of tissue-
SESSION 3 RODENT BIOASSAYS
specific carcinogenic potential.
E. D. Wachsmuth, Ciba-Geigy AG, Basel, Switzerland:
Chemically induced cell turnover in the kidney and its
possible role in carcinogenesis.
J. A. Swenberg, Chemical Industry Institute of Toxicology,
Research Triangle Park, North Carolina: The influence of
cytotoxicity in the appearance of induced and spontane-
ous tumors.
Chairperson: P. N. Magee, Temple University School of Medicine, Philadelphia, Pennsylvania
P M. Newberne, Massachusetts Institute of Technology,
Cambridge: Nongenotoxic mouse liver carcinogens.
A. K. Ghoshal, University of Toronto, Ontario, Canada: The
induction of liver cancer by dietary deficiency without
SESSION 4 SOLID STATE CARCINOGENESIS
added carcinogens.
F. J. C. Roe, London, England: The problem of pseudocar-
cinogenicity in rodent bioassays.
Chairperson: H. C. Pitot, University of Wisconsin Medical School, Madison
K. G. Brand, Timmendorfer Strand, Federal Republic of
Germany: Solid-state carcinogenesis.
M. M. Coombs, Imperial Cancer Research Fund Laborato-
ries, London, England: Biogenic silica fibers and skin
cancer.
H. Heck, Chemical Industry Institute of Toxicology, Research
Triangle Park, North Carolina: The induction of calculi
and hyperplasia in weanling rats by terephthalic acid and
dimethyl terephthalate-An apparent threshold.
SESSION 5 EXAMPLES OF NONGENOTOXIC CARCINOGENS
Chairperson: H. S. Rosenkranz, Case Western Reserve University, Cleveland, Ohio
W. F. Greenlee, Chemical Industry Institute of Toxicology,
Research Triangle Park, North Carolina: TCDD-
Mechanisms of growth regulation and their potential role
in carcinogenicity.
B. E. Butterworth, Chemical Industry Institute of Toxicology,
SESSION 6 CELL CULTURE MODELS
Research Triangle Park, North Carolina: DEHP.
R. L. Anderson, The Procter & Gamble Company, Cincinnati,
Ohio: The mechanism of nitrilotriacetate (NTA)-associated
urinary tract tumorigenesis.
Chairperson: L. Diamond, Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania
Craig J. Boreiko, Chemical Industry Institute of Toxicology,
Research Triangle Park, North Carolina: Modulation of
transformed focus formation in cultures of C3H/10T1/2
cells.
H. Yamasaki, International Agency for Research on Cancer,
Lyon, France: The role of cell-to-cell communication in
promotion.
J. C. Barrett, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina:
Epigenetic and genetic mechanisms of presumed
nongenotoxic carcinogens.
P A. Cerutti, Swiss Institute for Experimental Cancer
Research, Lausanne: Mechanisms of action of prooxidant
promoters.
SESSION 7 REGULATORY CONSIDERATIONS
Chairperson: D. E. Stevenson, Shell Development Company, Houston, Texas
R. W. Tennant, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina: Some
implications of National Toxicology Program genetic
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toxicity test results on chemicals tested in rodents for
carcinogenicity and noncarcinogenicity.
H. E. Scribner, Rohm and Haas Company, Spring House,
Pennsylvania: Practical approaches to evaluating
nongenotoxic carcinogens.
G. N. Williams, American Health Foundation, Valhalla, New
York: Definition of human cancer risk.
Applications of DNA Probes
I. B. Weinstein, Columbia University College of Physicians &
Surgeons, New York, New York: Uniform risk assessment
policy for all carcinogens.
April 20-April 23
ARRANGED BY
L. S. Lerman, Genetics Institute, Cambridge, Massachusetts
SESSION 1 HUMAN GENETIC DISEASE AND CHROMOSOME MAPPING. I
K. E. Davies, John Radcliffe Hospital, Oxford, England:
Diagnosis of Duchenne muscular dystrophy, X-linked
phosphataemic rickets, and X-linked mental retardation.
L. M. Kunkel, Children's Hospital Medical Center, Boston,
Massachusetts: Molecular genetics of Duchenne
muscular dystrophy.
C. T. Caskey, Baylor College of Medicine, Houston, Texas:
Molecular basis on origin of Lesch-Nyhan mutations.
J.-L. Mandel, Faculte de Medicine de Strasbourg, France:
DNA probes and linkage analysis in the region of the
fragile X-mental retardation locus.
S. A. Latt, Children's Hospital Medical Center, Boston,
Massachusetts: Use of DNA probes to study
chromosome deletions and amplification.
T. B. Shows, Roswell Park Memorial Institute, Buffalo, New
York: Mapping chromosome II and cancer gene markers.
D. W. Russell, University of Texas Health Science Center,
Dallas, Texas: The molecular genetics of familial
hypercholesterolemia.
SESSION 2 HUMAN GENETIC DISEASE AND CHROMOSOME MAPPING. II
U. Francke, Yale University School of Medicine, New Haven,
Connecticut: Detection of microdeletions with
bytogenetics and DNA probes.
A. J. Jeffreys, University of Leicester, England: Hypervariable
DNA and genetic "fingerprints."
R. L. White, University of Utah School of Medicine, Salt Lake
City: Linkage maps of human chromosomes.
G. Ruvkun, Massachusetts General Hospital, Cambridge:
Polymorphism mapping using repetitive elements.
H. Lehrach, European Molecular Biology Laboratory,
Heidelberg, Federal Republic of Germany: Molecular
approaches to mammalian genetics.
F. S. Collins, University of Michigan, Ann Arbor:
Chromosome hopping.
H. Donis-Keller, Collaborative Research, Lexington,
Massachusetts: Application of RFLP probes to genetic
mapping and clinical diagnosis in humans.
SESSION 3 PHYSICAL SEPARATIONS, NEW PROBE TECHNOLOGY, AND MICROBIOLOGY.
I
W. Gray, Lawrence Livermore National Laboratory,
Livermore, California: Flow cytogenetics-
(1) Chromosome classification and purification;
(2) production of chromosome-specific recombinant DNA
libraries; (3) chromosome-specific fluorescence DNA-
DNA hybridization.
C. Smith, Columbia University College of Physicians &
Surgeons, New York, New York: Macrorestriction
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mapping by pulsed-field gel electrophoresis.
M. Olson, Washington University School of Medicine, St.
Louis, Missouri: Electrophoretic separations of large DNA
molecules.
R. W. Davis, Stanford University Medical Center, California:
Separation and mapping of large-molecular-weight DNA
by alternating homogeneous electric fields.
D. C. Ward, Yale University, New Haven, Connecticut.
H. A. Erlich, Cetus Corporation, Emeryville, California:
Genetic analysis using enzymatic amplification of specific
genomic consequences.
A. T Haase, University of Minnesota Medical Center,
Minneapolis: Analysis of infections and pathological
conditions by in situ hybridization. L. Lerman
SESSION 4 PHYSICAL SEPARATIONS, NEW PROBE TECHNOLOGY, AND MICROBIOLOGY.
II
M. Ranki, Orion Genetic Engineering Laboratory, Helsinki,
Finland: Nucleic acid sandwich hybridization: Methodol-
ogy and applications to microbial diagnosis.
R. B. Wallace, Beckman Research Institute/City of Hope,
Duarte, California: Synthetic DNA probes.
R. M. Myers, University of California, School of Medicine,
San Francisco: Assays for detecting single base changes
in cloned and genomic DNA.
M. Collins, Genetics Institute, Cambridge, Massachusetts:
SESSION 5 VIRUSES, CANCER, AND PARASITES
L. Gissmann, German Cancer Research Center, Heidelberg,
Federal Republic of Germany: Human papillomavirus
DNA in genital cancer.
M. A. Israel, National Cancer Institute, Bethesda, Maryland:
Molecular approaches to the diagnosis of cancer.
J. Sklar, Stanford University School of Medicine, California:
DNA arrangements in lymphoid neoplasia and their
application to diagnosis.
D. H. Spector, University of California, San Diego, La Jolla:
Molecular analysis of cytomegalovirus infections.
D. F Wirth, Harvard School of Public Health, Boston,
Massachusetts: DNA probes in the detection of parasitic
infections.
DNA strand displacement-A novel diagnostic approach.
A. E. Smith, Integrated Genetics, Framingham,
Massachusetts: Development of diagnostic DNA probes.
F C. Tenover, Veterans Administration Medical Center, Seattle,
Washington: Use of DNA probes for epidemiologic
studies of antibiotic resistance genes.
L. S. Lerman, Genetics Institute, Cambridge, Massachusetts:
Helic stability and genetic analysis.
K. Davies, A. Jeffreys
Gene Transfer Vectors for Mammalian Cells
October 14-October 17
ARRANGED BY
J. H. Miller, University of California, Los Angeles
SESSION 1
Mutagenesis
M. P. Ca los, Stanford University School of Medicine, Califor-
nia: Analysis of mutation in human cells using shuttle
vectors.
J. H. Miller, University of California, Los Angeles, and Phaik
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Mooi-Leong, Yale University, New Haven, Connecticut:
Comparison of mutagenesis in bacterial and mammalian
cells.
K. Dixon, National Institute of Child Health and Human
Development, Bethesda, Maryland: Use of a SV40-based
shuttle vector to analyze spontaneous and UV-induced
mutations arising in mammalian cells.
M. Seidman, Otsuka Pharmaceutical Co., Ltd., Rockville,
Maryland: Mutagenesis of a shuttle vector plasmid in
normal human and xeroderma cells.
SESSION 2
Mutagenesis (continued)
E. Dogliotti, Massachusetts Institute of Technology,
Cambridge: Construction of shuttle vectors for studying
the genetic effects of defined chemical carcinogen-DNA
base adducts in mammalian cells.
V. M. Maher, Michigan State University, East Lansing: Kinds
of mutations formed when a shuttle vector containing
adduct of BPDE replicates in human cells.
M. Hoekstra, Scripps Clinic and Research Foundation, La
Jolla, California: A method of transposon mutagenesis in
yeast.
Bacterial Vectors
N. Pagratis, University of Chicago, Illinois: Construction of
broad-host-range expression vectors for bacteria.
Vaccinia
B. Moss, National Institutes of Health, Bethesda, Maryland:
Vaccinia virus vectors.
Adenovirus
Y. Gluzman, Cold Spring Harbor Laboratory, New York:
Adenovirus vectors.
SESSION 3
Mammalian Vectors
Retroviruses
C. Cepko, Harvard Medical School, Boston, Massachusetts:
Gene transfer into primary neural cells using retrovirus
vectors.
J. Dougherty, University of Wisconsin, Madison: Retrovirus
vectors and their variation.
BPV
M. Botchan, University of California, Berkeley: (1) Negative
regulation of papillomavirus replicon. (2) Use of
SESSION 4
EBV
A. J. Levine, Princeton University, New Jersey: Epstein-Barr
virus plasmids.
Expression in Mammalian Cells
C. Gorman, Genentech, Inc., South San Francisco, Califor-
nia: Factor VIII expression in mammalian cells.
N. Sarver, Meloy Laboratories, Springfield, Virginia:
Expression of complete and abridged F.III using BPV
shuttle vectors.
L. McConlogue, Cetus Corporation, Emeryville, California:
Amplification vector based on ODCase.
T. V. Ramabhadran, Monsanto Company, St. Louis, Missouri:
Host cell-specific variation in the posttranslational
processing of engineered proteins.
R. Kaufman, Genetics Institute, Cambridge, Massachusetts:
Translational control in transfected mammalian cells.
F. Hutchinson, Yale University, New Haven, Connecticut:
Mutagenesis in an E. coli gpt gene stably incorporated in
the genome of CHO cells.
N. Drinkwater, University of Wisconsin, Madison: Use of EBV
shuttle vectors for analysis of mutagenesis in human
cells.
M. Ca los, Y. Gluzman
retroviruses for the study of DNA tumor virus
transformation.
G. N. Pavlakis, N.C.I.-Frederick Cancer Research Facility,
Maryland: Applications of BPV and retroviral vectors.
Insect Baculovirus
G. Ju, Hoffmann-La Roche Inc., Nutley, New Jersey: Use of
an insect baculovirus vector system.
J. Miller
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SESSION 5
Gene Therapy
D. St. Louis, The Salk Institute, San Diego, California: Transfer
of genes in whole animals.
Plants
J. Schell, University of Gent, Belgium: Regulation of
expression of genes introduced in plants.
Transgenic Mice
S. Camper, The Institute for Cancer Research, Philadelphia,
Pennsylvania: Developmental regulation of the a-fetal
protein gene in transgenic mice.
G. Lozano, Princeton University, New Jersey: Regulation of
expression of SV40 early genes in transgenic mice.
Mechanistic Approaches to Developmental Toxicology
October 19-October 22
ARRANGED BY
J. A. McLachlan, National Institute of Environmental Health Sciences, Research Triangle
Park, North Carolina
R. M. Pratt, National Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina
C. L. Markert, North Carolina State University, Raleigh
SESSION 1 IN VITRO APPROACHES
Chairperson: R. M. Pratt, National Institute of Environmental Sciences, Research Triangle Park, North Carolina
N. Bournais-Verdiabasis, City of Hope Medical Center,
Duarte, California: Altered differentiation and induction of
heat-shock proteins in Drosophila embryonic cells
associated with teratogen treatment.
A. Braun, Massachusetts Institute of Technology, Cambridge:
Teratogen metabolism.
T. H. Shepard, University of Washington, Seattle: Whole
embryo culture-Normal and abnormal development.
L. Saxen, University of Helsinki, Finland: Renal development
in vitro.
Discussants: R. E. Morrissey, National Institute of Environ-
mental Health Sciences, Research Triangle Park, North
Carolina, and F Welsch, Chemical Industry Institute of
Toxicology, Research Triangle Park, North Carolina.
SESSION 2 MOLECULAR AND EXPERIMENTAL EMBRYOLOGY
Chairperson: J. A. McLachlan, National Institutes of Environmental Health Sciences, Research Triangle Park, North Carolina
R. Pedersen, University of California, San Francisco: Cell
lineage of mammalian germ layers.
P M. lannacone, Northwestern University, Chicago, Illinois:
Models of organogenesis based on mosaic pattern
analysis in chimeric rats.
M. Levine, Columbia University, New York, New York: Spatial
regulation of homeobox gene expression in Drosophila.
G. Edelman, Rockefeller University, New York, New York:
Role of cell recognition in normal development.
SESSION 3 NON-MAMMALIAN MODELS
C. L. Markert, North Carolina State University, Raleigh: Are
heat-shock proteins involved in development?
Discussants: J. G. Scandalios, North Carolina State
University, Raleigh, and L. Saxen, University of Helsinki,
Finland.
J. M. Rice, N.C.I.-Frederick Cancer Research Center,
Maryland: Mechanisms of transplacental carcinogenesis:
Mutation, oncogene activation, and tumor promotion.
Chairperson: C. L. Markert, North Carolina State University, Raleigh
J. G. Scandalios, North Carolina State University, Raleigh:
Expression of developmentally regulated genes in maize,
under normal and stressed conditions.
E. M. Johnson, Jefferson Medical College, Philadelphia,
Pennsylvania: Patterns of developmental toxicity evaluated
in hydra "embryos."
M. Solursh, University of Iowa, Iowa City: Studies on normal
and abnormal differentiation of the chick limb
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mesenchyme.
T D. Sabourin, Battelle Columbus Division, Ohio: Compara-
tive evaluation of a short-term test for development effects
using frog embryos.
Discussants: D. Kochhar, Jefferson Medical College,
Philadelphia. Pennsylvania, and L. Dencker, University of
Uppsala, Sweden.
SESSION 4 EXPERIMENTAL ANIMAL-HUMAN COMPARISONS
Chairperson: R. L. Brent, Jefferson Medical College, Philadelphia, Pennsylvania
R. M. Pratt, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina:
Receptor-dependent mechanisms of retinoid-induced
craniofacial malformations.
E. J. Lammer, Massachusetts General Hospital, Boston:
Patterns of malformations among fetuses and infants
exposed to retinoic acid (isotretinoin) in utero.
J. A. McLachlan, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina:
Mechanisms for induction of differentiation defects
associated with diethylstilbestrol.
A. F Haney, Duke University Medical Center, Durham, North
Carolina: Structural and functional malformations in
humans exposed in utero to diethylstilbestrol.
Discussants: W. J. Scott, Jr., Children's Hospital Medical
Center, Cincinnati, Ohio, and R. Miller, University of
Rochester School of Medicine, New York
R. L. Brent, Jefferson Medical College, Philadelphia,
Pennsylvania: Etiology of unknown causes of birth
defects.
SESSION 5 RISK ASSESSMENT
Chairperson: G. P. Oakley, Centers for Disease Control, Atlanta, Georgia
J. Manson, Smith, Kline and French Laboratories, Philadel-
phia, Pennsylvania: Biological considerations for risk
estimation in developmental toxicology.
J. Springer, Food and Drug Administration, Washington, D.C.:
Regulatory perspectives of teratogenic risk assessment.
N. Kaplan, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina:
Angiogenesis
Quantification of risk in teratology.
J. Hanson, University of Iowa, Iowa City: Teratogen informa-
tion systems and their use in assessment of human risk.
Discussants: C. A. Kimmel, U.S. Environmental Protection
Agency, Washington, D.C., and G. P. Oakley, Centers for
Disease Control, Atlanta, Georgia.
November 2-November 5
ARRANGED BY
D. B. Rifkin, New York University Medical Center, New York
M. Klagsbrun, Children's Hospital Medical Center, Boston, Massachusetts
SESSION 1 FGF (OR HBGF); PROTEIN STRUCTURE, GENE STRUCTURE AND RECEPTORS. I
Chairperson: p A. D'Amore, Children's Hospital Medical Center, Boston, Massachusetts
acidic fibroblast growth factor.
M. Petitou, Institut Choay, Paris, France: A heparin hexasac-
charide fragment able to bind to anionic endothelial cell
growth factor-Preparation and structure.
M. Klagsbrun, Children's Hospital Medical Center, Boston,
Massachusetts: Opening remarks.
K. A. Thomas, Merck Sharp & Dohme Research Laborato-
ries, Rahway, New Jersey: Structure and activities of
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M. Klagsbrun, Children's Hospital Medical Center, Boston,
Massachusetts: Multiple forms of basic FGF.
J. C. Fiddis, California Biotechnology Inc., Mountain View:
Genes for the angiogenic growth factors-Basic and
acidic FGF.
A. Sommer, Synergen, Inc., Boulder, Colorado: Primary
structure of human basic fibroblast growth factor derived
from protein and cDNA sequencing.
SESSION 2 FGF (OR HBGF); PROTEIN STRUCTURE, GENE STRUCTURE AND RECEPTORS. II
Chairperson: R. D. Rosenberg, Massachusetts Institute of Technology, Cambridge
T. Maciag, Biotechnology Research Center, Rockville,
Maryland: Endothelial cell growth factor and its receptor.
Y. Courtois, INSERM, Paris, France: Modulation of growth
factor (EDGFs and FGFs) activity and fixation in develop-
ment and pathogenesis of the eye.
D. Barritault, Universite Paris, France: Eye-derived growth
factors-Early events and receptor studies.
D. Moscatelli, New York University Medical Center, New York:
Presence of basic fibroblast growth factor in a variety of
cells and its binding to cells.
I. Vlodaysky, Hadassah University Hospital, Jerusalem,
Israel: Heparin-binding growth factors produced by
normal and malignant cells are sequestered and
stabilized by the subendothelial extracellular matrix.
SESSION 3 ANGIOGENESIS FACTORS
Chairperson: T. Maciag, Biotechnology Research Center, Rockville, Maryland
P E. DiCorleto, Cleveland Clinic Institute, Ohio: Production of
PDGF-like protein by endothelial cells.
A. B. Roberts, National Cancer Institute, Bethesda,
Maryland: Type-p-transforming growth factor-Stimulator
or inhibitor of angiogenesis?
C. Haudenschild, Boston University School of Medicine,
Massachusetts: Nonpeptide angiogenesis factors.
J. Caste llot, Harvard University Medical School, Boston,
Massachusetts: Differentiation-dependent stimulation of
angiogenesis by 3T3-adipocyte.
S. Kumar, Christie Hospital and Holt Radium Institute,
Manchester, England: Hyaluronic acid and angiogenesis.
M. J. Banda, University of California, San Francisco:
Regulation of endothelial cell metalloproteinase activity.
SESSION 4 ANGIOGENESIS INHIBITORS, BIOLOGY OF VASCULAR CELLS
Chairperson: D. B. Rifkin, New York University Medical Center, New York
J. Folkman, Children's Hospital Medical Center, Boston,
Massachusetts: Inhibitors of angiogenesis-Angiogenic
steroids.
D. B. Rifkin, New York University Medical Center, New York:
Studies on the regulation of protease activity during cell
invasion and angiogenesis.
B. M. Glaser, Johns Hopkins Hospital, Baltimore, Maryland:
Retinal pigment epithelial cell release inhibitors of
neovascularization.
P A. D'Amore, Children's Hospital Medical Center, Boston,
Massachusetts: Role of pericytes in microvascular growth
control.
P. Bohlen, University of Zurich, Switzerland: Inhibitors of
endothelial cell proliferation.
R. Auerbach, University of Wisconsin, Madison: Endothelial
cell specificity and angiogenesis. D. Rifkin
SESSION 5 ANGIOGENESIS IN VIVO
Chairperson: J. Folkman, Children's Hospital Medical Center, Boston, Massachusetts
W. Risau, Max-Planck Institut, Tubingen, Federal Republic of
Germany: Regulation of blood-vessel development.
M. M. Sholley, Virginia Commonwealth University, Richmond:
Proliferation and migration of irradiated endothelial cells.
J. M. Davidson, Vanderbilt University School of Medicine,
Nashville, Tennessee: Wound repair, growth factors, and
connective tissue metabolism.
D. R. Knighton, University of Minnesota Hospital,
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Minneapolis: Environmental regulation of macrophage
angiogenesis.
H. M. Jensen, University of California School of Medicine,
Davis: Angiogenesis induced by "normal" human breast
tissue-A probable marker for precancel-.
J. Folkman, Children's Hospital Medical Center, Boston,
Massachusetts: Closing remarks.
Congressional Workshop on Radon in the Home
November 12-November 14
ARRANGED BY
S. Prentis, Cold Spring Harbor Laboratory, New York
SESSION 1
J. Harley, Hoboken, New Jersey: Introduction/history/
measurement procedures.
B. L. Cohen, Department of Physics, University of
SESSION 2
N. H. Harley, Department of Environmental Medicine, New
York University, New York: Epidemiology and risk
estimates.
J. T. Tappan, ARIX Sciences Incorporated, Grand Junction,
Colorado: Mitigation procedures and results.
SESSION 3
E. Hotte, New Jersey Department of Environmental
Protection, Trenton: State responses to the radon
problem.
R. Guimond, Office of Radiation Programs, U.S. Environmen-
tal Protection Agency, Washington, D.C.: Federal
responses to the radon problem.
The Neurochemistry of Aging
Pittsburgh, Pennsylvania: Distribution of exposures in the
United States.
November 30-December 3
ARRANGED BY
P. Davies, Albert Einstein College of Medicine, Bronx, New York
C. E. Finch, University of Southern California, Los Angeles
SESSION -1 NEUROCHEMISTRY
Chairperson: P. Davies, Albert Einstein College of Medicin
D. M. Bowen, Institute of Neurology, London, England:
Neurochemical identity of degenerate (tangle-bearing)
cortical neurones.
D. G. Morgan, University of Southern California, Los
Angeles: Neurotransmitter receptors in Alzheimer's
disease and normal aging.
S. I. Rapoport, National Institute on Aging, Bethesda,
Maryland: Functional assessment of altered neurochemis-
try in aging and Alzheimer's disease-Tissue loss and
metabolic deficits as measured with CT and positron
emission tomography.
e, Bronx, New York
F H. Gage, University of California, San Diego: Intracerebral
neuronal grafting of identified cell types into the aging
brain.
C. W. Cotman, University of California, Irvine: Excitatory
amino acid receptors and Alzheimer's disease.
G. E. Gibson, Burke Rehabilitation Center, White Plains, New
York: Interactions of calcium and neurotransmitter
metabolism during aging.
J. Goldman, Albert Einstein College of Medicine, Bronx, New
York: Altered calcium metabolism in Alzheimer's disease.
SESSION 2 NEUROENDOCRINOLOGY
Chairperson: C. E. Finch, University of Southern California, Los Angeles
Neuroendocrine aging-Human brain mRNA.
C. E. Finch, University of Southern California, Los Angeles:
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J. R. Sladek, Jr, University of Rochester Medical Center,
New York: Fetal neuronal transplants reverse
Parkinsonism symptoms in MPTP-treated monkeys.
J. W. Rowe, Harvard Medical School, Boston,
Massachusetts: Sympathetic nervous system activity in
aging man.
P M. Wise, University of Maryland School of Medicine,
Baltimore: Hypothalamic monoamine function during
aging-Its role in the onset of reproductive infertility.
SESSION 3 FIBROUS PROTEINS
Chairperson: D. J. Selkoe, Brigham and Women's Hospital,
D. J. Selkoe, Brigham and Women's Hospital, Boston,
Massachusetts: Molecular comparison of intraneuronal
paired helical filaments and extracellular amyloid fibrils in
Alzheimer's disease.
S. B. Prusiner, University of California School of Medicine,
San Francisco: Prion proteins and degenerative
neurologic disorders.
S.-H. Yen, Albert Einstein College of Medicine, Bronx, New
York: Alzheimer's neurofibrillary tangles.
SESSION 4 CHROMOSOME 21
R. E. Brinton, Rockefeller University, New York, New York:
Neurochemical dissection of the mneumonic process-
Where the system can falter.
R. M. Sapolsky, Salk Institute, San Diego, California: Protect-
ing the injured hippocampus by attenuating glucocorti-
coid secretion.
J. H. Morrison, Research Institute of Scripps Clinic, La Jolla,
California: Plaque and tangle distribution and cortico-
cortical degeneration in Alzheimer's disease.
Boston, Massachusetts
H. M. Wisniewski, Institute for Basic Research in Develop-
mental Disabilities, Staten Island, New York: Ultrastruc-
ture, immunology, and biochemistry of paired helical
filaments and plaque amyloid.
P. Gambetti, Case Western Reserve University, Cleveland,
Ohio: Aging and neuronal cytoskeleton.
F Gaskin, Oklahoma Medical Research Foundation,
Oklahoma City: Autoantibodies to neurofibrillary tangles
and brain tissue in Alzheimer's disease and aging.
Chairperson: C. J. Epstein, University of California School of Medicine, San Francisco
C. J. Epstein, University of California School of Medicine,
San Francisco: Pathogenic relationships between Down's
syndrome and Alzheimer's disease.
D. Patterson, Eleanor Roosevelt Institute for Cancer
Research, Denver, Colorado: Somatic-cell genetic and
molecular dissection of chromosome 21.
A. C. Warren, Johns Hopkins University, Baltimore,
Maryland: DNA polymorphism haplotypes of human
chromosome 21- Molecular analysis of the mechanism of
nondisjunction.
M. L. Oster-Granite, Johns Hopkins Hospital, Baltimore,
Maryland: The trisomic 16 mouse and Down's
syndrome-Relevance of Alzheimer's disease.
G. G. Glenner, University of California, San Diego: The
amyloid fibril protein(s) of Alzheimer's disease and adult
Down's syndrome.
H. M. Wisniewski, Institute for Basic Research in Develop-
mental Disabilities, Staten Island, New York: Neuropathol-
ogy and dementia in people with Down's syndrome.
SESSION 5 MOLECULAR AND GENETIC APPROACHES TO AGING
Chairperson: L. L. Heston, University of Minnesota, Minneapolis
L. L. Heston, University of Minnesota, Minneapolis: Family
studies in Alzheimer's disease.
D. Goldgaber, National Institute of Neurological and
Communicative Disorders and Stroke, Bethesda,
Maryland: Isolation, characterization, and chromosomal
localization of human brain cDNA clones coding for the
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precursor of the amyloid of Alzheimer's disease and
aging brain.
J. F Gusella, Massachusetts General Hospital, Boston:
Investigation of familial Alzheimer's disease of DNA
markers.
A. Roses, Duke University Medical Center Durham, North
Carolina: Molecular genetic strategies in Alzheimer's
disease.
P. Davies, Albert Einstein College of Medicine, Bronx, New
York: Molecular studies of a new protein in Alzheimer's
disease.
Discussants:
D. Aswad, University of California, Irvine
J. H. Morrison, Scripps Clinic and Research Foundation, La
Jolla, California
K. O'Malley, Washington University Medical School, St. Louis,
Missouri
M. L. Oster-Granite, Johns Hopkins University, Baltimore,
Maryland
S. B. Prusiner, University of California, San Francisco, School
of Medicine
R. D. Terry, University of California, San Diego
L. P Weiner, University of Southern California, Los Angeles

EDUCATIO
NAL
ACTIVITIES

Postgraduate Courses
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory
is aimed at meeting the special need for training in interdisciplinary subjects that
are either so new or so specialized that they are not adequately treated by
universities. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into
research in a particular area. To ensure up-to-date coverage of current research
work, we bring together a workshop staff from many laboratories around the world
and supplement this staff with a series of seminar speakers.
Single-channel Methods: Expression and Recording
June 6-June 26
INSTRUCTORS
Dionne, Vincent E., Ph.D., University of California, San Diego
White, Michael M., Ph.D., University of Pennsylvania, Philadelphia
Snutch, Terry, Ph.D., California Institute of Technology, Pasadena
Corey, David, Ph.D., Harvard University, Cambridge, Massachusetts
Yellen, Gary, Ph.D., University of Maryland, College Park
ASSISTANT
Stevens, Meg, B.A., Harvard University, Cambridge, Massachusetts
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The technologies of molecular biology and patch -clamping promise
major
revisions and novel approaches for the examination of many neurobiological
problems. Applications of these methods to study the physiology and biophysics
of ion channels were taught in this intensive laboratory and lecture course.
Students concentrated initially on the basic aspects of these two methods, then
proceeded to more integrated studies. Single-channel recording: the
fabrication of
patch electrodes, giga-seal formation, cell-attached, cell-free and whole-cell
recordings, the design and implementation of recording equipment, and the
theory and analysis of single-channel currents. Single-channel expression: mRNA
purification and handling, the use of Xenopus oocytes and cultured cells as
expression systems, the injection of foreign mRNA into oocytes to express ion-
channels, and the characterization of newly expressed ion-channels using voltage-
clamp and patch-clamp methods on the oocyte. There were opportunities during
the final week of the course for students to undertake special projects of their own
design which utilized the methods being taught.
PARTICIPANTS
Adamek, Gloria, Ph.D., University of Cincinnati, Ohio
Bender, Alex, Ph.D., University of Saskatchewan, Canada
Edge, Mark, B.S., University of Alabama, Birmingham
Golowasch, Jorge, B.A., Brandeis University, Waltham,
Massachusetts
LaMotte, Robert, Ph.D., Yale University, New Haven,
Connecticut
Marban, Eduardo, Ph.D., Johns Hopkins University,
Baltimore, Maryland
Marcus, Emilie, B.A., Yale University, New Haven,
Connecticut
Oesterle, Elizabeth, Ph.D., Purdue University, Lafayette,
Indiana
Pietrobon, Daniela, Ph.D., University of Padova, Italy
Pradier, Laurent, B.S., University of California, Davis
SEMINARS
Beam, K., Colorado State University. Measuring ion channel
distribution and density with the loose-patch clamp.
Sahley, C.L., Yale University. Single ion channels and
behavioral plasticity.
Moczydlowski, E.G., University of Cincinnati. In vitro
expression: Application of planar bilayers to ion.
Stevens, C.F., Yale University. Glutamate receptors in the
central nervous system.
Molecular Embryology of the Mouse
June 6-June 26
INSTRUCTORS
Rossant, Janet, Ph.D., University of Toronto, Canada
Pedersen, Roger, Ph.D., University of California, San Francisco
Beddington, R., Ph.D., University of Oxford, England
Robertson, Liz, Ph.D., University of Cambridge, England
ASSISTANT
Watson, A., M.S., University of Western Ontario, London, Canada
This course was designed for molecular biologists, biochemists and cell biologists
interested in applying their expertise to the study of mouse embryonic develop-
ment. Lecture and laboratory components of the course emphasized both the
practical aspects of working with mouse embryos and the conceptual basis of
current embryonic research. The following procedures and their potential applica-
tions were described: isolation and culture of germ cells and preimplantation and
postimplantation embryos, embryo transfer, establishment of embryo-derived stem
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cell lines, germ layer separation, chimera formation, nuclear transplantation,
microinjection of DNA into eggs, retroviral infection of embryos, microinjection of
cell lineage tracers, in situ hybridization and immunofluorescence and
immunoperoxidase techniques.
PARTICIPANTS
Bikoff, Elizabeth, Ph.D., Mt. Sinai School of Medicine, New
York, New York
Black, Douglas, B.A., Yale University, New Haven,
Connecticut
D'Agostaro, Giacomo, Ph.D., University of Toronto, Canada
Darling, Susan, Ph.D., Imperial College Research Fund,
London, England
DePinho, Ronald, M.D., Columbia Presbyterian Medical
Center, New York, New York
Fienberg, Allen, B.A., Yale University, New Haven,
Connecticut
Fotedar, Rati, M.A., University of Alberta, Canada
Lilly, Frank, Ph.D., Albert Einstein College of Medicine,
Bronx, New York
Merlino, Glenn, Ph.D., NCI, National Institutes of Health,
Bethesda, Maryland
Richman, Adam, B.A., Yale University, New Haven,
Connecticut
Tsukamoto, Ann, Ph.D., University of California, San
Francisco
Tucker, Gordon, Ph.D., CNRS, Paris, France
Tyner, Angela, B.A., University of Chicago, Illinois
Wind le, Jolene, Ph.D., Salk Institute, La Jolla, California
SEMINARS
Chalfie, M., Columbia University. Lineage analysis in C.
elegans.
Costantini, F, Columbia University. Gene expression in
transgenic mice.
Fox, N., Wistar Institute. Stage-specific antigens.
Hanahan, D., Cold Spring Harbor Laboratory. Oncogenes in
transgenic mice.
Jaenisch, R., Whitehead Institute. Retroviruses and
insertional mutagenesis.
Magnusson, T., Case Western Reserve. Developmental
mutations.
Mahon, K., National Institutes of Health. Lens development
and tumor formation.
McLaren, A., MRC Mammalian Development Unit. Sex
determination.
Papaidannou, V., Tufts University. Comparative embryology.
Petersen, A., McGill University. Neurological mutants and
chimeras.
Rudd le, F, Yale University. Homeo box genes.
Sargent, T, National Institutes of Health. Molecular embryol-
ogy of Xenopus.
Schatter, G., Florida State University. Cytoskeleton.
Schultz, G., University of Calgary. Gene expression in early
embryos.
Solter, D., Wistar Institute. Nuclear transplantation.
Wassarman, P, Roche Institute. ZP proteins.
Struhl, G., Harvard University. Drosophila developmental
genetics.
Hogan, B., NIMR. Endoderm differentiation.
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Advanced Bacterial Genetics
June 6-June 26
INSTRUCTORS
Berget, Peter B., Ph.D., University of Texas Medical School, Houston
Maurer, Russel, Ph.D., Case Western Reserve University School of Medicine, Cleveland,
Ohio
Weinstock, George, Ph.D., University of Texas Medical School, Houston
ASSISTANTS
Bultema, Sarah Highlander, Ph.D., University of Texas Medical School, Houston
Lancy, Edward, M.S., Case Western Reserve University School of Medicine, Cleveland, Ohio
Weiseman, Jane, M.S., University of Texas Medical School, Houston
This laboratory course demonstrated genetic approaches that can be used to
analyze biological processes and their regulation as well as detailed
structure/function relationships of genes. Techniques covered included: isolation,
complementation and mapping of mutations, use of transposable genetic
elements, construction of gene fusions, cloning and manipulation of DNA, and
DNA sequencing. The course consisted of a set of experiments incorporating
most of these techniques supplemented with lectures and discussions.
PARTICIPANTS
Caillet, Joel, M.S., Institut de Biologie, Paris, France
Collier, David, B.S., University of North Carolina, Chapel Hill
Daeschel, Mark, Ph.D., U.S. Department of Agriculture,
Raleigh, North Carolina
Garcia-Bustos, Jose, Ph.D., Rockefeller University, New York,
New York
GOtt, Peter M.S., University of Konstanz, Federal Republic of
Germany
Hirschberg, Rona, Ph.D., University of Missouri, Kansas City
Hughes, Edward, Ph.D., Yale University, New Haven,
Connecticut
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Kinder, Susan, M.D., University of Texas, San Antonio
Lenstra, Reijer, Ph.D., HOpital St. Louis, Paris, France
Libertin, Claudia, M.D., University of Illinois, Chicago
Merlin, Dale, M.S., Indiana University, Bloomington
Moore, Karen, B.A., University of California, Los Angeles
Romesser, James, Ph.D., I.E. du Pont de Nemours &
Company, Wilmington, Delaware
Solomon, Kimberly, M.S., University of Maryland, College
Park
Tropp, Burton E., Ph.D., Queens College, Flushing, New York
Wower, Iwona, Ph.D., University of Massachusetts, Amherst
SEMINARS
Sternberg, N., E.I. du Pont de Nemours & Co. Processing
the bacteriophage P1 packaging site is regulated by
adenine methylation.
Mekalanos, J., Harvard Medical School. Molelular genetics
of cholera toxin.
Berg, D., Washington University School of Medicine.
Mechanism and control of transposition.
Short le, D., Johns Hopkins School of Medicine. Genetic
analysis of the stability of staphylococcal nuclease to
reversible denaturation.
Miller, C., Case Western Reserve University School of
Medicine. Oxygen regulation of peptidase T and other
Salmonella genes.
Manoil, C., Harvard Medical School. Using gene fusions to
study membrane protein topology.
Gross, C., University of Wisconsin. The heat-shock response
in E. coll.
Molecular Neurobiology of Human Disease
June 10-June 20
INSTRUCTORS
Black, Ira B., M.D., Cornell University Medical Center, New York, New York
Breakefield, Xandra, Ph.D., E.K. Shriver Center and Harvard Medical School, Boston,
Massachusetts
Gusella, James, Ph.D., Massachusetts General Hospital, Boston
This intensive seminar course explored the molecular and cellular basis of
abnormal neural function. It focused on basic scientific studies that have provided
insight into the etiology and pathogenesis of neurologic and psychiatric diseases.
Emphasis was also placed on new techniques in neuroscience and molecular
genetics that should provide additional insights. Topics included: molecular
pathology of neurotransmitter derangement, developmental plasticity and choice
of neurotransmitter phenotype, synthesis and regulation of neuropeptides, cellular
events in neural regeneration and brain transplantation, neural pathways involved
in pain syndromes, genetic linkage analysis using DNA polymorphisms, defects in
DNA repair, activation of one genes and genetic homozygosity in neural tumors,
mutations causing the Lesch-Nyhan syndrome and lipidoses and possible means
of gene therapy, autoimmune diseases, brain imaging and metabolism, epilepsy
and seizure disorders, viral infections of the nervous system and amyloidosis,
experimental models of learning and memory.
PARTICIPANTS
Blumberg, Benjamin M., Ph.D., University of Medicine and
Dentistry of New Jersey, Newark
Cattaneo, Roberto, B., Ph.D., University of Zurich,
Switzerland
Chen, Karen S., B.A., University of California, San Diego
Cooper, David N., Ph.D., University of London, England
Crowley, Joan C., Ph.D., University of Medicine and
Dentistry of New Jersey, Newark
Evans, Bradley K., M.D., Rockefeller University, New York,
New York
Garofalo, Lorella, PS., McGill University, Montreal, Canada
Gaston, Sandra M., Ph.D., Massachusetts Institute of
Technology, Cambridge
Hsu, Yun-Pung, Ph.D., Massachusetts Institute of Technol-
ogy, Cambridge
Joho, Rolf H., Ph.D., Baylor College of Medicine, Waco,
Texas
MacDonald, Margaret, B.S. Washington University, St. Louis,
Missouri
Marchionni, Mark, University of Michigan, Ann Arbor
McDonald, John W., B.S., University of Michigan, Ann Arbor
Schmidt, Robert W., M.D., Ph.D., Washington University
School of Medicine, St. Louis, Missouri
Shaw, Marlene V., Ph.D., University of Southern Indiana,
Evansville
Shivers, Brenda D., Ph.D., Tulane University Medical School,
New Orleans, Louisiana
Short, Priscilla M., M.D., Mt. Sinai Medical Center, New York,
New York
Streichenberg, Catherine M., Sc. Nat. Eth, University of
Zurich, Switzerland
Whaley, William, Ph.D., University of Arkansas, Fayetteville
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Molecular Biology of the Nervous System
June 22-July 6
INSTRUCTORS
McKay, Ronald D., Ph.D., Massachusetts Institute of Technology, Cambridge
Zipursky, Larry, Ph.D., University of California, Los Angeles
Reichardt, Louis, Ph.D., University of California, San Francisco
Evans, Ronald M., Ph.D., Salk Institute, San Diego, California
This lecture course was designed for neuroscientists who wish to understand the
concepts and methods of molecular biology and their application to problems in
neuroscience. The participants were drawn from a wide range of backgrounds.
The methods of recombinant DNA technology were introduced in a series of
lectures. These were followed by lectures from visiting faculty. The lectures
covered a variety of topics to give an overview of the molecular mechanisms
underlying the development and function of the nervous system.
PARTICIPANTS
Abe, Miyako, Ph.D., Dana Farber Cancer Institute, Boston,
Massachusetts
Coleman, Paul D., Ph.D., University of Rochester, New York
Erlander, Mark, M.S., University of California, Los Angeles
Finocchiaro, Gaetano, M.D., Yale University, New Haven,
Connecticut
Fults, Daniel W., M.D., University of North Carolina, Chapel
Hill
Haas, Caro la A., M.S., Max Planck Institute, Martinsried,
Federal Republic of Germany
Jones, Kathryn J., Ph.D., Rockefeller University, New York,
New York
Kushner, Leslie, Ph.D., Albert Einstein School of Medicine,
Bronx, New York
Lad, Rajnikant, M.D., National Institutes of Health, Bethesda,
Maryland
Lendahl, Urban, M.S., Karolinska Institute, Stockholm,
Sweden
Seizinger, Bernd, M.S., Massachusetts General Hospital,
Boston
Soule, Christophe, Ph.D., CNRS, Paris, France
Suzue, Toshihiko, Ph.D., California Institute of Technology,
Pasadena
Walton, Kevin, B.A., Johns Hopkins University, Baltimore,
Maryland
Woodford, Barbara, M.A., University of California, Los
Angeles
Zagotta, William, B.S., Stanford University, California
Zaremba, Sam, Ph.D., Yale University, New Haven,
Connecticut
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SEMINARS
Green, M., Harvard University. RNA processing.
Roeder, R., Rockefeller University. Mechanisms of gene
transcription.
Zipursky, S.L., University of California, Los Angeles, Gene
expression in the developing Drosophila eye.
Rothman, J., Stanford University. Signals controlling the
organization of cells.
Manser, T, Princeton University. The immune system.
Tsein, R., Yale University. Electrophysiology of calcium
channels.
Agnew, W., Yale University. Biochemistry of sodium channels.
Stroud, R., University of California, San Francisco. Structure
of the acetylcholine receptor.
Neurobiology of Drosophila
June 29-July 19
Schwarz, J., Columbia University. Second message systems
and synaptic modulation.
Rutishauser, U., Case Western Reserve University. Cell
adhesion molecules.
Levine, M., Columbia University. Segmentation and homeotic
genes in Drosophila.
Greenberg, M., Harvard Medical School. Oncogenes in the
nervous system.
Bate, M., Cambridge University. Neurogenesis.
Bentley, B., University of California, Berkeley. Cellular
mechanisms of neurite outgrowth.
INSTRUCTORS
Bate, MI, Ph.D., University of Cambridge, England
Jan, Lily, Ph.D., Howard Hughes Medical Institute and University of California, San
Francisco
Jan, Yuh Nung, Ph.D., Howard Hughes Medical Institute and University of California, San
Francisco
ASSISTANT
Schwarz, Tom, Ph.D., Howard Hughes Medical Institute and University of California, San
Francisco
The use of genetics as a tool in addition to physiological, anatomical and
biochemical techniques has opened up questions in neurobiology that are
otherwise difficult to address. Drosophila is an ideal organism for such studies
because of its well-developed classical and molecular genetics. This
laboratory/lecture course provides an introduction to current research in neuronal
function and development in Drosophila. It is intended for researchers at all levels
who may want to use Drosophila as an experimental system for studying
neurobiology.
The course began with a crash course of lectures and laboratory exercises on
Drosophila genetics and other techniques which make Drosophila research
distinctive, such as cytogenetics and DNA transformation. The main emphasis,
however, was on studies of the nervous system.
The course covered basic electrophysiological techniques, as applied to
mutants with altered ion channels or sensory physiology. It also included mutant
analysis of complex behaviors, such as courtship, circadian rhythm, learning and
memory.
In the developmental section, processes of neurogenesis including determina-
tion and pathway formation were examined. The course familiarized students with
various preparations, including the embryonic nervous system, imaginal discs, and
adult nervous system. It also reviewed the different approaches being used in
attempts to unravel the molecular basis of neural development.
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PARTICIPANTS
Bodary, Sarah, Ph.D., University of California, San Francisco
Brand, Michael, M.A., University of Cologne, Federal
Republic of Germany
Ellis, Hilary, Ph.D., University of California, San Diego
Mecklenburg, Kirk, B.S., Ohio State University, Columbus
Provost, Nicole, M., M.S., University of Washington, Seattle
Schejter, Eyal D., B.A., Weisman Institute, Rehovot, Israel
Schneider, Lynne, B.A., Washington University, St. Louis,
Missouri
Stein, David, B.S., Stanford University, California
Weinzierl, Robert, B.S., University of Cambridge, England
Ramos, Ricardo, M.D., Yale University, New Haven,
Connecticut
SEMINARS
Timpe, L., University of California, San Francisco. Introduc-
tion to behavioral mutants.
.
Mutations affecting synaptic transmission.
Ganetzky, B., University of Wisconsin. Drosophila genetics.
Pardue, M.L., Massachusetts Institute of Technology.
Cytogenetics.
Spradling, A., Carnegie Institution of Washington. Hybrid
dysgenesis and p element transformation.
.
Chorion gene amplification.
Quinn, W., Massachusetts Institute of Technology. Learning
mutants.
Fischbach, K.F., Institut fOr Biologie 3. Mutations affecting
the adult central nervous system.
Nusslein-Volhard, C., Max Planck Institut fOr Entwicklungsbio-
logie. Early embryogenesis.
Martinez-Arias, A., MRC Laboratory of Molecular Biology.
Segmentation.
Doe, C., Stanford University. Neurogenesis in embryos.
Campos-Ortega, J., Institut fOr Entwicklungsphysiologie.
Mutations affecting embryonic neurogenesis.
Palka, J., University of Washington. Neurogenesis in imaginal
wing disks.
.
Projection of sensory neurons in adults.
Hall, J., Brandeis University. Mutations affecting sexual
behavior and circadian rhythm.
Ready, D., Princeton University. Neurogenesis in imaginal
eye disks and the sevenless mutation.
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Advanced Techniques in Molecular Cloning
June 29-July 19
INSTRUCTORS
Zoller, Mark, Ph.D., Cold Spring Harbor Laboratory, New York
Brosius, Jurgen, Ph.D., Columbia University, New York
ASSISTANTS
Williamson, Nicky, B.S., Imperial College, London, England
Johnson, Karen, B.S., Cold Spring Harbor Laboratory, New York
This laboratory and lecture course on advanced aspects of molecular cloning was
designed for scientists who are familiar with basic recombinant DNA techniques.
The course consisted of experiments in the construction of cDNA libraries,
screening of libraries with oligonucleotides and antibodies, in vitro mutagenesis of
a cloned gene by oligonucleotide directed mutagenesis, M13 cloning and
sequencing, gene synthesis, preparation of RNA from SP6 vectors, the use of
computers for DNA and protein sequence analysis, and expression of foreign
genes in E. coli.
Guest instructors presented the application of these techniques to the analysis
of cloned genes as well as discussing alternative approaches not covered in the
laboratory section. Knowledge of basic techniques of recombinant DNA was a
prerequisite for admission to the course.
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PARTICIPANTS
Acuto, Oreste, Ph.D., Dana-Farber Cancer Institute, Boston,
Massachusetts
Cesarman, Ethel, M.D., New York University, New York
Cline, Thomas W., Ph.D., Princeton University, New Jersey
Fuqua, Suzanne A., Ph.D., University of Texas Health
Science Center, San Antonio
Georgiou, George, Ph.D., Cornell University, Ithaca, New
York
Hatch, Christopher, L., Ph.D., NCI, National Institutes of
Health, Bethesda, Maryland
Kenyon, Cynthia J., Ph.D., Medical Research Council,
Cambridge, England
Kiss, Tamas, B.S., Hungarian Academy of Science, Szeged,
Hungary
Lotan, liana, Ph.D., Columbia University, New York, New
York
Mansour, Tag, Stanford University, California
O'Connor Daniel, M.D., University of California, San Diego
Raehse, Regina, B.S., Paul Ehrlich Institute, Frankfurt,
Federal Republic of Germany
Server, Alfred C., Ph.D., University of Texas Health Science
Center, Houston
Smith, Chari D., B.A., Brandeis University, Waltham,
Massachusetts
Staneloni, Roberto J., Ph.D., Rockefeller University, New
York, New York
Yadven, Mitchell W., B.S., George Washington University,
Washington, D.C.
SEMINARS
Cone, R., Cold Spring Harbor Laboratory. Immortalization of
epithialium-like cells by Eta.
Gubler, U., Hoffmann-La Roche. Posttranslational processing
of cholecystokinin in pig brain.
Brosius, J., Columbia University. A small brain-specific RNA.
Roberts, R., Cold Spring Harbor Laboratory. The applica-
tions of computers to molecular biology.
Helfman, D., Cold Spring Harbor Laboratory. Isolation of
specific cDNAs by antibody screening.
Henikoff, S., Fred Hutchinson Cancer Center. Peculiar
features of a locus encoding purine pathway activities in
Drosophila.
Wallace, B., City of Hope. Principles of oligonucleotide
hybridization.
Zoller, M., Cold Spring Harbor Laboratory. Strategies for site-
directed mutagenesis.
Cate, R., Biogen. Cellular and molecular biology of Mullerian
inhibiting substance.
Wallner, B., Biogen. Isolation and characterization of two
human phospholipase-A2-inhibiting proteins.
Ulmer, K., University of Maryland. Protein engineering.
Studier, W., Brookhaven National Laboratory. Expression of
protein T7 vectors.
Schatzman, A., Smith Kline and Beckman. Expression of
foreign proteins in E. coli.
Urdea, M., Chiron Corporation. Strategies in gene synthesis.
Smith, M., University of British Columbia. Use of
oligonucleotides as primers and probes.
Molecular and Developmental Biology of Plants
June 29-July 19
INSTRUCTORS
Horsch, Robert, Ph.D., Monsanto Corp., St. Louis, Missouri
Messing, Joachim, Ph.D., Waksman Institute, Rutgers University, Piscataway, New Jersey
Sussex, Ian, Ph.D., Yale University, New Haven, Connecticut
ASSISTANTS
Chereskin, Barbara, Ph.D., Waksman Institute, Rutgers University, Piscataway, New Jersey
Kurihara, Julie, B.S., Waksman Institute, Rutgers University, Piscataway, New Jersey
Kirk, Nancy, B.S., Yale University, New Haven, Connecticut
Smith, Alan, Ph.D., Monsanto Corp., St. Louis, Missouri
This course provided an intensive overview of current topics and techniques
in
plant biology, with emphasis on molecular and developmental
biology and
genetics. It was designed for scientists with working knowledge
of molecular
techniques who are either working with plant systems or wish to.
The course
consisted of a rigorous lecture series, a hands-on laboratory,
and informal
discussions, not to mention a wonderful picnic. 18 different guest
speakers
provided both an in-depth discussion of their work and an
overview of their
specialty as well as informal discussions after their seminars.
The laboratory
covered established and novel techniques in plant biology,
including plant
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structure and development, nucleic acid manipulations, gene transfer techniques,
tissue and cell culture techniques, photosynthesis, and genetics and cytogenetics
of maize.
PARTICIPANTS
Anthony, Janice L., M.S., Texas A & M University, College
Station
Arias, Jonathan A., M.S., University of Colorado, Boulder
Bagg, Ann, B.S., University of California, Berkeley
Baumann, Goetz, B.S., University of Bielfeld, Federal
Republic of Germany
Beeching, Jon, Ph.D., University of Bath, England
Breitenberger, Caroline A., Ph.D., Massachusetts Institute of
Technology, Cambridge
Destefano, Luis Julio, M.S., Louisiana State University, Baton
Rouge
Fouser, Lynette, A., Ph.D., University of Toronto, Canada
Gal, Susannah, B.A., National Institutes of Health, Bethesda,
Maryland
Hatzios, Kriton K., Ph.D., Virginia Polytechnic Institute,
Blacksburg
Jen, George C., Ph.D., Massachusetts Institute of Technol-
ogy, Cambridge
Rodaway, Shirley J., Ph.D., American Cyanamid Co.,
Princeton, New Jersey
Sheahan, John J., B.S., University of Wisconsin, Madison
Signer, Ethan R., Ph.D., Massachusetts Institute of Technol-
ogy, Cambridge
Stuitje, Antoine, Ph.D., Free University, Amsterdam, The
Netherlands
SEMINARS
Alberscheim, P., University of Georgia. Oligosaccharides in
cell-to-cell interactions.
Burr, B., Brookhaven National Laboratory. The use of RFLP
in mapping plant genes.
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Nasrallah, J., Cornell University. Molecular biology of self-
incompatibility.
Sommerville, C., Michigan State University. Genetic
manipulation of the Arabidopsis genome.
Lamb, C., Salk Institute. Cellular responses to stress.
Quail, F, University of Wisconsin. Phytochrome-induced
genes.
Crouch, M., Indiana University. Seed development.
Beachy, R., Washington University. Soybean storage protein
genes.
. TMV resistance in transgenic plants.
Hall, T., Texas A & M. Molecular functions of plant RNA
viruses.
Staskowizc, B., University of California. Molecular
approaches to pathogenesis.
Dellaporta, S., Yale University. Transposable elements in
maize.
Goodman, H., Massachusetts General Hospital. Gene
amplification in plants.
Gronenborn, B., Max-Planck Institute. Wheat dwarf virus
replication.
Palmer, J., University of Michigan. The organization of plant
mitochondrial DNA.
Hanson, M., Cornell University. Organelle genetics.
Bogorad, L., Harvard University. Chloroplast structure and
function.
Theologis, A., Washington University. Hormone-regulated
genes.
Developmental Neurobiology
July 16-July 28
INSTRUCTORS
Patterson, Paul, Ph.D., California Institute of Technology, Pasadena
Goodman, Corey, Ph.D., Stanford University, California
The aim of this lecture course was to review established principles and recent
advances in developmental neurobiology. Major topics considered were: prolifera-
tion, migration, and aggregation of nerve cells; factors influencing the differentia-
tion of neurons; trophic interactions in neural development; cell adhesion and cell
recognition; genetic programs for development; the guidance of axons to targets;
and the formation of synaptic connections. Particular emphasis was given to
synapse formation and to mechanisms underlying the specificity of this process.
Finally, the operation of developmental principles was examined in the context of
the mammalian visual system and in the development of learning and behavior.
PARTICIPANTS
Brugg, Bernard, M.S., Friedrich Miescher Institute, Basel,
Switzerland
Carpenter, Ellen M., B.A., University of Chicago, Illinois
Cepko, Constance, Ph.D., Harvard Medical School, Boston,
Massachusetts
Ernsberger, Uwe, B.S., Max-Planck Institute, Martinsried,
Federal Republic of Germany
French-Constant, Charles, M.A., University College London,
England
Garcia Alonso, Luis A., M.S. University Autonoma, Madrid,
Spain
Hashimoto, Yasuhiro, M.D., University of Pennsylvania,
Philadelphia
Hen, Rene, Ph.D., Columbia University. New York, New York
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Jay, Daniel, Ph.D., Harvard Medical School, Boston,
Massachusetts
Lim, Tit, B.S., Cambridge University, England
Mahanthappa, Negesh, B.A., California Institute of Technol-
ogy, Pasadena
Minth, Carolyn, Ph.D., Purdue University, Lafayette,
Indiana
Nicolas, Jean-Francois, Ph.D., Institut Pasteur, Paris,
France
Nybroe, Ole, Ph.D., University of Copenhagen, Denmark
Petursdottir, Gudrun, M.A., University of Oslo, Norway
Rydel, Russell, M.S., New York University, New York
Sharpe, Arlene, Ph.D., Whitehead Institute, Cambridge,
Massachusetts
Thomas, Steven, B.A., University of Michigan, Ann Arbor
Tiemeyer, Michael, B.A., Johns Hopkins University,
Baltimore, Maryland
Wayne, Denise, B.A., University of Florida, Gainesville
Zak, Naomi, Ph.D., Weizmann Institute, Rehovot, Israel
Zuniga, Martha Celilia, Ph.D., University of Texas, Austin
SEMINARS
Spitzer, N., University of California, San Diego. Early
vertebrate neural development.
Rakic, F, Yale University. Cell proliferation and migration
during neuronal development.
Hortiz, R., Massachusetts Institute of Technology. Neuronal
development in the nematode.
Bray, D., Medical Research Council. Mechanisms of growth
cone extension.
Landmesser, L., University of Connecticut. Axon guidance in
vertebrates.
Sanes, J., Washington University. Synapse formation.
Purves, D., Washington University. Neural specificity and
synapse rearrangement in the PNS.
Fraser, S., University of California, Irvine. Neural specificity in
the retinotactal system.
Bonhoeffer, F., Max-Plank Institute, Tubingen. Specificity of
retinal growth cones in vivo and in vitro.
Rutishauser, U., Case Western Reserve. Cell adhesion
molecules.
Jessell, T., Columbia University. Cell recognition during
sensory neuron development.
Shatz, C., Stanford University. Development of the
mammalian visual system.
Abrams, R., Columbia University. Mechanisms of learning in
Aplysia and hippocampus.
Nottebohm, F, Rockefeller University. Plasticity, learning, and
neurogenesis in song birds.
Immunoglobulins: Molecular Probes of the Nervous System
July 21-August 10
INSTRUCTORS
Silberstein, Laura, Ph.D., Stanford University, California
Evans, Christopher, Ph.D., Stanford University, California
Hockfield, Susan, Ph.D., Yale University, New Haven, Connecticut
ASSISTANT
Tre loar, Allison, Yale University, New Haven, Connecticut
Over the last decade antibodies have become powerful and popular reagents in
neurobiological research. This course, intended for research scientists of all levels,
was designed to provide an advanced understanding of the power and limitations
of immunoglobulins both as biochemical and anatomical reagents. Through
laboratory work and lectures we will explore immunochemical and
immunohistochemical techniques in detail, and the application of these techniques
to current issues in neurobiology.
The laboratory work will include: generation of monoclonal antibodies; prepara-
tion and characterization of antibodies to synthetic peptides and to complex
antigens; solid phase immunoassays; antibody characterization and purification;
antigen purification using antibody affinity methods; Western blotting; antibody
conjugation; biochemical characterization of neuropeptides using RIA and HPLC;
and light and electron microscopic immunohistochemistry.
A series of lectures by invited speakers will cover: structure and function of
immunoglobulins; molecular and cellular immunology; hybridoma technology;
studies using synthetic peptides; immunological characterization of the acetylcho-
line receptor; and immunological characterization of neuronal diversity.
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PARTICIPANTS
Bicker, Gerd G., Ph.D., Free University, Berlin, Federal
Republic of Germany
DeAzeredo, Fernando, Ph.D., Federal Fluminense University,
Brazil
Keshishian, Haig, Ph.D., Yale University, New Haven,
Connecticut
Levi, Andrea, Ph.D., National Institutes of Health, Bethesda,
Maryland
Lowenstein, Pedro R., Ph.D., Johns Hopkins University,
Baltimore, Maryland
Martin, Kathleen, B.A., Yale University, New Haven,
Connecticut
Paterson, Jean, Ph.D., University of Manitoba, Canada
Rice, Margaret E., Ph.D., New York University Medical
Center, New York
Smyth, Joan, B.A., Trinity College, Dublin, Ireland
SEMINARS
Steiner, L., Massachusetts Institute of Technology.
Immunoglobulins.
. Immunoglobulin superfamily.
Woodland, B., University of Massachusetts Medical Center.
Cellular immunology-Introduction.
. Cellular immunology-Conclusion.
Padlan, E., National Institutes of Health. Three-dimensional
structure of immunoglobulin.
Dwyer, D., University of Alabama. Regulation of the immune
response by anti-idiotypes.
Janeway, C., Yale University School of Medicine. Role of T
cells in the generation and regulation antibody
responses.
Lymphocytic receptor repertoires: Genetic origin and
selective influences on expression.
Alt, F., Columbia University College of Physicians &
Surgeons. Development of the immunoglobulin heavy-
chain variable region genes repertoire.
Lindstrom, J., Salk Institute. Probing acetylcholine receptor
with monoclonal antibodies.
Levitt, P, Medical College of Pennsylvania. Antibodies reveal
partitions and boundaries in CNS development.
Barald, K., University of Michigan Medical School. No-flow
cytometer isolation of neural crest subpopulations with
monoclonal antibodies.
Scharff, M., Albert Einstein College of Medicine. Tailormaking
monoclonal antibodies: Modifications of the technology
and the generation of mutant antibodies.
Carlson, S., University of Washington. TAP-1, a nerve terminal
anchorage protein from electric organ.
Van Den Pol, A., Yale University School of Medicine. Use
and interpretation of ultrastructure immunocytochemistry.
Hockfield, S., Yale University. A monoclonal antibody that
demonstrates organization and development of
mammalian central visual area.
Evans, C., Stanford Medical School. Antibodies as probes for
neuroactive peptides.
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Molecular Cloning of Eukaryotic Genes
July 21-August 10
INSTRUCTORS
Bothwell, Al, Ph.D., Yale School of Medicine, New Haven, Connecticut
Alt, Fred, Ph.D., Columbia University, New York, New York
Lehrach, Han, Ph.D., European Molecular Biology Laboratory, Heidelberg, Federal Republic
of Germany
ASSISTANTS
LeClair, Ken, B.A., Yale University, New Haven, Connecticut
Lutzker, Stuart, B.A., Columbia University, New York, New York
Craig, Alister, Ph.D., European Molecular Biology Laboratory, Heidelberg, Federal Republic
of Germany
This laboratory and lecture course covered the principles of recombinant DNA
technology and the application of these procedures to the study of eukaryotic
genes. The isolation and characterization of lymphocyte specific genes were
emphasized. Among the topics covered were: construction of cDNA libraries in
plasmid or bacteriophage vectors, construction of bacteriophage X, and cosmid
libraries of high-molecular-weight eukaryotic DNA, screening DNA libraries with
gene-specific hybridization probes and by recombination, purification and
characterization of recombinant clones using restriction endonuclease and blot
hybridization analyses, and reintroduction and expression of cloned genes in
heterologous systems. Strategies for isolating genes that encode rare mRNA
sequences will be discussed. Guest lecturers discussed the application of
molecular cloning procedures to the study of specific eukaryotic gene systems.
PARTICIPANTS
Adeyemo, Oyewole, Ph.D., University of Ibadan, Nigeria
Braciale, Thomas, Ph.D., Washington University, St. Louis,
Missouri
Burridge, Keith, Ph.D., University of North Carolina, Chapel
Hill
Conrad, Patricia Ann, Ph.D., International Laboratory for
Research on Animal Diseases, Nairobi, Kenya
Ekblom, Peter, Ph.D., Max-Planck Institut, Tubingen, Federal
Republic of Germany
Fu, Xiao Chang, Ph.D., Sichuan Cancer Institute, Chengdu,
People's Republic of China
Goldberg, Alfred, Ph.D., Harvard Medical School,
Cambridge, Massachusetts
Good, Michael, Ph.D., National Institutes of Health,
Bethesda, Maryland
Kondor-Koch, Claudia, Ph.D., University of Frankfurt, Federal
Republic of Germany
Maher, Pamela, Ph.D., University of California, San Diego
Merisko, Elaine, Ph.D., University of Kansas Medical Center,
Kansas City
O'Donnell, Paul, Ph.D., Memorial Sloan Kettering Cancer
Center, New York
Podolsky, Daniel, M.D., Massachusetts General Hospital,
Boston
Rock, Kenneth, M.D., Harvard Medical School, Boston,
Massachusetts
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Saling, Patricia, Ph.D., Duke University, Durham, North
Carolina
Smith, Helene, Ph.D., Peralta Cancer Research Institute,
Oakland, California
SEMINARS
Hood, L., California Institute of Technology. Structure and
function of antigen receptor genes.
. Biotechnology
McKnight, S., Fred Hutchinson Cancer Center. Regulation of
transcription.
Mulligan, R., Whitehead Institute. Use of retrovirus vectors to
analyze hematopoietic differentiation.
Sen, R., Whitehead Institute. DNA sequences involved in
tissue-specific expression in lymphocytes.
Costantini, F, Columbia University. Gene regulation in
transgenic mice.
Goff, S., Columbia University. Definition of retrovirus genes
by in vitro mutagenesis.
Gluzman, Y., Cold Spring Harbor Laboratory. Eukaryotic
cloning vectors.
Kellems, R., Baylor University. Isolation and characterization
of the adenosine deaminase gene and gene therapy.
Hanahan, D., Cold Spring Harbor Laboratory. Oncogenesis
and transgenic mice.
LeClair, K., Yale University. Molecular cloning of the murine
Ly6 T-cell differentiation antigen.
Mutational analysis of the Ig heavy-chain promoter.
Development of a T-cell-dependent and T-cell-
independent immune response.
Lee, F:, DNAX Corporation. Molecular characterization of
hematopoietic growth factors.
Schimke, R., Stanford University. On the generation of gene
amplification and other chromosomal rearrangements. I.
On the generation of gene amplification and other
chromosomal rearrangements. II
Yeast Genetics
Murray, N., University of Edinburgh. Lambda cloning
vectors.
Snyder, M., Yale University. Use of A,gt11 to clone and study
yeast gene products.
Wig ler, M., Cold Spring Harbor Laboratory. Structure and
function of cellular oncogenes.
Kaufman, R., Genetics Institute. Molecular genetics of factor
VIII.
Tucker, P, University of Texas Southwestern Medical School.
Regulation of Ig gene assembly and isotype expression.
July 21-August 10
INSTRUCTORS
Sherman, Fred, Ph.D., University of Rochester, New York
Fink, Gerald, Ph.D., Massachusetts Institute of Technology, Cambridge
Hicks, James, Ph.D., Scripps Clinic and Research Foundation, La Jolla, California
ASSISTANTS
Bulgaz, Elena, Ph.D., Scripps Clinic and Research Foundation, La Jolla,
California
Dietrich, Fred, B.A., Whitehead Institute, Cambridge, Massachusetts
The major laboratory techniques used in the genetic analysis of yeast were
studied, including the isolation and characterization of
chromosomal and
mitochondria! mutants, tetrad analysis, chromosomal mapping,
mitotic recombina-
tion, and test of allelism and complementation.
Micromanipulation used in tetrad
analysis was carried out by all students. Recombinant DNA
techniques, including
yeast transformation, filter hybridization, and gel electrophoresis
were applied to
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cloning and genetic analysis of yeast DNA. Lectures on fundamental aspects of
yeast genetics were presented along with seminars given by outside speakers on
topics of current interest.
PARTICIPANTS
Barnes, Larry, D., Ph.D., University of Texas Health Science
Center, San Antonio
Benton, Bret, State University of New York, Stony Brook
Bretscher, Anthony, Ph.D., Cornell University, Ithaca, New
York
Brown, Julie A., B.S., University of Virginia, Charlottesville
Cunningham, Kyle, B.A., University of California, Los
Angeles
Gross, David S., Ph.D., Louisiana State University, Shreveport
Norwich, Arthur L., M.D., Yale University, New Haven,
Connecticut
Jansen, Kathrin, Ph.D., Cornell University, Ithaca, New York
Kline, Connie J., B.S., Yale University, New Haven,
Connecticut
Kwon-Chung, K.J., Ph.D., National Institutes of Health,
Bethesda, Maryland
Maguire, Michael E., Ph.D., Case Western Reserve
University, Cleveland, Ohio
Skalka, Anna, Ph.D., Roche Institute, Nutley, New Jersey
Smith, John A., Ph.D., Massachusetts General Hospital,
Boston
Thomason, Lynn C., B.S., University of Oregon, Eugene
Toyn, Jeremy J., B.S., EMBL, Heidelberg, Federal Republic
of Germany
Yarbough, Patrice 0., Ph.D., University of Texas Health
Science Center, Dallas
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SEMINARS
Wig ler, M., Cold Spring Harbor Laboratory. Growth
regulation in yeast.
Broach, J., Princeton University. Mechanisms of plasmid
propagation in yeast.
Zoller, M., Cold Spring Harbor Laboratory. Expression on
yeast cAMP-dependent protein kinase in E. coli.
Carlson, M., Columbia University. Glucose repression
controlled by a protein kinase.
Guarente, L., Massachusetts Institute of Technology.
Regulation of the yeast cycl gene.
Klar, A., Cold Spring Harbor Laboratory. Developmental
switches of mating type in fission yeast.
Tye, B.-K., Cornell University. DNA replication in yeast.
Guthrie, C., University of California, San Francisco. RNA
processing and snRNAs in yeast.
Mason, T., University of Massachusetts. Mitochondrial and
cytoplasmic histidine tRNA synthetase.
Sternglanz, R., State University of New York, Stony Brook.
Yeast DNA topoisomerases.
Warner, J., Albert Einstein College of Medicine. Ribosomal
genes and their regulation.
Petes, T., University of Chicago. Structural and functional
flexibility of the yeast genome.
Prakash, L., University of Rochester. Structure and function
of yeast DNA repair genes.
Douglas, M., University of Texas, Dallas. Genetic anal;sis of
protein localization in mitochondria.
Tzagoloff, A., Columbia University. Genetics of mitochondrial
biogenesis.
Computational Neuroscience
July 31-August 11
INSTRUCTORS
Atkeson, Christopher, Ph.D., Massachusetts Institute of Technology, Cambridge
Bizzi, Emilio, M.D., Massachusetts Institute of Technology, Cambridge
ASSISTANT
McIntyre, Joe, Massachusetts Institute of Technology, Cambridge
This intensive lecture/laboratory course examined computational approaches in
motor control, with the theme that understanding of the computational problems,
the constraints on solutions to these problems, and the range of possible solutions
can help guide research in neuroscience.
The most prominent successes of information processing approaches have
come in areas where strong inputs from neurobiological, behavioral, and computa-
tional approaches interact. The goals of this course were to expose students to
areas where interdisciplinary approaches have been important, and to help
students integrate computational approaches into their own research. The course
included a computer based laboratory so that students can actively explore
computational issues, as well as interact with prominent research workers in the
field.
The course focused on computational approaches to the study of motor
control, and their interactions with motor control neuroscience. Examples were
taken from single- and multi-articular arm movements; body posture and
locomotion; hand control; oculomotor control; and "simpler" nervous systems.
Areas addressed were movement planning, kinematics, dynamics, control,
actuation and sensing.
PARTICIPANTS
Arista, Francesco, B.S., University of Louivain, Belgium
Belczynski, Carl, B.S., University of Michigan, Ann Arbor
Bootsma, Reinoud, Ph.D., Free University, Amsterdam, The
Netherlands
Drucker, Steven, B.S., Brown University, Providence, Rhode
Island
Faye, Ian, B.S., Massachusetts Institute of Technology,
Cambridge
Flanagan, John R., M.A., McGill University, Montreal,
Canada
Hartman, Leo, B.S., University of Rochester, New York
Jaeger, Robert J., Ph.D., Chicago Institue of Technology,
Illinois
Lou, Jau-Shin, M.D., Barrow Neurological Institute, Phoenix,
Arizona
MacFarland, Jenny L., B.S., University of Washington, Seattle
Miller, Crispin, B.S., Massachusetts Institute of Technology,
Cambridge
Moody, Charles James, Ph.D., Southern Illinois University
Medical School, Springfield
Otten, Egbert, Ph.D., University of Groninger, The
Netherlands
Pelisson, Denis, M.S., INSERM, Paris, France
Sachdev, Robert, B.S., University of Michigan, Ann Arbor
Schwarz, Urs, M.S., University Hospital, Zurich, Switzerland
Wang, Hongbin, B.S., University of Minnesota, St Paul
Weir, Donald, B.A., University of Oxford, England
Weytjens, Jan, M.D., University of Groningen, The
Netherlands
Wylie, Richard M., Ph.D., Walter Reed Army Institute,
Washington, D.C.
SEMINARS
Hollerbach, J., Massachusetts Institute of Technology.
Multijoint kinematics: Human results.
Kalaska, J., University of Montreal. Neural representations for
motor control.
Hogan, N., Massachusetts Institute of Technology. Using
optical control theory to model behavior.
.
Minimum jerk movements.
Mussa- Ivaldi, F., Massachusetts Institute of Technology.
Multijoint arm studies.
Humphrey, D., Emory University School of Medicine. Central
control of voluntary arm and hand movements.
Hinton, G., Carnegie Mellon University. Connectionist
approaches to motor control.
Getting, P., University of Iowa. Neural network reconstruc-
tion: Mechanisms for motor pattern generation.
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Abbs, J., University of Wisconsin. Temporal and spatial
coordination of multiarticulate movements: Potential
neural mechanisms.
Hollerbach, J., Massachusetts Institute of Technology. Tactile
sensing and hand control.
Robert, M., Carnegie Mellon University. The dynamics of
running in robots.
Loeb, G., National Institutes of Health. Models of the cat
hindlimb.
Ghez, C., Columbia University. Motor psychophysics.
Lisberger, S., University of California, San Francisco. Visual
motion processing and sensory-motor integration for
smooth pursuit eye movements.
Optican, L., National Institutes of Health. Adaptive control of
saccadic eye movements.
Sparks, D., University of Alabama. The role of the superior
colliculus and other brainstem areas in the control of
saccadic eye movements.
Seminars
Cold Spring Harbor Seminars were initiated to provide a semiformal avenue for
communication between the various research groups at the Laboratory. They are
particularly useful for research personnel who have joined the Laboratory during
the summer. The seminars also afford a necessary opportunity for the graduate
students and postgraduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed below, seminars were
given by many others involved in research at this Laboratory.
1985-1986
September
Jacek Skowronski, NCI, National Institutes of Health,
Bethesda, Maryland: Long interspersed repeated
sequences in mammals searching for function.
H. Robert Guy, NCI, National Institutes of Health, Bethesda,
Maryland: Approaches to predicting membrane channel
protein structure from their sequences.
John Anderson, Harvard University, Cambridge,
Massachusetts: The structure of a phage repressor-
operator complex.
Tom Poulos, Genex Corporation, Rockville, Maryland: Haem
enzyme structure and function.
October
Luis Parada, The Whitehead Institute, Cambridge,
Massachusetts: Oncogene effects on primary rodent
cells.
Walter Schaffner, University of Zurich, Switzerland:
Enhancers and tissue specificity of transcription.
November
Arthur Horwich, Yale University School of Medicine, New
Haven, Connecticut: Genetic analysis of a mitochondrial
targeting sequence.
Steve Mayfield, University of Geneva, Switzerland:
Chlamydomonas transformation vectors.
James W. Pflugrath, Max-Planck Institute, Martinsried,
Federal Republic of Germany.: Amylase inhibitor-X-ray
structure and modeling studies.
Kenneth Marians, Memorial Sloan-Kettering Cancer Center,
New York, New York: The role of topoisomerase I in
pBR322 DNA replication in vitro.
Frank McCormick, Cetus Corporation, Emeryville, California:
New aspects of ras structure and function.
Robert Simpson, Arko Plant Research Center, Dublin,
California: Multiple uses of agrobacteria to alter plant
phenotypes.
Hsin Ming Yang, Oncogene Science, Seattle, Washington:
Characterization and biosynthesis of a human melanoma
associated proteoglycan.
James Manley, Columbia University, New York, New York:
Processing of animal cell mRNA.
Richard Garber, University of Washington, Seattle: Molecular
functions and misfunctions of the Drosophila homeotic
gene Antennapedia.
December
Rodrigo Bravo, European Molecular Biology Laboratory,
Heidelberg, Federal Republic of Germany: Early genes
induced by growth factors in quiescent cells.
Ueli Aebi, Johns Hopkins University, Baltimore, Maryland:
Study of protein structure and protein-protein interactions
by high-resolution electron microscopy and digital
imaging processing.
Michele Sawadogo, Rockefeller University, New York, New
York: DNA binding specificity of USF: A human gene-
specific transcription factor required for maximum
expression of the adenovirus major late promoter.
Steve Whitehead, Harvard Medical School, Cambridge
Massachusetts: Molecular biology of the human acute
phase reactant C-reactive protein.
January
Don Cleveland, Johns Hopkins University, Baltimore,
Maryland: Tubulin gene expression-Regulation at two
levels.
Martha Mutchler, Cornell University, Ithaca, New York: Two
experimental systems in tomato.
Chris Norbury, Imperial Cancer Research Fund, London,
England: Cellular sequences that influence 3' processing
of viral mRNA in polyoma-transformed cell lines.
David Frendewey, Institute of Cell and Tumor Biology,
Heidelberg, Federal Republic of Germany: Assembly of a
pre-mRNA splicing complex and mechanistic
complications.
Ray Geste land, University of Utah, Salt Lake City: Ribosomal
frameshifting.
Ron Evans, Salk Institute, San Diego, California: The
structure and expression of the glucocorticoid receptor.
February
Richard Morimoto, Northwestern University, Chicago, Illinois:
Multiple regulatory controls for human HSP70 expression.
Yasuji Oshima, Osaka University, Japan: Regulatory circuit
for phosphatase synthesis in Saccharomyces.
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March
Keith Burridge, University of North Carolina, Chap le Hill:
Transmembrane linkage between the extracellular matrix
and actin cytoskeleton.
Venketesan Sundaressen, University of California, Berkeley:
The molecular genetics of Robertson's mutator-A maize
transposable element.
Claire Morre, Massachusetts Institute of Technology,
Cambridge: In vitro cleavage and polyadenylation of
eukaryotic mRNA.
James Lees-Miller, University of Alberta, Canada: Purification
and characterization of two novel proteins from smooth
muscle.
Jonathan Jones, Advanced Genetic Sciences, Inc., Oakland,
California: Maximizing the expression of a bacterial
chitinase gene in plant cells.
Giuseppe Gavizzi, University of Milan, Italy: Genetics of
Sn-A tissue-specific, light-sensitive genetic element in
maize.
Tom O'Halloran, Massachusetts Institute of Technology,
Cambridge: Overproduction, purification, and character-
ization of the MerR metallo-regulatory protein.
Ken Lipson, Memorial Sloan-Kettering Cancer Center, New
York, New York: Regulation of the insulin receptor.
April
Craig Rosen, Dana-Farber Cancer Center, Boston,
Massachusetts: Regulation of HTLV-I and HTLV -II gene
expression.
Ed Stavnezer, University of Cincinnati Medical Center, Ohio:
Products and activities of the v-ski oncogene.
Kenneth Ferguson, University of Texas, Dallas: Guanine
nucleotide binding to G proteins.
R. Bertolotti, CNRS, Gif- sur- Yvette, France: Normal and
neoplastic differentiation-Programming genes, gene
dosage, and shuttle vectors.
Bernardo Nadal-Ginard, Harvard University, Cambridge,
Massachusetts: Promoter selection and alternative RNA
splicing-Mechanisms used to generate contractile
protein diversity.
Nouria Hernandez, Yale University, New Haven, Connecticut:
Are small snRNA genes transcribed by a specialized
RNA polymerase?
May
Jim Roberts, Fred Hutchinson Cancer Center, Seattle,
Washington: Negative control of DNA replication in the
composite SV40-BPV plasmid.
Wilson H. Burgess, Meloy Laboratories, Gaithersburg,
Maryland: Structural evidence that 13-endothelial cell
growth factor is the precursor of a-ECGF and acidic-FGF.
Heidi Ernst, University of California, Davis: Cloning and
characterization of sequences encoding the a subunit of
translational initiation factor 01F-2.
David Foster, Rockefeller University, New York, New York:
The transformation potential of the fps gene of Fujinami
sarcoma virus and its cellular progenitor.
Jeremy Paul, Massachusetts Institute of Technology,
Cambridge: Structure-function analysis of fibronectin.
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Clark Tibbetts, Vanderbilt University, Nashville, Tennessee: A
functional domain and target for adenovirus E1A
autorepression.
Michael Gilman, Whitehead Institute, Cambridge,
Massachusetts: Intracellular mediators of c-fos induction.
June
Masafumi Tanaka, Jackson Laboratories, Bar Harbor, Maine:
A cellular enhancer element which is active in embryonal
carcinoma (EC) cells.
David Shore, Medical Research Council, London, England:
Characterization and isolation of proteins involved in
control of the silent yeast mating-type genes.
Mike Fried, Imperial Cancer Research Foundation, London,
England: The use of "expression selection" in the study of
gene regulation in mammalian cells.
Franz Thiebaut, Laboratoire d'histologie du Cerchar, Verneuil-
en-Halatte, France: Use of backscattered electron
imaging for studying nuclear or nucleolar structure.
July
Moshe Oren, Weizmann Institute, Rehovot, Israel: Properties
of p53 oncogenes.
August
Elizabeth Gateff, Johannes Gutenburg Universitat, Mainz,
Federal Republic of Germany: Recessive oncogenes of
D. melanogaster.
September
Dennis Carroll, University of Massachusetts, Amherst: Signal
transduction and the regulation of membrane-
cytoskeleton associations of the human erythrocyte.
Benny Shilo, Weizmann Institute, Rehovot, Israel: The
Drosophila EGF receptor.
Susan P. Williams, University of Alberta, Canada: Structural
and functional analysis of phosphoproteins.
Susan Lobo, Florida State University, Tallahassee: Expression
of mouse U1B genes in vivo and in vitro.
Bruce Futcher, McMaster University, Hamilton, Canada:
Recombinational amplification of 2-micron plasmid of
yeast.
Carol W. Greider, University of California, Berkeley: Telomere
elongation in vitro.
October
Leslie Goodwin, New York University, New York: Isolation
and characterization of a cell resembling prothymocytes.
Emily Wilson, Emory University, Atlanta, Georgia: Role of
protein kinase C in neutrophil activation-Studies utilizing
sphingold long-chain bases as inhibitors.
William Hanratty, University of Pittsburgh, Pennsylvania:
Conditional mutants of Drosophila oncogenes.
November
Paul Walton, University of Pennsylvania, Philadelphia:
Trans location of the Mr-dependent phosphadidate
phosphohydrolase between the cytosol and endoplasmic
reticulum as a method of enzymic control.
Thomas Peterson, CSIRO, Canberra, Australia: Exploring the
maize P locus-A molecular and genetic analysis.
Bob Kingston, Massachusetts General Hospital, Boston:
Regulation of human HSP70 transcription by heat and by
oncogenes.
Gordon Foulkes, National Institute for Medical Research,
London, England: Extracellular and intranuclear events in
Albelson-transformed cells.
Robert Rjian, University of California, Berkeley: Interplay of
multiple sequence-specific transcription factors at
enhancers and promoters.
David Knipe, Harvard Medical School, Boston,
Massachusetts: Herpes simplex virus nuclear proteins
and the regulation of viral gene expression.
December
Hiroto Okayama, National Institutes of Health, Bethesda,
Maryland: A cDNA expression cloning system.
Adolf Graessmann, University of Berlin, Federal Republic of
Germany: DNA methylation, chromatin structure, and
regulation of gene expression.
Pam Silver, Princeton University, New Jersey: Nuclear protein
localization in yeast.
Peter Ruvolo, Albert Einstein College of Medicine, Bronx,
New York: Single-stranded DNA-binding proteins from
conjugative plasmids in E. coli.
Robert H. Singer, University of Massachusetts, Amherst: In
situ hybridization-Analysis of the intracellular localization
of mRNAs for cytoskeleton proteins.
Mark Diamond, University of Buffalo, New York: Synthesis
and turnover of a rat hepatocyte canaliculus glycoprotein.
Art Bruskin, University of California, San Francisco: Transfor-
mation of mammalian cells by retroviruses containing erb
or myc.

Undergraduate Research
An important aspect of the summer program at the Laboratory is the participation
of college undergraduate students in active research projects under the supervi-
sion of full-time laboratory staff members. The program was initiated in 1959. Since
that year, 290 students have completed the course, and many have gone on to
creative careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the
fundamental principles of biology, (2) an increased awareness of major problem
areas under investigation, (3) better understanding of the physical and intellectual
tools for modern research and the pertinence of this information to future training,
and (4) a personal acquaintance with research, research workers, and centers for
study.
The following students, selected from a large number of applicants, took part in
the program, which was supported by Alfred P. Sloan Foundation, Burroughs
Wellcome Fund, American Cyanamid Company, Robertson Research Fund, and
Pfizer Inc.
Peter Argani, Princeton University
Research Advisor: Yakov Gluzman
Origin-specific binding of SV40 large T antigen.
Sean Burgess, University of Colorado
Research Advisor: Winship Herr
Late transcription in SV40.
Nina Cap lin, Duke University
Research Advisor: William Welch
Purification of the major mammalian glucose-regulated
proteins.
Mark Eisner, Stanford University
Research Advisor: Scott Powers
Localization and characterization of supC: A suppressor of
the heat-shock sensitivity phenotype induced by the
Ras2va1l9 mutation in yeast.
Irene Griff, Massachusetts Institute of Technology
Research Advisor: Fevzi Daldal
Isolation and identification of stigmatellin-resistant mutations
in the Pet operon in R. capsulata.
Martin Horvath, Brown University
Research Advisor: Bruce Stillman
Characterizing the ABF1 binding site of ARS1 in vivo.
Brad Johnson, Yale University
Research Advisors: Ashok Bhagwat and Richard Roberts
Sequencing of EcoRII endonuclease gene.
Ethel Johnson, Vanderbilt University
Research Advisor: David Helfman
Sequence determination and analysis of introns in rat
embryonic fibroblast tropomyosin 1.
317
Abhijeet Le le, Jesus College, Cambridge
Research Advisor: Edward Harlow
Identification of cellular mediators of E1A action by random
mutagenesis of E1A-transformed cells.
William Moomaw, State University of New York, Albany
Research Advisor: Stephen Dellaporta
Identification of Ac2 elements in the DNA of maize stocks
showing responder element activity.
Nicholas Morrissey, University of Rochester
Research Advisor: Andrew Rice
Characteristics of double-stranded RNA required for the
activation of the protein kinase, DAI.
Roya Namvar, New York University
Research Advisor: Douglas Youvan
Oligonucleotide-directed site-specific mutagenesis of the
light-harvesting I antenna genes of Rhodobacter
capsu/ata.
Scott Panzer, Harvard University
Research Advisor: Douglas Hanahan
Expresson patterns of papilloma viruses in transgenic mice.
Henry Stapp, Hampshire College
Research Advisor: Pablo Scolnik
Study of in vitro carotenoid biosynthesis and in vitro
assembly of functional light-harvesting II complex with
Rhodobacter capsu/ata.
Wendy Weiher, University of Pennsylvania
Research Advisor: Roger Cone
Efficiency of oncogene transfection into E1A immortalized rat
cells.
DNA Literacy Program
Since the explosion of information made possible by the invention of the printing
press, a democracy has needed to be a society of literates. Similarly, the growing
importance of molecular biology demands a society of DNA literates. Unfortu-
nately, DNA science is advancing so fast that the gap between biotechnological
progress and public understanding widens every day.
The overreaching goal of Cold Spring Harbor Laboratory's DNA Literacy
Program is to close this biotechnology understanding gap. Our primary target
audiences are secondary and freshman college instructors who teach both
general biology and advanced elective courses. Since biology constitutes the most
widely studied science in the United States, its instruction offers a major channel
through which science literacy in general and DNA literacy in particular can be
spread.
We believe that DNA literacy must become biology teachers' foremost concern.
The current failure to emphasize DNA science in our schools means failure to
teach the most exciting topics biology has to offer; failure to present socially and
personally relevant issues; and, in the final analysis, failure to fulfill teaching's most
important function-to prepare citizens capable of informed votes on policy issues.
The DNA Literacy Program now consists of two elements: the local Cold Spring
Harbor Curriculum Study and the national Vector DNA Science Workshop
Program. Close interaction, over the past two years with 250 educators from 12
states and Great Britain, has helped us crystallize program goals and evaluate our
progress toward reaching them.
Dr Morris Birnbaum, right, research associate at Memorial
Sloan-Kette
lation
riof ng
Glucose Transport':
Cancer Center,
talks with students and teachers after his lecture "Molecular
Regu
the fourth of six Great Moments Lectures.
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The Vector Mobile DNA
Laboratory Staff: (I. to r.) Pro-
gram Director David Mick los,
DNA Workshop Coordinator
Christine Bartels, summer
lab aide Jeff Mondschein,
and Technical Advisor Dr.
Greg Freyer (below).
Cold Spring Harbor Curriculum Study
The Curriculum Study was founded in January 1985 as a consortium between
Cold Spring Harbor Laboratory and eight local school districts. The program,
which has grown to include 19 school districts on Long Island and in Westchester
County, uses local resources and teaching systems as a proving ground for novel
educational materials on DNA science.
Program Director David Mick los and Dr. Greg Freyer, now a research associate
at Memorial Sloan-Kettering Cancer Center, developed an articulated set of lab
experiences introducing teachers to the major concepts and techniques of
molecular biology. Their protocols, presuming no specific prior knowledge, are the
basis of a five-day workshop, Recombinant DNA for Beginners, which has
become the central component of our educational efforts.
Our experience indicates that the hands-on summer workshop is a good format
for acquainting teachers with the laboratory materials and training them to initiate
lab-teaching at their own schools. After holding a regional workshop both in 1985
and 1986 for about 40 individuals each, we estimate that at least 600 students
have now performed experiments under the supervision of participating teachers.
Participants setting up DNA science labs for their classes receive further support
through joint equipment purchase options, telephone consultation, and site visits
by Cold Spring Harbor staff. In the Great Moments lecture series for students and
teachers held at Grace Auditorium, renowned speakers from both the Laboratory
and outside institutions cover a number of notable achievements and current
issues in molecular biology.
Vector DNA Science Workshop Program
The successful Curriculum Study experience in New York State and interest from
numerous educators around the country suggested the feasibility of a mobile
laboratory which would carry all equipment and reagents necessary to administer
Recombinant DNA for Beginners workshops at any location the United States. In
summer 1986 a grant from Citibank, N.A., allowed us to equip our first Vector van
and take the teacher-training course on the road. Vector Workshops were held in
seven locations: Huntington and Irvington, New York; Boston, Massachusetts;
Concord, New Hampshire; Chicago, Illinois; Milwaukee, Wisconsin; and Davis,
California.
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Thus, the complete set of experiments was successfully performed by over 200
enthusiastic high school and college teachers nationwide. Survey data indicate that
all of them felt excited and reinvigorated in their profession, gained increased
awareness and understanding of DNA science, and were stimulated to seek more
information on their own. Within months of the Vector experience, many of them
have been able to restructure their generally outdated syllabi to accommodate
molecular biology topics, and a significant number have actually started to
introduce DNA labs to their classes.
We have found, however, that regional teaching infrastructures-cluttered
syllabi, meager equipment funds, lack of teacher support and incentives, and
inadequate class time-are major obstacles to successful lab implementation. In
the future, many of our activities will be directed at increasing administrators'
awareness and creating follow-up activities for workshop participants.
Prospectus
For summer 1987, we have scheduled double the number of teacher-training
courses and purchased a second Vector van. Again, our excursions will take us to
various parts of the country, from New York City and New England to sites in the
Southeast, Midwest and West. We are now in the process of recruiting staff
members for Vector II.
The lab manual accompanying the workshop, Recombinant DNA for
Beginners: A First Laboratory Course in Molecular Biology, will be jointly
published by Cold Spring Harbor Laboratory Press and Carolina Biological Supply
Company this year. Carolina Biological, with its well-established distribution
network, will help us retool science classrooms by marketing both the manual and
all necessary reagents.
It has become apparent that crucial to widespread biotechnology will be a
national clearinghouse and teacher-training center specializing in DNA science
education. We are now looking for major support from foundations, biotechnology-
oriented companies, and public agencies that will make reality our dream to
develop a DNA Learning Center at Cold Spring Harbor. Proposed features of the
facility include a teaching laboratory, computer graphics laboratory, DNA library,
and science media development unit, all aimed at bringing the excitement of
molecular biology to the lay public.
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Students and teachers re-
ceive supplies for an experi-
ment during a Vector
Workshop.
Proposed DNA Learning
Center in Cold Spring Har-
bor Village.
Teachers prepare to sepa-
rate DNA fragments using
gel electrophoresis.
Students practice methods
for bacterial cuture.
Support
Support of the DNA Literacy Program has been provided by a consortium of
ifoundations, companies, and private individuals, ncluding Citibank, N.A., the J.M.
Foundation, the Josiah Macy, Jr. Foundation, Bethesda Research Laboratories, the
Richard Lounsbery Foundation, Fotodyne Incorporated, Amersham Corporation,
Cetus Corporation, New England Biolabs Foundation, Eli Lilly Research Laborato-
ries, Pioneer Hi-Bred International, Inc., the Dorcus Cummings Memorial Fund of
the Long Island Biological Association, The Harris Trust, and Mr. and Mrs. Oliver R.
Grace.
Our activities are coordinated with numerous educational and research institu-
tions, including the New York State Bureau of Science Education, Science
Teachers Association of New York State, Science Supervisors Association, National
Science Teachers Association, New York City Board of Education, State University
of New York, California State Board of Education, Biotechnology Program of the
University of California at Davis, Macy Bioprep Program, Marquette University,
Cleveland Clinic Foundation, Argonne National Laboratory, North Carolina Biotech-
nology Center, Utah State University, Bronx High School of Science, Thomas
Jefferson High School for Science and Technology, St. Paul's School, Choate
Rosemary Hall, and the Winsor School.
The Curriculum Study consists of the following school districts: Cold Spring
Harbor Central School District; Commack Union Free School District; East Williston
Union Free School District; Great Neck Union Free School District; Half Hollow
Hills Central School District; Herricks Union Free School District; Huntington Union
Free School District; Irvington Union Free School District; Jericho Union Free
School District; Lawrence Union Free School District; Manhasset Union Free
School District; North Shore Central School District; Northport-East Northport
Union Free School District; Oyster Bay-East Norwich Central School District;
Plainview-Old Bethpage Central School District; Port ledge School; Port Washington
Union Free School District; Sachem Central School District at Holbrook; Syosset
Central School District.
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Nature Study Program
The Nature Study Program gives elementary and secondary school students the
opportunity to acquire a greater knowledge and understanding of their environ-
ment. Through a series of specialized field courses, students can engage in such
introductory programs as Nature Detectives, Seashore Life, and Pebble Pups, as
well as more advanced programs such as Marine Biology and Nature
Photography.
During the summer of 1986 a total of 320 students participated in the Nature
Study Program. Most classes were held outdoors, when weather permitted, or at
the Uplands Farm Nature Preserve, the headquarters of the Long Island Chapter
of the Nature Conservancy. The Laboratory has equipped and maintains
classrooms/laboratories as well as a darkroom at Uplands Farm. This facility is
used as a base for the student's exploration of the local environment. Field classes
are held on Laboratory grounds, St. John's Preserve, Shu Swamp Preserve,
Caumsett State Park, the Cold Spring Harbor Fish Hatchery, and the Muttontown
Preserve, as well as other local preserves and sanctuaries. Students in Marine
Biology participated in a whale watch aboard the Finback II, operated by the
Okeanos Ocean Research Foundation Inc. Hampton Bays, New York.
In addition to the four-week courses, a series of one-day marine biology
workshops was offered to students. Studies on the marine ecology of L.I. Sound
were conducted aboard the 100 foot Sloop Clearwater chartered from Hudson
River Sloop Clearwater, Inc. of Poughkeepsie, New York. Students were able to
study the Sound chemically, physically, and biologically using the ship's instrumen-
tation. The three-day Adventure Education class took students on an 18 mile bike
hike to Caumsett State Park, a six-mile canoe trip on the Nissequogue River, and a
day of sailing on the Sloop Clearwater.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor,
Nassau Community College
INSTRUCTORS
Ruth Burgess, B.A., naturalist, Nassau County BOCES
Joanna Cardinali, M.A., naturalist, Nassau County BOCES
Steven Lander, M.S., science coordinator, Harborfields School District
Fred Maasch, M.S., science teacher, Islip High School
Maryann Manzilillo, M.A., naturalist, Nassau County BOCES
Linda Payoski, B.A., science teacher, Uniondale High School
Marjorie Pizza, B.A., science teacher, Glen Cove School District
COURSES
Nature Bugs
Nature Detectives
Advanced Nature Study
Introduction to Ecology
Frogs, Flippers, and Fins
Pebble Pups
Bird Study
Fresh Water Life
Seashore Life
Vertebrate Biology
Marine Biology
Nature Photography
Adventure Education
Marine Biology Workshops
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FINANCIAL STATEMENT
BALANCE SHEET-year ended December 31, 1986 31
with comparative figures for year ended Dece,
ASSETS
1985
1986 1985
COLD SPRING
HARBOR
CURRENT FUNDS
Unrestricted
Cash and Short-term investments $12,044,160 $11,567,359
LABORATORY Accounts Receivable 452,317 286,511
Prepaid expenses and other assets 502,059 480,909
Inventory of books 246,453 218,043
Total unrestricted 13,244,989 12,552,822
Restricted
Marketable securities
(quoted market 1986-$2,000,000;
1985-$850,000) 212,500 212,500
Grants and contracts receivable 3,283,509 6,648,896
Due from unrestricted fund 1,803,052 501,239
Total restricted 5,299,061 7,362,635
Total current funds $18,544,050 $19,915,457
ENDOWMENT FUNDS
Robertson Research Fund
Cash 1,104,670 231,649
Marketable securities
(quoted market 1986-$24,573,649;
1985-$22,240,523) 20,533,544 18,393,860
Total Robertson Research Fund 21,638,214 18,625,509
Olney Memorial Fund
Cash 3,191 1,138
Marketable Securities
(quoted market 1986-$48,044;
1985-$41,928) 30,593 32,101
Total Olney Memorial Fund 36,784 33,239
Unrestricted Endowment Fund
Cash 139,074
Total Unrestricted Endowment Fund 139,074
Total endowment funds $21,814,072 $18,658,748
PLANT FUNDS
Investments 718,012 879,871
Due from unrestricted fund 2,741,895 3,594,835
Land and improvements 1,471,432 1,340,375
Buildings 17,858, 736 16,374,820
Furniture, fixtures and equipment 4,550,467 3,846,120
Books and periodicals 365,630 365,630
Construction in progress 631,106 406,541
28,337,278 26,808,192
Less allowance for depreciation
and amortization 6,947,936 5,896,757
Total plant funds $21,389,342 $20,911,435
Total Cold Spring Harbor
Laboratory funds $61,747,464 $59,485,640
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LIABILITIES AND FUND BALANCES
1986 1985
CURRENT FUNDS
Unrestricted
Accounts payable $ 815,477 $ 854,619
Deferred income 165,000 150,000
Due to Banbury Center 227,668 148,944
Due to plant fund 2,741,895 3,594,835
Due to restricted fund 1,803,052 501,239
Fund balance 7,491,897 7,303,185
Total unrestricted 13,244,989 12,552,822
Restricted
Accounts payable 137,520 275,171
Fund balance 5,161,541 7,087,464
Total restricted 5,299,061 7,362,635
Total current funds $18,544,050 $19,915,457
ENDOWMENT FUNDS
Fund balance $21,814,072 $18,658,748
PLANT FUNDS
Loan payable
Fund balance
Total Plant Funds
Total Cold Spring Harbor
Laboratory funds
8,000,000
13,389,342
8,000,000
12,911,435
$21,389,342 $20,911,435
$$61,747,464 59,485,640
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ASSETS
BANBURY CENTER
1986 1985
CURRENT FUNDS
Unrestricted
Cash 700 700
Prepaid and deferred expenses 14,148 5,726
Inventory of books 62,605 56,299
Due from CSHL unrestricted fund 191,758 103,322
269,211Total unrestricted 166,047
Restricted
Grants and contracts receivable 125,003 99,141
Due from CSHL unrestricted fund 35,910 45,622
Total restricted 160,913 144,763
Total current funds $ 430,124 $ 310,810
ENDOWMENT FUNDS
Robertson Maintenance Fund
Cash 221,406 10,707
Marketable securities
(quoted market 1986-$3,930,272;
1985-$3,637,079) 3,292,985 3,013,692
Total endowment funds $ 3,514,391 $ 3,024,399
PLANT FUNDS
Land 772,500 772,500
Buildings 846,028 846,028
Furniture, fixtures and equipment 191,383 191,383
1,809,911 1,809,911
Less allowance for depreciation 419,112 387,505
Total plant funds $ 1,390,799 $ 1,422,406
Total Banbury Center funds $ 5,335,314 $ 4,757,615
Total Cold Spring Harbor Laboratory
and Banbury Center funds $67,082,778 $64,243,255
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LIABILITIES AND FUND BALANCES
1986 1985
CURRENT FUNDS
Unrestricted
Accounts payable $ 34,756 $ 8,142
Fund balance 234,455 157,905
Total unrestricted 269,211 166,047
Restricted
Accounts payable 2,181 4,577
Fund balance 158,732 140,186
Total restricted 160,913 144,763
Total current funds $ 430,124 $ 310,810
ENDOWMENT FUNDS
Fund balance $ 3,514,391 $ 3,024,399
PLANT FUNDS
Fund balance $ 1,390,799 $ 1,422,406
Total Banbury Center funds $ 5,335,314 $ 4,757,615
Total Cold Spring Harbor Laboratory
and Banbury Center funds $67,082,778 $64,243,255
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CURRENT REVENUES, EXPENSES AND TRANSFERS
year ended December 31, 1986
with comparative figures for year ended December 31, 1985
COLD SPRING
HARBOR
REVENUES
Grants and contracts
Indirect cost allowances on grants
1986 1985
$15,869,438$13,819,752
LABORATORY and contracts 4,533,243 4,406,047
Contributions
Unrestricted 243,906 332,423
Restricted, Capital and Endowment 1,082,585 278,483
Long Island Biological Association 160,000 100,000
Robertson Research Fund Distribution 650,000 575,000
Royalty and licensing fees 105,861 197,000
Summer programs 721,951 553,395
Laboratory rental 20,732 20,732
Marina rental 63,423 61,278
Investment income 905,418 903,132
Publications sales 1,356,928 1,432,527
Dining Hall 776,767 638,690
Rooms and apartments 303,484 248,854
Other sources 19,716 22,968
Total revenues 24,763,766 25,639,967
EXPENSES
Research" 12,055,370 11,710,764
Summer and training programs* 1,999,031 1,660,496
Publications sales* 1,013,374 1,029,060
Dining hall* 854,967 769,574
Research support 359,542 400,341
Library 285,024 267,341
Operation and maintenance of plant 2,442,498 2,413,788
General and Administrative 2,031,514 1,965,647
Depreciation 1,061,477 1,046,630
Total expenses 22,102,797 21,263,641
TRANSFERS
Capital building projects 2,248,761 3,805,100
Total expenses and transfers 24,351,558 25,068,741
Excess of revenues over
expenses and transfers $ 412,208 $ 571,226
* Reported exclusive of an allocation for research support, operation and maintenance of plant, general
and administrative, library, and depreciation expenses.
330
1986 1985
BANBURY CENTER REVENUES
Endowment income $ 120,000 $ 112,000Grants and contributions 431,642 335,210
Indirect cost allowances on grants
and contracts 21,265 28,445
Rooms and apartments 124,000 97,026
Publications 142,300 133,164
Conference fees 27,980 22,086
Dining Hall 60,985 42,314
Total revenues 928,172 770,245
EXPENSES
Conferences 264,932 188,559
Publications 123,156 124,563
Operation and maintenance of plant 154,278 124,760
Program administration 252,629 222,715
Depreciation 31,607 30,486
Capital plant 11,000
Total expenses 826,602 702,083
Excess of revenues over
expenses $ 101,570 $ 68,162
NOTE: Copies of our complete, audited financial statements,
certified by our independent auditors, Peat,
Marwick, Mitchell & Co., are available upon request from the Comptroller,
Cold Spring Harbor
Laboratory.
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COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 1986
Federal Grants and Contracts
43.1%
Endowments
4.5%
Auxiliary Activities
17.4%
Foundation Grants
12.1%
Corporate Contributions
and Grants 16.2%
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Private Contributions
2.1%
Interest and
Miscellaneous 4.6%
;;
,
°
,
FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory is a nonprofit research and educational institution
chartered by the University of the State of New York. Contributions are tax exempt
under the provisions of Section 501(c)(3) of the Internal Revenue Code. In addition,
the Laboratory has been designated a "public charity" and, therefore, may receive
funds resulting from the termination of "private" foundations.
Because its endowment is limited and the uses of research grants are formally
restricted, the Laboratory depends on generous contributions from private
foundations, sponsors, and friends for central institutional needs and capital
improvements.
Over the years, the Laboratory has won a reputation for innovative research
and high-level science education. By training young scientists in the latest
experimental techniques, it has helped spur the development of many research
fields, including tumor virology, cancer genes, gene regulation, moveable genetic
elements, yeast genetics, and molecular neurobiology. However, the continued
development of new research programs and training courses requires substantial
support from private sources.
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities You can generally deduct the full amount of the gift on your income tax return,
and, of course, you need pay no capital gains tax on the stock's appreciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Harbor
Laboratory.
(2) Deliver the stock certificates to your broker with instructions to him to open an account
for Cold Spring Harbor Laboratory and hold the securities in that account pending
instructions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold
Spring Harbor Laboratory, Cold Spring Harbor, New York 11724. In a separate
envelope send an executed stock power.
Bequests Probably most wills need to be updated. Designating Cold Spring Harbor
Laboratory as beneficiary ensures that a bequest will be utilized as specified for continuing
good.
Appreciated real estate or personal property Sizable tax benefits can result from such
donations; the Laboratory can use some in its program and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's
specific desires as to extent, timing, and tax needs.
Conversion of private foundation to "public" status on termination This may be done
by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets of
the private foundation are accounted for as a separate fund and used for the purposes
specified by the donor. Alternatively, the private foundation can be established as a
"supporting organization of Cold Spring Harbor Laboratory."
For additional information, please contact the Director of Public Affairs and Development,
Cold Spring Harbor Laboratory, Box 100, Cold Spring Harbor, N.Y. 11724, or call
516-367-8455.
GRANTS FOR RESEARCH AND EDUCATION
January 1, 1986-December 31, 1986
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant Total Award
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Cancer Research Center, Drs. Watson,
Sambrook, Roberts and Mathews
Gene Organization, Drs. Watson and Sambrook
1/77-12/86
4/81- 3/86
$18,604,426
5,626,997
Research Support Dr. Beach 12/84-11/87 361,511
Dr. Beach 9/86- 8/89 578,929*
Dr. Blose 12/78-11/87 1,094,594
Dr. Dellaporta 7/85- 6/88 534,805
Dr. Feramisco 7/80- 7/86 686,968
Dr. Feramisco 4/85- 3/88 535,534
Dr. Franza 9/85- 7/88 478,689
Dr. Garrels 1/85-12/89 2,028,833
Dr. Helfman 9/85- 8/88 572,760
Dr. Hicks 7/81- 6/86 1,623,433
Dr. Klar 7/81- 3/87 1,572,978
Dr. Kurtz 4/80- 3/86 606,389
Dr. Mathews 4/80- 3/86 729,283
Dr. Roberts 9/86- 8/89 303,642*
Dr. Stillman 7/83- 6/92 1,869,678
Dr. Watson 4/85- 3/86 146,986
Dr. Watson 4/86- 3/87 144,681*
Dr. Welch 4/84- 3/87 314,933
Dr. Wig ler 7/85- 6/92 8,426,929
Dr. Zoller 9/85- 8/88 545,752
Fellowships Dr. Bar-Sagi 9/85- 8/87 47,000
Dr. Cheley 10/86- 3/88 37,494*
Dr. Bautch 9/83- 8/86 57,244
Dr. Field 10/86- 9/89 63,996*
Dr. Gerard 5/84- 4/86 38,204
Dr. Livi 10/83-10/86 57,244
Dr. McLeod 2/85- 1/88 63,996
Dr. Morris 11/86-10/89 82,008*
Dr. Quinlan 6/84- 5/87 57,244
Dr. Potashkin 10/85- 9/88 64,886
Training Institutional, Dr. Grodzicker
7/78- 8/89 1,291,646
Course Support Advanced Bacterial Genetics,
Drs. Hicks and Klar
Cancer Center, Dr. Grodzicker
Neurobiology, Dr. Hockfield
Neurobiology, Dr. Hockfield
5/80- 4/88
6/82-12/86
6/79- 3/86
5/82- 4/90
302,523
657,174
646,143
723,939
* New grants awarded in 1986
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Duration of Grant Total Award
Grantor Program/Principal Investigator
1986 24,719*Meeting Support 51st Symposium: Molecular
Biology
of Homo sapiens
Hepatitis B Virus 1986 5,000*
Papilloma Virus 1986 12,000*
DNA Topology
G-Proteins and Signal Transduction
1986
1986
1,500*
5,500*
RNA Processing 1986-1987 3,500*
Eukaryotic Transposable Elements 1986 2,000*
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Klar
8/86- 7/89 330,000*
Dr. Roberts 11/83- 5/85 120,908
Dr. Roberts 3/83- 8/86 40,592
Dr. Roberts 1/83- 5/90 640,000
Dr. Roberts 7/83-12/86 252,000
Course Support Plant Molecular Biology, Dr. Klar 5/84-12/86 121,676
Plant Molecular Biology, Dr. Klar 8/86- 1/90 137,490*
Meeting Support RNA Processing 1986-1987 12,400*
G-Proteins and Signal Transduction 1986 2,000*
Papilloma Viruses 1986 2,100*
Hepatitis B Viruses 1986 2,100*
Eukaryotic Transposable Elements 1986 5,000*
DNA Topology 1986 9,000*
51st Symposium: Molecular Biology
of Homo sapiens 1986 7,000*
DEPARTMENT OF AGRICULTURE
Research Support Dr. Dellaporta 9/85- 8/86 21,000
Dr. Dellaporta 9/84- 8/86 100,000
Dr. Hiatt 8/86- 7/89 165,000*
Meeting Support Eukaryotic Transposable Elements 1986 8,000*
DEPARTMENT OF ENERGY
Research Support Dr. Dellaporta 9/85- 8/86 75,000
Meeting Support Symposium: Molecular Biology
of Homo sapiens 1986 9,000*
NONFEDERAL GRANTS
Research Support
A. B.C. Foundation Dr. Wig ler 5/82- 4/87 600,000
Rita Allen Foundation Dr. Herr 9/85- 8/90 150,000
Rita Allen Foundation Dr. Stillman 1/83-12/87 150,000
American Cancer Society Dr. Beach 1/85-12/86 70,000
Drs. Stillman, Gluzman-Institutional Award 7/82- 6/87 185,000
* New grants awarded in 1986
336
Grantor Program/Principal Investigator Duration of Grant Total Award
Amersham International plc
Cancer Research Institute
Cornell University
Diabetes Research & Education
Foundation
Russell and Janet Doubleday
Fund
Exxon Research and
Engineering Company
International Foundation for
Cancer Research
Juvenile Diabetes Foundation
Leo Model Foundation
McKnight Foundation
Merck & Co., Inc.
Monsanto Company
Muscular Dystrophy Association
New England Biolabs, Inc.
Pfizer, Inc.
Phillips Petroleum Company
Pioneer Hi-Bred International, Inc.
Protein Databases Inc.
Marie Robertson Memorial Fund
Scripps Clinic
Fellowships
Alberts Heritage Foundation
for Medical Research
American Cancer Society
Arthritis Foundation
Cancer Research Institute
Anna Fuller Fund
Leukemia Society of America
Life Science Research Foundation
NYS Health Research Council
Robert H.P. Olney Memorial Fund
Rockefeller Foundation
Damon Runyon-Walter Winchell
Cancer Fund
Helen Hay Whitney Foundation
Training
American Cyanamid Company
Bristol-Myers Company
Burroughs Wellcome Fund
Dr. Wig ler
Dr. Wig ler, Professorship
Dr. Wig ler
Dr. Welch
Dr. Harlow
Dr. Franza
Dr. Siniscalco
Dr. Hanahan
General Support
Cooperative Research
Dr. Hanahan
Dr. Hanahan
General Support
Dr. Malmberg
Dr. Cone
Cooperative Research
Dr. Helfman
Dr. Mathews
Dr. Roberts
Dr. Wig ler
General Support
Cooperative Research
General Support
Neurobiology
Dr. Hanahan (subcontract)
Dr. Mizzen
Dr. Young
Dr. Morris
Dr. Cone
Dr. Young
Dr. Sturm
Dr. Efrat
Dr. Field
Dr. Hanahan
Dr. Colicelli
Dr. Bautch
Undergraduate Research
Dr. Hicks
Dr. Broek
Dr. Hearing
Dr. Hiatt
Dr. Sass
Dr. Kostriken
Undergraduate Research Program
Fellowship Support
Undergraduate Research Program
7/84- 6/86
1986-2012
1986
10/85- 9/87
11/86-10/87
4/86- 3/87
1/86- 8/86
5/86- 4/87
1986
1/82-12/86
10/84- 9/86
9/86- 9/88
1986
3/83- 2/86
1986
10/84- 9/90
7/86- 6/89
7/83-12/86
1986
1985-1990
1986
8/85- 4/91
1986
1986
1/86- 9/88
7/86- 6/87
8/84- 7/85
7/86-11/86
10/85- 9/87
8/85- 8/87
9/86- 8/88
9/86- 8/88
10/85- 9/86
7/84- 6/86
9/86- 8/89
9/86- 8/87
1986
9/84- 8/86
6/84- 5/86
9/84- 8/86
8/84- 5/86
9/84- 8/86
3/86- 2/89
1986
6/86- 5/91
1986
200,000
1,333,333*
10,000*
50,000
148,780*
25,000*
31,115*
19,960*
16,750*
7,500,000
50,000
66,000*
1,000*
105,000
20,000"
2,089,200
94,500*
88,776
10,000"
500,000
3,000*
2,500,000*
25,000*
125,000"
557,137*
19,730*
16,500
6,000*
48,000
46,000
51,000*
51,000*
18,000
44,280
105,000*
19,000*
4,733"
25,900
38,000
38,000
34,750
38,000
56,000*
7,000*
500,000*
10,500*
New grants awarded in 1986
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Grantor Program/Principal Investigator
Duration of Grant Total Award
Grass Foundation
Lucille P. Markey Foundation
Pfizer Inc.
Rockefeller Foundation
Alfred P. Sloan Foundation
Course Support
The Esther A. and Joseph
Klingenstein Fund
Alfred P. Sloan Foundation
Meeting Support
Rita Allen Foundation
Banbury Fund
Sanford C. Bernstein Foundation
Burroughs Wellcome Co.
Council for Tobacco Research
Johnson & Johnson
Life Technologies, Inc.
March of Dimes Birth Defects
Foundation
Otolaryngology Foundation
Rockefeller Foundation
DNA Literacy Program
Amersham Corporation
Citicorp/Citibank
Dorcas Cummings Memorial
Fund of Long Island
Biological Association
Fotodyne Incorporated
GIBCO/Bethesda Research
Laboratories
Mr. and Mrs. Oliver R. Grace
The Harris Trust
The J.M. Foundation
Richard Lounsbery Foundation
Miller Brewing Company
New England Biolabs Foundation
University of California, Davis
* New grants awarded in 1986
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Neurobiology Scholarships
Scholarship Support
Undergraduate Research Program
Scholarship Support
Undergraduate Research Program
Neurobiology Support
Computational Neuroscience Course
Symposium: Molecular Biology
of Homo sapiens
Symposium: Molecular Biology
of Home sapiens
Papilloma Virus
Papilloma Virus
Papilloma Virus
Vaccines
Poxvirus
Regulation of Liver Gene Expression
Papilloma Virus
Vaccines
Vector Workshop
Vector Van
DNA Education Center
Vector Workshop
Vector Workshop
DNA Education Center
DNA Education Center
Program Support
Vector Workshop
Vector Workshop
Vector Workshop
Vector Workshop
1980-1986
1985-1988
1986
1985-1986
1985-1988
1986-1988
1986-1989
1986
1986
1986
1986
1986
1986
1986
1986-1987
1986
1986-1988
1986
1986
1986
1986
1986
1986
1986
1986
1986
1986
1986
1986
101,670
150,000
7,000*
16,000
74,000
300,000
140,000 *
15,000*
15,000*
10,000*
6,500*
2,500*
5,000 *
100*
2,000 *
5,000*
45,000*
10, 000 *
30,000*
10,000*
9,000"
10,000*
20,000 *
10, 000 *
30,000"
10,000*
1, 000 *
7,000*
10, 000 *
BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant Total Award
FEDERAL GRANTS
NATIONAL SCIENCE FOUNDATION
Meeting Support Evolution and Environmental Spread
of Antibotic Resistance Genes 1986 $25,000*
DEPARTMENT OF ENERGY
Meeting Support Evolution and Environmental Spread
of Antibotic Resistance Genes 1986 25,000"
NONFEDERAL GRANTS
Meeting Support
American Cancer Society DNA Adduct Workshop 1986 11,253*
American Industrial Health
Council Inc. Nongenotoxic Carcinogenicity Conference 1986 25,000*
James S. McDonnell Foundation Conference Support 1985-1987 300,000 *
Risk Science Institute DNA Adducts Workshop 1986 10,000*
Shearson-American Express
Foundation Conference Support 1986 64,752*
Alfred P. Sloan Foundation Journalists' and Congressional Workshops 1984-1986 162,000
* New grants awarded in 1986
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ENDOWMENTS AND GIFTS FOR FACILITIES
ENDOWMENTS
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory Unrestricted Endowment Fund
1986 Contributors: Mr. G. Morgan Browne, Jr.
Mrs. Sinclair Hatch
Mr. and Mrs. George N. Lindsay
Mr. and Mrs. David L. Luke III
Mr. Taggart Whipple
Market Value*
$ 139,075
The Doubleday Professorship for Advanced Cancer Research
1,500,000
Robert H.P. Olney Memorial Fund
1986 Contributors: The Rev. Linda Peyton Hancock
Mr. Richard Olney III
Ms. Pamela Peyton Post
Mrs. Robert W. Tilney, Jr.
Robertson Research Fund
Robertson Maintenance Fund
Total Cold Spring Harbor
Long Island Biological Association (LIBA)
Dorcas Cummings Memorial Lecture Fund
Other Endowments
Total LISA
FACILITIES
51,235
25,678,319
4,151,678
$31,520,307
$58,633
37,487
$96,120
Oliver and Lorraine Grace Auditorium
Mr. & Mrs. Oliver R. Grace
Protein Databases Inc.
Mrs. Elizabeth B. Schneider
Construction
Construction
Construction
1986
1986
1986
$ 91,047t
25,000t
3,591t
Arthur and Walter Page Laboratory of Plant Genetics
Anonymous Construction 1986 25,000t
Charles E. Culpeper Foundation Construction 1985-1987 75,000
Ira W. De Camp Foundation Construction 1986 50,000t
Long Island Biological
Association Construction 1986 130,000t
National Science Foundation Construction 1983-1988 690,715
North Country Garden Club Construction 1986 1,000t
Dr. David B. Pall
William and Maude Pritchard
Construction 1986 105,057t
Charitable Trust Construction 1986 75,000t
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X-Ray Crystallography Laboratory
Market Value*
Mr. & Mrs. Oliver R. Grace Equipment 1986 50,000t
Lucille P. Markey
Charitable Trust Equipment 1986-1988 863,500t
Jones Laboratory
McKnight Foundation Equipment for Neurobiology Course 1984-1986 110,000
Samuel Freeman Computer Center
Cancer Research Institute Equipment 1986 50,000t
Oliver S. and Jennie R.
Donaldson Charitable Trust Equipment 1986 50,000t
Samuel Freeman Charitable Trust Equipment 1985-1986 350,000
Lodge Building Fund
Dr. Mark Ptashne Construction 1986 45,625tt
* As of December 31, 1986
t New grants awarded in 1986
t Value of stock on December 31, 1986

ANNUAL GIVING PROGRAMS
Corporate Sponsor Program
Access to current research presented at high-level professional meetings is an
important resource for the biotechnology industry. Since 1984 the Corporate
Sponsor Program has encouraged increased interaction between academic and
industrial scientists, while at the same time providing financial stability for the
Laboratory's meetings program.
The annual $15,000 membership commitment from each Corporate Sponsor
has enabled the Laboratory to significantly expand its role as a clearinghouse for
high-level biotechnical information. With more than 3,600 scientists attending 25
conferences and 13 advanced training courses at the Laboratory and Banbury
Center in 1986, the Laboratory now offers the most comprehensive postgraduate
educational program available anywhere in the United States.
Among those attending 1986 meetings were 310 scientists representing 85
companies, an increase in corporate attendance of 48 percent from 1983. During
the same period, 1983-86, overall attendance increased 42 percent (from 2,540 to
3,610), and the number of meetings increased 32 percent (from 19 to 25).
Proceeds from the Corporate Sponsor Program allowed initiation of an ongoing
series of Special Banbury Conferences that focus on emerging areas of research
especially germane to industrial biotechnology. These high-level meetings are the
basis for the Laboratory's popular book series Current Communications in
Molecular Biology. Topics of 1986 conferences were "Mechanisms of Microbial
Energy Transduction," "Recombination Mechanisms in Yeast': "DNA Probes': "Gene
Transfer Vectors: and "Tumor Angiogenesis Factor'
Benefits to Sponsor companies include waiver of all fees for six representatives
at Cold Spring Harbor meetings and Special Banbury Conferences, gratis Cold
Spring Harbor and Banbury publications, and recognition in meeting abstracts
and publications.
In the past three years, 26 companies have participated in the Corporate
Sponsor Program. The membership renewal rate is 90 percent. 1986 members
of
the Corporate Sponsor Program-world leaders in the application of biotechnology
to health care, agriculture, and manufacturing-were:
Abbott Laboratories
American Cyanamid Company
Amersham International plc
Becton Dickinson and Company
Cetus Corporation
Ciba-Geigy Corporation
CPC International Inc.
E.I. du Pont de Nemours & Company
Genentech, Inc.
Genetics Institute
Hoffmann-La Roche Inc.
Eli Lilly and Company
Monsanto Company
Pall Corporation
Pfizer Inc.
Schering-Plough Corporation
Smith Kline & French Laboratories
Tambrands Inc.
The Upjohn Company
Wyeth Laboratories

Alumni Cabin Campaign
The Alumni Cabin Campaign was initiated in the fall as an experiment to answer
the question: "Do meeting attendees, course instructors, and former staff have
enough affection for Cold Spring Harbor to consider themselves alumni?"
The answer was a resounding "yes',' as biologists from around the world
recalled how their careers had benefited from the Cold Spring Harbor experience.
By year's end nearly 200 scientists (one in four asked) had contributed almost
$34,000 for construction of "Alumni Cabin:' one of six four-bedroom cabins
planned to replace existing, dilapidated structures. Gifts continue to be received in
1987, and it is hoped the campaign goal of $100,000 can be reached by the time
the cabins come into service in fall 1988. Construction is due to start in fall 1987.
Donations were received prior to December 31, 1986, from:
Dr. Stuart Aaronson
Dr. John Abelson
Dr. George Acs
Dr. Bruce M. Alberts
Dr. Frederick W. Alt
Dr. Peggy Anderson
Dr. Ralph B. Arlinghaus
Dr. John F Atkins
Dr. Frederick M. Ausubel
Dr. Baruj Benacerraf
Dr. Paul Berg
Dr. Max Birnsteil
Dr. J.M. Bishop
Dr. &linter Blobel
Dr. Tom Blumenthal
Dr. Xandra 0. Breakefield
Dr. Sydney Brenner
Dr. Thomas R. Broker
Dr. Donald Brown
Dr. Jeremy Bruenn
Dr. Joan S. Brugge
Dr. Ian Buckley
Dr. Keith Burridge
Dr. John Cairns
Dr. Charles R. Cantor
Dr. Thomas Caskey
Dr. Thomas R. Cech
Dr. Louise Chow
Dr. Francois Cuzin
Dr. James E. Darnell, Jr.
Miss Katya Davey
Dr. Julian Davies
Dr. Bernard D. Davis
Dr. Mark M. Davis
Dr. Vittorio Defensi
Dr. Paul M. Doty
Dr. John E. Dowling
Dr. Ashley R. Dunn
Dr. Walter Eckhart
Dr. Manfred Eigen
Dr. Sarah Elgin
Dr. Henry F Epstein
Dr. Octavio Fasano
Dr. Georg H. Fey
Dr. Thomas Flanagan
Dr. Naomi C. Franklin
Dr. Robert C. Gallo
Dr. Denise A. Galloway
Dr. Donald Ganem
Dr. Murray B. Gardner
Dr. Walter J. Gehring
Dr. Martin Gellert
Dr. James L. German, Ill
Dr. Nicholas W. Gillham
Dr. Howard M. Goodman
Dr. Adolf Graessmann
Dr. Howard Green
Dr. Maurice Green
Dr. Francois Gros
Dr. Michael Grunstein
Dr. Gary N. Gussin
Dr. Hidesaburo Hanafusa
Dr. Teruko Hanafusa
Dr. Rasika Harshey
Dr. William A. Haseltine
Mrs. Sinclair Hatch
Dr. Stanley Hattman
Dr. Ira Herskowitz
Dr. Lawrence E. Hightower
Dr. David Hirsh
Dr. Nancy H. Hopkins
Dr. R.B. Horsch
Dr. Marshall S. Horwitz
Dr. Rollin D. Hotchkiss
Dr. Martha M. Howe
Dr. Tony Hunter
Dr. Jerard Hurwitz
Dr. Masayori Inouye
Dr. Niels Kaj Jerne
Dr. Harumi Kasamatsu
Dr. Walter Keller
Dr. Thomas J. Kelly, Jr.
Dr. Daniel F. Klessig
Dr. Thomas Kornberg
Dr. Mathilde Krim
Dr. Arnold J. Levine
Dr. Edward B. Lewis
Dr. Jim Jung-Ching Lin
Dr. William F Loomis
Dr. Janice Pero Losick
Dr. Richard Losick
Dr. Janet I. Maclnnes
Dr. Nancy Maizels
Dr. G. Steven Martin
Dr. Fumio Matsumura
Dr. James K. McDougall
Dr. Calvin S. McLaughlin
Dr. Norman E. Melechen
Dr. Joachim Messing
Dr. George Miller
Dr. Jeffrey H. Miller
Dr. Gisela Mosig
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Dr. Noreen E. Murray
Dr. Kim Nasmyth
Dr. Frederick C. Neidhardt
Dr. Paul Neiman
Dr. Markus Noll
Dr. Masayasu Nomura
Dr. Paul V. O'Donnell
Dr. Harvey L. Ozer
Dr. Paul H. Patterson
Dr. Thoru Pederson
Dr. Manuel Perucho
Pharmacia AB on behalf of
Dr. Ulf Pettersson
Dr. Peter Phillipsen
Dr. Terry Platt
Dr. Dale Purvis
Dr. James P Quigley
Dr. Efraim Racker
Dr. Martin Raff
Dr. Frederic M. Richards
Dr Charles C. Richardson
Dr. John P. Richardson
Dr. Rex Risser
Dr. Harriet L. Robinson
Dr. John R. Roth
Dr. & Mrs. Gordon Sato
Professor Jeff Schell
Dr. Robert Schimke
Dr. Walter A. Scott
Dr. Lucy Shapiro
Dr. Thomas E. Shenk
Dr. Charles J. Sherr
Dr. Thomas J. Silhavy
Dr. Louis Siminovitch
Maxine & Daniel Singer
Dr. Anna Marie Skalka
Dr. Clive A. Slaughter
Dr. Helene S. Smith
Dr. Davor Solter
Dr. Joseph Sorge
Dr. Allan C. Spradling
Dr. Franklin W. Stahl
Dr. Gunther S. Stent
Dr. Joan A. Steitz
Dr. Chuck Stiles
Dr. Nigel D. Stow
Dr. Kevin Struhl
Dr. Williams C. Summers
Dr. Ian M. Sussex
Dr. Peter Tegtmeyer
Dr. Irwin Tessman
Dr. Jeremy Thorner
Dr. Lauren Thorner
Dr. Robert T. Tjian
Dr. George F. Vande Woude
Dr. Kevin M. Van Doren
Dr. Harold E. Varmus
Dr. Alexander Varsharsky
Dr. Inder M. Verma
Dr. Arthur Vogel
Dr. James C. Wang
Dr. James D. Watson
Dr. Robert E. Webster
Dr. Alan Weiner
Dr. I. Bernard Weinstein
Dr. Heiner Westphal
Dr. Daniel L. Wulff
Dr. Masao Yamada
Dr. Keith R. Yamamoto
Dr. Charles Yanofsky
Dr. Takashi Yura
Dr. Sam Zaremba
Dr. & Mrs. Norton Zinder
In memory of Ethel S. Tessman
Individual Contributions and Memorial Gifts
Mr. Carl W. Anderson
Madeline & Frances Antonuccio
Mr. & Mrs. J. Eugene Banks
Mr. & Mrs. Joseph Bards ley
Mr. & Mrs. Alfred N. Beadleston
Mr. Charles Bergmann
Mr. & Mrs. Harold S. Bohl
Miss Rowena A. Bowen
Dr. Roger L. Brotman
Mr. G. Morgan Browne, Jr.
Ms. Helen C. Caine
Mr. & Mrs. Salvatore Catanese
Dr. Lan Bo Chen
Mr. & Mrs. William L. Clay, Jr.
Mr. & Mrs. John P Cleary
Mr. Gerald Cohen
Mrs. Crispin Cooke
Robert & Susan Cooper
Mr. Duncan B. Cox
Mrs. Ralph Crews
Mrs. Frank Foster Crook
Ms. Loretta De Rose
Mr. & Mrs. J. Richardson Dilworth
Mrs. Charles Dolan
Dr. & Mrs. Lester Dubnick
Ms. Ivy Fairweather
Mrs. Edna Finnagann
Dr. & Mrs. Henry B. Fletcher
Mr. & Mrs. William Floyd-Jones
Ms. Anna Fortunati
Mr. Alan Fortunoff
Dr C.R. Fuerst
Ms. Helena Gaviola
Mrs. Marvin Gordon
Mr. & Mrs. Ronald Harding
Mr. Joseph Harding
Mr. & Mrs. Henry U. Harris
Miss Maxine Harrison
Mr. & Mrs. Carl W. Hedberg
Dr. & Mrs. Alfred D. Hershey
Dr. Ira Herskowitz
Dr. Bernhard Hirt
Mrs. George N. Houth
Mr. & Mrs. Warren C. Hutchins
Mr. Judson Hyatt
Ms. Amy Olney Johnson
Miss Elizabeth Kelly
Mr. & Mrs. Edward W. Kozlik
Mr. & Mrs. Ernest Labbe
Mr. & Mrs. Jerry Labbe
Mr. & Mrs. Joseph Labbe
Mrs. Lillian B. LaPerche
Mr. & Mrs. James L. Larocca
Mr. A. Brewster Lawrence, Jr.
Mr. & Mrs. Richard Leckerling
Mr. William Lehrfeld
Mrs. Alfred B. Lemon
Dr. & Mrs. Monroe Levin
Dr. James B. Lewis
Mr. James C. Lewis
Mr. & Mrs. John A. Lewis,
Daniel and Micah
Dr. Robert V. Lewis
Mr. Henry Luce III
Mr. & Mrs. William E. Mahoney
Mrs. Elizabeth Manwaring
Vincent & Bruna Marsella
Ms. Leila Laughlin McKnight
Mrs. Florence L. Meader
& Family
Mr. Richard K. Moore
Dr. Gisela Mosig
Mr & Mrs. Richard Neuendorffer
Mr. & Mrs. F.W. Pain
Mr & Mrs. Walter H. Page
Mrs. Lucile B. Palmero
Mr. & Mrs. John G. Pieper
Helen, Richard & Aloysia Poole
Mrs. Ethel S. Pratt
Mr. Waldron W. Proctor
Mr. Mike Psipsikas
Mr. & Mrs. Steve Rafting
Mr. & Mrs. Herbert E. Razee
Mr. C.L. (Bill) Reynolds
Mr. & Mrs. William H. Roland, Jr.
R.J. Rudden Associates, Inc.
Ms. Marilyn Louise Schmitt
Mrs. Elizabeth B. Schneider
Mr & Mrs. Clayton B. Seabury
Mr. & Mrs. Kenneth B. Sherman
Mr. & Mrs. Elmer R. Shippee
Mr. R.L. Shipman, Jr.
Dr. & Mrs. Walter Shropshire
Mr. Malcolm E. Smith, Jr.
The Rev. & Mrs. John Snook, Jr.
Miss Dorothea L. Stubbe
Mrs. Vrylena 0. Syms
Professor Alfred Tissieres
Mrs. Beatrice Uzzo
Dr. James C. Wang
Dr. James D. Watson
Dr. Banice M. Webber
Mr. Robert A. Weisberg
Dr. Charles A. Werner
Mr. Taggart Whipple
Dr. Michael Wig ler
Dr. Anthony Yu
Mr. Robert J. Zindler
In memory of . . .
Jerome Baum
Gertrude Baumann
Mary Sleeper Bernard
Joseph Bertuca
Rosina Cox Boardman
Mary Clum
William Roger Deering
Cornelius Donovan
Jane Gudebrod
Norman J. Hertz
Helen H. Leckerling
Jeanne R. Leckerling
Edith I. Lewis
Dorothy Cooper Maguire
Robert H.P. Olney
Sigourney B. Olney
Elise LeHuray Cook Prout
Lois G. Shape
Anna M. Smirnow
Laura Dale Young
The LONG ISLAND BIOLOGICAL ASSOCIATION (LIBA)
and Its Relation to the Cold Spring Harbor Laboratory
Biological research at Cold Spring Harbor began in 1890 when the Brooklyn
Institute of Arts and Sciences was looking for a place to set up a summer
laboratory as the headquarters of its Department of Zoology. Representatives of
the Institute were invited by Eugene S. Blackford, at that time the Fish
Commissioner of the State of New York, to inspect a site on Bungtown Road
across Northern Boulevard (25A) from the Fish Hatchery. The site was found to be
ideal, and so the original Laboratory was organized with Mr. Blackford as
president of the Board of Trustees. The land was leased from Mr. John D. Jones,
whose family since 1819 had operated various industries including shipbuilding,
coopering, and textile manufacture (later whaling, also) at the head of Cold Spring
Harbor. Bungtown Road, which runs through the Lab property, got its name from
the factory that specialized in making bungs-or stoppers-for barrels.
In 1892 the Laboratory's land was leased for a dollar a year from the Wawepex
Society, which Mr. Jones had organized as a corporation for holding real estate
and for investing funds for the propagation of fishes and for scientific research. In
1904 the Wawepex Society leased additional land to the Carnegie Institution of
Washington, which wanted to locate a Department of Experimental Evolution in the
Cold Spring Harbor area. Charles B. Davenport, who had been directing the
Laboratory since 1896, assumed the additional duties of director of the Carnegie
Institution's experimental station. It is interesting to note that Mr. Davenport lived in
what came to be known later as the Carnegie Dormitory, the Victorian house on
25A built by John D. Jones before the turn of the century, and recently repainted
in its original colors.
The Long Island Biological Association was established in 1924 when the
Brooklyn Institute decided to discontinue its research at Cold Spring Harbor and
offered its laboratory to two universities. Fortunately, a local group of interested
neighbors decided to assume responsibility for the Lab, and thus LIBA came into
being. For 38 years LIBA actually operated the Laboratory in conjunction with the
Carnegie Institution, but in 1962 it seemed advisable for the Laboratory to be
reorganized as an independent unit. Therefore, the property on which it now
stands was conveyed to it by LIBA, which, however, still retains reversionary rights.
Today LIBA is one of twelve institutions participating in the support of the
Laboratory, each institution being represented on the Lab's Board of Trustees.
What has happened, in effect, is that LIBA has become an expanding group of
local "Friends of the Laboratory" who help support it through annual contributions.
Also, from time to time, the Association undertakes campaigns to finance special
important projects for which the Lab cannot obtain funds from the Federal
Government or from other sources. For instance, in recent years, building the
James Laboratory Annex and the renovation of Blackford Hall, the rebuilding of
Williams House, the acquisition of the land formerly belonging to the Carnegie
Institution, and (in part) the construction of the new Grace Auditorium.
The affairs of LIBA are handled by a board of 28 directors who are elected to
office by the membership at an annual meeting. LIBA members are invited to
bring their friends to lectures and open houses at the Laboratory.
Membership in LIBA requires a minimum annual contribution (tax deductible) of $25 for a family. Further information can
be obtained from the Long Island Biological Association, Box 100, Cold Spring Harbor, N.Y. 11724, or by telephoning the
Laboratory at (516) 367-8319.
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Officers
Mr. George W. Cutting, Jr., Chairman
Mrs. George N. Lindsay, Vice-Chairman
Mr. James A. Eisenman, Treasurer
Mrs. John R Campbell, Secretary
Mr. G. Morgan Browne, Asst. Secretary/Treasurer
Directors
Mrs. Donald Arthur
Mrs. Gilbert A. Ball
Mr. Samuel R. Callaway
Mr. Lionel Chaikin
Mrs. Miner D. Crary, Jr.
Mr. Arthur M. Crocker
Mr. Roderick Cushman
Mr. Lawrence L. Davis
Mr. Charles Dolan
Mrs. Duncan Elder
Mrs. Henry U. Harris, Jr.
Mrs. Sinclair Hatch
Mr. George J. Hossfeld, Jr.
Mrs. Warren C. Hutchins
Mrs. Walter C. Meier
Mr. Arthur C. Merrill
Mr. F. Warren Moore
Mr. William F. Payson
Mr. Edward Pulling
Mr. John R. Reese
Mr. Harvey E. Sampson
Mr. Byam K. Stevens, Jr.
Dr. James D. Watson
Mrs. Bradford Weekes Ill
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CHAIRMAN'S REPORT
My first year as Chairman has been a busy one. The retirement of Edward Pulling
necessitated reassignment of many tasks which he handled so effectively over the
years. Fortunately, he has been available to counsel me when I needed it.
We began the year by transferring $30,000 to the Laboratory to complete our
pledge to finance production of the video documentary The Biological Revolution:
100 Years of Science at Cold Spring Harbor. The video is an important tool for
increasing community awareness of the importance of Cold Spring Harbor to the
world of molecular biology. Copies of the 30-minute cassette are available for loan
or purchase from the Carnegie Library at the Laboratory.
At our winter Directors' meeting, we moved to increase our earlier pledge of
$110,000 to the Plant Genetics Program at Uplands Farm. Consequently, in April
we transferred $130,000 to the Laboratory for use in this project. LIBAs contribu-
tion has been a significant factor in establishing this research center which is
certain to play an important part in developing molecular biology in the plant field.
One of the immediate objectives is technology for a corn plant that is a more
effective food producer, particularly in arid areas.
In May LIBA members heard an authority on the AIDS virus, Dr. Robert Gallo
from the National Institutes of Health, give the Dorcas Cummings Memorial
Lecture. We read daily about the dangers of this killer virus.
LIBA members at Grace Auditorium dedication
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The Laboratory's Symposium, the LIBA dinner parties, and the dedication of
the Oliver and Lorraine Grace Auditorium began the most active summer of
meetings and courses in the laboratory's history with more than 3,600 participants.
At the dedication of the auditorium, Dr. Daniel E. Koshland, Jr., professor of
biochemistry at the University of California at Berkeley and editor of Science
magazine, spoke of the important function the facility will play in increasing the
interchange of ideas. We must remember that the Laboratory's importance
includes its function as an independent center for meetings and high level
courses, as well as its leadership role in research.
As a result of ongoing discussions with the Laboratory's administration
regarding its needs and LIBAs support role, two actions were taken. First, we
determined that the Laboratory must be able to offer grants to young scientists to
help them in their first year while they establish their research credentials to the
point where they can apply for competitive grants from foundations and
government agencies. To initiate the program we set out to fund four LIBA
Fellowships at $25,000 each. This program will give the LIBA membership a real
sense of participating in the direct suport of scientists at the Laboratory.
Second, although LIBA has traditionally supported capital projects at the
Laboratory, we determined that an organized annual effort would better serve the
Laboratory's needs. This decision led to two basic changes: 1) A "giving year"
beginning October 1 to meet the desires of the membership for tax planning and
2) Establishment of the Cold Spring Harbor Laboratory Associates. The Associates
Program gives special recognition to those who donate at a higher level
($1,000 or
more) and offers them the opportunity to expand their knowlege of molecular
biology through scientific briefings and hands-on workshops.
For the first time, therefore, we are reporting contributions
totalling $104,528.64
from 349 members during the year ending September 30, 1986.
Since then,
membership has risen to 500, including 84 Cold Spring Harbor Laboratory
Associates. Contributors since the beginning of the new giving year
will be listed
in next year's Annual Report.
I have greatly enjoyed representing the LIBA membership. I have particularly
enjoyed working with Jim Watson, Morgan Browne, and the
administration in
determining how LIBA can best serve the Laboratory.
George W. Cutting, Jr., Chairman
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Members
of the Long Island Biological Association
Mr. Amyas Ames
Mr. & Mrs. Hoyt Ammidon
Drs. Harold & Shirley Andersen
Mr. Santos Angeles
Mr. & Mrs. S. Reed Anthony
Mr. Robert W. Anthony
Mr. & Mrs. J.S. Armentrout
Mrs. Donald Arthur
Mrs. Robert W. Ayer
Mr & Mrs. Benjamin H Balkind
Mrs. Gilbert A. Ball
Mrs. George C. Barclay
Dr & Mrs. Henry Bard
Mr. John S. Barker
Mr. Edmund C. Bartlett
Mr. F Roberts Blair
Mrs. Mary Lenore Blair
Mrs. Margery Blumenthal
Mr. & Mrs. Allen L. Boorstein
Mr & Mrs. William Braden
Mrs. Leonie T. Brigham
Dr. & Mrs. Arik Brissenden
Mr & Mrs. F Sedgwick Browne
Mr. & Mrs. G. Morgan Browne
Mr & Mrs. James Bryan, Jr
Mr. & Mrs. Julian Buckley
Mr & Mrs. John Busby
Mr. Clarence Buxton
& Mrs. Samuel R. Callaway
Mr & Mrs. John P Campbell
Mr & Mrs. Ward C. Campbell
Miss Martha Worth Carder
Mr & Mrs. Thomas C. Cattrall
Centerbrook Associates
Mr & Mrs. Lionel Chaikin
Mr & Mrs. Gilbert W. Chapman, Jr
Mr. Harry G. Charlston
Mr. Paul J. Chase
Mrs. Helen Chenery
Mr. & Mrs. Anwar Chitayat
Mr. Jan S. Chock
Mr. & Mrs. David C. Clark
Mrs. Robert L. Clarkson
Dr & Mrs. Peter Cohn
Mr. & Mrs. Francis X. Coleman, Jr
Mr & Mrs. John H. Colemen
Mrs. John K. Colgate
Mr & Mrs. Patrick Collins
Mr. & Mrs. Joseph Conolly, Jr
Mrs. Christine Corey
& Mrs. Charles L. Craig
Mr & Mrs. Miner D. Crary, Jr.
Mrs. Ralph Crews
Mr. & Mrs. Arthur M. Crocker
Mr. & Mrs. Robert Cuddeback
Mr & Mrs. Robert L. Cummings
* (October 1, 1985-September 30, 1986)
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Mr. Robert L. Cummings, Ill
Mr & Mrs. Richard T. Cunniff
Mr. & Mrs. Roderick H. Cushman
Mr & Mrs. A. Neville Cutting
Mr. & Mrs. George W. Cutting, Jr.
Miss Lucy Cutting
Mr. Theodore Danforth
Mr & Mrs. Norris Darrell, Jr
Miss Katya Davey
Mr & Mrs. Lawrence L. Davis
Mrs. F Trubee Davison
Mr & Mrs. Raymond DeClairville
Dr. Thomas J. Degnan
Mr. Louis Delalio
Mr. & Mrs. Donald L. Deming
Mr. & Mrs. Douglas C. Despard, Jr.
Mr. & Mrs. Joseph C. Dey
Mr & Mrs. Charles F. Dolan
Mr & Mrs. Joseph P Downer
Mr. E. Richard Droesch
Dr & Mrs. Lester Dubnick
Mrs. Euguene Dubois
Mr & Mrs. James C. Dudley
Dr. & Mrs. John L. Duffy
Mr & Mrs. E.P. Dunlaevy
Dr & Mrs. Gerald L. Eastman
Dr. & Mrs. James D. Ebert
Mr & Mrs. Paul S. Eckhoff
Mr. & Mrs. James A. Eisenman
Mrs. Fred J. Eissler
Mr & Mrs. Duncan Elder
Mr. & Mrs. Ashton G. Eldredge
Mr. & Mrs. William Everdell
Mr. & Mrs. Joel M. Fairman
Mr & Mrs. Harold L. Fates
Mr. John R. Fell, Jr.
Mr. & Mrs. Joseph G. Fogg
Mr & Mrs. George S. Franklin, Jr
Mrs. Mary Freedman
Mr & Mrs. Jack B. Friedman
Mr. D. Kent Gale
Mr. & Mrs. Clarence E. Galston
Mr & Mrs. John W. Galston
Mrs. James E. Gardner Jr.
Mr. & Mrs. Robert B. Gardner, Jr
Mr & Mrs. Charles S. Gay
Mr & Mrs. David George
Mrs. John C. Gibbons
Mr & Mrs. Stephen E. Gilhuley
Dr. & Mrs. H. Bentley Glass
Mrs. J. Wooderson Glenn
Mr. & Mrs. Bernard Gloisten
Mr C.F. Gordon
Mr. & Mrs. Oliver R. Grace
Mr. & Mrs. Austen T. Gray
Mr & Mrs. Alfred T. Gregory
Mr. & Mrs. Sidney Hack
Mr. & Mrs. John W.B. Hadley
Dr. Elizabeth Hansen
Mr. & Mrs. Gordon Hargraves
Mr. & Mrs. Henry U. Harris
Mr & Mrs. Henry U. Harris, Jr
Dr. & Mrs. Chester Hartenstein
Mr. & Mrs. Rolf D. Hartmann
Mr & Mrs. Horace Havemeyer, Jr
Mr. & Mrs. Thomas M. Hearn
Mr. & Mrs. James E. Hellier
Mr. & Mrs. Charles L. Hewitt
Mr. & Mrs. Charles Hickmann
Mr & Mrs. Robert L. Hoguet
Mr. & Mrs. George Howard
Mr. & Mrs. Charles J. Hubbard
Mr. & Mrs. Philip G. Hull
Miss Clarine Hurdle
Mr. & Mrs. Warren Hutchins
Mrs. David Ingraham
Mr & Mrs. Frederic B. Ingraham
Mr. & Mrs. Valdemar F. Jacobsen
Mr. & Mrs. Irving D. Jakobson
Mr & Mrs. Robert D. Jay
Mrs. B. Brewster Jennings
Mr. & Mrs. L.S. Johnson
Mrs. Ruth B. Jordan
Mr. & Mrs. John Juda, Jr
Mrs. Morris I. Karpen
Dr. & Mrs. Francis Keil
Mrs. Walter Kernan
Miss Louis M. King
Mr & Mrs. Francis S. Kinney
Mr. & Mrs. Jeffrey Klein
Mr. & Mrs. Richard Kline
Mr Arthur Knapp
Mrs. Robert P Koenig
Mr. & Mrs. Jack Kolodny
Mr. & Mrs. Edward W. Kozlik
Mr. & Mrs. Paul Kramer
Mr. & Mrs. Morton Kunst ler
Mr & Mrs. Edward M. Lamont
Dr. Laurie Landeau
Mrs. Orin T Leach
Mr. & Mrs. Leslie S. Learned
Mrs. Randall J. LeBoeuf, Jr
Mr & Mrs. Henry C. Lee
Rev. & Mrs. T. Carleton Lee
Mr. Robert K. Lewis
Dr. Robert V. Lewis
Mr. & Mrs. George N. Lindsay, Jr
Mr & Mrs. Robert V. Lindsay
Capt. & Mrs. V.S. Littauer
Mr & Mrs. Robert F. Little
Mr. & Mrs. Angus Littlejohn
Mr & Mrs. John H. Livingston
Mr & Mrs. Candido V. Llovera
Mr. & Mrs. Alan J. Long
Mrs. Grace E. Lotowycz
Mrs. John F. MacKay
Mr & Mrs. Malcolm MacKay
Mr. & Mrs. Sayre MacLeod
Mr James N. Macri
Mr. & Mrs. Vincent Macri
Mrs. Henry R. Macy
Mr & Mrs. John Maroney
Mrs. John B. Marsh
Mr. Elias Martin
Mrs. John M. Martin
Mr & Mrs. Milward W. Martin, II
Mr. & Mrs. William H. Mathers
Mr & Mrs. Victor C. McCuaig
Mr & Mrs. Victor McElheny
Mr & Mrs. Angus P. McIntyre
Mr & Mrs. Randall P McIntyre
Mr & Mrs. Lawrence M. Mead
Dr & Mrs. Walter Meier
Mr Arthur C. Merrill
Mrs. Frances Meurer
Mr & Mrs. Leo M. Meyer
Mr. Richard W. Meyer
Mr & Mrs. Kennedy B. Middendorf
Mr & Mrs. Andrew 0. Miller
Mr & Mrs. William H. Miller
Mr. Dudley H. Mills
Mr & Mrs. George G. Montgomery, Jr
Mrs. F. Franklin Moon
Mr & Mrs. James D. Mooney, Jr
Mr & Mrs. F. Warren Moore
Mr & Mrs. George Morgese
Mr & Mrs. Grinnell Morris
Mr. Charles Morton
Mr. & Mrs. Frederick R. Moseley, Jr.
Mr & Mrs. Gardner M. Mundy
Mr. & Mrs. George Murnane
Mr & Mrs. Francis W. Murray
New York Community Trust
Mr & Mrs. John S. Nichols
Mr & Mrs. Adams H. Nickerson
Mrs. John W. Nields
Mr Lawrence W. Northam
North Country Garden Club
Mr & Mrs. Charles P Noyes
Mr & Mrs. David C. Noyes
Mr & Mrs. George D. O'Neill
Mr & Mrs. Richard B. Opsahl
Mr. Thomas Orne
Mr. & Mrs. Robert J. Osterhus
Mr & Mrs. Arthur W. Page, Jr.
Mr & Mrs. John H. Page
Mr & Mrs. Walter H. Page
Mr. & Mrs. Samuel D. Parkinson
Mr & Mrs. Nicholas Parks
Mr & Mrs. Joseph M. Parriott
Mr. & Mrs. William Parsons
Mr & Mrs. William Parsons, Jr.
Mr & Mrs. Fremont C. Peck
Mr & Mrs. William H. Peck
Mr & Mrs. Donald R. Peirce
Mr & Mrs. John M. Perkins
Mrs. Susan R. Peterson
Mrs. Richard Pierson
Mr & Mrs. Robert Pilkington
Mr & Mrs. James J. Pirtle
Mr & Mrs. Collier Platt
Mrs. Francis T.P. Plimpton
Mr & Mrs. Martin Pollak
& Mrs. Edward Everett Post
Mrs. H. Irving Pratt
Mr & Mrs. Richardson Pratt
Dr William Preston
Mr. Edward Pulling
Mr. Thomas L. Pulling
Mr & Mrs. Preston V. Pumphrey
Mr & Mrs. Tarrant Putnam
Mr. & Mrs. James T Pyle
Mr & Mrs. John R. Reese
Mr & Mrs. Willis L.M. Reese
Mr. A.G. Reid
Mrs. Cornelius J. Reid
Dr & Mrs. Robert M. Reiss
Mr. Bernard J. Reverdin
Mr & Mrs. John T Ricks
Mr & Mrs. George H. Roberts
Mr & Mrs. Samuel B. Rogers
Miss Elizabeth Roosevelt
Mrs. Philip J. Roosevelt
Mrs. Quenton Roosevelt
Mr & Mrs. Arthur W. Rossiter, Jr
Mr & Mrs. Walter N. Rothschild, Jr
Mrs. FE. Ruland
Dr. Claire A. Ryan
Mr & Mrs. Harold P Salembier
Mr & Mrs. Bernard Salzberg
Mr & Mrs. Harvey Sampson
Mr & Mrs. John K. Sands
Mr. Rudolph J. Santoro
Mr. & Mrs. Carl Schlanger
Dr & Mrs. Carl J. Schmidlapp
Dr. Irving M. Schneider
Mr & Mrs. Hermann G. Schwab
Mr & Mrs. David R. Schwarz
Mr & Mrs. Enrique Senior
Mr & Mrs. Frederick Seymour
Mr & Mrs. Marvin J. Sharfin
Dr & Mrs. Edward M. Shepard
Mr & Mrs. Robert Sheridan
Mr. Paul W. Siegert
Dr & Mrs. Paul Siminoff
Mr. & Mrs. Rowland G. Skinner
Mr. Richard Slade
Mr & Mrs. Robert Smirnow
Mr & Mrs. William G. Smith
Mr & Mrs. William S. Smoot
Mr & Mrs. Sedgwick Snedeker
Mr & Mrs. James Sommermeyer
Mr Thaddeus Spencer
Mr. & Mrs. Gerhard G. Spielmann
Mrs. Julian C. Stanley
Mr & Mrs. James F. Stebbins
Mr. David Stein
Mr & Mrs. Byam K. Stevens, Jr
Dr & Mrs. Kingsley M. Stevens
Mr & Mrs. John C. Stevenson
Mr & Mrs. Norman W. Stewart
Mr & Mrs. Richard Storrs
Mr & Mrs. Joseph S. Stout, Jr
Mr & Mrs. Richard Sykes
Mr & Mrs. John W. Taylor
Mr & Mrs. Daniel G. Tenney, Jr
Mr & Mrs. Dudley B. Tenney
Mr & Mrs. Charles R. Thompson
Mrs. Denyse D. Thors
Mr. & Mrs. Alexander Tomlinson
Mr & Mrs. George Toumanoff
Mr & Mrs. Martin B. Travis
Mr & Mrs. Bronson Trevor, Jr
Mr & Mrs. Stanley Trotman
Mrs. Ernest T. Turner
Mr. Wilfred 0. Uhl
Mr & Mrs. Stephen Van R. Ulman
Mrs. John F. Van Vranken
Dr & Mrs. Thornton Vandersall
Mr & Mrs. Martin Victor
Mr. Eric Von Raits
Mr. Oliver Wadsworth
Mr & Mrs. Colton P Wagner
Mrs. Robert P Walton
Mr & Mrs. Charles W.B. Wardell
Dr & Mrs. David E. Warden
Mrs. Ethelbert Warfield
Mr & Mrs. Bradford Warner
Mr & Mrs. Harold L. Warner
Mr & Mrs. Morris Wasser
Mrs. Bradford G. Weekes
Mr & Mrs. Bradford Weekes, Ill
Mr & Mrs. R. Ray Weekes
Mr. Townsend U. Weekes
Mr. John C. Weghorn
Mr & Mrs. L.B. Wehle, Jr
Mr & Mrs. Christian Wenk
Mr & Mrs. Taggart Whipple
Mr. Theodore S. Wickersham
Mr & Mrs. Douglas Williams
Mr & Mrs. Duane N. Williams
Mr & Mrs. Ichabod T. Williams
Mrs. John C. Wilmerding
Mrs. Henry Wingate
Mrs. Scudder Winslow
Mr. & Mrs. Frederick C. Witsell
Mrs. Helen C. Woodbridge
Mr & Mrs. James A. Woods
Mrs. Ethel Woolverton
Mr. William H. Woolverton, Jr
Miss Flavia Helen Wyeth
Mr & Mrs. Robert Young, Jr.
Mr. Robert Zakary
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Laboratory Staff
Research Staff
John Anderson
David Beach
Carmen Birchmeier
Daniel Broek
Fevzi Daldal
James Feramisco
Robert Franza
David Frendewey
James Garrels
Michael Gilman
Yakov Gluzman
Douglas Hanahan
Edward Harlow
David Helfman
Nouria Hernandez
Winship Herr
Andrew Hiatt
Amar Klar
Daniel Marshak
Michael Mathews
Elizabeth Moran
James Pflugrath
Scott Powers
Andrew Rice
David Spector
Bruce Stillman
Venkatesan Sundaresan
Takashi Toda
William Welch
Eileen White
Michael Wig ler
Mark Zoller
Postdoctoral Research Fellows
Dafna Bar-Sagi
Thomas Baumruker
Victoria Bautch
Ashok Bhagwat
Graeme Bolger
Robert Cafferkey
Dennis Carroll
Steven Cheley
James D. Watson, Director
G. Morgan Browne, Administrative Director
John P. Maroney, Assistant Administrative Director
William P. Keen, Comptroller
Jack Richards, Director Buildings & Grounds
Stephen J. Prentis, Executive Director of Publications and
Banbury Center Director
Richard J. Roberts, Assistant Director for Research
Terri I. Grodzicker, Assistant Director for Academic Affairs
John Colicelli
Roger Cone
Edgar Davidson
John Diffley
Giulio Draetta
Shimon Efrat
Susan Erster
Micaela Fairman
Kenneth Ferguson
Anne Fernandez-Solt
Jeffrey Field
JoAnne Figueiredo
Leslie Goodwin
Joan Harper
Wendy Heiger
Matthew Kostura
Adrian Krainer
Jeffrey Kuret
Eugenia Lamas
Jeremy Lamb
Michael Lambert
Patsy Lin
George Livi
Brenda Lowe
Avudaiappan Maran
Maureen McLeod
Tamar Michaeli
Lee Mizzen
Beat Mollet
Judy Potashkin
Karl Riabowol
William Ryan
Philip Sass
Margaret Sharma
Sreenath Sharma
Richard Sturm
Neil Sullivan
Masafumi Tanaka
Dallan Young
Genetics Research Unit
Carnegie Institution
of Washington
Alfred D. Hershey
Barbara McClintock
Visiting Scientists
Arie Admon
Andre-Patrick Arrigo
Loren Field
Seth Grant
Esa Kuismanen
Junichi Nikawa
Maragret Raybuck
Support Staff
Patricia Bird
Carol Marcincuk
Marilyn Goodwin
Mary Hannaford
James Kos
Laurie Lowman
Philip Renna
Joseph Suhan
Madeline Szadkowski
Barbara Weinkauff
Graduate Students
Susan Alpert
Robert Booher
Leonardo Brizuela
Karen Buchkovich
Scott Cameron
Mary Chapman
Paul Chomet
Christine Herrmann
Margaret Kelly
Lonny Levin
Duncan McVey
Kenneth Mel lits
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PublicationsLaboratory AidesRobert O'Malley
Brian Ondek Alison Beg leiter Nancy Ford
Gregory Prelich Glen Boyor Annette Kirk
Susan Smith Mitchell Cap lin
Carmel la Stephens Rodney Chisum Dorothy Brown
Peter Whyte Connie Hallaran Mary Cozza
Carrie-Ann Juiliano Judith Cuddihy
Sharon Losee Joan Ebert
Laboratory Technicians Thomas Mathews Michele Ferguson
Barbara Ahrens Vincent Meschan
Douglas Owen
Carmelita Bautista Sandra Penzi
Elizabeth Ritcey
Georgia Binns Bernadette Shenko
Marie Sullivan
Pauline Tanenholz
Gladys Blose
Cecile Chang
Jennifer Clarke Medium Makers
Michael Delannoy
Library/Marketing
Susan Allan
Amy Denton Rodrigo Elsin Susan Cooper
Barbara Faha Margaret Falkowski
Linda Finn LibraryMary Freedman
Kelly Flynn Kristine Duhamel
Richard Frank
Ronnie Packer Catherine Erb
Margaret Wallace
Jeffrey Hager Genemary Falvey
Patricia Hinton
Gloria Wilson Gordon Hubbard
Sajida Ismail Laura Hyman
Maria Jaramillo Melissa HymanElectronic Data
Karen Johnson Carol O'SheaProcessing Center
Amy Kamenick Wanda Stolen
Diane Kozak Michael Balamuth Marketing
Nancy Kronenberg
Gilda Mak Christopher Keller
Petra Durnin
Robert Pace Elaine GavegliaLisa Manche
Krystyna Marcinczak Peter Markiewicz
Amy Gibson
Robert McGuirk
Maureen Spirn
Jean Mclndoo
Lisa Miglio Safety and Core
Mary Mulcahy Facilities Service Accounting
Phyllis Myers Arthur Brings Accounting
Kathy O'Neill Guy Cozza
Maryellen Pizzolato Safety Mary Ellen Goldstein
Linda Rodgers Christopher Hubert Dorrine Lambert
Janet Ross Marlene Rubino Fred Lukas
Heidi Sacco Harris Animal Facility Patti Maroney
Nicholas Santoro Diane Biedermann Carlos Mendez
Monika Stein June Polistina
Sachiko Toda Lena DiLacio
Robert Tonner Carolyn O'Loughlin Fulfilment
Patricia Wendel Robert Williams Charlaine Apsel
Karin Weule Art Department Ann Felten
Jeanne Wiggins Michael Ockler Luigi Molinaro
Nicola Williamson Barbara TerryJonathan Wood David Greene
Research Associates Robert Borruso Jennifer Blovsky
Pedram Argani August Dulis Patricia Kurfess
Jean Roberts Grants
Susan SchultzTechnical Services
Shinta Cheng Clifford Sutkevich
Abhijeet-Jayant Le le
Ian Mohr
Development and
Public Affairs
David Mick los
Christine Bartels
Ellen Skaggs
Herb Parsons
Susan Zehl
Personnel and Meetings
William Putnam
Personnel
Cortney Armstrong
Jacqueline Maidel
Merilyn Simkins
Meetings
Maureen Berejka
Chris Brett
Karen Otto
Michela McBride
Diane Tighe
Barbara Ward
Purchasing
Peter Rice
Deon Baker
Nancy Baldwin
Sande Chmelev
Bruce Fahibusch
Robert Gensel
Charles Lamonte
John Lillie
Elissa Oliver
James Sabin
Central Administration
Roberta Salant
Andrea Stephenson
Buildings and Grounds
Administration
Peter Stahl
Barbara Cuff
Charles Schneider
Banbury Grounds and Maintenance
Daniel Miller
Christopher Kershow
Carpentry and Painting
Diamond Scarduzio
John Chilcott
Lawrence Daw
John Meyer
Joseph Pirnak
Paul Thomas
Custodial
Willie Gardner
Robert Brymer
Charles Gould
Michael Grant
George Leedham
Brian Leite
Daniel Jusino
Alfred Nickel
Donald Rose
Steven Tang
Electrical and Mechanical
Maintenance
Russell Allen
Robert Collins
Frank Messina
Owen Stewart
Grounds
Hans Trede
Vincent Carey
Joseph Ellis
John Robert Fuchs
Robert lwanejko
Christopher McEvoy
Harry Wozniak
Housekeeping
Dorothy Youngs
Rita Abrams
Carol Caldarelli
Turid Mikalsen
Barbara Robinson
Cherie Thurn
Plumbing
Lane Smith
Douglas Haskett
Security
Paul Anzalone
Frank Carberry
Banbury Center
Judith Blum
Dessie Carter
Katya Davey
Christopher Kershow
Beatrice To liver
Scientific Staff Departures
During 1986
Senior Staff Scientist
James Hicks
Senior Staff Investigators
Stephen Dellaporta
David Kurtz
Clive Slaughter
Staff Investigators
Stephen Hinton
Tohru Kataoka
Pablo Scolnick
Paul Thomas
Douglas Youvan
Visiting Scientists
Diane Esposito
Mark Homonoff
Krystyna-Slaska Kiss
Massimo Romani
Marcel lo Siniscalco
Postdoctoral Fellows
William Addison
Jychian Chen
Claude Dery
Robert Gerard
Giovanni Guiliano
Janet Hearing
Tohru Kamata
Yuriko Kataoka
Antal Kiss
Richard Kostriken
John Langstaff
Nora Sarvetnick
Petra Schumann
Marie Wooten
Bradley Zerler
Graduate Students
Edward Bylina
Christine Mitchell
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